PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gubb, J; Bloor, K				Gubb, James; Bloor, Karen			Should patients be able to pay top-up fee's to receive the treatment they want?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gubb, James] Civitas, Hlth Unit, London SW1P 2EZ, England; [Bloor, Karen] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Gubb, J (corresponding author), Civitas, Hlth Unit, London SW1P 2EZ, England.	james.gubb@civitas.org.uk; keb3@york.ac.uk		Bloor, Karen/0000-0003-4852-9854					0	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1104	1105		10.1136/bmj.39563.453183.AD	http://dx.doi.org/10.1136/bmj.39563.453183.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	302NM	18460556	Green Published			2022-12-28	WOS:000255975100036
J	Collins, PJ; Haire, LF; Lin, YP; Liu, JF; Russell, RJ; Walker, PA; Skehel, JJ; Martin, SR; Hay, AJ; Gamblin, SJ				Collins, Patrick J.; Haire, Lesley F.; Lin, Yi Pu; Liu, Junfeng; Russell, Rupert J.; Walker, Philip A.; Skehel, John J.; Martin, Stephen R.; Hay, Alan J.; Gamblin, Steven J.			Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants	NATURE			English	Article							IN-VITRO; A H5N1; SIALIC-ACID; INHIBITORS; DESIGN; SENSITIVITY; VARIANTS; ALTER	The potential impact of pandemic influenza makes effective measures to limit the spread and morbidity of virus infection a public health priority. Antiviral drugs are seen as essential requirements for control of initial influenza outbreaks caused by a new virus, and in pre- pandemic plans there is a heavy reliance on drug stockpiles. The principal target for these drugs is a virus surface glycoprotein, neuraminidase, which facilitates the release of nascent virus and thus the spread of infection. Oseltamivir (Tamiflu) and zanamivir ( Relenza) are two currently used neuraminidase inhibitors that were developed using knowledge of the enzyme structure(1,2). It has been proposed that the closer such inhibitors resemble the natural substrate, the less likely they are to select drug- resistant mutant viruses that retain viability(3). However, there have been reports of drug- resistant mutant selection in vitro(4) and from infected humans(5,6). We report here the enzymatic properties and crystal structures of neuraminidase mutants from H5N1- infected patients that explain the molecular basis of resistance. Our results show that these mutants are resistant to oseltamivir but still strongly inhibited by zanamivir owing to an altered hydrophobic pocket in the active site of the enzyme required for oseltamivir binding. Together with recent reports of the viability and pathogenesis of H5N1 ( ref. 7) and H1N1 ( ref. 8) viruses with neuraminidases carrying these mutations, our results indicate that it would be prudent for pandemic stockpiles of oseltamivir to be augmented by additional antiviral drugs, including zanamivir.	[Collins, Patrick J.; Haire, Lesley F.; Lin, Yi Pu; Liu, Junfeng; Walker, Philip A.; Skehel, John J.; Martin, Stephen R.; Hay, Alan J.; Gamblin, Steven J.] Natl Inst Med Res, MRC, London NW7 1AA, England; [Russell, Rupert J.] Univ St Andrews, Interdisciplinary Ctr Human & Avian Influenza Res, Sch Biol, St Andrews KY16 9ST, Fife, Scotland	MRC National Institute for Medical Research; University of St Andrews	Gamblin, SJ (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk		liu, junfeng/0000-0001-5825-5397; Gamblin, Steve/0000-0001-5331-639X	Medical Research Council [MC_U117512711, MC_U117584222, MC_U117512723] Funding Source: Medline; MRC [MC_U117512723, MC_U117584222, MC_U117512711] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER AT, 1987, PROTEINS, V2, P111, DOI 10.1002/prot.340020205; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives J, 2000, J CLIN VIROL, V18, P251; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lackenby A, 2008, EURO SURVEILL, V13; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Murphy B.R, 1996, FIELDS VIROLOGY, P1397; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005; Yen HL, 2007, J VIROL, V81, P12418, DOI 10.1128/JVI.01067-07	35	396	436	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 26	2008	453	7199					1258	U61		10.1038/nature06956	http://dx.doi.org/10.1038/nature06956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18480754	Bronze			2022-12-28	WOS:000257075800047
J	Hafting, T; Fyhn, M; Bonnevie, T; Moser, MB; Moser, EI				Hafting, Torkel; Fyhn, Marianne; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.			Hippocampus-independent phase precession in entorhinal grid cells	NATURE			English	Article							CORTEX LAYER-II; THETA-RHYTHM; PLACE CELLS; SUBTHRESHOLD OSCILLATIONS; PYRAMIDAL CELLS; SPATIAL MAP; EXPERIENCE; DYNAMICS; NEURONS; MODEL	Theta- phase precession in hippocampal place cells(1) is one of the best- studied experimental models of temporal coding in the brain. Theta- phase precession is a change in spike timing in which the place cell fires at progressively earlier phases of the extracellular theta rhythm as the animal crosses the spatially restricted firing field of the neuron(1-5). Within individual theta cycles, this phase advance results in a compressed replication of the firing sequence of consecutively activated place cells along the animal's trajectory(2,6-8), at a timescale short enough to enable spike-time-dependent plasticity between neurons in different parts of the sequence. The neuronal circuitry required for phase precession has not yet been established. The fact that phase precession can be seen in hippocampal output stuctures such as the prefrontal cortex(9) suggests either that efferent structures inherit the precession from the hippocampus or that it is generated locally in those structures. Here we show that phase precession is expressed independently of the hippocampus in spatially modulated grid cells(10,11) in layer II of medial entorhinal cortex, one synapse upstream of the hippocampus. Phase precession is apparent in nearly all principal cells in layer II but only sparsely in layer III. The precession in layer II is not blocked by inactivation of the hippocampus, suggesting that the phase advance is generated in the grid cell network. The results point to possible mechanisms for grid formation and raise the possibility that hippocampal phase precession is inherited from entorhinal cortex.	[Hafting, Torkel; Fyhn, Marianne; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway; [Hafting, Torkel; Fyhn, Marianne; Bonnevie, Tora; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Ctr Biol Memory, NO-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, NO-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Hafting, Torkel/0000-0002-0928-3487				ALONSO A, 1989, NATURE, V342, P175, DOI 10.1038/342175a0; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Dickson CT, 1997, NEUROSCIENCE, V81, P937, DOI 10.1016/S0306-4522(97)00263-7; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Erchova I, 2004, J PHYSIOL-LONDON, V560, P89, DOI 10.1113/jphysiol.2004.069930; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamam BN, 2000, J COMP NEUROL, V418, P457; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jones MW, 2005, HIPPOCAMPUS, V15, P867, DOI 10.1002/hipo.20119; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; Kloosterman F, 2003, J COMP NEUROL, V455, P156, DOI 10.1002/cne.10472; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schmitz D, 1998, NEUROSCIENCE, V85, P999, DOI 10.1016/S0306-4522(98)00113-4; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	30	293	294	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1248	U50		10.1038/nature06957	http://dx.doi.org/10.1038/nature06957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18480753				2022-12-28	WOS:000257075800045
J	Muller, B; Sheen, J				Muller, Bruno; Sheen, Jen			Cytokinin and auxin interaction in root stem-cell specification during early embryogenesis	NATURE			English	Article							ARABIDOPSIS RESPONSE REGULATORS; TOBACCO BY-2 CELLS; SIGNAL-TRANSDUCTION; DNA-BINDING; GENE; THALIANA; FAMILY; SHOOT; SCARECROW; MERISTEM	Plant stem-cell pools, the source for all organs, are first established during embryogenesis. It has been known for decades that cytokinin and auxin interact to control organ regeneration in cultured tissue(1). Auxin has a critical role in root stem-cell specification in zygotic embryogenesis(2,3), but the early embryonic function of cytokinin is obscure(4-6). Here, we introduce a synthetic reporter to visualize universally cytokinin output in vivo. Notably, the first embryonic signal is detected in the hypophysis, the founder cell of the root stem-cell system. Its apical daughter cell, the precursor of the quiescent centre, maintains phosphorelay activity, whereas the basal daughter cell represses signalling output. Auxin activity levels, however, exhibit the inverse profile. Furthermore, we show that auxin antagonizes cytokinin output in the basal cell lineage by direct transcriptional activation of ARABIDOPSIS RESPONSE REGULATOR genes, ARR7 and ARR15, feedback repressors of cytokinin signalling. Loss of ARR7 and ARR15 function or ectopic cytokinin signalling in the basal cell during early embryogenesis results in a defective root stem-cell system. These results provide a molecular model of transient and antagonistic interaction between auxin and cytokinin critical for specifying the first root stem-cell niche.	[Muller, Bruno; Sheen, Jen] Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Mol Biol, Massachusetts Gen Hosp,Dept Genet, Boston, MA 02114 USA.	mueller@molbio.mgh.harvard.edu; sheen@molbio.mgh.harvard.edu	Mueller, Bruno/E-9888-2017	Mueller, Bruno/0000-0003-2664-7219	NIGMS NIH HHS [R01 GM070567-04, R01 GM070567, R01 GM060493-08, R01 GM060493] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060493, R01GM070567] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aloni R, 2004, PLANTA, V220, P177, DOI 10.1007/s00425-004-1381-8; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Guilfoyle T, 1998, PLANT PHYSIOL, V118, P341, DOI 10.1104/pp.118.2.341; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Imamura A, 2003, PLANT CELL PHYSIOL, V44, P122, DOI 10.1093/pcp/pcg014; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Laureys F, 1998, FEBS LETT, V426, P29, DOI 10.1016/S0014-5793(98)00297-X; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lohar DP, 2004, PLANT J, V38, P203, DOI 10.1111/j.1365-313X.2004.02038.x; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Orchard CB, 2005, PLANT J, V44, P290, DOI 10.1111/j.1365-313X.2005.02524.x; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Rashotte AM, 2003, PLANT PHYSIOL, V132, P1998, DOI 10.1104/pp.103.021436; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Roslan HA, 2001, PLANT J, V28, P225, DOI 10.1046/j.1365-313X.2001.01146.x; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Sauer M, 2004, PLANT J, V40, P835, DOI 10.1111/j.1365-313X.2004.02248.x; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Weijers D, 2005, CURR OPIN PLANT BIOL, V8, P32, DOI 10.1016/j.pbi.2004.11.001; Weijers D, 2001, DEVELOPMENT, V128, P4289; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	36	465	490	6	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1094	U7		10.1038/nature06943	http://dx.doi.org/10.1038/nature06943			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18463635	Green Accepted			2022-12-28	WOS:000256839900055
J	Maris, JM; Mosse, YP; Bradfield, JP; Hou, CP; Monni, S; Scott, RH; Asgharzadeh, S; Attiyeh, EF; Diskin, SJ; Laudenslager, M; Winter, C; Cole, KA; Glessner, JT; Kim, C; Frackelton, EC; Casalunovo, T; Eckert, AW; Capasso, M; Rappaport, EF; McConville, C; London, WB; Seeger, RC; Rahman, N; Devoto, M; Grant, SFA; Li, HZ; Hakonarson, H				Maris, John M.; Mosse, Yael P.; Bradfield, Jonathan P.; Hou, Cuiping; Monni, Stefano; Scott, Richard H.; Asgharzadeh, Shahab; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Glessner, Joseph T.; Kim, Cecilia; Frackelton, Edward C.; Casalunovo, Tracy; Eckert, Andrew W.; Capasso, Mario; Rappaport, Eric F.; McConville, Carmel; London, Wendy B.; Seeger, Robert C.; Rahman, Nazneen; Devoto, Marcella; Grant, Struan F. A.; Li, Hongzhe; Hakonarson, Hakon			Chromosome 6p22 locus associated with clinically aggressive neuroblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARENTAL OCCUPATIONAL EXPOSURES; HIGH-RISK NEUROBLASTOMA; GENE AMPLIFICATION; GENOME; PREDISPOSITION; EPIDEMIOLOGY; CHEMOTHERAPY	Background: Neuroblastoma is a malignant condition of the developing sympathetic nervous system that most commonly affects young children and is often lethal. Its cause is not known. Methods: We performed a genomewide association study by first genotyping blood DNA samples from 1032 patients with neuroblastoma and 2043 control subjects of European descent using the Illumina HumanHap550 BeadChip. Samples from three independent groups of patients with neuroblastoma (a total of 720 patients) and 2128 control subjects were then genotyped to replicate significant associations. Results: We observed a significant association between neuroblastoma and the common minor alleles of three consecutive single-nucleotide polymorphisms (SNPs) at chromosome band 6p22 and containing the predicted genes FLJ22536 and FLJ44180 (P=1.71 x 10(-9) to 7.01 x 10(-10); allelic odds ratio, 1.39 to 1.40). Homozygosity for the at-risk G allele of the most significantly associated SNP, rs6939340, resulted in an increased likelihood of the development of neuroblastoma (odds ratio, 1.97; 95% confidence interval, 1.58 to 2.45). Subsequent genotyping of the three 6p22 SNPs in three independent case series confirmed our observation of an association (P=9.33 x 10(-15) at rs6939340 for joint analysis). Patients with neuroblastoma who were homozygous for the risk alleles at 6p22 were more likely to have metastatic (stage 4) disease (P=0.02), amplification of the MYCN oncogene in the tumor cells (P=0.006), and disease relapse (P=0.01). Conclusions: A common genetic variation at chromosome band 6p22 is associated with susceptibility to neuroblastoma.	[Maris, John M.; Mosse, Yael P.; Hou, Cuiping; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Rappaport, Eric F.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Maris, John M.; Mosse, Yael P.; Hou, Cuiping; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Rappaport, Eric F.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Bradfield, Jonathan P.; Glessner, Joseph T.; Kim, Cecilia; Frackelton, Edward C.; Casalunovo, Tracy; Eckert, Andrew W.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Capasso, Mario; Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Maris, John M.; Mosse, Yael P.; Hou, Cuiping; Attiyeh, Edward F.; Diskin, Sharon J.; Laudenslager, Marci; Winter, Cynthia; Cole, Kristina A.; Rappaport, Eric F.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Maris, John M.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Monni, Stefano; Devoto, Marcella; Li, Hongzhe] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Capasso, Mario; Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Scott, Richard H.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Asgharzadeh, Shahab; Seeger, Robert C.] Childrens Hosp Los Angeles, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Capasso, Mario] Univ Naples Federico II, Ctr Ingn Genet Biotecnol Avanzate, Naples, Italy; [McConville, Carmel] Univ Birmingham, Div Reprod & Child Hlth, Birmingham, W Midlands, England; [McConville, Carmel] Univ Birmingham, CRUK Inst Canc Studies, Birmingham, W Midlands, England; [London, Wendy B.] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [London, Wendy B.] Childrens Oncol Grp, Gainesville, FL 32611 USA; [Devoto, Marcella] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of London; Institute of Cancer Research - UK; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Naples Federico II; University of Birmingham; University of Birmingham; State University System of Florida; University of Florida; Children's Oncology Group (COG); Sapienza University Rome	Maris, JM (corresponding author), Childrens Hosp Philadelphia, Div Oncol, 907A,3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	maris@chop.edu; hakonarson@chop.edu	Cole, Kristina/M-3922-2015; Rappaport, Eric/GRO-4051-2022; Devoto, Marcella/AAP-7595-2021; Rahman, Nazneen/B-8890-2012; London, Wendy Beth/ABA-8948-2021; London, Wendy/ABD-4624-2021; Capasso, Mario/D-1617-2014; Rahman, Nazneen/D-2802-2013	London, Wendy Beth/0000-0003-3571-6538; Rahman, Nazneen/0000-0003-4376-0440; DEVOTO, MARCELLA/0000-0002-4431-5114; Glessner, Joseph/0000-0001-5131-2811; Capasso, Mario/0000-0003-3306-1259; Grant, Struan/0000-0003-2025-5302	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Medical Research Council [G0000934] Funding Source: Medline; NCI NIH HHS [R01-CA78454, R01 CA124709, U10 CA098543-06, U10 CA098543, R01 CA124709-01A2, R01-CA60104, U10-CA98543, R01 CA060104] Funding Source: Medline; NIEHS NIH HHS [R01 ES009911, R01-ES009911] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [U10CA098543, R01CA124709, R01CA060104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009911] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berthold F, 2005, LANCET ONCOL, V6, P649, DOI 10.1016/S1470-2045(05)70291-6; Brodeur G. M., 2006, PRINCIPLES PRACTICE, P933; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; De Roos AJ, 2001, AM J EPIDEMIOL, V154, P106, DOI 10.1093/aje/154.2.106; De Roos AJ, 2001, EPIDEMIOLOGY, V12, P508, DOI 10.1097/00001648-200109000-00008; George RE, 2005, J CLIN ONCOL, V23, P6466, DOI 10.1200/JCO.2005.05.582; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Longo L, 2007, HUM HERED, V63, P205, DOI 10.1159/000099997; LOOK AT, 1991, J CLIN ONCOL, V9, P581, DOI 10.1200/JCO.1991.9.4.581; Maris JM, 2005, PEDIAT ONCOL, P21; Maris JM, 2002, CANCER RES, V62, P6651; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Olshan AF, 1999, CANCER CAUSE CONTROL, V10, P539, DOI 10.1023/A:1008998925889; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Shojaei-Brosseau T, 2004, PEDIATR BLOOD CANCER, V42, P99, DOI 10.1002/pbc.10381; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Yang N, 2005, HUM GENET, V118, P382, DOI 10.1007/s00439-005-0012-1	26	211	219	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 12	2008	358	24					2585	2593		10.1056/NEJMoa0708698	http://dx.doi.org/10.1056/NEJMoa0708698			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311IJ	18463370	Green Accepted			2022-12-28	WOS:000256593600006
J	Bouatia-Naji, N; Rocheleau, G; Van Lommel, L; Lemaire, K; Schuit, F; Cavalcanti-Proenca, C; Marchand, M; Hartikainen, AL; Sovio, U; De Graeve, F; Rung, J; Vaxillaire, M; Tichet, J; Marre, M; Balkau, B; Weill, J; Elliott, P; Jarvelin, MR; Meyre, D; Polychronakos, C; Dina, C; Sladek, R; Froguel, P				Bouatia-Naji, Nabila; Rocheleau, Ghislain; Van Lommel, Leentje; Lemaire, Katleen; Schuit, Frans; Cavalcanti-Proenca, Christine; Marchand, Marion; Hartikainen, Anna-Liisa; Sovio, Ulla; De Graeve, Franck; Rung, Johan; Vaxillaire, Martine; Tichet, Jean; Marre, Michel; Balkau, Beverley; Weill, Jacques; Elliott, Paul; Jarvelin, Marjo-Riitta; Meyre, David; Polychronakos, Constantin; Dina, Christian; Sladek, Robert; Froguel, Philippe			A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; REGULATORY PROTEIN; DIABETES-MELLITUS; MORTALITY RISK; POPULATION; DISEASE; LOCUS	Several studies have shown that healthy individuals with fasting plasma glucose ( FPG) levels at the high end of the normal range have an increased risk of mortality. To identify genetic determinants that contribute to interindividual variation in FPG, we tested 392,935 single- nucleotide polymorphisms ( SNPs) in 654 normoglycemic participants for association with FPG, and we replicated the most strongly associated SNP ( rs560887, P = 4 x 10(-7)) in 9353 participants. SNP rs560887 maps to intron 3 of the G6PC2 gene, which encodes glucose- 6- phosphatase catalytic subunit- related protein ( also known as IGRP), a protein selectively expressed in pancreatic islets. This SNP was associated with FPG ( linear regression coefficient beta = -0.06 millimoles per liter per A allele, combined P = 4 x 10(-23)) and with pancreatic beta cell function ( Homa-B model, combined P = 3 x 10(-13)) in three populations; however, it was not associated with type 2 diabetes risk. We speculate that G6PC2 regulates FPG by modulating the set point for glucose- stimulated insulin secretion in pancreatic beta cells.	[Bouatia-Naji, Nabila; Cavalcanti-Proenca, Christine; Marchand, Marion; De Graeve, Franck; Vaxillaire, Martine; Meyre, David; Dina, Christian; Froguel, Philippe] Univ Lille 2, CNRS, Inst Biol, Pasteur Inst Lille,UMR 8090, F-59019 Lille, France; [Rocheleau, Ghislain; Rung, Johan; Polychronakos, Constantin; Sladek, Robert] McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3A 1A4, Canada; [Rocheleau, Ghislain; Rung, Johan; Polychronakos, Constantin; Sladek, Robert] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Van Lommel, Leentje; Lemaire, Katleen; Schuit, Frans] Katholieke Univ Leuven, Gene Express Unit, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Hartikainen, Anna-Liisa] Dept Obstet & Gynaecol, Oulu 90014, Finland; [Sovio, Ulla; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Tichet, Jean] Inst Inter Reg Sante IRSA, F-37520 La Riche, France; [Marre, Michel] Hop Xavier Bichat, INSERM, U695, F-75722 Paris, France; [Balkau, Beverley] Univ Paris Sud, INSERM, U780, IFR69, F-94807 Villejuif, France; [Weill, Jacques] Jean Flandre Hosp, Pediat Endocrine Unit, F-59037 Lille, France; [Jarvelin, Marjo-Riitta] Oulu Univ, Dept Publ Hlth & Gen Practice, Oulu 90014, Finland; [Polychronakos, Constantin] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3H 1P3, Canada; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; McGill University; KU Leuven; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite de Lille - ISITE; CHU Lille; University of Oulu; McGill University; Imperial College London	Froguel, P (corresponding author), Univ Lille 2, CNRS, Inst Biol, Pasteur Inst Lille,UMR 8090, F-59019 Lille, France.	p.froguel@imperial.ac.uk	Dina, Christian R/D-3535-2015; Meyre, David/D-7315-2011; Sovio, Ulla/H-8532-2019; Bouatia-Naji, Nabila/AGF-1400-2022; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019; BOUATIA-NAJI, NABILA/D-5863-2013; Polychronakos, Constantin/B-8151-2008	Dina, Christian R/0000-0002-7722-7348; Meyre, David/0000-0003-4850-7444; Sovio, Ulla/0000-0002-0799-1105; Bouatia-Naji, Nabila/0000-0001-5424-2134; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Rung, Johan/0000-0001-5875-8429; Marre, Michel/0000-0002-3071-1837; Polychronakos, Constantin/0000-0002-7624-6635	MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cuesta-Munoz AL, 2004, DIABETES, V53, P2164, DOI 10.2337/diabetes.53.8.2164; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Levitan EB, 2008, DIABETOLOGIA, V51, P267, DOI 10.1007/s00125-007-0882-y; Loos RJF, 2007, DIABETES, V56, P1943, DOI 10.2337/db07-0055; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Marz W, 2004, CIRCULATION, V109, P2844, DOI 10.1161/01.CIR.0000129306.44085.C4; Orho-Melander M, 2007, DIABETOLOGIA, V50, pS40; Panzer C, 2002, DIABETES, V51, P803, DOI 10.2337/diabetes.51.3.803; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Qiao Q, 2003, DIABETES CARE, V26, P688; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shieh JJ, 2004, FEBS LETT, V562, P160, DOI 10.1016/S0014-5793(04)00223-6; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	23	186	192	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1085	1088		10.1126/science.1156849	http://dx.doi.org/10.1126/science.1156849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18451265	Green Accepted			2022-12-28	WOS:000256059800048
J	Rosenzweig, C; Karoly, D; Vicarelli, M; Neofotis, P; Wu, QG; Casassa, G; Menzel, A; Root, TL; Estrella, N; Seguin, B; Tryjanowski, P; Liu, CZ; Rawlins, S; Imeson, A				Rosenzweig, Cynthia; Karoly, David; Vicarelli, Marta; Neofotis, Peter; Wu, Qigang; Casassa, Gino; Menzel, Annette; Root, Terry L.; Estrella, Nicole; Seguin, Bernard; Tryjanowski, Piotr; Liu, Chunzhen; Rawlins, Samuel; Imeson, Anton			Attributing physical and biological impacts to anthropogenic climate change	NATURE			English	Article							LONG-TERM CHANGES; DISCONTINUOUS PERMAFROST; PHENOLOGY; VARIABILITY; RETREAT; TRENDS	Significant changes in physical and biological systems are occurring on all continents and in most oceans, with a concentration of available data in Europe and North America. Most of these changes are in the direction expected with warming temperature. Here we show that these changes in natural systems since at least 1970 are occurring in regions of observed temperature increases, and that these temperature increases at continental scales cannot be explained by natural climate variations alone. Given the conclusions from the Intergovernmental Panel on Climate Change (IPCC) Fourth Assessment Report that most of the observed increase in global average temperatures since the mid-twentieth century is very likely to be due to the observed increase in anthropogenic greenhouse gas concentrations, and furthermore that it is likely that there has been significant anthropogenic warming over the past 50 years averaged over each continent except Antarctica, we conclude that anthropogenic climate change is having a significant impact on physical and biological systems globally and in some continents.	[Rosenzweig, Cynthia; Vicarelli, Marta; Neofotis, Peter] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Rosenzweig, Cynthia; Vicarelli, Marta; Neofotis, Peter] Columbia Ctr Climate Syst Res, New York, NY 10025 USA; [Karoly, David] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Wu, Qigang] Univ Oklahoma, Sch Meteorol, Norman, OK 73019 USA; [Casassa, Gino] Ctr Estudios Cient, Valdivia, Chile; [Menzel, Annette; Estrella, Nicole] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Root, Terry L.] Stanford Univ, Ctr Environm Sci & Policy, Stanford, CA 94305 USA; [Seguin, Bernard] INRA Unite Agroclim, F-84914 Avignon 9, France; [Tryjanowski, Piotr] Adam Mickiewicz Univ, Dept Behav Ecol, Inst Environm Biol, PL-61614 Poznan, Poland; [Liu, Chunzhen] China Water Informat Ctr, Beijing 100761, Peoples R China; [Rawlins, Samuel] Caribbean Epidemiol Ctr, Port Of Spain, Trinidad Tobago; [Imeson, Anton] 3D Environm Change, NL-1851 AM Heiloo, Netherlands	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Melbourne; University of Oklahoma System; University of Oklahoma - Norman; Technical University of Munich; Stanford University; INRAE; Adam Mickiewicz University	Rosenzweig, C (corresponding author), NASA, Goddard Inst Space Studies, 2800 Broadway, New York, NY 10025 USA.	crosenzweig@giss.nasa.gov	Tryjanowski, Piotr/C-1367-2009; Casassa, Gino/AAX-6142-2020; Menzel, Annette/B-1105-2013; Karoly, David J/C-8262-2011	Menzel, Annette/0000-0002-7175-2512; Karoly, David J/0000-0002-8671-2994; Estrella, Nicole/0000-0002-1028-0048				Asshoff R, 2006, GLOBAL CHANGE BIOL, V12, P848, DOI 10.1111/j.1365-2486.2006.01133.x; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaulieu N, 2003, CAN J EARTH SCI, V40, P1393, DOI 10.1139/E03-056; Bounoua L, 2002, CLIMATIC CHANGE, V52, P29, DOI 10.1023/A:1013051420309; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; Dyurgerov M.B., 2005, 58 U COL BOULD I ARC; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Feddema J, 2005, CLIM DYNAM, V25, P581, DOI 10.1007/s00382-005-0038-z; Forbes DL, 2004, MAR GEOL, V210, P169, DOI 10.1016/j.margeo.2004.05.009; Frauenfeld OW, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004245; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Giorgi F, 2002, CLIM DYNAM, V18, P675, DOI 10.1007/s00382-001-0204-x; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Menzel A, 2006, GLOBAL ECOL BIOGEOGR, V15, P498, DOI 10.1111/j.1466-822x.2006.00247.x; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Milly PCD, 2005, NATURE, V438, P347, DOI 10.1038/nature04312; Mitchell JFB, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P695; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Orviku K, 2003, J COASTAL RES, V19, P364; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Portner H.-O., 2022, CLIMATE CHANGE 2022, P3; Reichert BK, 2002, J CLIMATE, V15, P3069, DOI 10.1175/1520-0442(2002)015<3069:RGREIV>2.0.CO;2; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Root TL, 2005, P NATL ACAD SCI USA, V102, P7465, DOI 10.1073/pnas.0502286102; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Smith TM, 2005, J CLIMATE, V18, P2021, DOI 10.1175/JCLI3362.1; Solomon S., 2007, PHYS SCI BASIS WORKI; Sorvari S, 2002, GLOBAL CHANGE BIOL, V8, P171, DOI 10.1046/j.1365-2486.2002.00463.x; Stott PA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017324; Wu PL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021570; Yoshikawa K, 2003, PERMAFROST PERIGLAC, V14, P151, DOI 10.1002/ppp.451	39	895	934	9	649	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					353	U20		10.1038/nature06937	http://dx.doi.org/10.1038/nature06937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480817				2022-12-28	WOS:000255868400043
J	Zon, LI				Zon, Leonard I.			Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal	NATURE			English	Review							CANONICAL WNT PATHWAY; IN-VIVO; DEPENDENCE DISTINGUISHES; BETA-CATENIN; PROGENITOR PROLIFERATION; DEFINITIVE HEMATOPOIESIS; FUNCTIONAL ANTAGONISM; BMI1-DEFICIENT MICE; LINEAGE COMMITMENT; MYELOID-LEUKEMIA	When stem cells divide, they can generate progeny with the same developmental potential as the original cell, a process referred to as self-renewal. Self-renewal is driven intrinsically by gene expression in a cell-type-specific manner and is modulated through interactions with extrinsic cues from the environment, such as growth factors. However, despite the prevalence of the term self-renewal in the scientific literature, this process has not been defined at the molecular level. Haematopoietic stem cells are an excellent model for the study of self-renewal because they can be isolated prospectively, manipulated relatively easily and assessed by using well-defined assays. Establishing the principles of self-renewal in haematopoietic stem cells will lead to insights into the mechanisms of self-renewal in other tissues.	Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Zon, LI (corresponding author), Childrens Hosp, Stem Cell Program, Karp 7,1 Blackfan Circle, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bondos S., 2006, SCI STKE, V355, ppe38; Bowie MB, 2007, BLOOD, V109, P5043, DOI 10.1182/blood-2006-08-037770; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; CONGDON K, IN PRESS STEM CELLS; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Davidson AJ, 2003, NATURE, V425, P300, DOI 10.1038/nature01973; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Frohling S, 2007, CELL CYCLE, V6, P2241, DOI 10.4161/cc.6.18.4656; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Magnusson M, 2007, EXP HEMATOL, V35, P1421, DOI 10.1016/j.exphem.2007.05.011; Magnusson M, 2007, BLOOD, V109, P3687, DOI 10.1182/blood-2006-10-054676; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Ohta H, 2002, J EXP MED, V195, P759, DOI 10.1084/jem.20011911; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Petit-Cocault L, 2007, DEVELOPMENT, V134, P3031, DOI 10.1242/dev.001818; Pilon N, 2006, DEV BIOL, V289, P55, DOI 10.1016/j.ydbio.2005.10.005; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schnabel CA, 2000, ONCOGENE, V19, P608, DOI 10.1038/sj.onc.1203371; Shiotsugu J, 2004, DEVELOPMENT, V131, P2653, DOI 10.1242/dev.01129; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Walkley CR, 2005, NAT CELL BIOL, V7, P172, DOI 10.1038/ncb1214; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	100	214	220	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					306	313		10.1038/nature07038	http://dx.doi.org/10.1038/nature07038			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480811				2022-12-28	WOS:000255868400037
J	Ahn, TK; Avenson, TJ; Ballottari, M; Cheng, YC; Niyogi, KK; Bassi, R; Fleming, GR				Ahn, Tae Kyu; Avenson, Thomas J.; Ballottari, Matteo; Cheng, Yuan-Chung; Niyogi, Krishna K.; Bassi, Roberto; Fleming, Graham R.			Architecture of a charge-transfer state regulating light harvesting in a plant antenna protein	SCIENCE			English	Article							PHOTOSYSTEM-II; ENERGY-DISSIPATION; GREEN PLANTS; OXYGENIC PHOTOSYNTHESIS; TRANSIENT ABSORPTION; CATION FORMATION; COMPLEX; MECHANISM; PSBS; IDENTIFICATION	Energy- dependent quenching of excess absorbed light energy ( qE) is a vital mechanism for regulating photosynthetic light harvesting in higher plants. All of the physiological characteristics of qE have been positively correlated with charge transfer between coupled chlorophyll and zeaxanthin molecules in the light- harvesting antenna of photosystem II ( PSII). We found evidence for charge- transfer quenching in all three of the individual minor antenna complexes of PSII ( CP29, CP26, and CP24), and we conclude that charge- transfer quenching in CP29 involves a delocalized state of an excitonically coupled chlorophyll dimer. We propose that reversible conformational changes in CP29 can "tune" the electronic coupling between the chlorophylls in this dimer, thereby modulating the energy of the chlorophyll-zeaxanthin charge- transfer state and switching on and off the charge- transfer quenching during qE.	[Ballottari, Matteo; Bassi, Roberto] Univ Verona, Dept Sci & Technol, I-37134 Verona, Italy; [Ahn, Tae Kyu; Niyogi, Krishna K.; Fleming, Graham R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ahn, Tae Kyu; Avenson, Thomas J.; Cheng, Yuan-Chung; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ahn, Tae Kyu; Avenson, Thomas J.; Cheng, Yuan-Chung; Fleming, Graham R.] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Avenson, Thomas J.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Verona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bassi, R (corresponding author), Univ Verona, Dept Sci & Technol, I-37134 Verona, Italy.	bassi@sci.univr.it; grfleming@lbl.gov	Cheng, Yuan-Chung/A-6566-2008; Ballottari, Matteo/N-1916-2019; Ahn, Tae Kyu/A-5838-2013	Cheng, Yuan-Chung/0000-0003-0125-4267; Ballottari, Matteo/0000-0001-8410-3397; Ahn, Tae Kyu/0000-0002-7474-6513; bassi, roberto/0000-0002-4140-8446				Amarie S, 2007, J PHYS CHEM B, V111, P3481, DOI 10.1021/jp066458q; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Cinque G, 2000, BIOPHYS J, V79, P1706, DOI 10.1016/S0006-3495(00)76423-X; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dreuw A, 2003, PHYS CHEM CHEM PHYS, V5, P3247, DOI 10.1039/b304944b; Hagfeldt A, 2000, ACCOUNTS CHEM RES, V33, P269, DOI 10.1021/ar980112j; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Moore TA, 2002, PHILOS T R SOC B, V357, P1481, DOI 10.1098/rstb.2002.1147; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Rhee KH, 1997, NATURE, V389, P522, DOI 10.1038/39103; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406	27	437	444	15	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					794	797		10.1126/science.1154800	http://dx.doi.org/10.1126/science.1154800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467588	Green Submitted			2022-12-28	WOS:000255644400041
J	Kenfield, SA; Stampfer, MJ; Rosner, BA; Colditz, GA				Kenfield, Stacey A.; Stampfer, Meir J.; Rosner, Bernard A.; Colditz, Graham A.			Smoking and smoking cessation in relation to mortality in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPITHELIAL OVARIAN-CANCER; CIGARETTE-SMOKING; EPIDEMIOLOGIC EVIDENCE; COLORECTAL-CANCER; TOBACCO; RISK; PREVENTION	Context Smoking is associated with an increased risk of total and cause- specific death, but the rate of mortality risk reduction after quitting compared with continuing to smoke is uncertain. There is inadequate or insufficient evidence to infer the presence or absence of a causal relationship between smoking and ovarian cancer and colorectal cancer. Objective To assess the relationship between cigarette smoking and smoking cessation on total and cause- specific mortality in women. Design, Setting, and Participants Prospective observational study of 104 519 female participants in the Nurses' Health Study with follow- up from 1980 to 2004. Main Outcome Measure Hazard ratios ( HRs) for total mortality, further categorized into vascular and respiratory diseases, lung cancer, other cancers, and other causes. Results A total of 12 483 deaths occurred in this cohort, 4485 ( 35.9%) among never smokers, 3602 ( 28.9%) among current smokers, and 4396 ( 35.2%) among past smokers. Compared with never smokers, current smokers had an increased risk of total mortality ( HR, 2.81; 95% confidence interval [ CI], 2.68- 2.95) and all major cause- specific mortality. The HR for cancers classified by the 2004 surgeon general's report to be smoking- related was 7.25 ( 95% CI, 6.43- 8.18) and 1.58 ( 95% CI, 1.45- 1.73) for other cancers. Compared with never smokers, the HR for colorectal cancer was 1.63 ( 95% CI, 1.29- 2.05) for current smokers and 1.23 ( 95% CI, 1.02- 1.49) for former smokers. A significant association was not observed for ovarian cancer. Significant trends were observed for earlier age at initiation of smoking for total mortality ( P=. 003), respiratory disease mortality ( P=. 001), and all smoking- related cancer mortality ( P=. 001). The excess risk for all- cause mortality decreases to the level of a never smoker 20 years after quitting, with different time frames for risk reduction observed across outcomes. Approximately 64% of deaths among current smokers and 28% of deaths among former smokers were attributable to cigarette smoking. Conclusions Most of the excess risk of vascular mortality due to smoking in women may be eliminated rapidly upon cessation and within 20 years for lung diseases. Postponing the age of smoking initiation reduces the risk of respiratory disease, lung cancer, and other smoking- related cancer deaths but has little effect on other cause-specific mortality. These data suggest that smoking is associated with an increased risk of colorectal cancer mortality but not ovarian cancer mortality.	[Kenfield, Stacey A.; Stampfer, Meir J.; Rosner, Bernard A.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [Kenfield, Stacey A.; Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rosner, Bernard A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Rosner, Bernard A.] Harvard Univ, Sch Med, Boston, MA USA; [Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Washington University (WUSTL)	Kenfield, SA (corresponding author), Brigham & Womens Hosp, Channing Lab, Dept Med, 181 Longwood Ave,Room 452, Boston, MA 02115 USA.	skenfiel@hsph.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R25CA098566, T32CA009001, R01CA141298] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09001, T32 CA009001-33, R01 CA141298, R25CA098566, R25 CA098566, T32 CA009001, R25 CA098566-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BURNS DM, 1996, MONOGRAPH NATL CANC, V8, P113; *CDCP, 2004 YOUTH TOB SURV; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Green A, 2001, CANCER CAUSE CONTROL, V12, P713, DOI 10.1023/A:1011297403819; Holmes MD, 2007, INT J CANCER, V120, P2672, DOI 10.1002/ijc.22575; International Agency for Research on Cancer (IARC), 2007, REV RISK QUITT SMOK, V11; Johnston L. D., 2003, MONITORING FUTURE NA, V1; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Marchbanks PA, 2000, OBSTET GYNECOL, V95, P255, DOI 10.1016/S0029-7844(99)00531-1; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; ROBINS J, 1987, J CHRON DIS, V40, pS139, DOI 10.1016/S0021-9681(87)80018-8; ROBINS J, 1989, STAT MED, V8, P679, DOI 10.1002/sim.4780080608; Samet JM, 2007, EPIDEMIOLOGY, V18, P649, DOI 10.1097/EDE.0b013e3181271afa; SPARROW D, 1978, J CHRON DIS, V31, P425, DOI 10.1016/0021-9681(78)90006-1; Stead LF, 2000, TOB CONTROL, V9, P169, DOI 10.1136/tc.9.2.169; Sussman S, 1999, SUBST USE MISUSE, V34, P1469, DOI 10.3109/10826089909039411; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; *WHO, TOB ATL	25	261	272	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2037	2047		10.1001/jama.299.17.2037	http://dx.doi.org/10.1001/jama.299.17.2037			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460664	Green Accepted			2022-12-28	WOS:000255552700020
J	Kuipers, EJ; Surawicz, CM				Kuipers, Ernst J.; Surawicz, Christina M.			Clostridium difficile infection	LANCET			English	Editorial Material							DISEASE; METRONIDAZOLE; VANCOMYCIN; DIARRHEA; EPIDEMIOLOGY; STRAIN		[Kuipers, Ernst J.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Kuipers, Ernst J.] Erasmus MC Univ Med Ctr, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Surawicz, Christina M.] Univ Washington, Harborview Med Ctr, Sch Med, Div Gastroenterol,Dept Med, Seattle, WA 98104 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harborview Medical Center; University of Washington; University of Washington Seattle	Kuipers, EJ (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands.	e.j.kuipers@erasmusmc.nl	Kuipers, Ernst J/H-3293-2019; Smits, Wiep Klaas/A-8366-2008; Steer, Andrew C/C-2840-2013	Kuipers, Ernst J/0000-0002-0633-3098; Smits, Wiep Klaas/0000-0002-7409-2847; 				COHEN SH, IN PRESS INFECT CONT, P5231; Fernandez A, 2004, J CLIN GASTROENTEROL, V38, P414, DOI 10.1097/00004836-200405000-00005; Gerding DN, 2005, CLIN INFECT DIS, V40, P1598, DOI 10.1086/430317; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; McFarland LV, 2000, J PEDIATR GASTR NUTR, V31, P220, DOI 10.1097/00005176-200009000-00004; Miller MA, 2007, CLIN INFECT DIS, V45, pS122, DOI 10.1086/519257; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nelson R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub3; Numan SC, 2007, GUT, V56, P888, DOI 10.1136/gut.2006.119016; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Surawicz CM, 2000, CLIN INFECT DIS, V31, P1012, DOI 10.1086/318130; Wanahita A, 2003, AM J MED, V115, P543, DOI 10.1016/S0002-9343(03)00420-0; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265	19	48	51	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1486	1488		10.1016/S0140-6736(08)60635-2	http://dx.doi.org/10.1016/S0140-6736(08)60635-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456087				2022-12-28	WOS:000255668300008
J	Theoharides, TC				Theoharides, Theoharis C.			Mast cells and pancreatic cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Theoharides, Theoharis C.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA USA	Tufts University; Tufts Medical Center	Theoharides, TC (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.							Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x	5	53	54	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1860	1861		10.1056/NEJMcibr0801519	http://dx.doi.org/10.1056/NEJMcibr0801519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434656				2022-12-28	WOS:000255209200018
J	Keiser, J; Utzinger, J				Keiser, Jennifer; Utzinger, Juerg			Efficacy of current drugs against soil-transmitted helminth infections - Systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NEGLECTED TROPICAL DISEASES; RANDOMIZED CONTROLLED-TRIALS; HUMAN HOOKWORM INFECTIONS; NEMATODE INFECTIONS; ANTHELMINTIC EFFICACY; SOUTHERN REGION; CLINICAL-TRIALS; ALBENDAZOLE; MEBENDAZOLE; SCHISTOSOMIASIS	Context More than a quarter of the human population is likely infected with soil-transmitted helminths ( Ascaris lumbricoides, hookworm, and Trichuris trichiura) in highly endemic areas. Preventive chemotherapy is the mainstay of control, but only 4 drugs are available: albendazole, mebendazole, levamisole, and pyrantel pamoate. Objective To assess the efficacy of single- dose oral albendazole, mebendazole, levamisole, and pyrantel pamoate against A lumbricoides, hookworm, and T trichiura infections. Data Sources A systematic search of PubMed, ISI Web of Science, ScienceDirect, the World Health Organization library database, and the Cochrane Central Register of Controlled Trials ( 1960 to August 2007). Study Selection From 168 studies, 20 randomized controlled trials were included. Data Extraction and Data Synthesis Information on study year and country, sample size, age of study population, mean infection intensity before treatment, diagnostic method used, time between evaluations before and after treatment, cure rate ( the percentage of individuals who became helminth egg negative following treatment with an anthelminthic drug), egg reduction rate, adverse events, and trial quality was extracted. Relative risk, including a 95% confidence interval ( CI), was used to measure the effect of the drugs on the risk of infection prevalence with a random- effects model. Results Single- dose oral albendazole, mebendazole, and pyrantel pamoate for infection withAlumbricoides resulted in cure rates of 88%( 95% CI, 79%- 93%; 557 patients), 95% ( 95% CI, 91%- 97%; 309 patients), and 88%( 95% CI, 79%- 93%; 131 patients), respectively. Cure rates for infection with T trichiura following treatment with single- dose oral albendazole and mebendazole were 28% ( 95% CI, 13%- 39%; 735 patients) and 36% ( 95% CI, 16%- 51%; 685 patients), respectively. The efficacy of single- dose oral albendazole, mebendazole, and pyrantel pamoate against hookworm infections was 72% ( 95% CI, 59%- 81%; 742 patients), 15%( 95% CI, 1%- 27%; 853 patients), and 31%( 95% CI, 19%- 42%; 152 patients), respectively. Nopooled relative risks could be calculated for pyrantel pamoate against T trichiura and levamisole for any of the parasites investigated. Conclusions Single- dose oral albendazole, mebendazole, and pyrantel pamoate show high cure rates against A lumbricoides. For hookworm infection, albendazole was more efficacious than mebendazole and pyrantel pamoate. Treatment of T trichiura with single oral doses of current anthelminthics is unsatisfactory. New anthelminthics are urgently needed.	[Keiser, Jennifer] Swiss Trop Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland; [Utzinger, Juerg] Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Swiss Tropical & Public Health Institute	Keiser, J (corresponding author), Swiss Trop Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.	jennifer.keiser@unibas.ch						ABADI K, 1985, AM J TROP MED HYG, V34, P129, DOI 10.4269/ajtmh.1985.34.129; ABOO Oyediran, 1983, ROYAL SOC MED INT C, V57, P69; Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; Albonico M, 2002, T ROY SOC TROP MED H, V96, P685, DOI 10.1016/S0035-9203(02)90352-4; Albonico M, 2007, T ROY SOC TROP MED H, V101, P454, DOI 10.1016/j.trstmh.2006.09.003; [Anonymous], 2006, PREV CHEM HUM HELM C; Beach MJ, 1999, AM J TROP MED HYG, V60, P479, DOI 10.4269/ajtmh.1999.60.479; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; BWIBO NO, 1984, ROYAL SOC MED INT C, V61, P47; Chege S W, 1974, East Afr Med J, V51, P60; Chien F. L., 1989, Tropical Biomedicine, V6, P133; DeClercq D, 1997, AM J TROP MED HYG, V57, P25, DOI 10.4269/ajtmh.1997.57.25; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dodoo A, 2007, LANCET, V370, P465, DOI 10.1016/S0140-6736(07)61211-2; ELMASRY NA, 1983, T ROY SOC TROP MED H, V77, P160, DOI 10.1016/0035-9203(83)90056-1; FARID Z, 1984, ROYAL SOC MED INT C, V61, P31; Flohr C, 2007, AM J TROP MED HYG, V76, P732, DOI 10.4269/ajtmh.2007.76.732; GATTI F, 1972, Annales de la Societe Belge de Medecine Tropicale, V52, P19; Georgiev VS, 2000, EXPERT OPIN INV DRUG, V9, P1065, DOI 10.1517/13543784.9.5.1065; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; Horton J, 2000, PARASITOLOGY, V121, pS113, DOI 10.1017/S0031182000007290; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; ISMAIL M M, 1991, Ceylon Medical Journal, V36, P162; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; KALE OO, 1977, AFR J MED MED SCI, V6, P89; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Keiser J, 2007, CURR OPIN INFECT DIS, V20, P605, DOI 10.1097/QCO.0b013e3282f19ec4; Kolaczinski JH, 2007, TRENDS PARASITOL, V23, P485, DOI 10.1016/j.pt.2007.08.007; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Montresor A, 2007, T ROY SOC TROP MED H, V101, P773, DOI 10.1016/j.trstmh.2007.04.008; Montresor A., 2002, HELMINTH CONTROL SCH; Morgan P, 1983, MED Q J MED ASS MALA, V1, P4; Olds GR, 1999, J INFECT DIS, V179, P996, DOI 10.1086/314686; OVEDOFF DL, 1984, ROYAL SOC MED INT C, V61, P103; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Sacko M, 1999, T ROY SOC TROP MED H, V93, P195, DOI 10.1016/S0035-9203(99)90306-1; Sinniah B., 1990, Tropical Biomedicine, V7, P129; STEPHENSON LS, 1990, T ROY SOC TROP MED H, V84, P277, DOI 10.1016/0035-9203(90)90286-N; TEESDALE CH, 1986, ANN TROP MED PARASIT, V80, P565, DOI 10.1080/00034983.1986.11812067; THIENPONT D, 1969, AM J TROP MED HYG, V18, P520, DOI 10.4269/ajtmh.1969.18.520; UPATHAM ES, 1989, INT J PARASITOL, V19, P217, DOI 10.1016/0020-7519(89)90010-6; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; *WHO, 1997, US ESS DRUGS MOD LIS; Xiao SH, 2005, ACTA TROP, V94, P1, DOI 10.1016/j.actatropica.2005.01.013; Xiao Shu-hua, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P372; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5; 1998, MED LETT DRUGS THER, V40, P1; 1998, MED LETT DRUGS THER, V40, P28	54	545	568	3	103	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1937	1948		10.1001/jama.299.16.1937	http://dx.doi.org/10.1001/jama.299.16.1937			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291AD	18430913				2022-12-28	WOS:000255163800028
J	Obonyo, CO; Omondi, DSA; Mwinzi, PN				Obonyo, Charles O.; Omondi, Dickens S. A.; Mwinzi, Pauline N.			Public-health crisis after the election violence in Kenya	LANCET			English	Editorial Material									[Obonyo, Charles O.; Mwinzi, Pauline N.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu 40100, Kenya; [Omondi, Dickens S. A.] New Nyanza Prov Hosp, Kisumu, Kenya	Kenya Medical Research Institute	Obonyo, CO (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu 40100, Kenya.	Cobonyo@kisian.mimcom.net	Obonyo, Charles/AAX-5992-2020	Obonyo, Charles/0000-0003-0741-8533				Human Rights Watch, 2008, BALL B ORG POL VIOL; *IND MED UN, 2008, FOR INV POST EL VIOL; NYASATO R, 2008, STANDARD NAIROB 0318; *WHO, 2008, RAP ASS HLTH SIT NEE; *WHO, 2008, EM RESP CRIS KEN REV; World Health Organization, 2008, COMM DIS RISK ASS IN	6	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1319	1321		10.1016/S0140-6736(08)60575-9	http://dx.doi.org/10.1016/S0140-6736(08)60575-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291PE	18424311				2022-12-28	WOS:000255208500008
J	Gambotto, A; Barratt-Boyes, SM; de Jong, MD; Neumann, G; Kawaoka, Y				Gambotto, Andrea; Barratt-Boyes, Simon M.; de Jong, Menno D.; Neumann, Gabriele; Kawaoka, Yoshihiro			Human infection with highly pathogenic H5N1 influenza virus	LANCET			English	Review							ANTIVIRAL CYTOKINE RESPONSES; PROTECTIVE IMMUNE-RESPONSES; RECEPTOR-BINDING PROPERTIES; HEALTH-CARE WORKERS; SINGLE AMINO-ACID; AVIAN-INFLUENZA; A H5N1; HONG-KONG; DNA VACCINE; PANDEMIC INFLUENZA	Highly pathogenic H5N1 influenza A viruses have spread relentlessly across the globe since 2003, and they are associated with widespread death in poultry, substantial economic loss to farmers, and reported infections of more than 300 people with a mortality rate of 60%. The high pathogenicity of H5N1 influenza viruses and their capacity for transmission from birds to human beings has raised worldwide concern about an impending human influenza pandemic similar to the notorious H1N1 Spanish influenza of 1918. Since many aspects of H5N1 influenza research are rapidly evolving, we aim in this Seminar to provide an up-to-date discussion on select topics of interest to influenza clinicians and researchers. We summarise the clinical features and diagnosis of infection and present therapeutic options for H5N1 infection of people. We also discuss ideas relating to virus transmission, host restriction, and pathogenesis. Finally, we discuss vaccine development in view of the probable importance of vaccination in pandemic control.	[Gambotto, Andrea] Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Pittsburgh, PA 15219 USA; [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Mol Genet, Div Infect Dis, Pittsburgh, PA 15219 USA; [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Biochem, Div Infect Dis, Pittsburgh, PA 15219 USA; [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Med,Div Infect Dis, Pittsburgh, PA 15219 USA; [Barratt-Boyes, Simon M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Barratt-Boyes, Simon M.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA USA; [Barratt-Boyes, Simon M.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [de Jong, Menno D.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Neumann, Gabriele; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Tokyo, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Amsterdam; Academic Medical Center Amsterdam; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	Gambotto, A (corresponding author), Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Suite 412,300 Technol Dr, Pittsburgh, PA 15219 USA.	agamb@pitt.edu		Barratt Boyes, Simon/0000-0002-8869-4945	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069282] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI069282, N01-AO-00042] Funding Source: Medline; Wellcome Trust [077078/Z/05/Z] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; [Anonymous], AV INFL SIT EG UPD; Apisarnthanarak A, 2004, EMERG INFECT DIS, V10, P1321; BAUM LG, 1990, ACTA HISTOCHEM, P35; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; BOSCH FX, 1979, VIROLOGY, V95, P197, DOI 10.1016/0042-6822(79)90414-8; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Bukreyev A, 2005, J VIROL, V79, P13275, DOI 10.1128/JVI.79.21.13275-13284.2005; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Cha TA, 2000, J CLIN MICROBIOL, V38, P839, DOI 10.1128/JCM.38.2.839-845.2000; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Christensen JP, 2000, J VIROL, V74, P11690, DOI 10.1128/JVI.74.24.11690-11696.2000; Chumpolbanchorn Kamlang, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P102; Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CLEMENTS ML, 1992, J CLIN MICROBIOL, V30, P655, DOI 10.1128/JCM.30.3.655-662.1992; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crawford J, 1999, VACCINE, V17, P2265, DOI 10.1016/S0264-410X(98)00494-0; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; Drape RJ, 2006, VACCINE, V24, P4475, DOI 10.1016/j.vaccine.2005.08.012; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fujimoto S, 1998, LANCET, V352, P873, DOI 10.1016/S0140-6736(98)12449-2; FURMINGER IGS, 1998, TXB INFLUENZA, P325; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Goto H, 2001, J VIROL, V75, P9297, DOI 10.1128/JVI.75.19.9297-9301.2001; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayden F, 2005, ANTIVIR THER, V10, P873; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Ito T, 2000, VET MICROBIOL, V74, P71, DOI 10.1016/S0378-1135(00)00167-X; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kang SM, 2003, J VIROL, V77, P9823, DOI 10.1128/JVI.77.18.9823-9830.2003; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kodihalli S, 1997, J VIROL, V71, P3391, DOI 10.1128/JVI.71.5.3391-3396.1997; Kodihalli S, 1999, J VIROL, V73, P2094, DOI 10.1128/JVI.73.3.2094-2098.1999; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Lakey DL, 1996, J INFECT DIS, V174, P838, DOI 10.1093/infdis/174.4.838; Latham T, 2001, J VIROL, V75, P6154, DOI 10.1128/JVI.75.13.6154-6165.2001; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Leneva IA, 2001, ANTIMICROB AGENTS CH, V45, P1216, DOI 10.1128/AAC.45.4.1216-1224.2001; Leneva IA, 2000, ANTIVIR RES, V48, P101, DOI 10.1016/S0166-3542(00)00123-6; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li SQ, 1999, J INFECT DIS, V179, P1132, DOI 10.1086/314713; LI SQ, 1993, J VIROL, V67, P6667, DOI 10.1128/JVI.67.11.6667-6673.1993; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lipatov AS, 2003, J VIROL, V77, P3816, DOI 10.1128/JVI.77.6.3816-3823.2003; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; LUO GX, 1993, VIRUS RES, V29, P141; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Maricich SM, 2004, PEDIATRICS, V114, pE626, DOI 10.1542/peds.2004-0143; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Murphy BR, 2001, FIELDS VIROLOGY, P435; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; NAKAJIMA S, 1980, VIROLOGY, V101, P450, DOI 10.1016/0042-6822(80)90458-4; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; O'Neill E, 2000, J GEN VIROL, V81, P2689, DOI 10.1099/0022-1317-81-11-2689; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Park MS, 2006, P NATL ACAD SCI USA, V103, P8203, DOI 10.1073/pnas.0602566103; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; ROBINSON HL, 1993, VACCINE, V11, P957, DOI 10.1016/0264-410X(93)90385-B; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; SCHULMAN JL, 1977, J VIROL, V24, P170, DOI 10.1128/JVI.24.1.170-176.1977; Schultsz C, 2005, EMERG INFECT DIS, V11, P1158; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; STEINHAUER DA, 1991, VIROLOGY, V184, P445, DOI 10.1016/0042-6822(91)90867-B; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 2000, REV MED VIROL, V10, P337, DOI 10.1002/1099-1654(200009/10)10:5&lt;337::AID-RMV292&gt;3.0.CO;2-V; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; SUGIURA A, 1980, VIROLOGY, V101, P440, DOI 10.1016/0042-6822(80)90457-2; Swayne DE, 2005, AVIAN DIS, V49, P81, DOI 10.1637/7260-081104R; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Treanor JJ, 1996, J INFECT DIS, V173, P1467, DOI 10.1093/infdis/173.6.1467; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; ULMER JB, 1994, VACCINE, V12, P1541, DOI 10.1016/0264-410X(94)90081-7; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Veits J, 2006, P NATL ACAD SCI USA, V103, P8197, DOI 10.1073/pnas.0602461103; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; WEBSTER RG, 1994, VACCINE, V12, P1495, DOI 10.1016/0264-410X(94)90071-X; Wesley RD, 2004, VACCINE, V22, P3427, DOI 10.1016/j.vaccine.2004.02.040; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Williman J, 2006, VACCINE, V24, P4471, DOI 10.1016/j.vaccine.2005.08.011; Wood JM, 2001, PHILOS T R SOC B, V356, P1953, DOI 10.1098/rstb.2001.0981; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731; Yen HL, 2005, J INFECT DIS, V192, P665, DOI 10.1086/432008; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhou JF, 2006, J INFECT DIS, V193, P945, DOI 10.1086/500954; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	167	239	265	0	53	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1464	1475		10.1016/S0140-6736(08)60627-3	http://dx.doi.org/10.1016/S0140-6736(08)60627-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440429				2022-12-28	WOS:000255440600028
J	Yang, L; Soonpaa, MH; Adler, ED; Roepke, TK; Kattman, SJ; Kennedy, M; Henckaerts, E; Bonham, K; Abbott, GW; Linden, RM; Field, LJ; Keller, GM				Yang, Lei; Soonpaa, Mark H.; Adler, Eric D.; Roepke, Torsten K.; Kattman, Steven J.; Kennedy, Marion; Henckaerts, Els; Bonham, Kristina; Abbott, Geoffrey W.; Linden, R. Michael; Field, Loren J.; Keller, Gordon M.			Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population	NATURE			English	Article							SMOOTH-MUSCLE; HEART; SPECIFICATION; DIFFERENTIATION; PROLIFERATION; CARDIOGENESIS; REQUIREMENT; EXPRESSION	The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages(1). To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDRlow/C-KIT (CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR low/C-KIT neg cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDRlow/C-KITneg fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colonyforming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.	[Yang, Lei; Adler, Eric D.; Linden, R. Michael; Keller, Gordon M.] Mt Sinai Sch Med, Dept Gene & Cell Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Soonpaa, Mark H.; Field, Loren J.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Roepke, Torsten K.; Abbott, Geoffrey W.] Cornell Univ, Greenberg Div Cardiol, Dept Med, Weill Med Coll, New York, NY 10021 USA; [Roepke, Torsten K.; Abbott, Geoffrey W.] Cornell Univ, Greenberg Div Cardiol, Dept Pharmacol, Weill Med Coll, New York, NY 10021 USA; [Kattman, Steven J.; Kennedy, Marion; Keller, Gordon M.] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Henckaerts, Els; Linden, R. Michael] Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [Bonham, Kristina] VistaGen Therapeut Inc, San Francisco, CA 94080 USA	Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University-Purdue University Indianapolis; Cornell University; Cornell University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of London; King's College London	Keller, GM (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, Black Family Stem Cell Inst, 1425 Madison Ave, New York, NY 10029 USA.	gkeller@uhnresearch.ca	Henckaerts, Els/S-2727-2018; Yang, Lei/D-7462-2015	Abbott, Geoffrey/0000-0003-4552-496X; Henckaerts, Els Jeanny V/0000-0002-4624-7856; Keller, Gordon/0000-0001-9309-9297	NHLBI NIH HHS [R01 HL079275, R01 HL083126-03, R01 HL083126] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083126, R01HL079275] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; BRADY G, 1993, METHOD ENZYMOL, V225, P611; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; CONLON FL, 1994, DEVELOPMENT, V120, P1919; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; KONARZEWSKA H, 1995, CIRCULATION, V92, P1179, DOI 10.1161/01.CIR.92.5.1179; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meyer D, 1997, DEVELOPMENT, V124, P3575; Meyer T, 2004, DRUG SAFETY, V27, P763, DOI 10.2165/00002018-200427110-00002; MIMA T, 1995, P NATL ACAD SCI USA, V92, P467, DOI 10.1073/pnas.92.2.467; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Rubart M, 2007, NAT BIOTECHNOL, V25, P993, DOI 10.1038/nbt0907-993; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; SHIBATA EF, 1989, AM J PHYSIOL, V257, pH1773, DOI 10.1152/ajpheart.1989.257.6.H1773; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	30	1063	1154	1	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					524	U6		10.1038/nature06894	http://dx.doi.org/10.1038/nature06894			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18432194				2022-12-28	WOS:000256023700043
J	Duce, RA; LaRoche, J; Altieri, K; Arrigo, KR; Baker, AR; Capone, DG; Cornell, S; Dentener, F; Galloway, J; Ganeshram, RS; Geider, RJ; Jickells, T; Kuypers, MM; Langlois, R; Liss, PS; Liu, SM; Middelburg, JJ; Moore, CM; Nickovic, S; Oschlies, A; Pedersen, T; Prospero, J; Schlitzer, R; Seitzinger, S; Sorensen, LL; Uematsu, M; Ulloa, O; Voss, M; Ward, B; Zamora, L				Duce, R. A.; LaRoche, J.; Altieri, K.; Arrigo, K. R.; Baker, A. R.; Capone, D. G.; Cornell, S.; Dentener, F.; Galloway, J.; Ganeshram, R. S.; Geider, R. J.; Jickells, T.; Kuypers, M. M.; Langlois, R.; Liss, P. S.; Liu, S. M.; Middelburg, J. J.; Moore, C. M.; Nickovic, S.; Oschlies, A.; Pedersen, T.; Prospero, J.; Schlitzer, R.; Seitzinger, S.; Sorensen, L. L.; Uematsu, M.; Ulloa, O.; Voss, M.; Ward, B.; Zamora, L.			Impacts of atmospheric anthropogenic nitrogen on the open ocean	SCIENCE			English	Review							MARINE PRIMARY PRODUCTION; ORGANIC NITROGEN; ATLANTIC-OCEAN; DEPOSITION; NUTRIENTS; FIXATION; SEA; DENITRIFICATION; TRENDS; INPUTS	Increasing quantities of atmospheric anthropogenic fixed nitrogen entering the open ocean could account for up to about a third of the ocean's external (nonrecycled) nitrogen supply and up to similar to 3% of the annual new marine biological production, similar to 0.3 petagram of carbon per year. This input could account for the production of up to similar to 1.6 teragrams of nitrous oxide (N2O) per year. Although similar to 10% of the ocean's drawdown of atmospheric anthropogenic carbon dioxide may result from this atmospheric nitrogen fertilization, leading to a decrease in radiative forcing, up to about two-thirds of this amount may be offset by the increase in N2O emissions. The effects of increasing atmospheric nitrogen deposition are expected to continue to grow in the future.	[Duce, R. A.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Duce, R. A.] Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; [LaRoche, J.; Langlois, R.; Oschlies, A.] Leibniz Inst Meereswissensch, D-24105 Kiel, Germany; [Altieri, K.] Rutgers State Univ, Inst Marine & Coastal Sci, Rutgers NOAA CMER Program, New Brunswick, NJ 08901 USA; [Arrigo, K. R.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Baker, A. R.; Liss, P. S.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Capone, D. G.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Cornell, S.] Univ Bristol, QUEST Earth Sci, Bristol BS8 1RJ, Avon, England; [Dentener, F.] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy; [Galloway, J.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Ganeshram, R. S.] John Murray Labs, Edinburgh EH9 3JW, Midlothian, Scotland; [Geider, R. J.; Moore, C. M.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Kuypers, M. M.] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Liu, S. M.] Ocean Univ China, Key Lab Marine Chem Theory & Technol, Minist Educ, Coll Chem & Chem Engn, Qingdao 266100, Peoples R China; [Middelburg, J. J.] Netherlands Inst Ecol, NL-4401 NT Yerseke, Netherlands; [Nickovic, S.] World Meteorol Org, Atmospher Res & Environm Programme, CH-1211 Geneva 2, Switzerland; [Pedersen, T.] Univ Victoria, Victoria, BC V8W 3P6, Canada; [Prospero, J.; Zamora, L.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Schlitzer, R.] Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; [Sorensen, L. L.] Univ Aarhus, Natl Environm Res Inst, DK-8000 Aarhus C, Denmark; [Uematsu, M.] Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; [Ulloa, O.] Univ Concepcion, Dept Oceanog, Ctr Invest Oceanog, COPAS, Concepcion, Chile; [Ulloa, O.] Univ Concepcion, Nucl Milenio EMBA, Concepcion, Chile; [Voss, M.] Leibnitz Inst Balt Sea Res, D-18119 Rostock, Germany; [Ward, B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; National Oceanic Atmospheric Admin (NOAA) - USA; Rutgers State University New Brunswick; Stanford University; University of East Anglia; University of Southern California; University of Bristol; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Virginia; University of Edinburgh; University of Essex; Max Planck Society; Ocean University of China; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Victoria; University of Miami; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Aarhus University; University of Tokyo; Universidad de Concepcion; Universidad de Concepcion; Princeton University	Duce, RA (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	rduce@ocean.tamu.edu	Altieri, Katye/GWV-4512-2022; Galloway, James N/C-2769-2013; Cornell, Sarah/A-6502-2011; Duce, Robert A/A-9917-2010; Altieri, Katye/M-5231-2014; Ulloa, Osvaldo/E-1821-2011; Oschlies, Andreas/F-9749-2012; Zamora, Lauren M/E-6972-2011; Sørensen, Lise Lotte/M-5054-2016; LISS, Peter S./A-8219-2013; Baker, Alex R/D-1233-2011; Prospero, Joseph/AAT-6996-2020; LaRoche, Julie/A-1109-2010; Cornell, Sarah/F-7003-2014; Middelburg, Jack/B-4951-2011	Altieri, Katye/0000-0002-6778-4079; Galloway, James N/0000-0001-7676-8698; Cornell, Sarah/0000-0003-4367-1296; Altieri, Katye/0000-0002-6778-4079; Ulloa, Osvaldo/0000-0002-9501-5576; Oschlies, Andreas/0000-0002-8295-4013; Zamora, Lauren M/0000-0002-0878-4378; Sørensen, Lise Lotte/0000-0002-9823-589X; Baker, Alex R/0000-0002-8365-8953; Cornell, Sarah/0000-0003-4367-1296; Middelburg, Jack/0000-0003-3601-9072; LaRoche, Julie/0000-0003-4809-6411; nickovic, slobodan/0000-0003-3603-5515; Moore, Mark/0000-0002-9541-6046; Geider, Richard/0000-0003-3276-047X; Langlois, Rebecca/0000-0002-8382-4448; Voss, Maren/0000-0002-5827-9062; Prospero, Joseph/0000-0003-3608-6160; Arrigo, Kevin/0000-0002-7364-876X	Natural Environment Research Council [quest010001, NE/F017359/1] Funding Source: researchfish; NERC [NE/F017359/1, quest010001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Baker AR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018518; Bange HW, 2006, ATMOS ENVIRON, V40, P198, DOI 10.1016/j.atmosenv.2005.09.030; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Broecker WS, 1991, GLOBAL BIOGEOCHEM CY, V5, P191, DOI 10.1029/91GB01421; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; CONKRIGHT ME, 2002, WORLD OCEAN ATLAS 20, V4; CORNELL SE, 2003, ATMOS ENVIRON, V37, P2713; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Duarte CM, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000140; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; DUCKLOW HW, 1995, REV GEOPHYS, V33, P1271, DOI 10.1029/95RG00130; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Dyhrman ST, 2006, NATURE, V439, P68, DOI 10.1038/nature04203; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 1996, BIOGEOCHEMISTRY, V35, P3, DOI 10.1007/BF02179823; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Gnanadesikan A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001940; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Jickells T, 2006, BIOGEOSCIENCES, V3, P271, DOI 10.5194/bg-3-271-2006; Jin X, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018458; Krishnamurthy A, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000334; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Mace KA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002997; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; MICHAELS AF, 1993, GLOBAL BIOGEOCHEM CY, V7, P339, DOI 10.1029/93GB00178; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moore JK, 2006, TELLUS B, V58, P560, DOI 10.1111/j.1600-0889.2006.00209.x; Nakamura T, 2006, ATMOS ENVIRON, V40, P7259, DOI 10.1016/j.atmosenv.2006.06.026; Oschlies A, 2001, DEEP-SEA RES PT II, V48, P2173, DOI 10.1016/S0967-0645(00)00184-3; PAERL HW, 1985, NATURE, V315, P747, DOI 10.1038/315747a0; Prospero JM, 1996, BIOGEOCHEMISTRY, V35, P27, DOI 10.1007/BF02179824; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Sarmiento JL, 2002, SEA BIOL PHYSICAL IN, V12, P337; Schlitzer R, 2007, J PHYS OCEANOGR, V37, P259, DOI 10.1175/JPO3011.1; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Solomon S., 2007, PHYS SCI BASIS WORKI	42	748	803	21	546	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					893	897		10.1126/science.1150369	http://dx.doi.org/10.1126/science.1150369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487184	Green Submitted			2022-12-28	WOS:000255868300032
J	Offit, PA				Offit, Paul A.			Vaccines and autism revisited - The Hannah Poling case	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.							[Anonymous], 2002, IMMUNIZATION SAFETY; Dingle JH., 1964, STUDY 25000 ILLNESSE; Offit PA, 2002, PEDIATRICS, V109, P124, DOI 10.1542/peds.109.1.124; ROVNER J, 2008, CASE STOKES DEBATE A	4	46	48	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2089	2091		10.1056/NEJMp0802904	http://dx.doi.org/10.1056/NEJMp0802904			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480200				2022-12-28	WOS:000255849300001
J	Wise, J				Wise, Jacqui			Everyone's a radiologist now	BRITISH MEDICAL JOURNAL			English	Editorial Material												Jacquiyoung1@gmail.com						*AM I ULTR MED, 2006, TRAIN GUID PHYS WHO; [Anonymous], 2005, ULTR TRAIN REC MED S; Bodenham AR, 2006, BRIT J ANAESTH, V96, P414, DOI 10.1093/bja/ael032; British Medical Ultrasound Society, BUS CAS PRACT TRAIN; Hertzberg BS, 2000, AM J ROENTGENOL, V174, P1221, DOI 10.2214/ajr.174.5.1741221; National Institite for Clinical Excellence, 2002, GUIDANCE USE ULTRASO; *ROYAL COLL RAD RO, RIGHT TEST RIGHT TIM; *U S CAR, ULTR DEV PUTS SOM CU; Ultrasound training by radiology departments for other medical specialties: resource implications and requirements, 2007, ULTR TRAIN RAD DEP O	9	22	22	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1041	1043		10.1136/bmj.39560.444468.AD	http://dx.doi.org/10.1136/bmj.39560.444468.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18467410	Green Published			2022-12-28	WOS:000256103300024
J	Kerbel, RS				Kerbel, Robert S.			Molecular origins of cancer: Tumor angiogenesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOTHELIAL GROWTH-FACTOR; ANTIANGIOGENIC THERAPY; PROGENITOR CELLS; ANTI-VEGF; METRONOMIC CHEMOTHERAPY; EMBRYONIC LETHALITY; SURROGATE MARKER; DRUG-RESISTANCE; FACTOR RECEPTOR; BEVACIZUMAB		[Kerbel, Robert S.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Kerbel, Robert S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Kerbel, RS (corresponding author), Odette Canc Ctr, S-217,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca	Peng, Chunwei/F-6788-2010		NATIONAL CANCER INSTITUTE [R01CA041233] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA041233] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P6890, DOI 10.1073/pnas.1131491100; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bender JG, 2004, DRUG RESIST UPDATE, V7, P289, DOI 10.1016/j.drup.2004.09.001; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; BERENSON A, 2006, NY TIMES        0215; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bertolini F, 2003, CANCER RES, V63, P4342; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Blagosklonny MV, 2005, CANCER BIOL THER, V4, P1307, DOI 10.4161/cbt.4.12.2315; Bocci G, 2004, CANCER RES, V64, P6616, DOI 10.1158/0008-5472.CAN-04-0401; Browder T, 2000, CANCER RES, V60, P1878; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Conejo-Garcia JR, 2005, BLOOD, V105, P679, DOI 10.1182/blood-2004-05-1906; Dallas NA, 2007, CANCER METAST REV, V26, P433, DOI 10.1007/s10555-007-9070-2; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dong XW, 2007, CRIT REV ONCOL HEMAT, V62, P105, DOI 10.1016/j.critrevonc.2006.11.006; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Ellis LM, 2006, MOL CANCER THER, V5, P1099, DOI 10.1158/1535-7163.MCT-05-0538; Escudier B, 2007, NEW ENGL J MED, V357, P203; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Eskens FALM, 2006, EUR J CANCER, V42, P3127, DOI 10.1016/j.ejca.2006.09.015; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Garcia AA, 2008, J CLIN ONCOL, V26, P76, DOI 10.1200/JCO.2007.12.1939; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Grunewald M, 2006, CELL, V126, P811, DOI 10.1016/j.cell.2006.08.015; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Karashima T, 2007, INT J ONCOL, V30, P937; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Kerbel RS, 2006, SCIENCE, V312, P1171, DOI 10.1126/science.1125950; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kessler T, 2007, CURR DRUG TARGETS, V8, P257, DOI 10.2174/138945007779940089; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Klement G, 2006, J CLIN INVEST, V116, P3084, DOI 10.1172/JCI08829C1; Klement G, 2006, J CLIN INVEST, V116, P2827, DOI 10.1172/JCI08829C1; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; LLOVET J, 2007, P AM SOC CLIN ONCO S, V25, pS18; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mancuso P, 2006, BLOOD, V108, P452, DOI 10.1182/blood-2005-11-4570; Marx J, 2003, SCIENCE, V301, P1308, DOI 10.1126/science.301.5638.1308; Miller KD, 2003, ANN ONCOL, V14, P20, DOI 10.1093/annonc/mdg033; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Sandler A, 2007, NEW ENGL J MED, V356, P318; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2005, BLOOD, V106, P3058, DOI 10.1182/blood-2005-04-1422; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Siemann DW, 2004, CANCER-AM CANCER SOC, V100, P2491, DOI 10.1002/cncr.20299; Spring H, 2005, P NATL ACAD SCI USA, V102, P18111, DOI 10.1073/pnas.0507158102; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Willett CG, 2005, J CLIN ONCOL, V23, P8136, DOI 10.1200/JCO.2005.02.5635; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	106	1741	1859	2	304	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2039	2049		10.1056/NEJMra0706596	http://dx.doi.org/10.1056/NEJMra0706596			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463380	Green Accepted			2022-12-28	WOS:000255577700008
J	Albert, CM; Cook, NR; Gaziano, JM; Zaharris, E; MacFadyen, J; Danielson, E; Buring, JE; Manson, JE				Albert, Christine M.; Cook, Nancy R.; Gaziano, J. Michael; Zaharris, Elaine; MacFadyen, Jean; Danielson, Eleanor; Buring, Julie E.; Manson, JoAnn E.			Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREAL GRAIN FLOUR; PLASMA HOMOCYSTEINE; STROKE PREVENTION; MYOCARDIAL-INFARCTION; LOWERING HOMOCYSTEINE; VASCULAR-DISEASE; METAANALYSIS; SUPPLEMENTATION; RESTENOSIS; DESIGN	Context Recent randomized trials among patients with preexisting cardiovascular disease ( CVD) have failed to support benefits of B- vitamin supplementation on cardiovascular risk. Observational data suggest benefits may be greater among women, yet women have been underrepresented in published randomized trials. Objective To test whether a combination of folic acid, vitamin B6, and vitamin B12 lowers risk of CVD among high- risk women with and without CVD. Design, Setting, and Participants Within an ongoing randomized trial of antioxidant vitamins, 5442 women who were US health professionals aged 42 years or older, with either a history of CVD or 3 or more coronary risk factors, were enrolled in a randomized, double- blind, placebo- controlled trial to receive a combination pill containing folic acid, vitamin B6, and vitamin B12 or a matching placebo, and were treated for 7.3 years from April 1998 through July 2005. Intervention Daily intake of a combination pill of 2.5 mg of folic acid, 50 mg of vitamin B6, and 1 mg of vitamin B12. Main Outcome Measures A composite outcome of myocardial infarction, stroke, coronary revascularization, or CVD mortality. Results Compared with placebo, a total of 796 women experienced a confirmed CVD event ( 406 in the active group and 390 in the placebo group). Patients receiving active vitamin treatment had similar risk for the composite CVD primary end point ( 226.9/ 10 000 person- years vs 219.2/ 10 000 person- years for the active vs placebo group; relative risk [ RR], 1.03; 95% confidence interval [ CI], 0.90- 1.19; P=. 65), as well as for the secondary outcomes including myocardial infarction( 34.5/10 000 person-years vs 39.5/ 10 000 person years; RR, 0.87; 95% CI, 0.63- 1.22; P=. 42), stroke ( 41.9/ 10 000 person- years vs 36.8/ 10 000 person- years; RR, 1.14; 95% CI, 0.82- 1.57; P=. 44), and CVD mortality( 50.3/ 10 000 person- years vs 49.6/ 10 000 person- years; RR, 1.01; 95% CI, 0.76- 1.35; P=. 93). In a blood substudy, geometric mean plasma homocysteine level was decreased by 18.5%( 95% CI, 12.5%- 24.1%; P <. 001) in the active group ( n= 150) over that observed in the placebo group ( n= 150), for a difference of 2.27 mu mol/L ( 95% CI, 1.54- 2.96 mu mol/L). Conclusion After 7.3 years of treatment and follow- up, a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high- risk women, despite significant homocysteine lowering. Trial Registration clinicaltrials. gov Identifier: NCT00000541.	[Albert, Christine M.; Cook, Nancy R.; Gaziano, J. Michael; Zaharris, Elaine; MacFadyen, Jean; Danielson, Eleanor; Buring, Julie E.; Manson, JoAnn E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA; [Albert, Christine M.; Gaziano, J. Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiovasc Med, Boston, MA 02215 USA; [Gaziano, J. Michael; Buring, Julie E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA 02215 USA; [Gaziano, J. Michael] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Buring, Julie E.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; [Cook, Nancy R.; Buring, Julie E.; Manson, JoAnn E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Albert, CM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	calbert@partners.org		Albert, Christine/0000-0002-2081-1121	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL047959, R01HL046959] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL046959-12, R01 HL046959-13, HL47959, R01 HL046959-07, R01 HL046959-09, R01 HL046959-11, R01 HL046959, R01 HL046959-13S1, R01 HL046959-08, R01 HL046959-10] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bassuk SS, 2004, J WOMENS HEALTH, V13, P99, DOI 10.1089/154099904322836519; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 2002, ARTERIOSCL THROM VAS, V22, P488, DOI 10.1161/hq0302.105369; Bostom AG, 2001, ANN INTERN MED, V135, P133, DOI 10.7326/0003-4819-135-2-200107170-00014; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Carlsson CM, 2007, LANCET, V369, P1841, DOI 10.1016/S0140-6736(07)60830-7; Clarke R, 2006, AM HEART J, V151, P282, DOI 10.1016/j.ahj.2005.04.025; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Cook NR, 2007, ARCH INTERN MED, V167, P1610, DOI 10.1001/archinte.167.15.1610; Hak AE, 2000, ATHEROSCLEROSIS, V149, P163, DOI 10.1016/S0021-9150(99)00321-4; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lobo RA, 2003, MENOPAUSE, V10, P271, DOI 10.1097/01.GME.0000072222.06570.94; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507	23	375	411	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2027	2036		10.1001/jama.299.17.2027	http://dx.doi.org/10.1001/jama.299.17.2027			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460663	Green Accepted, Bronze			2022-12-28	WOS:000255552700019
J	Wharam, JF; Galbraith, AA; Kleinman, KP; Soumerai, SB; Ross-Degnan, D; Landon, BE				Wharam, J. Frank; Galbraith, Alison A.; Kleinman, Ken P.; Soumerai, Stephen B.; Ross-Degnan, Dennis; Landon, Bruce E.			Cancer screening before and after switching to a high-deductible health plan	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC DISEASE SCORE; LONGITUDINAL DATA-ANALYSIS; COLORECTAL-CANCER; INSURANCE COVERAGE; OFFICE VISIT; SERVICES; MAMMOGRAPHY; GUIDELINES	Background: Health plans with high deductibles could lead patients to avoid preventive care, such as cancer screening. Objective: To determine the effect of membership in a high-deductible health plan on cervical, breast, and colorectal cancer screening. Design: Before-after comparison between groups. Setting: A high-deductible health plan and an HMO in Massachusetts. The high-deductible health plan fully covered mammography Papanicolaou tests, and fecal occult blood testing (FOBT) but not colonoscopy, flexible sigmoidoscopy, or double-contrast barium enema (DCBE). Participants: 3169 high-deductible health plan members and 27 022 HMO members (who served as controls). Measurements: Change in the proportions of patients undergoing breast, cervical, and colorectal cancer screening. Results: Cancer screening in the high-deductible health plan group was unchanged from baseline to follow-up (adjusted ratios of change, 1.04 [95% CI, 0.91 to 1.191 for breast cancer, 1.04 [CI 0.92 to 1.17] for cervical cancer, and 1.02 [CI, 0.89 to 1.16] for colorectal cancer). High-deductible health plan members had colonoscopy, flexible sigmoidoscopy, and DCBE less often (ratio of change, 0.73 [CI, 0.56 to 0.95]) and FOBT more often (ratio of change, 1.16 [CI, 1.01 to 1.33]) than HMO members. Limitations: Population screening frequency was probably underestimated because the study could not assess screening before the baseline year. The study may have included people ineligible for screening because of previous colectomy, mastectomy, or hysterectomy. The findings are limited to a population with relatively high socioeconomic status, which is typical of employed, commercially insured populations. Conclusion: Members of a high-deductible health plan did not seem to change their use of breast, cervical, and colorectal cancer screening when tests were fully covered. However, members may have substituted a fully covered screening test (FOBT) for tests subject to the deductible (colonoscopy, flexible sigmoidoscopy, and DCBE).	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Wharam, JF (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jwharam@parttiers.org		Wharam, James/0000-0003-2053-0757; Kleinman, Ken/0000-0002-5600-5834				Anderson WF, 2002, JNCI-J NATL CANCER I, V94, P1126; BECK RG, 1980, MED CARE, V18, P787, DOI 10.1097/00005650-198008000-00001; BEEBE M, 2006, CPT 2007 STAND ED CU; Berg AO, 2002, ANN INTERN MED, V137, P129, DOI 10.7326/0003-4819-137-2-200207160-00014; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; BRIAN EW, 1974, MED CARE, V12, P1; Canadian Task Force on Preventive Health Care, 2001, CMAJ, V165, P206; CHERKIN DC, 1989, MED CARE, V27, P1036, DOI 10.1097/00005650-198911000-00005; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Davis Karen, 2004, Issue Brief (Commonw Fund), P1; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Fishman PA, 1999, MED CARE, V37, P874, DOI 10.1097/00005650-199909000-00004; Friedman C, 2002, MED CARE, V40, P1060, DOI 10.1097/00005650-200211000-00007; Gabel J, 2005, HEALTH AFFAIR, V24, P1273, DOI 10.1377/hlthaff.24.5.1273; Ginsburg PB, 2004, NEW ENGL J MED, V351, P1591, DOI 10.1056/NEJMp048159; *HEDIS, 2006, NQMC0011112 HEDIS; *HEDIS, 2006, NQMC001111 HEDIS; *HEDIS, 2005, NQMC001742 HEDIS; *HJ KAIS FAM FDN C, 2007, EMPL HLTH BEN 2007 A; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; JOHNSON RE, 1994, J CLIN EPIDEMIOL, V47, P1191, DOI 10.1016/0895-4356(94)90106-6; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Lee TH, 2005, NEW ENGL J MED, V353, P1202, DOI 10.1056/NEJMp058209; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liang SY, 2004, AM J MANAG CARE, V10, P99; Lohr K N, 1986, Med Care, V24, pS1; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Rice T, 1994, Med Care Rev, V51, P235, DOI 10.1177/107755879405100302; RODDY PC, 1986, MED CARE, V24, P873, DOI 10.1097/00005650-198609000-00009; Rowe JW, 2008, HEALTH AFFAIR, V27, P113, DOI 10.1377/hlthaff.27.1.113; RUBIN RJ, 1995, NEW ENGL J MED, V333, P733; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Shearer G, 2004, HEALTH SERV RES, V39, P1159, DOI 10.1111/j.1475-6773.2004.00280.x; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Solanki G, 2000, HEALTH SERV RES, V34, P1331; Solanki G, 1999, AM J PREV MED, V17, P127, DOI 10.1016/S0749-3797(99)00057-4; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; U.S. Bureau of Census, 1994, GEOGR AR REF MAN; *US PREV SERV TASK, 2003, REC RAT SCR CERV CAN; *US PREV SERV TASK, 2002, REC RAT SCR BREAST C; *US PREV SERV TASK, 2002, REC RAT SCR COL CANC; Varghese RK, 2005, CANCER EPIDEM BIOMAR, V14, P744, DOI 10.1158/1055-9965.EPI-04-0477; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	48	58	58	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					647	655		10.7326/0003-4819-148-9-200805060-00004	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458277				2022-12-28	WOS:000255731800002
J	Salmena, L; Carracedo, A; Pandolfi, PP				Salmena, Leonardo; Carracedo, Arkaitz; Pandolfi, Pier Paolo			Tenets of PTEN tumor suppression	CELL			English	Review							HEMATOPOIETIC STEM-CELLS; TENSIN-HOMOLOG; NUCLEAR PTEN; CELLULAR-TRANSFORMATION; PROMOTER METHYLATION; NEGATIVE REGULATION; MUTATIONAL SPECTRA; PROTEIN EXPRESSION; PROSTATE-CANCER; CYCLE ARREST	Since its discovery as the elusive tumor suppressor gene at the frequently mutated 10q23 locus, PTEN has been identified as lost or mutated in several sporadic and heritable tumor types. A decade of work has established that PTEN is a nonredundant phosphatase that is essential for regulating the highly oncogenic prosurvival PI3K/AKT signaling pathway. This review discusses emerging modes of PTEN function and regulation, and speculates about how manipulation of PTEN function could be used for cancer therapy.	[Salmena, Leonardo; Carracedo, Arkaitz; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Genet Program, Boston, MA 02115 USA; [Salmena, Leonardo; Carracedo, Arkaitz; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol,Canc Genet Program, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Genet Program, New Res Bldg,330 Brookline Ave, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Salmena, Leonardo/0000-0003-4023-658X				Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bose S, 1998, ONCOGENE, V17, P123, DOI 10.1038/sj.onc.1201940; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chappell WH, 2005, CELL CYCLE, V4, P1389, DOI 10.4161/cc.4.10.2028; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chow JYC, 2007, CARCINOGENESIS, V28, P2321, DOI 10.1093/carcin/bgm159; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Chung JH, 2006, HUM MOL GENET, V15, P2553, DOI 10.1093/hmg/ddl177; Dahia PLM, 2000, ENDOCR-RELAT CANCER, V7, P115, DOI 10.1677/erc.0.0070115; Davidson B, 2008, HUM PATHOL, V39, P87, DOI 10.1016/j.humpath.2007.05.014; Deleris P, 2003, J BIOL CHEM, V278, P38884, DOI 10.1074/jbc.M300816200; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feilotter HE, 1999, BRIT J CANCER, V79, P718, DOI 10.1038/sj.bjc.6690115; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fridberg M, 2007, LEUKEMIA LYMPHOMA, V48, P2221, DOI 10.1080/10428190701636443; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Ginn-Pease ME, 2003, CANCER RES, V63, P282; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Gray IC, 1998, BRIT J CANCER, V78, P1296, DOI 10.1038/bjc.1998.674; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Han SY, 2000, CANCER RES, V60, P3147; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Kang YH, 2002, LAB INVEST, V82, P285, DOI 10.1038/labinvest.3780422; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Leupin N, 2003, BRIT J HAEMATOL, V121, P97, DOI 10.1046/j.1365-2141.2003.04227.x; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lindsay Y, 2006, J CELL SCI, V119, P5160, DOI 10.1242/jcs.000133; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Liu JL, 2005, MOL CELL BIOL, V25, P6211, DOI 10.1128/MCB.25.14.6211-6224.2005; Liu JL, 2007, CANCER RES, V67, P11054, DOI 10.1158/0008-5472.CAN-07-1263; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Mirmohammadsadegh A, 2006, CANCER RES, V66, P6546, DOI 10.1158/0008-5472.CAN-06-0384; Moorehead RA, 2003, J BIOL CHEM, V278, P50422, DOI 10.1074/jbc.M306894200; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; NAHI H, 2008, BR J HAEMATOL   0312, DOI DOI 10.1111/J.1365-2141.2008.07074; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Patel L, 2001, CURR BIOL, V11, P764, DOI 10.1016/S0960-9822(01)00225-1; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CELL CYCLE, V4, P927, DOI 10.4161/cc.4.7.1795; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sano T, 1999, CANCER RES, V59, P1820; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi W, 2003, INT J CANCER, V104, P195, DOI 10.1002/ijc.10909; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tang YF, 2006, CANCER RES, V66, P6139, DOI 10.1158/0008-5472.CAN-06-0772; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Vivanco I, 2007, CANCER CELL, V11, P555, DOI 10.1016/j.ccr.2007.04.021; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Whelan JT, 2007, CELL CYCLE, V6, P80, DOI 10.4161/cc.6.1.3648; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou XP, 2000, AM J PATHOL, V157, P1123, DOI 10.1016/S0002-9440(10)64627-5; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zysman MA, 2002, AM J PATHOL, V160, P795, DOI 10.1016/S0002-9440(10)64902-4	121	833	905	1	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					403	414		10.1016/j.cell.2008.04.013	http://dx.doi.org/10.1016/j.cell.2008.04.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455982	Bronze			2022-12-28	WOS:000255503900012
J	Schlenk, RF; Dohner, K; Krauter, J; Frohling, S; Corbacioglu, A; Bullinger, L; Habdank, M; Spath, D; Morgan, M; Benner, A; Schlegelberger, B; Heil, G; Ganser, A; Dohner, H				Schlenk, Richard F.; Doehner, Konstanze; Krauter, Juergen; Froehling, Stefan; Corbacioglu, Andrea; Bullinger, Lars; Habdank, Marianne; Spaeth, Daniela; Morgan, Michael; Benner, Axel; Schlegelberger, Brigitte; Heil, Gerhard; Ganser, Arnold; Doehner, Hartmut		German Austrian Acute Myeloid	Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; KINASE DOMAIN MUTATIONS; PROGNOSTIC-SIGNIFICANCE; FAVORABLE PROGNOSIS; YOUNGER ADULTS; NUCLEOPHOSMIN NPM1; CEBPA MUTATIONS; C/EBP-ALPHA; AML 10	Background: Mutations occur in several genes in cytogenetically normal acute myeloid leukemia (AML) cells: the nucleophosmin gene (NPM1), the fms-related tyrosine kinase 3 gene (FLT3), the CCAAT/enhancer binding protein (alpha) gene (CEPBA), the myeloid-lymphoid or mixed-lineage leukemia gene (MLL), and the neuroblastoma RAS viral oncogene homolog (NRAS). We evaluated the associations of these mutations with clinical outcomes in patients. Methods: We compared the mutational status of the NPM1, FLT3, CEBPA, MLL, and NRAS genes in leukemia cells with the clinical outcome in 872 adults younger than 60 years of age with cytogenetically normal AML. Patients had been entered into one of four trials of therapy for AML. In each study, patients with an HLA-matched related donor were assigned to undergo stem-cell transplantation. Results: A total of 53% of patients had NPM1 mutations, 31% had FLT3 internal tandem duplications (ITDs), 11% had FLT3 tyrosine kinase-domain mutations, 13% had CEBPA mutations, 7% had MLL partial tandem duplications (PTDs), and 13% had NRAS mutations. The overall complete-remission rate was 77%. The genotype of mutant NPM1 without FLT3-ITD, the mutant CEBPA genotype, and younger age were each significantly associated with complete remission. Of the 663 patients who received postremission therapy, 150 underwent hematopoietic stem-cell transplantation from an HLA-matched related donor. Significant associations were found between the risk of relapse or the risk of death during complete remission and the leukemia genotype of mutant NPM1 without FLT3-ITD (hazard ratio, 0.44; 95% confidence interval [CI], 0.32 to 0.61), the mutant CEBPA genotype (hazard ratio, 0.48; 95% CI, 0.30 to 0.75), and the MLL-PTD genotype (hazard ratio, 1.56; 95% CI, 1.00 to 2.43), as well as receipt of a transplant from an HLA-matched related donor (hazard ratio, 0.60; 95% CI, 0.44 to 0.82). The benefit of the transplant was limited to the subgroup of patients with the prognostically adverse genotype FLT3-ITD or the genotype consisting of wild-type NPM1 and CEBPA without FLT3-ITD. Conclusions: Genotypes defined by the mutational status of NPM1, FLT3, CEBPA, and MLL are associated with the outcome of treatment for patients with cytogenetically normal AML.	[Schlenk, Richard F.; Doehner, Konstanze; Froehling, Stefan; Corbacioglu, Andrea; Bullinger, Lars; Habdank, Marianne; Spaeth, Daniela; Doehner, Hartmut] Univ Hosp Ulm, Dept Internal Med 3, D-89081 Ulm, Germany; [Krauter, Juergen; Morgan, Michael; Schlegelberger, Brigitte; Heil, Gerhard; Ganser, Arnold] Hannover Med Sch, D-3000 Hannover, Germany; [Benner, Axel] German Canc Res Ctr, D-6900 Heidelberg, Germany	Ulm University; Hannover Medical School; Helmholtz Association; German Cancer Research Center (DKFZ)	Dohner, H (corresponding author), Univ Hosp Ulm, Dept Internal Med 3, Robert Koch Str 8, D-89081 Ulm, Germany.	hartmut.doehner@uniklinik-ulm.de	Döhner, Hartmut/C-8933-2016; Schlenk, Richard/AAG-3218-2019; Bullinger, Lars/AAL-7965-2020	Döhner, Hartmut/0000-0003-2116-5536; Bullinger, Lars/0000-0002-5890-5510				[Anonymous], 2007, R LANG ENV STAT COMP; Barjesteh van Waalwijk van Doorn-Khosrovani S, 2003, HEMATOL J, V4, P31; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; CALIGIURI MA, 1994, CANCER RES, V54, P370; Caligiuri MA, 1998, CANCER RES, V58, P55; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cornelissen JJ, 2007, BLOOD, V109, P3658, DOI 10.1182/blood-2006-06-025627; Delaunay J, 2003, BLOOD, V102, P462, DOI 10.1182/blood-2002-11-3527; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Dohner K, 2002, J CLIN ONCOL, V20, P3254, DOI 10.1200/JCO.2002.09.088; Ernst P, 2002, CURR OPIN HEMATOL, V9, P282, DOI 10.1097/00062752-200207000-00004; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2005, NEW ENGL J MED, V352, P740; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gale RE, 2005, BLOOD, V106, P3658, DOI 10.1182/blood-2005-03-1323; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Lowenberg Bob, 2003, Hematology Am Soc Hematol Educ Program, P82; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; Mead AJ, 2007, BLOOD, V110, P1262, DOI 10.1182/blood-2006-04-015826; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, CURR OPIN HEMATOL, V14, P106, DOI 10.1097/MOH.0b013e32801684c7; Nakao M, 1996, LEUKEMIA, V10, P1911; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Preudhomme C, 2002, BLOOD, V100, P2717, DOI 10.1182/blood-2002-03-0990; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Schlenk RF, 2004, J CLIN ONCOL, V22, P3741, DOI 10.1200/JCO.2004.03.012; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Schubbert S, 2007, CURR OPIN GENET DEV, V17, P15, DOI 10.1016/j.gde.2006.12.004; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Whitman SP, 2001, CANCER RES, V61, P7233; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yanada M, 2005, LEUKEMIA, V19, P1345, DOI 10.1038/sj.leu.2403838	46	1231	1297	1	79	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1909	1918		10.1056/NEJMoa074306	http://dx.doi.org/10.1056/NEJMoa074306			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450602	Bronze			2022-12-28	WOS:000255387900005
J	Grbic, A; Jiang, L; Merlin, R				Grbic, Anthony; Jiang, Lei; Merlin, Roberto			Near-field plates: Subdiffraction focusing with patterned surfaces	SCIENCE			English	Article							RESOLUTION; MICROSCOPE; SUPERLENS	Using a patterned, grating- like plate to control the electromagnetic near field, we demonstrate focusing well beyond the diffraction limit at similar to 1 gigahertz. The near- field plate consists of only capacitive elements and focuses microwaves emanating from a cylindrical source to a spot of size approximate to lambda/20 ( half- power beamwidth), where lambda is the free- space wavelength. These plates will find application in antennas, beam- shaping devices, nonradiative wireless power- transfer systems, microscopy, and lithography.	[Grbic, Anthony] Univ Michigan, Dept Elect Engn & Comp Sci, Radiat Lab, Ann Arbor, MI 48109 USA; [Jiang, Lei; Merlin, Roberto] Univ Michigan, Frontiers Opt Coherent & Ultrafast Sci Ctr, Ann Arbor, MI 48109 USA; [Jiang, Lei; Merlin, Roberto] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Grbic, A (corresponding author), Univ Michigan, Dept Elect Engn & Comp Sci, Radiat Lab, Ann Arbor, MI 48109 USA.	agrbic@umich.edu		Merlin, Roberto/0000-0002-5584-0248	Div Of Electrical, Commun & Cyber Sys [0747623] Funding Source: National Science Foundation	Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0; Engheta N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.095504; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; GRBIC A, IN PRESS IEEE T ANTE; GRIBIC A, 2004, PHYS REV LETT, V92; Harrington RF, 1993, FIELD COMPUTATION MO; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; LEWIS A, 1984, ULTRAMICROSCOPY, V13, P227, DOI 10.1016/0304-3991(84)90201-8; Melville DOS, 2005, OPT EXPRESS, V13, P2127, DOI 10.1364/OPEX.13.002127; Merlin R, 2007, SCIENCE, V317, P927, DOI 10.1126/science.1143884; Novotny L., 2012, PRINCIPLES NANOOPTIC; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865; Synge EH, 1928, PHILOS MAG, V6, P356; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025	15	199	217	6	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					511	513		10.1126/science.1154753	http://dx.doi.org/10.1126/science.1154753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18440924				2022-12-28	WOS:000255249300045
J	Madden, JM; Graves, AJ; Zhang, F; Adams, AS; Briesacher, BA; Ross-Degnan, D; Gurwitz, JH; Pierre-Jacques, M; Safran, DG; Adler, GS; Soumerai, SB				Madden, Jeanne M.; Graves, Amy J.; Zhang, Fang; Adams, Alyce S.; Briesacher, Becky A.; Ross-Degnan, Dennis; Gurwitz, Jerry H.; Pierre-Jacques, Marsha; Safran, Dana Gelb; Adler, Gerald S.; Soumerai, Stephen B.			Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRESCRIPTION-DRUG COVERAGE; PATIENT POPULATION; COMMON OUTCOMES; NATIONAL-SURVEY; BENEFICIARIES; BENEFIT; RISK; EXPENDITURES; ENROLLEES; HUNGER	Context Cost- related medication nonadherence ( CRN) has been a persistent problem for individuals who are elderly and disabled in the United States. The impact of Medicare prescription drug coverage ( Part D) on CRN is unknown. Objective To estimate changes in CRN and forgoing basic needs to pay for drugs following Part D implementation. Design, Setting, and Participants In a population- level study design, changes in study outcomes between 2005 and 2006 before and after Medicare Part D implementation were compared with historical changes between 2004 and 2005. The community-dwelling sample of the nationally representative Medicare Current Beneficiary Survey ( unweighted unique n= 24 234; response rate, 72.3%) was used, and logistic regression analyses were controlled for demographic characteristics, health status, and historical trends. Main Outcome Measures Self- reports of CRN ( skipping or reducing doses, not obtaining prescriptions) and spending less on basic needs to afford medicines. Results The unadjusted, weighted prevalence of CRN was 15.2% in 2004, 14.1% in 2005, and 11.5% after Part D implementation in 2006. The prevalence of spending less on basic needs was 10.6% in 2004, 11.1% in 2005, and 7.6% in 2006. Adjusted analyses comparing 2006 with 2005 and controlling for historical changes ( 2005 vs 2004) demonstrated significant decreases in the odds of CRN ( ratio of odds ratios [ ORs], 0.85; 95% confidence interval [ CI], 0.74- 0.98; P=. 03) and spending less on basic needs ( ratio of ORs, 0.59; 95% CI, 0.48- 0.72; P <. 001). No significant changes in CRN were observed among beneficiaries with fair to poor health ( ratio of ORs, 1.00; 95% CI, 0.82- 1.21; P=. 97), despite high baseline CRN prevalence for this group ( 22.2% in 2005) and significant decreases among beneficiaries with good to excellent health ( ratio of ORs, 0.77; 95% CI, 0.63- 0.95; P=. 02). However, significant reductions in spending less on basic needs were observed in both groups ( fair to poor health: ratio of ORs, 0.60; 95% CI, 0.47- 0.75; P <. 001; and good to excellent health: ratio of ORs, 0.57; 95% CI, 0.44- 0.75; P <. 001). Conclusions In this survey population, there was evidence for a small but significant overall decrease in CRN and forgoing basic needs following Part D implementation. However, no net decrease in CRN after Part D was observed among the sickest beneficiaries, who continued to experience higher rates of CRN.	[Madden, Jeanne M.; Graves, Amy J.; Zhang, Fang; Adams, Alyce S.; Ross-Degnan, Dennis; Pierre-Jacques, Marsha; Soumerai, Stephen B.] Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; [Madden, Jeanne M.; Graves, Amy J.; Zhang, Fang; Adams, Alyce S.; Ross-Degnan, Dennis; Pierre-Jacques, Marsha; Soumerai, Stephen B.] Harvard Pilgrim Hlth Care, Boston, MA 02215 USA; [Briesacher, Becky A.; Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Div Geriatr Med, Worcester, MA USA; [Briesacher, Becky A.; Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, Worcester, MA USA; [Safran, Dana Gelb] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Safran, Dana Gelb] Blue Cross & Blue Shield Massachusetts, Boston, MA USA; [Adler, Gerald S.] Ctr Medicare & Medicaid Serv, Off Res Dev & Informat, Baltimore, MD USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Tufts University; Centers for Medicare & Medicaid Services	Madden, JM (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	jeanne_madden@hms.harvard.edu	Zhang, Fang/HHN-2153-2022		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028745, R01AG022362, K01AG031836] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS010391, 2U18HS010391] Funding Source: Medline; NIA NIH HHS [K01 AG031836-01A1, R01AG022362, K01 AG031836, R01 AG022362, R01 AG028745, R01AG028745] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams AS, 2001, HEALTH AFFAIR, V20, P276, DOI 10.1377/hlthaff.20.1.276; Adams AS, 2001, ANNU REV PUBL HEALTH, V22, P49, DOI 10.1146/annurev.publhealth.22.1.49; Blustein J, 2000, HEALTH AFFAIR, V19, P219, DOI 10.1377/hlthaff.19.2.219; BREISACHER B, MED DISABLED BENEFIC; Briesacher BA, 2005, HEALTH SERV RES, V40, P1279, DOI 10.1111/j.1475-6773.2005.00432.x; Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; *C US, 2006, AN PRES BUDG PROP FI; Chisholm MA, 2002, ARCH INTERN MED, V162, P780, DOI 10.1001/archinte.162.7.780; CRIPPEN DL, 2002, PROJECTIONS MED PRES; Crystal S, 2000, J GERONTOL B-PSYCHOL, V55, pS51; *CTR MED MED SERV, SOURC SER HLTH HLTH; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; FRIED LP, 1991, J AM GERIATR SOC, V39, P117, DOI 10.1111/j.1532-5415.1991.tb01612.x; Hanson KW, 2003, HLTH AFF MILLWOOD S; Heisler M, 2004, MED CARE, V42, P626, DOI 10.1097/01.mlr.0000129352.36733.cc; Heiss F, 2006, HEALTH AFFAIR, V25, pW344, DOI 10.1377/hlthaff.25.w344; *HJ KAIS FAM FDN, 2007, OV MED PART D ORG PL; *HJ KAIS FAM FDN, PRESCR DRUG TRENDS F; *HJ KAIS FAM FDN, 2006, MED PRESCR DRUG BEN; *HJ KAIS FAM FDN, 2005, MED CHARTB 2005; *KAIS FAM FDN, TRANS DUAL EL MED PA; *KAIS FAM FDN, 2006, EARL EXP MED BEN PRE; *KAIS FAM FDN, VOIC BEN EARL EXP ME; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Kersey MA, 1999, ACAD EMERG MED, V6, P1109, DOI 10.1111/j.1553-2712.1999.tb00112.x; LASCHOBER MA, 2002, HLTH AFF MILLWOOD, pW127; LEVKOFF SE, 1988, J AM GERIATR SOC, V36, P622, DOI 10.1111/j.1532-5415.1988.tb06158.x; LEVY J, 2008, 9 ANN JOINT C RET RE; Nelson K, 1998, JAMA-J AM MED ASSOC, V279, P1211, DOI 10.1001/jama.279.15.1211; Neuman P, 2007, HEALTH AFFAIR, V26, pW630, DOI 10.1377/hlthaff.26.5.w630; PIERREJACQUES M, IN PRESS MED CARE; Poisal JA, 2000, HEALTH AFFAIR, V19, P248, DOI 10.1377/hlthaff.19.2.248; Poisal JK, 2003, HEALTH CARE FINANC R, V25, P23; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; SAFRAN DG, 2002, HLTH AFF MILLWOOD; Sarndal C. E., 2003, MODEL ASSISTED SURVE; Schoenberg NE, 2007, GERONTOLOGIST, V47, P423, DOI 10.1093/geront/47.4.423; Smith C, 2006, HEALTH AFFAIR, V25, P186, DOI 10.1377/hlthaff.25.1.186; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; Stuart B, 2001, HEALTH AFFAIR, V20, P86, DOI 10.1377/hlthaff.20.2.86; Stuart B, 2000, Issue Brief (Commonw Fund), P1; STUART B, 2005, HLTH AFF MILLWOOD S; THOMAS CP, 2005, HLTH AFF MILLWOOD S; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	47	197	201	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1922	1928		10.1001/jama.299.16.1922	http://dx.doi.org/10.1001/jama.299.16.1922			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291AD	18430911	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000255163800026
J	Hanna, J; Markoulaki, S; Schorderet, P; Carey, BW; Beard, C; Wernig, M; Creyghton, MP; Steine, EJ; Cassady, JP; Foreman, R; Lengner, CJ; Dausman, JA; Jaenisch, R				Hanna, Jacob; Markoulaki, Styliani; Schorderet, Patrick; Carey, Bryce W.; Beard, Caroline; Wernig, Marius; Creyghton, Menno P.; Steine, Eveline J.; Cassady, John P.; Foreman, Ruth; Lengner, Christopher J.; Dausman, Jessica A.; Jaenisch, Rudolf			Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency	CELL			English	Article							NUCLEAR TRANSFER; STEM-CELLS; GENE REARRANGEMENT; MOUSE; FIBROBLASTS; MICE; GENERATION; LIVER; PAX5; HOMEOSTASIS	Pluripotent cells can be derived from fibroblasts by ectopic expression of defined transcription factors. A fundamental unresolved question is whether terminally differentiated cells can be reprogrammed to pluripotency. We utilized transgenic and inducible expression of four transcription factors (Oct4, Sox2, Klf4, and c-Myc) to reprogram mouse B lymphocytes. These factors were sufficient to convert nonterminally differentiated B cells to a pluripotent state. However, reprogramming of mature B cells required additional interruption with the transcriptional state maintaining B cell identity by either ectopic expression of the myeloid transcription factor CCAAT/enhancer-binding-protein-alpha (C/EBP alpha) or specific knockdown of the B cell transcription factor Pax5. Multiple iPS lines were clonally derived from both nonfully and fully differentiated B lymphocytes, which gave rise to adult chimeras with germline contribution, and to late-term embryos when injected into tetraploid blastocysts. Our study provides definite proof for the direct nuclear reprogramming of terminally differentiated adult cells to pluripotency.	[Hanna, Jacob; Markoulaki, Styliani; Schorderet, Patrick; Carey, Bryce W.; Beard, Caroline; Wernig, Marius; Creyghton, Menno P.; Steine, Eveline J.; Cassady, John P.; Foreman, Ruth; Lengner, Christopher J.; Dausman, Jessica A.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Carey, Bryce W.; Cassady, John P.; Foreman, Ruth; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Lengner, Christopher/0000-0002-0574-5189	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R37 CA084198-08, 5-R37-CA084198, 5-R01-CA087869, R01 CA087869, R37 CA084198] Funding Source: Medline; NICHD NIH HHS [R01 HD045022, R01 HD045022-05] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; PHS HHS [5-R01-HDO45022] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; BYME JA, 2007, NATURE, V450, P497; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Grompe M, 2005, GASTROENTEROLOGY, V128, P2158, DOI 10.1053/j.gastro.2005.04.022; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; LEWIS S, 1982, CELL, V30, P807, DOI 10.1016/0092-8674(82)90285-9; Li JS, 2007, P NATL ACAD SCI USA, V104, P2738, DOI 10.1073/pnas.0611358104; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Matthews VB, 2004, HEPATOLOGY, V40, P759, DOI 10.1002/hep.20396; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Milne CD, 2004, EUR J IMMUNOL, V34, P2647, DOI 10.1002/eji.200425400; NADEL B, 1990, EMBO J, V9, P435, DOI 10.1002/j.1460-2075.1990.tb08128.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Oberdoerffer P, 2003, J EXP MED, V197, P1165, DOI 10.1084/jem.20030402; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	50	620	774	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					250	264		10.1016/j.cell.2008.03.028	http://dx.doi.org/10.1016/j.cell.2008.03.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423197	Bronze, Green Accepted			2022-12-28	WOS:000255052000015
J	Wu, XM; Tu, XL; Joeng, KS; Hilton, MJ; Williams, DA; Long, FX				Wu, Ximei; Tu, Xiaolin; Joeng, Kyu Sang; Hilton, Matthew J.; Williams, David A.; Long, Fanxin			Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling	CELL			English	Article							CONVERGENT EXTENSION MOVEMENTS; SUBCELLULAR-LOCALIZATION; AXIS FORMATION; PIK3CA GENE; VERTEBRATE GASTRULATION; PLANAR POLARITY; DROSOPHILA EYE; RHO GTPASES; PATHWAY; PROTEIN	Canonical Wnt signaling critically regulates cell fate and proliferation in development and disease. Nuclear localization of beta-catenin is indispensable for canonical Wnt signaling; however, the mechanisms governing beta-catenin nuclear localization are not well understood. Here we demonstrate that nuclear accumulation of beta-catenin in response to Wnt requires Rac1 activation. The role of Rac1 depends on phosphorylation of beta-catenin at Ser191 and Ser605, which is mediated by JNK2 kinase. Mutations of these residues significantly affect Wnt-induced beta-catenin nuclear accumulation. Genetic ablation of Rac1 in the mouse embryonic limb bud ectoderm disrupts canonical Wnt signaling and phenocopies deletion of beta-catenin in causing severe truncations of the limb. Finally, Rac1 interacts genetically with beta-catenin and Dkk1 in controlling limb outgrowth. Together these results uncover Rac1 activation and subsequent beta-catenin phosphorylation as a hitherto uncharacterized mechanism controlling canonical Wnt signaling and may provide additional targets for therapeutic intervention of this important pathway.	[Wu, Ximei; Tu, Xiaolin; Joeng, Kyu Sang; Hilton, Matthew J.; Long, Fanxin] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Joeng, Kyu Sang; Long, Fanxin] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Long, Fanxin] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Williams, David A.] Cincinnati Childrens Hosp, Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Long, FX (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	flong@wustl.edu		Hilton, Matthew/0000-0003-3165-267X; Wu, Ximei/0000-0002-3316-893X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062757, R01DK065789] Funding Source: NIH RePORTER; NIAMS NIH HHS [5T32AR07033, T32 AR007033] Funding Source: Medline; NICHD NIH HHS [P01 HD070394] Funding Source: Medline; NIDDK NIH HHS [R01 DK065789-04, R01 DK 065789, R01 DK065789, R01 DK 62757, R01 DK062757, R01 DK065789-03] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barrow JR, 2003, GENE DEV, V17, P394, DOI 10.1101/gad.1044903; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Bruinsma SP, 2007, P NATL ACAD SCI USA, V104, P7098, DOI 10.1073/pnas.0701686104; Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Jones WM, 2005, GENETICS, V169, P2075, DOI 10.1534/genetics.104.039735; Kawashima T, 2006, J CELL BIOL, V175, P937, DOI 10.1083/jcb.200604073; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Long FX, 2001, DEVELOPMENT, V128, P5099; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Neufeld KL, 2000, EMBO REP, V1, P519; Penzo-Mendez A, 2003, DEV BIOL, V257, P302, DOI 10.1016/S0012-1606(03)00067-8; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yao Y, 2003, P NATL ACAD SCI USA, V100, P12759, DOI 10.1073/pnas.2134254100	52	365	375	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					340	353		10.1016/j.cell.2008.01.052	http://dx.doi.org/10.1016/j.cell.2008.01.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423204	Green Accepted, Bronze			2022-12-28	WOS:000255052000022
J	Lanzkron, S; Strouse, JJ; Wilson, R; Beach, MC; Haywood, C; Park, H; Witkop, C; Bass, EB; Segal, JB				Lanzkron, Sophie; Strouse, John J.; Wilson, Renee; Beach, Mary Catherine; Haywood, Carlton; Park, HaeSong; Witkop, Catherine; Bass, Eric B.; Segal, Jodi B.			Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease	ANNALS OF INTERNAL MEDICINE			English	Review							LONG-TERM HYDROXYUREA; CHRONIC MYELOGENOUS LEUKEMIA; DIDANOSINE PLUS STAVUDINE; PLACEBO-CONTROLLED TRIAL; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; FETAL-HEMOGLOBIN; INTERFERON-ALPHA; HIGH-RISK; CHILDREN	Background: Hydroxyurea is the only approved drug for treatment of sickle cell disease. Objective: To synthesize the published literature on the efficacy, effectiveness, and toxicity of hydroxyurea when used in adults with sickle cell disease. Data Sources: MEDLINE, EMBASE, TOXLine, and CINAHL were searched through 30 June 2007. Study Selection: Randomized trials, observational studies, and case reports evaluating efficacy and toxicity of hydroxyurea in adults with sickle cell disease, and toxicity studies of hydroxyurea in other conditions that were published in English. Data Extraction: Paired reviewers abstracted data on study design, patient characteristics, and outcomes sequentially and did quality assessments independently. Data Synthesis: In the single randomized trial, the hemoglobin level was higher in hydroxyurea recipients than placebo recipients after 2 years (difference, 6 g/L), as was fetal hemoglobin (absolute difference, 3.2%). The median number of painful crises was 44% lower than in the placebo group. The 12 observational studies that enrolled adults reported a relative increase in fetal hemoglobin of 4% to 20% and a relative reduction in crisis rates by 68% to 84%. Hospital admissions declined by 18% to 32%. The evidence suggests that hydroxyurea may impair spermatogenesis. Limited evidence indicates that hydroxyurea treatment in adults with sickle cell disease is not associated with leukemia. Likewise, limited evidence suggests that hydroxyurea and leg ulcers are not associated in patients with sickle cell disease, and evidence is insufficient to estimate the risk for skin neoplasms, although these outcomes can be attributed to hydroxyurea in other conditions. Limitation: Only English-language articles were included, and some studies were of lower quality. Conclusion: Hydroxyurea has demonstrated efficacy in adults with sickle cell disease. The paucity of long-term studies limits conclusions about toxicity.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lanzkron, S (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Suite 7300, Baltimore, MD 21205 USA.		Lanzkron, Sophie/AFU-9516-2022; Strouse, J/A-2690-2008; Park, Haeseong/AAL-7982-2021; Lanzkron, Sophie/AAD-7584-2022	Lanzkron, Sophie/0000-0002-2878-0251; Strouse, J/0000-0003-0341-1457; Park, Haeseong/0000-0002-3430-8463; Lanzkron, Sophie/0000-0002-2878-0251; Haywood Jr., Carlton/0000-0002-3574-7871; Bass, Eric/0000-0001-9106-527X; Beach, Mary Catherine/0000-0002-1112-6309	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088511] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL088511, R01 HL088511-02, F31 HL082037, R01 HL088511-03, R01 HL088511-01A1] Funding Source: Medline; PHS HHS [290-02-0018] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AG HEALTHC RES QU, 2007, METH REF MAN COMP EF, P1; Al-Jam'a AH, 2002, SAUDI MED J, V23, P1411; [Anonymous], 2003, PSYCHOL HLTH MED; Aslanidis S, 2006, EUR J HAEMATOL, V77, P89, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2643.x; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Ballas SK, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-59; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bloch MT, 2006, JAIDS-J ACQ IMM DEF, V42, P192, DOI 10.1097/01.qai.0000219779.50668.e6; BROUSTET A, 1991, EUR J CANCER, V27, pS18, DOI 10.1016/0277-5379(91)90558-U; CallotMellot C, 1996, ARCH DERMATOL, V132, P1395, DOI 10.1001/archderm.132.11.1395; Chaine B, 2001, ARCH DERMATOL, V137, P467; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Charache S, 1996, MEDICINE, V75, P300, DOI 10.1097/00005792-199611000-00002; Charache S, 1995, CONTROL CLIN TRIALS, V16, P432, DOI 10.1016/S0197-2456(95)00098-4; CORTELAZZO S, 1995, NEW ENGL J MED, V332, P1132, DOI 10.1056/NEJM199504273321704; de Montalembert M, 1999, ARCH DIS CHILD, V81, P437, DOI 10.1136/adc.81.5.437; de Montalembert M, 2006, HAEMATOLOGICA, V91, P125; Debaun Michael R, 2007, Hematology Am Soc Hematol Educ Program, P482; deMontalembert M, 1997, J PEDIAT HEMATOL ONC, V19, P313, DOI 10.1097/00043426-199707000-00009; ELHAZMI MAF, 1992, ACTA HAEMATOL-BASEL, V88, P170; Fattori A, 2005, HEMATOL J, V5, P589, DOI 10.1038/sj.thj.6200572; Ferguson RP, 2002, AM J HEMATOL, V70, P326, DOI 10.1002/ajh.10184; Ferster A, 2003, BRIT J HAEMATOL, V123, P368, DOI 10.1046/j.1365-2141.2003.04614.x; Ferster A, 2001, BLOOD, V97, P3628, DOI 10.1182/blood.V97.11.3628; Finazzi G, 2000, BRIT J HAEMATOL, V110, P577, DOI 10.1046/j.1365-2141.2000.02188.x; Frank I, 2004, AIDS RES HUM RETROV, V20, P916, DOI 10.1089/aid.2004.20.916; Garozzo G, 2000, HAEMATOLOGICA, V85, P1216; Grigg A, 2007, INTERN MED J, V37, P190, DOI 10.1111/j.1445-5994.2006.01290.x; Gulbis B, 2005, BLOOD, V105, P2685, DOI 10.1182/blood-2004-07-2704; Hackney AC, 1997, CLIN SCI, V92, P481, DOI 10.1042/cs0920481; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; HASSELL K, 2007, 35 ANN CONV NAT SICK, P173; Havlir DV, 2001, AIDS, V15, P1379, DOI 10.1097/00002030-200107270-00007; HEHLMANN R, 1993, BLOOD, V82, P398, DOI 10.1182/blood.V82.2.398.bloodjournal822398; Hehlmann R, 2003, LEUKEMIA, V17, P1529, DOI 10.1038/sj.leu.2403006; HEHLMANN R, 1994, BLOOD, V84, P4064, DOI 10.1182/blood.V84.12.4064.bloodjournal84124064; Horsburgh D, 2003, J CLIN NURS, V12, P307, DOI 10.1046/j.1365-2702.2003.00683.x; Huang YW, 2003, AM J HEMATOL, V74, P125, DOI 10.1002/ajh.10388; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jones JK, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P557; Kattamis A, 2004, PEDIATR HEMAT ONCOL, V21, P335, DOI 10.1080/08880010490440473; Kersgard C, 2001, AM J HEMATOL, V68, P215, DOI 10.1002/ajh.1183; Kiladjian JJ, 2006, SEMIN THROMB HEMOST, V32, P417, DOI 10.1055/s-2006-942762; Kinney TR, 1999, BLOOD, V94, P1550; Kluin-Nelemans JC, 1998, BLOOD, V91, P2713; Lincoln TM, 2004, J ANXIETY DISORD, V18, P515, DOI 10.1016/S0887-6185(03)00040-9; LOENING SA, 1981, J UROLOGY, V125, P812, DOI 10.1016/S0022-5347(17)55216-7; Loukopoulos D, 2000, BLOOD CELL MOL DIS, V26, P453, DOI 10.1006/bcmd.2000.0328; Loukopoulos D, 1998, ANN NY ACAD SCI, V850, P120, DOI 10.1111/j.1749-6632.1998.tb10469.x; McClish Donna K, 2005, Health Qual Life Outcomes, V3, P50, DOI 10.1186/1477-7525-3-50; Moore RD, 2000, AM J HEMATOL, V64, P26, DOI 10.1002/(SICI)1096-8652(200005)64:1<26::AID-AJH5>3.3.CO;2-6; Moschovi M, 2001, PEDIATR HEMAT ONCOL, V18, P371, DOI 10.1080/088800101316921985; Najean Y, 1997, BLOOD, V90, P3370, DOI 10.1182/blood.V90.9.3370; *NIH, 2002, MAN SICKL CELL DIS; O'Branski EE, 2001, J AM ACAD DERMATOL, V44, P859, DOI 10.1067/mjd.2001.113471; Olivieri NF, 1998, J PEDIAT HEMATOL ONC, V20, P26, DOI 10.1097/00043426-199801000-00004; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Ratanawongsa N, 2008, ACAD MED, V83, P274, DOI 10.1097/ACM.0b013e3181637925; Rauch A, 1999, BLOOD, V94, p415A; Rigano P, 2001, HEMOGLOBIN, V25, P9, DOI 10.1081/HEM-100103065; Rutschmann OT, 2000, AIDS, V14, P2145, DOI 10.1097/00002030-200009290-00011; Rutschmann OT, 1998, AIDS, V12, pF71, DOI 10.1097/00002030-199808000-00003; Rutschmann OT, 1998, ANTIVIR THER, V3, P65; Schultz WH, 2003, AM J HEMATOL, V74, P249, DOI 10.1002/ajh.10427; Scott JP, 1996, J PEDIATR-US, V128, P820, DOI 10.1016/S0022-3476(96)70335-9; SEGAL JB, 2008, AHRQ PUBLICATION; Seminari E, 1999, INT J CLIN PHARM TH, V37, P514; Shapiro BS, 1997, J PAIN SYMPTOM MANAG, V14, P168, DOI 10.1016/S0885-3924(97)00019-5; Shelby MD, 2005, BIRTH DEFECTS RES B, V74, P9, DOI 10.1002/bdrb.20029; SHELBY MD, 2007, NTP CERHR EXPERT PAN; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; STEPHENS RL, 1984, CANCER-AM CANCER SOC, V53, P406, DOI 10.1002/1097-0142(19840201)53:3<406::AID-CNCR2820530307>3.0.CO;2-3; Swindells S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-23; Thauvin-Robinet C, 2001, LEUKEMIA, V15, P1309, DOI 10.1038/sj.leu.2402168; Tobin GA, 2004, J ADV NURS, V48, P388, DOI 10.1111/j.1365-2648.2004.03207.x; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Venigalla P, 2002, BLOOD, V100, P363, DOI 10.1182/blood-2002-03-0754; Vicari P, 2005, AM J HEMATOL, V78, P243, DOI 10.1002/ajh.20293; VICHINSKY EP, 1994, BLOOD, V83, P1124; VOSKARIDOU E, 1995, BRIT J HAEMATOL, V89, P479, DOI 10.1111/j.1365-2141.1995.tb08352.x; Wang WC, 2001, J PEDIATR-US, V139, P790, DOI 10.1067/mpd.2001.119590; Ware RE, 2002, BLOOD, V99, P10, DOI 10.1182/blood.V99.1.10; Wilson S, 2000, ANN INTERN MED, V133, P925, DOI 10.7326/0003-4819-133-11-200012050-00029; WRIGHT CC, 1988, ACCIDENT ANAL PREV, V20, P199, DOI 10.1016/0001-4575(88)90004-8; Zimmerman SA, 2004, BLOOD, V103, P2039, DOI 10.1182/blood-2003-07-2475	88	157	169	1	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2008	148	12					939	+		10.7326/0003-4819-148-12-200806170-00221	http://dx.doi.org/10.7326/0003-4819-148-12-200806170-00221			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	323DU	18458272	Green Accepted			2022-12-28	WOS:000257425000006
J	Guelen, L; Pagie, L; Brasset, E; Meuleman, W; Faza, MB; Talhout, W; Eussen, BH; de Klein, A; Wessels, L; de Laat, W; van Steensel, B				Guelen, Lars; Pagie, Ludo; Brasset, Emilie; Meuleman, Wouter; Faza, Marius B.; Talhout, Wendy; Eussen, Bert H.; de Klein, Annelies; Wessels, Lodewyk; de Laat, Wouter; van Steensel, Bas			Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions	NATURE			English	Article							GENE-EXPRESSION; MEMBRANE PROTEIN; HUMAN GENOME; CELLS; ARCHITECTURE; LOCALIZATION; EMERIN; TRANSCRIPTION; MECHANISMS; PERIPHERY	The architecture of human chromosomes in interphase nuclei is still largely unknown. Microscopy studies have indicated that specific regions of chromosomes are located in close proximity to the nuclear lamina (NL)(1-3). This has led to the idea that certain genomic elements may be attached to the NL, which may contribute to the spatial organization of chromosomes inside the nucleus. However, sequences in the human genome that interact with the NL in vivo have not been identified. Here we construct a high-resolution map of the interaction sites of the entire genome with NL components in human fibroblasts. This map shows that genome - lamina interactions occur through more than 1,300 sharply defined large domains 0.1 - 10 megabases in size. These lamina-associated domains ( LADs) are typified by low gene- expression levels, indicating that LADs represent a repressive chromatin environment. The borders of LADs are demarcated by the insulator protein CTCF, by promoters that are oriented away from LADs, or by CpG islands, suggesting possible mechanisms of LAD confinement. Taken together, these results demonstrate that the human genome is divided into large, discrete domains that are units of chromosome organization within the nucleus.	[Guelen, Lars; Pagie, Ludo; Meuleman, Wouter; Faza, Marius B.; Talhout, Wendy; Wessels, Lodewyk; van Steensel, Bas] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Brasset, Emilie; de Laat, Wouter] Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; [Eussen, Bert H.; de Klein, Annelies] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Meuleman, Wouter; Wessels, Lodewyk] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands	Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	b.v.steensel@nki.nl	Brasset, Emilie/J-6684-2015	Meuleman, Wouter/0000-0002-1196-5401; Brasset, Emilie/0000-0003-2479-7969; de Laat, Wouter/0000-0002-6393-595X				Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bengtsson L, 2004, CURR OPIN CELL BIOL, V16, P73, DOI 10.1016/j.ceb.2003.11.012; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Imai S, 1997, MOL BIOL CELL, V8, P2407, DOI 10.1091/mbc.8.12.2407; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murmann AE, 2005, EXP CELL RES, V311, P14, DOI 10.1016/j.yexcr.2005.07.020; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Parada LA, 2003, TRENDS CELL BIOL, V13, P393, DOI 10.1016/S0962-8924(03)00149-1; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	35	1278	1307	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					948	U83		10.1038/nature06947	http://dx.doi.org/10.1038/nature06947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18463634				2022-12-28	WOS:000256632000050
J	Du, X; She, E; Gelbart, T; Truksa, J; Lee, P; Xia, Y; Khovananth, K; Mudd, S; Mann, N; Moresco, EMY; Beutler, E; Beutler, B				Du, Xin; She, Ellen; Gelbart, Terri; Truksa, Jaroslav; Lee, Pauline; Xia, Yu; Khovananth, Kevin; Mudd, Suzanne; Mann, Navjiwan; Moresco, Eva Marie Y.; Beutler, Ernest; Beutler, Bruce			The serine protease TMPRSS6 is required to sense iron deficiency	SCIENCE			English	Article							HEPCIDIN EXPRESSION; LIVER HEPCIDIN; ANEMIA; HYPOXIA; INFLAMMATION; MOUSE; MICE; HEMOCHROMATOSIS; INTERLEUKIN-6; TRANSCRIPTION	Hepcidin, a liver- derived protein that restricts enteric iron absorption, is the key regulator of body iron content. Several proteins induce expression of the hepcidin- encoding gene Hamp in response to infection or high levels of iron. However, mechanism( s) of Hamp suppression during iron depletion are poorly understood. We describe mask: a recessive, chemically induced mutant mouse phenotype, characterized by progressive loss of body ( but not facial) hair and microcytic anemia. The mask phenotype results from reduced absorption of dietary iron caused by high levels of hepcidin and is due to a splicing defect in the transmembrane serine protease 6 gene Tmprss6. Overexpression of normal TMPRSS6 protein suppresses activation of the Hamp promoter, and the TMPRSS6 cytoplasmic domain mediates Hamp suppression via proximal promoter element( s). TMPRSS6 is an essential component of a pathway that detects iron deficiency and blocks Hamp transcription, permitting enhanced dietary iron absorption.	[Du, Xin; She, Ellen; Xia, Yu; Khovananth, Kevin; Mudd, Suzanne; Mann, Navjiwan; Moresco, Eva Marie Y.; Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA; [Gelbart, Terri; Truksa, Jaroslav; Lee, Pauline; Beutler, Ernest] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Truksa, Jaroslav/AAB-5089-2020; Truksa, Jaroslav/G-9454-2014	Truksa, Jaroslav/0000-0002-8967-7354; Truksa, Jaroslav/0000-0002-8967-7354; Gelbart, Terri/0000-0002-7863-1262; Moresco, Eva Marie/0000-0002-2049-7291	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI054523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053505] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI054523-019005, U54 AI054523, AI054523] Funding Source: Medline; NIDDK NIH HHS [DK53505-09, R01 DK053505-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Beutler E, 2004, SCIENCE, V306, P2051, DOI 10.1126/science.1107224; Deloche C, 2007, EUR J DERMATOL, V17, P507; GITLIN D, 1962, J CLIN INVEST, V41, P344, DOI 10.1172/JCI104488; Kawabata H, 2005, BLOOD, V105, P376, DOI 10.1182/blood-2004-04-1416; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Roy CN, 2005, CURR OPIN HEMATOL, V12, P107, DOI 10.1097/00062752-200503000-00001; RUSSELL ES, 1970, TRANSPLANT P, V2, P144; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Truksa J, 2007, BLOOD, V110, P3436, DOI 10.1182/blood-2007-05-091108; Truksa J, 2007, BRIT J HAEMATOL, V139, P138, DOI 10.1111/j.1365-2141.2007.06728.x; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	26	442	464	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1088	1092		10.1126/science.1157121	http://dx.doi.org/10.1126/science.1157121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18451267	Green Accepted			2022-12-28	WOS:000256059800049
J	Darzi, A				Darzi, Ara			Quality and the NHS Next Stage Review	LANCET			English	Editorial Material									[Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Biosurg & Surg Technol, London W2 1NY, England	Imperial College London	Darzi, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Biosurg & Surg Technol, London W2 1NY, England.	ournhs@dh.gsi.gov.uk						Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; *CENTR OFF MIN HLT, 1948, NEW NATL HLTH SERV; Hales BM, 2006, J CRIT CARE, V21, P231, DOI 10.1016/j.jcrc.2006.06.002; Levine M, 1972, PSYCHIAT ETHICS; Lord Darzi A., 2007, OUR NHS OUR FUTURE N; THOMAS L, 1977, SCI TECHNOLOGY MED	6	35	35	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1563	1564		10.1016/S0140-6736(08)60672-8	http://dx.doi.org/10.1016/S0140-6736(08)60672-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298VO	18468532				2022-12-28	WOS:000255715400010
J	LeBlanc, K; Frassoni, F; Ball, L; Locatelli, F; Roelofs, H; Lewis, I; Lanino, E; Sundberg, B; Bernardo, ME; Remberger, M; Dini, G; Egeler, RM; Bacigalupo, A; Fibbe, W; Ringden, O				LeBlanc, Katarina; Frassoni, Francesco; Ball, Lynne; Locatelli, Franco; Roelofs, Helene; Lewis, Ian; Lanino, Edoardo; Sundberg, Berit; Bernardo, Maria Ester; Remberger, Mats; Dini, Giorgio; Egeler, R. Maarten; Bacigalupo, Andrea; Fibbe, Willem; Ringden, Olle		Dev Committee European Grp Blood M	Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study	LANCET			English	Article							BONE-MARROW; TRANSPLANTATION; RESPONSES; ENGRAFTMENT; THERAPY; FAILURE; VIVO; COTRANSPLANTATION; RECOVERY; INHIBIT	Background Severe graft-versus-host disease (GVHD) is a life-threatening complication after allogeneic transplantation with haemopoietic stem cells. Mesenchymal stem cells modulate immune responses in vitro and in vivo. We aimed to assess whether mesenchymal stem cells could ameliorate GVHD after haemopoietic-stem-cell transplantation. Methods Patients with steroid-resistant, severe, acute GVHD were treated with mesenchymal stem cells, derived with the European Group for Blood and Marrow Transplantation ex-vivo expansion procedure, in a multicentre, phase II experimental study. We recorded response, transplantation-related deaths, and other adverse events for up to 60 months' follow-up from infusion of the cells. Findings Between October, 2001, and January, 2007, 55 patients were treated. The median dose of bone-marrow derived mesenchymal stem cells was 1.4x10(6) (Min-max range 0.4-9x10(6)) cells per kg bodyweight. 27 patients received one dose, 22 received two doses, and six three to five doses of cells obtained from HLA-identical sibling donors (n=5), haploidentical donors (n=18), and third-party HLA-mismatched donors (n=69). 30 patients had a complete response and nine showed improvement. No patients had side-effects during or immediately after infusions of mesenchymal stem cells. Response rate was not related to donor HLA-match. Three patients had recurrent malignant disease and one developed de-novo acute myeloid leukaemia of recipient origin. Complete responders had lower transplantation-related mortality 1 year after infusion than did patients with partial or no response (11 [37%] of 30 vs 18 [72%] of 25; p=0.002) and higher overall survival 2 years after haemopoietic-stem-cell transplantation (16 [53%] of 30 vs four [16%] of 25; p=0 . 018). Interpretation Infusion of mesenchymal stem cells expanded in vitro, irrespective of the donor, might be an effective therapy for patients with steroid-resistant, acute GVHD. Funding Swedish Cancer Society Children's Cancer Foundation, Swedish Research Council, Cancer Society in Stockholm, Cancer and Allergy Foundation, Karolinska. Institutet, Istituto Superiore di Sanita, European Union, Regione Lombardia, Fondazione CARIPLO, Associazione Italiana Ricerca contro il Cancro, Compagnia di San Paolo Torino, Progetto CARIGE Cellule Staminali, European Commission, Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Ricerca Finalizzata Regione Liguria 2005 Assistenza Domiciliare, Dutch Programme for Tissue Engineering.	[LeBlanc, Katarina; Sundberg, Berit; Remberger, Mats; Ringden, Olle] Karolinska Univ Hosp, Haematol Ctr, Stockholm, Sweden; [LeBlanc, Katarina; Sundberg, Berit; Remberger, Mats; Ringden, Olle] Karolinska Univ Hosp, Ctr Allogen Stem Cell Transplantat, Div Clin Immunol, Stockholm, Sweden; [Frassoni, Francesco; Bacigalupo, Andrea] Osped San Martino Genova, Ctr Cellule Staminali & Terapia Cellulare, Genoa, Italy; [Frassoni, Francesco; Bacigalupo, Andrea] Osped San Martino Genova, Div Ematol, Genoa, Italy; [Lanino, Edoardo; Dini, Giorgio] IRCCS G Gaslini, Dipartimento Ematol & Oncol, Genoa, Italy; [Ball, Lynne; Egeler, R. Maarten] Leiden Univ, Med Ctr, Dept Paediat, Leiden, Netherlands; [Roelofs, Helene; Fibbe, Willem] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Locatelli, Franco; Bernardo, Maria Ester] Univ Pavia, Oncoematol Pediat, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Lewis, Ian] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; IRCCS Fondazione San Matteo; University of Pavia; Institute Medical & Veterinary Science Australia	LeBlanc, K (corresponding author), Karolinska Inst, Div Clin Immunol & Transfus Med, SE-14186 Stockholm, Sweden.	katarina.leblanc@ki.se	Le Blanc, Katarina/L-4631-2019; Frassoni, Francesco/K-3971-2018	Frassoni, Francesco/0000-0003-1262-0648; Lanino, Edoardo/0000-0003-4872-6778	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Blume KG, 2004, THOMAS HEMATOPOIETIC; Deeg HJ, 2007, BLOOD, V109, P4119, DOI 10.1182/blood-2006-12-041889; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GOLDMAN JM, 1982, LANCET, V2, P623; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Remberger M, 2001, CLIN TRANSPLANT, V15, P147, DOI 10.1034/j.1399-0012.2001.150301.x; RINGDEN O, 1985, TRANSPLANTATION, V40, P39; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; STORB R, 1985, IMMUNOL REV, V88, P215, DOI 10.1111/j.1600-065X.1985.tb01160.x; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	30	1996	2056	5	210	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 10	2008	371	9624					1579	1586		10.1016/S0140-6736(08)60690-X	http://dx.doi.org/10.1016/S0140-6736(08)60690-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468541				2022-12-28	WOS:000255715400025
J	Lutkenhaus, J				Lutkenhaus, Joe			Biochemistry - Tinkering with acellular division	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; CELL-DIVISION; ASSEMBLY DYNAMICS; Z-RING; MINE; OSCILLATION; PLACEMENT; SYSTEM; ROLES; CYCLE		[Lutkenhaus, Joe] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Lutkenhaus, J (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA.	jlutkenh@kumc.edu			NIGMS NIH HHS [R37GM09764] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4	18	7	7	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					755	756		10.1126/science.1158463	http://dx.doi.org/10.1126/science.1158463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467579				2022-12-28	WOS:000255644400027
J	Sanmartin, O; Guillen, C				Sanmartin, Onofre; Guillen, Carlos			Fluorescence diagnosis of subclinical actinic keratoses	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sanmartin, Onofre; Guillen, Carlos] Inst Valenciano Oncol, E-46009 Valencia, Spain	Instituto Valenciano De Oncologia	Sanmartin, O (corresponding author), Inst Valenciano Oncol, E-46009 Valencia, Spain.	osanmartinj@gmail.com	Jimenez, Onofre Sanmartin/T-2938-2019						0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					E21	E21		10.1056/NEJMicm071130	http://dx.doi.org/10.1056/NEJMicm071130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463372				2022-12-28	WOS:000255577700010
J	Richards, JB; Rivadeneira, F; Inouye, M; Pastinen, TM; Soranzo, N; Wilson, SG; Andrew, T; Falchi, M; Gwilliam, R; Ahmadi, KR; Valdes, AM; Arp, P; Whittaker, P; Verlaan, DJ; Jhamai, M; Kumanduri, V; Moorhouse, M; van Meurs, JB; Hofman, A; Pols, HAP; Hart, D; Zhai, G; Kato, BS; Mullin, BH; Zhang, F; Deloukas, P; Uitterlinden, AG; Spector, TD				Richards, J. B.; Rivadeneira, F.; Inouye, M.; Pastinen, T. M.; Soranzo, N.; Wilson, S. G.; Andrew, T.; Falchi, M.; Gwilliam, R.; Ahmadi, K. R.; Valdes, A. M.; Arp, P.; Whittaker, P.; Verlaan, D. J.; Jhamai, M.; Kumanduri, V.; Moorhouse, M.; van Meurs, J. B.; Hofman, A.; Pols, H. A. P.; Hart, D.; Zhai, G.; Kato, B. S.; Mullin, B. H.; Zhang, F.; Deloukas, P.; Uitterlinden, A. G.; Spector, T. D.			Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study	LANCET			English	Article							BODY-MASS INDEX; ORAL CORTICOSTEROIDS; GENE POLYMORPHISMS; COMMON VARIANT; RISK; RECEPTOR; WOMEN; OSTEOPROTEGERIN; PROBABILITY; CHILDHOOD	Background Osteoporosis is diagnosed by the measurement of bone mineral density which is a highly heritable and multifactorial trait. We aimed to identify genetic loci that are associated with bone mineral density. Methods In this genome-wide association study, we identified the most promising of 314075 single nucleotide polymorphisms (SNPs) in 2094 women in a UK study. We then tested these SNPs for replication in 6463 people from three other cohorts in western Europe. We also investigated allelic expression in lymphoblast cell lines. We tested the association between the replicated SNPs and osteoporotic fractures with data from two studies. Findings We identified genome-wide evidence for an association between bone mineral density and two SNPs (p<5x10(-8)). The SNPs were rs4355801, on chromosome 8, near to the TNFRSF11B (osteoprotegerin) gene, and rs3736228, on chromosome 11 in the LRP5 (lipoprotein-receptor-related protein) gene. A non-synonymous SNP in the LRP5 gene was associated with decreased bone mineral density (rs3736228, p=6.3x10(-12) for lumbar spine and p=1.9x10(-4) for femoral neck) and an increased risk of both osteoporotic fractures (odds ratio [OR] 1.3, 95% Cl 1.09-1.52, p=0.002) and osteoporosis (OR 1.3, 1.08-1.63, p=0.008). Three SNPs near the TNFRSF11B gene were associated with decreased bone mineral density (top SNP, rs4355801: p=7.6x10(-10) for lumbar spine and p=3.3x10(-8) for femoral neck) and increased risk of osteoporosis (OR 1.2, 95% Cl 1 .01-1.42, p=0.038). For carriers of the risk allele at rs4355801, expression of TNFRSF11B in lymphoblast cell lines was halved (p=3.0x10(-6)). 1883 (22%) of 8557 people were at least heterozygous for these risk alleles, and these alleles had a cumulative association with bone mineral density (trend p=2.3x10(-17)). The presence of both risk alleles increased the risk of osteoporotic fractures (OR 1 .3, 1.08-1.63, p=0.006) and this effect was independent of bone mineral density. Interpretation Two gene variants of key biological proteins increase the risk of osteoporosis and osteoporotic fracture. The combined effect of these risk alleles on fractures is similar to that of most well-replicated environmental risk factors, and they are present in more than one in five white people, suggesting a potential role in screening. Funding Wellcome Trust, European Commission, NWO Investments, Arthritis Research Campaign, Chronic Disease Research Foundation, Canadian Institutes of Health Research, European Society for Clinical and Economic Aspects of Osteoporosis, Genome Canada, Genome Quebec, Canada Research Chairs, National Health and Medical Research Council of Australia, and European Union.	[Richards, J. B.; Andrew, T.; Falchi, M.; Ahmadi, K. R.; Valdes, A. M.; Hart, D.; Zhai, G.; Kato, B. S.; Zhang, F.; Spector, T. D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Rivadeneira, F.; Arp, P.; Jhamai, M.; Moorhouse, M.; van Meurs, J. B.; Pols, H. A. P.; Uitterlinden, A. G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Rivadeneira, F.; Hofman, A.; Pols, H. A. P.; Uitterlinden, A. G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Inouye, M.; Soranzo, N.; Gwilliam, R.; Whittaker, P.; Kumanduri, V.; Deloukas, P.] Wellcome Trust Sanger Inst, Hinxton, England; [Pastinen, T. M.; Verlaan, D. J.] McGill Univ, Genome Quebec Innovat Ctr, Dept Human Genet, Montreal, PQ, Canada; [Wilson, S. G.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Wilson, S. G.; Mullin, B. H.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Verlaan, D. J.] Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada	University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Wellcome Trust Sanger Institute; McGill University; University of Western Australia; University of Western Australia; Universite de Montreal	Spector, TD (corresponding author), St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London SE1 7EH, England.	tim.spector@kcl.ac.uk	Deloukas, Panos/B-2922-2013; Mullin, Benjamin/H-5493-2014; Falchi, Mario/F-5956-2013; Rivadeneira, Fernando/O-5385-2015; Richards, J Brent/AAF-4225-2019; Spector, Tim D/F-6533-2012; Ahmadi, Kourosh R/B-6379-2012; Andrew, Toby/O-8868-2017	Deloukas, Panos/0000-0001-9251-070X; Rivadeneira, Fernando/0000-0001-9435-9441; Richards, J Brent/0000-0002-3746-9086; Inouye, Michael/0000-0001-9413-6520; Andrew, Toby/0000-0001-8838-4384; Wilson, Scott/0000-0002-0357-1373; Falchi, Mario/0000-0002-5646-1004; Valdes, Ana M./0000-0003-1141-4471; Mullin, Benjamin/0000-0003-0743-770X; Soranzo, Nicole/0000-0003-1095-3852	Arthritis Research UK [17489] Funding Source: Medline; Versus Arthritis [17489] Funding Source: Medline; Wellcome Trust [077011] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		Arden NK, 1996, J BONE MINER RES, V11, P530; Arden NK, 1996, BRIT J RHEUMATOL, V35, P1299; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Coleman T, 2004, BRIT MED J, V328, P575, DOI 10.1136/bmj.328.7439.575; *CONS IH, 2007, NATURE, V449, P10; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Fang Y, 2005, AM J HUM GENET, V77, P807, DOI 10.1086/497438; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; Hofbauer LC, 2000, J CLIN ENDOCR METAB, V85, P2355, DOI 10.1210/jc.85.7.2355; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P466, DOI 10.1007/BF00143123; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hsu YH, 2006, HUM GENET, V118, P568, DOI 10.1007/s00439-005-0062-4; Ioannidis JPA, 2004, JAMA-J AM MED ASSOC, V292, P2105, DOI 10.1001/jama.292.17.2105; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Langdahl BL, 2002, J BONE MINER RES, V17, P1245, DOI 10.1359/jbmr.2002.17.7.1245; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ralston SH, 2006, PLOS MED, V3, P515, DOI 10.1371/journal.pmed.0030090; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Richards JB, 2007, J BONE MINER RES, V22, P228, DOI 10.1359/JBMR.061109; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stolk L, 2007, J CLIN ENDOCR METAB, V92, P3206, DOI 10.1210/jc.2006-2136; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Ueland T, 2007, BONE, V40, P175, DOI 10.1016/j.bone.2006.06.022; Uitterlinden AG, 2006, ANN INTERN MED, V145, P255, DOI 10.7326/0003-4819-145-4-200608150-00005; van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; van Staa TP, 2000, QJM-MON J ASSOC PHYS, V93, P105, DOI 10.1093/qjmed/93.2.105; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; WILLIAMS FM, 2007, AETA RHEUM PORT, V32, P103	57	501	531	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1505	1512		10.1016/S0140-6736(08)60599-1	http://dx.doi.org/10.1016/S0140-6736(08)60599-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18455228	Green Published, Green Accepted			2022-12-28	WOS:000255668300026
J	Guest, J				Guest, James			Ecology - How reefs respond to mass coral spawning	SCIENCE			English	Editorial Material							GREAT-BARRIER-REEF; AUSTRALIA; FISH/		Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Guest, J (corresponding author), Univ Newcastle Upon Tyne, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	james.guest@ncl.ac.uk	Guest, James/D-5179-2011	Guest, James/0000-0002-9714-9009				BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2001, MAR FRESHWATER RES, V52, P865, DOI 10.1071/MF00144; Eyre BD, 2008, LIMNOL OCEANOGR, V53, P997, DOI 10.4319/lo.2008.53.3.0997; Glud RN, 2008, LIMNOL OCEANOGR, V53, P1014, DOI 10.4319/lo.2008.53.3.1014; Guest JR, 2005, INVERTEBR REPROD DEV, V48, P207, DOI 10.1080/07924259.2005.9652186; Hagman Derek K., 1998, Gulf of Mexico Science, V16, P170; HAMNER WM, 1988, B MAR SCI, V42, P459; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; SIMPSON CJ, 1993, CORAL REEFS, V12, P185, DOI 10.1007/BF00334478; Wild C, 2008, CORAL REEFS, V27, P123, DOI 10.1007/s00338-007-0298-7; Wild C, 2004, MAR ECOL PROG SER, V271, P159, DOI 10.3354/meps271159; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; [No title captured]	14	14	14	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					621	623		10.1126/science.1155285	http://dx.doi.org/10.1126/science.1155285			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451290				2022-12-28	WOS:000255454300031
J	Devereaux, PJ; Yang, H; Yusuf, S; Guyatt, G; Leslie, K; Villar, JC; Xavier, D; Chrolavicius, S; Greenspan, L; Pogue, J; Pais, P; Liu, LS; Xu, SC; Malaga, G; Avezum, A; Chan, M; Montori, VM; Jacka, M; Choi, P				Devereaux, P. J.; Yang, Homer; Yusuf, Salim; Guyatt, Gordon; Leslie, Kate; Villar, Juan Carlos; Xavier, Denis; Chrolavicius, Susan; Greenspan, Launi; Pogue, Janice; Pais, Prem; Liu, Lisheng; Xu, Shouchun; Malaga, German; Avezum, Alvaro; Chan, Matthew; Montori, Victor M.; Jacka, Mike; Choi, Peter		POISE Study Grp	Effects of extended-release metoprolol succinate inpatients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial	LANCET			English	Article							PERIOPERATIVE BETA-BLOCKADE; ACUTE MYOCARDIAL-INFARCTION; HIGH-RISK PATIENTS; VASCULAR-SURGERY; MULTICENTER TRIAL; CLINICAL-TRIALS; CARDIAC EVENTS; ISCHEMIA; PLACEBO; MORTALITY	Background Trials of beta blockers in patients undergoing non-cardiac surgery have reported conflicting results. This randomised controlled trial, done in 190 hospitals in 23 countries, was designed to investigate the effects of perioperative beta blockers. Methods We randomly assigned 8351 patients with, or at risk of, atherosclerotic disease who were undergoing non-cardiac surgery to receive extended-release metoprolol succinate (n=4174) or placebo (n=4177), by a computerised randomisation phone service. Study treatment was started 2-4 h before surgery and continued for 30 days. Patients, health-care providers, data collectors, and outcome adjudicators were masked to treatment allocation. The primary endpoint was a composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal cardiac arrest. Analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00182039. Findings All 8351 patients were included in analyses; 8331 (99.8%) patients completed the 30-day follow-up. Fewer patients in the metoprolol group than in the placebo group reached the primary endpoint (244 [5.8%] patients in the metoprolol group vs 290 [6.9%] in the placebo group; hazard ratio 0 . 84, 95% CI 0 . 70-0.99; p=0.0399). Fewer patients in the metoprolol group than in the placebo group had a myocardial infarction (176 [4.2%] vs 239 [5.7%] patients; 0 .73, 0.60-0.89; p=0. 0017). However, there were more deaths in the metoprolol group than in the placebo group (129 [3 . 1%] vs 97 [2.3%] patients; 1 . 33, 1.03-1.74; p=0.0317). More patients in the metoprolol group than in the placebo group had a stroke (41 [1 . 0%] vs 19 [0.5%] patients; 2.17, 1.26-3.74; p=0.0053). Interpretation Our results highlight the risk in assuming a perioperative beta-blocker regimen has benefit without substantial harm, and the importance and need for large randomised trials in the perioperative setting. Patients are unlikely to accept the risks associated with perioperative extended-release metoprolol. Funding Canadian Institutes of Health Research; Commonwealth Government of Australia's National Health and Medical Research Council; Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo), Spain; British Heart Foundation; AstraZeneca.	[Devereaux, P. J.] McMaster Univ, Fac Hlth Sci Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada	McMaster University	Devereaux, PJ (corresponding author), McMaster Univ, Fac Hlth Sci Clin Epidemiol & Biostat, Room 2C8,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	philipj@mcmaster.ca	Villar Centeno, Juan Carlos/AAX-5401-2021; Devereaux, PJ/AAY-1757-2021; Bryson, Gregory Lyle/AAG-5108-2019; de Nadal, Miriam/J-8127-2017; Dieguez, Marcelo Garcia/AAW-5810-2020; Beattie, William Scott/A-4352-2008; Chan, Matthew/J-2884-2013; Devereaux, PJ/AAF-2862-2019; Wijeysundera, Duminda/L-3350-2018; Merchant, Richard N/P-3859-2017; Darvas, Katalin/X-9666-2019; Avezum, Alvaro AA/K-6137-2016; Avezum, Alvaro/AAP-7687-2020; GIN, Tony/J-2521-2013	Bryson, Gregory Lyle/0000-0003-3583-9802; de Nadal, Miriam/0000-0002-4559-2463; Chan, Matthew/0000-0002-3574-7855; Wijeysundera, Duminda/0000-0002-5897-8605; Merchant, Richard N/0000-0002-8526-2477; Darvas, Katalin/0000-0003-4322-7523; Avezum, Alvaro AA/0000-0002-3073-6890; GIN, Tony/0000-0001-7283-6761; Gilbert, Kenneth/0000-0003-0024-9941; Kerridge, Ross/0000-0002-7503-346X; Malaga, German/0000-0002-7828-300X; Myles, Paul/0000-0002-3324-5456; Urrutia, Gerard/0000-0002-8850-0960; Yusuf, Salim/0000-0003-4776-5601; SIGAMANI, ALBEN/0000-0002-6927-1947; Canon-Montanez, Wilson/0000-0003-0729-5342; Montori, Victor/0000-0003-0595-2898; Malmstedt, Jonas/0000-0002-2758-9623; RAMANA, P V/0000-0003-4654-0590; Villar, Juan Carlos/0000-0002-7047-7299; Marin-Neto, Jose Antonio/0000-0002-8651-8833; Leslie, Kate/0000-0001-8512-3517; Phrommintikul, Arintaya/0000-0003-3986-1951; Albuquerque, Denilson/0000-0003-1883-6546; Held, Claes/0000-0001-9402-7404; Rojas-Reyes, Maria Ximena/0000-0001-5752-7653	British Heart Foundation Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Bayliff CD, 1999, ANN THORAC SURG, V67, P182, DOI 10.1016/S0003-4975(98)01226-0; BLOMQVIST I, 1988, EUR J CLIN PHARMACOL, V33, pS19, DOI 10.1007/BF00578408; Chen ZM, 2005, LANCET, V366, P1622; Devereaux PJ, 2006, AM HEART J, V152, P223, DOI 10.1016/j.ahj.2006.05.019; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011; Devereaux PJ, 2005, CAN MED ASSOC J, V173, P779, DOI 10.1503/cmaj.050316; Devereaux PJ, 2004, CAN MED ASSOC J, V171, P245, DOI 10.1503/cmaj.1031619; EGSTRUP K, 1988, EUR J CLIN PHARMACOL, V33, pS45, DOI 10.1007/BF00578412; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Jakobsen CJ, 1997, ACTA ANAESTH SCAND, V41, P1324, DOI 10.1111/j.1399-6576.1997.tb04652.x; Juul AB, 2006, BMJ-BRIT MED J, V332, P1482, DOI 10.1136/bmj.332.7556.1482; Kohsaka S, 2005, ARCH INTERN MED, V165, P1643, DOI 10.1001/archinte.165.14.1643; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; MANGANO DT, 1999, BAILLIERE CLIN ANAES, V13, P335; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; PARKER SD, 1995, CRIT CARE MED, V23, P1954, DOI 10.1097/00003246-199512000-00003; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Powell JT, 2005, J VASC SURG, V41, P602, DOI 10.1016/j.jvs.2005.01.048; Raby KE, 1999, ANESTH ANALG, V88, P477, DOI 10.1097/00000539-199903000-00002; Sametz W, 1999, EUR J CLIN INVEST, V29, P582; STONE JG, 1988, BRIT J ANAESTH, V61, P675, DOI 10.1093/bja/61.6.675; Urban MK, 2000, ANESTH ANALG, V90, P1257, DOI 10.1097/00000539-200006000-00001; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; Yang H, 2006, AM HEART J, V152, P983, DOI 10.1016/j.ahj.2006.07.024; Zaugg M, 1999, ANESTHESIOLOGY, V91, P1674, DOI 10.1097/00000542-199912000-00020; Zaugg M, 2007, ANESTHESIOLOGY, V107, P33, DOI 10.1097/01.anes.0000267530.62344.a4	30	1371	1420	1	58	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2008	371	9627					1839	1847		10.1016/S0140-6736(08)60601-7	http://dx.doi.org/10.1016/S0140-6736(08)60601-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NL	18479744	Bronze			2022-12-28	WOS:000256325500027
J	Guler, AD; Ecker, JL; Lall, GS; Haq, S; Altimus, CM; Liao, HW; Barnard, AR; Cahill, H; Badea, TC; Zhao, HQ; Hankins, MW; Berson, DM; Lucas, RJ; Yau, KW; Hattar, S				Gueler, Ali D.; Ecker, Jennifer L.; Lall, Gurprit S.; Haq, Shafiqul; Altimus, Cara M.; Liao, Hsi-Wen; Barnard, Alun R.; Cahill, Hugh; Badea, Tudor C.; Zhao, Haiqing; Hankins, Mark W.; Berson, David M.; Lucas, Robert J.; Yau, King-Wai; Hattar, Samer			Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision	NATURE			English	Article							RETINAL GANGLION-CELLS; RESPONSES; PROJECTIONS; LIGHT	Rod and cone photoreceptors detect light and relay this information through a multisynaptic pathway to the brain by means of retinal ganglion cells (RGCs)(1). These retinal outputs support not only pattern vision but also non- image- forming ( NIF) functions, which include circadian photoentrainment and pupillary light reflex ( PLR). In mammals, NIF functions are mediated by rods, cones and the melanopsin- containing intrinsically photosensitive retinal ganglion cells (ipRGCs)(2,3). Rod - cone photoreceptors and ipRGCs are complementary in signalling light intensity for NIF functions(4-12). The ipRGCs, in addition to being directly photosensitive, also receive synaptic input from rod - cone networks(13,14). To determine how the ipRGCs relay rod - cone light information for both image- forming and non- image- forming functions, we genetically ablated ipRGCs in mice. Here we show that animals lacking ipRGCs retain pattern vision but have deficits in both PLR and circadian photoentrainment that are more extensive than those observed in melanopsin knockouts(8,10,11). The defects in PLR and photoentrainment resemble those observed in animals that lack phototransduction in all three photoreceptor classes(6). These results indicate that light signals for irradiance detection are dissociated from pattern vision at the retinal ganglion cell level, and animals that cannot detect light for NIF functions are still capable of image formation.	[Gueler, Ali D.; Ecker, Jennifer L.; Altimus, Cara M.; Zhao, Haiqing; Hattar, Samer] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Lall, Gurprit S.; Barnard, Alun R.; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Haq, Shafiqul; Liao, Hsi-Wen; Cahill, Hugh; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Hankins, Mark W.] Univ Oxford, Oxford OX3 7BN, England; [Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Johns Hopkins University; University of Manchester; Johns Hopkins University; University of Oxford; Brown University	Hattar, S (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	robert.lucas@manchester.ac.uk; shattar@jhu.edu	Hattar, Samer/W-6927-2019; Badea, Tudor Constantin/B-1654-2018	Badea, Tudor Constantin/0000-0003-3086-6713; Lall, Gurprit/0000-0003-3725-4795; Guler, Ali Deniz/0000-0001-8218-850X; Lucas, Robert/0000-0002-1088-8029	NEI NIH HHS [R01 EY006837, R01 EY014596-01, R01 EY014596-03, R01 EY014596-06, R01 EY014596-04, R01 EY006837-21, R01 EY014596-02, R01 EY006837-20A1, R01 EY006837-18, R01 EY014596-05, R01 EY006837-16A1, R01 EY017137, R01 EY014596] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904-04, R01 DC006904, R01 DC006904-02, R01 DC006904-03, R01 DC006904-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM076430-01, R01 GM076430-04, R01 GM076430-02, R01 GM076430, R01 GM076430-05, R01 GM076430-03] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006837, R01EY014596, R01EY017137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], 1988, EYE BRAIN VISION; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sollars PJ, 2003, VISUAL NEUROSCI, V20, P601, DOI 10.1017/S0952523803206027; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wee R, 2002, J NEUROSCI, V22, P10427; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751	26	577	591	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					102	+		10.1038/nature06829	http://dx.doi.org/10.1038/nature06829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18432195	Green Accepted			2022-12-28	WOS:000255398800047
J	Burbine, TH				Burbine, Thomas H.			Planetary science - Identifying ancient asteroids	SCIENCE			English	Editorial Material							RICH INCLUSIONS		[Burbine, Thomas H.] Mt Holyoke Coll, Dept Astron, S Hadley, MA 01075 USA	Mount Holyoke College	Burbine, TH (corresponding author), Mt Holyoke Coll, Dept Astron, S Hadley, MA 01075 USA.	tburbine@mtholyoke.edu						Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BELL JF, 1988, LUNAR PLANET SCI, V19, P57; BURBINE TH, 1992, METEORITICS, V27, P424, DOI 10.1111/j.1945-5100.1992.tb00224.x; Bus SJ, 2002, ICARUS, V158, P106, DOI 10.1006/icar.2002.6857; Fagan TJ, 2007, METEORIT PLANET SCI, V42, P1221, DOI 10.1111/j.1945-5100.2007.tb00570.x; GRIMM RE, 1989, ICARUS, V82, P242; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Sunshine JM, 2008, SCIENCE, V320, P514, DOI 10.1126/science.1154340; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	10	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					457	458		10.1126/science.1157604	http://dx.doi.org/10.1126/science.1157604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436762				2022-12-28	WOS:000255249300023
J	Darland-Ransom, M; Wang, XC; Sun, CL; Mapes, J; Gengyo-Ando, K; Mitani, S; Xue, D				Darland-Ransom, Monica; Wang, Xiaochen; Sun, Chun-Ling; Mapes, James; Gengyo-Ando, Keiko; Mitani, Shohei; Xue, Ding			Role of C-elegans TAT-1 protein in maintaining plasma membrane phosphatidylserine asymmetry	SCIENCE			English	Article							CELL CORPSE ENGULFMENT; C-ELEGANS; APOPTOTIC CELLS; AMINOPHOSPHOLIPID TRANSLOCASE; GENETIC INTERFERENCE; ATPASE-II; DEATH; RECEPTOR; PHAGOCYTOSIS; EXPRESSION	The asymmetrical distribution of phospholipids on the plasma membrane is critical for maintaining cell integrity and physiology and for regulating intracellular signaling and important cellular events such as clearance of apoptotic cells. How phospholipid asymmetry is established and maintained is not fully understood. We report that the Caenorhabditis elegans P- type adenosine triphosphatase homolog, TAT-1, is critical for maintaining cell surface asymmetry of phosphatidylserine ( PS). In animals deficient in tat-1, PS is abnormally exposed on the cell surface, and normally living cells are randomly lost through a mechanism dependent on PSR- 1, a PS- recognizing phagocyte receptor, and CED- 1, which contributes to recognition and engulfment of apoptotic cells. Thus, tat- 1 appears to function in preventing appearance of PS in the outer leaflet of plasma membrane, and ectopic exposure of PS on the cell surface may result in removal of living cells by neighboring phagocytes.	[Darland-Ransom, Monica; Wang, Xiaochen; Sun, Chun-Ling; Mapes, James; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Gengyo-Ando, Keiko; Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu	Gengyo-Ando, Keiko/B-2753-2012; Gengyo-Ando, Keiko/AAC-4504-2019	XUE, DING/0000-0002-8429-8136; Ransom, Monica/0000-0002-7527-7122	NIGMS NIH HHS [R01 GM059083, R01 GM088241, R01 GM079097, R01 GM59083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM088241, R01GM079097] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AULAND ME, 1994, P NATL ACAD SCI USA, V91, P10938, DOI 10.1073/pnas.91.23.10938; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2001, CELL DEATH DIFFER, V8, P582, DOI 10.1038/sj.cdd.4400856; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; HARRISON RAP, 1990, J REPROD FERTIL, V88, P343, DOI 10.1530/jrf.0.0880343; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kelly WG, 1997, GENETICS, V146, P227; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641; Wang XC, 2007, NAT CELL BIOL, V9, P541, DOI 10.1038/ncb1574; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zahn TR, 2001, J COMP NEUROL, V429, P127, DOI 10.1002/1096-9861(20000101)429:1&lt;127::AID-CNE10&gt;3.0.CO;2-H; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Zullig S, 2007, CURR BIOL, V17, P994, DOI 10.1016/j.cub.2007.05.024	24	101	119	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					528	531		10.1126/science.1155847	http://dx.doi.org/10.1126/science.1155847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436785				2022-12-28	WOS:000255249300050
J	Weisel, JW				Weisel, John W.			Biophysics - Enigmas of blood clot elasticity	SCIENCE			English	Editorial Material							FIBRIN; FIBERS		[Weisel, John W.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu						Brown AEX, 2007, BIOPHYS J, V92, pL39, DOI 10.1529/biophysj.106.101261; Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c; Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102; Ferry J. D., 1988, BIOL SYNTHETIC POLYM, P41; Lim BBC, 2008, STRUCTURE, V16, P449, DOI 10.1016/j.str.2007.12.019; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; MULLER MF, 1984, J MOL BIOL, V174, P369, DOI 10.1016/0022-2836(84)90343-7; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	14	62	62	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					456	457		10.1126/science.1154210	http://dx.doi.org/10.1126/science.1154210			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436761				2022-12-28	WOS:000255249300022
J	Yang, CG; Yi, CQ; Duguid, EM; Sullivan, CT; Jian, X; Rice, PA; He, C				Yang, Cai-Guang; Yi, Chengqi; Duguid, Erica M.; Sullivan, Christopher T.; Jian, Xing; Rice, Phoebe A.; He, Chuan			Crystal structures of DNA/RNA repair enzymes AlkB and ABH2 bound to dsDNA	NATURE			English	Article							OXIDATIVE DEMETHYLATION; ALKYLATION DAMAGE; DNA; BACTERIAL; LESIONS; 3-METHYLTHYMINE; PROTEIN; IRON; 1-METHYLGUANINE; 8-OXOGUANINE	Escherichia coli AlkB and its human homologues ABH2 and ABH3 repair DNA/ RNA base lesions by using a direct oxidative dealkylation mechanism. ABH2 has the primary role of guarding mammalian genomes against 1- meA damage by repairing this lesion in double- stranded DNA ( dsDNA), whereas AlkB and ABH3 preferentially repair single- stranded DNA ( ssDNA) lesions and can repair damaged bases in RNA. Here we show the first crystal structures of AlkB - dsDNA and ABH2 - dsDNA complexes, stabilized by a chemical cross- linking strategy. This study reveals that AlkB uses an unprecedented base- flipping mechanism to access the damaged base: it squeezes together the two bases flanking the flipped- out one to maintain the base stack, explaining the preference of AlkB for repairing ssDNA lesions over dsDNA ones. In addition, the first crystal structure of ABH2, presented here, provides a structural basis for designing inhibitors of this human DNA repair protein.	[Yang, Cai-Guang; Yi, Chengqi; Duguid, Erica M.; Sullivan, Christopher T.; Jian, Xing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, C (corresponding author), Univ Chicago, Dept Chem, 929 E 57th St, Chicago, IL 60637 USA.	chuanhe@uchicago.edu	Jian, Xing/N-3753-2018	Jian, Xing/0000-0002-0043-8729; Duguid, Erica/0000-0003-4319-1030; Yi, Chengqi/0000-0003-2540-9729	NIGMS NIH HHS [GM071440, R01 GM071440, R01 GM071440-03] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W.L, PYMOL MOL GRAPHICS S; Dinglay S, 2000, GENE DEV, V14, P2097; Duguid EM, 2003, CHEM BIOL, V10, P827, DOI 10.1016/j.chembiol.2003.08.007; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Friedberg EC, 1995, DNA REPAIR MUTAGENES; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Lange SJ, 1998, CURR OPIN CHEM BIOL, V2, P159, DOI 10.1016/S1367-5931(98)80057-4; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lee DH, 2005, J BIOL CHEM, V280, P39448, DOI 10.1074/jbc.M509881200; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Mishina Y, 2003, J AM CHEM SOC, V125, P8730, DOI 10.1021/ja034636c; Mishina Y, 2005, J AM CHEM SOC, V127, P14594, DOI 10.1021/ja055957m; Mishina Y, 2004, J AM CHEM SOC, V126, P16930, DOI 10.1021/ja045066z; Mishina Y, 2004, NUCLEIC ACIDS RES, V32, P1548, DOI 10.1093/nar/gkh319; Mishina Y, 2006, J INORG BIOCHEM, V100, P670, DOI 10.1016/j.jinorgbio.2005.12.018; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Read RJ, 2003, ACTA CRYSTALLOGR D, V59, P404, DOI 10.1107/S0907444903000490; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	44	193	199	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					961	U4		10.1038/nature06889	http://dx.doi.org/10.1038/nature06889			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432238	Green Accepted			2022-12-28	WOS:000255208600032
J	Chung, KF; Pavord, ID				Chung, Kian Fan; Pavord, Ian D.			Chronic cough 1 - Prevalence, pathogenesis, and causes of chronic cough	LANCET			English	Review							CHRONIC PERSISTENT COUGH; POSTNASAL-DRIP-SYNDROME; GASTROESOPHAGEAL REFLUX DISEASE; SOLE PRESENTING MANIFESTATION; BRONCHOALVEOLAR LAVAGE FLUID; CAPSAICIN-INDUCED COUGH; GLASS BOTTLE WORKERS; AIR-FLOW OBSTRUCTION; RESPIRATORY SYMPTOMS; EOSINOPHILIC BRONCHITIS	Cough is a reflex action of the respiratory tract that is used to clear the upper airways. Chronic cough lasting for more than 8 weeks is common in the community. The causes include cigarette smoking, exposure to cigarette smoke, and exposure to environmental pollution, especially particulates. Diseases causing chronic cough include asthma, eosinophilic bronchitis, gastro-oesophageal reflux disease, postnasal drip syndrome or rhinosinusitis, chronic obstructive pulmonary disease, pulmonary fibrosis, and bronchiectasis. Doctors should always work towards a clear diagnosis, considering common and rare illnesses. In some patients, no cause is identified, leading to the diagnosis of idiopathic cough. Chronic cough is often associated with an increased response to tussive agents such as capsaicin. Plastic changes in intrinsic and synaptic excitability in the brainstem, spine, or airway nerves can enhance the cough reflex, and can persist in the absence of the initiating cough event. Structural and inflammatory airway mucosal changes in non-asthmatic chronic cough could represent the cause or the traumatic response to repetitive coughing. Effective control of cough requires not only controlling the disease causing the cough but also desensitisation of cough pathways.	[Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London SW3 6LY, England; [Chung, Kian Fan] Royal Brompton Hosp, London SW3 6LY, England; [Pavord, Ian D.] Univ Hosp Leicester NHS Trust, Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Inst Lung Hlth, Leicester, Leics, England	Imperial College London; Royal Brompton Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, Dovehouse St, London SW3 6LY, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Pavord, Ian/0000-0002-4288-5973	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		BALUK P, 1992, J COMP NEUROL, V319, P586, DOI 10.1002/cne.903190408; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; BARBEE RA, 1991, CHEST, V99, P20, DOI 10.1378/chest.99.1.20; Bayer-Oglesby L, 2006, AM J EPIDEMIOL, V164, P1190, DOI 10.1093/aje/kwj338; Benini L, 2000, GUT, V46, P762, DOI 10.1136/gut.46.6.762; BERKIN KE, 1988, BMJ-BRIT MED J, V296, P1279, DOI 10.1136/bmj.296.6632.1279; Birkebaek NH, 1999, CLIN INFECT DIS, V29, P1239, DOI 10.1086/313448; Birring SS, 2004, EUR RESPIR J, V23, P199, DOI 10.1183/09031936.03.00066403; Birring SS, 2004, AM J RESP CRIT CARE, V169, P15, DOI 10.1164/rccm.200308-1092OC; Birring SS, 2003, THORAX, V58, P1066, DOI 10.1136/thorax.58.12.1066; Bonham AC, 2006, RESP PHYSIOL NEUROBI, V152, P312, DOI 10.1016/j.resp.2006.02.010; BONNET R, 1995, CHEST, V108, P581, DOI 10.1378/chest.108.2.581; BOULET LP, 1994, AM J RESP CRIT CARE, V149, P482, DOI 10.1164/ajrccm.149.2.8306050; BraunFahrlander C, 1997, AM J RESP CRIT CARE, V155, P1042, DOI 10.1164/ajrccm.155.3.9116984; Brichtling CE, 2000, AM J RESP CRIT CARE, V162, P878, DOI 10.1164/ajrccm.162.3.9909064; Brightling CE, 2000, EUR RESPIR J, V15, P682, DOI 10.1034/j.1399-3003.2000.15d10.x; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Brightling CE, 1999, AM J RESP CRIT CARE, V160, P406, DOI 10.1164/ajrccm.160.2.9810100; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; BUCCA C, 1995, J ALLERGY CLIN IMMUN, V95, P52, DOI 10.1016/S0091-6749(95)70152-4; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Canning BJ, 2006, RESP PHYSIOL NEUROBI, V152, P223, DOI 10.1016/j.resp.2006.03.001; Carney IK, 1997, AM J RESP CRIT CARE, V156, P211, DOI 10.1164/ajrccm.156.1.9605044; Carter Edward R, 2006, Cough, V2, P11, DOI 10.1186/1745-9974-2-11; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Cerveri I, 2003, EUR RESPIR J, V22, P413, DOI 10.1183/09031936.03.00121103; CHOUDRY NB, 1989, AM REV RESPIR DIS, V140, P137, DOI 10.1164/ajrccm/140.1.137; CHOUDRY NB, 1992, EUR RESPIR J, V5, P296; Chung KF, 2006, EUR RESPIR J, V27, P230, DOI 10.1183/09031936.06.00089405; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372, DOI 10.1164/ajrccm.164.3.2004029; Coyle Michael A, 2005, Cough, V1, P3, DOI 10.1186/1745-9974-1-3; CULLINAN P, 1993, J EPIDEMIOL COMMUN H, V47, P27, DOI 10.1136/jech.47.1.27; CULLINAN P, 1992, RESP MED, V86, P143, DOI 10.1016/S0954-6111(06)80231-3; David GL, 2005, THORAX, V60, P1052, DOI 10.1136/thx.2005.042960; DAVIS SF, 1995, CLIN INFECT DIS, V20, P621, DOI 10.1093/clinids/20.3.621; de Jongste JC, 2003, THORAX, V58, P998, DOI 10.1136/thorax.58.11.998; de Marco R, 2007, AM J RESP CRIT CARE, V175, P32, DOI 10.1164/rccm.200603-381OC; Doherty MJ, 2000, THORAX, V55, P1028, DOI 10.1136/thorax.55.12.1028; Doherty MJ, 2000, THORAX, V55, P643, DOI 10.1136/thorax.55.8.643; Eccles R, 2003, COUGH: CAUSES, MECHANISMS AND THERAPY, P259, DOI 10.1002/9780470755846.ch25; FERRARI M, 1995, AM J RESP CRIT CARE, V151, P557, DOI 10.1164/ajrccm.151.2.7842220; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Ford CN, 2005, JAMA-J AM MED ASSOC, V294, P1534, DOI 10.1001/jama.294.12.1534; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; Fujimura M, 2005, RESPIROLOGY, V10, P201, DOI 10.1111/j.1440-1843.2005.00686.x; Fujimura M, 2003, THORAX, V58, P14, DOI 10.1136/thorax.58.1.14; Fujimura M, 2000, CLIN EXP ALLERGY, V30, P41; Fujimura M, 1997, J ASTHMA, V34, P119, DOI 10.3109/02770909709075656; Gehring U, 2002, EUR RESPIR J, V19, P690, DOI 10.1183/09031936.02.01182001; Gibson PG, 2002, THORAX, V57, P178, DOI 10.1136/thorax.57.2.178; GIBSON PG, 1989, LANCET, V1, P1346; Gibson PG, 1998, J ALLERGY CLIN IMMUN, V101, P320, DOI 10.1016/S0091-6749(98)70242-8; GIBSON PG, 1995, CLIN EXP ALLERGY, V25, P127, DOI 10.1111/j.1365-2222.1995.tb01017.x; Gilberg S, 2002, J INFECT DIS, V186, P415, DOI 10.1086/341511; Gordon SB, 1998, OCCUP MED-OXFORD, V48, P455, DOI 10.1093/occmed/48.7.455; Gordon SB, 1997, AM J RESP CRIT CARE, V156, P206, DOI 10.1164/ajrccm.156.1.9610042; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Harnden A, 2006, BRIT MED J, V333, P174, DOI 10.1136/bmj.38870.655405.AE; HEINO M, 1990, AM REV RESPIR DIS, V141, P428, DOI 10.1164/ajrccm/141.2.428; Ho SY, 2007, ANN EPIDEMIOL, V17, P126, DOI 10.1016/j.annepidem.2006.06.010; HOFFSTEIN V, 1994, CAN RESPIR J, V1, P40; Hope-Gill BDM, 2003, AM J RESP CRIT CARE, V168, P995, DOI 10.1164/rccm.200304-597OC; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; HUTCHINGS HA, 1993, RESP MED, V87, P379, DOI 10.1016/0954-6111(93)90052-2; ING AJ, 1994, AM J RESP CRIT CARE, V149, P160, DOI 10.1164/ajrccm.149.1.8111576; Ing AJ, 2004, PULM PHARMACOL THER, V17, P403, DOI 10.1016/j.pupt.2004.09.023; Irwin RS, 2006, CHEST, V130, P362, DOI 10.1378/chest.130.2.362; IRWIN RS, 1993, CHEST, V104, P1511, DOI 10.1378/chest.104.5.1511; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Irwin RS, 2002, CHEST, V121, P1132, DOI 10.1378/chest.121.4.1132; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; JACK CIA, 1995, THORAX, V50, P201, DOI 10.1136/thx.50.2.201; Jacoby DB, 2004, PULM PHARMACOL THER, V17, P333, DOI 10.1016/j.pupt.2004.09.014; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Jatakanon A, 1999, THORAX, V54, P234, DOI 10.1136/thx.54.3.234; Joad JP, 2004, AM J RESP CRIT CARE, V169, P499, DOI 10.1164/rccm.200308-1139OC; KAMEI RK, 1991, PEDIATR CLIN N AM, V38, P593; Kastelik JA, 2005, EUR RESPIR J, V25, P235, DOI 10.1183/09031936.05.00140803; KATSUMATA U, 1989, TOHOKU J EXP MED, V158, P105, DOI 10.1620/tjem.158.105; Kimber J, 1998, J NEUROL NEUROSUR PS, V65, P583, DOI 10.1136/jnnp.65.4.583; Kohno S, 2006, RESPIROLOGY, V11, pS135, DOI 10.1111/j.1400-1843.2006.00920.x; Kok C, 2003, AM J HUM GENET, V73, P632, DOI 10.1086/377591; Kollarik M, 2006, RESP PHYSIOL NEUROBI, V152, P243, DOI 10.1016/j.resp.2005.12.008; Kwon NH, 2006, CHEST, V129, P1142, DOI 10.1378/chest.129.5.1142; Kwong K, 2005, J PHYSIOL-LONDON, V564, P437, DOI 10.1113/jphysiol.2004.078725; Kwong K, 2002, J APPL PHYSIOL, V93, P1419, DOI 10.1152/japplphysiol.00382.2002; Lalloo UG, 1998, EUR RESPIR J, V11, P702; Lee SY, 2001, CHEST, V120, P1114, DOI 10.1378/chest.120.4.1114; Ludviksdottir D, 1996, CHEST, V109, P1262, DOI 10.1378/chest.109.5.1262; LUNDBACK B, 1991, EUR RESPIR J, V4, P257; Madison JM, 2005, CURR OPIN PULM MED, V11, P412, DOI 10.1097/01.mcp.0000174249.07762.37; Mazzone SB, 2007, AM J RESP CRIT CARE, V176, P327, DOI 10.1164/rccm.200612-1856OC; McGarvey LPA, 1998, THORAX, V53, P738, DOI 10.1136/thx.53.9.738; McGarvey LPA, 1999, EUR RESPIR J, V13, P59; McLeod Robbie L, 2006, Cough, V2, P10, DOI 10.1186/1745-9974-2-10; Mello CJ, 1996, ARCH INTERN MED, V156, P997, DOI 10.1001/archinte.156.9.997; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2004, PULM PHARMACOL THER, V17, P343, DOI 10.1016/j.pupt.2004.09.005; Morice AH, 2002, PULM PHARMACOL THER, V15, P253, DOI 10.1006/pupt.2002.0352; MORICE AH, 2006, THORAX, V61, pS21; Mund E, 2005, CHEST, V127, P1714, DOI 10.1378/chest.127.5.1714; Mund E, 2001, THORAX, V56, P450, DOI 10.1136/thorax.56.6.450; NICHOL G, 1990, THORAX, V45, P694, DOI 10.1136/thx.45.9.694; Niimi A, 2000, LANCET, V356, P564, DOI 10.1016/S0140-6736(00)02584-8; Niimi A, 2005, J ALLERGY CLIN IMMUN, V116, P565, DOI 10.1016/j.jaci.2005.07.010; Niimi A, 2004, THORAX, V59, P608, DOI 10.1136/thx.2003.012906; Niimi A, 1998, EUR RESPIR J, V11, P1064, DOI 10.1183/09031936.98.11051064; Niimi A, 2007, PULM PHARMACOL THER, V20, P383, DOI 10.1016/j.pupt.2006.10.014; Novitsky YW, 2002, SURG ENDOSC, V16, P567, DOI 10.1007/s00464-001-8328-y; OCONNELL F, 1994, AM J RESP CRIT CARE, V150, P374, DOI 10.1164/ajrccm.150.2.8049818; Ojoo JC, 2003, LANCET, V361, P674, DOI 10.1016/S0140-6736(03)12603-7; Osman LM, 2001, THORAX, V56, P138, DOI 10.1136/thorax.56.2.138; Ours TM, 1999, AM J GASTROENTEROL, V94, P3131, DOI 10.1111/j.1572-0241.1999.01504.x; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Pierse N, 2006, THORAX, V61, P216, DOI 10.1136/thx.2004.036418; POE RH, 1989, CHEST, V95, P723, DOI 10.1378/chest.95.4.723; POWER JT, 1984, AM REV RESPIR DIS, V130, P999; PRATTER MR, 1993, ANN INTERN MED, V119, P977, DOI 10.7326/0003-4819-119-10-199311150-00003; Pratter MR, 2006, CHEST, V129, p63S, DOI 10.1378/chest.129.1_suppl.63S; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; SANTAMBROGIO F, 1987, ANNU REV PHYSIOL, V49, P622; Schelegle ES, 2001, RESP PHYSIOL, V125, P17, DOI 10.1016/S0034-5687(00)00202-4; Segala C, 2004, ARCH ENVIRON HEALTH, V59, P669, DOI 10.1080/00039890409602952; Sekizawa S, 2003, J PHYSIOL-LONDON, V552, P547, DOI 10.1113/jphysiol.2003.051326; Shannon R, 1998, J APPL PHYSIOL, V84, P2020, DOI 10.1152/jappl.1998.84.6.2020; Shirahata K, 2005, RESPIROLOGY, V10, P354, DOI 10.1111/j.1440-1843.2005.00709.x; Smith J, 2006, CHEST, V130, P379, DOI 10.1016/S0012-3692(15)51851-5; SMYRNIOS NA, 1995, CHEST, V108, P991, DOI 10.1378/chest.108.4.991; Suwanprathes P, 2003, AM J MED, V115, p31S, DOI 10.1016/S0002-9343(03)00190-6; Torrego A, 2006, THORAX, V61, P706, DOI 10.1136/thx.2005.049767; TURNERWARWICK M, 1980, THORAX, V35, P171, DOI 10.1136/thx.35.3.171; Undem BJ, 2004, J PHYSIOL-LONDON, V556, P905, DOI 10.1113/jphysiol.2003.060079; Vedal S, 1998, AM J RESP CRIT CARE, V157, P1034, DOI 10.1164/ajrccm.157.4.9609008; Weinfeld D, 2002, ANN ALLERG ASTHMA IM, V89, P419, DOI 10.1016/S1081-1206(10)62045-5; Widdicombe J, 2006, EUR RESPIR J, V28, P10, DOI 10.1183/09031936.06.00096905; Widdicombe JG, 1998, RESP PHYSIOL, V114, P5, DOI 10.1016/S0034-5687(98)00076-0; WIDDICOMBE JG, 1954, J PHYSIOL-LONDON, V123, P55, DOI 10.1113/jphysiol.1954.sp005033; Widdicombe J, 2006, RESP PHYSIOL NEUROBI, V152, P320, DOI 10.1016/j.resp.2006.02.018; Wong CH, 1999, THORAX, V54, P62, DOI 10.1136/thx.54.1.62; Wu DN, 2002, CHEST, V122, P505, DOI 10.1378/chest.122.2.505; Zemp E, 1999, AM J RESP CRIT CARE, V159, P1257, DOI 10.1164/ajrccm.159.4.9807052	151	376	420	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1364	1374		10.1016/S0140-6736(08)60595-4	http://dx.doi.org/10.1016/S0140-6736(08)60595-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424325				2022-12-28	WOS:000255208500027
J	Singh, NK; Mehta, D; White, P				Singh, Nishith K.; Mehta, Dharmesh; White, Peter			Another reason to dislike medication	LANCET			English	Editorial Material							CHRONIC OCCULT ASPIRATION		[Singh, Nishith K.] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA; [Mehta, Dharmesh] Univ Arizona, Maricopa Med Ctr, Dept Internal Med, Phoenix, AZ USA; [Mehta, Dharmesh] Mayo Clin Scottsdale Affiliate, Phoenix, AZ USA; [White, Peter] So Illinois Univ, Sch Med, Dept Pulm Med, Springfield, IL USA	Southern Illinois University System; Southern Illinois University; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix; Southern Illinois University System; Southern Illinois University	Singh, NK (corresponding author), 1617 Westchester Blvd 2, Springfield, IL 62704 USA.	nsingh@siumed.edu						Barnes TW, 2006, MAYO CLIN PROC, V81, P172, DOI 10.4065/81.2.172; Matsuse T, 1996, CHEST, V110, P1289, DOI 10.1378/chest.110.5.1289; Nehra D, 2002, ANN SURG, V235, P346, DOI 10.1097/00000658-200203000-00006	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 19	2008	371	9621					1388	1388		10.1016/S0140-6736(08)60598-X	http://dx.doi.org/10.1016/S0140-6736(08)60598-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424328				2022-12-28	WOS:000255208500030
J	Phillips, AN; Pillay, D; Miners, AH; Bennett, DE; Gilks, CF; Lundgren, JD				Phillips, Andrew N.; Pillay, Deenan; Miners, Alec H.; Bennett, Diane E.; Gilks, Charles F.; Lundgren, Jens D.			Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model	LANCET			English	Article							ZIDOVUDINE COMBINATION THERAPY; THYMIDINE ANALOG MUTATIONS; SUB-SAHARAN AFRICA; HIV-1-INFECTED PATIENTS; COST-EFFECTIVENESS; NAIVE PATIENTS; POOR SETTINGS; HIV TREATMENT; LAMIVUDINE; ADHERENCE	Background In lower-income countries, WHO recommends a population-based approach to antiretroviral treatment with standardised regimens and clinical decision making based on clinical status and, where available CD4 cell count, rather than viral load. Our aim was to study the potential consequences of such monitoring strategies, especially in terms of survival and resistance development. Methods A validated computer simulation model of HIV infection and the effect of antiretroviral therapy was used to compare survival, use of second-line regimens, and development of resistance that result from different strategies-based on viral load, CD4 cell count, or clinical observation alone-for determining when to switch people starting antiretroviral treatment with the WHO-recommended first-line regimen of stavudine, lamivudine, and nevirapine to second-line antiretroviral treatment. Findings Over 5 years, the predicted proportion of potential life-years survived was 83% with viral load monitoring (switch when viral load >500 copies per mL), 82% with CD4 cell count monitoring (switch at 50% drop from peak), and 82% with clinical monitoring (switch when two new WHO stage 3 events or a WHO stage 4 event occur). Corresponding values over 20 years were 67%, 64%, and 64%. Findings were robust to variations in model specification in extensive univariable and multivariable sensitivity analyses. Although survival was slightly longer with viral load monitoring, this strategy was not the most cost effective. Interpretation For patients on the first-line regimen of stavudine, lamivudine, and nevirapine the benefits of viral load or CD4 cell count monitoring over clinical monitoring alone are modest. Development of cheap and robust versions of these assays is important, but widening access to antiretrovirals-with or without laboratory monitoring-is currently the highest priority.	[Phillips, Andrew N.] UCL, Dept Primary Care & Populat Sci, Royal Free & Univ Coll Med Sch, HIV Epidemiol & Biostat Grp, London, England; [Phillips, Andrew N.] UCL, Royal Free Ctr HIV Med, Royal Free & Univ Coll Med Sch, London, England; [Pillay, Deenan] UCL, Ctr Virol, Dept Infect, Royal Free & Univ Coll Med Sch, London, England; [Pillay, Deenan] Hlth Protect Agcy, Ctr Infect, London, England; [Miners, Alec H.] London Sch Hyg & Trop Med, London WC1, England; [Bennett, Diane E.; Gilks, Charles F.] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Lundgren, Jens D.] Rigshosp, Ctr Viral Dis, KMA, DK-2100 Copenhagen, Denmark; [Lundgren, Jens D.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	University of London; University College London; University of London; University College London; University of London; University College London; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Rigshospitalet; University of Copenhagen; University of Copenhagen	Phillips, AN (corresponding author), UCL, Dept Primary Care & Populat Sci, Royal Free & Univ Coll Med Sch, HIV Epidemiol & Biostat Grp, London, England.	a.phillips@pcps.ucl.ac.uk	Lundgren, Jens/AAE-6876-2019; Gilks, Charles/B-4184-2012; Phillips, Andrew N/B-4427-2008	Gilks, Charles/0000-0002-8953-3123; Phillips, Andrew N/0000-0003-2384-4807; Lundgren, Jens/0000-0001-8901-7850				Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Ait-Khaled M, 2002, AIDS, V16, P1686, DOI 10.1097/00002030-200208160-00017; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Bagchi S, 2007, CLIN INFECT DIS, V44, P135, DOI 10.1086/510072; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bangsberg DR, 2007, AIDS READ, V17, pS11; BASENERO A, 2007, 4 INT AIDS SOC C HIV; Benzie AA, 2007, AIDS, V21, P1423, DOI 10.1097/QAD.0b013e3281532ca7; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; Campbell TB, 2005, CLIN INFECT DIS, V41, P236, DOI 10.1086/430709; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Colebunders R, 2005, CLIN INFECT DIS, V41, P386, DOI 10.1086/431490; Cooper DA, 1997, LANCET, V349, P1413, DOI 10.1016/S0140-6736(97)04441-3; Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; Eron JJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1581, DOI 10.1097/00126334-200412150-00009; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Godin G, 2005, AIDS CARE, V17, P493, DOI 10.1080/09540120412331291715; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Hill A, 2007, AIDS, V21, P361, DOI 10.1097/QAD.0b013e328012c560; Holguin A, 2006, AIDS REV, V8, P98; HOSSEINIPOUR M, 2007, 4 INT AIDS SOC C HIV; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118; Kuritzkes DR, 1999, AIDS, V13, P685, DOI 10.1097/00002030-199904160-00009; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Maldarelli F, 2003, ANTIVIR THER, V8, pS149; *MED SANS FRONT, UNT WEB PRIC RED PRI; Miller LG, 2002, J GEN INTERN MED, V17, P1, DOI 10.1046/j.1525-1497.2002.09004.x; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Mouroux M, 2001, ANTIVIR THER, V6, P179; Phillips AN, 2007, HIV MED, V8, P536, DOI 10.1111/j.1468-1293.2007.00507.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sow PS, 2007, JAIDS-J ACQ IMM DEF, V44, P262, DOI 10.1097/QAI.0b013e31802bf109; Staszewski S, 1996, JAMA-J AM MED ASSOC, V276, P111, DOI 10.1001/jama.276.2.111; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Vijayaraghavan A, 2007, JAIDS-J ACQ IMM DEF, V46, P91; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2007, US LIQ MED CULT DRUG, P1; World Health Organization, 2006, ANT THER HIV INF AD	51	141	145	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1443	1451		10.1016/S0140-6736(08)60624-8	http://dx.doi.org/10.1016/S0140-6736(08)60624-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440426				2022-12-28	WOS:000255440600025
J	Eliades, SJ; Wang, XQ				Eliades, Steven J.; Wang, Xiaoqin			Neural substrates of vocalization feedback monitoring in primate auditory cortex	NATURE			English	Article							SPEECH PRODUCTION; RESPONSES; VOICE; SCHIZOPHRENIA; MODULATION; MARMOSETS; MONKEY; SIGN; FMRI	Vocal communication involves both speaking and hearing, often taking place concurrently. Vocal production, including human speech and animal vocalization, poses a number of unique challenges for the auditory system. It is important for the auditory system to monitor external sounds continuously from the acoustic environment during speaking despite the potential for sensory masking by self-generated sounds(1). It is also essential for the auditory system to monitor feedback of one's own voice. This self-monitoring may play a part in distinguishing between self-generated or externally generated(2,3) auditory inputs and in detecting errors in our vocal production(4). Previous work in humans(5-10) and other animals(11-13) has demonstrated that the auditory cortex is largely suppressed during speaking or vocalizing. Despite the importance of self-monitoring, the underlying neural mechanisms in the mammalian brain, in particular the role of vocalization-induced suppression, remain virtually unknown. Here we show that neurons in the auditory cortex of marmoset monkeys (Callithrix jacchus) are sensitive to auditory feedback during vocal production, and that changes in the feedback alter the coding properties of these neurons. Furthermore, we found that the previously described cortical suppression during vocalization actually increased the sensitivity of these neurons to vocal feedback. This heightened sensitivity to vocal feedback suggests that these neurons may have an important role in auditory self-monitoring.	[Eliades, Steven J.; Wang, Xiaoqin] Johns Hopkins Univ, Sch Med, Lab Auditory Neurophysiol, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Eliades, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Lab Auditory Neurophysiol, Dept Biomed Engn, Baltimore, MD 21205 USA.	seliades@jhu.edu; xiaoqin.wang@jhu.edu		Eliades, Steven/0000-0002-6503-2252				Brumm H, 2004, J EXP BIOL, V207, P443, DOI 10.1242/jeb.00768; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Crone NE, 2001, NEUROLOGY, V57, P2045, DOI 10.1212/WNL.57.11.2045; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039; Hashimoto Y, 2003, HUM BRAIN MAPP, V20, P22, DOI 10.1002/hbm.10119; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Johns LC, 2001, PSYCHOL MED, V31, P705, DOI 10.1017/S0033291701003774; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; Miller CT, 2006, J COMP PHYSIOL A, V192, P27, DOI 10.1007/s00359-005-0043-z; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Poulet JFA, 2002, NATURE, V418, P872, DOI 10.1038/nature00919; Snowdon CT, 1999, ETHOLOGY, V105, P893, DOI 10.1046/j.1439-0310.1999.00483.x; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; TIMMONS BA, 1972, J SPEECH HEAR DISORD, V37, P476, DOI 10.1044/jshd.3704.476; VONBEKESY G, 1949, J ACOUST SOC AM, V21, P217; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	30	276	278	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1102	U8		10.1038/nature06910	http://dx.doi.org/10.1038/nature06910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18454135				2022-12-28	WOS:000256839900057
J	Champion, DJ; Ransom, SM; Lazarus, P; Camilo, F; Bassa, C; Kaspi, VM; Nice, DJ; Freire, PCC; Stairs, IH; van Leeuwen, J; Stappers, BW; Cordes, JM; Hessels, JWT; Lorimer, DR; Arzoumanian, Z; Backer, DC; Bhat, NDR; Chatterjee, S; Cognard, I; Deneva, JS; Faucher-Giguere, CA; Gaensler, BM; Han, JL; Jenet, FA; Kasian, L; Kondratiev, VI; Kramer, M; Lazio, J; McLaughlin, MA; Venkataraman, A; Vlemmings, W				Champion, David J.; Ransom, Scott M.; Lazarus, Patrick; Camilo, Fernando; Bassa, Cees; Kaspi, Victoria M.; Nice, David J.; Freire, Paulo C. C.; Stairs, Ingrid H.; van Leeuwen, Joeri; Stappers, Ben W.; Cordes, James M.; Hessels, Jason W. T.; Lorimer, Duncan R.; Arzoumanian, Zaven; Backer, Don C.; Bhat, N. D. Ramesh; Chatterjee, Shami; Cognard, Ismael; Deneva, Julia S.; Faucher-Giguere, Claude-Andre; Gaensler, Bryan M.; Han, JinLin; Jenet, Fredrick A.; Kasian, Laura; Kondratiev, Vlad I.; Kramer, Michael; Lazio, Joseph; McLaughlin, Maura A.; Venkataraman, Arun; Vlemmings, Wouter			An eccentric binary millisecond pulsar in the galactic plane	SCIENCE			English	Article							RADIO PULSARS; NEUTRON-STAR; EVOLUTION; SYSTEMS; 2MASS; MASS	Binary pulsar systems are superb probes of stellar and binary evolution and the physics of extreme environments. In a survey with the Arecibo telescope, we have found PSR J1903+ 0327, a radio pulsar with a rotational period of 2.15 milliseconds in a highly eccentric ( e = 0.44) 95- day orbit around a solar mass ( M.) companion. Infrared observations identify a possible main- sequence companion star. Conventional binary stellar evolution models predict neither large orbital eccentricities nor main- sequence companions around millisecond pulsars. Alternative formation scenarios involve recycling a neutron star in a globular cluster, then ejecting it into the Galactic disk, or membership in a hierarchical triple system. A relativistic analysis of timing observations of the pulsar finds its mass to be 1.74 +/- 0.04 M. an unusually high value.	[Champion, David J.; Lazarus, Patrick; Bassa, Cees; Kaspi, Victoria M.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Champion, David J.] CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Ransom, Scott M.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Camilo, Fernando] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Nice, David J.] Bryn Mawr Coll, Dept Phys, Bryn Mawr, PA 19010 USA; [Freire, Paulo C. C.; Venkataraman, Arun] Natl Astron & Ionosphere Ctr, Arecibo Observ, Arecibo, PR 00612 USA; [Stairs, Ingrid H.; Kasian, Laura] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [van Leeuwen, Joeri; Backer, Don C.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Stappers, Ben W.; Kramer, Michael] Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England; [Cordes, James M.; Deneva, Julia S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Hessels, Jason W. T.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Lorimer, Duncan R.; Kondratiev, Vlad I.; McLaughlin, Maura A.] W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; [Arzoumanian, Zaven] NASA, Ctr Res & Explorat Space Sci & Technol, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Arzoumanian, Zaven] NASA, Xray Astrophys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Bhat, N. D. Ramesh] Swinburne Univ Technol, Hawthorn, Vic 3122, Australia; [Chatterjee, Shami; Gaensler, Bryan M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Cognard, Ismael] CNRS, Lab Phys & Chim Environm, UMR 6115, F-45071 Orleans 2, France; [Faucher-Giguere, Claude-Andre] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Han, JinLin] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Jenet, Fredrick A.] Univ Texas Brownsville, Ctr Gravitat Wave Astron, Brownsville, TX 78520 USA; [Lazio, Joseph] USN, Res Lab, Washington, DC 20375 USA; [Vlemmings, Wouter] Univ Bonn, Argelander Inst Astron, D-53121 Bonn, Germany	McGill University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Radio Astronomy Observatory (NRAO); Columbia University; Bryn Mawr College; National Aeronautics & Space Administration (NASA); University of British Columbia; University of California System; University of California Berkeley; University of Manchester; Jodrell Bank Centre for Astrophysics; Cornell University; University of Amsterdam; West Virginia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Swinburne University of Technology; University of Sydney; Centre National de la Recherche Scientifique (CNRS); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Chinese Academy of Sciences; National Astronomical Observatory, CAS; University of Texas System; University of Texas Rio Grande Valley; United States Department of Defense; United States Navy; Naval Research Laboratory; University of Bonn	Champion, DJ (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	David.Champion@atnf.csiro.au	Han, JinLin/AAK-9225-2020; Faucher-Giguere, Claude-Andre/AAC-5298-2019; Kondratiev, Vladislav I./N-1105-2015; Freire, Paulo/ABE-8926-2021; Gaensler, Bryan M/F-8655-2010; Chatterjee, Shami/AAE-8374-2022; Lorimer, Duncan/ABH-7909-2020; Hessels, Jason/GTO-3261-2022; Bhat, Ramesh/B-7396-2013	Kondratiev, Vladislav I./0000-0001-8864-7471; Freire, Paulo/0000-0003-1307-9435; Hessels, Jason/0000-0003-2317-1446; van Leeuwen, Joeri/0000-0001-8503-6958; Gaensler, Bryan/0000-0002-3382-9558; Han, JinLin/0000-0002-9274-3092; McLaughlin, Maura/0000-0001-7697-7422; Nice, David/0000-0002-6709-2566; Bhat, Ramesh/0000-0002-8383-5059; Bassa, Cees/0000-0002-1429-9010; Champion, David/0000-0003-1361-7723; Ransom, Scott/0000-0001-5799-9714; /0000-0002-2700-9916; Kramer, Michael/0000-0002-4175-2271				ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Benjamin RA, 2003, PUBL ASTRON SOC PAC, V115, P953, DOI 10.1086/376696; Cardini D, 2007, ASTROPHYS J, V666, P393, DOI 10.1086/519991; Cordes JM, 2006, ASTROPHYS J, V637, P446, DOI 10.1086/498335; Ferrario L, 2006, MON NOT R ASTRON SOC, V367, P1323, DOI 10.1111/j.1365-2966.2006.10058.x; Ferrario L, 2007, MON NOT R ASTRON SOC, V375, P1009, DOI 10.1111/j.1365-2966.2006.11365.x; Ford EB, 2000, ASTROPHYS J, V535, P385, DOI 10.1086/308815; Freire PCC, 2008, ASTROPHYS J, V675, P670, DOI 10.1086/526338; FREIRE PCC, 2008, IN PRESS ASTROPHYS J; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; Gnedin OY, 1997, ASTROPHYS J, V474, P223, DOI 10.1086/303441; Kaspi VM, 2002, ASTR SOC P, V271, P3; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Lattimer JM, 2007, PHYS REP, V442, P109, DOI 10.1016/j.physrep.2007.02.003; Lopez-Corredoira M, 2002, ASTRON ASTROPHYS, V394, P883, DOI 10.1051/0004-6361:20021175; Lorimer DR, 2007, MON NOT R ASTRON SOC, V379, P282, DOI 10.1111/j.1365-2966.2007.11946.x; Quaintrell H, 2003, ASTRON ASTROPHYS, V401, P313, DOI 10.1051/0004-6361:20030120; Ransom SM, 2005, SCIENCE, V307, P892, DOI 10.1126/science.1108632; Ransom SM, 2002, ASTRON J, V124, P1788, DOI 10.1086/342285; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Stairs IH, 2004, SCIENCE, V304, P547, DOI 10.1126/science.1096986; Standish EA, 2004, ASTRON ASTROPHYS, V417, P1165, DOI 10.1051/0004-6361:20035663; TAYLOR JH, 1989, ASTROPHYS J, V345, P434, DOI 10.1086/167917; THOMPSON C, 1993, ASTROPHYS J, V408, P194, DOI 10.1086/172580; Wex N, 1998, MON NOT R ASTRON SOC, V298, P67, DOI 10.1046/j.1365-8711.1998.01570.x; You XP, 2007, ASTROPHYS J, V671, P907, DOI 10.1086/522227	27	148	149	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1309	1312		10.1126/science.1157580	http://dx.doi.org/10.1126/science.1157580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18483399	Green Submitted			2022-12-28	WOS:000256441100036
J	Kruijshaar, ME; Watson, JM; Drobniewski, F; Anderson, C; Brown, TJ; Magee, JG; Smith, EG; Story, A; Abubakar, I				Kruijshaar, Michelle E.; Watson, John M.; Drobniewski, Francis; Anderson, Charlotte; Brown, Timothy J.; Magee, John G.; Smith, E. Grace; Story, Alistair; Abubakar, Ibrahim			Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data	BRITISH MEDICAL JOURNAL			English	Article							MULTIDRUG-RESISTANCE; NORTH LONDON; RISK-FACTORS; TUBERCULOSIS; EPIDEMIOLOGY; OUTBREAK; TB	Objective To identify recent trends in, and factors associated with, resistance to antituberculosis drugs in England, Wales, and Northern Ireland. Design Cohort of tuberculosis cases reported to the enhanced tuberculosis surveillance system matched to data on drug susceptibility and national strain typing data. Setting England, Wales, and Northern Ireland 1998-2005. Main outcome measures Unadjusted and adjusted odds ratios for drug resistance and associated factors. Proportion of multidrug resistant tuberculosis cases clustered. Results 28 620 culture confirmed cases were available for analysis. The proportion of cases resistant to isoniazid increased from 5% to 7%. Rifampicin resistance increased from 1.0% to 1.2% and multidrug resistance from 0.8% to 0.9%. Ethambutol and pyrazinamide resistance remained stable at around 0.4% and 0.6%, respectively. Regression analyses showed a significant increase in isoniazid resistance outside London (odds ratio 1.04, 95% confidence interval 1.01 to 1.07, a year, associated with changes in age (0.98, 0.98 to 0.99, a year), place of birth (1.49, 1.16 to 1.92), and ethnicity (P<0.05). In London, the rise (1.05, 1.02 to 1.08, a year) was related mainly to an ongoing outbreak. Increases in rifampicin resistance (1.06, 1.01 to 1.11, a year) and multidrug resistance (1.06, 1.00 to 1.12, a year) were small. A fifth of patients with multidrug resistant tuberculosis in 2004-5 had indistinguishable strain types, and one case was identified as extensively drug resistant. Conclusions The rise in isoniazid resistance reflects increasing numbers of patients from sub-Saharan Africa and the Indian subcontinent, who might have acquired resistance abroad, and inadequate control of transmission in London. The observed increases highlight the need for early case detection, rapid testing of susceptibility to drugs, and improved treatment completion.	[Kruijshaar, Michelle E.; Watson, John M.; Anderson, Charlotte; Story, Alistair; Abubakar, Ibrahim] Hlth Protect Agcy, Dept Resp Dis, Ctr Infect, London NW9 5EQ, England; [Drobniewski, Francis; Brown, Timothy J.] Univ London St Bartholomews Hosp Med Coll, Queen Marys Sch Med & Dent, Mycobacterium Reference Unit, London E1 2AT, England; [Magee, John G.] Newcastle Gen Hosp, Reg Ctr Mycobacteriol, Hlth Protect Agcy N E, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Smith, E. Grace] Heart England NHS Fdn Trust, Reg Ctr Mycobacteriol, Hlth Protect Agcy, Birmingham B9 5SS, W Midlands, England; [Abubakar, Ibrahim] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	Health Protection Agency; University of London; Queen Mary University London; Newcastle General Hospital; Health Protection Agency; Heart of England NHS Foundation Trust; University of East Anglia	Kruijshaar, ME (corresponding author), Hlth Protect Agcy, Dept Resp Dis, Ctr Infect, London NW9 5EQ, England.	michelle.kruijshaar@hpa.org.uk		Abubakar, Ibrahim/0000-0002-0370-1430				[Anonymous], 2007, GLOB TUB CONTR SURV; *APPL MATHS BVBA, 2004, BIONUMERICS MAN; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Djuretic T, 2002, THORAX, V57, P477, DOI 10.1136/thorax.57.6.477; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; Espinal MA, 2001, INT J TUBERC LUNG D, V5, P887; *EUROTB, 2007, SURV TUB EUR REP TUB; Falzon D, 2006, INT J TUBERC LUNG D, V10, P954; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; *HLTH PROT AG, 2003, ANN REP TUB CAS REP; Irish C, 1999, BMJ-BRIT MED J, V318, P497, DOI 10.1136/bmj.318.7182.497; KRUIJSHAAR ME, 2007, TUBERCULOSIS UK ANN; Maguire H, 2006, THORAX, V61, P547, DOI 10.1136/thx.2005.052423; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Moniruzzaman A, 2006, INT J TUBERC LUNG D, V10, P631; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; *NAT COORD TUB SUR, 2007, SURV TUB EUR REP TUB; Rose AMC, 2001, THORAX, V56, P173, DOI 10.1136/thorax.56.3.173; Ruddy MC, 2004, THORAX, V59, P279, DOI 10.1136/thx.2003.010405; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; *WHO, 2006, XDR TB EXT DRUG RES	23	32	32	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 31	2008	336	7655					1231	+		10.1136/bmj.39546.573067.25	http://dx.doi.org/10.1136/bmj.39546.573067.25			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311PS	18456593	Green Published, Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000256612700031
J	Phillips, RJ; Zuber, MT; Smrekar, SE; Mellon, MT; Head, JW; Tanaka, KL; Putzig, NE; Milkovich, SM; Campbell, BA; Plaut, JJ; Safaeinili, A; Seu, R; Biccari, D; Carter, LM; Picardi, G; Orosei, R; Mohit, PS; Heggy, E; Zurek, RW; Egan, AF; Giacomoni, E; Russo, F; Cutigni, M; Pettinelli, E; Holt, JW; Leuschen, CJ; Marinangeli, L				Phillips, Roger J.; Zuber, Maria T.; Smrekar, Suzanne E.; Mellon, Michael T.; Head, James W.; Tanaka, Kenneth L.; Putzig, Nathaniel E.; Milkovich, Sarah M.; Campbell, Bruce A.; Plaut, Jeffrey J.; Safaeinili, Ali; Seu, Roberto; Biccari, Daniela; Carter, Lynn M.; Picardi, Giovanni; Orosei, Roberto; Mohit, P. Surdas; Heggy, Essam; Zurek, Richard W.; Egan, Anthony F.; Giacomoni, Emanuele; Russo, Federica; Cutigni, Marco; Pettinelli, Elena; Holt, John W.; Leuschen, Carl J.; Marinangeli, Lucia			Mars north polar deposits: Stratigraphy, age, and geodynamical response	SCIENCE			English	Article							LAYERED DEPOSITS; EVOLUTION; REGION; CAP; SUBSURFACE; RHEOLOGY; HISTORY; CRUSTAL; MANTLE	The Shallow Radar ( SHARAD) on the Mars Reconnaissance Orbiter has imaged the internal stratigraphy of the north polar layered deposits of Mars. Radar reflections within the deposits reveal a laterally continuous deposition of layers, which typically consist of four packets of finely spaced reflectors separated by homogeneous interpacket regions of nearly pure ice. The packet/ interpacket structure can be explained by approximately million- year periodicities in Mars' obliquity or orbital eccentricity. The observed similar to 100- meter maximum deflection of the underlying substrate in response to the ice load implies that the present- day thickness of an equilibrium elastic lithosphere is greater than 300 kilometers. Alternatively, the response to the load may be in a transient state controlled by mantle viscosity. Both scenarios probably require that Mars has a subchondritic abundance of heat- producing elements.	[Phillips, Roger J.; Putzig, Nathaniel E.; Egan, Anthony F.] SW Res Inst, Boulder, CO 80302 USA; [Phillips, Roger J.] Washington Univ, St Louis, MO 63130 USA; [Zuber, Maria T.] MIT, Cambridge, MA 02139 USA; [Smrekar, Suzanne E.; Milkovich, Sarah M.; Plaut, Jeffrey J.; Safaeinili, Ali; Zurek, Richard W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Mellon, Michael T.] Univ Colorado, Boulder, CO 80309 USA; [Head, James W.] Brown Univ, Providence, RI 02912 USA; [Tanaka, Kenneth L.] US Geol Survey, Flagstaff, AZ 86001 USA; [Campbell, Bruce A.; Carter, Lynn M.] Smithsonian Inst, Washington, DC 20013 USA; [Seu, Roberto; Biccari, Daniela; Picardi, Giovanni; Giacomoni, Emanuele; Russo, Federica; Cutigni, Marco] Univ Roma La Sapienza, Dipartimento InfoCom, I-00184 Rome, Italy; [Orosei, Roberto] Ist Nazl Astrofis, I-00133 Rome, Italy; [Mohit, P. Surdas] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Mohit, P. Surdas] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Heggy, Essam] Lunar & Planetary Inst, Houston, TX 77058 USA; [Heggy, Essam] Inst Phys Globe, Paris, France; [Pettinelli, Elena] Univ Roma Tre, I-00146 Rome, Italy; [Holt, John W.] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Leuschen, Carl J.] Univ Kansas, Lawrence, KS 66045 USA; [Marinangeli, Lucia] Univ Annunzio, I-65127 Pescara, Italy	Washington University (WUSTL); Massachusetts Institute of Technology (MIT); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; Brown University; United States Department of the Interior; United States Geological Survey; Smithsonian Institution; Sapienza University Rome; Istituto Nazionale Astrofisica (INAF); University of California System; University of California San Diego; Scripps Institution of Oceanography; University of British Columbia; UDICE-French Research Universities; Universite Paris Cite; Roma Tre University; University of Texas System; University of Texas Austin; University of Kansas; G d'Annunzio University of Chieti-Pescara	Phillips, RJ (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	roger@boulder.swri.edu	Heggy, Essam/AAL-8124-2020; Carter, Lynn/D-2937-2012; Smrekar, Suzanne/AAH-8074-2020; Holt, John/C-4896-2009; Heggy, Essam/E-8250-2013; Mellon, Michael/C-3456-2016	Heggy, Essam/0000-0001-7476-2735; Carter, Lynn/0000-0002-6245-4142; Smrekar, Suzanne/0000-0001-8775-075X; Heggy, Essam/0000-0001-7476-2735; PETTINELLI, Elena/0000-0002-7066-6516; MARINANGELI, Lucia/0000-0001-5417-6122; Putzig, Nathaniel/0000-0003-4485-6321				BANERDT WB, 1986, J GEOPHYS RES-SOLID, V91, P403, DOI 10.1029/JB091iB01p00403; Belleguic V, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002437; BLASIUS RK, 1982, ICARUS, V50, P140; Breuer D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001999; Byrne S, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001615; CALVIN WM, 2008, LUNAR PLANET SCI, V39, P1939; CARISTAN Y, 1982, J GEOPHYS RES, V87, P6781, DOI 10.1029/JB087iB08p06781; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Edgett KS, 2003, GEOMORPHOLOGY, V52, P289, DOI 10.1016/S0169-555X(02)00262-3; Fishbaugh KE, 2005, ICARUS, V174, P444, DOI 10.1016/j.icarus.2004.06.021; Grott M, 2008, ICARUS, V193, P503, DOI 10.1016/j.icarus.2007.08.015; Haberle RA, 2003, ICARUS, V161, P66, DOI 10.1016/S0019-1035(02)00017-9; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; Herkenhoff KE, 2007, SCIENCE, V317, P1711, DOI 10.1126/science.1143544; Johnson CL, 2005, EARTH PLANET SC LETT, V230, P241, DOI 10.1016/j.epsl.2004.10.038; Johnson CL, 2000, ICARUS, V144, P313, DOI 10.1006/icar.1999.6310; KARATO S, 1993, SCIENCE, V260, P771, DOI 10.1126/science.260.5109.771; Langevin Y, 2005, SCIENCE, V307, P1581, DOI 10.1126/science.1109438; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; MCNUTT MK, 1984, J GEOPHYS RES, V89, P1180, DOI 10.1029/JB089iB13p11180; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Milkovich SM, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002349; Mohit PS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002654; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI [10.1029/2006JE002772, 10.1029/2007JE002944]; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Tanaka KL, 2008, ICARUS, V196, P318, DOI 10.1016/j.icarus.2008.01.021; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; Wieczorek MA, 2008, ICARUS, V196, P506, DOI 10.1016/j.icarus.2007.10.026; Zuber MT, 2007, SCIENCE, V317, P1718, DOI 10.1126/science.1146995	34	224	228	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1182	1185		10.1126/science.1157546	http://dx.doi.org/10.1126/science.1157546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18483402	Green Published			2022-12-28	WOS:000256233000029
J	Bainbridge, JWB; Smith, AJ; Barker, SS; Robbie, S; Henderson, R; Balaggan, K; Viswanathan, A; Holder, GE; Stockman, A; Tyler, N; Petersen-Jones, S; Bhattacharya, SS; Thrasher, AJ; Fitzke, FW; Carter, BJ; Rubin, GS; Moore, AT; Ali, RR				Bainbridge, James W. B.; Smith, Alexander J.; Barker, Susie S.; Robbie, Scott; Henderson, Robert; Balaggan, Kamaljit; Viswanathan, Ananth; Holder, Graham E.; Stockman, Andrew; Tyler, Nick; Petersen-Jones, Simon; Bhattacharya, Shomi S.; Thrasher, Adrian J.; Fitzke, Fred W.; Carter, Barrie J.; Rubin, Gary S.; Moore, Anthony T.; Ali, Robin R.			Effect of gene therapy on visual function in Leber's congenital amaurosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADENOASSOCIATED VIRAL VECTORS; RETINAL-PIGMENT EPITHELIUM; RPE65 MUTATIONS; DYSTROPHY; CYCLE; DOGS; ISOMEROHYDROLASE; IDENTIFICATION; ISOMERASE; PROTEIN	Early-onset, severe retinal dystrophy caused by mutations in the gene encoding retinal pigment epithelium-specific 65-kD protein (RPE65) is associated with poor vision at birth and complete loss of vision in early adulthood. We administered to three young adult patients subretinal injections of recombinant adeno-associated virus vector 2/2 expressing RPE65 complementary DNA (cDNA) under the control of a human RPE65 promoter. There were no serious adverse events. There was no clinically significant change in visual acuity or in peripheral visual fields on Goldmann perimetry in any of the three patients. We detected no change in retinal responses on electroretinography. One patient had significant improvement in visual function on microperimetry and on dark-adapted perimetry. This patient also showed improvement in a subjective test of visual mobility. These findings provide support for further clinical studies of this experimental approach in other patients with mutant RPE65.	[Bainbridge, James W. B.; Smith, Alexander J.; Barker, Susie S.; Robbie, Scott; Henderson, Robert; Balaggan, Kamaljit; Viswanathan, Ananth; Holder, Graham E.; Stockman, Andrew; Bhattacharya, Shomi S.; Fitzke, Fred W.; Rubin, Gary S.; Moore, Anthony T.; Ali, Robin R.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Bainbridge, James W. B.; Viswanathan, Ananth; Holder, Graham E.; Rubin, Gary S.; Moore, Anthony T.; Ali, Robin R.] Moorfields Eye Hosp, London, England; [Bainbridge, James W. B.; Rubin, Gary S.; Moore, Anthony T.; Ali, Robin R.] UCL, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Tyler, Nick] UCL, Dept Civil & Environm Engn, London, England; [Thrasher, Adrian J.; Ali, Robin R.] UCL, Inst Child Hlth, London, England; [Petersen-Jones, Simon] Michigan State Univ, E Lansing, MI 48824 USA; [Carter, Barrie J.] Targeted Genet Corp, Seattle, WA USA	University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Michigan State University	Ali, RR (corresponding author), UCL, Inst Ophthalmol, Bath St, London EC1V 9EL, England.	r.ali@ucl.ac.uk	Petersen-Jones, Simon/B-3822-2018; Bhattacharya, Shom/N-2926-2016; Henderson, Robert/AAA-2660-2020; Tyler, Nick/C-1656-2008; Smith, Alexander/A-5142-2009	Petersen-Jones, Simon/0000-0002-7410-2304; Bhattacharya, Shom/0000-0002-1601-6344; Henderson, Robert/0000-0002-5250-6404; Tyler, Nick/0000-0001-7079-1301; Thrasher, Adrian/0000-0002-6097-6115; Ali, Robin/0000-0003-3126-6517; Bainbridge, James/0000-0003-1318-8201	Great Ormond Street Hospital Childrens Charity [V1223] Funding Source: researchfish	Great Ormond Street Hospital Childrens Charity		Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Auricchio A, 2005, CURR GENE THER, V5, P339, DOI 10.2174/1566523054065020; Gao GP, 1998, HUM GENE THER, V9, P2353, DOI 10.1089/hum.1998.9.16-2353; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Lotery AJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P538; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2003, J HERED, V94, P31, DOI 10.1093/jhered/esg015; Narfstrom K, 2003, INVEST OPHTH VIS SCI, V44, P1663, DOI 10.1167/iovs.02-0595; Paunescu K, 2005, GRAEF ARCH CLIN EXP, V243, P417, DOI 10.1007/s00417-004-1020-x; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Znoiko SL, 2002, INVEST OPHTH VIS SCI, V43, P1604	24	1482	1610	2	143	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2008	358	21					2231	2239		10.1056/NEJMoa0802268	http://dx.doi.org/10.1056/NEJMoa0802268			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303EK	18441371	Green Published			2022-12-28	WOS:000256023600005
J	Ryu, D; Kang, HS; Cho, JY; Das, S				Ryu, Dongsu; Kang, Hyesung; Cho, Jungyeon; Das, Santabrata			Turbulence and magnetic fields in the large-scale structure of the universe	SCIENCE			English	Article							COSMOLOGICAL SHOCK-WAVES; FARADAY-ROTATION; GALAXY CLUSTERS; ACCELERATION; SIMULATIONS; ORIGIN	The nature and origin of turbulence and magnetic fields in the intergalactic space are important problems that are yet to be understood. We propose a scenario in which turbulent-flow motions are induced via the cascade of the vorticity generated at cosmological shocks during the formation of the large-scale structure. The turbulence in turn amplifies weak seed magnetic fields of any origin. Supercomputer simulations show that the turbulence is subsonic inside clusters and groups of galaxies, whereas it is transonic or mildly supersonic in filaments. Based on a turbulence dynamo model, we then estimated that the average magnetic field strength would be a few microgauss (mu G) inside clusters and groups, approximately 0.1 mu G around clusters and groups, and approximately 10 nanogauss in filaments. Our model presents a physical mechanism that transfers the gravitational energy to the turbulence and magnetic field energies in the large-scale structure of the universe.	[Ryu, Dongsu; Cho, Jungyeon] Chungnam Natl Univ, Dept Astron & Space Sci, Taejon 305764, South Korea; [Kang, Hyesung] Pusan Natl Univ, Dept Earth Sci, Pusan 609735, South Korea; [Das, Santabrata] Sejong Univ, Astrophys Res Ctr Struct & Evolut Cosmos, Seoul 143747, South Korea	Chungnam National University; Pusan National University; Sejong University	Ryu, D (corresponding author), Chungnam Natl Univ, Dept Astron & Space Sci, Taejon 305764, South Korea.	ryu@canopus.cnu.ac.kr	Ryu, Dongsu/C-2270-2016; Kang, Hyesung/ABF-5189-2020	Ryu, Dongsu/0000-0002-5455-2957; Cho, Jungyeon/0000-0003-1725-4376; Kang, Hyesung/0000-0002-4674-5687; Das, Santabrata/0000-0003-4399-5047				BELL AR, 1978, MON NOT R ASTRON SOC, V182, P147, DOI 10.1093/mnras/182.2.147; BIERMANN L, 1950, Z NATURFORSCH A, V5, P65; BINNEY J, 1974, MON NOT R ASTRON SOC, V168, P73, DOI 10.1093/mnras/168.1.73; BLANDFORD RD, 1978, ASTROPHYS J, V221, pL29, DOI 10.1086/182658; Carilli CL, 2002, ANNU REV ASTRON ASTR, V40, P319, DOI 10.1146/annurev.astro.40.060401.093852; Cho J, 2000, ASTROPHYS J, V538, P217, DOI 10.1086/309127; Clarke TE, 2001, ASTROPHYS J, V547, pL111, DOI 10.1086/318896; DAS S, 2008, IN PRESS ASTROPHYS J, V681; Davies G, 2000, ASTROPHYS J, V540, P755, DOI 10.1086/309358; Gaensler BM, 2004, NEW ASTRON REV, V48, P1003, DOI 10.1016/j.newar.2004.09.003; Govoni F, 2004, INT J MOD PHYS D, V13, P1549, DOI 10.1142/S0218271804005080; Kang H, 2007, ASTROPHYS J, V669, P729, DOI 10.1086/521717; Kronberg PP, 2001, ASTROPHYS J, V560, P178, DOI 10.1086/322767; Kulsrud RM, 1997, ASTROPHYS J, V480, P481, DOI 10.1086/303987; KULSRUD RM, 2008, REP PROG PHYS, V71; Medvedev MV, 2006, ASTROPHYS J, V642, pL1, DOI 10.1086/504470; Murgia M, 2004, ASTRON ASTROPHYS, V424, P429, DOI 10.1051/0004-6361:20040191; Nagai D, 2007, ASTROPHYS J, V655, P98, DOI 10.1086/509868; Pfrommer C, 2006, MON NOT R ASTRON SOC, V367, P113, DOI 10.1111/j.1365-2966.2005.09953.x; QUEST KB, 1988, J GEOPHYS RES, V93, P9649, DOI 10.1029/JA093iA09p09649; Ryu D, 1998, ASTRON ASTROPHYS, V335, P19; Ryu D, 2003, ASTROPHYS J, V593, P599, DOI 10.1086/376723; RYU DS, 1993, ASTROPHYS J, V414, P1, DOI 10.1086/173051; Schuecker P, 2004, ASTRON ASTROPHYS, V426, P387, DOI 10.1051/0004-6361:20041039; Subramanian K, 2006, MON NOT R ASTRON SOC, V366, P1437, DOI 10.1111/j.1365-2966.2006.09918.x; Vogt C, 2005, ASTRON ASTROPHYS, V434, P67, DOI 10.1051/0004-6361:20041839; Volk HJ, 1999, ASTROPART PHYS, V11, P73, DOI 10.1016/S0927-6505(99)00029-8; WEIBEL ES, 1959, PHYS REV LETT, V2, P83, DOI 10.1103/PhysRevLett.2.83; Xu YZ, 2006, ASTROPHYS J, V637, P19, DOI 10.1086/498336	29	325	326	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					909	912		10.1126/science.1154923	http://dx.doi.org/10.1126/science.1154923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487187	Green Submitted			2022-12-28	WOS:000255868300036
J	Guthrie, JA; Sheridan, MB				Guthrie, J. Ashley; Sheridan, Maria B.			Rational imaging - Investigation of abdominal. pain to detect pancreatic cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material							ENDOSCOPIC ULTRASONOGRAPHY; COMPUTED-TOMOGRAPHY; DIAGNOSIS; ADENOCARCINOMA		[Guthrie, J. Ashley; Sheridan, Maria B.] St James Univ Hosp, Dept Clin Radiol, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Guthrie, JA (corresponding author), St James Univ Hosp, Dept Clin Radiol, Lincoln Wing, Leeds LS9 7TF, W Yorkshire, England.	ashley.guthrie@leedsth.nhs.uk						Bipat S, 2005, J COMPUT ASSIST TOMO, V29, P438, DOI 10.1097/01.rct.0000164513.23407.b3; DeWitt J, 2004, ANN INTERN MED, V141, P753, DOI 10.7326/0003-4819-141-10-200411160-00006; Karlson BM, 1999, RADIOLOGY, V213, P107, DOI 10.1148/radiology.213.1.r99oc25107; Kelsen DP, 1997, SURGERY, V122, P53, DOI 10.1016/S0039-6060(97)90264-6; Michaels AJ, 2007, WORLD J GASTROENTERO, V13, P3575, DOI 10.3748/wjg.v13.i26.3575; Michl P, 2006, BEST PRACT RES CL GA, V20, P227, DOI 10.1016/j.bpg.2005.10.005; Prokesch RW, 2002, RADIOLOGY, V224, P764, DOI 10.1148/radiol.2243011284; Rosch T, 2004, GASTROINTEST ENDOSC, V60, P390, DOI 10.1016/S0016-5107(04)01732-8; Schima W, 2007, EUR RADIOL, V17, P638, DOI 10.1007/s00330-006-0435-7	9	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1067	1069		10.1136/bmj.39525.415521.AD	http://dx.doi.org/10.1136/bmj.39525.415521.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18467415	Green Published			2022-12-28	WOS:000256103300032
J	Saura, D; Rodriguez, D; Marin, F; de la Morena, G; Solis, I; Valdes, M				Saura, Daniel; Rodriguez, Daniel; Marin, Francisco; de la Morena, Gonzalo; Solis, Ines; Valdes, Mariano			Unable to speak - because of a drip	LANCET			English	Editorial Material							CONTRAST ECHOCARDIOGRAPHY		[Saura, Daniel; Rodriguez, Daniel; Marin, Francisco; de la Morena, Gonzalo; Solis, Ines; Valdes, Mariano] Hosp Univ Virgen Arrixaca, Serv Cardiol, Murcia 30120, Spain	Hospital Clinico Universitario Virgen de la Arrixaca	Saura, D (corresponding author), Hosp Univ Virgen Arrixaca, Serv Cardiol, Ctra Murcia Cartagena S-N, Murcia 30120, Spain.	danielsaura@secardiologia.es	de la Morena, Gonzalo/B-4077-2017; Marin, Francisco/AAD-9429-2022	de la Morena, Gonzalo/0000-0001-8495-7085; Saura, Daniel/0000-0002-7824-2814				BOMMER WJ, 1984, J AM COLL CARDIOL, V3, P6, DOI 10.1016/S0735-1097(84)80423-4; Lucas RV, 1995, HEART DIS INFANTS CH, P874; SRIVASTAVA TN, 1995, ANN INTERN MED, V122, P396, DOI 10.7326/0003-4819-122-5-199503010-00025	3	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 10	2008	371	9624					1636	1636		10.1016/S0140-6736(08)60696-0	http://dx.doi.org/10.1016/S0140-6736(08)60696-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468547				2022-12-28	WOS:000255715400032
J	Metzger, BE; Lowe, LP; Dyer, AR; Trimble, ER; Chaovarindr, U; Coustan, DR; Hadden, DR; McCance, DR; Hod, M; McIntyre, HD; Oats, JJN; Persson, B; Rogers, MS; Sacks, DA				Metzger, Boyd E.; Lowe, Lynn P.; Dyer, Alan R.; Trimble, Elisabeth R.; Chaovarindr, Udom; Coustan, Donald R.; Hadden, David R.; McCance, David R.; Hod, Moshe; McIntyre, Harold David; Oats, Jeremy J. N.; Persson, Bengt; Rogers, Michael S.; Sacks, David A.		HAPO Study Cooperative Res Grp	Hyperglycemia and adverse pregnancy outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE-TOLERANCE TEST; INTERNATIONAL WORKSHOP-CONFERENCE; GESTATIONAL DIABETES-MELLITUS; CARBOHYDRATE INTOLERANCE; WOMEN; RECOMMENDATIONS; CLASSIFICATION; CRITERIA; IMPACT	Background: It is controversial whether maternal hyperglycemia less severe than that in diabetes mellitus is associated with increased risks of adverse pregnancy outcomes. Methods: A total of 25,505 pregnant women at 15 centers in nine countries underwent 75-g oral glucose-tolerance testing at 24 to 32 weeks of gestation. Data remained blinded if the fasting plasma glucose level was 105 mg per deciliter (5.8 mmol per liter) or less and the 2-hour plasma glucose level was 200 mg per deciliter (11.1 mmol per liter) or less. Primary outcomes were birth weight above the 90th percentile for gestational age, primary cesarean delivery, clinically diagnosed neonatal hypoglycemia, and cord-blood serum C-peptide level above the 90th percentile. Secondary outcomes were delivery before 37 weeks of gestation, shoulder dystocia or birth injury, need for intensive neonatal care, hyperbilirubinemia, and preeclampsia. Results: For the 23,316 participants with blinded data, we calculated adjusted odds ratios for adverse pregnancy outcomes associated with an increase in the fasting plasma glucose level of 1 SD (6.9 mg per deciliter [0.4 mmol per liter]), an increase in the 1-hour plasma glucose level of 1 SD (30.9 mg per deciliter [1.7 mmol per liter]), and an increase in the 2-hour plasma glucose level of 1 SD (23.5 mg per deciliter [1.3 mmol per liter]). For birth weight above the 90th percentile, the odds ratios were 1.38 (95% confidence interval [CI], 1.32 to 1.44), 1.46 (1.39 to 1.53), and 1.38 (1.32 to 1.44), respectively; for cord-blood serum C-peptide level above the 90th percentile, 1.55 (95% CI, 1.47 to 1.64), 1.46 (1.38 to 1.54), and 1.37 (1.30 to 1.44); for primary cesarean delivery, 1.11 (95% CI, 1.06 to 1.15), 1.10 (1.06 to 1.15), and 1.08 (1.03 to 1.12); and for neonatal hypoglycemia, 1.08 (95% CI, 0.98 to 1.19), 1.13 (1.03 to 1.26), and 1.10 (1.00 to 1.12). There were no obvious thresholds at which risks increased. Significant associations were also observed for secondary outcomes, although these tended to be weaker. Conclusions: Our results indicate strong, continuous associations of maternal glucose levels below those diagnostic of diabetes with increased birth weight and increased cord-blood serum C-peptide levels.	[Metzger, Boyd E.; Lowe, Lynn P.; Dyer, Alan R.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Trimble, Elisabeth R.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Chaovarindr, Udom] Rajavithi Hosp, Bangkok, Thailand; [Coustan, Donald R.] Brown Univ, Sch Med, Women & Infants Hosp Rhode Isl, Providence, RI 02912 USA; [Hadden, David R.; McCance, David R.] Royal Jubilee Matern Hosp, Belfast, Antrim, North Ireland; [Hod, Moshe] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Helen Schneider Hosp Women, IL-49100 Petah Tiqwa, Israel; [McIntyre, Harold David; Oats, Jeremy J. N.] Univ Queensland, Mater Misericordiae Mothers Hosp, Brisbane, Qld, Australia; [Persson, Bengt] Karolinska Inst, Stockholm, Sweden; [Rogers, Michael S.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Sacks, David A.] Kaiser Fdn Hosp, Bellflower, CA USA	Northwestern University; Feinberg School of Medicine; Queens University Belfast; Rajavithi Hospital; Brown University; Women & Infants Hospital Rhode Island; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Queensland; Karolinska Institutet; Chinese University of Hong Kong; Prince of Wales Hospital; Kaiser Permanente	Metzger, BE (corresponding author), Northwestern Univ, Feinberg Sch Med, 645 N Michigan Ave,Suite 530-22, Chicago, IL 60611 USA.	bem@northwestern.edu	McIntyre, Harold D/F-1888-2010; Cowley, David M/M-9674-2013; Liley, Helen Gwendolin/C-5608-2011; Peacock, Ann/H-6617-2015	McIntyre, Harold D/0000-0001-8819-5794; Cowley, David M/0000-0002-4153-934X; Liley, Helen Gwendolin/0000-0002-8249-9516; Halliday, Henry/0000-0001-7978-4992; Peacock, Ann/0000-0002-5282-8155; Deerochanawong, Chaicharn/0000-0001-9666-7050; Cutter, Gary/0000-0002-8455-980X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034242, R01HD034243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989, M01RR000080, M01RR000048] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000080, M01-RR00080, UL1 RR024989, M01-RR00048] Funding Source: Medline; NICHD NIH HHS [R01-HD34242, R01-HD34243] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alkalay AL, 2006, AM J PERINAT, V23, P115, DOI 10.1055/s-2006-931912; *AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS77; BRODY SC, 2003, SCREENING GESTATIONA; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chan A, 2004, J PAEDIATR CHILD H, V40, P340, DOI 10.1111/j.1440-1754.2004.00398.x; Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69; Coustan DR, 1996, JAMA-J AM MED ASSOC, V275, P1199, DOI 10.1001/jama.275.15.1199; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; HUNTER DJS, 1989, EFFECTIVE CARE PREGN, P403; JARRETT RJ, 1981, LANCET, V2, P1220; Jensen DM, 2001, AM J OBSTET GYNECOL, V185, P413, DOI 10.1067/mob.2001.115864; Landon MB, 2007, DIABETES CARE, V30, pS194, DOI 10.2337/dc07-s215; LANGER O, 1987, AM J OBSTET GYNECOL, V157, P758, DOI 10.1016/S0002-9378(87)80045-5; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Nesbitt GS, 2006, CLIN TRIALS, V3, P397, DOI 10.1177/174077450607695; OSULLIVAN JB, 1964, DIABETES, V13, P278; Pedersen J., 1952, THESIS COPENHAGEN, V230; SACKS DA, 1995, AM J OBSTET GYNECOL, V172, P607, DOI 10.1016/0002-9378(95)90580-4; SERMER M, 1995, AM J OBSTET GYNECOL, V173, P146, DOI 10.1016/0002-9378(95)90183-3; SPELLACY WN, 1985, OBSTET GYNECOL, V66, P158; TUFFNELL DJ, 2003, COCHRANE DB SYST REV, V3; Vambergue A, 2000, DIABETIC MED, V17, P203, DOI 10.1046/j.1464-5491.2000.00237.x; World Health Organization, 1980, WHO TECHN REP SER, V646, P1; World Health Organization, 2004, ICD 10 INT STAT CLAS, V2nd; Yang XL, 2002, DIABETES CARE, V25, P1619, DOI 10.2337/diacare.25.9.1619	26	3480	3600	12	340	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					1991	2002						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463375	Bronze			2022-12-28	WOS:000255577700003
J	Griffith, LC				Griffith, Leslie C.			CaMKII: New tricks for an old dog	CELL			English	Editorial Material							DEPENDENT PROTEIN-KINASE; AUTOPHOSPHORYLATION; ACTIVATION; CALMODULIN; HEART	Calcium/calmodulin-dependent protein kinase II (CaMKII) is a pivotal signaling molecule in both the brain and the heart. In this issue of Cell, Erickson et al. (2008) demonstrate a mechanism for CaMKII activation by reactive oxygen species that provides a direct link between kinase activation and cardiac dysfunction.	[Griffith, Leslie C.] Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA; [Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Dept Biol, Waltham, MA 02454 USA.	griffith@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NINDS NIH HHS [P01 NS044232, P01 NS044232-070003] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044232] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; PATTON BL, 1990, J BIOL CHEM, V265, P11204; Schulman H, 2004, J NEUROSCI, V24, P8399, DOI 10.1523/JNEUROSCI.3606-04.2004; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215	8	8	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					397	399		10.1016/j.cell.2008.04.018	http://dx.doi.org/10.1016/j.cell.2008.04.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455979	Bronze, Green Accepted			2022-12-28	WOS:000255503900009
J	Gabriely, I; Leu, JP; Barzel, US				Gabriely, Ilan; Leu, James P.; Barzel, Uriel S.			Back to basics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MILK-ALKALI SYNDROME; PARATHYROID-HORMONE; HYPERCALCEMIA		[Gabriely, Ilan; Leu, James P.; Barzel, Uriel S.] Montefiore Med Ctr, Dept Med, Div Endocrinol & Metab, Bronx, NY 10467 USA; [Gabriely, Ilan; Leu, James P.; Barzel, Uriel S.] Albert Einstein Coll Med, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Barzel, US (corresponding author), Montefiore Med Grp, 3400 Bainbridge Ave, Bronx, NY 10467 USA.	ubarzel@montefiore.org						Beall DP, 2006, AM J MED SCI, V331, P233, DOI 10.1097/00000441-200605000-00001; BEALL DP, 1995, MEDICINE, V74, P89, DOI 10.1097/00005792-199503000-00004; BLEICH HL, 1979, NEW ENGL J MED, V301, P535; BURNETT CH, 1950, J CLIN INVEST, V29, P169, DOI 10.1172/JCI102243; GANOTE CE, 1975, ARCH PATHOL, V99, P650; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Jacobs TP, 2005, J CLIN ENDOCR METAB, V90, P6316, DOI 10.1210/jc.2005-0675; Palmer W L, 1968, Proc Inst Med Chic, V27, P75; SCHOLZ DA, 1954, J CLIN ENDOCR METAB, V14, P1074, DOI 10.1210/jcem-14-9-1074; ZUCKER GM, 1983, JAMA-J AM MED ASSOC, V250, P2198	10	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1952	1956		10.1056/NEJMcps0706188	http://dx.doi.org/10.1056/NEJMcps0706188			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450607				2022-12-28	WOS:000255387900011
J	Rajendran, L; Schneider, A; Schlechtingen, G; Weidlich, S; Ries, J; Braxmeier, T; Schwille, P; Schulz, JB; Schroeder, C; Simons, M; Jennings, G; Knolker, HJ; Simons, K				Rajendran, Lawrence; Schneider, Anja; Schlechtingen, Georg; Weidlich, Sebastian; Ries, Jonas; Braxmeier, Tobias; Schwille, Petra; Schulz, Joerg B.; Schroeder, Cornelia; Simons, Mikael; Jennings, Gary; Knoelker, Hans-Joachim; Simons, Kai			Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting	SCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; BACE; NEURODEGENERATION; CHOLESTEROL; INVOLVEMENT; MODULATORS; PEPTIDE	beta-secretase plays a critical role in beta- amyloid formation and thus provides a therapeutic target for Alzheimer's disease. Inhibitor design has usually focused on active- site binding, neglecting the subcellular localization of active enzyme. We have addressed this issue by synthesizing a membrane- anchored version of a beta- secretase transition- state inhibitor by linking it to a sterol moiety. Thus, we targeted the inhibitor to active beta- secretase found in endosomes and also reduced the dimensionality of the inhibitor, increasing its local membrane concentration. This inhibitor reduced enzyme activity much more efficiently than did the free inhibitor in cultured cells and in vivo. In addition to effectively targeting beta- secretase, this strategy could also be used in designing potent drugs against other membrane protein targets.	[Rajendran, Lawrence; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Schneider, Anja; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Schlechtingen, Georg; Braxmeier, Tobias; Jennings, Gary; Knoelker, Hans-Joachim] JADO Technol GmbH, D-01307 Dresden, Germany; [Schlechtingen, Georg; Weidlich, Sebastian; Braxmeier, Tobias; Schroeder, Cornelia; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, D-01069 Dresden, Germany; [Ries, Jonas; Schwille, Petra] Biotec, Biotechnol Zentrum, D-01307 Dresden, Germany; [Schulz, Joerg B.] Ctr Neurol Med, D-37073 Gottingen, Germany	Max Planck Society; Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de	Schneider, Anja/F-5293-2010; Schulz, Jorg B./D-9786-2012; Ries, Jonas/P-3027-2014	Schulz, Jorg B./0000-0002-8903-0593; Simons, Kai/0000-0002-9231-9996; Schneider, Anja/0000-0001-9540-8700; Simons, Mikael/0000-0001-5329-192X; Rajendran, Lawrence/0000-0002-6390-1821; Ries, Jonas/0000-0002-6640-9250				Adam G., 1968, STRUCTURAL CHEM MOL, P198; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Capell A, 2002, J BIOL CHEM, V277, P5637, DOI 10.1074/jbc.M109119200; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hills ID, 2007, CURR OPIN DRUG DISC, V10, P383; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; Koo EH, 2002, TRAFFIC, V3, P763, DOI 10.1034/j.1600-0854.2002.31101.x; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Resh MD, 2004, SUB CELL BIOCHEM, V37, P217; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Schmidt B, 2006, CURR TOP MED CHEM, V6, P377, DOI 10.2174/156802606776287027; Simons M, 2001, NEUROLOGY, V57, P1089, DOI 10.1212/WNL.57.6.1089; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Tung JS, 2002, J MED CHEM, V45, P259, DOI 10.1021/jm0155695; Vassar R, 2002, ADV DRUG DELIVER REV, V54, P1589, DOI 10.1016/S0169-409X(02)00157-6; WANG R, 1991, J BIOL CHEM, V266, P16960	25	221	230	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					520	523		10.1126/science.1156609	http://dx.doi.org/10.1126/science.1156609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436784				2022-12-28	WOS:000255249300048
J	Stone, GW; Midei, M; Newman, W; Sanz, M; Hermiller, JB; Williams, J; Farhat, N; Mahaffey, KW; Cutlip, DE; Fitzgerald, PJ; Sood, P; Su, XL; Lansky, AJ				Stone, Gregg W.; Midei, Mark; Newman, William; Sanz, Mark; Hermiller, James B.; Williams, Jerome; Farhat, Naim; Mahaffey, Kenneth W.; Cutlip, Donald E.; Fitzgerald, Peter J.; Sood, Poornima; Su, Xiaolu; Lansky, Alexandra J.		SPIRIT III Investigators	Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							END-POINTS; RESTENOSIS; LESIONS; VASCULOPATHY; THROMBOSIS; COVERAGE	Context A thin, cobalt- chromium stent eluting the antiproliferative agent everolimus from a nonadhesive, durable fluoropolymer has shown promise in preliminary studies in improving clinical and angiographic outcomes in patients with coronary artery disease. Objective To evaluate the safety and efficacy of an everolimus- eluting stent compared with a widely used paclitaxel- eluting stent. Design, Setting, and Patients The SPIRIT III trial, a prospective, randomized, single-blind, controlled trial enrolling patients at 65 academic and community- based US institutions between June 22, 2005, and March 15, 2006. Patients were 1002 men and women undergoing percutaneous coronary intervention in lesions 28 mm or less in length and with reference vessel diameter between 2.5 and 3.75 mm. Angiographic follow- up was prespecified at 8 months in 564 patients and completed in 436 patients. Clinical follow- up was performed at 1, 6, 9, and 12 months. Interventions Patients were randomized 2: 1 to receive the everolimus- eluting stent ( n= 669) or the paclitaxel- eluting stent ( n= 333). Main Outcome Measures The primary end point was noninferiority or superiority of angiographic in- segment late loss. The major secondary end point was noninferiority assessment of target vessel failure events ( cardiac death, myocardial infarction, or target vessel revascularization) at 9 months. An additional secondary end point was evaluation of major adverse cardiac events ( cardiac death, myocardial infarction, or target lesion revascularization) at 9 and 12 months. Results Angiographic in- segment late loss was significantly less in the everolimus-eluting stent group compared with the paclitaxel group ( mean, 0.14 [ SD, 0.41] mm vs 0.28 [ SD, 0.48] mm; difference, - 0.14 [ 95% CI, - 0.23 to - 0.05]; P <=. 004). The everolimus stent was noninferior to the paclitaxel stent for target vessel failure at 9 months ( 7.2% vs 9.0%, respectively; difference, - 1.9% [ 95% CI, - 5.6% to 1.8%]; relative risk, 0.79 [ 95% CI, 0.51 to 1.23]; P <. 001). The everolimus stent compared with the paclitaxel stent resulted in significant reductions in composite major adverse cardiac events both at 9 months ( 4.6% vs 8.1%; relative risk, 0.56 [ 95% CI, 0.34 to 0.94]; P=. 03) and at 1 year ( 6.0% vs 10.3%; relative risk, 0.58 [ 95% CI, 0.37 to 0.90]; P=. 02), due to fewer myocardial infarctions and target lesion revascularization procedures. Conclusions In this large- scale, prospective randomized trial, an everolimus-eluting stent compared with a paclitaxel- eluting stent resulted in reduced angiographic late loss, noninferior rates of target vessel failure, and fewer major adverse cardiac events during 1 year of follow- up. Trial Registration clinicaltrials. gov Identifier: NCT00180479.	[Stone, Gregg W.; Lansky, Alexandra J.] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; [Midei, Mark] St Joseph Med Ctr, Towson, MD USA; [Newman, William] Wake Med Ctr, Raleigh, NC USA; [Sanz, Mark] St Patricks Hosp, Missoula, MT USA; [Hermiller, James B.] Heart Ctr Indiana, Indianapolis, IN USA; [Williams, Jerome] Presbyterian Hosp, Charlotte, NC USA; [Farhat, Naim] EMH Reg Med Ctr, Elyria, OH USA; [Mahaffey, Kenneth W.] Duke Clin Res Inst, Durham, NC USA; [Cutlip, Donald E.] Harvard Univ, Clin Res Inst, Boston, MA 02115 USA; [Fitzgerald, Peter J.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA; [Sood, Poornima; Su, Xiaolu] Abbott Vasc, Santa Clara, CA USA	Cardiovascular Research Foundation (CRF); Columbia University; Duke University; Harvard University; Stanford University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Floor, New York, NY 10022 USA.	gs2184@columbia.edu						Al Suwaidi J, 2000, JAMA-J AM MED ASSOC, V284, P1828, DOI 10.1001/jama.284.14.1828; Avery RK, 2003, NEW ENGL J MED, V349, P829, DOI 10.1056/NEJMp038124; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; Joner M, 2006, CIRCULATION, V114, P506; Kastrati A, 1998, CIRCULATION, V97, P2396, DOI 10.1161/01.CIR.97.24.2396; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Marx SO, 2001, CIRCULATION, V104, P852, DOI 10.1161/01.CIR.104.8.852; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Morikawa T, 1995, J Biopharm Stat, V5, P297, DOI 10.1080/10543409508835115; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Pocock SJ, 2008, J AM COLL CARDIOL, V51, P23, DOI 10.1016/j.jacc.2007.07.084; Ruygrok P, 2007, J AM COLL CARDIOL, V49, p28B; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys Patrick W, 2005, EuroIntervention, V1, P58; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175	27	478	501	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1903	1913		10.1001/jama.299.16.1903	http://dx.doi.org/10.1001/jama.299.16.1903			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291AD	18430909	Bronze			2022-12-28	WOS:000255163800024
J	Max, X; Yoon, SO; Richardson, CJ; Julich, K; Blenis, J				Max, Xiaoju; Yoon, Sang-Oh; Richardson, Celeste J.; Julich, Kristina; Blenis, John			SKAR links pre-mRNA splicing to mTOR/S6K1-mediated enhanced translation efficiency of spliced mRNAs	CELL			English	Article							EXON JUNCTION COMPLEX; NONSENSE-MEDIATED DECAY; MAMMALIAN-CELLS; GENE-EXPRESSION; BINDING PROTEIN; INITIATION; CYTOPLASM; INTRONS; NUCLEUS; GROWTH	Different protein complexes form on newly spliced mRNA to ensure the accuracy and efficiency of eukaryotic gene expression. For example, the exon junction complex (EJC) plays an important role in mRNA surveillance. The EJC also influences the first, or pioneer round of protein synthesis through a mechanism that is poorly understood. We show that the nutrient-, stress-, and energy-sensing checkpoint kinase, mTOR, contributes to the observed enhanced translation efficiency of spliced over nonspliced mRNAs. We demonstrate that, when activated, S6K1 is recruited to the newly synthesized mRNA by SKAR, which is deposited at the EJC during splicing, and that SKAR and S6K1 increase the translation efficiency of spliced mRNA. Thus, SKAR-mediated recruitment of activated S6K1 to newly processed mRNPs serves as a conduit between mTOR checkpoint signaling and the pioneer round of translation when cells exist in conditions supportive of protein synthesis.	[Max, Xiaoju; Yoon, Sang-Oh; Richardson, Celeste J.; Julich, Kristina; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	jblenis@hms.harvard.edu			NIGMS NIH HHS [GM051405] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; CALLIS J, 1987, GENE DEV, V1, P1183, DOI 10.1101/gad.1.10.1183; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gudikote JP, 2005, NAT STRUCT MOL BIOL, V12, P801, DOI 10.1038/nsmb980; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lejeune Fabrice, 2004, Methods Mol Biol, V257, P115, DOI 10.1385/1-59259-750-5:115; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Ma XJ, 2003, EMBO J, V22, P1889, DOI 10.1093/emboj/cdg191; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Methot N, 1996, RNA, V2, P38; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Wilkinson MF, 2005, TRENDS GENET, V21, P143, DOI 10.1016/j.tig.2005.01.007; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	42	232	239	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					303	313		10.1016/j.cell.2008.02.031	http://dx.doi.org/10.1016/j.cell.2008.02.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423201	Bronze			2022-12-28	WOS:000255052000019
J	Nagalakshmi, U; Wang, Z; Waern, K; Shou, C; Raha, D; Gerstein, M; Snyder, M				Nagalakshmi, Ugrappa; Wang, Zhong; Waern, Karl; Shou, Chong; Raha, Debasish; Gerstein, Mark; Snyder, Michael			The transcriptional landscape of the yeast genome defined by RNA sequencing	SCIENCE			English	Article							GENE	The identification of untranslated regions, introns, and coding regions within an organism remains challenging. We developed a quantitative sequencing- based method called RNA- Seq for mapping transcribed regions, in which complementary DNA fragments are subjected to high- throughput sequencing and mapped to the genome. We applied RNA- Seq to generate a high- resolution transcriptome map of the yeast genome and demonstrated that most ( 74.5%) of the nonrepetitive sequence of the yeast genome is transcribed. We confirmed many known and predicted introns and demonstrated that others are not actively used. Alternative initiation codons and upstream open reading frames also were identified for many yeast genes. We also found unexpected 3'- end heterogeneity and the presence of many overlapping genes. These results indicate that the yeast transcriptome is more complex than previously appreciated.	[Nagalakshmi, Ugrappa; Wang, Zhong; Waern, Karl; Raha, Debasish; Snyder, Michael] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Shou, Chong; Gerstein, Mark; Snyder, Michael] Yale Univ, Program Comp Sci & Computat Biol, New Haven, CT 06520 USA; [Gerstein, Mark; Snyder, Michael] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	michael.snyder@yale.edu	Wang, Zhong/E-7897-2011; Wang, Zhong/J-3244-2019; Albers, Pieter/I-2563-2017	Wang, Zhong/0000-0002-6307-0458; Snyder, Michael/0000-0003-0784-7987	NATIONAL CANCER INSTITUTE [R01CA077808] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA077808, R01 CA077808-12] Funding Source: Medline; NHGRI NIH HHS [P50 HG002357, P50 HG002357-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ADAMS MD, 1995, NATURE, V377, P3; ALBRIGHT CF, 1990, J BIOL CHEM, V265, P7042; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gerstein MB, 2007, GENOME RES, V17, P669, DOI 10.1101/gr.6339607; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Snyder M, 2003, SCIENCE, V300, P258, DOI 10.1126/science.1084354	16	1699	1781	13	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1344	1349		10.1126/science.1158441	http://dx.doi.org/10.1126/science.1158441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18451266	Green Accepted			2022-12-28	WOS:000256441100046
J	Cavey, M; Rauzi, M; Lenne, PF; Lecuit, T				Cavey, Matthieu; Rauzi, Matteo; Lenne, Pierre-Francois; Lecuit, Thomas			A two-tiered mechanism for stabilization and immobilization of E-cadherin	NATURE			English	Article							SINGLE-PARTICLE TRACKING; CELL-CELL ADHESION; ADHERENS JUNCTIONS; EPITHELIAL-CELLS; ALPHA-CATENIN; DROSOPHILA EMBRYO; ACTIN; POLARITY; ENDOCYTOSIS; MEMBRANE	Epithelial tissues maintain a robust architecture which is important for their barrier function, but they are also remodelled through the reorganization of cell - cell contacts. Tissue stability requires intercellular adhesion mediated by E- cadherin, in particular its trans- association in homophilic complexes supported by actin filaments through beta- and alpha- catenin. How alpha- catenin dynamic interactions between E- cadherin/ beta- catenin and cortical actin control both stability and remodelling of adhesion is unclear. Here we focus on Drosophila homophilic E- cadherin complexes rather than total E- cadherin, including diffusing 'free' E- cadherin, because these complexes are a better proxy for adhesion. We find that E- cadherin complexes partition in very stable microdomains ( that is, bona fide adhesive foci which are more stable than remodelling contacts). Furthermore, we find that stability and mobility of these microdomains depend on two actin populations: small, stable actin patches concentrate at homophilic E- cadherin clusters, whereas a rapidly turning over, contractile network constrains their lateral movement by a tethering mechanism. alpha- Catenin controls epithelial architecture mainly through regulation of the mobility of homophilic clusters and it is largely dispensable for their stability. Uncoupling stability and mobility of E- cadherin complexes suggests that stable epithelia may remodel through the regulated mobility of very stable adhesive foci.	[Cavey, Matthieu; Rauzi, Matteo; Lecuit, Thomas] Univ Aix Marseille 2, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, F-13288 Marseille 09, France; [Rauzi, Matteo; Lenne, Pierre-Francois] Univ Aix Marseille 3, CNRS, Inst Fresnel, UMR 6133, F-13397 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Aix Marseille 2, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Campus Luminy Case 907, F-13288 Marseille 09, France.	lenne@fresnel.fr; lecuit@ibdm.univ-mrs.fr	Ladoux, Benoit/A-9879-2013	Lenne, Pierre-Francois/0000-0003-1066-7506; Rauzi, Matteo/0000-0002-6313-0668				Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; CAVEY M, 2008, IMAGING CELLULAR MOL; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Cliffe A, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-37; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Kametani Y, 2007, NAT CELL BIOL, V9, P92, DOI 10.1038/ncb1520; KARTENBECK J, 1991, J CELL BIOL, V113, P881, DOI 10.1083/jcb.113.4.881; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kofron M, 1997, DEVELOPMENT, V124, P1553; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Oda H, 2001, J CELL SCI, V114, P493; Pilot F, 2006, NATURE, V442, P580, DOI 10.1038/nature04935; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; Thiery JP, 2003, CURR OPIN GENET DEV, V13, P365, DOI 10.1016/S0959-437X(03)00088-1; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Troyanovsky RB, 2006, MOL BIOL CELL, V17, P3484, DOI 10.1091/mbc.E06-03-0190; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	42	303	308	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					751	U2		10.1038/nature06953	http://dx.doi.org/10.1038/nature06953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18480755				2022-12-28	WOS:000256415300036
J	McGinty, RK; Kim, J; Chatterjee, C; Roeder, RG; Muir, TW				McGinty, Robert K.; Kim, Jaehoon; Chatterjee, Champak; Roeder, Robert G.; Muir, Tom W.			Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation	NATURE			English	Article							H3 METHYLATION; UBIQUITINATION; CYSTEINE; DOT1P; YEAST; CORE; MONOUBIQUITINATION; LIGATION; PROTEINS; DOMAIN	Numerous post- translational modifications of histones have been described in organisms ranging from yeast to humans(1). Growing evidence for dynamic regulation of these modifications, position- and modification- specific protein interactions, and biochemical crosstalk between modifications has strengthened the 'histone code' hypothesis, in which histone modifications are integral to choreographing the expression of the genome(1,2). One such modification, ubiquitylation of histone H2B ( uH2B) on lysine 120 ( K120) in humans(3), and lysine 123 in yeast(4), has been correlated with enhanced methylation of lysine 79 ( K79) of histone H3 ( refs 5 - 8), by K79- specific methyltransferase Dot1 ( KMT4)(9-11). However, the specific function of uH2B in this crosstalk pathway is not understood. Here we demonstrate, using chemically ubiquitylated H2B, a direct stimulation of hDot1L- mediated intranucleosomal methylation of H3 K79. Two traceless orthogonal expressed protein ligation ( EPL) reactions were used to ubiquitylate H2B site- specifically. This strategy, using a photolytic ligation auxiliary and a desulphurization reaction, should be generally applicable to the chemical ubiquitylation of other proteins. Reconstitution of our uH2B into chemically defined nucleosomes, followed by biochemical analysis, revealed that uH2B directly activates methylation of H3 K79 by hDot1L. This effect is mediated through the catalytic domain of hDot1L, most likely through allosteric mechanisms. Furthermore, asymmetric incorporation of uH2B into dinucleosomes showed that the enhancement of methylation was limited to nucleosomes bearing uH2B. This work demonstrates a direct biochemical crosstalk between two modifications on separate histone proteins within a nucleosome.	[McGinty, Robert K.; Chatterjee, Champak; Muir, Tom W.] Rockefeller Univ, Lab Synth Prot Chem, New York, NY 10065 USA; [Kim, Jaehoon; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Muir, TW (corresponding author), Rockefeller Univ, Lab Synth Prot Chem, New York, NY 10065 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022; Chatterjee, Champak/R-7214-2017; Kim, Jaehoon/G-2711-2011	Muir, Tom/0000-0001-9635-0344; Kim, Jaehoon/0000-0003-4035-0438	NCI NIH HHS [R01 CA129325] Funding Source: Medline; NIGMS NIH HHS [R01 GM086868, T32 GM007739, GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM086868] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chatterjee C, 2007, ANGEW CHEM INT EDIT, V46, P2814, DOI 10.1002/anie.200605155; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Henry KW, 2002, NAT STRUCT BIOL, V9, P565, DOI 10.1038/nsb0802-565; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Owen-Hughes T, 1999, METH MOL B, V119, P319; Pentelute BL, 2007, ORG LETT, V9, P687, DOI 10.1021/ol0630144; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Smith AB, 2002, ORG LETT, V4, P4041, DOI 10.1021/ol026736d; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; WANG SS, 1977, J ORG CHEM, V42, P1286, DOI 10.1021/jo00428a004; WEST MHP, 1980, NUCLEIC ACIDS RES, V8, P4671, DOI 10.1093/nar/8.20.4671; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yan LZ, 2001, J AM CHEM SOC, V123, P526, DOI 10.1021/ja003265m; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	37	398	407	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					812	U12		10.1038/nature06906	http://dx.doi.org/10.1038/nature06906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18449190	Green Accepted, Green Published			2022-12-28	WOS:000256415300050
J	Guo, W; Lasky, JL; Chang, CJ; Mosessian, S; Lewis, X; Xiao, Y; Yeh, JE; Chen, JY; Iruela-Arispe, ML; Varella-Garcia, M; Wu, H				Guo, Wei; Lasky, Joseph L.; Chang, Chun-Ju; Mosessian, Sherly; Lewis, Xiaoman; Xiao, Yun; Yeh, Jennifer E.; Chen, James Y.; Iruela-Arispe, M. Luisa; Varella-Garcia, Marileila; Wu, Hong			Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; C-MYC; NOTCH1; EXPRESSION; CANCER; MOUSE; LEUKEMIA/LYMPHOMA; TRANSLOCATIONS; INACTIVATION; DELETION	Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance(1). The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self- renewable leukaemia stem cells (LSCs) are enriched in the c-Kit(mid)CD3(+)Lin(-) compartment, where unphosphorylated beta-catenin is significantly increased. Conditional ablation of one allele of the beta-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the beta-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-Kit mid CD3(+)Lin(-) LSCs and CD3(+) leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities(2,3), leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.	[Guo, Wei; Chang, Chun-Ju; Mosessian, Sherly; Lewis, Xiaoman; Chen, James Y.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Lasky, Joseph L.] Univ Calif Los Angeles, Dept Pediat Hematol Oncol, Los Angeles, CA 90095 USA; [Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; [Wu, Hong] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Xiao, Yun; Varella-Garcia, Marileila] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Med Oncol,Univ Colorado Canc Ctr, Denver, CO 80262 USA; [Yeh, Jennifer E.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Massachusetts Institute of Technology (MIT)	Wu, H (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hwu@mednet.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Yeh, Jennifer/0000-0003-3144-6702; Chang, Chunju/0000-0003-2887-9603; Mosessian, Sherly/0000-0002-8665-5053	NATIONAL CANCER INSTITUTE [P30CA016042, R01CA121110] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA121110, CA16042, R01 CA121110-01A1, P30 CA016042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boomer T, 2001, LEUKEMIA, V15, P95, DOI 10.1038/sj.leu.2401988; BOROWITZ MJ, 1993, AM J CLIN PATHOL, V100, P534, DOI 10.1093/ajcp/100.5.534; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Brault V, 2001, DEVELOPMENT, V128, P1253; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; ERIKSON J, 1986, SCIENCE, V232, P884, DOI 10.1126/science.3486470; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Putti MC, 1998, BLOOD, V92, P795; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	27	174	188	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					529	U7		10.1038/nature06933	http://dx.doi.org/10.1038/nature06933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18463637	Green Accepted			2022-12-28	WOS:000256023700044
J	Garlick, PB; Brown, G				Garlick, Pamela B.; Brown, Gavin			Widening participation in medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOCIAL-CLASS; SCHOOL; EDUCATION; SEX		[Garlick, Pamela B.] Kings Coll London, London SE1 1UL, England; [Brown, Gavin] Univ Leicester, Leicester LE1 7RH, Leics, England	University of London; King's College London; University of Leicester	Garlick, PB (corresponding author), Kings Coll London, London SE1 1UL, England.	pamela.garlick@kcl.ac.uk						Admissions to Higher Education Steering Group, 2004, FAIR ADM HIGH ED REC; Archer L, 2001, GENDER EDUC, V13, P431, DOI 10.1080/09540250120081779; Brown G, 2007, HEALTH PLACE, V13, P520, DOI 10.1016/j.healthplace.2006.07.001; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Greenhalgh T, 2004, BRIT MED J, V328, P1541, DOI 10.1136/bmj.328.7455.1541; KAMIEN M, 1990, MED J AUSTRALIA, V153, P105, DOI 10.5694/j.1326-5377.1990.tb136804.x; *KINGS COLL LOND, 2006, CHALL ENG YOUNG PEOP; Lumb AB, 2004, MED EDUC, V38, P1002, DOI 10.1111/j.1365-2929.2004.01912.x; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; *OECD, 2005, ED GLANC; Preston J, 2007, WHITENESS AND CLASS IN EDUCATION, P1; Reay D, 2001, J EDUC POLICY, V16, P333; Reay D, 2005, SOCIOLOGY, V39, P911, DOI 10.1177/0038038505058372; Seyan K, 2004, BRIT MED J, V328, P1545, DOI 10.1136/bmj.328.7455.1545	14	48	48	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1111	1113		10.1136/bmj.39508.606157.BE	http://dx.doi.org/10.1136/bmj.39508.606157.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483054	Green Published			2022-12-28	WOS:000255975100038
J	Leonardi, CL; Kimball, AB; Papp, KA; Yeilding, N; Guzzo, C; Wang, YH; Li, S; Dooley, LT; Gordon, KB				Leonardi, Craig L.; Kimball, Alexa B.; Papp, Kim A.; Yeilding, Newman; Guzzo, Cynthia; Wang, Yuhua; Li, Shu; Dooley, Lisa T.; Gordon, Kenneth B.		PHOENIX 1 Study Investigators	Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)	LANCET			English	Article							CYTOKINE; IL23R; SKIN; KERATINOCYTES; PATHOGENESIS; ASSOCIATION; DERMATOLOGY; EXPRESSION; THERAPIES; DISORDER	Background interleukins 12 and 23 have important roles in the pathophysiology of psoriasis. We assessed ustekinumab, a human monoclonal antibody directed against these cytokines, for the treatment of psoriasis. Methods In this phase III, parallel, double-blind, placebo-controlled study, 766 patients with moderate-to-severe psoriasis were randomly assigned to receive ustekinumab 45 mg (n=255) or 90 mg (n=256) at weeks 0 and 4 and then every 12 weeks; or placebo (n=255) at weeks 0 and 4, with subsequent crossover to ustekinumab at week 12. Patients who were initially randomised to receive ustekinumab at week 0 who achieved long-term response (at least 75% improvement in psoriasis area and severity index [PASI 75] at weeks 28 and 40) were re-randomised at week 40 to maintenance ustekinumab or withdrawal from treatment until loss of response. Both randomisations were done with a minimisation method via a centralised interactive voice response system. The primary endpoint was the proportion of patients achieving PASI 75 at week 12. Analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00267969. Findings All randomised patients were included in the efficacy analysis. 171 (67.1%) patients receiving ustekinumab 45 mg, 170 (66.4%) receiving ustekinumab 90 mg, and eight (3.1%) receiving placebo achieved PASI 75 at week 12 (difference in response rate vs placebo 63.9%, 95% CI 57.8-70.1, p < 0.0001 for 45 mg and 63.3%, 57.1-69.4, p < 0.0001 for 90 mg). At week 40, long-term response had been achieved by 150 patients in the 45 mg group and 172 patients in the 90 mg group. Of these, 162 patients were randomly assigned to maintenance ustekinumab and 160 to withdrawal. PASI 75 response was better maintained to at least 1 year in those receiving maintenance ustekinumab than in those withdrawn from treatment at week 40 (p<0.0001 by log-rank test). During the placebo-controlled phase, adverse events occurred in 278 (54.5%) of the 510 patients receiving ustekinumab and 123 (48.2%) of the 255 receiving placebo. Serious adverse events occurred in six (1.2%) of 510 patients receiving ustekinumab and in two (0.8%) of 255 receiving placebo in this phase. The pattern of adverse events was much the same in the placebo crossover and randomised withdrawal phases as it was in the placebo-controlled phase. Interpretation Ustekinumab seems to be efficacious for the treatment of moderate-to-severe psoriasis; dosing every 12 weeks maintains efficacy for at least a year in most patients.	[Leonardi, Craig L.] St Louis Univ, Sch Med, St Louis, MO 63103 USA; [Kimball, Alexa B.] Harvard Univ, Sch Med, Boston, MA USA; [Papp, Kim A.] Prob Med Res, Waterloo, ON, Canada; [Papp, Kim A.] Univ Western Ontario, London, ON, Canada; [Yeilding, Newman; Guzzo, Cynthia; Wang, Yuhua; Li, Shu; Dooley, Lisa T.] Centocor Inc, Malvern, PA 19355 USA; [Gordon, Kenneth B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Gordon, Kenneth B.] Evanston NW Healthcare, Chicago, IL USA	Saint Louis University; Harvard University; Harvard Medical School; Western University (University of Western Ontario); Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Northwestern University; Feinberg School of Medicine; NorthShore University Health System	Gordon, KB (corresponding author), Evanston NW Healthcare, Div Dermatol, 9977 Woods Dr, Skokie, IL 60077 USA.	kgordon@enh.org	Kimball, Alexandra B./M-6347-2019	Kimball, Alexandra B./0000-0001-9405-0479; Smith, Stacy/0000-0002-4384-6888; Papp, Kim A./0000-0001-9557-3642				BruchGerharz D, 1996, J EXP MED, V184, P2007, DOI 10.1084/jem.184.5.2007; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Carlin CS, 2004, J AM ACAD DERMATOL, V50, P859, DOI 10.1016/j.jaad.2003.09.014; de Jong R, 1998, SCIENCE, V280, P1435; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Geng D, 2005, J PHARMACEUT BIOMED, V39, P364, DOI 10.1016/j.jpba.2005.04.045; Gordon KB, 2005, ARCH DERMATOL, V141, P82, DOI 10.1001/archderm.141.1.82; Hong K, 1999, J IMMUNOL, V162, P7480; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Nestle FO, 2004, J INVEST DERMATOL, V123, pXIV, DOI 10.1111/j.0022-202X.2004.23488.x; Nickoloff BJ, 2006, J AM ACAD DERMATOL, V54, pS143, DOI 10.1016/j.jaad.2005.10.059; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Philipp S, 2006, EXPERT OPIN THER TAR, V10, P817, DOI 10.1517/14728222.10.6.817; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Richards HL, 2006, J EUR ACAD DERMATOL, V20, P370, DOI 10.1111/j.1468-3083.2006.01565.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Sterry W, 2004, BRIT J DERMATOL, V151, P3, DOI 10.1111/j.1365-2133.2004.06070.x; Torti DC, 2007, J AM ACAD DERMATOL, V57, P1059, DOI 10.1016/j.jaad.2007.07.016; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vanden Eijnden S, 2005, EUR J IMMUNOL, V35, P469, DOI 10.1002/eji.200425677; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	35	1229	1312	1	73	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1665	1674		10.1016/S0140-6736(08)60725-4	http://dx.doi.org/10.1016/S0140-6736(08)60725-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486739				2022-12-28	WOS:000256002200025
J	Vrijens, B; Vincze, G; Kristanto, P; Urquhart, J; Burnier, M				Vrijens, Bernard; Vincze, Gabor; Kristanto, Paulus; Urquhart, John; Burnier, Michel			Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; MEDICATION; HYPERTENSION; PERSISTENCE; THERAPY; DISEASE; PLASMA; TIME; CARE	Objective To describe characteristics of dosing history in patients prescribed a once a day antihypertensive medication. Design Longitudinal database study. Setting Clinical studies archived in database for 1989-2006. Participants Patients who participated in the studies whose dosing histories were available through electronic monitoring. Main outcome measures Persistence with prescribed anti hypertensive treatment and execution of their once a day drug dosing regimens. Results The database contained dosing histories of 4783 patients with hypertension. The data came from 21 phase IV clinical studies, with lengths ranging from 30 to 330 days and involving 43 different antihypertensive drugs, including angiotensin 11 receptor blockers (n=2088), calcium channel blockers (n=937), angiotensin converting enzyme inhibitors (n=665), P blockers (n=195), and diuretics (n=155). About half of the patients who were prescribed an antihypertensive drug had stopped taking it within one year. On any day, patients who were still engaged with the drug dosing regimen omitted about 10% of the scheduled doses: 42% of these omissions were of a single day's dose, whereas 43% were part of a sequence of several days (three or more days that is, drug "holidays"). Almost half of the patients had at least one drug holiday a year. The likelihood that a patient would discontinue treatment early was inversely related to the quality of his or her daily execution of the dosing regimen. Conclusions Early discontinuation of treatment and suboptimal daily adherence to execution of the prescribed regimens are the most common facets of poor adherence with once a day antihypertensive drug treatments. The shortfalls in drug exposure that these dosing errors create might be a common cause of low rates of blood pressure control and high variability in responses to prescribed antihypertensive drugs.	[Vrijens, Bernard; Kristanto, Paulus] Pharmion Res Ctr, B-4600 Vise, Belgium; [Vrijens, Bernard] Univ Liege, Dept Biostat & Med Informat, Liege, Belgium; [Vincze, Gabor] Novartis Pharmaceut, Basel, Switzerland; [Urquhart, John] Univ Calif San Francisco, Ctr Drug Dev Sci, San Francisco, CA 94143 USA; [Burnier, Michel] Univ Lausanne Hosp, Div Nephrol & Hypertens Consultat, Lausanne, Switzerland	University of Liege; Novartis; University of California System; University of California San Francisco; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Vrijens, B (corresponding author), Pharmion Res Ctr, Rue Cyclistes Frontiere 24, B-4600 Vise, Belgium.	bernard.vrijens@pharmionic.com	Jain, Rakesh K/I-1384-2017; Yuan, Fan/A-1287-2011	Jain, Rakesh K/0000-0001-7571-3548; Vrijens, Bernard/0000-0002-9090-1253				Black HR, 1997, ARCH INTERN MED, V157, P2413; Bloom BS, 2001, BMJ-BRIT MED J, V323, P647, DOI 10.1136/bmj.323.7314.647; Burnier M, 2001, J HYPERTENS, V19, P335, DOI 10.1097/00004872-200102000-00022; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; Canto JG, 2003, JAMA-J AM MED ASSOC, V290, P947, DOI 10.1001/jama.290.7.947; Caro JJ, 1999, CAN MED ASSOC J, V160, P41; CRAMER JA, 1990, ARCH INTERN MED, V150, P1509, DOI 10.1001/archinte.150.7.1509; Cramer JA, 1999, J NERV MENT DIS, V187, P53, DOI 10.1097/00005053-199901000-00009; DUESING R, 2001, CURR HYPERTENS REP, V3, P488; Ebrahim S, 1998, HEALTH TECHNOL ASSES, V2, pi; FEINSTEIN AR, 1990, ARCH INTERN MED, V150, P1377, DOI 10.1001/archinte.150.7.1377; Feldman SR, 2007, J AM ACAD DERMATOL, V57, P81, DOI 10.1016/j.jaad.2007.04.005; Girard P, 1996, J PHARMACOKINET BIOP, V24, P265, DOI 10.1007/BF02353671; Halpern MT, 2006, HYPERTENSION, V47, P1039, DOI 10.1161/01.HYP.0000222373.59104.3d; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Hyre Amanda D, 2007, J Clin Hypertens (Greenwich), V9, P179, DOI 10.1111/j.1524-6175.2007.06372.x; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Morgan Steven G, 2004, Can J Clin Pharmacol, V11, pe267; PULLAR T, 1989, ANN RHEUM DIS, V48, P871, DOI 10.1136/ard.48.10.871; Rosen MI, 2004, BEHAV RES THER, V42, P409, DOI 10.1016/S0005-7967(03)00149-9; RUBIO A, 1992, CLIN PHARMACOKINET, V22, P238, DOI 10.2165/00003088-199222030-00006; RUDD P, 1990, CLIN PHARMACOL THER, V48, P676, DOI 10.1038/clpt.1990.211; SCHNEIDER MP, 2003, J INFORM TECHNOLOGY, V1, P419; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; Urquhart J, 1996, EUR HEART J, V17, P8, DOI 10.1093/eurheartj/17.suppl_A.8; Urquhart J, 1998, ADV DRUG DELIVER REV, V33, P207, DOI 10.1016/S0169-409X(98)00029-5; Urquhart J., 2005, EUR J HOSP PHARM SCI, V103, P103; Vrijens B, 2006, PHARMACOEPIDEM DR S, V15, P115, DOI 10.1002/pds.1198; Vrijens B, 2005, J CLIN PHARMACOL, V45, P461, DOI 10.1177/0091270004274433; Vrijens B, 1997, CONTROL CLIN TRIALS, V18, P187, DOI 10.1016/S0197-2456(96)00235-8; Vrijens B, 1999, STAT METHODS MED RES, V8, P247, DOI 10.1191/096228099669221405; Waeber B, 1999, CLIN EXP HYPERTENS, V21, P973, DOI 10.3109/10641969909061025	32	555	570	1	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1114	1117		10.1136/bmj.39553.670231.25	http://dx.doi.org/10.1136/bmj.39553.670231.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18480115	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000255975100039
J	Fu, Y; Zhu, Y; Zhang, K; Yeung, M; Durocher, D; Xiao, W				Fu, Yu; Zhu, Yu; Zhang, Ke; Yeung, ManTek; Durocher, Daniel; Xiao, Wei			Rad6-Rad18 mediates a eukaryotic SOS response by ubiquitinating the 9-1-1 checkpoint clamp	CELL			English	Article							DNA-DAMAGE CHECKPOINT; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; POSTREPLICATION REPAIR; CONJUGATING-ENZYME; ESCHERICHIA-COLI; S-PHASE; COMPLEX-FORMATION	Bacteria employ a coordinated SOS response to DNA damage by enhancing transcription, translesion synthesis, and recombination; a similar phenomenon has not been reported in eukaryotes. Here, we demonstrate that the ubiquitination complex Rad6-Rad18 is required for the increased transcription of a large number of yeast genes in response to DNA damage. Rad6-Rad18 promotes DNA-damage-dependent transcriptional induction as well as checkpoint functions by catalyzing monoubiquitination at the K197 residue of the Rad17 subunit of the 9-1-1 complex. Rad17 ubiquitination invokes both DNA damage responsive pathways by promoting efficient Rad53 phosphorylation, possibly through the recruitment or maintenance of the 9-1-1 clamp at sites of lesions. Taken together, the Rad6-Rad18 complex is involved in the control of global gene regulation in a way reminiscent of the bacterial SOS response and plays key roles in coordinating several DNA damage response pathways through ubiquitination of two DNA clamps, PCNA and 9-1-1.	[Fu, Yu; Zhu, Yu; Zhang, Ke; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada; [Yeung, ManTek; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Yeung, ManTek; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Saskatchewan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Xiao, W (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	wei.xiao@usask.ca	FU, YU Vincent/AAX-4936-2021; Durocher, Daniel/A-7733-2010	FU, YU Vincent/0000-0001-8251-2306; Durocher, Daniel/0000-0003-3863-8635; Xiao, Wei/0000-0001-7568-0782; Yeung, ManTek/0000-0002-9800-942X				Aboussekhra A, 1996, EMBO J, V15, P3912, DOI 10.1002/j.1460-2075.1996.tb00765.x; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CHEN J, 1990, EMBO J, V9, P4569, DOI 10.1002/j.1460-2075.1990.tb07910.x; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Frei C, 2000, GENE DEV, V14, P81; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Fu Y, 2006, NUCLEIC ACIDS RES, V34, P1876, DOI 10.1093/nar/gkl100; Fu Y, 2003, DNA REPAIR, V2, P1435, DOI 10.1016/j.dnarep.2003.08.013; Fu Yu, 2006, Methods Mol Biol, V313, P257; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; GRIFFITHS DJF, 1995, EMBO J, V14, P5812, DOI 10.1002/j.1460-2075.1995.tb00269.x; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang HH, 1997, MOL CELL BIOL, V17, P6693, DOI 10.1128/MCB.17.11.6693; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jia XD, 2004, GENETICS, V166, P753, DOI 10.1534/genetics.166.2.753; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kiser GL, 1996, MOL BIOL CELL, V7, P703, DOI 10.1091/mbc.7.5.703; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Kondo T, 1999, MOL CELL BIOL, V19, P1136; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Liu YL, 1997, MOL MICROBIOL, V23, P777, DOI 10.1046/j.1365-2958.1997.2701631.x; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Lustgarten V, 1999, MOL CELL BIOL, V19, P4480; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Melo JA, 2001, GENE DEV, V15, P2809; MORRISON A, 1988, MOL CELL BIOL, V8, P1179, DOI 10.1128/MCB.8.3.1179; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Navas TA, 1996, GENE DEV, V10, P2632, DOI 10.1101/gad.10.20.2632; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sherman F., 1983, METHODS YEAST GENETI; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Xiao W, 2000, GENETICS, V155, P1633; XIAO W, 1993, MOL CELL BIOL, V13, P7213, DOI 10.1128/MCB.13.12.7213; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157; Xiao W, 2001, MUTAT RES-DNA REPAIR, V487, P137, DOI 10.1016/S0921-8777(01)00113-6; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838; Zhu Y, 1998, NUCLEIC ACIDS RES, V26, P5402, DOI 10.1093/nar/26.23.5402; Zhu Y, 2001, MOL GENET GENOMICS, V266, P436; Zubko MK, 2006, METHOD ENZYMOL, V409, P285, DOI 10.1016/S0076-6879(05)09016-6	62	62	64	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					601	611		10.1016/j.cell.2008.02.050	http://dx.doi.org/10.1016/j.cell.2008.02.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485869	Bronze			2022-12-28	WOS:000255903300016
J	Barry, MJ; Kaufman, DS; Wu, C; Zietman, AL; McDougal, WS; Young, RH; Talcott, JA; Dahl, DM				Barry, Michael J.; Kaufman, Donald S.; Wu, Chin-Lee; Zietman, Anthony L.; McDougal, W. Scott; Young, Robert H.; Talcott, James A.; Dahl, Douglas M.			Case 15-2008: A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer - Anatomical diagnosis - Adenocarcinoma of the prostate, Gleason score 6 of 10, clinical stage T1c	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RADICAL PROSTATECTOMY; PSA VELOCITY; RISK; MEN; VOLUME; FINASTERIDE; PREDICTION; BIOPSIES; THERAPY; DEATH		[Barry, Michael J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kaufman, Donald S.] Massachusetts Gen Hosp, Hematol Oncol Unit, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Barry, Michael J.; Kaufman, Donald S.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Wu, Chin-Lee] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Barry, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Talcott, James/CAG-8759-2022					Albertsen PC, 2005, J NATL CANCER I, V97, P1248, DOI 10.1093/jnci/dji248; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; ARIAS E, 2006, NATL VITAL STAT REPO, V54; Chappell B, 2005, BJU INT, V95, P1141, DOI 10.1111/j.1464-410X.2005.05551.x; Cheng L, 2005, J UROLOGY, V174, P898, DOI 10.1097/01.ju.0000169134.28610.66; Collins MM, 1997, JAMA-J AM MED ASSOC, V278, P1516, DOI 10.1001/jama.278.18.1516; CUPP MR, 1995, J UROLOGY, V153, P1543, DOI 10.1016/S0022-5347(01)67458-5; D'Amico AV, 2006, J UROLOGY, V176, P2010, DOI 10.1016/j.juro.2006.07.045; D'Amico AV, 2005, JAMA-J AM MED ASSOC, V294, P440, DOI 10.1001/jama.294.4.440; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Denberg TD, 2006, CANCER, V107, P620, DOI 10.1002/cncr.22033; DIETRICK DD, 1995, UROLOGY, V45, P987, DOI 10.1016/S0090-4295(99)80119-8; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Humphrey P, 2003, PROSTATE PATHOLOGY, P138; Klotz L, 2005, J CLIN ONCOL, V23, P8165, DOI 10.1200/JCO.2005.03.3134; Lerner SE, 1996, J UROLOGY, V156, P137, DOI 10.1016/S0022-5347(01)65967-6; Martin RM, 2006, J UROLOGY, V176, P439, DOI 10.1016/j.juro.2006.03.030; Miller DC, 2006, JNCI-J NATL CANCER I, V98, P1134, DOI 10.1093/jnci/djj308; O'Connor AM, 2003, JNCI-J NATL CANCER I, V95, P570, DOI 10.1093/jnci/95.8.570; Parker C, 2006, BRIT J CANCER, V94, P1361, DOI 10.1038/sj.bjc.6603105; Pinthus JH, 2006, J UROLOGY, V176, P979, DOI 10.1016/j.juro.2006.04.102; Sheridan TB, 2008, J UROLOGY, V179, P901, DOI 10.1016/j.juro.2007.10.062; SOX HC, 2006, INTERACTIVE TXB CLIN; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; Young RH, 2000, ATLAS TUMOR PATHOL, P111	30	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2161	2168		10.1056/NEJMcpc0707057	http://dx.doi.org/10.1056/NEJMcpc0707057			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480209				2022-12-28	WOS:000255849300011
J	Passier, R; van Laake, LW; Mummery, CL				Passier, Robert; van Laake, Linda W.; Mummery, Christine L.			Stem-cell-based therapy and lessons from the heart	NATURE			English	Review							LEFT-VENTRICULAR FUNCTION; BONE-MARROW-CELLS; PROGENITOR CELLS; SMOOTH-MUSCLE; CARDIAC MYOCYTES; MOUSE MODEL; MYOCARDIAL-INFARCTION; HEMATOPOIETIC-CELLS; CARDIOMYOCYTES; TRANSPLANTATION	The potential usefulness of human embryonic stem cells for therapy derives from their ability to form any cell in the body. This potential has been used to justify intensive research despite some ethical concerns. In parallel, scientists have searched for adult stem cells that can be used as an alternative to embryonic cells, and, for the heart at least, these efforts have led to promising results. However, most adult cardiomyocytes are unable to divide and form new cardiomyocytes and would therefore be unable to replace those lost as a result of disease. Basic questions - for example, whether cardiomyocyte replacement or alternatives, such as providing the damaged heart with new blood vessels or growth factors to activate resident stem cells, are the best approach - remain to be fully addressed. Despite this, preclinical studies on cardiomyocyte transplantation in animals and the first clinical trials with adult stem cells have recently been published with mixed results.	[Passier, Robert; van Laake, Linda W.; Mummery, Christine L.] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Passier, Robert; Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 AA Leiden, Netherlands; [van Laake, Linda W.] Univ Med Ctr Utrecht, Div Heart & Lungs, NL-3584 CX Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	Mummery, CL (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	c.l.mummery@lumc.nl		Mummery, Christine/0000-0002-4549-6535				Adler ED, 2007, NAT CLIN PRACT CARD, V4, P2, DOI 10.1038/ncpcardio0729; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Beqqali A, 2006, STEM CELLS, V24, P1956, DOI 10.1634/stemcells.2006-0054; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038; CINTRON G, 1993, CIRCULATION, V87, P17; Dai W, 2007, J MOL CELL CARDIOL, V43, P504, DOI 10.1016/j.yjmcc.2007.07.001; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB; Evans SM, 2007, SEMIN CELL DEV BIOL, V18, P153, DOI 10.1016/j.semcdb.2006.12.009; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Feygin J, 2007, AM J PHYSIOL-HEART C, V293, pH1772, DOI 10.1152/ajpheart.00242.2007; Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70; Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Guan K, 2007, J MOL CELL CARDIOL, V43, P377, DOI 10.1016/j.yjmcc.2007.07.056; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Huber I, 2007, FASEB J, V21, P2551, DOI 10.1096/fj.05-5711com; Jain M, 2001, CIRCULATION, V103, P1920; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leobon B, 2003, P NATL ACAD SCI USA, V100, P7808, DOI 10.1073/pnas.1232447100; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Limbourg FP, 2005, EUR J HEART FAIL, V7, P722, DOI 10.1016/j.ejheart.2005.06.005; Liu J, 2007, STEM CELLS, V25, P3038, DOI 10.1634/stemcells.2007-0549; Lu SJ, 2007, NAT METHODS, V4, P501, DOI 10.1038/nmeth1041; Lunde K, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.07.003; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Menard C, 2005, LANCET, V366, P1005, DOI 10.1016/S0140-6736(05)67380-1; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Moelker AD, 2007, J MOL CELL CARDIOL, V42, P735, DOI 10.1016/j.yjmcc.2007.01.005; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narayan AD, 2006, BLOOD, V107, P2180, DOI 10.1182/blood-2005-05-1922; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parmacek MS, 2005, CELL, V120, P295, DOI 10.1016/j.cell.2005.01.025; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Pelacho B, 2007, J TISSUE ENG REGEN M, V1, P51, DOI 10.1002/term.7; Pouly J, 2008, J THORAC CARDIOV SUR, V135, P673, DOI 10.1016/j.jtcvs.2007.10.024; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; Rubart M, 2003, AM J PHYSIOL-CELL PH, V284, pC1654, DOI 10.1152/ajpcell.00469.2002; Schachinger Volker, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS23, DOI 10.1038/ncpcardio0441; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tian XH, 2006, STEM CELLS, V24, P1370, DOI 10.1634/stemcells.2005-0340; Urbanek K, 2003, P NATL ACAD SCI USA, V100, P10440, DOI 10.1073/pnas.1832855100; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; van Laake LW, 2006, CIRCULATION, V114, P2288, DOI 10.1161/CIRCULATIONAHA.106.639161; Wang ZZ, 2007, NAT BIOTECHNOL, V25, P317, DOI 10.1038/nbt1287; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Xue T, 2005, CIRCULATION, V111, P11, DOI 10.1161/01.CIR.0000151313.18547.A2; Yoshioka T, 2005, STEM CELLS, V23, P355, DOI 10.1634/stemcells.2004-0200; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	100	429	465	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					322	329		10.1038/nature07040	http://dx.doi.org/10.1038/nature07040			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480813				2022-12-28	WOS:000255868400039
J	Schenk, P; Matsuyama, I; Nimmo, F				Schenk, Paul; Matsuyama, Isamu; Nimmo, Francis			True polar wander on Europa from global-scale small-circle depressions	NATURE			English	Article							ICE SHELL; REORIENTATION; CONVERGENCE; TECTONICS; PLANETS; SURFACE	The tectonic patterns and stress history of Europa are exceedingly complex(1) and many large-scale features remain unexplained. True polar wander, involving reorientation of Europa's floating outer ice shell about the tidal axis with Jupiter, has been proposed(2) as a possible explanation for some of the features. This mechanism is possible if the icy shell is latitudinally variable in thickness and decoupled from the rocky interior. It would impose high stress levels on the shell, leading to predictable fracture patterns(3). No satisfactory match to global-scale features has hitherto been found for polar wander stress patterns(3). Here we describe broad arcuate troughs and depressions on Europa that do not fit other proposed stress mechanisms in their current position. Using imaging from three spacecraft, we have mapped two global-scale organized concentric antipodal sets of arcuate troughs up to hundreds of kilometres long and 300 m to similar to 1.5 km deep. An excellent match to these features is found with stresses caused by an episode of 806 true polar wander. These depressions also appear to be geographically related to other large-scale bright and dark lineaments(4,5), suggesting that many of Europa's tectonic patterns may also be related to true polar wander.	[Schenk, Paul] Lunar & Planetary Inst, Houston, TX 77058 USA; [Matsuyama, Isamu] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	Carnegie Institution for Science; University of California System; University of California Santa Cruz	Schenk, P (corresponding author), Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA.	schenk@lpi.usra.edu		Matsuyama, Isamu/0000-0002-2917-8633				Figueredo PH, 2004, ICARUS, V167, P287, DOI 10.1016/j.icarus.2003.09.016; Figueredo PH, 2000, J GEOPHYS RES-PLANET, V105, P22629, DOI 10.1029/1999JE001107; Geissler PE, 1998, NATURE, V391, P368, DOI 10.1038/34869; Greeley R, 2004, CAMB PLANET, P329; Greenberg R, 1998, ICARUS, V135, P64, DOI 10.1006/icar.1998.5986; Greenberg R, 2004, ICARUS, V167, P313, DOI 10.1016/j.icarus.2003.09.025; GREENBERG R, 1984, ICARUS, V58, P186, DOI 10.1016/0019-1035(84)90038-1; Grundy WM, 2007, SCIENCE, V318, P234, DOI 10.1126/science.1147623; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; JANES DM, 1988, J GEOPHYS RES-SOLID, V93, P3127, DOI 10.1029/JB093iB04p03127; Leith AC, 1996, ICARUS, V120, P387, DOI 10.1006/icar.1996.0058; Matsuyama I, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002942; Matsuyama I, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002447; Matsuyama I, 2008, ICARUS, V195, P459, DOI 10.1016/j.icarus.2007.12.003; Matsuyama I, 2007, ICARUS, V191, P401, DOI 10.1016/j.icarus.2007.05.006; MELOSH HJ, 1977, ICARUS, V31, P221, DOI 10.1016/0019-1035(77)90035-5; MELOSH HJ, 1980, ICARUS, V44, P745, DOI 10.1016/0019-1035(80)90141-4; Nimmo F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002347; Nimmo F, 2006, NATURE, V441, P614, DOI 10.1038/nature04821; OJAKANGAS GW, 1989, ICARUS, V81, P242, DOI 10.1016/0019-1035(89)90053-5; Prockter L, 2005, ICARUS, V177, P305, DOI 10.1016/j.icarus.2005.08.003; Prockter LM, 2000, J GEOPHYS RES-PLANET, V105, P9483, DOI 10.1029/1999JE001226; Sarid AR, 2002, ICARUS, V158, P24, DOI 10.1006/icar.2002.6873; SCHENK P, 2005, LUNAR PLANET SCI C, V30; SCHENK P, 2001, LUNAR PLANET SCI C, V32; SCHENK PM, 1989, ICARUS, V79, P75, DOI 10.1016/0019-1035(89)90109-7; SCHENK PM, 1987, ICARUS, V72, P209, DOI 10.1016/0019-1035(87)90126-6; STEVENSON D, 2000, LUNAR PLANET SCI C, V31; WILLEMANN RJ, 1984, ICARUS, V60, P701, DOI 10.1016/0019-1035(84)90174-X	29	41	41	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					368	371		10.1038/nature06911	http://dx.doi.org/10.1038/nature06911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480819				2022-12-28	WOS:000255868400046
J	Loose, M; Fischer-Friedrich, E; Ries, J; Kruse, K; Schwille, P				Loose, Martin; Fischer-Friedrich, Elisabeth; Ries, Jonas; Kruse, Karsten; Schwille, Petra			Spatial regulators for bacterial cell division self-organize into surface waves in vitro	SCIENCE			English	Article							ESCHERICHIA-COLI; MIN-PROTEINS; PATTERN-FORMATION; POLE OSCILLATION; RAPID POLE; RING; LOCALIZATION; INHIBITOR; MEMBRANE; SEPTUM	In the bacterium Escherichia coli, the Min proteins oscillate between the cell poles to select the cell center as division site. This dynamic pattern has been proposed to arise by self- organization of these proteins, and several models have suggested a reaction- diffusion type mechanism. Here, we found that the Min proteins spontaneously formed planar surface waves on a flat membrane in vitro. The formation and maintenance of these patterns, which extended for hundreds of micrometers, required adenosine 5 '- triphosphate (ATP), and they persisted for hours. We present a reaction- diffusion model of the MinD and MinE dynamics that accounts for our experimental observations and also captures the in vivo oscillations.	[Kruse, Karsten] Univ Saarland, D-66041 Saarbrucken, Germany; [Loose, Martin; Ries, Jonas; Schwille, Petra] Tech Univ Dresden, Biotechnol Zentrum, D-01307 Dresden, Germany; [Loose, Martin; Schwille, Petra] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Fischer-Friedrich, Elisabeth] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Saarland University; Technische Universitat Dresden; Max Planck Society; Max Planck Society	Kruse, K (corresponding author), Univ Saarland, Postfach 151150, D-66041 Saarbrucken, Germany.	k.kruse@physik.uni-saarland.de; petra.schwille@biotec.tu-dresden.de	Ries, Jonas/Q-5157-2019; Schwille, Petra/A-4983-2010; Kruse, Karsten/GOG-8298-2022; Fischer-Friedrich, Elisabeth/B-2697-2017; Ries, Jonas/P-3027-2014	Kruse, Karsten/0000-0001-8665-2349; Fischer-Friedrich, Elisabeth/0000-0002-2433-916X; Ries, Jonas/0000-0002-6640-9250; Loose, Martin/0000-0001-7309-9724				BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Fischer-Friedrich E, 2007, PHYS BIOL, V4, P38, DOI 10.1088/1478-3975/4/1/005; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Meacci G, 2005, PHYS BIOL, V2, P89, DOI 10.1088/1478-3975/2/2/002; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; Nicolis G, 1977, SELF ORG NONEQUILIBR; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572	20	373	378	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					789	792		10.1126/science.1154413	http://dx.doi.org/10.1126/science.1154413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467587				2022-12-28	WOS:000255644400039
J	Schuetz, C; Huck, K; Gudowius, S; Megahed, M; Feyen, O; Hubner, B; Schneider, DT; Manfras, B; Pannicke, U; Willemze, R; Knuchel, R; Gobel, U; Schulz, A; Borkhardt, A; Friedrich, W; Schwarz, K; Niehues, T				Schuetz, Catharina; Huck, Kirsten; Gudowius, Sonja; Megahed, Mosaad; Feyen, Oliver; Hubner, Bernd; Schneider, Dominik T.; Manfras, Burkhard; Pannicke, Ulrich; Willemze, Rein; Knuechel, Ruth; Goebel, Ulrich; Schulz, Ansgar; Borkhardt, Arndt; Friedrich, Wilhelm; Schwarz, Klaus; Niehues, Tim			An immunodeficiency disease with RAG mutations and granulomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; IN-VIVO REVERSION; OMENN-SYNDROME; T-CELLS; LYMPHOCYTES; REPERTOIRE; RESOLUTION; DEFECTS	We describe three unrelated girls who had an immunodeficiency disease with granulomas in the skin, mucous membranes, and internal organs. All three girls had severe complications after viral infections, including B-cell lymphoma associated with Epstein-Barr virus (EBV). Other findings were hypogammaglobulinemia, a diminished number of T and B cells, and sparse thymic tissue on ultrasonography. Molecular analysis revealed that the patients were compound heterozygotes for mutations in recombination activating gene 1 or 2 (RAG1 or RAG2). In each case, both parents were heterozygous carriers of a RAG mutation. The mutations were associated with reduced function of RAG in vitro (3 to 30% of normal activity). The parents and one sibling in the three families were healthy.	[Schuetz, Catharina; Schulz, Ansgar; Friedrich, Wilhelm] Univ Hosp Ulm, Dept Pediat & Adolescent Med, Ulm, Germany; [Manfras, Burkhard] Univ Hosp Ulm, Dept Internal Med, Ulm, Germany; [Pannicke, Ulrich] Univ Hosp Ulm, Inst Transfus Med, Ulm, Germany; [Schwarz, Klaus] Inst Clin Transfus Med & Immunogenet, Ulm, Germany; [Huck, Kirsten; Gudowius, Sonja; Feyen, Oliver; Hubner, Bernd; Schneider, Dominik T.; Goebel, Ulrich; Borkhardt, Arndt; Niehues, Tim] Univ Dusseldorf, Univ Klinikum Dusseldorf, Childrens Hosp, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany; [Knuechel, Ruth] Univ Hosp Aachen, Dept Pathol, Aachen, Germany; [Megahed, Mosaad] Univ Hosp Aachen, Dept Dermatol, Aachen, Germany; [Willemze, Rein] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands	Ulm University; Ulm University; Ulm University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Niehues, T (corresponding author), Univ Dusseldorf, Acad Hosp, HELIOS Klinikum Krefeld, Ctr Child & Adolescent Hlth, Lutherpl 40, D-47805 Krefeld, Germany.	tim.niehues@helios-kliniken.de	Pannicke, Ulrich/D-7348-2014	Schneider, Dominik T./0000-0001-8153-1601				Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; de Villartay JP, 2005, J CLIN INVEST, V115, P3291, DOI 10.1172/JCI25178; Ehl S, 2005, J CLIN INVEST, V115, P3140, DOI 10.1172/JCI25221; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Kanathur N, 2000, SOUTHERN MED J, V93, P631; LEVINE TS, 1994, BRIT J DERMATOL, V130, P118, DOI 10.1111/j.1365-2133.1994.tb06896.x; Manfras BJ, 1997, J IMMUNOL METHODS, V210, P235, DOI 10.1016/S0022-1759(97)00197-X; Marzano AV, 2001, J AM ACAD DERMATOL, V44, P710, DOI 10.1067/mjd.2001.112916; Mechanic LJ, 1997, ANN INTERN MED, V127, P613, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00005; Pujol RM, 1999, DERMATOLOGY, V198, P156, DOI 10.1159/000018093; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Signorini S, 1999, BLOOD, V94, P3468, DOI 10.1182/blood.V94.10.3468.422k34_3468_3478; Sobacchi C, 2006, HUM MUTAT, V27, P1174, DOI 10.1002/humu.20408; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81	19	157	164	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2030	2038		10.1056/NEJMoa073966	http://dx.doi.org/10.1056/NEJMoa073966			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463379				2022-12-28	WOS:000255577700007
J	Stevenson, DG				Stevenson, David G.			Planning for the future - Long-term care and the 2008 election	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stevenson, DG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							[Anonymous], 2007, LONG TERM CARE FINAN; Grabowski DC, 2007, MILBANK Q, V85, P579, DOI 10.1111/j.1468-0009.2007.00502.x; National Commission for Quality Long-Term Care, 2007, IS INT REC IMPR QUAL; VLADECK BC, 1980, 20 CENTURY FUND UNLO; Wiener JM, 2001, MILBANK Q, V79, P207, DOI 10.1111/1468-0009.00204	5	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					1985	1987		10.1056/NEJMp0802347	http://dx.doi.org/10.1056/NEJMp0802347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296WY	18463373				2022-12-28	WOS:000255577700001
J	Fleisher, LA; Poldermans, D				Fleisher, Lee A.; Poldermans, Don			Perioperative beta blockade: where do we go from here?	LANCET			English	Editorial Material							NONCARDIAC SURGERY; VASCULAR-SURGERY; RISK PATIENTS; GUIDELINES		[Fleisher, Lee A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Poldermans, Don] Erasmus MC, Dept Surg, Rotterdam, Netherlands	University of Pennsylvania; Erasmus University Rotterdam; Erasmus MC	Fleisher, LA (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	Lee.fleisher@uphs.upenn.edu	Lee A, Fleisher/Q-9894-2019					Cruickshank JM, 2000, EUR HEART J, V21, P354, DOI 10.1053/euhj.1999.1717; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Hjalmarson A, 1999, LANCET, V353, P2001; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; *POISE STUD GROUP, 2008, LANCET; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; POLDERMANS D, IN PRESS J AM COLL C; Poldermans D, 2006, J AM COLL CARDIOL, V48, P964, DOI 10.1016/j.jacc.2006.03.059; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516	9	62	64	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2008	371	9627					1813	1814		10.1016/S0140-6736(08)60662-5	http://dx.doi.org/10.1016/S0140-6736(08)60662-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NL	18479743				2022-12-28	WOS:000256325500004
J	Goldstein, SL; Soffer, G; Langmuir, CH; Lehnert, KA; Graham, DW; Michael, PJ				Goldstein, Steven L.; Soffer, Gad; Langmuir, Charles H.; Lehnert, Kerstin A.; Graham, David W.; Michael, Peter J.			Origin of a 'Southern Hemisphere' geochemical signature in the Arctic upper mantle	NATURE			English	Article							MID-ATLANTIC RIDGE; SOUTHWEST INDIAN RIDGE; HETEROGENEITY BENEATH; PERIDOTITE XENOLITHS; ENRICHED MANTLE; GAKKEL RIDGE; OCEAN-RIDGE; TRACE; MORB; ISOTOPE	The Gakkel ridge, which extends under the Arctic ice cap for similar to 1,800 km, is the slowest spreading ocean ridge on Earth. Its spreading created the Eurasian basin, which is isolated from the rest of the oceanic mantle by North America, Eurasia and the Lomonosov ridge. The Gakkel ridge thus provides unique opportunities to investigate the composition of the sub- Arctic mantle and mantle heterogeneity and melting at the lower limits of seafloor spreading. The first results of the 2001 Arctic Mid- Ocean Ridge Expedition ( ref. 1) divided the Gakkel ridge into three tectonic segments, composed of robust western and eastern volcanic zones separated by a `sparsely magmatic zone'. On the basis of Sr - Nd - Pb isotope ratios and trace elements in basalts from the spreading axis, we show that the sparsely magmatic zone contains an abrupt mantle compositional boundary. Basalts to the west of the boundary display affinities to the Southern Hemisphere 'Dupal' isotopic province(2), whereas those to the east - closest to the Eurasian continent and where the spreading rate is slowest display affinities to 'Northern Hemisphere' ridges. The western zone is the only known spreading ridge outside the Southern Hemisphere that samples a significant upper- mantle region with Dupal- like characteristics. Although the cause of Dupal mantle has been long debated, we show that the source of this signature beneath the western Gakkel ridge was subcontinental lithospheric mantle that delaminated and became integrated into the convecting Arctic asthenosphere. This occurred as North Atlantic mantle propagated north into the Arctic during the separation of Svalbard and Greenland.	[Goldstein, Steven L.; Soffer, Gad; Lehnert, Kerstin A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Goldstein, Steven L.; Soffer, Gad] Columbia Univ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Langmuir, Charles H.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Graham, David W.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Michael, Peter J.] Univ Tulsa, Dept Geosci, Tulsa, OK 74104 USA	Columbia University; Columbia University; Harvard University; Oregon State University; University of Tulsa	Goldstein, SL (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, 61 Route 9W, Palisades, NY 10964 USA.	steveg@ldeo.columbia.edu	Graham, David/C-3612-2014	Graham, David/0000-0002-7411-1905; Michael, Peter/0000-0003-2829-9502; Lehnert, Kerstin/0000-0001-7036-1977				ARNDT NT, 1989, TECTONOPHYSICS, V161, P201, DOI 10.1016/0040-1951(89)90154-6; BARLING J, 1994, J PETROL, V35, P1017, DOI 10.1093/petrology/35.4.1017; Blythe AE, 1998, TECTONICS, V17, P621, DOI 10.1029/98TC01890; CASTILLO P, 1988, NATURE, V336, P667, DOI 10.1038/336667a0; CLAGUE DA, 1982, J PETROL, V23, P447, DOI 10.1093/petrology/23.3.447; Class C, 1997, EARTH PLANET SC LETT, V150, P245, DOI 10.1016/S0012-821X(97)00089-7; Dick HJB, 2003, NATURE, V426, P405, DOI 10.1038/nature02128; Dosso L, 1999, EARTH PLANET SC LETT, V170, P269, DOI 10.1016/S0012-821X(99)00109-0; DUPRE B, 1983, NATURE, V303, P142, DOI 10.1038/303142a0; Escrig S, 2004, NATURE, V431, P59, DOI 10.1038/nature02904; Geldmacher J, 2008, EARTH PLANET SC LETT, V265, P167, DOI 10.1016/j.epsl.2007.10.001; Hanan BB, 2004, NATURE, V432, P91, DOI 10.1038/nature03026; HART SR, 1984, NATURE, V309, P753, DOI 10.1038/309753a0; HAWKESWORTH CJ, 1986, NATURE, V322, P356, DOI 10.1038/322356a0; Hofmann, 1996, EARTH PROCESSES READ, V95, P429; Ionov DA, 2002, J PETROL, V43, P2261, DOI 10.1093/petrology/43.12.2261; Ionov DA, 2002, J PETROL, V43, P2219, DOI 10.1093/petrology/43.12.2219; Janney PE, 2005, J PETROL, V46, P2427, DOI 10.1093/petrology/egi060; Kempton PD, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2002GC000320; KLEIN EM, 1988, NATURE, V333, P623, DOI 10.1038/333623a0; le Roux PJ, 2002, EARTH PLANET SC LETT, V203, P479, DOI 10.1016/S0012-821X(02)00832-4; LEROEX AP, 1989, J PETROL, V30, P947, DOI 10.1093/petrology/30.4.947; MAHONEY JJ, 1989, J GEOPHYS RES-SOLID, V94, P4033, DOI 10.1029/JB094iB04p04033; Meyzen CM, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000979; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; Muhe R, 1997, EARTH PLANET SC LETT, V152, P1, DOI 10.1016/S0012-821X(97)00152-0; Niida K, 1999, CONTRIB MINERAL PETR, V135, P18, DOI 10.1007/s004100050495; Rehkamper M, 1997, EARTH PLANET SC LETT, V147, P93, DOI 10.1016/S0012-821X(97)00009-5; Ritzmann O, 2003, GEOPHYS J INT, V152, P139, DOI 10.1046/j.1365-246X.2003.01836.x; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; SHIREY SB, 1987, NATURE, V325, P217, DOI 10.1038/325217a0; SKJELKVALE BL, 1989, J VOLCANOL GEOTH RES, V37, P1, DOI 10.1016/0377-0273(89)90110-8; Zhang SQ, 2005, J PETROL, V46, P829, DOI 10.1093/petrology/egi002	34	87	92	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					89	+		10.1038/nature06919	http://dx.doi.org/10.1038/nature06919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451860				2022-12-28	WOS:000255398800044
J	Finch, R				Finch, Rob			When is a polyclinic not a polyclinic?	BRITISH MEDICAL JOURNAL			English	Editorial Material												roberto_finchley@hotmail.com						Day M, 2007, BRIT MED J, V335, P61, DOI 10.1136/bmj.39273.467697.DB; Mayor S, 2008, BRIT MED J, V336, P412, DOI 10.1136/bmj.39496.687245.DB; Roland M, 2008, BMJ-BRIT MED J, V336, P625, DOI 10.1136/bmj.39510.702234.80	3	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					916	918		10.1136/bmj.39552.381053.DB	http://dx.doi.org/10.1136/bmj.39552.381053.DB			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18436945	Green Published			2022-12-28	WOS:000255540900025
J	Gaut, BS; Ross-Ibarra, J				Gaut, Brandon S.; Ross-Ibarra, Jeffrey			Perspective - Selection on major components of angiosperm genomes	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; TRANSPOSABLE ELEMENT; PLANT GENOMES; DNA CONTENT; GENE; EVOLUTION; RICE; HETEROCHROMATIN; AMPLIFICATION; CHROMOSOMES	Angiosperms are a relatively recent evolutionary innovation, but their genome sizes have diversified remarkably since their origin, at a rate beyond that of most other taxa. Genome size is often correlated with plant growth and ecology, and extremely large genomes may be limited both ecologically and evolutionarily. Yet the relationship between genome size and natural selection remains poorly understood. The manifold cellular and physiological effects of large genomes may be a function of selection on the major components that contribute to genome size, such as transposable elements and gene duplication. To understand the nature of selection on these genomic components, both population- genetic and comparative approaches are needed.	[Gaut, Brandon S.; Ross-Ibarra, Jeffrey] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Gaut, BS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	bgaut@uci.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954				Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; GASNEUF T, 2006, GENOME BIOL, V7, pR13; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hollister JD, 2007, MOL BIOL EVOL, V24, P2515, DOI 10.1093/molbev/msm197; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Knight CA, 2005, ANN BOT-LONDON, V95, P177, DOI 10.1093/aob/mci011; LACOUR LF, 1978, PHILOS T ROY SOC B, V285, P61; Lockton S, 2005, TRENDS GENET, V21, P60, DOI 10.1016/j.tig.2004.11.013; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Neafsey DE, 2004, MOL BIOL EVOL, V21, P2310, DOI 10.1093/molbev/msh243; RAYBURN AL, 1994, PLANT BREEDING, V112, P318, DOI 10.1111/j.1439-0523.1994.tb00690.x; RAYBURN AL, 1985, AM J BOT, V72, P1610, DOI 10.2307/2443312; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Shoja V, 2006, MOL BIOL EVOL, V23, P2134, DOI 10.1093/molbev/msl085; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; TORKAMANZEHI A, 1992, GENETICS, V131, P73; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wright SI, 2001, GENETICS, V158, P1279; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920	30	40	46	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					484	486		10.1126/science.1153586	http://dx.doi.org/10.1126/science.1153586			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436777				2022-12-28	WOS:000255249300036
J	Georghiou, L				Georghiou, Luke			Europe's research system must change	NATURE			English	Editorial Material									Univ Manchester, Manchester Business Sch, Manchester Inst Innovat Res, Manchester M15 6PB, Lancs, England	University of Manchester	Georghiou, L (corresponding author), Univ Manchester, Manchester Business Sch, Manchester Inst Innovat Res, Manchester M15 6PB, Lancs, England.		Georghiou, Luke/J-1345-2014	Georghiou, Luke/0000-0002-3324-4955				Coombs R, 2002, SCIENCE, V296, P471, DOI 10.1126/science.1068350; *EUR COURT AUD, 92007 EUR COURT AUD; Laredo P, 2003, SCI PUBL POLICY, V30, P4, DOI DOI 10.3152/147154303781780713; Mustar P., 2006, KEY FIGURES SCI TECH	4	11	11	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					935	936		10.1038/452935a	http://dx.doi.org/10.1038/452935a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432225				2022-12-28	WOS:000255208600018
J	Munshi, NC; Digumarthy, S; Rahemtullah, A; Taqueti, V; Harris, NL; Weinger, RS; Bazari, H; Murali, MR				Munshi, Nikhil C.; Digumarthy, Subba; Rahemtullah, Aliyah; Taqueti, Viviany; Harris, Nancy Lee; Weinger, Ronald S.; Bazari, Hasan; Murali, Mandakolathur R.			A man with rheumatoid arthritis and lymphadenopathy - Gamma heavy-chain disease and rheumatoid arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODEL; GENE		[Munshi, Nikhil C.] Dana Farber Canc Inst, Boston Vet Affairs Healthcare Syst, Boston, MA 02115 USA; [Munshi, Nikhil C.] Dana Farber Canc Inst, Jerome Lipper Ctr Multiple Myeloma, Boston, MA 02115 USA; [Digumarthy, Subba] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rahemtullah, Aliyah] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Munshi, Nikhil C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Digumarthy, Subba] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Rahemtullah, Aliyah] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Munshi, NC (corresponding author), Dana Farber Canc Inst, Boston Vet Affairs Healthcare Syst, Boston, MA 02115 USA.		Munshi, Nikhil/ABE-2338-2021					Al-Saleem T, 2005, BLOOD, V105, P2274, DOI 10.1182/blood-2004-07-2755; ALEXANDER A, 1988, J CLIN INVEST, V82, P1244, DOI 10.1172/JCI113722; ALEXANDER A, 1982, P NATL ACAD SCI-BIOL, V79, P3260, DOI 10.1073/pnas.79.10.3260; DICKSON JR, 1989, SEMIN ARTHRITIS RHEU, V18, P247, DOI 10.1016/0049-0172(89)90045-0; FERMAND JP, 1989, MEDICINE, V68, P321, DOI 10.1097/00005792-198911000-00001; Fermand JP, 1999, HEMATOL ONCOL CLIN N, V13, P1281, DOI 10.1016/S0889-8588(05)70127-1; FERRY JA, 1997, ATLAS LYMPHOID HYPER, P36; FRANKLIN EC, 1964, J EXP MED, V120, P691, DOI 10.1084/jem.120.5.691; GROGAN TM, 2001, TUMOURS HEMATOPOIETI, V3, P154; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; Lecuit M, 2004, NEW ENGL J MED, V350, P239, DOI 10.1056/NEJMoa031887; RAMBAUD JC, 1983, CANCER-AM CANCER SOC, V51, P686, DOI 10.1002/1097-0142(19830215)51:4<686::AID-CNCR2820510423>3.0.CO;2-#; Wahner-Roedler DL, 2005, BEST PRACT RES CL HA, V18, P729, DOI 10.1016/j.beha.2005.01.029; Wahner-Roedler DL, 2003, MEDICINE, V82, P236, DOI 10.1097/00005792-200307000-00002; WAHNERROEDLER DL, 1992, AM J HEMATOL, V40, P56, DOI 10.1002/ajh.2830400112; Waterston A, 2004, ACTA ONCOL, V43, P698, DOI 10.1080/02841860410002752	16	19	19	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1838	1848		10.1056/NEJMcpc0800959	http://dx.doi.org/10.1056/NEJMcpc0800959			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434654				2022-12-28	WOS:000255209200012
J	Carlile, TM; Amon, A				Carlile, Thomas M.; Amon, Angelika			Meiosis I is established through division-specific translational control of a cyclin	CELL			English	Article							B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; CDC14 PHOSPHATASE; PROTEIN-KINASE; YEAST MEIOSIS; ANAPHASE; MITOSIS; CDC28	In budding yeast, key meiotic events such as DNA replication, recombination, and the meiotic divisions are controlled by Clb cyclin-dependent kinases (Clb-CDKs). Using a novel synchronization procedure, we have characterized the activity of these Clb-CDKs and observed a surprising diversity in their regulation during the meiotic divisions. Clb1-CDK activity is restricted to meiosis I, and Clb3-CDK activity to meiosis II, through 5'UTR-mediated translational control of its transcript. The analysis of cells inappropriately producing Clb3-CDKs during meiosis I furthermore defines Clb3 as an inhibitor of the meiosis I chromosome segregation program. Our results demonstrate an essential role for Clb-CDK regulation in establishing the meiotic chromosome segregation pattern.	[Carlile, Thomas M.; Amon, Angelika] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Carlile, Thomas M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; Carlile, Thomas/0000-0002-7699-9354	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM062207-07, R01 GM062207, GM62207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; COLLART MA, 1993, CURRENT PROTOCOLS MO, V2; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; DAHMANN C, 1995, GENETICS, V140, P957; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dirick L, 1998, SCIENCE, V281, P1854, DOI 10.1126/science.281.5384.1854; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005; Ishiguro K, 2007, J CELL SCI, V120, P367, DOI 10.1242/jcs.03324; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Kiburz BM, 2008, MOL BIOL CELL, V19, P1199, DOI 10.1091/mbc.E07-06-0584; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; MCCARROLL RM, 1994, GENETICS, V138, P47; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Picard D, 1999, NUCL RECEPTORS PRACT, P261; Salah SM, 2000, CHROMOSOMA, V109, P27, DOI 10.1007/s004120050409; Shonn MA, 2002, GENE DEV, V16, P1659, DOI 10.1101/gad.975802; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; XU L, 1995, MOL CELL BIOL, V12, P6572; Zachariae W, 1996, MOL BIOL CELL, V7, P791, DOI 10.1091/mbc.7.5.791	39	137	138	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					280	291		10.1016/j.cell.2008.02.032	http://dx.doi.org/10.1016/j.cell.2008.02.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423199	Green Accepted, Bronze			2022-12-28	WOS:000255052000017
J	Orendi, J				Orendi, Jeorge			Health-care organisation, hospital-bed occupancy, and MRSA	LANCET			English	Editorial Material									[Orendi, Jeorge] Univ Hosp N Staffordshire, Dept Med Microbiol & Infect Control, Stoke On Trent ST4 7PX, Staffs, England	Keele University	Orendi, J (corresponding author), Univ Hosp N Staffordshire, Dept Med Microbiol & Infect Control, Stoke On Trent ST4 7PX, Staffs, England.	jeorge.orendi@uhns.nhs.uk						Cunningham JB, 2005, J HOSP INFECT, V61, P189, DOI 10.1016/j.jhin.2005.04.014; Cunningham Joseph B, 2006, Br J Nurs, V15, P656; *DEP HLTH, 2008, 8278 DEP HLTH; Department of Health, 2007, 9163 DEP HLTH; European Antimicrobial Resistance Surveillance System (EARSS), 2007, EARSS ANN REP 2006; *HC COMM PUBL ACC, 2005, 554 HC COMM PUBL ACC; Organization for Economic Co-Operation and Development (OECD), 2007, HLTH GLANC 2007 OECD	7	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1401	1402		10.1016/S0140-6736(08)60610-8	http://dx.doi.org/10.1016/S0140-6736(08)60610-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294XW	18440417				2022-12-28	WOS:000255440600010
J	BRUNGER, AT				BRUNGER, AT			FREE R-VALUE - A NOVEL STATISTICAL QUANTITY FOR ASSESSING THE ACCURACY OF CRYSTAL-STRUCTURES	NATURE			English	Article							MOLECULAR-DYNAMICS; FACTOR REFINEMENT; PENICILLOPEPSIN; MINIMIZATION; RESOLUTION; ENERGY; 2.8-A	THE determination of macromolecular structure by crystallography involves fitting atomic models to the observed diffraction data 1. The traditional measure of the quality of this fit, and presumably the accuracy of the model, is the R value. Despite stereochemical restraints 2, it is possible to overfit or 'misfit' the diffraction data: an incorrect model can be refined to fairly good R values as several recent examples have shown 3. Here I propose a reliable and unbiased indicator of the accuracy of such models. By analogy with the cross-validation method 4,5 of testing statistical models I define a statistical quantity (R(T)free) that measures the agreement between observed and computed structure factor amplitudes for a 'test' set of reflections that is omitted in the modelling and refinement process. As examples show, there is a high correlation between R(T)free and the accuracy of the atomic model phases. This is useful because experimental phase information is usually inaccurate, incomplete or unavailable. I expect that R(T)free will provide a measure of the information content of recently proposed models of thermal motion and disorder 6-8, time-averaging 9 and bulk solvent 10.	YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511	Yale University	BRUNGER, AT (corresponding author), YALE UNIV,HOWARD HUGHES MED INST,NEW HAVEN,CT 06511, USA.			Brunger, Axel/0000-0001-5121-2036				BADGER J, 1991, P NATL ACAD SCI USA, V88, P622, DOI 10.1073/pnas.88.2.622; BRANDEN CI, 1990, NATURE, V343, P687, DOI 10.1038/343687a0; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1991, ANNU REV PHYS CHEM, V42, P197, DOI 10.1146/annurev.pc.42.100191.001213; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P585, DOI 10.1107/S0108767390002355; BRUNGER AT, 1988, J MOL BIOL, V203, P803, DOI 10.1016/0022-2836(88)90211-2; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, X PLOR VERSION 21; CHAPMAN MS, 1988, SCIENCE, V241, P71, DOI 10.1126/science.3133767; CHEN GM, 1991, SCIENCE, V252, P1390; CURMI PA, IN PRESS J BIOL CHEM; DIAMOND R, 1990, ACTA CRYSTALLOGR A, V46, P425, DOI 10.1107/S0108767390002082; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; GROS P, 1990, SCIENCE, V249, P1149, DOI 10.1126/science.2396108; HAMILTON WC, 1965, ACTA CRYSTALLOGR, V18, P502, DOI 10.1107/S0365110X65001081; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HSU IN, 1977, NATURE, V266, P140, DOI 10.1038/266140a0; JACK A, 1978, ACTA CRYSTALLOGR A, V34, P931, DOI 10.1107/S0567739478001904; JAMES MNG, 1983, J MOL BIOL, V163, P299, DOI 10.1016/0022-2836(83)90008-6; JENSEN LH, 1985, METHOD ENZYMOL, V115, P227; KONNERT JH, 1980, ACTA CRYSTALLOGR A, V36, P344, DOI 10.1107/S0567739480000794; KURIYAN J, 1991, PROTEINS, V10, P340, DOI 10.1002/prot.340100407; KURIYAN J, 1991, P NATL ACAD SCI USA, V88, P2773, DOI 10.1073/pnas.88.7.2773; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; PRESS WH, 1986, NUMERICAL RECIPES, P498; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; STOUT GH, 1989, XRAY STRUCTURE DETER, P343; Wuthrich K., 1986, NMR PROTEINS NUCL AC	29	3858	3914	3	100	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JAN 30	1992	355	6359					472	475		10.1038/355472a0	http://dx.doi.org/10.1038/355472a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HB530	18481394				2022-12-28	WOS:A1992HB53000078
J	Shen, JX; Feng, AS; Xu, ZM; Yu, ZL; Arch, VS; Yu, XJ; Narins, PM				Shen, Jun-Xian; Feng, Albert S.; Xu, Zhi-Min; Yu, Zu-Lin; Arch, Victoria S.; Yu, Xin-Jian; Narins, Peter M.			Ultrasonic frogs show hyperacute phonotaxis to female courtship calls	NATURE			English	Article							COMMUNICATION; SIGNALS; VOCALIZATIONS	Sound communication plays a vital role in frog reproduction(1,2), in which vocal advertisement is generally the domain of males. Females are typically silent, but in a few anuran species they can produce a feeble reciprocal call(3) or rapping sounds(4) during courtship. Males of concave- eared torrent frogs ( Odorrana tormota) have demonstrated ultrasonic communication capacity(5). Although females of O. tormota have an unusually well- developed vocal production system(6), it is unclear whether or not they produce calls or are only passive partners in a communication system dominated by males. Here we show that before ovulation, gravid females of O. tormota emit calls that are distinct from males' advertisement calls, having higher fundamental frequencies and harmonics and shorter call duration. In the field and in a quiet, darkened indoor arena, these female calls evoke vocalizations and extraordinarily precise positive phonotaxis ( a localization error of <1 degrees), rivalling that of vertebrates with the highest localization acuity ( barn owls(7,8), dolphins, elephants and humans(9)). The localization accuracy of O. tormota is remarkable in light of their small head size ( interaural distance of <1 cm), and suggests an additional selective advantage of high- frequency hearing beyond the ability to avoid masking by low- frequency background noise(5).	[Shen, Jun-Xian; Xu, Zhi-Min; Yu, Zu-Lin] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China; [Feng, Albert S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Feng, Albert S.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Arch, Victoria S.; Narins, Peter M.] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA 90095 USA; [Narins, Peter M.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Yu, Xin-Jian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shen, JX (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Biophys, Beijing 100101, Peoples R China.	shenjx@sun5.ibp.ac.cn	YU, ZULIN/D-7979-2012					Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; Cai HX, 2007, ZOOTAXA, P49; Capranica RR, 1965, RES MONOGRAPH, V33; Christensen-Dalsgaard J, 2005, SPR HDB AUD, V25, P67, DOI 10.1007/0-387-28863-5_4; Duellman W. E., 1986, BIOL AMPHIBIANS; Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GLAW F, 1994, FIELDGUIDE AMPHIBIAN; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; Kelley DB, 1999, DESIGN OF ANIMAL COMMUNICATION, P9; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; MARQUEZ R, 1995, BEHAVIOUR, V132, P151, DOI 10.1163/156853995X00342; McClelland BE, 1996, J EXP BIOL, V199, P1907; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; NARINS PM, 1986, BEHAV ECOL SOCIOBIOL, V19, P135, DOI 10.1007/BF00299948; Narins PM, 2007, HEARING SOUND COMMUN; Randall JE, 2001, ICHTHYOL RES, V48, P3, DOI 10.1007/s10228-001-8111-z; ROY D, 1995, CURR SCI INDIA, V69, P265; Roy D, 1997, CURR SCI INDIA, V72, P923; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; [No title captured]	25	78	95	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					914	U46		10.1038/nature06719	http://dx.doi.org/10.1038/nature06719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18469804				2022-12-28	WOS:000256632000042
J	Metzger, RJ; Klein, OD; Martin, GR; Krasnow, MA				Metzger, Ross J.; Klein, Ophir D.; Martin, Gail R.; Krasnow, Mark A.			The branching programme of mouse lung development	NATURE			English	Article							3-DIMENSIONAL MODEL; MORPHOGENESIS; ARCHITECTURE; EPITHELIUM; MECHANISMS; EVOLUTION; PATTERNS; ORIGIN; GENES	Mammalian lungs are branched networks containing thousands to millions of airways arrayed in intricate patterns that are crucial for respiration. How such trees are generated during development, and how the developmental patterning information is encoded, have long fascinated biologists and mathematicians. However, models have been limited by a lack of information on the normal sequence and pattern of branching events. Here we present the complete three- dimensional branching pattern and lineage of the mouse bronchial tree, reconstructed from an analysis of hundreds of developmental intermediates. The branching process is remarkably stereotyped and elegant: the tree is generated by three geometrically simple local modes of branching used in three different orders throughout the lung. We propose that each mode of branching is controlled by a genetically encoded subroutine, a series of local patterning and morphogenesis operations, which are themselves controlled by a more global master routine. We show that this hierarchical and modular programme is genetically tractable, and it is ideally suited to encoding and evolving the complex networks of the lung and other branched organs.	[Metzger, Ross J.; Krasnow, Mark A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Metzger, Ross J.; Krasnow, Mark A.] Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA; [Metzger, Ross J.; Klein, Ophir D.; Martin, Gail R.] Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94158 USA; [Klein, Ophir D.; Martin, Gail R.] Univ Calif San Francisco, Sch Med, Program Dev Biol, San Francisco, CA 94158 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Metzger, RJ (corresponding author), Univ Calif San Francisco, Sch Med, Dept Anat, San Francisco, CA 94158 USA.	ross.metzger@ucsf.edu; krasnow@cmgm.stanford.edu		Klein, Ophir/0000-0002-6254-7082	NATIONAL CANCER INSTITUTE [R01CA078711] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075769] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA078711-04, R01 CA078711, R01 CA078711-02, R01 CA078711-05, R01 CA078711-03] Funding Source: Medline; NHLBI NIH HHS [R01 HL075769-02, R01 HL075769-04, R01 HL075769-03, R01 HL075769, R01 HL075769-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AEBY C, 1880, BRONCHIALBAUM SAUGET; Al-Awqati Q, 1998, KIDNEY INT, V54, P1832, DOI 10.1046/j.1523-1755.1998.00196.x; ALESCIO T, 1960, Arch Ital Anat Embriol, V65, P323; Bejan A., 2000, SHAPE STRUCTURE ENG; BORGHESE E, 1950, J ANAT, V84, P287; Boyden EA, 1955, SEGMENTAL ANATOMY LU; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; EPPIG JT, 2005, MOUSE GENOME DATABAS; Flint JM, 1906, AM J ANAT, V6, P1; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; HEISS R, 1919, ARCH ANAT PHYSIOL, P1; HIRAI Y, 1989, DEVELOPMENT, V105, P263; His W., 1887, Archiv fuer Anatomie und Physiologie Anat Abth, P89; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; Hummel K. P., 1959, Journal of Heredity, V50, P9; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; MASSOUD EAS, 1993, PEDIATR PULM, V15, P89, DOI 10.1002/ppul.1950150205; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; MEINHARDT H, 1976, DIFFERENTIATION, V6, P117, DOI 10.1111/j.1432-0436.1976.tb01478.x; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miura T, 2008, CURR TOP DEV BIOL, V81, P291, DOI 10.1016/S0070-2153(07)81010-6; NELSON TR, 1988, IEEE T MED IMAGING, V7, P321, DOI 10.1109/42.14515; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Prusinkiewicz P, 2007, SCIENCE, V316, P1452, DOI 10.1126/science.1140429; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tebockhorst S, 2007, J APPL PHYSIOL, V102, P294, DOI 10.1152/japplphysiol.00665.2006; Thomson AA, 2006, DIFFERENTIATION, V74, P382, DOI 10.1111/j.1432-0436.2006.00101.x; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Weibel E R., 1984, PATHWAY OXYGEN; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; WEIBEL ER, 1962, SCIENCE, V137, P577, DOI 10.1126/science.137.3530.577; WELLS LJ, 1954, AM J ANAT, V95, P163, DOI 10.1002/aja.1000950202; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	42	513	519	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					745	U1		10.1038/nature07005	http://dx.doi.org/10.1038/nature07005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463632	Green Accepted			2022-12-28	WOS:000256415300035
J	Blum, A				Blum, Alan			Alchemy, the safer cigarette, and Philip Morris	LANCET			English	Editorial Material							TOBACCO		Univ Alabama, Ctr Study Tobacco & Soc, Tuscaloosa, AL 35401 USA	University of Alabama System; University of Alabama Tuscaloosa	Blum, A (corresponding author), Univ Alabama, Ctr Study Tobacco & Soc, Tuscaloosa, AL 35401 USA.	ABlum@cchs.ua.edu						*ALTR GROUP INC, 2007, 2006 ANN REP; BOWE C, 2007, FINANCIAL TIMES 0829; CAMILLERI LC, 2007, 2007 ALTR ANN M SHAR; FINORA J, 2007, TOBACCO INT      DEC, P14; MILLER GH, 1985, NEW YORK STATE J MED, V85, P313; MILLIGAN J, 2007, VIRGINIA BUSINES APR, P9; OCONNELL V, 2008, WALL STREET J   0129; *P MORR COMP INC, 1989, 1988 ANN REP; RICKERT WS, 1983, NEW YORK STATE J MED, V83, P1269; Siegel M, 2006, LANCET, V368, P266, DOI 10.1016/S0140-6736(06)69052-1; Smith EA, 2003, AM J PUBLIC HEALTH, V93, P553, DOI 10.2105/AJPH.93.4.553; *TOB IND RES COMM, 1954, CHICAGO AM      0104, P7; 2008, TOBACCO REPORTER MAR, P45	13	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1644	1646		10.1016/S0140-6736(08)60705-9	http://dx.doi.org/10.1016/S0140-6736(08)60705-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486727				2022-12-28	WOS:000256002200007
J	Schunemann, HJ; Oxman, AD; Brozek, J; Glasziou, P; Jaeschke, R; Vist, GE; Williams, JW; Kunz, R; Craig, J; Montori, VM; Bossuyt, P; Guyatt, GH				Schuenemann, Holger J.; Oxman, Andrew D.; Brozek, Jan; Glasziou, Paul; Jaeschke, Roman; Vist, Gunn E.; Williams, John W., Jr.; Kunz, Regina; Craig, Jonathan; Montori, Victor M.; Bossuyt, Patrick; Guyatt, Gordon H.		GRADE Working Grp	GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUSPECTED ACUTE UROLITHIASIS; HELICAL COMPUTED-TOMOGRAPHY; HUNTINGTONS-DISEASE; INTRAVENOUS PYELOGRAPHY; NATRIURETIC PEPTIDE; SPECIFICITY; SENSITIVITY; ACCURACY; METAANALYSIS; GUIDELINES		[Schuenemann, Holger J.; Brozek, Jan] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, I-00144 Rome, Italy; [Schuenemann, Holger J.; Guyatt, Gordon H.] McMaster Univ, CLARITY Res Grp, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Oxman, Andrew D.; Vist, Gunn E.] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Glasziou, Paul] Univ Oxford, Ctr Evidence Based Med, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Jaeschke, Roman] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Williams, John W., Jr.] Duke Univ, Dept Med, Durham, NC 27705 USA; [Williams, John W., Jr.] Durham VA Med Ctr, Durham, NC 27705 USA; [Kunz, Regina] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Craig, Jonathan] Univ Sydney, Dept Nephrol, Childrens Hosp Westmead, Screening & Test Evaluat Program,Sch Publ Hlth, Sydney, NSW 2006, Australia; [Montori, Victor M.] Mayo Clin, Coll Med, Knowledge & Encounter Res Unit, Dept Med, Rochester, MN 55905 USA; [Bossuyt, Patrick] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1100 DE Amsterdam, Netherlands	McMaster University; Norwegian Knowledge Centre for Health Services; University of Oxford; McMaster University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of Basel; University of Sydney; Mayo Clinic; University of Amsterdam; Academic Medical Center Amsterdam	Schunemann, HJ (corresponding author), Italian Natl Canc Inst Regina Elena, Dept Epidemiol, I-00144 Rome, Italy.	schuneh@mcmaster.ca	Djulbegovic, Benjamin/I-3661-2012; Craig, Jonathan/E-2813-2013; Oxman, Andrew/Y-3004-2019; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M./B-4557-2016; Williams, John/AAM-4572-2020; Harding, Richard/G-9729-2012; Whittington, Craig/B-1380-2008; Fervers, Béatrice/AAD-1847-2022; Bossuyt, Patrick M/AAR-1183-2021	Djulbegovic, Benjamin/0000-0003-0671-1447; Craig, Jonathan/0000-0002-2548-4035; Oxman, Andrew/0000-0002-5608-5061; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M./0000-0003-4427-0128; Williams, John/0000-0002-5267-5558; Whittington, Craig/0000-0002-1950-0334; Fervers, Béatrice/0000-0003-3498-6499; Bossuyt, Patrick M/0000-0003-4427-0128; Flottorp, Signe/0000-0003-2961-7461; Schunemann, Holger/0000-0003-3211-8479; Montori, Victor/0000-0003-0595-2898; Tuut, Mariska/0000-0002-0880-6215				Almqvist EW, 2003, CLIN GENET, V64, P300, DOI 10.1034/j.1399-0004.2003.00157.x; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Bossuyt PMM, 2000, LANCET, V356, P1844, DOI 10.1016/S0140-6736(00)03246-3; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; FLETCHER RH, 1986, ANN INTERN MED, V104, P66, DOI 10.7326/0003-4819-104-1-66; Guyatt Gordon, 2004, ACP J Club, V140, pA11; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Hamon M, 2006, J AM COLL CARDIOL, V48, P1896, DOI 10.1016/j.jacc.2006.08.028; HLATKY MA, 1984, AM J MED, V77, P64, DOI 10.1016/0002-9343(84)90437-6; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Maat-Kievit A, 2000, J NEUROL NEUROSUR PS, V69, P579, DOI 10.1136/jnnp.69.5.579; Moe GW, 2007, CIRCULATION, V115, P3103, DOI 10.1161/CIRCULATIONAHA.106.666255; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; MULROW CD, 1989, J GEN INTERN MED, V4, P288, DOI 10.1007/BF02597398; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Worster A, 2002, ANN EMERG MED, V40, P280, DOI 10.1067/mem.2002.126170; Worster A, 2002, CAN ASSOC RADIOL J, V53, P144	27	831	875	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1106	1110		10.1136/bmj.39500.677199.AE	http://dx.doi.org/10.1136/bmj.39500.677199.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483053	Green Submitted, Green Published			2022-12-28	WOS:000255975100037
J	Arrow, KJ; Forsythe, R; Gorham, M; Hahn, R; Hanson, R; Ledyard, JO; Levmore, S; Litan, R; Milgrom, P; Nelson, FD; Neumann, GR; Ottaviani, M; Schelling, TC; Shiller, RJ; Smith, VL; Snowberg, E; Sunstein, CR; Tetlock, PC; Tetlock, PE; Varian, HR; Wolfers, J; Zitzewitz, E				Arrow, Kenneth J.; Forsythe, Robert; Gorham, Michael; Hahn, Robert; Hanson, Robin; Ledyard, John O.; Levmore, Saul; Litan, Robert; Milgrom, Paul; Nelson, Forrest D.; Neumann, George R.; Ottaviani, Marco; Schelling, Thomas C.; Shiller, Robert J.; Smith, Vernon L.; Snowberg, Erik; Sunstein, Cass R.; Tetlock, Paul C.; Tetlock, Philip E.; Varian, Hal R.; Wolfers, Justin; Zitzewitz, Eric			Economics - The promise of prediction markets	SCIENCE			English	Editorial Material									[Hahn, Robert] Amer Enterprise Inst Publ Policy Res, Reg Markets Ctr, Washington, DC 20036 USA; [Arrow, Kenneth J.; Milgrom, Paul] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Forsythe, Robert] Univ S Florida, Coll Business, Tampa, FL 33620 USA; [Gorham, Michael] IIT, Stuart Sch Business, Chicago, IL 60661 USA; [Hanson, Robin] George Mason Univ, Dept Econ, Fairfax, VA 22030 USA; [Ledyard, John O.] CALTECH, Dept Econ, Pasadena, CA 91125 USA; [Levmore, Saul; Sunstein, Cass R.] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Litan, Robert] Kauffman Fdn, Kansas City, MO 64110 USA; [Nelson, Forrest D.; Neumann, George R.] Univ Iowa, Dept Econ, Iowa City, IA 52242 USA; [Ottaviani, Marco] Northwestern Univ, JL Kellogg Grad Sch Management, Evanston, IL 60208 USA; [Schelling, Thomas C.] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA; [Shiller, Robert J.] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Smith, Vernon L.] Chapman Univ, Sch Law, Orange, CA 92866 USA; [Snowberg, Erik] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Tetlock, Philip E.] Yale Univ, Sch Management, New Haven, CT 06520 USA; [Tetlock, Philip E.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Varian, Hal R.] Univ Calif Berkeley, Sch Informat, Berkeley, CA 94720 USA; [Wolfers, Justin] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Zitzewitz, Eric] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	American Enterprise Institute for Public Policy Research; Stanford University; State University System of Florida; University of South Florida; Illinois Institute of Technology; George Mason University; California Institute of Technology; University of Chicago; University of Iowa; Northwestern University; University System of Maryland; University of Maryland College Park; Yale University; Chapman University System; Chapman University; Stanford University; Yale University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Pennsylvania; Dartmouth College	Hahn, R (corresponding author), Amer Enterprise Inst Publ Policy Res, Reg Markets Ctr, Washington, DC 20036 USA.	rhahn@aei.org	Forsythe, Robert/H-5818-2012; Sunstein, Cass/AAV-8196-2020; Milgrom, Paul/AAF-3285-2019	Forsythe, Robert/0000-0002-5821-1519; Milgrom, Paul/0000-0002-1919-4138; Ottaviani, Marco/0000-0002-0943-162X				ARROW K, 2007, AEI BROOKINGS JOINT; BERG J, IN PRESS INT J FOREC; Cowgill B., 2008, USING PREDICTION MAR; Hahn RW, 2006, J REGUL ECON, V29, P265, DOI 10.1007/s11149-006-7399-z; Hahn RW, 2005, HARVARD J LAW PUBL P, V29, P213; Hanson RD, 1999, IEEE INTELL SYST APP, V14, P16; Hanson Robin, 2003, P ACM INT C EL COMM, P272; Manski CF, 2006, ECON LETT, V91, P425, DOI 10.1016/j.econlet.2006.01.004; Ottaviani M, 2007, J EUR ECON ASSOC, V5, P554, DOI 10.1162/jeea.2007.5.2-3.554; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Shiller R. J., 1993, MACRO MARKETS CREATI; Snowberg E, 2007, Q J ECON, V122, P807, DOI 10.1162/qjec.122.2.807; Sunstein Cass R., 2006, INFOTOPIA MANY MINDS; Tetlock P. C, 2008, LIQUIDITY PREDICTION; Wolfers J, 2004, J ECON PERSPECT, V18, P107, DOI 10.1257/0895330041371321; WOLFERS J, 2005, INTERPRETING PREDICT	16	161	165	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					877	878		10.1126/science.1157679	http://dx.doi.org/10.1126/science.1157679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	301AH	18487176				2022-12-28	WOS:000255868300024
J	Wang, L; Du, FH; Wang, XD				Wang, Lai; Du, Fenghe; Wang, Xiaodong			TNF-alpha induces two distinct caspase-8 activation pathways	CELL			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; INDUCED CELL-DEATH; INDUCED APOPTOSIS; KINASE RIP; DEPENDENT APOPTOSIS; STRUCTURAL BASIS; C-FLIP; PROTEIN; SMAC/DIABLO	The inflammatory response of mammalian cells to TNF-alpha can be switched to apoptosis either by cotreatment with a protein synthesis inhibitor, cycloheximide, or Smac mimetic, a small molecule mimic of Smac/Diablo protein. Cycloheximide promotes caspase-8 activation by eliminating endogenous caspase-8 inhibitor, c-FLIP, while Smac mimetic does so by triggering autodegradation of cIAP1 and cIAP2 (cIAP1/2), leading to the release of receptor interacting protein kinase (RIPK1) from the activated TNF receptor complex to form a caspase-8-activating complex consisting of RIPK1, FADD, and caspase-8. This process also requires the action of CYLD, a RIPK1 K63 deubiquitinating enzyme. RIPK1 is critical for caspase-8 activation-induced by Smac mimetic but dispensable for that triggered by cycloheximide. Moreover, Smac mimetic-induced caspase-8 activation is not blocked by endogenous c-FLIP. These findings revealed that TNF-alpha is able to induce apoptosis via two distinct caspase-8 activation pathways that are differentially regulated by cIAP1/2 and c-FLIP.	[Wang, Lai; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Wang, Lai; Du, Fenghe; Wang, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xiaodong.wang@utsouthwestern.edu		Wang, Xiaodong/0000-0001-9885-356X	NCI NIH HHS [P01 CA 95471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Muppidi JR, 2004, IMMUNITY, V21, P461, DOI 10.1016/j.immuni.2004.10.001; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	42	947	993	10	124	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					693	703		10.1016/j.cell.2008.03.036	http://dx.doi.org/10.1016/j.cell.2008.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485876	Bronze			2022-12-28	WOS:000255903300023
J	Xu, Y; Shi, Y; Ding, S				Xu, Yue; Shi, Yan; Ding, Sheng			A chemical approach to stem-cell biology and regenerative medicine	NATURE			English	Review							SELF-RENEWAL; SMALL-MOLECULE; DIRECTED DIFFERENTIATION; NEURONAL DIFFERENTIATION; PROGENITOR CELLS; SMOOTH-MUSCLE; PLURIPOTENT; DERIVATION; FIBROBLASTS; GENERATION	An improved understanding of stem-cell and regenerative biology, as well as a better control of stem-cell fate, is likely to produce treatments for many devastating diseases and injuries. Chemical approaches are starting to have an increasingly important role in this young field. Attention has focused on chemical approaches that allow the precise manipulation of cells in vitro to obtain homogeneous cell types for cell-based therapies. Another promising approach is the development of conventional chemical and biological therapeutics to stimulate endogenous cells to regenerate. Such therapeutics can act on target cells or their niches in vivo to promote cell survival, proliferation, differentiation, reprogramming and homing.	[Xu, Yue; Shi, Yan; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Ding, S (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sding@scripps.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD053759, R21HD058110] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH074404] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL084295] Funding Source: Medline; NICHD NIH HHS [HD053759, HD058110] Funding Source: Medline; NIMH NIH HHS [MH074404] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chen SB, 2004, J AM CHEM SOC, V126, P410, DOI 10.1021/ja037390k; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe JP, 2007, CHEM BIOL, V14, P1019, DOI 10.1016/j.chembiol.2007.07.016; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Warashina M, 2006, ANGEW CHEM INT EDIT, V45, P591, DOI 10.1002/anie.200503089; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; WYANG Y, 2007, CELL STEM CELL, V1, P165; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104; Zhang QS, 2007, P NATL ACAD SCI USA, V104, P7444, DOI 10.1073/pnas.0702136104	68	265	288	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					338	344		10.1038/nature07042	http://dx.doi.org/10.1038/nature07042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480815				2022-12-28	WOS:000255868400041
J	Cescon, DW; Etchells, E				Cescon, David W.; Etchells, Edward			Barcoded medication administration - A last line of defense	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ADVERSE DRUG EVENTS; BAR-CODE TECHNOLOGY; ERRORS		[Etchells, Edward] Sunnybrook Hlth Sci Ctr, Ctr Hlth Serv Sci, Toronto, ON M4N 3M5, Canada; [Etchells, Edward] Sunnybrook Hlth Sci Ctr, Dept Med, Patient Safety Serv, Toronto, ON M4N 3M5, Canada; [Cescon, David W.; Etchells, Edward] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Etchells, E (corresponding author), Sunnybrook Hlth Sci Ctr, Ctr Hlth Serv Sci, Room C410,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	edward.etchells@sunnybrook.ca						BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Cochran GL, 2007, JT COMM J QUAL PATIE, V33, P293, DOI 10.1016/S1553-7250(07)33034-1; Cummings J, 2005, AM J HEALTH-SYST PH, V62, P2626, DOI 10.2146/ajhp050222; Englebright JD, 2005, J NURS ADMIN, V35, P410; *FOOD DRUG ADM, 2003, FED REGISTER, V68, P12500; *FOOD DRUG ADM, 2003, FDA RUL REQ BAR COD; Hurley AC, 2007, J NURS ADMIN, V37, P343, DOI 10.1097/01.NNA.0000285114.60689.02; *I MED, 2000, TO ERR IS HUM BUILD; Jacobson PD, 2008, JAMA-J AM MED ASSOC, V299, P208, DOI 10.1001/jama.2007.12; Johnson Connie L, 2002, J Healthc Inf Manag, V16, P46; Maviglia SM, 2007, ARCH INTERN MED, V167, P788, DOI 10.1001/archinte.167.8.788; Paoletti RD, 2007, AM J HEALTH-SYST PH, V64, P536, DOI 10.2146/ajhp060140; Pedersen CA, 2006, AM J HEALTH-SYST PH, V63, P327, DOI 10.2146/ajhp050538; Poon EG, 2006, ANN INTERN MED, V145, P426, DOI 10.7326/0003-4819-145-6-200609190-00006; Sakowski J, 2005, AM J HEALTH-SYST PH, V62, P2619, DOI 10.2146/ajhp050138	15	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2200	2202		10.1001/jama.299.18.2200	http://dx.doi.org/10.1001/jama.299.18.2200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477788				2022-12-28	WOS:000255790000029
J	Dember, LM; Beck, GJ; Allon, M; Delmez, JA; Dixon, BS; Greenberg, A; Himmelfarb, J; Vazquez, MA; Gassman, JJ; Greene, T; Radeva, MK; Braden, GL; Ikizler, TA; Rocco, MV; Davidson, IJ; Kaufman, JS; Meyers, CM; Kusek, JW; Feldman, HI				Dember, Laura M.; Beck, Gerald J.; Allon, Michael; Delmez, James A.; Dixon, Bradley S.; Greenberg, Arthur; Himmelfarb, Jonathan; Vazquez, Miguel A.; Gassman, Jennifer J.; Greene, Tom; Radeva, Milena K.; Braden, Gregory L.; Ikizler, T. Alp; Rocco, Michael V.; Davidson, Ingemar J.; Kaufman, James S.; Meyers, Catherine M.; Kusek, John W.; Feldman, Harold I.		Dialysis Access Consortium Study G	Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; TICLOPIDINE; PREVENTION; THROMBOSIS; SALVAGE	Context The arteriovenous fistula is the preferred type of vascular access for hemodialysis because of lower thrombosis and infection rates and lower health care expenditures compared with synthetic grafts or central venous catheters. Early failure of fistulas due to thrombosis or inadequate maturation is a barrier to increasing the prevalence of fistulas among patients treated with hemodialysis. Small, inconclusive trials have suggested that antiplatelet agents may reduce thrombosis of new fistulas. Objective To determine whether clopidogrel reduces early failure of hemodialysis fistulas. Design, Setting, and Participants Randomized, double- blind, placebo-controlled trial conducted at 9 US centers composed of academic and community nephrology practices in 2003- 2007. Eight hundred seventy- seven participants with end-stage renal disease or advanced chronic kidney disease were followed up until 150 to 180 days after fistula creation or 30 days after initiation of dialysis, whichever occurred later. Intervention Participants were randomly assigned to receive clopidogrel ( 300- mg loading dose followed by daily dose of 75 mg; n= 441) or placebo ( n= 436) for 6 weeks starting within 1 day after fistula creation. Main Outcome Measures The primary outcome was fistula thrombosis, determined by physical examination at 6 weeks. The secondary outcome was failure of the fistula to become suitable for dialysis. Suitability was defined as use of the fistula at a dialysis machine blood pump rate of 300 mL/ min or more during 8 of 12 dialysis sessions. Results Enrollment was stopped after 877 participants were randomized based on a stopping rule for intervention efficacy. Fistula thrombosis occurred in 53 ( 12.2%) participants assigned to clopidogrel compared with 84 ( 19.5%) participants assigned to placebo ( relative risk, 0.63; 95% confidence interval, 0.46- 0.97; P=. 018). Failure to attain suitability for dialysis did not differ between the clopidogrel and placebo groups ( 61.8% vs 59.5%, respectively; relative risk, 1.05; 95% confidence interval, 0.941.17; P=. 40). Conclusion Clopidogrel reduces the frequency of early thrombosis of new arteriovenous fistulas but does not increase the proportion of fistulas that become suitable for dialysis. Trial Registration clinicaltrials. gov Identifier: NCT00067119.	[Dember, Laura M.; Kaufman, James S.] Boston Univ, Sch Med, Renal Sect, Boston, MA 02118 USA; [Kaufman, James S.] VA Boston Healthcare Syst, Boston, MA USA; [Beck, Gerald J.; Gassman, Jennifer J.; Radeva, Milena K.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Allon, Michael] Univ Alabama, Birmingham, AL USA; [Delmez, James A.] Washington Univ, St Louis, MO USA; [Dixon, Bradley S.] Univ Iowa, Iowa City, IA USA; [Greenberg, Arthur] Duke Univ, Durham, NC USA; [Himmelfarb, Jonathan] Maine Med Ctr, Portland, ME 04102 USA; [Vazquez, Miguel A.; Davidson, Ingemar J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Greene, Tom] Univ Utah, Salt Lake City, UT USA; [Braden, Gregory L.] Baystate Med Ctr, Springfield, MA USA; [Ikizler, T. Alp] Vanderbilt Univ, Nashville, TN USA; [Rocco, Michael V.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Meyers, Catherine M.; Kusek, John W.] NIDDKD, NIH, Bethesda, MD 20892 USA; [Feldman, Harold I.] Univ Penn, Philadelphia, PA 19104 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); University of Iowa; Duke University; Maine Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Utah System of Higher Education; University of Utah; Baystate Medical Center; Vanderbilt University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania	Dember, LM (corresponding author), Boston Univ, Sch Med, Renal Sect, EBRC 504,650 Albany St, Boston, MA 02118 USA.	ldember@bu.edu		Dixon, Bradley/0000-0002-2534-3259; Ikizler, Talat/0000-0002-5717-4218; Greenberg, Arthur/0000-0002-2838-8401	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK058985, U01DK058973, U01DK058966, U01DK058981, U01DK058982, U01DK058978, U01DK058968, U01DK058986] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK058973, U01DK058986, U01DK058985, U01 DK058982, U01DK058973, U01DK058978, U01 DK058986, U01DK058982, U01 DK058968, U01 DK058966, U01DK058968, U01 DK058985, U01DK058981, U01 DK058978, U01 DK058981, U01DK058966] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert F., 1981, DIALYSIS TRANSPLANT, V10, p167C; Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; ANDRASSY K, 1974, KLIN WOCHENSCHR, V52, P348, DOI 10.1007/BF01468835; Beathard GA, 2003, KIDNEY INT, V64, P1487, DOI 10.1046/j.1523-1755.2003.00210.x; Dember LM, 2005, CLIN TRIALS, V2, P413, DOI 10.1191/1740774505cn118oa; Falk A, 2006, J VASC INTERV RADIOL, V17, P807, DOI 10.1097/01.RVI.0000217928.43396.35; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; FISKERSTRAND CE, 1985, ARTIF ORGANS, V9, P61, DOI 10.1111/j.1525-1594.1985.tb04349.x; GART JJ, 1979, ENVIRON HEALTH PERSP, V32, P157, DOI 10.2307/3429013; Grontoft KC, 1998, SCAND J UROL NEPHROL, V32, P276; GRONTOFT KC, 1985, SCAND J UROL NEPHROL, V19, P55, DOI 10.3109/00365598509180223; JANICKI K, 1992, International Urology and Nephrology, V24, P83, DOI 10.1007/BF02552122; JANICKI K, 1994, DIALYSIS TRANSPLANT, V23, P576; Jennison C, 2000, GROUP SEQUENTIAL MET; Kaufman JS, 2000, SEMIN DIALYSIS, V13, P40, DOI 10.1046/j.1525-139x.2000.00012.x; Lacson E, 2007, AM J KIDNEY DIS, V50, P379, DOI 10.1053/j.ajkd.2007.06.006; MANTEL N, 1959, J NATL CANCER I, V22, P719; MICHIE DD, 1977, CURR THER RES CLIN E, V22, P196; Ohira S, 2006, THER APHER DIAL, V10, P449, DOI 10.1111/j.1744-9987.2006.00410.x; Turmel-Rodrigues L, 2001, NEPHROL DIAL TRANSPL, V16, P2365, DOI 10.1093/ndt/16.12.2365; *US REN DAT SYST, 2005, 2005 ANN DAT REP ATL; *US REN DAT SYST, 2007, 2007 ANN DAT REP ATL; Vascular Access 2006 Work Group, 2006, AM J KIDNEY DIS S1, V48, pS176	23	557	574	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2164	2171		10.1001/jama.299.18.2164	http://dx.doi.org/10.1001/jama.299.18.2164			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477783	Green Accepted, Bronze			2022-12-28	WOS:000255790000023
J	Martyn, C				Martyn, Christopher			The secret lives of doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material												cmartyn@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1044	1044		10.1136/bmj.39570.465266.59	http://dx.doi.org/10.1136/bmj.39570.465266.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18467411	Green Published			2022-12-28	WOS:000256103300025
J	Applegate, PJ; Lowell, TV; Alley, RB				Applegate, Patrick J.; Lowell, Thomas V.; Alley, Richard B.			Comment on "absence of cooling in New Zealand and the adjacent ocean during the younger dryas chronozone"	SCIENCE			English	Editorial Material							FRANZ-JOSEF-GLACIER; COSMOGENIC NUCLIDES; SOUTHERN ALPS; MORAINES; LANDFORMS; ADVANCE		[Applegate, Patrick J.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Lowell, Thomas V.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Alley, Richard B.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Cincinnati; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Applegate, PJ (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	papplega@geosc.psu.edu	Barrows, Timothy T/E-8471-2011	Barrows, Timothy T/0000-0003-2614-7177; Lowell, Thomas/0000-0001-7826-0636				APPLEGATE PJ, 2007, GEOL SOC AM ABS PROG, V39, P142; Balco G, 2006, QUAT GEOCHRONOL, V1, P15, DOI 10.1016/j.quageo.2006.06.014; Barrows TT, 2007, SCIENCE, V318, P86, DOI 10.1126/science.1145873; BEVINGTON PR, 2002, DATA REDUCTION ERROR, pCH4; DENTON GH, 1994, SCIENCE, V264, P1434, DOI 10.1126/science.264.5164.1434; Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; HALLET B, 1994, SCIENCE, V265, P937, DOI 10.1126/science.265.5174.937; Ivy-Ochs S, 2007, QUATERN INT, V164-65, P53, DOI 10.1016/j.quaint.2006.12.008; Putkonen J, 2003, QUATERNARY RES, V59, P255, DOI 10.1016/S0033-5894(03)00006-1; Turney CSM, 2007, QUATERNARY SCI REV, V26, P3037, DOI 10.1016/j.quascirev.2007.09.014; Wratt DS, 2000, ATMOS RES, V52, P261, DOI 10.1016/S0169-8095(99)00038-1; ZREDA MG, 1994, WATER RESOUR RES, V30, P3127, DOI 10.1029/94WR00760	12	28	28	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877								10.1126/science.1152098	http://dx.doi.org/10.1126/science.1152098			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467574				2022-12-28	WOS:000255644400019
J	Walker, BD; Burton, DR				Walker, Bruce D.; Burton, Dennis R.			Toward an AIDS vaccine	SCIENCE			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; CYTOTOXIC T-LYMPHOCYTES; RETROVIRUSES HTLV-III; HIV-1 INFECTION; VIRAL LOAD; CELL RESPONSES; GASTROINTESTINAL-TRACT; IMMUNE-RESPONSES; ONE-STEP; ANTIBODY	A quarter century of scientific discovery has been applied to developing an AIDS vaccine, yet this goal remains elusive. Specific characteristics of the virus, including the extreme genetic variability in circulating viral isolates worldwide, biological properties of HIV that impede immune attack, and a high mutation rate that allows for rapid escape from adaptive immune responses, render this a huge challenge. However, evidence of protection against AIDS viruses in animal models and control of HIV in humans under certain circumstances, together with scientific advances in understanding disease pathogenesis, provide a strong rationale and objective paths to continue the pursuit of an effective AIDS vaccine to stem the global epidemic.	[Walker, Bruce D.] Massachusetts Gen Hosp, Boston, MA 02129 USA; [Walker, Bruce D.] Harvard Univ, Sch Med, Boston, MA 02129 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Scripps Research Institute	Walker, BD (corresponding author), Massachusetts Gen Hosp, Boston, MA 02129 USA.	bwalker@partners.org; burton@scripps.edu			NIAID NIH HHS [R01 AI030914] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; BALTIMORE D, 2008, AAAS ANN M BOST MA 1; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Excler JL, 2007, AIDS, V21, P2259, DOI 10.1097/QAD.0b013e3282eee70c; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lifson JD, 2002, NATURE, V415, P272, DOI 10.1038/415272b; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Moore J P, 1995, AIDS, V9 Suppl A, pS117; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Saez-Cirion A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-81; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; SARNGADHARAN MG, 1984, SCIENCE, V224, P506, DOI 10.1126/science.6324345; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SCHUPBACH J, 1984, SCIENCE, V224, P503, DOI 10.1126/science.6200937; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Steinbrook R, 2007, NEW ENGL J MED, V357, P2653, DOI 10.1056/NEJMp0708117; Walker BD, 2001, NAT IMMUNOL, V2, P473, DOI 10.1038/88656; WATKINS D, 2008, IN PRESS NAT MED; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2003, J EXP MED, V197, P1365, DOI 10.1084/jem.20022138; Yang OO, 2002, J VIROL, V76, P1626, DOI 10.1128/JVI.76.4.1626-1631.2002	53	275	361	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					760	764		10.1126/science.1152622	http://dx.doi.org/10.1126/science.1152622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467582				2022-12-28	WOS:000255644400030
J	Haissaguerre, M; Derval, N; Sacher, F; Jesel, L; Deisenhofer, I; de Roy, L; Pasquie, J; Nogami, A; Babuty, D; Yli-Mayry, S; De Chillou, C; Scanu, P; Mabo, P; Matsuo, S; Probst, V; Le Scouarnec, S; Defaye, P; Schlaepfer, J; Rostock, T; Lacroix, D; Lamaison, D; Lavergne, T; Aizawa, Y; Englund, A; Anselme, F; O'Neill, M; Hocini, M; Lim, KT; Knecht, S; Veenhuyzen, GD; Bordachar, P; Chauvin, M; Jais, P; Coureau, G; Chene, G; Klein, GJ; Clementy, J				Haissaguerre, Michel; Derval, Nicolas; Sacher, Frederic; Jesel, Laurence; Deisenhofer, Isabel; de Roy, Luc; Pasquie, Jean-Luc; Nogami, Akihiko; Babuty, Dominique; Yli-Mayry, Sinikka; De Chillou, Christian; Scanu, Patrice; Mabo, Philippe; Matsuo, Seiichiro; Probst, Vincent; Le Scouarnec, Solena; Defaye, Pascal; Schlaepfer, Juerg; Rostock, Thomas; Lacroix, Dominique; Lamaison, Dominique; Lavergne, Thomas; Aizawa, Yoshifusa; Englund, Anders; Anselme, Frederic; O'Neill, Mark; Hocini, Meleze; Lim, Kang Teng; Knecht, Sebastien; Veenhuyzen, George D.; Bordachar, Pierre; Chauvin, Michel; Jais, Pierre; Coureau, Gaelle; Chene, Genevieve; Klein, George J.; Clementy, Jacques			Sudden cardiac arrest associated with early repolarization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT ELEVATION; LONG QT SYNDROME; VENTRICULAR-FIBRILLATION; BRUGADA-SYNDROME; CLINICAL CHARACTERISTICS; ARRHYTHMIC DEATH; J-WAVE; ELECTROCARDIOGRAM; PATIENT; VARIANT	Background: Early repolarization is a common electrocardiographic finding that is generally considered to be benign. Its potential to cause cardiac arrhythmias has been hypothesized from experimental studies, but it is not known whether there is a clinical association with sudden cardiac arrest. Methods: We reviewed data from 206 case subjects at 22 centers who were resuscitated after cardiac arrest due to idiopathic ventricular fibrillation and assessed the prevalence of electrocardiographic early repolarization. The latter was defined as an elevation of the QRS-ST junction of at least 0.1 mV from baseline in the inferior or lateral lead, manifested as QRS slurring or notching. The control group comprised 412 subjects without heart disease who were matched for age, sex, race, and level of physical activity. Follow-up data that included the results of monitoring with an implantable defibrillator were obtained for all case subjects. Results: Early repolarization was more frequent in case subjects with idiopathic ventricular fibrillation than in control subjects (31% vs. 5%, P<0.001). Among case subjects, those with early repolarization were more likely to be male and to have a history of syncope or sudden cardiac arrest during sleep than those without early repolarization. In eight subjects, the origin of ectopy that initiated ventricular arrhythmias was mapped to sites concordant with the localization of repolarization abnormalities. During a mean (+/-SD) follow-up of 61+/-50 months, defibrillator monitoring showed a higher incidence of recurrent ventricular fibrillation in case subjects with a repolarization abnormality than in those without such an abnormality (hazard ratio, 2.1; 95% confidence interval, 1.2 to 3.5; P=0.008). Conclusions: Among patients with a history of idiopathic ventricular fibrillation, there is an increased prevalence of early repolarization.	[Haissaguerre, Michel; Derval, Nicolas; Sacher, Frederic; Matsuo, Seiichiro; Hocini, Meleze; Lim, Kang Teng; Knecht, Sebastien; Bordachar, Pierre; Jais, Pierre; Coureau, Gaelle; Chene, Genevieve; Clementy, Jacques] Univ Bordeaux, Hop Cardiol Haut Leveque, F-33604 Bordeaux, France; [Jesel, Laurence; Chauvin, Michel] CHU Strasbourg, F-67000 Strasbourg, France; [Pasquie, Jean-Luc] CHU Montpellier, Montpellier, France; [Babuty, Dominique] CHU Tours, Tours, France; [De Chillou, Christian] CHU Nancy, Nancy, France; [Scanu, Patrice] CHU Caen, F-14000 Caen, France; [Mabo, Philippe] CHU Rennes, Rennes, France; [Probst, Vincent; Le Scouarnec, Solena] CHU Nantes, F-44035 Nantes 01, France; [Defaye, Pascal] CHU Grenoble, F-38043 Grenoble, France; [Lacroix, Dominique] CHU Lille, F-59037 Lille, France; [Lamaison, Dominique] CHU Clermont Ferrand, Clermont Ferrand, France; [Lavergne, Thomas] CHU Paris, Paris, France; [Anselme, Frederic] CHU Rouen, Rouen, France; [Deisenhofer, Isabel] Herzzentrum, Munich, Germany; [Rostock, Thomas] Univ Hamburg, Hosp Eppendorf, D-20246 Hamburg, Germany; [de Roy, Luc] Clin Mt Godinne, Louvain, Belgium; [Nogami, Akihiko] Yokohama Rosai Hosp, Yokohama, Kanagawa, Japan; [Aizawa, Yoshifusa] Niigata Univ Sch, Niigata, Japan; [Yli-Mayry, Sinikka] Tampere Univ Hosp, Tampere, Finland; [Schlaepfer, Juerg] Ctr Hosp, Lausanne, Switzerland; [Englund, Anders] Orebro Med Ctr Hosp, Orebro, Sweden; [O'Neill, Mark] St Marys Hosp, London, England; [Veenhuyzen, George D.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Klein, George J.] London Hlth Sci Ctr, London, ON, Canada	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montpellier; CHU de Montpellier; CHU Tours; CHU de Nancy; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Rennes; Nantes Universite; CHU de Nantes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite de Lille - ISITE; CHU Lille; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); CHU de Rouen; German Heart Centre Munich; University of Hamburg; Yokohama Rosai Hospital; Niigata University; Tampere University; Tampere University Hospital; Imperial College London; Libin Cardiovascular Institute Of Alberta; University of Calgary; London Health Sciences Centre	Haissaguerre, M (corresponding author), Univ Bordeaux, Hop Cardiol Haut Leveque, F-33604 Bordeaux, France.	michel.haissaguerre@chu-bordeaux.fr	Coureau, Gaelle/T-4571-2019; Pieroni, Maurizio/K-8488-2019; Klein, George/G-3313-2011; probst, vincent/D-4996-2015; de+CHILLOU, Christian/AAV-3626-2021; chene, genevieve/H-8665-2014; Pasquié, Jean Luc/O-2216-2018; Defaye, Pascal/S-6110-2019; Le Scouarnec, Solena/D-3547-2015	probst, vincent/0000-0002-5492-8619; chene, genevieve/0000-0002-8368-6460; Pasquié, Jean Luc/0000-0003-3773-5804; Le Scouarnec, Solena/0000-0003-3444-2125; Deisenhofer, Isabel/0000-0001-5826-6846; O'Neill, Mark/0000-0002-6070-7177				AIZAWA Y, 1993, AM HEART J, V126, P1473, DOI 10.1016/0002-8703(93)90550-S; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Behr ER, 2007, HEART, V93, P601, DOI 10.1136/hrt.2006.099598; Brugada J, 1998, CIRCULATION, V97, P457; Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1; Daimon M, 2000, PACE, V23, P405, DOI 10.1111/j.1540-8159.2000.tb06770.x; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; Garg A, 1998, J CARDIOVASC ELECTR, V9, P642, DOI 10.1111/j.1540-8167.1998.tb00947.x; Gussak I, 2000, J ELECTROCARDIOL, V33, P299, DOI 10.1054/jelc.2000.18106; Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kalla H, 2000, J CARDIOVASC ELECTR, V11, P95, DOI 10.1111/j.1540-8167.2000.tb00743.x; Klatsky AL, 2003, AM J MED, V115, P171, DOI 10.1016/S0002-9343(03)00355-3; Loire R, 1996, ARCH MAL COEUR VAISS, V89, P13; Mehta M, 1999, CLIN CARDIOL, V22, P59, DOI 10.1002/clc.4960220203; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; OTTO CM, 1984, ANN INTERN MED, V101, P45, DOI 10.7326/0003-4819-101-1-45; Priori SG, 1997, CIRCULATION, V95, P265; Shinohara T, 2006, HEART RHYTHM, V3, P1082, DOI 10.1016/j.hrthm.2006.05.016; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Takagi M, 2000, J CARDIOVASC ELECTR, V11, P844, DOI 10.1111/j.1540-8167.2000.tb00062.x; Takeuchi T, 2003, PACE, V26, P632, DOI 10.1046/j.1460-9592.2003.00106.x; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; VISKIN S, 1990, AM HEART J, V120, P661, DOI 10.1016/0002-8703(90)90025-S; WELLENS HJJ, 1992, CIRCULATION, V85, P92; Zhang L, 2005, CIRCULATION, V112, pU765; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	28	937	973	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2016	2023		10.1056/NEJMoa071968	http://dx.doi.org/10.1056/NEJMoa071968			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463377				2022-12-28	WOS:000255577700005
J	Murphy, MS				Murphy, M. Stephen			Management of bloody diarrhoea in children in primary care	BRITISH MEDICAL JOURNAL			English	Review							INFLAMMATORY-BOWEL-DISEASE; ANTIBIOTIC-TREATMENT; DIAGNOSIS; INFANTS; PURPURA; POLYP		[Murphy, M. Stephen] Univ Birmingham, Sch Med, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England; [Murphy, M. Stephen] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham B4 6NH, W Midlands, England	University of Birmingham; University of Birmingham	Murphy, MS (corresponding author), Univ Birmingham, Sch Med, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England.	m.s.murphy@bham.ac.uk						Aalberse J, 2007, ANN RHEUM DIS, V66, P1648, DOI 10.1136/ard.2006.069187; Arvola T, 2006, PEDIATRICS, V117, pE760, DOI 10.1542/peds.2005-1069; Cabrera-Abreu JC, 2004, ARCH DIS CHILD, V89, P69; DUBOULAY CEH, 1983, J CLIN PATHOL, V36, P1264, DOI 10.1136/jcp.36.11.1264; FORD EG, 1992, ANN SURG, V215, P172, DOI 10.1097/00000658-199202000-00013; Gupta SK, 2001, AM J GASTROENTEROL, V96, P1695, DOI 10.1016/S0002-9270(01)02423-6; Libow JA, 2000, PEDIATRICS, V105, P336, DOI 10.1542/peds.105.2.336; Maayan-Metzger Ayala, 2004, J Perinatol, V24, P494, DOI 10.1038/sj.jp.7211135; MACDONALD IAR, 1995, J ACCID EMERG MED, V12, P182; Mack DR, 2007, PEDIATRICS, V119, P1113, DOI 10.1542/peds.2006-1865; MILLS RW, 1990, CLIN PEDIATR, V29, P474, DOI 10.1177/000992289002900812; Ostlie DJ, 2003, J PEDIATR SURG, V38, P1039, DOI 10.1016/S0022-3468(03)00187-8; Poon KKH, 1997, J PEDIATR-US, V130, P327, DOI 10.1016/S0022-3476(97)70366-4; Sawczenko A, 2003, ARCH DIS CHILD, V88, P995, DOI 10.1136/adc.88.11.995; Siahanidou T, 2004, J PEDIATR SURG, V39, P791, DOI 10.1016/j.jpedsurg.2004.03.027; Sirinavin S, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.Cd001167:Cd001167, DOI 10.1002/14651858.CD001167:CD001167]; Spray C, 2001, ACTA PAEDIATR, V90, P400, DOI 10.1080/080352501750126230; SWENSON D, 1960, NEW ENGL J MED, V262, P64; SWENSON O, 1973, J PEDIATR SURG, V8, P587, DOI 10.1016/0022-3468(73)90395-3; Ternhag A, 2007, CLIN INFECT DIS, V44, P696, DOI 10.1086/509924; Ukarapol N, 2007, WORLD J SURG, V31, P395, DOI 10.1007/s00268-005-0686-5; Uppal SS, 2006, CLIN EXP RHEUMATOL, V24, pS26; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Xanthakos SA, 2005, J PEDIATR GASTR NUTR, V41, P16, DOI 10.1097/01.MPG.0000161039.96200.F1	25	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 3	2008	336	7651					1010	1015		10.1136/bmj.39542.440417.BE	http://dx.doi.org/10.1136/bmj.39542.440417.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300EZ	18456632	Green Published			2022-12-28	WOS:000255808400045
J	Laughlin, ST; Baskin, JM; Amacher, SL; Bertozzi, CR				Laughlin, Scott T.; Baskin, Jeremy M.; Amacher, Sharon L.; Bertozzi, Carolyn R.			In vivo imaging of membrane-associated glycans in developing zebrafish	SCIENCE			English	Article							O-LINKED GLYCOSYLATION; LIVING ANIMALS; CELL; VISUALIZATION; MECHANISMS; PROTEINS; DISEASE	Glycans are attractive targets for molecular imaging but have been inaccessible because of their incompatibility with genetically encoded reporters. We demonstrated the noninvasive imaging of glycans in live developing zebrafish, using a chemical reporter strategy. Zebrafish embryos were treated with an unnatural sugar to metabolically label their cell- surface glycans with azides. Subsequently, the embryos were reacted with fluorophore conjugates by means of copper- free click chemistry, enabling the visualization of glycans in vivo at subcellular resolution during development. At 60 hours after fertilization, we observed an increase in de novo glycan biosynthesis in the jaw region, pectoral fins, and olfactory organs. Using a multicolor detection strategy, we performed a spatiotemporal analysis of glycan expression and trafficking and identified patterns that would be undetectable with conventional molecular imaging approaches.	[Laughlin, Scott T.; Baskin, Jeremy M.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Amacher, Sharon L.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Mol Foundry, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu	Baskin, Jeremy/X-7077-2019	Baskin, Jeremy/0000-0003-2939-3138	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061952, R01GM058867, R37GM058867] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM061952-06A2S1, GM061952, R37 GM058867, R01 GM061952, R01 GM058867, R01 GM058867-11, GM058867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; Beatty KE, 2006, ANGEW CHEM INT EDIT, V45, P7364, DOI 10.1002/anie.200602114; CARLSSON SR, 1993, ARCH BIOCHEM BIOPHYS, V304, P65, DOI 10.1006/abbi.1993.1322; Chang PV, 2007, J AM CHEM SOC, V129, P8400, DOI 10.1021/ja070238o; Clement M, 2004, J CELL SCI, V117, P5059, DOI 10.1242/jcs.01350; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Sawa M, 2006, P NATL ACAD SCI USA, V103, P12371, DOI 10.1073/pnas.0605418103; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200	19	764	833	32	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					664	667		10.1126/science.1155106	http://dx.doi.org/10.1126/science.1155106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451302	Green Accepted			2022-12-28	WOS:000255454300046
J	Tureci, HE; Ge, L; Rotter, S; Stone, AD				Tureci, Hakan E.; Ge, Li; Rotter, Stefan; Stone, A. Douglas			Strong interactions in multimode random lasers	SCIENCE			English	Article							RANDOM-MEDIA; FEEDBACK	Unlike conventional lasers, diffusive random lasers ( DRLs) have no resonator to trap light and no high- Q resonances to support lasing. Because of this lack of sharp resonances, the DRL has presented a challenge to conventional laser theory. We present a theory able to treat the DRL rigorously and provide results on the lasing spectra, internal fields, and output intensities of DRLs. Typically DRLs are highly multimode lasers, emitting light at a number of wavelengths. We show that the modal interactions through the gain medium in such lasers are extremely strong and lead to a uniformly spaced frequency spectrum, in agreement with recent experimental observations.	[Tureci, Hakan E.] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Ge, Li; Rotter, Stefan; Stone, A. Douglas] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Yale University	Tureci, HE (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	tureci@phys.ethz.ch	Rotter, Stefan/E-1997-2011; Ge, Li/A-5171-2012	Rotter, Stefan/0000-0002-4123-1417; Tureci, Hakan/0000-0003-4210-3027; Ge, Li/0000-0002-1922-4464				Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278; Cao H, 2003, WAVE RANDOM MEDIA, V13, pR1, DOI 10.1088/0959-7174/13/3/201; Cao H, 2001, PHYS REV LETT, V86, P4524, DOI 10.1103/PhysRevLett.86.4524; HAKEN H, 1963, Z PHYS, V173, P261, DOI 10.1007/BF01377828; Haken H., 1985, LIGHT LASER DYNAMICS, V2; KOGELNIK H, 1972, J APPL PHYS, V43, P2327, DOI 10.1063/1.1661499; KUDROLLI A, 1994, PHYS REV E, V49, pR11, DOI 10.1103/PhysRevE.49.R11; LAWANDY NM, 1994, NATURE, V368, P436, DOI 10.1038/368436a0; Milner V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.073901; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; PRADHAN P, 1994, PHYS REV B, V50, P9644, DOI 10.1103/PhysRevB.50.9644; Tureci HE, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.013813; Tureci HE, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.043822; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; van der Molen KL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.143901; Vanneste C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.143902	18	317	325	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					643	646		10.1126/science.1155311	http://dx.doi.org/10.1126/science.1155311			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451297	Green Submitted			2022-12-28	WOS:000255454300039
J	Moreno, JC; Klootwijk, W; van Toor, H; Pinto, G; D'Alessandro, M; Leger, A; Goudie, D; Polak, M; Gruters, A; Visser, TJ				Moreno, Jose C.; Klootwijk, Willem; van Toor, Hans; Pinto, Graziella; D'Alessandro, Mariella; Leger, Aubene; Goudie, David; Polak, Michel; Gruters, Annette; Visser, Theo J.			Mutations in the iodotyrosine deiodinase gene and hypothyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL HYPOTHYROIDISM; DI-IODOTYROSINE; SERIAL ANALYSIS; METABOLISM; CLONING	DEHAL1 has been identified as the gene encoding iodotyrosine deiodinase in the thyroid, where it controls the reuse of iodide for thyroid hormone synthesis. We screened patients with hypothyroidism who had features suggestive of an iodotyrosine deiodinase defect for mutations in DEHAL1. Two missense mutations and a deletion of three base pairs were identified in four patients from three unrelated families; all the patients had a dramatic reduction of in vitro activity of iodotyrosine deiodinase. Patients had severe goitrous hypothyroidism, which was evident in infancy and childhood. Two patients had cognitive deficits due to late diagnosis and treatment. Thus, mutations in DEHAL1 led to a deficiency in iodotyrosine deiodinase in these patients. Because infants with DEHAL1 defects may have normal thyroid function at birth, they may be missed by neonatal screening programs for congenital hypothyroidism.	[Moreno, Jose C.; Klootwijk, Willem; van Toor, Hans; Visser, Theo J.] Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Pinto, Graziella; Polak, Michel] Hop Necker Enfants Malad, INSERM, Unite 845, Paris, France; [Leger, Aubene] Grp Hosp Pitie Salpetriere, F-75634 Paris, France; [D'Alessandro, Mariella] Univ Dundee, Canc Res UK Cell Struct Res Grp, Dundee, Scotland; [Goudie, David] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Univ Hosp Natl Hlth Serv Trust, Dundee DD1 9SY, Scotland; [Gruters, Annette] Humboldt Univ, Charite Hosp, Berlin, Germany	Erasmus University Rotterdam; Erasmus MC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Dundee; University of Dundee; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Moreno, JC (corresponding author), Erasmus Univ, Erasmus Med Ctr, Dept Internal Med, Room Ee 593,Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	j.morenonavarro@erasmusmc.nl	Visser, Theo J/C-8059-2013	Visser, Theo J/0000-0002-6997-284X				Andersson M, 2005, B WORLD HEALTH ORGAN, V83, P518; CHOUFOER JC, 1960, J CLIN ENDOCR METAB, V20, P983, DOI 10.1210/jcem-20-7-983; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; de Vijlder JJM, 2003, EUR J ENDOCRINOL, V149, P247, DOI 10.1530/eje.0.1490247; Gnidehou S, 2004, FASEB J, V18, P1574, DOI 10.1096/fj.04-2023fje; GRUTERS A, 1994, HORM RES, V41, P3, DOI 10.1159/000183869; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; HUTCHISON JH, 1956, LANCET, V270, P1035; HUTCHISON JH, 1954, J CLIN ENDOCR METAB, V14, P869, DOI 10.1210/jcem-14-8-869; Lavado-Autric R, 2003, J CLIN INVEST, V111, P1073, DOI 10.1172/JCI200316262; MCDOUGALL TR, 2000, WERNER INGBARS THYRO, P355; MEINHOLD H, 1991, J CLIN ENDOCR METAB, V72, P945, DOI 10.1210/jcem-72-4-945; Moreno JC, 2003, HORM RES, V60, P96, DOI 10.1159/000074509; Moreno JC, 2002, NEW ENGL J MED, V347, P95, DOI 10.1056/NEJMoa012752; Moreno JC, 2001, GENOMICS, V75, P70, DOI 10.1006/geno.2001.6586; MURRAY P, 1965, LANCET, V1, P183; *NEW ENGL CONG HYP, 1981, LANCET, V14, P1095; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Pedraza PE, 2006, ENDOCRINOLOGY, V147, P2098, DOI 10.1210/en.2005-1325; QUERIDO A, 1956, J CLIN ENDOCR METAB, V16, P1096, DOI 10.1210/jcem-16-8-1096; ROCHE J, 1952, BIOCHIM BIOPHYS ACTA, V9, P161, DOI 10.1016/0006-3002(52)90143-1; ROSENBERG IN, 1979, J BIOL CHEM, V254, P2318; STANBURY JB, 1956, J CLIN ENDOCR METAB, V16, P735, DOI 10.1210/jcem-16-6-735	24	125	136	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1811	1818		10.1056/NEJMoa0706819	http://dx.doi.org/10.1056/NEJMoa0706819			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434651				2022-12-28	WOS:000255209200007
J	Birchler, JA; Kavi, HH				Birchler, James A.; Kavi, Harsh H.			Molecular biology - Slicing and dicing for small RNAs	SCIENCE			English	Editorial Material									[Birchler, James A.; Kavi, Harsh H.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Birchler, JA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	birchlerj@missouri.edu	KAVI, HARSH/B-5391-2014					Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Chicas A, 2004, NUCLEIC ACIDS RES, V32, P4237, DOI 10.1093/nar/gkh764; CZECH B, 2008, NATURE; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; OKAMURA K, 2008, NATURE; PADDISON PJ, 2008, CURRENT TOPICS MICRO, V320; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; TAM OH, 2008, NATURE; WATANABE T, 2008, NATURE	11	24	27	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1023	1024		10.1126/science.1159018	http://dx.doi.org/10.1126/science.1159018			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18467555				2022-12-28	WOS:000256059800028
J	Braunwald, E				Braunwald, Eugene			Biomarkers in heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							C-REACTIVE PROTEIN; NATRIURETIC PEPTIDE LEVELS; TARGETED ANTICYTOKINE THERAPY; CORONARY-ARTERY-DISEASE; AMINO-TERMINAL PROBNP; CARDIAC TROPONIN-I; FAMILY-MEMBER ST2; PROGNOSTIC VALUE; CIRCULATING LEVELS; MATRIX-METALLOPROTEINASE		Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Braunwald, E (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, 350 Longwood Ave, Boston, MA 02115 USA.	ebraunwald@partners.org	Di Stefano, Antonino/AAB-8041-2020; Eleuteri, Ermanno/E-9554-2019	Di Stefano, Antonino/0000-0003-3479-0875; Eleuteri, Ermanno/0000-0002-3764-7743				Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; Anand IS, 2005, CIRCULATION, V112, P1428, DOI 10.1161/CIRCULATIONAHA.104.508465; Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Arab S, 2006, J AM COLL CARDIOL, V48, P1733, DOI 10.1016/j.jacc.2006.06.063; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; CHIDSEY CA, 1962, NEW ENGL J MED, V267, P650, DOI 10.1056/NEJM196209272671305; CHIDSEY CA, 1965, AM J MED, V39, P442, DOI 10.1016/0002-9343(65)90211-1; Cicoira M, 2004, J CARD FAIL, V10, P403, DOI 10.1016/j.cardfail.2004.01.010; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; ELSTER SK, 1956, AM HEART J, V51, P533, DOI 10.1016/0002-8703(56)90099-0; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; Grieve DJ, 2003, EUR HEART J, V24, P2161, DOI 10.1016/j.ehj.2003.10.015; Gullestad L, 2005, AM J CARDIOL, V95, p17C, DOI 10.1016/j.amjcard.2005.03.008; Hayashi M, 2003, CIRCULATION, V107, P2559, DOI 10.1161/01.CIR.0000068340.96506.0F; Hokamaki J, 2004, J AM COLL CARDIOL, V43, P1880, DOI 10.1016/j.jacc.2004.01.028; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; Hudson MP, 2004, AM HEART J, V147, P546, DOI 10.1016/j.ahj.2003.10.014; Hulsmann M, 1998, J AM COLL CARDIOL, V32, P1695, DOI 10.1016/S0735-1097(98)00437-9; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; JOUGASAKI M, 1995, CIRCULATION, V92, P286, DOI 10.1161/01.CIR.92.3.286; Jourdain P, 2007, J AM COLL CARDIOL, V49, P1733, DOI 10.1016/j.jacc.2006.10.081; Kameda K, 2003, EUR HEART J, V24, P2180, DOI 10.1016/j.ehj.2003.09.022; Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161; Kato J, 1996, J CLIN ENDOCR METAB, V81, P180, DOI 10.1210/jc.81.1.180; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Khan SQ, 2007, J AM COLL CARDIOL, V49, P1525, DOI 10.1016/j.jacc.2006.12.038; King MK, 2003, CIRC RES, V92, P177, DOI 10.1161/01.RES.0000052312.41419.55; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Kittleson MM, 2007, HEART, V93, P365, DOI 10.1136/hrt.2006.090845; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; La Vecchia L, 2000, J HEART LUNG TRANSPL, V19, P644, DOI 10.1016/S1053-2498(00)00120-0; Latini R, 2004, EUR HEART J, V25, P292, DOI 10.1016/j.ehj.2003.10.030; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Lee DS, 2005, CURR OPIN CARDIOL, V20, P201, DOI 10.1097/01.hco.0000161832.04952.6a; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li YW, 2004, CIRC RES, V95, P627, DOI 10.1161/01.RES.0000141528.54850.bd; Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mann DL, 2005, AM J CARDIOL, V95, p9C, DOI 10.1016/j.amjcard.2005.03.007; Mann DL, 2004, CIRCULATION, V109, P1594, DOI 10.1161/01.CIR.0000124490.27666.B2; Manolio T, 2003, NEW ENGL J MED, V349, P1587, DOI 10.1056/NEJMp038136; Masson S, 2006, CLIN CHEM, V52, P1528, DOI 10.1373/clinchem.2006.069575; Masson S, 2006, J CARD FAIL, V12, P375, DOI 10.1016/j.cardfail.2006.02.013; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Moe GW, 2007, CIRCULATION, V115, P3103, DOI 10.1161/CIRCULATIONAHA.106.666255; Moraes DL, 2000, CIRCULATION, V102, P1718, DOI 10.1161/01.CIR.102.14.1718; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Nagaya N, 2000, CIRCULATION, V101, P498, DOI 10.1161/01.CIR.101.5.498; Ng LL, 2006, AM HEART J, V152, P94, DOI 10.1016/j.ahj.2005.09.020; Okuyama M, 1997, AM J CARDIOL, V79, P1698, DOI 10.1016/S0002-9149(97)00228-2; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Omland T, 2007, HYPERTENSION, V49, P1392, DOI 10.1161/HYPERTENSIONAHA.107.087742; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Polidori MC, 2004, J CARD FAIL, V10, P334, DOI 10.1016/j.cardfail.2003.11.004; Querejeta R, 2000, CIRCULATION, V101, P1729; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schrier RW, 2006, AM J MED, V119, pS47, DOI 10.1016/j.amjmed.2006.05.007; Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Sliwa K, 2004, CIRCULATION, V109, P750, DOI 10.1161/01.CIR.0000112568.48837.60; Sugiura T, 2005, J CARD FAIL, V11, P504, DOI 10.1016/j.cardfail.2005.04.025; Suzuki T, 1998, AM HEART J, V136, P362, DOI 10.1053/hj.1998.v136.89908; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Tang WHW, 2007, CIRCULATION, V116, pE99, DOI 10.1161/CIRCULATIONAHA.107.185267; Tang WHW, 2006, AM J CARDIOL, V98, P796, DOI 10.1016/j.amjcard.2006.04.018; Tang WHW, 2003, CIRCULATION, V108, P2964, DOI 10.1161/01.CIR.0000106903.98196.B6; Teerlink John R, 2005, Curr Heart Fail Rep, V2, P191, DOI 10.1007/BF02696649; Ueland T, 2004, J AM COLL CARDIOL, V44, P1970, DOI 10.1016/j.jacc.2004.06.076; Ungvari Zoltan, 2005, Current Vascular Pharmacology, V3, P221, DOI 10.2174/1570161054368607; van Kimmenade RR, 2006, J AM COLL CARDIOL, V48, P1217, DOI 10.1016/j.jacc.2006.03.061; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Venugopal SK, 2005, CURR OPIN NEPHROL HY, V14, P33, DOI 10.1097/00041552-200501000-00006; Vickery S, 2005, AM J KIDNEY DIS, V46, P610, DOI 10.1053/j.ajkd.2005.06.017; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zannad F, 2001, CIRCULATION, V103, P476; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zimmet JM, 2006, CIRCULATION, V114, P1531, DOI 10.1161/CIRCULATIONAHA.105.605519	88	914	1130	0	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2148	2159		10.1056/NEJMra0800239	http://dx.doi.org/10.1056/NEJMra0800239			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480207				2022-12-28	WOS:000255849300008
J	Schroeder, T				Schroeder, Timm			Imaging stem-cell-driven regeneration in mammals	NATURE			English	Review							RED-FLUORESCENT-PROTEIN; HEMATOPOIETIC STEM; PROGENITOR CELLS; SURFACE PROTEIN; GENE-EXPRESSION; REPORTER GENE; MOUSE; MICROSCOPY; IDENTIFICATION; DYNAMICS	The ability to observe biological processes continuously, instead of at discrete time points, holds great promise for the study of tissue regeneration. Ideally, single cells would be followed continuously within large tissue volumes (such as organs) over long periods of time. Technical limitations, however, preclude such studies. But, recently, there have been improvements in imaging technologies and biologically compatible labelling agents. Together with new insights into the molecular characteristics of stem cells, which are ultimately responsible for the regenerative potential of all tissues, researchers are now much closer to applying single-cell imaging approaches to research into regeneration and its clinical applications.	[Schroeder, Timm] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schroeder, T (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010	Schroeder, Timm/0000-0001-9320-0252				Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bonasio R, 2007, P NATL ACAD SCI USA, V104, P14753, DOI 10.1073/pnas.0705201104; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Ebert SN, 2007, STEM CELLS, V25, P2936, DOI 10.1634/stemcells.2007-0216; Fernandez-Suarez M, 2007, NAT BIOTECHNOL, V25, P1483, DOI 10.1038/nbt1355; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gao WZ, 2003, J AM CHEM SOC, V125, P11146, DOI 10.1021/ja036126o; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Heck S, 2003, BLOOD, V101, P903, DOI 10.1182/blood-2002-06-1861; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Jacobs RE, 2003, NAT CELL BIOL, pSS10, DOI 10.1038/nrm1195; Josserand V, 2007, GENE THER, V14, P1587, DOI 10.1038/sj.gt.3303028; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kelly KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000665; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Matz MV, 2002, BIOESSAYS, V24, P953, DOI 10.1002/bies.10154; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizrahi A, 2007, NAT NEUROSCI, V10, P444, DOI 10.1038/nn1875; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Naik S, 2007, P NATL ACAD SCI USA, V104, P17465, DOI 10.1073/pnas.0704465104; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita C, 2004, BIOTECHNIQUES, V36, P418, DOI 10.2144/04363ST01; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Ray P, 2007, CANCER RES, V67, P3085, DOI 10.1158/0008-5472.CAN-06-2402; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Schroeder T, 2005, ANN NY ACAD SCI, V1044, P201, DOI 10.1196/annals.1349.025; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Sosnovik DE, 2007, CIRCULATION, V115, P1384, DOI 10.1161/CIRCULATIONAHA.106.663351; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Sumner JP, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2800294; Suzuki N, 2006, P NATL ACAD SCI USA, V103, P2202, DOI 10.1073/pnas.0508928103; Swirski FK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001075; Takayanagi SI, 2006, BLOOD, V107, P4317, DOI 10.1182/blood-2005-09-3747; Tannous BA, 2006, NAT METHODS, V3, P391, DOI 10.1038/NMETH875; Tao W, 2007, STEM CELLS, V25, P670, DOI 10.1634/stemcells.2006-0553; TSIEN RY, 2003, NAT REV MOL CELL BIO, V4, pSS16; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; Verveer PJ, 2007, NAT METHODS, V4, P311, DOI 10.1038/NMETH1017; Vinegoni C, 2008, NAT METHODS, V5, P45, DOI 10.1038/NMETH1149; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; WOOD KV, 1989, SCIENCE, V244, P700, DOI 10.1126/science.2655091; Yamanaka Y, 2007, DEV CELL, V13, P884, DOI 10.1016/j.devcel.2007.10.016; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794; Zacharakis G, 2005, P NATL ACAD SCI USA, V102, P18252, DOI 10.1073/pnas.0504628102; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104	75	166	173	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					345	351		10.1038/nature07043	http://dx.doi.org/10.1038/nature07043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480816				2022-12-28	WOS:000255868400042
J	Campbell, R; Starkey, F; Holliday, J; Audrey, S; Bloor, M; Parry-Langdon, N; Hughes, R; Moore, L				Campbell, R.; Starkey, F.; Holliday, J.; Audrey, S.; Bloor, M.; Parry-Langdon, N.; Hughes, R.; Moore, L.			An informal school-based peer-led intervention for smoking prevention in adolescence (ASSIST): a cluster randomised trial	LANCET			English	Article							CIGARETTE-SMOKING; YOUNG-PEOPLE; EDUCATION; PERSPECTIVES; CHALLENGES	Background Schools in many countries undertake programmes for smoking prevention, but systematic reviews have shown mixed evidence of their effectiveness. Most peer-led approaches have been classroom-based, and rigorous assessments are scarce. We assessed the effectiveness of a peer-led intervention that aimed to prevent smoking uptake in secondary schools. Methods We undertook a cluster randomised controlled trial of 10730 students aged 12-13 years in 59 schools in England and Wales. 29 schools (5372 students) were randomly assigned by stratified block randomisation to the control group to continue their usual smoking education and 30 (5358 students) to the intervention group. The intervention (ASSIST [A Stop Smoking In Schools Trial] programme) consisted of training influential students to act as peer supporters during informal interactions outside the classroom to encourage their peers not to smoke. Follow-up was immediately after the intervention and at 1 and 2 years. Primary outcomes were smoking in the past week in both the school year group and in a group at high risk of regular smoking uptake, which was identified at baseline as occasional, experimental, or ex-smokers. Analysis was by intention to treat. This study is registered, number ISRCTN55572965. Findings The odds ratio of being a smoker in intervention compared with control schools was 0 . 75 (95% Cl 0 . 55-1.01) immediately after the intervention (n=9349 students), 0.77 (0.59-0.99) at 1-year follow-up (n=9147), and 0 . 85 (0.72-1. 01) at 2-year follow-up (n=8756). The corresponding odds ratios for the high-risk group were 0 . 79 (0 . 55-1 . 13 [n=3561]), 0.75 (0.56-0.99 [n=3483]), and 0 . 85 (0.70-1.02 [n=3294]), respectively. In a three-tier multilevel model with data from all three follow-ups, the odds of being a smoker in intervention compared with control schools was 0 . 78 (0.64-0.96). Interpretation The results suggest that, if implemented on a population basis, the ASSIST intervention could lead to a reduction in adolescent smoking prevalence of public-health importance.	[Campbell, R.; Starkey, F.; Audrey, S.; Hughes, R.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Holliday, J.; Moore, L.] Cardiff Univ, Cardiff Inst Soc Hlth & Eth, Cardiff, Wales; [Bloor, M.] Univ Glasgow, Ctr Drug Misuse Res, Glasgow, Lanark, Scotland; [Parry-Langdon, N.] Off Natl Stat, Newport, England	University of Bristol; Cardiff University; University of Glasgow	Campbell, R (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England.	Rona.Campbell@bristol.ac.uk	Bujan, Miren Karmele/F-5542-2014; /K-7215-2019	Holliday, Jo/0000-0003-4568-7320; Hughes, Rachael/0000-0003-0766-1410; Moore, Laurence/0000-0003-2182-823X	Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Audrey S., 2004, Health Education Journal, V63, P266, DOI 10.1177/001789690406300307; Audrey S, 2008, HEALTH EDUC J, V67, P74, DOI 10.1177/0017896908089387; Audrey S, 2006, SOC SCI MED, V63, P320, DOI 10.1016/j.socscimed.2005.12.010; Audrey S, 2006, HEALTH EDUC RES, V21, P366, DOI 10.1093/her/cyl029; Backett-Milburn K, 2000, HEALTH EDUC RES, V15, P85, DOI 10.1093/her/15.1.85; Bloor M, 1999, HLTH ED J, V58, P17; BOREHAM R, 2001, SMOKING DRINKIN DRUG; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; *CDCP, POP OP LEAD POL COMM; Chassin L, 2000, HEALTH PSYCHOL, V19, P223, DOI 10.1037//0278-6133.19.3.223; Currie C., 1998, HLTH BEHAV SCH AGED; de Vries H, 2006, TOB CONTROL, V15, P83, DOI 10.1136/tc.2003.007237; de Vries H, 2006, HEALTH EDUC RES, V21, P116, DOI 10.1093/her/cyh048; Denscombe M, 2001, DRUG-EDUC PREV POLIC, V8, P7, DOI 10.1080/09687630124121; *DEP ED SKILLS, 2005, STAT ED ED TRAIN STA; DiFranza JR, 2007, ARCH PEDIAT ADOL MED, V161, P704, DOI 10.1001/archpedi.161.7.704; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Green J, 2001, Promot Educ, V8, P65, DOI 10.1177/102538230100800203; Harden A., 1999, REV EFFECTIVENESS AP; HART G, 2003, EFFECTIVE SEXUAL HLT, P191; Hoffman BR, 2006, SUBST USE MISUSE, V41, P103, DOI 10.1080/10826080500368892; HOLLIDAY J, 2006, THESIS CARDIFF U; HOLSTEIN B, 2004, WHO POLICY SERIES, P165; Honjo K, 2006, SOC SCI MED, V62, P317, DOI 10.1016/j.socscimed.2005.06.011; Kelly J., 1995, OPINION LEADER HIV P; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Maxwell KA, 2002, J YOUTH ADOLESCENCE, V31, P267, DOI 10.1023/A:1015493316865; Orme J., 1999, HLTH ED, V1, P8, DOI DOI 10.1108/09654289910248472; Parkin S, 2000, DRUG-EDUC PREV POLIC, V7, P293; Peto R, 2004, TOBACCO PUBLIC HLTH, P281; Rogers EM., 1983, DIFFUSION INNOVATION; SOWDEN A, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001291; Starkey F, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-43; TAIOLI E, 1991, NEW ENGL J MED, V325, P968; Thomas R, 2002, COCHRANE DB SYST REV, V4; Turner G, 1999, HEALTH EDUC RES, V14, P235, DOI 10.1093/her/14.2.235; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; Wiehe SE, 2005, J ADOLESCENT HEALTH, V36, P162, DOI 10.1016/j.jadohealth.2004.12.003; World Health Organization, 2003, WHO FRAM CONV TOB CO	40	277	280	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1595	1602		10.1016/S0140-6736(08)60692-3	http://dx.doi.org/10.1016/S0140-6736(08)60692-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298VO	18468543	Green Published			2022-12-28	WOS:000255715400027
J	Dillehay, TD; Ramirez, C; Pino, M; Collins, MB; Rossen, J; Pino-Navarro, JD				Dillehay, Tom D.; Ramirez, C.; Pino, M.; Collins, M. B.; Rossen, J.; Pino-Navarro, J. D.			Monte Verde: Seaweed, food, medicine, and the peopling of South America	SCIENCE			English	Article							PACIFIC; POLYSACCHARIDES; RHODOPHYTA; NORTH	The identification of human artifacts at the early archaeological site of Monte Verde in southern Chile has raised questions of when and how people reached the tip of South America without leaving much other evidence in the New World. Remains of nine species of marine algae were recovered from hearths and other features at Monte Verde II, an upper occupational layer, and were directly dated between 14,220 and 13,980 calendar years before the present (similar to 12,310 and 12,290 carbon- 14 years ago). These findings support the archaeological interpretation of the site and indicate that the site's inhabitants used seaweed from distant beaches and estuarine environments for food and medicine. These data are consistent with the ideas that an early settlement of South America was along the Pacific coast and that seaweeds were important to the diet and health of early humans in the Americas.	[Dillehay, Tom D.] Vanderbilt Univ, Dept Anthropol, Nashville, TN 37265 USA; [Dillehay, Tom D.] Univ Austral Chile, Inst Ciencias Soc, Valdivia, Chile; [Ramirez, C.] Univ Austral Chile, Inst Bot, Valdivia, Chile; [Pino, M.] Univ Austral Chile, Inst Geociencias, Valdivia, Chile; [Collins, M. B.] Univ Texas Austin, Texas Archeol Res Lab, Austin, TX 78712 USA; [Rossen, J.] Ithaca Coll, Dept Anthropol, Ithaca, NY 14850 USA; [Pino-Navarro, J. D.] Univ Austral Chile, Ctr Estud Ambientales, Valdivia, Chile	Vanderbilt University; Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile; University of Texas System; University of Texas Austin; Universidad Austral de Chile	Dillehay, TD (corresponding author), Vanderbilt Univ, Dept Anthropol, Nashville, TN 37265 USA.	tom.d.dillehay@vanderbilt.edu	PINO, MARIO/A-2709-2008; Pino, Mario/GPP-7219-2022	PINO, MARIO/0000-0001-6181-353X; 				Buschmann AH, 2001, J APPL PHYCOL, V13, P255, DOI 10.1023/A:1011140932246; Castilla JC, 2005, BIOL INVASIONS, V7, P213, DOI 10.1007/s10530-004-0198-5; Damonte EB, 2004, CURR MED CHEM, V11, P2399, DOI 10.2174/0929867043364504; Dillehay T. D, 1989, PALEOENVIRONMENT SIT, VI; Dillehay T. D., 1997, ARCHAEOLOGICAL CONTE, VII; DILLEHAY TD, 2000, NEW PREHISTORY SETTL; DIXON JE, 1999, BONES BOATS BISON; ERLANDSON J, 2002, MEMOIRS CALIFORNIA A, V27, P52; FLADMARK KR, 1979, AM ANTIQUITY, V44, P55, DOI 10.2307/279189; GRUHN R, 1994, METHODS THEORY INVES, P24; Jackson D, 2007, CURR ANTHROPOL, V48, P725, DOI 10.1086/520965; Keefer DK, 1998, SCIENCE, V281, P1833, DOI 10.1126/science.281.5384.1833; Lavallee D., 1999, B I FRANCAIS ETUDES, V28, P13; MARTINEZ AL, 1979, AM ANTIQUITY, V44, P309, DOI 10.2307/279082; Matsuhiro B, 1996, HYDROBIOLOGIA, V321, P77, DOI 10.1007/BF00018679; MCHUGH DJ, 1991, HYDROBIOLOGIA, V221, P19, DOI 10.1007/BF00028359; Meltzer DJ, 2004, DEV QUA SCI, V1, P539; NODA H, 1990, HYDROBIOLOGIA, V204, P577, DOI 10.1007/BF00040290; PINONAVARRO JD, 2007, INFORME ETNOGRAFICO; Ramirez C., 1989, MONTE VERDE LATE PLE, P147; Ramirez ME, 1991, MONOGRAFIAS BIOL, V5; ROSSEN J, 1997, MONTE VERDE LATE PLE, V2, P331; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Santelices B., 1989, ALGAS MARINAS CHILE; Smit AJ, 2004, J APPL PHYCOL, V16, P245, DOI 10.1023/B:JAPH.0000047783.36600.ef; TURNER NJ, 2005, EATING HEATING TRADI, P153; UGENT D, 1989, MONTE VERDE LATE PLE, V1, P911; Varela DA, 2006, J APPL PHYCOL, V18, P827, DOI 10.1007/s10811-006-9102-2; Westermeier R, 1999, HYDROBIOLOGIA, V399, P137, DOI 10.1023/A:1017021626951	29	336	345	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					784	786		10.1126/science.1156533	http://dx.doi.org/10.1126/science.1156533			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467586				2022-12-28	WOS:000255644400037
J	Lin, HS; Lee, E; Hestir, K; Leo, C; Huang, MM; Bosch, E; Halenbeck, R; Wu, G; Zhou, A; Behrens, D; Hollenbaugh, D; Linnemann, T; Qin, MM; Wong, J; Chu, KT; Doberstein, SK; Williams, LT				Lin, Haishan; Lee, Ernestine; Hestir, Kevin; Leo, Cindy; Huang, Minmei; Bosch, Elizabeth; Halenbeck, Robert; Wu, Ge; Zhou, Aileen; Behrens, Dirk; Hollenbaugh, Diane; Linnemann, Thomas; Qin, Minmin; Wong, Justin; Chu, Keting; Doberstein, Stephen K.; Williams, Lewis T.			Discovery of a cytokine and its receptor by functional screening of the extracellular proteome	SCIENCE			English	Article							GROWTH-FACTOR	To understand the system of secreted proteins and receptors involved in cell- cell signaling, we produced a comprehensive set of recombinant secreted proteins and the extracellular domains of transmembrane proteins, which constitute most of the protein components of the extracellular space. Each protein was tested in a suite of assays that measured metabolic, growth, or transcriptional responses in diverse cell types. The pattern of responses across assays was analyzed for the degree of functional selectivity of each protein. One of the highly selective proteins was a previously undescribed ligand, designated interleukin- 34 ( IL- 34), which stimulates monocyte viability but does not affect responses in a wide spectrum of other assays. In a separate functional screen, we used a collection of extracellular domains of transmembrane proteins to discover the receptor for IL- 34, which was a known cytokine receptor, colony-stimulating factor 1 ( also called macrophage colony- stimulating factor) receptor. This systematic approach is thus useful for discovering new ligands and receptors and assessing the functional selectivity of extracellular regulatory proteins.	[Lin, Haishan; Lee, Ernestine; Hestir, Kevin; Leo, Cindy; Huang, Minmei; Bosch, Elizabeth; Halenbeck, Robert; Wu, Ge; Zhou, Aileen; Behrens, Dirk; Hollenbaugh, Diane; Linnemann, Thomas; Qin, Minmin; Wong, Justin; Chu, Keting; Doberstein, Stephen K.; Williams, Lewis T.] Five Prime Therapeut Inc, San Francisco, CA 94158 USA; [Williams, Lewis T.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Williams, LT (corresponding author), Five Prime Therapeut Inc, 1650 Owens St,Suite 200, San Francisco, CA 94158 USA.	rusty.williams@fiveprime.com						Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; LEE EA, IN PRESS PROTEIN PEP; Nissen-Druey C, 2005, ACTA HAEMATOL-BASEL, V113, P5, DOI 10.1159/000081987; PEREIRA C, 2004, BIOPROCESS INT, V2, P70; TESTA NG, 1993, HAEMOPOIESIS PRACTIC; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485	14	523	611	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					807	811		10.1126/science.1154370	http://dx.doi.org/10.1126/science.1154370			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467591				2022-12-28	WOS:000255644400045
J	Robledo, L; Elzerman, J; Jundt, G; Atature, M; Hogele, A; Falt, S; Imamoglu, A				Robledo, Lucio; Elzerman, Jeroen; Jundt, Gregor; Atature, Mete; Hoegele, Alexander; Faelt, Stefan; Imamoglu, Atac			Conditional dynamics of interacting quantum dots	SCIENCE			English	Article							SINGLE-ELECTRON; SPIN	Conditional quantum dynamics, where the quantum state of one system controls the outcome of measurements on another quantum system, is at the heart of quantum information processing. We demonstrate conditional dynamics for two coupled quantum dots, whereby the probability that one quantum dot makes a transition to an optically excited state is controlled by the presence or absence of an optical excitation in the neighboring dot. Interaction between the dots is mediated by the tunnel coupling between optically excited states and can be optically gated by applying a laser field of the right frequency. Our results represent substantial progress toward realization of an optically effected controlled- phase gate between two solid- state qubits.	[Robledo, Lucio; Elzerman, Jeroen; Jundt, Gregor; Hoegele, Alexander; Faelt, Stefan; Imamoglu, Atac] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Atature, Mete] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge	Imamoglu, A (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	imamoglu@phys.ethz.ch	Atature, Mete/ABD-9297-2020; Elzerman, Jeroen M/J-3551-2012; Robledo, Lucio M/F-3120-2011; Fält, Stefan/F-8171-2010; Hogele, Alexander/C-1080-2016	Elzerman, Jeroen M/0000-0002-4596-8483; Atature, Mete/0000-0003-3852-0944; Hogele, Alexander/0000-0002-0178-9117				Alen B, 2003, APPL PHYS LETT, V83, P2235, DOI 10.1063/1.1609243; Atature M, 2007, NAT PHYS, V3, P101, DOI 10.1038/nphys521; Atature M, 2006, SCIENCE, V312, P551, DOI 10.1126/science.1126074; Bayer M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195315; Berezovsky J, 2006, SCIENCE, V314, P1916, DOI 10.1126/science.1133862; Calarco T, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012310; Faelt S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.106401; Gammon D, 1996, PHYS REV LETT, V76, P3005, DOI 10.1103/PhysRevLett.76.3005; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hettich C, 2002, SCIENCE, V298, P385, DOI 10.1126/science.1075606; Krenner HJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.057402; KRONER M, PREPRINT; Li XQ, 2003, SCIENCE, V301, P809, DOI 10.1126/science.1083800; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Mikkelsen MH, 2007, NAT PHYS, V3, P770, DOI 10.1038/nphys736; Petroff PM, 2001, PHYS TODAY, V54, P46, DOI 10.1063/1.1381102; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Scully M.O., 1997, QUANTUM OPT; Stinaff EA, 2006, SCIENCE, V311, P636, DOI 10.1126/science.1121189; Unold T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.137404; Warburton RJ, 2000, NATURE, V405, P926, DOI 10.1038/35016030	21	127	128	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					772	775		10.1126/science.1155374	http://dx.doi.org/10.1126/science.1155374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467585				2022-12-28	WOS:000255644400033
J	Moore, JS; Kraft, ML				Moore, Jeffrey S.; Kraft, Mary L.			Chemistry - Synchronized self-assembly	SCIENCE			English	Editorial Material									[Moore, Jeffrey S.; Kraft, Mary L.] Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Moore, JS (corresponding author), Univ Illinois, Sch Chem Sci, Urbana, IL 61801 USA.	jsmoore@uiuc.edu; mlkraft@uiuc.edu						Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Fialkowski M, 2006, J PHYS CHEM B, V110, P2482, DOI 10.1021/jp054153q; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191	6	47	49	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					620	621		10.1126/science.1157225	http://dx.doi.org/10.1126/science.1157225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451289				2022-12-28	WOS:000255454300030
J	Stramma, L; Johnson, GC; Sprintall, J; Mohrholz, V				Stramma, Lothar; Johnson, Gregory C.; Sprintall, Janet; Mohrholz, Volker			Expanding oxygen-minimum zones in the tropical oceans	SCIENCE			English	Article							EXTINCTION; SEA	Oxygen-poor waters occupy large volumes of the intermediate- depth eastern tropical oceans. Oxygen- poor conditions have far- reaching impacts on ecosystems because important mobile macroorganisms avoid or cannot survive in hypoxic zones. Climate models predict declines in oceanic dissolved oxygen produced by global warming. We constructed 50- year time series of dissolved- oxygen concentration for select tropical oceanic regions by augmenting a historical database with recent measurements. These time series reveal vertical expansion of the intermediate- depth low- oxygen zones in the eastern tropical Atlantic and the equatorial Pacific during the past 50 years. The oxygen decrease in the 300- to 700- m layer is 0.09 to 0.34 micromoles per kilogram per year. Reduced oxygen levels may have dramatic consequences for ecosystems and coastal economies.	[Stramma, Lothar] Univ Kiel, Inst Meereswissensch, GEOMAR, IFM, D-24105 Kiel, Germany; [Johnson, Gregory C.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Sprintall, Janet] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Mohrholz, Volker] Balt Sea Res Inst Warnemunde, D-18112 Rostock, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California San Diego; Scripps Institution of Oceanography	Stramma, L (corresponding author), Univ Kiel, Inst Meereswissensch, GEOMAR, IFM, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	lstramma@ifm-geomar.de	Johnson, Gregory C/I-6559-2012	Johnson, Gregory C/0000-0002-8023-4020; Mohrholz, Volker/0000-0003-0778-9182; Stramma, Lothar/0000-0003-1391-4808				Bange HW, 2005, PROG OCEANOGR, V65, P145, DOI 10.1016/j.pocean.2005.03.002; Benton MJ, 2003, TRENDS ECOL EVOL, V18, P358, DOI 10.1016/S0169-5347(03)00093-4; BOPP LB, 2002, GLOBAL BIOGEOCHEM CY, V16; Garcia H.E., 2005, GEOPHYS RES LETT, V32; GARCIA HE, 2006, NOAA ATLAS NESDIS, V63, P1; Gould W.J., 2006, WEATHER, V61, P17, DOI [10.1256/wea.56.05, DOI 10.1256/WEA.56.05, DOI 10.1007/s00338-008-0361-z]; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Jones CE, 2001, AM J SCI, V301, P112, DOI 10.2475/ajs.301.2.112; Joos F., 2003, EOS T AM GEOPHYS UN, V84, P197, DOI [10.1029/2003EO210001, DOI 10.1029/2003EO210001, DOI 10.1029/2003E0210001]; Kortzinger A, 2004, SCIENCE, V306, P1337, DOI 10.1126/science.1102557; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Matear R. J., 2003, GLOBAL BIOGEOCHEM CY, V17; MATEAR RJ, 2000, GEOCHEM GEOPHYS GEOS, V1; Stramma L, 2003, ELSEV OCEANOGR SERIE, V68, P1; Stramma L, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004369; vonsStorch H., 1999, STAT ANAL CLIMATE RE, DOI DOI 10.1017/CBO9780511612336; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Wignall PB, 1996, SCIENCE, V272, P1155, DOI 10.1126/science.272.5265.1155; WUNSCH C, 1996, OCEAN CIRCULATION IN	19	925	954	7	413	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					655	658		10.1126/science.1153847	http://dx.doi.org/10.1126/science.1153847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451300				2022-12-28	WOS:000255454300043
J	Wardle, DA; Nilsson, MC; Zackrisson, O				Wardle, David A.; Nilsson, Marie-Charlotte; Zackrisson, Olle			Fire-derived charcoal causes loss of forest humus	SCIENCE			English	Article							BLACK CARBON		[Wardle, David A.; Nilsson, Marie-Charlotte; Zackrisson, Olle] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden	Swedish University of Agricultural Sciences	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden.	david.wardle@svek.slu.se	Wardle, David A./F-6031-2011; Hegethorn, Marie-Charlotte Nilsson/B-1802-2017	Wardle, David A./0000-0002-0476-7335; Hegethorn, Marie-Charlotte Nilsson/0000-0002-9254-2223				Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Hamer U, 2004, ORG GEOCHEM, V35, P823, DOI 10.1016/j.orggeochem.2004.03.003; Hammes K, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002914; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Neff JC, 2002, GLOBAL CHANGE BIOL, V8, P872, DOI 10.1046/j.1365-2486.2002.00517.x; Pietikainen J, 2000, OIKOS, V89, P231, DOI 10.1034/j.1600-0706.2000.890203.x; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; ZACLROSSPM P, POLPS, V88, P20	10	452	531	8	309	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					629	629		10.1126/science.1154960	http://dx.doi.org/10.1126/science.1154960			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451294				2022-12-28	WOS:000255454300035
J	Oprea, GE; Kroeber, S; McWhorter, ML; Rossoll, W; Mueller, S; Krawczak, M; Bassell, GJ; Beattie, CE; Wirth, B				Oprea, Gabriela E.; Kroeber, Sandra; McWhorter, Michelle L.; Rossoll, Wilfried; Mueller, Stefan; Krawczak, Michael; Bassell, Gary J.; Beattie, Christine E.; Wirth, Brunhilde			Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy	SCIENCE			English	Article							DISEASE GENE-PRODUCT; MESSENGER-RNA; SMN PROTEIN; DELETIONS; IDENTIFICATION; SEVERITY	Homozygous deletion of the survival motor neuron 1 gene ( SMN1) causes spinal muscular atrophy ( SMA), the most frequent genetic cause of early childhood lethality. In rare instances, however, individuals are asymptomatic despite carrying the same SMN1 mutations as their affected siblings, thereby suggesting the influence of modifier genes. We discovered that unaffected SMN1- deleted females exhibit significantly higher expression of plastin 3 ( PLS3) than their SMA- affected counterparts. We demonstrated that PLS3 is important for axonogenesis through increasing the F- actin level. Overexpression of PLS3 rescued the axon length and outgrowth defects associated with SMN down- regulation in motor neurons of SMA mouse embryos and in zebrafish. Our study suggests that defects in axonogenesis are the major cause of SMA, thereby opening new therapeutic options for SMA and similar neuromuscular diseases.	[Oprea, Gabriela E.; Kroeber, Sandra; Wirth, Brunhilde] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Oprea, Gabriela E.; Kroeber, Sandra; Wirth, Brunhilde] Univ Cologne, Inst Genet, D-50931 Cologne, Germany; [Oprea, Gabriela E.; Mueller, Stefan; Wirth, Brunhilde] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [McWhorter, Michelle L.; Beattie, Christine E.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [McWhorter, Michelle L.; Beattie, Christine E.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Rossoll, Wilfried; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany	University of Cologne; University of Cologne; University of Cologne; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Emory University; University of Kiel	Wirth, B (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	brunhilde.wirth@uk-koeln.de	Krawczak, Michael/A-8964-2010; Oprea, Gabriela Elena/AAM-5356-2020; Wirth, Brunhilde/H-3192-2019	Krawczak, Michael/0000-0003-2603-1502; Rossoll, Wilfried/0000-0002-9622-541X; Wirth, Brunhilde/0000-0003-4051-5191; Oprea, Gabriela Elena/0000-0001-5467-5247; McWhorter, Michelle/0000-0001-6931-4946	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD001799, R01HD055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, R01NS050414] Funding Source: NIH RePORTER; NICHD NIH HHS [P30 HD001799, R01 HD055835, HD055835, P30 HD024064] Funding Source: Medline; NINDS NIH HHS [P30 NS055077, R01NS50414, R01 NS050414] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; COBBEN JM, 1995, AM J HUM GENET, V57, P805; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lin CS, 1999, DNA CELL BIOL, V18, P27, DOI 10.1089/104454999315592; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Munsat T, 1996, NEUROMUSCULAR DISORD, V6, P125, DOI 10.1016/0960-8966(95)00032-1; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Prior TW, 2004, AM J MED GENET A, V130A, P307, DOI 10.1002/ajmg.a.30251; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; RUDNIKSCHONEBORN S, 1994, AM J MED GENET, V51, P70, DOI 10.1002/ajmg.1320510115; Wang CH, 1996, HUM MOL GENET, V5, P359, DOI 10.1093/hmg/5.3.359; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	21	365	386	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					524	527		10.1126/science.1155085	http://dx.doi.org/10.1126/science.1155085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18440926	Green Accepted			2022-12-28	WOS:000255249300049
J	Noskoviak, K; Broome, E				Noskoviak, Kyle; Broome, Elizabeth			Babesiosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Noskoviak, Kyle; Broome, Elizabeth] Univ Calif San Diego, Med Ctr, San Diego, CA 92115 USA	University of California System; University of California San Diego	Noskoviak, K (corresponding author), Univ Calif San Diego, Med Ctr, San Diego, CA 92115 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					E19	E19		10.1056/NEJMicm070903	http://dx.doi.org/10.1056/NEJMicm070903			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434647				2022-12-28	WOS:000255209200011
J	Ajani, AE; Lefkovits, J				Ajani, Andrew E.; Lefkovits, Jeffrey			Approaching an age of reason with antiplatelet therapy	LANCET			English	Editorial Material							ACUTE CORONARY SYNDROMES; PLATELET INHIBITION; ACTIVE METABOLITE; DOSE CLOPIDOGREL; PRASUGREL; ASPIRIN; GREATER		[Ajani, Andrew E.; Lefkovits, Jeffrey] Royal Melbourne Hosp, Dept Cardiol, Parkville, Vic 3050, Australia	Royal Melbourne Hospital	Ajani, AE (corresponding author), Royal Melbourne Hosp, Dept Cardiol, Parkville, Vic 3050, Australia.	andrew.ajani@mh.org.au						King Spencer B 3rd, 2008, J Am Coll Cardiol, V51, P172, DOI 10.1016/j.jacc.2007.10.002; Ndrepepa G, 2008, J AM COLL CARDIOL, V51, P690, DOI 10.1016/j.jacc.2007.10.040; Niitsu Y, 2005, SEMIN THROMB HEMOST, V31, P184, DOI 10.1055/s-2005-869524; Payne CD, 2007, J CARDIOVASC PHARM, V50, P555, DOI 10.1097/FJC.0b013e3181492209; Serebrulany VL, 2007, AM J CARDIOL, V99, P288, DOI 10.1016/j.amjcard.2006.07.091; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494	11	3	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 19	2008	371	9621					1315	1316		10.1016/S0140-6736(08)60573-5	http://dx.doi.org/10.1016/S0140-6736(08)60573-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424309				2022-12-28	WOS:000255208500006
J	Isken, O; Kim, YK; Hosoda, N; Mayeur, GL; Hershey, JWB; Maquat, LE				Isken, Olaf; Kim, Yoon Ki; Hosoda, Nao; Mayeur, Greg L.; Hershey, John W. B.; Maquat, Lynne E.			Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay	CELL			English	Article							EXON JUNCTION COMPLEX; MAMMALIAN-CELLS; SURVEILLANCE COMPLEX; GENOTOXIC STRESS; P-BODIES; PROTEIN; INITIATION; DEGRADATION; BINDING; YEAST	In mammalian cells, nonsense-mediated mRNA decay (NMD) generally requires that translation terminates sufficiently upstream of a post-splicing exon junction complex (EJC) during a pioneer round of translation. The subsequent binding of Upf1 to the EJC triggers Upf1 phosphorylation. We provide evidence that phospho-Upf1 functions after nonsense codon recognition during steps that involve the translation initiation factor eIF3 and mRNA decay factors. Phospho-Upf1 interacts directly with eIF3 and inhibits the eIF3-dependent conversion of 40S/Met-tRNAi(Met)/mRNA to translationally competent 80S/Met-tRNAi(Met)/mRNA initiation complexes to repress continued translation initiation. Consistent with phospho-Upf1 impairing eIF3 function, NMD fails to detectably target nonsense-containing transcripts that initiate translation independently of eIF3 from the CrPV IRES. There is growing evidence that translational repression is a key transition that precedes mRNA delivery to the degradation machinery. Our results uncover a critical step during NMD that converts a pioneer translation initiation complex to a translationally compromised mRNP.	[Isken, Olaf; Kim, Yoon Ki; Hosoda, Nao; Maquat, Lynne E.] Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA; [Mayeur, Greg L.; Hershey, John W. B.] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA	University of Rochester; University of California System; University of California Davis	Maquat, LE (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075; Kim, Yoon Ki/0000-0003-1303-072X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074593, P01GM073732, R37GM074593] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM074593, GM074593, GM073732, P01 GM073732, R01 GM074593] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWNLUEDI ML, 1982, BIOCHEMISTRY-US, V21, P4202, DOI 10.1021/bi00261a002; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; BU X, 1993, J BIOL CHEM, V268, P4975; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DARNBROUGH C, 1972, BIOCHEM BIOPH RES CO, V48, P1556, DOI 10.1016/0006-291X(72)90891-1; DOUDNA JA, 2007, TRANSLATIONAL CONTRO, P129; Durand S, 2007, J CELL BIOL, V178, P1145, DOI 10.1083/jcb.200611086; ERNST H, 1987, J BIOL CHEM, V262, P1206; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holbrook JA, 2006, EMBO REP, V7, P722, DOI 10.1038/sj.embor.7400721; Hosoda N, 2006, MOL CELL BIOL, V26, P3085, DOI 10.1128/MCB.26.8.3085-3097.2006; Hosoda N, 2005, NAT STRUCT MOL BIOL, V12, P893, DOI 10.1038/nsmb995; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lejeune F, 2004, NAT STRUCT MOL BIOL, V11, P992, DOI 10.1038/nsmb824; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Matsuda D, 2007, NAT STRUCT MOL BIOL, V14, P974, DOI 10.1038/nsmb1297; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pestova TV, 2001, RNA, V7, P1496, DOI 10.1017/S135583820101038X; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Robertson MEM, 1999, RNA, V5, P1167, DOI 10.1017/S1355838299990301; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Stanley W M Jr, 1974, Methods Enzymol, V29, P530; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Woeller CF, 2008, EMBO REP, V9, P446, DOI 10.1038/embor.2008.36; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001	57	220	222	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					314	327		10.1016/j.cell.2008.02.030	http://dx.doi.org/10.1016/j.cell.2008.02.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423202	Bronze, Green Accepted			2022-12-28	WOS:000255052000020
J	Yang, L; Anderson, DE; Baecher-Allan, C; Hastings, WD; Bettelli, E; Oukka, M; Kuchroo, VK; Hafler, DA				Yang, Li; Anderson, David E.; Baecher-Allan, Clare; Hastings, William D.; Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.; Hafler, David A.			IL-21 and TGF-beta are required for differentiation of human T(H)17 cells	NATURE			English	Article							GROWTH-FACTOR-BETA; T-CELLS; GENERATION; PATHWAYS; LINEAGE; CONTEXT; IL-17	The recent discovery of CD4(+) T cells characterized by secretion of interleukin ( IL)- 17 (T(H)17 cells) and the naturally occurring regulatory FOXP3(+) CD4 T cell ( nT(reg)) has had a major impact on our understanding of immune processes not readily explained by the T(H)1/T(H)2 paradigm. T(H)17 and nT(reg) cells have been implicated in the pathogenesis of human autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and psoriasis(1,2). Our recent data and the work of others demonstrated that transforming growth factor-beta ( TGF-beta) and IL- 6 are responsible for the differentiation of naive mouse T cells into T(H)17 cells, and it has been proposed that IL-23 may have a critical role in stabilization of the T(H)17 phenotype(3-5). A second pathway has been discovered in which a combination of TGF-beta and IL- 21 is capable of inducing differentiation of mouse T(H)17 cells in the absence of IL- 6 ( refs 6 - 8). However, TGF-beta and IL- 6 are not capable of differentiating human T(H)17 cells(2,9) and it has been suggested that TGF-beta may in fact suppress the generation of human T(H)17 cells(10). Instead, it has been recently shown that the cytokines IL-1 beta, IL- 6 and IL- 23 are capable of driving IL- 17 secretion in short- term CD4(+) T cell lines isolated from human peripheral blood(11), although the factors required for differentiation of naive human CD4 to T(H)17 cells are still unknown. Here we confirm that whereas IL-1 beta and IL- 6 induce IL- 17A secretion from human central memory CD4(+) T cells, TGF-beta and IL- 21 uniquely promote the differentiation of human naive CD4(+) T cells into T(H)17 cells accompanied by expression of the transcription factor RORC2. These data will allow the investigation of this new population of T(H)17 cells in human inflammatory disease.	[Yang, Li; Anderson, David E.; Baecher-Allan, Clare; Hastings, William D.; Bettelli, Estelle; Oukka, Mohamed; Kuchroo, Vijay K.; Hafler, David A.] Harvard Univ, Sch Med, Div Mol Immunol, Ctr Neurol Dis,Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Anderson, DE (corresponding author), Harvard Univ, Sch Med, Div Mol Immunol, Ctr Neurol Dis,Brigham & Womens Hosp, Boston, MA 02115 USA.	danderson@rics.bwh.harvard.edu			NIAID NIH HHS [P01 AI039671-14, U19 AI070352, R01 AI073542, R01 AI073542-02, R01 AI073542-03, P01 AI039671, R01 AI073542-01, U19 AI070352-03] Funding Source: Medline; NINDS NIH HHS [R37 NS024247, P01 NS038037-080006, P01 NS038037, R37 NS024247-20] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070352, P01AI039671, R01AI073542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS024247, P01NS038037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Laurence A, 2007, NAT IMMUNOL, V8, P903, DOI 10.1038/ni0907-903; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wei L, 2007, J BIOL CHEM, V282, P34605, DOI 10.1074/jbc.M705100200; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	14	752	818	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 17	2008	454	7202					350	U55		10.1038/nature07021	http://dx.doi.org/10.1038/nature07021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326ND	18469800	Green Accepted			2022-12-28	WOS:000257665300042
J	Cai, CL; Martin, JC; Sun, YF; Cui, L; Wang, LC; Ouyang, K; Yang, L; Bu, L; Liang, XQ; Zhang, XX; Stallcup, WB; Denton, CP; McCulloch, A; Chen, J; Evans, SM				Cai, Chen-Leng; Martin, Jody C.; Sun, Yunfu; Cui, Li; Wang, Lianchun; Ouyang, Kunfu; Yang, Lei; Bu, Lei; Liang, Xingqun; Zhang, Xiaoxue; Stallcup, William B.; Denton, Christopher P.; McCulloch, Andrew; Chen, Ju; Evans, Sylvia M.			A myocardial lineage derives from Tbx18 epicardial cells	NATURE			English	Article							SMOOTH-MUSCLE-CELLS; PERICARDIAL MESODERM; HEART; POPULATION; EXPRESSION; MOUSE; DIFFERENTIATION; MORPHOGENESIS; MESOTHELIUM; SEPTUM	Understanding the origins and roles of cardiac progenitor cells is important for elucidating the pathogenesis of congenital and acquired heart diseases(1,2). Moreover, manipulation of cardiac myocyte progenitors has potential for cell- based repair strategies for various myocardial disorders(3). Here we report the identification in mouse of a previously unknown cardiac myocyte lineage that derives from the proepicardial organ. These progenitor cells, which express the T- box transcription factor Tbx18, migrate onto the outer cardiac surface to form the epicardium, and then make a substantial contribution to myocytes in the ventricular septum and the atrial and ventricular walls. Tbx18- expressing cardiac progenitors also give rise to cardiac fibroblasts and coronary smooth muscle cells. The pluripotency of Tbx18 proepicardial cells provides a theoretical framework for applying these progenitors to effect cardiac repair and regeneration.	[Cai, Chen-Leng; Sun, Yunfu; Cui, Li; Yang, Lei; Bu, Lei; Zhang, Xiaoxue; Evans, Sylvia M.] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA; [Martin, Jody C.; McCulloch, Andrew] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ouyang, Kunfu; Liang, Xingqun; Chen, Ju; Evans, Sylvia M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY 10029 USA; [Cai, Chen-Leng] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA; [Wang, Lianchun] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Stallcup, William B.] Burnham Inst, Dev Neurobiol Programme, La Jolla, CA 92037 USA; [Denton, Christopher P.] UCL Royal Free & Univ Coll Med Sch, Ctr Rheumatol, London NW3 2PF, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Georgia; University of Georgia; Sanford Burnham Prebys Medical Discovery Institute; University of London; University College London; UCL Medical School	Evans, SM (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA.	syevans@ucsd.edu	Evans, Sylvia/G-1980-2015; Yang, Lei/D-7462-2015; Chen, Ju/E-5579-2011; ouyang, kunfu/B-3073-2011	ouyang, kunfu/0000-0003-0292-375X; BU, LEI/0000-0003-4476-2157	NCRR NIH HHS [P41 RR005351] Funding Source: Medline; NHLBI NIH HHS [DP1 HL117649, R01 HL070867, T32 HL007444] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444, DP1HL117649, R01HL070867] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Franco D, 2006, DEV BIOL, V294, P366, DOI 10.1016/j.ydbio.2006.02.045; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Hadjantonakis AK, 2003, NAT REV GENET, V4, P613, DOI 10.1038/nrg1126; KELLY R, IN PRESS HEART DEV R; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kruithof BPT, 2006, DEV BIOL, V295, P507, DOI 10.1016/j.ydbio.2006.03.033; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Perez-Pomares JM, 2002, INT J DEV BIOL, V46, P1005; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Subramanian SV, 2002, CARDIOVASC RES, V54, P539, DOI 10.1016/S0008-6363(02)00270-5; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zheng B, 2002, AM J PATHOL, V160, P1609, DOI 10.1016/S0002-9440(10)61108-X; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	29	569	603	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 3	2008	454	7200					104	U4		10.1038/nature06969	http://dx.doi.org/10.1038/nature06969			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321MC	18480752	Green Accepted			2022-12-28	WOS:000257308300046
J	Aveyard, P; Johnson, C; Fillingham, S; Parsons, A; Murphy, M				Aveyard, Paul; Johnson, Carol; Fillingham, Sally; Parsons, Amanda; Murphy, Mike			Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WITHDRAWAL; SYMPTOMS; DEPENDENCE; ABSTINENCE; THERAPY; TOBACCO	Objective To test the efficacy of nortriptyline plus nicotine replacement therapy compared with placebo plus nicotine replacement therapy for smoking cessation. Design Pragmatic randomised controlled trial. Setting National Health Service stop smoking service clinics. Participants 901 people trying to stop smoking. Interventions Participants chose their nicotine replacement product, including combinations of nicotine replacement therapy, and received behavioural support. Nortriptyline was started one to two weeks before quit day, with the dose increased from 25 mg to 75 mg daily for eight weeks and reduced if not tolerated. Main outcome measures Primary outcome was prolonged confirmed abstinence at six months. Secondary outcomes were prolonged abstinence at 12 months, drug use, severity of side effects, nicotine withdrawal symptoms, and urges to smoke. Results 72 of 445 (16%) people using nortriptyline and 55 of 456 (12%) using placebo achieved prolonged abstinence at six months (relative risk 1.34, 95% confidence interval 0.97 to 1.86). At 12 months the corresponding values were 49 (11%) for nortriptyline and 40 (9%) for placebo (1.26, 0.84 to 1.87). 337 (79%) people in the nortriptyline arm and 325 (75%) in the placebo arm were taking combination treatment on quit day, median 75 mg per day in both groups. More people in the nortriptyline arm than in the placebo arm took lower doses. The nortriptyline arm had noticeably higher severity ratings for dry mouth and constipation than the placebo arm, with slightly higher ratings for sweating and feeling shaky. Both groups had similar urges to smoke, but nortriptyline reduced depression and anxiety. Overall, withdrawal symptom scores did not differ. Conclusions Nortriptyline and nicotine replacement therapy are both effective for smoking cessation but the effect of the combination is less than the sum of the parts and there is no evidence that combination treatment is more effective than either alone. Trial registration Current Controlled Trials.	[Aveyard, Paul; Fillingham, Sally; Parsons, Amanda] Univ Birmingham, Div Primary Care & Publ Hlth, Birmingham B15 2TT, W Midlands, England; [Johnson, Carol] Univ Birmingham, Sch Hlth Sci, Birmingham B15 2TT, W Midlands, England; [Murphy, Mike] Univ Oxford, Childhood Canc Res Grp, Oxford OX1 2JD, England	University of Birmingham; University of Birmingham; University of Oxford	Aveyard, P (corresponding author), Univ Birmingham, Div Primary Care & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	p.n.aveyard@bham.ac.uk		Aveyard, Paul/0000-0002-1802-4217	Cancer Research UK Funding Source: Medline; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aveyard P, 2007, THORAX, V62, P898, DOI 10.1136/thx.2006.071837; CAHILL K, 2007, COCHRANE DB SYST REV; CAHILL K, 2007, COCHRANE DB SYST REV; Covey LS, 2002, AM J PSYCHIAT, V159, P1731, DOI 10.1176/appi.ajp.159.10.1731; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Cryan JF, 2003, DRUG DISCOV TODAY, V8, P1025, DOI 10.1016/S1359-6446(03)02890-3; HAJEK P, 1989, BRIT J ADDICT, V84, P591; Hall SM, 2004, AM J PSYCHIAT, V161, P2100, DOI 10.1176/appi.ajp.161.11.2100; Hall SM, 1998, ARCH GEN PSYCHIAT, V55, P683, DOI 10.1001/archpsyc.55.8.683; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Prochazka AV, 2004, ARCH INTERN MED, V164, P2229, DOI 10.1001/archinte.164.20.2229; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Shiffman S, 2004, NICOTINE TOB RES, V6, P599, DOI 10.1080/14622200410001734067; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; STEAD LF, 2008, COCHRANE DB SYST REV; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2004, PSYCHOPHARMACOLOGY, V177, P195, DOI 10.1007/s00213-004-1923-6; West R, 2002, ADDICTION, V97, P501, DOI 10.1046/j.1360-0443.2002.00104.x; West R, 2001, PSYCHOPHARMACOLOGY, V155, P115, DOI 10.1007/s002130100712	22	38	39	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2008	336	7655					1223	+		10.1136/bmj.39545.852616.BE	http://dx.doi.org/10.1136/bmj.39545.852616.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311PS	18441375	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000256612700029
J	Dinneny, JR; Long, TA; Wang, JY; Jung, JW; Mace, D; Pointer, S; Barron, C; Brady, SM; Schiefelbein, J; Benfey, PN				Dinneny, Jose R.; Long, Terri A.; Wang, Jean Y.; Jung, Jee W.; Mace, Daniel; Pointer, Solomon; Barron, Christa; Brady, Siobhan M.; Schiefelbein, John; Benfey, Philip N.			Cell identity mediates the response of Arabidopsis roots to abiotic stress	SCIENCE			English	Article							TRANSCRIPTION FACTOR EXPRESSION; GENE-EXPRESSION; HAIR DEVELOPMENT; LOW-TEMPERATURE; SALT STRESS; THALIANA; DROUGHT; GROWTH; PLANTS; IRON	Little is known about the way developmental cues affect how cells interpret their environment. We characterized the transcriptional response to high salinity of different cell layers and developmental stages of the Arabidopsis root and found that transcriptional responses are highly constrained by developmental parameters. These transcriptional changes lead to the differential regulation of specific biological functions in subsets of cell layers, several of which correspond to observable physiological changes. We showed that known stress pathways primarily control semiubiquitous responses and used mutants that disrupt epidermal patterning to reveal cell-layer-specific and inter-cell-layer effects. By performing a similar analysis using iron deprivation, we identified common cell-type-specific stress responses and revealed the crucial role the environment plays in defining the transcriptional outcome of cell-fate decisions.	[Dinneny, Jose R.; Long, Terri A.; Wang, Jean Y.; Jung, Jee W.; Pointer, Solomon; Brady, Siobhan M.; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Mace, Daniel; Benfey, Philip N.] Duke Univ, Inst Genome Sci, Durham, NC 27708 USA; [Mace, Daniel; Benfey, Philip N.] Duke Univ, Policy Ctr Syst Biol, Durham, NC 27708 USA; [Barron, Christa; Schiefelbein, John] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	Duke University; Duke University; Duke University; University of Michigan System; University of Michigan	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Brady, Siobhan/AAY-1729-2021; Dinneny, Jose/J-8312-2012; Long, Terri/AAA-1984-2020	Dinneny, Jose/0000-0002-3998-724X; Brady, Siobhan/0000-0001-9424-8055; Long, Terri/0000-0001-7846-0195				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao YQ, 2001, PLANT J, V28, P145, DOI 10.1046/j.1365-313X.2001.01142.x; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Burssens S, 2000, PLANTA, V211, P632, DOI 10.1007/s004250000334; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Halperin SJ, 2003, J EXP BOT, V54, P1269, DOI 10.1093/jxb/erg134; Jones MA, 2006, PLANT J, V45, P83, DOI 10.1111/j.1365-313X.2005.02609.x; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kwak SH, 2005, SCIENCE, V307, P1111, DOI 10.1126/science.1105373; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Ma SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r49; Mace DL, 2006, BIOINFORMATICS, V22, pE323, DOI 10.1093/bioinformatics/btl228; MARCOTTE WR, 1989, PLANT CELL, V1, P969, DOI 10.2307/3868997; Muller M, 2004, PLANT PHYSIOL, V134, P409, DOI 10.1104/pp.103.029066; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; Nambara E, 1998, PLANT CELL PHYSIOL, V39, P853, DOI 10.1093/oxfordjournals.pcp.a029444; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Pagant S, 2002, PLANT CELL, V14, P2001, DOI 10.1105/tpc.002873; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schellmann S, 2002, EMBO J, V21, P5036, DOI 10.1093/emboj/cdf524; SCHERES B, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0101; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Wang HY, 2007, PLANTA, V226, P897, DOI 10.1007/s00425-007-0535-x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251	34	522	537	5	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					942	945		10.1126/science.1153795	http://dx.doi.org/10.1126/science.1153795			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18436742				2022-12-28	WOS:000255868300045
J	Schoffler, MS; Titze, J; Petridis, N; Jahnke, T; Cole, K; Schmidt, LPH; Czasch, A; Akoury, D; Jagutzki, O; Williams, JB; Cherepkov, NA; Semenov, SK; McCurdy, CW; Rescigno, TN; Cocke, CL; Osipov, T; Lee, S; Prior, MH; Belkacem, A; Landers, AL; Schmidt-Bocking, H; Weber, T; Dorner, R				Schoeffler, M. S.; Titze, J.; Petridis, N.; Jahnke, T.; Cole, K.; Schmidt, L. Ph. H.; Czasch, A.; Akoury, D.; Jagutzki, O.; Williams, J. B.; Cherepkov, N. A.; Semenov, S. K.; McCurdy, C. W.; Rescigno, T. N.; Cocke, C. L.; Osipov, T.; Lee, S.; Prior, M. H.; Belkacem, A.; Landers, A. L.; Schmidt-Boecking, H.; Weber, Th.; Doerner, R.			Ultrafast probing of core hole localization in N-2	SCIENCE			English	Article							MOMENTUM SPECTROSCOPY; SYMMETRY-BREAKING; ANGULAR-DISTRIBUTIONS; RECOIL-ION; PHOTOIONIZATION; SPECTRUM; SHELL; DECAY	Although valence electrons are clearly delocalized in molecular bonding frameworks, chemists and physicists have long debated the question of whether the core vacancy created in a homonuclear diatomic molecule by absorption of a single x-ray photon is localized on one atom or delocalized over both. We have been able to clarify this question with an experiment that uses Auger electron angular emission patterns from molecular nitrogen after inner-shell ionization as an ultrafast probe of hole localization. The experiment, along with the accompanying theory, shows that observation of symmetry breaking (localization) or preservation (delocalization) depends on how the quantum entangled Bell state created by Auger decay is detected by the measurement.	[Schoeffler, M. S.; Titze, J.; Petridis, N.; Jahnke, T.; Cole, K.; Schmidt, L. Ph. H.; Czasch, A.; Akoury, D.; Jagutzki, O.; Schmidt-Boecking, H.; Doerner, R.] Goethe Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany; [Akoury, D.; McCurdy, C. W.; Rescigno, T. N.; Osipov, T.; Lee, S.; Prior, M. H.; Belkacem, A.; Weber, Th.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Williams, J. B.; Landers, A. L.] Auburn Univ, Dept Phys, Auburn, AL 36849 USA; [Cherepkov, N. A.; Semenov, S. K.] State Univ Aerosp Instrumentat, St Petersburg 190000, Russia; [Cocke, C. L.] Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA	Goethe University Frankfurt; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Auburn University System; Auburn University; Saint Petersburg State University of Aerospace Instrumentation; Kansas State University	Schoffler, MS (corresponding author), Goethe Univ Frankfurt, Inst Kernphys, Max von Laue Str 1, D-60438 Frankfurt, Germany.	schoeffler@atom.uni-frankfurt.de	Jahnke, Till/AGE-4901-2022; Landers, Allen/C-1213-2013; MCCURDY, CLYDE/GRE-7874-2022; Doerner, Reinhard/A-5340-2008; Weber, Thorsten/K-2586-2013; Schoeffler, Markus S/B-6261-2008	Doerner, Reinhard/0000-0002-3728-4268; Weber, Thorsten/0000-0003-3756-2704; Schoeffler, Markus S/0000-0001-9214-6848				Adachi J, 2007, J PHYS B-AT MOL OPT, V40, pF285, DOI 10.1088/0953-4075/40/20/F01; BAGUS PS, 1972, J CHEM PHYS, V56, P224, DOI 10.1063/1.1676850; Bjorneholm O, 2000, PHYS REV LETT, V84, P2826, DOI 10.1103/PhysRevLett.84.2826; CEDERBAUM LS, 1977, J CHEM PHYS, V66, P5084, DOI 10.1063/1.433763; DILL D, 1978, PHYS REV LETT, V41, P1230, DOI 10.1103/PhysRevLett.41.1230; DOMCKE W, 1977, CHEM PHYS, V25, P189, DOI 10.1016/0301-0104(77)87075-4; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; Ehara M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181144; GADEA FX, 1991, PHYS REV LETT, V66, P883, DOI 10.1103/PhysRevLett.66.883; Gagnon E, 2007, SCIENCE, V317, P1374, DOI 10.1126/science.1144920; Hattass M, 2004, REV SCI INSTRUM, V75, P2373, DOI 10.1063/1.1765764; Hergenhahn U, 2001, J PHYS CHEM A, V105, P5704, DOI 10.1021/jp0038456; Jagutzki O, 2002, NUCL INSTRUM METH A, V477, P244, DOI 10.1016/S0168-9002(01)01839-3; Jahnke T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.073002; KINTOP JA, 1991, PHYS REV A, V43, P3348, DOI 10.1103/PhysRevA.43.3348; Kivimaki A, 1997, PHYS REV LETT, V79, P998, DOI 10.1103/PhysRevLett.79.998; Kosugi N, 2003, CHEM PHYS, V289, P117, DOI 10.1016/S0301-0104(02)00791-7; Lundqvist M, 1996, J PHYS B-AT MOL OPT, V29, P1489, DOI 10.1088/0953-4075/29/8/013; Malinovskaya SA, 2000, INT J QUANTUM CHEM, V80, P950, DOI 10.1002/1097-461X(2000)80:4/5<950::AID-QUA44>3.0.CO;2-G; Martin F, 2007, SCIENCE, V315, P629, DOI 10.1126/science.1136598; Rolles D, 2005, NATURE, V437, P711, DOI 10.1038/nature04040; Schumann FO, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.257604; Semenov SK, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032707; Semenov SK, 2004, J PHYS B-AT MOL OPT, V37, P1331, DOI 10.1088/0953-4075/37/6/015; SHIGEMASA E, 1995, PHYS REV LETT, V74, P359, DOI 10.1103/PhysRevLett.74.359; SNYDER LC, 1971, J CHEM PHYS, V55, P95, DOI 10.1063/1.1675565; STANTON JF, 1992, J CHEM PHYS, V97, P5554, DOI 10.1063/1.463762; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Weber T, 2001, J PHYS B-AT MOL OPT, V34, P3669, DOI 10.1088/0953-4075/34/18/305; Werner WSM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.038302; ZAHRINGER K, 1992, PHYS REV A, V45, P318, DOI 10.1103/PhysRevA.45.318; Zare R. N., 1972, MOL PHOTOCHEM, V4, P1	32	147	147	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					920	923		10.1126/science.1154989	http://dx.doi.org/10.1126/science.1154989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487190				2022-12-28	WOS:000255868300039
J	Uren, AG; Kool, J; Matentzoglu, K; de Ridder, J; Mattison, J; van Uitert, M; Lagcher, W; Sie, D; Tanger, E; Cox, T; Reinders, M; Hubbard, TJ; Rogers, J; Jonkers, J; Wessels, L; Adams, DJ; van Lohuizen, M; Berns, A				Uren, Anthony G.; Kool, Jaap; Matentzoglu, Konstantin; de Ridder, Jeroen; Mattison, Jenny; van Uitert, Miranda; Lagcher, Wendy; Sie, Daoud; Tanger, Ellen; Cox, Tony; Reinders, Marcel; Hubbard, Tim J.; Rogers, Jane; Jonkers, Jos; Wessels, Lodewyk; Adams, David J.; van Lohuizen, Maarten; Berns, Anton			Large-scale mutagenesis in p19(ARF)- and p53- Deficient mice identifies cancer genes and their collaborative networks	CELL			English	Article							RETROVIRAL INSERTIONAL MUTAGENESIS; TUMOR-SUPPRESSOR GENE; T-CELL LYMPHOMAGENESIS; TRANSCRIPTION FACTOR; HUMAN BREAST; LEUKEMIA; PATHWAY; P53; MUTATIONS; DEFICIENT	p53 and p19 ARF are tumor suppressors frequently mutated in human tumors. In a high- throughput screen in mice for mutations collaborating with either p53 or p19(ARF) deficiency, we identified 10,806 retroviral insertion sites, implicating over 300 loci in tumorigenesis. This dataset reveals 20 genes that are specifically mutated in either p19(ARF)-deficient, p53-deficient or wildtype mice ( including Flt3, mmu-mir-106a-363, Smg6, and Ccnd3), as well as networks of significant collaborative and mutually exclusive interactions between cancergenes. Furthermore, we found candidate tumor suppressor genes, as well as distinct clusters of insertions within genes like Flt3 and Notch1 that induce mutants with different spectra of genetic interactions. Cross species comparative analysis with aCGH data of human cancer cell lines revealed known and candidate oncogenes ( Mmp13, Slamf6, and Rreb1) and tumor suppressors ( Wwox and Arfrp2). This dataset should prove to be a rich resource for the study of genetic interactions that underlie tumorigenesis.	[de Ridder, Jeroen; van Uitert, Miranda; Jonkers, Jos; Wessels, Lodewyk] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Uren, Anthony G.; Kool, Jaap; Matentzoglu, Konstantin; Lagcher, Wendy; Tanger, Ellen; van Lohuizen, Maarten; Berns, Anton] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Uren, Anthony G.; Kool, Jaap; Matentzoglu, Konstantin; Lagcher, Wendy; Tanger, Ellen; van Lohuizen, Maarten; Berns, Anton] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [de Ridder, Jeroen; Reinders, Marcel; Wessels, Lodewyk] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands; [Mattison, Jenny; Cox, Tony; Rogers, Jane; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Sie, Daoud] Netherlands Canc Inst, Cent Microarray Facil, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology; Wellcome Trust Sanger Institute; Netherlands Cancer Institute	Wessels, L (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	l.wessels@nki.nl; da1@sanger.ac.uk; m.v.lohuizen@nki.nl; a.berns@nki.nl	Hubbard, Tim J.P./AAT-4571-2020; Hubbard, Tim J/C-2567-2008; Uren, Anthony G/A-5784-2009; Jonkers, Jos/AAG-3246-2019	Hubbard, Tim J.P./0000-0002-1767-9318; Hubbard, Tim J/0000-0002-1767-9318; Uren, Anthony G/0000-0002-6019-7111; Jonkers, Jos/0000-0002-9264-9792; de Ridder, Jeroen/0000-0002-0828-3477; Adams, David/0000-0001-9490-0306; Sie, Daoud/0000-0001-6762-2582	Cancer Research UK Funding Source: Medline; Wellcome Trust [76943, 077198] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Beverly LJ, 2003, CANCER CELL, V3, P551, DOI 10.1016/S1535-6108(03)00137-5; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; CUYPERS HT, 1984, CELL, V37, P141; Dave UP, 2004, SCIENCE, V303, P333, DOI 10.1126/science.1091667; DAVID YB, 1988, ONCOGENE, V3, P179; de Ridder J, 2007, BIOINFORMATICS, V23, pI133, DOI 10.1093/bioinformatics/btm202; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ebinu JO, 2000, BLOOD, V95, P3199; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Frank B, 2005, NEW ENGL J MED, V353, P313; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Glud SZ, 2005, BLOOD, V106, P3546, DOI 10.1182/blood-2005-02-0493; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kelly-Spratt KS, 2004, PLOS BIOL, V2, P1138, DOI 10.1371/journal.pbio.0020242; Kim AC, 1997, GENOMICS, V46, P291, DOI 10.1006/geno.1997.5029; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lee H, 2005, MOL CARCINOGEN, V44, P219, DOI 10.1002/mc.20136; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li GC, 1998, MOL CELL, V2, P1, DOI 10.1016/S1097-2765(00)80108-2; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Moore L, 2003, ONCOGENE, V22, P7831, DOI 10.1038/sj.onc.1206985; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Sharma VM, 2007, CELL CYCLE, V6, P927, DOI 10.4161/cc.6.8.4134; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slape C, 2007, CANCER RES, V67, P5148, DOI 10.1158/0008-5472.CAN-07-0075; Stewart M, 2007, CANCER RES, V67, P5126, DOI 10.1158/0008-5472.CAN-07-0433; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; SYCH F, 1978, CANC RES CLIN ONCOL, V92, P105; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	66	151	154	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					727	741		10.1016/j.cell.2008.03.021	http://dx.doi.org/10.1016/j.cell.2008.03.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485879	hybrid, Green Published			2022-12-28	WOS:000255903300026
J	Fauci, AS				Fauci, Anthony S.			25 years of HIV	NATURE			English	Editorial Material							AIDS		NIAID, NIH, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.		Franzeck, Fabian C/B-5055-2011					[Anonymous], AIDS EP UPD DEC 2007; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Gallo RC, 2003, NEW ENGL J MED, V349, P2283, DOI 10.1056/NEJMp038194; Kasper DL, 2008, HARRISONS PRINCIPLES, Vseventeenth, P1137; LEVY JA, 2002, HIV PATHOGENESIS AID	6	69	79	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					289	290		10.1038/453289a	http://dx.doi.org/10.1038/453289a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480799	Bronze			2022-12-28	WOS:000255868400026
J	Spencer, TJ; Osborn, T; Kohl, PA				Spencer, Todd J.; Osborn, Tyler; Kohl, Paul A.			Materials science - High-frequency chip connections	SCIENCE			English	Editorial Material									[Spencer, Todd J.; Osborn, Tyler; Kohl, Paul A.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Spencer, TJ (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	kohl@gatech.edu						[Anonymous], 2007, INT TECHNOLOGY ROADM; Cho H, 2008, IEEE ELECTR DEVICE L, V29, P122, DOI 10.1109/LED.2007.911617; Choi ZS, 2007, J APPL PHYS, V102, DOI 10.1063/1.2795663; Gaylord TK, 2007, APPL OPTICS, V46, P6476, DOI 10.1364/AO.46.006476; Kim TH, 2003, J VAC SCI TECHNOL A, V21, P449, DOI 10.1116/1.1537716; Li BZ, 2004, MICROELECTRON RELIAB, V44, P365, DOI 10.1016/j.microrel.2003.11.004; Osborn T, 2008, J ELECTROCHEM SOC, V155, pD308, DOI 10.1149/1.2839007; Spencer TJ, 2007, IEEE T MICROW THEORY, V55, P1919, DOI 10.1109/TMTT.2007.904326	8	20	20	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					756	757		10.1126/science.1157129	http://dx.doi.org/10.1126/science.1157129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467580				2022-12-28	WOS:000255644400028
J	Krueger, AB; Stone, AA				Krueger, Alan B.; Stone, Arthur A.			Assessment of pain: a community-based diary survey in the USA	LANCET			English	Article							CHRONIC MUSCULOSKELETAL PAIN; GENERAL-POPULATION; PREVALENCE; HEALTH	Background Pain is costly and a major reason for seeking medical care. Our aim was to assess the proportion of people experiencing pain, and the severity of pain, at randomly selected times in a representative sample of individuals in the USA. Methods A community-based telephone survey was designed that attempted to contact about 10 700 individuals by random-digit dialling. After collecting diary information for one 24-h period, ratings of pain on a 0-6 anchored scale for three randomly selected 15-min intervals of the day were obtained. Outcome measures were the proportion of intervals with non-zero pain, the proportion of intervals with pain above 3 (the scale midpoint), and the average pain rating. Activities of those individuals who reported substantial pain were also examined. To make the results representative of the US population, sample data were adjusted with sample weights developed by the Gallup Organisation. Findings 3982 individuals were interviewed (response rate 37%). After adjustment for weighting, 28.8% of men and 26.6% of women reported feeling some pain at sampled times. Those with lower income or less education spent a higher proportion of time in pain and reported higher average pain than did those with higher income or more education. The average pain rating increased with age, although it reached a plateau between the ages of about 45 years and 75 years, with little difference between men and women. Satisfaction with life or health and the pain indicators tended to move in opposite directions. Interpretation The diary-survey methods described here could be used to study pain at the population level, and will enable the combination of pain assessments with information about activities of daily living. Funding US National Institute of Aging, Hewlett Foundation.	[Krueger, Alan B.] Princeton Univ, Dept Econ, Princeton, NJ 08540 USA; [Krueger, Alan B.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08540 USA; [Stone, Arthur A.] SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA	Princeton University; Princeton University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Krueger, AB (corresponding author), Princeton Univ, Dept Econ, Robertson Hall,Prospect Ave, Princeton, NJ 08540 USA.	akrueger@princeton.edu	Stone, Arthur A./AAC-3610-2019		NIA NIH HHS [P30 AG024928] Funding Source: Medline; NICHD NIH HHS [R24 HD047879] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024928] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American Association for Public Opinion Research, 2006, STAND DEF FIN DISP C, V4th; Ashenfelter O. C., 1999, HDB LABOR EC C, V3, P3417, DOI DOI 10.1016/S1573-4463(99)30042-0; ATLAS S, 2007, ED DISABILITY PREVAL; *BEH RISK SURV SYS, SUMM DAT QUAL REP 20; BRADBURN NM, 1987, SCIENCE, V236, P157, DOI 10.1126/science.3563494; Buskila D, 2000, J RHEUMATOL, V27, P1521; Catala E, 2002, EUR J PAIN-LONDON, V6, P133, DOI 10.1053/eujp.2001.0310; *CDCP, 2006, HLTH US 2006 CHARTB, P68; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Gerdle B, 2004, J RHEUMATOL, V31, P1399; Gorin AA, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P405; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; KAPTEYN A, 2006, DYNAMICS WORK DISABI; Litcher-Kelly L, 2007, J PAIN, V8, P906, DOI 10.1016/j.jpain.2007.06.009; MAGNI G, 1990, PAIN, V43, P299, DOI 10.1016/0304-3959(90)90027-B; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; SMITH JP, 1993, J ECON PERSPECT, V13, P145; STAGNITTI M, 2004, TOP 5 THERAPEUTIC CL; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; TURUNEN J, THESIS U KUOPIO FINL; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1; VONKORFF M, 1990, PAIN, V40, P279, DOI 10.1016/0304-3959(90)91125-3; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; 2007, CHAIN DRUG REV, V29, P62	27	92	92	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1519	1525		10.1016/S0140-6736(08)60656-X	http://dx.doi.org/10.1016/S0140-6736(08)60656-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456101	Green Submitted			2022-12-28	WOS:000255668300028
J	Diaz, J; Ingall, E; Benitez-Nelson, C; Paterson, D; de Jonge, MD; McNulty, I; Brandes, JA				Diaz, Julia; Ingall, Ellery; Benitez-Nelson, Claudia; Paterson, David; de Jonge, Martin D.; McNulty, Ian; Brandes, Jay A.			Marine polyphosphate: A key player in geologic phosphorus sequestration	SCIENCE			English	Article							SEDIMENTS; FLUXES; WATERS; CARBON	The in situ or authigenic formation of calcium phosphate minerals in marine sediments is a major sink for the vital nutrient phosphorus. However, because typical sediment chemistry is not kinetically conducive to the precipitation of these minerals, the mechanism behind their formation has remained a fundamental mystery. Here, we present evidence from high- sensitivity x- ray and electrodialysis techniques to describe a mechanism by which abundant diatom- derived polyphosphates play a critical role in the formation of calcium phosphate minerals in marine sediments. This mechanism can explain the puzzlingly dispersed distribution of calcium phosphate minerals observed in marine sediments worldwide.	[Diaz, Julia; Ingall, Ellery] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Benitez-Nelson, Claudia] Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA; [Benitez-Nelson, Claudia] Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA; [Paterson, David; de Jonge, Martin D.; McNulty, Ian] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Brandes, Jay A.] Skidaway Inst Oceanog, Savannah, GA 31411 USA	University System of Georgia; Georgia Institute of Technology; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; United States Department of Energy (DOE); Argonne National Laboratory; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography	Ingall, E (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	ingall@eas.gatech.edu	de Jonge, Martin D/C-3400-2011; Ingall, Ellery/A-5447-2008	de Jonge, Martin D/0000-0001-7731-6175; Ingall, Ellery/0000-0003-1954-0317; Benitez-Nelson, Claudia/0000-0002-1004-5048				AIGEO TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Brandes JA, 2007, MAR CHEM, V103, P250, DOI 10.1016/j.marchem.2006.09.004; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Clark LL, 1999, AM J SCI, V299, P724, DOI 10.2475/ajs.299.7-9.724; KARL DM, 2002, BIOGEOCHEMISTRY MARI, pCH6; Katz ME, 2004, ANNU REV ECOL EVOL S, V35, P523, DOI 10.1146/annurev.ecolsys.35.112202.130137; Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309; Lawerence BA, 1998, ARCH MICROBIOL, V169, P195, DOI 10.1007/s002030050560; Louanchi F, 2001, DEEP-SEA RES PT I, V48, P1581, DOI 10.1016/S0967-0637(00)00086-8; Mateo P, 2006, J PHYCOL, V42, P61, DOI 10.1111/j.1529-8817.2006.00180.x; MIYATA K, 1986, MAR BIOL, V93, P291, DOI 10.1007/BF00508266; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; Sannigrahi P, 2005, GEOCHEM T, V6, P52, DOI [10.1063/1.1946447, 10.1186/1467-4866-6-52]; Sannigrahi P, 2006, GEOCHIM COSMOCHIM AC, V70, P5868, DOI 10.1016/j.gca.2006.08.037; Schulz HN, 2005, SCIENCE, V307, P416, DOI 10.1126/science.1103096; SOLORZAN.L, 1968, LIMNOL OCEANOGR, V13, P515, DOI 10.4319/lo.1968.13.3.0515; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; VANCAPPELLEN P, 1991, GEOCHIM COSMOCHIM AC, V55, P1219; Vetter TA, 2007, SEP PURIF TECHNOL, V56, P383, DOI 10.1016/j.seppur.2007.04.012	25	187	193	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					652	655		10.1126/science.1151751	http://dx.doi.org/10.1126/science.1151751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451299				2022-12-28	WOS:000255454300042
J	Varjosalo, M; Bjorklund, M; Cheng, F; Syvanen, H; Kivioja, T; Kilpinen, S; Sun, Z; Kallioniemi, O; Stunnenberg, HG; He, WW; Ojala, P; Taipale, J				Varjosalo, Markku; Bjorklund, Mikael; Cheng, Fang; Syvanen, Heidi; Kivioja, Teemu; Kilpinen, Sami; Sun, Zairen; Kallioniemi, Olli; Stunnenberg, Hendrik G.; He, Wei-Wu; Ojala, Paivi; Taipale, Jussi			Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling	CELL			English	Article							PROTEIN-KINASE; KAPOSIS-SARCOMA; TRANSCRIPTIONAL ACTIVITY; CUBITUS INTERRUPTUS; DNA-SEQUENCES; HUMAN GENOME; MEK KINASE; 1 GENE; ACTIVATION; PATHWAY	To allow genome-scale identification of genes that regulate cellular signaling, we cloned > 90% of all human full-length protein kinase cDNAs and constructed the corresponding kinase activity-deficient mutants. To establish the utility of this resource, we tested the effect of expression of the kinases on three different cellular signaling models. In all screens, many kinases had a modest but significant effect, apparently due to crosstalk between signaling pathways. However, the strongest effects were found with known regulators and novel components, such as MAP3K10 and DYRK2, which we identified in a mammalian Hedgehog (Hh) signaling screen. DYRK2 directly phosphorylated and induced the proteasome-dependent degradation of the key Hh pathway-regulated transcription factor, GLI2. MAP3K10, in turn, affected GLI2 indirectly by modulating the activity of DYRK2 and the known Hh pathway component, GSK3b. Our results establish kinome expression screening as a highly effective way to identify physiological signaling pathway components and genes involved in pathological signaling crosstalk.	[Varjosalo, Markku; Bjorklund, Mikael; Cheng, Fang; Syvanen, Heidi; Kivioja, Teemu; Kilpinen, Sami; Kallioniemi, Olli; Ojala, Paivi; Taipale, Jussi] Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Genome Scale Biol Program, FI-00014 Helsinki, Finland; [Varjosalo, Markku; Bjorklund, Mikael; Syvanen, Heidi; Kivioja, Teemu; Taipale, Jussi] Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; [Varjosalo, Markku; Bjorklund, Mikael; Syvanen, Heidi; Taipale, Jussi] Univ Helsinki, High Throughput Ctr, FI-00014 Helsinki, Finland; [Kivioja, Teemu] Univ Helsinki, Dept Comp Sci, FI-00014 Helsinki, Finland; [Kilpinen, Sami; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Ctr Med Biotechnol, FI-20520 Turku, Finland; [Kilpinen, Sami; Kallioniemi, Olli] Univ Turku, FI-20520 Turku, Finland; [He, Wei-Wu] OriGene Technol Inc, Rockville, MD 20850 USA; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; VTT Technical Research Center Finland; University of Turku; Radboud University Nijmegen	Ojala, P (corresponding author), Univ Helsinki, Inst Biomed, Biomedicum Helsinki, Genome Scale Biol Program, POB 63, FI-00014 Helsinki, Finland.	paivi.ojala@helsinki.fi; jussi.taipale@helsinki.fi	Kallioniemi, Olli P/H-5111-2011; Varjosalo, Markku/K-6424-2015; Björklund, Mikael/D-3362-2009; Ojala, Paivi M/J-3266-2014; Stunnenberg, Hendrik G./D-6875-2012; Bjorklund, Mikael/AAA-2894-2020	Kallioniemi, Olli P/0000-0002-3231-0332; Varjosalo, Markku/0000-0002-1340-9732; Björklund, Mikael/0000-0002-2176-681X; Stunnenberg, Hendrik G./0000-0002-0066-1576; Kilpinen, Sami/0000-0003-3444-2539; Ojala, Paivi/0000-0001-9065-1832				Akbarzadeh S, 2002, J BIOL CHEM, V277, P36280, DOI 10.1074/jbc.M204626200; Bajaj BG, 2006, VIROLOGY, V351, P18, DOI 10.1016/j.virol.2006.03.037; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2005, MOL CELL BIOL, V25, P7042, DOI 10.1128/MCB.25.16.7042-7053.2005; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hall DA, 2007, MECH AGEING DEV, V128, P161, DOI 10.1016/j.mad.2006.11.021; Hayward S Diane, 2006, Sci STKE, V2006, pre4; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacob J, 2003, EMBO REP, V4, P761, DOI 10.1038/sj.embor.embor896; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; Lee FS, 1997, CELL, V88, P213, DOI 10.1016/S0092-8674(00)81842-5; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; MENDENHALL MD, 1988, P NATL ACAD SCI USA, V85, P4426, DOI 10.1073/pnas.85.12.4426; Merchant M, 2005, MOL CELL BIOL, V25, P7054, DOI 10.1128/MCB.25.16.7054-7068.2005; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nishi Y, 2005, DEV BIOL, V288, P139, DOI 10.1016/j.ydbio.2005.09.053; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rainio EM, 2005, VIROLOGY, V333, P201, DOI 10.1016/j.virol.2005.01.001; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Varjosalo M, 2007, J CELL SCI, V120, P3, DOI 10.1242/jcs.03309; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; YAN MH, 1994, NATURE, V372, P798; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhou QH, 2006, GENETICS, V173, P2049, DOI 10.1534/genetics.106.061036	53	140	150	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					537	548		10.1016/j.cell.2008.02.047	http://dx.doi.org/10.1016/j.cell.2008.02.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455992	Bronze			2022-12-28	WOS:000255503900023
J	Althabe, F; Buekens, P; Bergel, E; Belizan, JM; Campbell, MK; Moss, N; Hartwell, T; Wright, LL				Althabe, Fernando; Buekens, Pierre; Bergel, Eduardo; Belizan, Jose M.; Campbell, Marci K.; Moss, Nancy; Hartwell, Tyler; Wright, Linda L.		Guidelines Trial Grp	A behavioral intervention to improve obstetrical care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							3RD STAGE; IMPLEMENTATION; MANAGEMENT; EPISIOTOMY; BALANCE; LABOR	Background: Implementation of evidence-based obstetrical practices remains a significant challenge. Effective strategies to disseminate and implement such practices are needed. Methods: We randomly assigned 19 hospitals in Argentina and Uruguay to receive a multifaceted behavioral intervention (including selection of opinion leaders, interactive workshops, training of manual skills, one-on-one academic detailing visits with hospital birth attendants, reminders, and feedback) to develop and implement guidelines for the use of episiotomy and management of the third stage of labor or to receive no intervention. The primary outcomes were the rates of prophylactic use of oxytocin during the third stage of labor and of episiotomy. The main secondary outcomes were postpartum hemorrhage and birth attendants' readiness to change their behavior with regard to episiotomies and management of the third stage of labor. The outcomes were measured at baseline, at the end of the 18-month intervention, and 12 months after the end of the intervention. Results: The rate of use of prophylactic oxytocin increased from 2.1% at baseline to 83.6% after the end of the intervention at hospitals that received the intervention and from 2.6% to 12.3% at control hospitals (P=0.01 for the difference in changes). The rate of use of episiotomy decreased from 41.1% to 29.9% at hospitals receiving the intervention but remained stable at control hospitals, with preintervention and postintervention values of 43.5% and 44.5%, respectively (P<0.001 for the difference in changes). The intervention was also associated with reductions in the rate of postpartum hemorrhage of 500 ml or more (relative rate reduction, 45%; 95% confidence interval [CI], 9 to 71) and of 1000 ml or more (relative rate reduction, 70%; 95% CI, 16 to 78). Birth attendants' readiness to change also increased in the hospitals receiving the intervention. The effects on the use of episiotomy and prophylactic oxytocin were sustained 12 months after the end of the intervention. Conclusions: A multifaceted behavioral intervention increased the prophylactic use of oxytocin during the third stage of labor and reduced the use of episiotomy. (ClinicalTrials.gov number, NCT00070720; Current Controlled Trials number, ISRCTN82417627.).	[Althabe, Fernando; Belizan, Jose M.] IECS, Buenos Aires, DF, Argentina; [Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Bergel, Eduardo] UN Dev Program UN Populat Fund WHO World Bank Spe, Geneva, Switzerland; [Campbell, Marci K.] Univ N Carolina, Chapel Hill, NC USA; [Moss, Nancy; Wright, Linda L.] NICHHD, Ctr Res Mothers & Children, Bethesda, MD 20892 USA; [Hartwell, Tyler] Res Triangle Inst Int, Res Triangle Pk, NC USA	Tulane University; World Health Organization; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Research Triangle Institute	Althabe, F (corresponding author), IECS, Viamonte 2146,3er Piso,C1056ABH, Buenos Aires, DF, Argentina.	althabef@gmail.com	Campbell, Michelle/B-5793-2008	Belizan, Jose/0000-0002-8412-3010	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040636, U01HD040477] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW005492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW005492] Funding Source: Medline; NICHD NIH HHS [U01 HD40477, U01 HD40636] Funding Source: Medline; NIDDK NIH HHS [DK 56350] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Althabe F, 2002, BRIT MED J, V324, P945, DOI 10.1136/bmj.324.7343.945; Althabe F, 2006, INT J GYNECOL OBSTET, V94, pS126, DOI 10.1016/S0020-7292(06)60006-4; Althabe Fernando, 2005, BMC Womens Health, V5, P4, DOI 10.1186/1472-6874-5-4; American College of Obstetricians-Gynecologists, 2006, Obstet Gynecol, V107, P957; Belizan M, 2007, HEALTH EDUC RES, V22, P839, DOI 10.1093/her/cym012; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; BEYER JM, 1978, IMPLEMENTING CHANGE; *BMJ PUBL GROUP, 2004, EV CLIN, V3; CAMPBELL MJ, 2000, STAT CONFIDENCE, P36; Carroli G, 2000, COCHRANE DB SYST REV; Chaillet N, 2006, OBSTET GYNECOL, V108, P1234, DOI 10.1097/01.AOG.0000236434.74160.8b; Colomar Mercedes, 2004, Ginecol Obstet Mex, V72, P455; *COMM ADV PUBL HLT, 1990, CLIN PRACT GUID DIR, P38; *DEP REPR HLTH RES, 2002, 5 WHO REPR HLTH LIB; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Elbourn DR., 2001, COCHRANE DB SYST REV, V4; Fenton JJ, 2005, FAM MED, V37, P410; Festin MR, 2003, B WORLD HEALTH ORGAN, V81, P286; Grimshaw J, 2000, FAM PRACT, V17, pS11, DOI 10.1093/fampra/17.suppl_1.S11; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gulmezoglu AM, 2007, BJOG-INT J OBSTET GY, V114, P16, DOI 10.1111/j.1471-0528.2006.01091.x; GUYAT GH, 1993, JAMA-J AM MED ASSOC, V270, P2096, DOI 10.1001/jama.270.17.2096; Hartmann K, 2005, JAMA-J AM MED ASSOC, V293, P2141, DOI 10.1001/jama.293.17.2141; HISS RG, 1978, P 17 ANN C RES MED E, P283; HOTHORN T, 2001, R NEWS, V1, P11; Hutton JL, 2001, STAT MED, V20, P473, DOI 10.1002/1097-0258(20010215)20:3<473::AID-SIM805>3.0.CO;2-D; Int Confederation Midwives, 2004, J MIDWIFERY WOM HEAL, V49, P76; KOZAK LJ, 2005, VITAL HLTH STAT 13, V158; Leviton LC, 1999, JAMA-J AM MED ASSOC, V281, P46, DOI 10.1001/jama.281.1.46; Lomas J, 1993, Int J Technol Assess Health Care, V9, P11; Murray DM, 1998, DESIGN ANAL GROUP RA; OLIPHANT TB, 2006, GUIDE NUMPY EBOOK; Phillips C A, 1994, Tex Med, V90, P44; Prendiville WJ, 2000, COCHRANE DB SYST REV, V3; PROCHASKA JO, 1994, HEALTH PSYCHOL, V13, P39, DOI 10.1037/0278-6133.13.1.39; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Raab GM, 2005, CLIN TRIALS, V2, P130, DOI 10.1191/1740774505cn075oa; Raab GM, 2001, STAT MED, V20, P351, DOI 10.1002/1097-0258(20010215)20:3<351::AID-SIM797>3.0.CO;2-C; Rogers EM., 1983, DIFFUSION INNOVATION; SULLIVAN R, 1998, CLIN TRAINING SKILLS; Thorp JM, 2007, BJOG-INT J OBSTET GY, V114, P1, DOI 10.1111/j.1471-0528.2006.01149.x	43	122	127	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1929	1940		10.1056/NEJMsa071456	http://dx.doi.org/10.1056/NEJMsa071456			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450604	Bronze			2022-12-28	WOS:000255387900007
J	Lyons, M				Lyons, Melinda			Do classical origins of medical terms endanger patients?	LANCET			English	Editorial Material									Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Cambridge	Lyons, M (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	mnl24@cam.ac.uk		Lyons, Melinda/0000-0003-1672-3599				Castleton B., 2003, QUALITY PRIMARY CARE, V11, P91; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; *FSF ED STAFF 2000, 2000, FLIGHT SAFETY FDN AI, V26, P3; Hudson P, 2003, QUAL SAF HEALTH CARE, V12, pI7, DOI 10.1136/qhc.12.suppl_1.i7; Lee SU, 2005, J BACK MUSCULOSKELET, V18, P15, DOI 10.3233/BMR-2005-181-203; Marcovitch H., 2005, BLACKS MED DICT; Schulmeister Lisa, 2006, Clin J Oncol Nurs, V10, P35, DOI 10.1188/06.CJON.35-41; Sheppard JE, 2008, ARCH DIS CHILD, V93, P204, DOI 10.1136/adc.2007.128132; THOM T, 2003, AIR PILOTS MANUAL; Toft B, 2005, HEALTH SERV MANAG RE, V18, P211, DOI 10.1258/095148405774518615; World Health Organization, 2007, PROM SAF MED CHILDR, P1	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1321	1322		10.1016/S0140-6736(08)60576-0	http://dx.doi.org/10.1016/S0140-6736(08)60576-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424312				2022-12-28	WOS:000255208500009
J	Clyne, JD; Miesenbock, G				Clyne, J. Dylan; Miesenboeck, Gero			Sex-specific control and tuning of the pattern generator for courtship song in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; REMOTE-CONTROL; REPRODUCTIVE-BEHAVIOR; NEURAL CIRCUITRY; FRUITLESS GENE; NEURONS; MELANOGASTER; EXPRESSION; MOSAICS; PROTEIN	The differentially spliced transcription factors encoded by the fruitless (fru) gene are key determinants of sexual behavior in Drosophila. They are expressed in a minority of neurons with limited dimorphisms and regulate neural processes that remain largely unknown. Here, we use light-activated ion channels to stimulate fru-expressing neurons in the thoracic-abdominal ganglia, enabling direct functional comparisons of homologous circuitry between sexes. Optical stimulation of males or females initiates the unilateral wing vibrations that normally generate the male courtship song. The pattern-generating circuit operates differently in the two sexes, producing wing movement and sound in both but authentic songs only in males and in females expressing male fru product. A song-like motor program is thus present in females but lies dormant because the neural commands required for song initiation are absent. Supplying such commands artificially reveals fru-specific differences in the internal dynamics of the song generator and sets the stage for exploring their physiological basis.	[Clyne, J. Dylan; Miesenboeck, Gero] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Miesenboeck, Gero] Univ Oxford, Dept Physiol Anat & AGenet, Oxford OX1 3PT, England	Yale University; University of Oxford	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@dpag.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228	Medical Research Council [G0701225, G0700888] Funding Source: Medline; MRC [G0701225, G0700888] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Appleton EV, 1922, PHILOS MAG, V43, P177, DOI 10.1080/14786442208633861; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; BORST A, 1990, BIOSCIENCE, V40, P292, DOI 10.2307/1311266; BRAND AH, 1994, DROSOPHILA MELANOGAS, P635; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; COGGSHALL JC, 1973, Z NATURFORSCH C, VC 28, P783; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; HALL JC, 1977, BEHAV GENET, V7, P291, DOI 10.1007/BF01066800; HALL JC, 1979, GENETICS, V92, P437; Hedwig B, 2000, J NEUROPHYSIOL, V83, P712, DOI 10.1152/jn.2000.83.2.712; Hirsch M., 1974, DIFFERENTIAL EQUATIO; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; KIEHN O, 1991, TRENDS NEUROSCI, V14, P68, DOI 10.1016/0166-2236(91)90023-N; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Rideout EJ, 2007, CURR BIOL, V17, P1473, DOI 10.1016/j.cub.2007.07.047; RODER L, 1992, DEVELOPMENT, V115, P1017; Roeder KD, 1935, BIOL BULL-US, V69, P203, DOI 10.2307/1537420; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; van der Pol B, 1926, PHILOS MAG, V2, P978; van der Pol B, 1934, P IRE, V22, P1051, DOI 10.1109/JRPROC.1934.226781; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; VONSCHILCHER F, 1979, J COMP PHYSIOL A, P85; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; WIERSMA CAG, 1964, COMP BIOCHEM PHYSIOL, V12, P509, DOI 10.1016/0010-406X(64)90153-7; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	50	205	207	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					354	363		10.1016/j.cell.2008.01.050	http://dx.doi.org/10.1016/j.cell.2008.01.050			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423205	Bronze			2022-12-28	WOS:000255052000023
J	Tarassov, K; Messier, V; Landry, CR; Radinovic, S; Molina, MMS; Shames, I; Malitskaya, Y; Vogel, J; Bussey, H; Michnick, SW				Tarassov, Kirill; Messier, Vincent; Landry, Christian R.; Radinovic, Stevo; Molina, Mercedes M. Serna; Shames, Igor; Malitskaya, Yelena; Vogel, Jackie; Bussey, Howard; Michnick, Stephen W.			An in vivo map of the yeast protein interactome	SCIENCE			English	Article							FRAGMENT COMPLEMENTATION ASSAYS; LARGE-SCALE IDENTIFICATION; SACCHAROMYCES-CEREVISIAE; PHYSICAL INTERACTOME; CELL-CYCLE; MEMBRANE; COMPLEXES; ENDOSOME; RETROMER; ARCHITECTURE	Protein interactions regulate the systems-level behavior of cells; thus, deciphering the structure and dynamics of protein interaction networks in their cellular context is a central goal in biology. We have performed a genome-wide in vivo screen for protein-protein interactions in Saccharomyces cerevisiae by means of a protein-fragment complementation assay (PCA). We identified 2770 interactions among 1124 endogenously expressed proteins. Comparison with previous studies confirmed known interactions, but most were not known, revealing a previously unexplored subspace of the yeast protein interactome. The PCA detected structural and topological relationships between proteins, providing an 8-nanometer-resolution map of dynamically interacting complexes in vivo and extended networks that provide insights into fundamental cellular processes, including cell polarization and autophagy, pathways that are evolutionarily conserved and central to both development and human health.	[Tarassov, Kirill; Messier, Vincent; Landry, Christian R.; Radinovic, Stevo; Molina, Mercedes M. Serna; Shames, Igor; Malitskaya, Yelena; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Landry, Christian R.; Michnick, Stephen W.] Univ Montreal, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Vogel, Jackie; Bussey, Howard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Universite de Montreal; Universite de Montreal; McGill University	Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, Casier Postal 6128,Succursale Centrville, Montreal, PQ H3C 3J7, Canada.	stephen.michnick@umontreal.ca	Landry, Christian R/F-3890-2011	Landry, Christian/0000-0003-3028-6866				Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Damelin M, 2002, BIOPHYS J, V83, P3626, DOI 10.1016/S0006-3495(02)75363-0; Deloche O, 2002, MOL BIOL CELL, V13, P4296, DOI 10.1091/mbc.02-07-0105; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MONOD J, 1968, P 11 NOB S SOD LID C; Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pu SY, 2007, PROTEOMICS, V7, P944, DOI 10.1002/pmic.200600636; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Yen WL, 2007, MOL BIOL CELL, V18, P581, DOI 10.1091/mbc.E06-07-0612; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x	36	560	571	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1465	1470		10.1126/science.1153878	http://dx.doi.org/10.1126/science.1153878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18467557				2022-12-28	WOS:000256676400037
J	Orlando, DA; Lin, CY; Bernard, A; Wang, JY; Socolar, JES; Iversen, ES; Hartemink, AJ; Haase, SB				Orlando, David A.; Lin, Charles Y.; Bernard, Allister; Wang, Jean Y.; Socolar, Joshua E. S.; Iversen, Edwin S.; Hartemink, Alexander J.; Haase, Steven B.			Global control of cell-cycle transcription by coupled CDK and network oscillators	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DEPENDENT KINASE; NUCLEAR-LOCALIZATION; REGULATED GENES; YEAST; PHOSPHORYLATION; EXPRESSION; INHIBITOR; GENOME; PHASE	A significant fraction of the Saccharomyces cerevisiae genome is transcribed periodically during the cell division cycle(1,2), indicating that properly timed gene expression is important for regulating cell- cycle events. Genomic analyses of the localization and expression dynamics of transcription factors suggest that a network of sequentially expressed transcription factors could control the temporal programme of transcription during the cell cycle(3). However, directed studies interrogating small numbers of genes indicate that their periodic transcription is governed by the activity of cyclin- dependent kinases (CDKs)(4). To determine the extent to which the global cell- cycle transcription programme is controlled by cyclin - CDK complexes, we examined genome- wide transcription dynamics in budding yeast mutant cells that do not express S- phase and mitotic cyclins. Here we show that a significant fraction of periodic genes are aberrantly expressed in the cyclin mutant. Although cells lacking cyclins are blocked at the G1/S border, nearly 70% of periodic genes continued to be expressed periodically and on schedule. Our findings reveal that although CDKs have a function in the regulation of cell- cycle transcription, they are not solely responsible for establishing the global periodic transcription programme. We propose that periodic transcription is an emergent property of a transcription factor network that can function as a cell- cycle oscillator independently of, and in tandem with, the CDK oscillator.	[Orlando, David A.; Lin, Charles Y.; Wang, Jean Y.; Haase, Steven B.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Orlando, David A.] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; [Bernard, Allister; Hartemink, Alexander J.] Duke Univ, Dept Comp Sci, Durham, NC 27708 USA; [Socolar, Joshua E. S.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Iversen, Edwin S.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Haase, SB (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	shaase@duke.edu	Socolar, Joshua/AAV-6822-2021	Socolar, Joshua/0000-0003-0532-7099; Haase, Steve/0000-0001-8127-8992	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM081883-030001, P50 GM081883, P50 GM081883-020001] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho W, 1999, MOL CELL BIOL, V19, P5267; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Orlando DA, 2007, CELL CYCLE, V6, P478, DOI 10.4161/cc.6.4.3859; Pic-Taylor A, 2004, MOL CELL BIOL, V24, P10036, DOI 10.1128/MCB.24.22.10036-10046.2004; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; SIDOROVA JM, 1995, MOL BIOL CELL, V6, P1641, DOI 10.1091/mbc.6.12.1641; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Toyn JH, 1997, GENETICS, V145, P85; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zwicker J, 1995, Prog Cell Cycle Res, V1, P91	32	215	216	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					944	U78		10.1038/nature06955	http://dx.doi.org/10.1038/nature06955			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18463633	Green Accepted			2022-12-28	WOS:000256632000049
J	Djulbegovic, B; Kumar, A				Djulbegovic, Benjamin; Kumar, Ambuj			Multiple myeloma: detecting the effects of new treatments	LANCET			English	Editorial Material							LENALIDOMIDE PLUS DEXAMETHASONE; ELDERLY-PATIENTS; PHASE-III; THALIDOMIDE; BORTEZOMIB; PREDNISONE; MELPHALAN; TRIAL; TRANSPLANTATION; CHEMOTHERAPY		[Djulbegovic, Benjamin] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol Malignancies, Tampa, FL 33612 USA; [Kumar, Ambuj] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Djulbegovic, B (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Hematol Malignancies, Tampa, FL 33612 USA.	benjamin.djulbegovic@moffitt.org	Kumar, Ambuj/I-4940-2012; Djulbegovic, Benjamin/I-3661-2012; Kumar, Ambuj/U-5268-2019; KUMAR, ASHOK/AAF-4055-2021	Djulbegovic, Benjamin/0000-0003-0671-1447; KUMAR, ASHOK/0000-0002-9244-0622				[Anonymous], 1998, J Clin Oncol, V16, P3832; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Djulbegovic B, 2001, ANN ONCOL, V12, P1611, DOI 10.1023/A:1013181331874; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Hulin C, 2007, J CLIN ONCOL, V25; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Kumar A, 2007, HAEMATOL-HEMATOL J, V92, P208; Kumar A, 2003, LANCET ONCOL, V4, P293, DOI 10.1016/S1470-2045(03)01077-5; Kumar A, 2006, CLIN EVID, V15, P1; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Rajkumar SV, 2007, J CLIN ONCOL, V25; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596	18	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1642	1644		10.1016/S0140-6736(08)60704-7	http://dx.doi.org/10.1016/S0140-6736(08)60704-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486726				2022-12-28	WOS:000256002200006
J	O'Manique, C; Labonte, R				O'Manique, Colleen; Labonte, Ronald			Rethinking (Product) RED	LANCET			English	Editorial Material									[Labonte, Ronald] Univ Ottawa, Inst Populat Hlth, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada; [O'Manique, Colleen] Trent Univ, Peterborough, ON K9J 7B8, Canada	University of Ottawa; Trent University	Labonte, R (corresponding author), Univ Ottawa, Inst Populat Hlth, Dept Epidemiol & Community Med, Ottawa, ON K1N 6N5, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					Bond P, 2007, INT J HEALTH SERV, V37, P171, DOI 10.2190/UK65-4235-N866-3R34; DIAMOND J, 2008, NY TIMES        0102; LABONTE R, 2004, FATAL INDIFFERENCE G; OManique C, 2004, INT POLIT ECON SER, P1, DOI 10.1057/9780230504080; 2006, LANCET, V368, P423; 2007, VANITY FAIR      JUL, P32	6	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 10	2008	371	9624					1561	1563		10.1016/S0140-6736(08)60671-6	http://dx.doi.org/10.1016/S0140-6736(08)60671-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468531				2022-12-28	WOS:000255715400009
J	Charmantier, A; McCleery, RH; Cole, LR; Perrins, C; Kruuk, LEB; Sheldon, BC				Charmantier, Anne; McCleery, Robin H.; Cole, Lionel R.; Perrins, Chris; Kruuk, Loeske E. B.; Sheldon, Ben C.			Adaptive phenotypic plasticity in response to climate change in a wild bird population	SCIENCE			English	Article							PARUS-MAJOR; LONG-TERM; SELECTION; REPRODUCTION; TEMPERATURE; PHENOLOGY	Rapid climate change has been implicated as a cause of evolution in poorly adapted populations. However, phenotypic plasticity provides the potential for organisms to respond rapidly and effectively to environmental change. Using a 47- year population study of the great tit ( Parus major) in the United Kingdom, we show that individual adjustment of behavior in response to the environment has enabled the population to track a rapidly changing environment very closely. Individuals were markedly invariant in their response to environmental variation, suggesting that the current response may be fixed in this population. Phenotypic plasticity can thus play a central role in tracking environmental change; understanding the limits of plasticity is an important goal for future research.	[Charmantier, Anne; McCleery, Robin H.; Cole, Lionel R.; Perrins, Chris; Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Charmantier, Anne] CNRS, Ctr Ecol Fonct & Evolut, Unite Mixte Rech, F-34293 Montpellier 5, France; [Kruuk, Loeske E. B.] Univ Edinburgh, Inst Evolut Biol, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Oxford; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Edinburgh	Sheldon, BC (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	ben.sheldon@zoo.ox.ac.uk	Kruuk, Loeske/AAB-8714-2019; Kruuk, Loeske E. B./J-3295-2012; Sheldon, Ben C/A-8056-2010; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Kruuk, Loeske/0000-0001-8588-1123; Kruuk, Loeske E. B./0000-0001-8588-1123; Sheldon, Ben C/0000-0002-5240-7828; 	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Balanya J, 2006, SCIENCE, V313, P1773, DOI 10.1126/science.1131002; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Brommer JE, 2005, EVOLUTION, V59, P1362; Cresswell W, 2003, J ANIM ECOL, V72, P356, DOI 10.1046/j.1365-2656.2003.00701.x; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Moller AP, 2004, ADV ECOL RES, V35, P111, DOI 10.1016/S0065-2504(04)35006-3; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Nussey DH, 2005, J ANIM ECOL, V74, P387, DOI 10.1111/j.1365-2656.2005.00941.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Reed TE, 2006, P R SOC B, V273, P2713, DOI 10.1098/rspb.2006.3631; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	25	871	883	12	751	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					800	803		10.1126/science.1157174	http://dx.doi.org/10.1126/science.1157174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467590				2022-12-28	WOS:000255644400043
J	Prahlad, V; Cornelius, T; Morimoto, RI				Prahlad, Veena; Cornelius, Tyler; Morimoto, Richard I.			Regulation of the cellular heat shock response in Caenorhabditis elegans by thermosensory neurons	SCIENCE			English	Article							PROTEIN; STRESS; FAMILY; HSP70	Temperature pervasively affects all cellular processes. In response to a rapid increase in temperature, all cells undergo a heat shock response, an ancient and highly conserved program of stress- inducible gene expression, to reestablish cellular homeostasis. In isolated cells, the heat shock response is initiated by the presence of misfolded proteins and therefore thought to be cell- autonomous. In contrast, we show that within the metazoan Caenorhabditis elegans, the heat shock response of somatic cells is not cell- autonomous but rather depends on the thermosensory neuron, AFD, which senses ambient temperature and regulates temperature- dependent behavior. We propose a model whereby this loss of cell autonomy serves to integrate behavioral, metabolic, and stress- related responses to establish an organismal response to environmental change.	[Prahlad, Veena; Cornelius, Tyler; Morimoto, Richard I.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA	Northwestern University	Morimoto, RI (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Rice Inst Biomed Res, Evanston, IL 60208 USA.	r-morimoto@northwestern.edu	Longo, Kenneth A/A-5631-2010	Prahlad, Veena/0000-0002-0413-6074	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038109, R01GM038109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026647] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Clark DA, 2007, J NEUROSCI, V27, P6083, DOI 10.1523/JNEUROSCI.1032-07.2007; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; FAWCETT TW, 1994, J BIOL CHEM, V269, P32272; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; SNUTCH TP, 1988, GENE, V64, P241, DOI 10.1016/0378-1119(88)90339-3; Sokolchik I, 2005, J NEUROSCI, V25, P1015, DOI 10.1523/JNEUROSCI.3107-04.2005; STRINGHAM EG, 1993, J EXP ZOOL, V266, P227, DOI 10.1002/jez.1402660309	18	235	260	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					811	814		10.1126/science.1156093	http://dx.doi.org/10.1126/science.1156093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467592	Green Accepted			2022-12-28	WOS:000255644400046
J	Wilde, AAM; Bhuiyan, ZA; Crotti, L; Facchini, M; De Ferrari, GM; Paul, T; Ferrandi, C; Koolbergen, DR; Odero, A; Schwartz, PJ				Wilde, Arthur A. M.; Bhuiyan, Zahurul A.; Crotti, Lia; Facchini, Mario; De Ferrari, Gaetano M.; Paul, Thomas; Ferrandi, Chiara; Koolbergen, Dave R.; Odero, Attilio; Schwartz, Peter J.			Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT STELLECTOMY; FOLLOW-UP; MUTATIONS; GENE; PREVENTION; DEATH	Catecholaminergic polymorphic ventricular tachycardia is a potentially lethal disease characterized by adrenergically mediated ventricular arrhythmias manifested especially in children and teenagers. Beta-blockers are the cornerstone of therapy, but some patients do not have a complete response to this therapy and receive an implantable cardioverter-defibrillator (ICD). Given the nature of catecholaminergic polymorphic ventricular tachycardia, ICD shocks may trigger new arrhythmias, leading to the administration of multiple shocks. We describe the long-term efficacy of surgical left cardiac sympathetic denervation in three young adults with catecholaminergic polymorphic ventricular tachycardia, all of whom had symptoms before the procedure and were symptom-free afterward.	[Wilde, Arthur A. M.; Bhuiyan, Zahurul A.; Koolbergen, Dave R.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Crotti, Lia; Odero, Attilio; Schwartz, Peter J.] Univ Pavia, I-27100 Pavia, Italy; [Crotti, Lia; De Ferrari, Gaetano M.; Ferrandi, Chiara; Odero, Attilio; Schwartz, Peter J.] IRCCS, Fdn Policlin S Matteo, Pavia, Italy; [Facchini, Mario; Schwartz, Peter J.] IRCCS, Ist Auxol, Milan, Italy; [Paul, Thomas] Univ Gottingen, Univ Childrens Hosp, Gottingen, Germany; [Schwartz, Peter J.] Univ Cape Town, ZA-7925 Cape Town, South Africa	University of Amsterdam; Academic Medical Center Amsterdam; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; IRCCS Istituto Auxologico Italiano; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cape Town	Wilde, AAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.a.wilde@amc.uva.nl	Crotti, Lia/AAB-3914-2019; De Ferrari, Gaetano M/K-5188-2016; Schwartz, Peter J/J-4267-2016; Facchini, Mario/AAB-1622-2020	De Ferrari, Gaetano M/0000-0003-4940-0876; Schwartz, Peter J/0000-0003-0367-1048; crotti, lia/0000-0001-8739-6527; Koolbergen, David/0000-0002-1297-5716				Coumel P., 1978, BRIT HEART J, V40, P28; Kontula K, 2005, CARDIOVASC RES, V67, P379, DOI 10.1016/j.cardiores.2005.04.027; Lahat H, 2001, CIRCULATION, V103, P2822; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512; Mohamed U, 2006, HEART RHYTHM, V3, P1486, DOI 10.1016/j.hrthm.2006.08.018; Napolitano C, 2007, HEART RHYTHM, V4, P675, DOI 10.1016/j.hrthm.2006.12.048; Postma AV, 2002, CIRC RES, V91, pE21, DOI 10.1161/01.RES.0000038886.18992.6B; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; REID DS, 1975, BRIT HEART J, V37, P339; Robinson M, 2007, HEART THYTHM S, V4, pS101; Rosso R, 2007, HEART RHYTHM, V4, P1149, DOI 10.1016/j.hrthm.2007.05.017; SCHWARTZ PJ, 1982, AM J CARDIOL, V49, P1185, DOI 10.1016/0002-9149(82)90043-1; SCHWARTZ PJ, 1976, AM J CARDIOL, V37, P1034, DOI 10.1016/0002-9149(76)90420-3; SCHWARTZ PJ, 1992, J CARDIOVASC ELECTR, V3, P2, DOI 10.1111/j.1540-8167.1992.tb01090.x; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; SCHWARTZ PJ, 1977, CIRC RES, V40, P536, DOI 10.1161/01.RES.40.6.536; SCHWARTZ PJ, 1984, ANN NY ACAD SCI, V427, P199, DOI 10.1111/j.1749-6632.1984.tb20785.x; Sumitomo N, 2003, HEART, V89, P66, DOI 10.1136/heart.89.1.66; Swan H, 1999, J AM COLL CARDIOL, V34, P2035, DOI 10.1016/S0735-1097(99)00461-1; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; WOLF MJ, 2007, HEART RHYTHM, V4; Zipes DP, 2006, J AM COLL CARDIOL, V48, pe247, DOI [10.1016/j.jacc.2006.07.010, DOI 10.1016/J.JACC.2006.07.010]	25	275	284	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2024	2029		10.1056/NEJMoa0708006	http://dx.doi.org/10.1056/NEJMoa0708006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463378				2022-12-28	WOS:000255577700006
J	Lawes, CMM; Vander Hoorn, S; Rodgers, A				Lawes, Carlene M. M.; Vander Hoorn, Stephen; Rodgers, Anthony		Int Soc Hypertens	Global burden of blood-pressure-related disease, 2001	LANCET			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; STROKE; MORTALITY; HYPERTENSION; DISABILITY	Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (>= 115 mm Hg systolic) was estimated for groups according to age (>= 30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias. Findings Worldwide, 7.6 million premature deaths (about 13.5% of the global total) and 92 million DALYs (6.0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributed to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45-69 years. Interpretation Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.	[Lawes, Carlene M. M.; Vander Hoorn, Stephen; Rodgers, Anthony] Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand	University of Auckland	Rodgers, A (corresponding author), Univ Auckland, Clin Trials Res Unit, Private Bag 92019, Auckland 1, New Zealand.	a.rodgers@ctru.auckland.ac.nz		Rodgers, Anthony/0000-0003-1282-1896				[Anonymous], 2001, NATL BURDEN DIS STUD; Beaglehole R., 2003, WORLD HLTH REPORT 20; CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; CONNOR WE, 1978, AM J CLIN NUTR, V31, P1131, DOI 10.1093/ajcn/31.7.1131; Elliott P, 1999, CLIN EXP HYPERTENS, V21, P571, DOI 10.3109/10641969909060990; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; He J, 1991, Epidemiology, V2, P88, DOI 10.1097/00001648-199103000-00002; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lawes C, 2004, COMP QUANTIFICATION, P281; Lawes Carlene M M, 2002, Semin Vasc Med, V2, P355, DOI 10.1055/s-2002-36765; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lawes CMM, 2006, J HYPERTENS, V24, P423, DOI 10.1097/01.hjh.0000209973.67746.f0; Lawes CMM, 2006, J HYPERTENS, V24, P413, DOI 10.1097/01.hjh.0000199801.72563.6f; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MACMAHON S, 1994, TXB HYPERTENSION, P46; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Mathers C., 1999, BURDEN DIS INJURY AU; *MIN HLTH, 1999, OUR HLTH OUR FUT; Ministry of Health, 2001, BURD DIS INJ NZ; Murray C.J, 1996, GLOBAL BURDEN DIS CO; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL., 2001, GLOBAL BURDEN DIS 20; Neal B, 2000, LANCET, V356, P1955; PAGE LB, 1974, CIRCULATION, V49, P1132, DOI 10.1161/01.CIR.49.6.1132; Qizilbash N, 1995, LANCET, V346, P1647; Reddy KS, 1998, CIRCULATION, V97, P596; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sever P., 1994, TXB HYPERTENSION, P22; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; Staessen JA, 2001, LANCET, V358, P1305, DOI 10.1016/S0140-6736(01)06411-X; Vander Hoorn S, 2004, COMP QUANTIFICATION, P2129; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; WHO, 2002, RED RISKS PROM HLTH	42	1624	1716	4	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1513	1518		10.1016/S0140-6736(08)60655-8	http://dx.doi.org/10.1016/S0140-6736(08)60655-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456100				2022-12-28	WOS:000255668300027
J	Summerfield, D				Summerfield, Derek			How scientifically valid is the knowledge base of global mental health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRAUMA; DEPRESSION; PREVALENCE; REFUGEES; WAR		[Summerfield, Derek] Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Summerfield, D (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8AF, England.	ederek.summerfield@slam.nhs.uk						Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Davis M, 2017, PLANET SLUMS; Hollifield M, 2002, JAMA-J AM MED ASSOC, V288, P611, DOI 10.1001/jama.288.5.611; Horton R, 2007, LANCET, V370, P806, DOI 10.1016/S0140-6736(07)61243-4; Hume F, 1994, Med War, V10, P4, DOI 10.1080/07488009408409136; Ingleby D, 2005, INT CUL PSY, P1; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; KIRMAYER L, 1989, SOC SCI MED, V29, P447; Kleinman A., 1985, CULTURE DEPRESSION S; KLEINMAN A, 1995, CULTURE PSYCHOL READ, P631; Mezzich JE, 1999, J NERV MENT DIS, V187, P457, DOI 10.1097/00005053-199908000-00001; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; Moncrieff J, 2002, BRIT J PSYCHIAT, V180, P193, DOI 10.1192/bjp.180.3.193; Ncayiyana DJ, 2007, BMJ-BRIT MED J, V335, P1272, DOI 10.1136/bmj.39420.432951.80; Patel V, 2007, LANCET, V370, P1055, DOI 10.1016/S0140-6736(07)61479-2; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Said Edward, 2012, CULTURE IMPERIALISM; Summerfield D, 2006, J ROY SOC MED, V99, P161, DOI 10.1258/jrsm.99.3.161; Summerfield D, 2003, INT J SOC PSYCHIATR, V49, P264, DOI 10.1177/0020764003494004; Summerfield D, 1999, SOC SCI MED, V48, P1449, DOI 10.1016/S0277-9536(98)00450-X	21	170	170	3	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2008	336	7651					992	994		10.1136/bmj.39513.441030.AD	http://dx.doi.org/10.1136/bmj.39513.441030.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300EZ	18456630	Green Published			2022-12-28	WOS:000255808400036
J	Lakkaraju, AKK; Mary, C; Scherrer, A; Johnson, AE; Strub, K				Lakkaraju, Asvin K. K.; Mary, Camille; Scherrer, Anne; Johnson, Arthur E.; Strub, Katharina			SRP keeps polypeptides translocation-competent by slowing translation to match limiting ER-targeting sites	CELL			English	Article							SIGNAL-RECOGNITION-PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; SECRETORY PROTEIN TRANSLOCATION; ELONGATION ARREST; ALU-DOMAIN; MICROSOMAL-MEMBRANES; BINDING-PROTEIN; SRP9/14 SUBUNIT; IN-VIVO; RIBOSOME	SRP is essential for targeting nascent chains to the endoplasmic reticulum, and it delays nascent chain elongation in cell-free translation systems. However, the significance of this function has remained unclear. We show that efficient protein translocation into the ER is incompatible with normal cellular translation rates due to rate-limiting concentrations of SRP receptor (SR). We complemented mammalian cells depleted of SRP14 by expressing mutant versions of the protein lacking the elongation arrest function. The absence of a delay caused inefficient targeting of preproteins leading to defects in secretion, depletion of proteins in the endogenous membranes, and reduced cell growth. The detrimental effects were reversed by either reducing the cellular protein synthesis rate or increasing SR expression. SRP therefore ensures that nascent chains remain translocation competent during the targeting time window dictated by SR. Since SRP-signal sequence affinities vary, the delay may also regulate which proteins are preferentially targeted.	[Lakkaraju, Asvin K. K.; Mary, Camille; Scherrer, Anne; Strub, Katharina] Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland; [Johnson, Arthur E.] Texas A&M Univ Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77840 USA	University of Geneva; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Strub, K (corresponding author), Univ Geneva, Dept Biol Cellulaire, CH-1211 Geneva, Switzerland.	strub@cellbio.unige.ch	Johnson, Arthur E/G-3457-2012	Lakkaraju, Asvin/0000-0001-8752-148X	NIGMS NIH HHS [R01GM26494, R01 GM026494-28, R01 GM026494] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026494] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bovia F, 1997, NUCLEIC ACIDS RES, V25, P318, DOI 10.1093/nar/25.2.318; BOVIA F, 1995, MOL BIOL CELL, V6, P471, DOI 10.1091/mbc.6.4.471; CONNOLLY T, 1991, SCIENCE, V252, P1171, DOI 10.1126/science.252.5009.1171; CONNOLLY T, 1986, J CELL BIOL, V103, P2253, DOI 10.1083/jcb.103.6.2253; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704; Guth S, 2004, EUR J BIOCHEM, V271, P3200, DOI 10.1111/j.1432-1033.2004.04252.x; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HARE JF, 1990, BIOCHIM BIOPHYS ACTA, V1031, P71, DOI 10.1016/0304-4157(90)90003-U; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; Huck L, 2004, NUCLEIC ACIDS RES, V32, P4915, DOI 10.1093/nar/gkh837; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lakkaraju AKK, 2007, EXP CELL RES, V313, P834, DOI 10.1016/j.yexcr.2006.12.003; LIPP J, 1987, J BIOL CHEM, V262, P1680; Liu L, 2003, J BIOL CHEM, V278, P18271, DOI 10.1074/jbc.M209215200; Lustig Y, 2005, J CELL SCI, V118, P4551, DOI 10.1242/jcs.02578; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; OKUN MM, 1992, J BIOL CHEM, V267, P11476; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Powers T, 1996, CURR BIOL, V6, P331, DOI 10.1016/S0960-9822(02)00484-0; RAPOPORT TA, 1987, J MOL BIOL, V195, P621, DOI 10.1016/0022-2836(87)90186-0; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Raue U, 2007, J BIOL CHEM, V282, P7809, DOI 10.1074/jbc.M611436200; RUTLEDGE EA, 1991, J BIOL CHEM, V266, P21125; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SIEGEL V, 1985, J CELL BIOL, V100, P1913, DOI 10.1083/jcb.100.6.1913; Terzi L, 2004, BIOCHEMISTRY-US, V43, P107, DOI 10.1021/bi0353777; Thomas Y, 1997, NUCLEIC ACIDS RES, V25, P1920, DOI 10.1093/nar/25.10.1920; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; Weichenrieder O, 2000, NATURE, V408, P167, DOI 10.1038/35041507; WIEDMANN M, 1987, J CELL BIOL, V104, P201, DOI 10.1083/jcb.104.2.201; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; WOLIN SL, 1993, J CELL BIOL, V121, P1211, DOI 10.1083/jcb.121.6.1211	45	92	94	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					440	451		10.1016/j.cell.2008.02.049	http://dx.doi.org/10.1016/j.cell.2008.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455985	Green Accepted, Bronze			2022-12-28	WOS:000255503900015
J	Lee, MS; Tienor, BJ				Lee, Michael S.; Tienor, Brian J.			Changes in the brain stem and fundus in malignant hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Michael S.; Tienor, Brian J.] Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lee, MS (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	mikelee@umn.edu	Lee, Michael/GZP-3892-2022						0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1951	1951		10.1056/NEJMicm067529	http://dx.doi.org/10.1056/NEJMicm067529			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450606				2022-12-28	WOS:000255387900009
J	Legido-Quigley, H; McKee, M; Walshe, K; Sunol, R; Nolte, E; Klazinga, N				Legido-Quigley, Helena; McKee, Martin; Walshe, Kieran; Sunol, Rosa; Nolte, Ellen; Klazinga, Niek			How can quality of health care be safeguarded across the European Union?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							4 MODELS; ACCREDITATION; VISITATIE		[Legido-Quigley, Helena; McKee, Martin; Nolte, Ellen] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Walshe, Kieran] Univ Manchester, Manchester M13 9PL, Lancs, England; [Sunol, Rosa] Univ Autonoma Barcelona, Inst Univ Avedis Donabedian, CIBERESP, E-08193 Barcelona, Spain; [Klazinga, Niek] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of Manchester; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Amsterdam; Academic Medical Center Amsterdam	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Sunol, Rosa/AAS-7276-2021; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Sunol, Rosa/0000-0003-1902-833X; Mckee, Martin/0000-0002-0121-9683; Walshe, Kieran/0000-0002-0696-480X; Nolte, Ellen/0000-0002-2289-117X				Bertinato L., 2005, POLICY BRIEF CROSS B; Burgers JS, 2003, INT J QUAL HEALTH C, V15, P31, DOI 10.1093/intqhc/15.1.31; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; *COM ED RCA, 2004, REV CALIDAD ASISTENC, V19; Donahue KT, 2000, INT J QUAL HEALTH C, V12, P243, DOI 10.1093/intqhc/12.3.243; Donaldson L, 2004, B WORLD HEALTH ORGAN, V82, P892; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Engels Y, 2005, FAM PRACT, V22, P215, DOI 10.1093/fampra/cmi002; *EPSU HOSPEEM, 2006, CROSS BORD RECR HOSP; EXPERT RG, 1998, EXP OP SEM BUD, V11; GULACSI L, 2001, HUNGARIAN HLTH CARE; Huisman W, 2007, CLIN CHEM LAB MED, V45, P268, DOI 10.1515/CCLM.2007.037; Kanavos P, 2000, J Health Serv Res Policy, V5, P231; Kaprio L A, 1978, Ann N Y Acad Sci, V310, P145, DOI 10.1111/j.1749-6632.1978.tb22065.x; Klazinga N, 2000, INT J QUAL HEALTH C, V12, P183, DOI 10.1093/intqhc/12.3.183; Legido-Quigley H, 2007, BRIT MED J, V334, P188, DOI 10.1136/bmj.39086.497639.68; Lombarts MJMH, 2001, HEALTH POLICY, V58, P191, DOI 10.1016/S0168-8510(01)00158-0; Lombarts MJMH, 2005, J EVAL CLIN PRACT, V11, P587, DOI 10.1111/j.1365-2753.2005.00595.x; McKee M, 2002, IMPACT EU LAW HLTH C; McKee M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39398.456493.80; MERKUR S, IN PRESS CLIN MED; Nabitz U, 2000, INT J QUAL HEALTH C, V12, P191, DOI 10.1093/intqhc/12.3.191; Permanand G, 2006, CLIN MED, V6, P87, DOI 10.7861/clinmedicine.6-1-87; ROBINSON R, 1995, BRIT MED J, V310, P755, DOI 10.1136/bmj.310.6982.755; SOMEKH D, 2007, WORKING PACKAGE, V2; Sweeney J, 2000, INT J QUAL HEALTH C, V12, P203, DOI 10.1093/intqhc/12.3.203; VALIGARDA S, 2001, HLTH CARE SYSTEMS TR; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	28	35	35	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2008	336	7650					920	923		10.1136/bmj.39538.584190.47	http://dx.doi.org/10.1136/bmj.39538.584190.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296KC	18436947	Green Accepted, Green Published			2022-12-28	WOS:000255540900027
J	Fairn, GD; Grinstein, S				Fairn, Gregory D.; Grinstein, Sergio			Cell biology - A one-sided signal	SCIENCE			English	Editorial Material							PHOSPHATIDYLSERINE; ASYMMETRY; RECEPTOR		[Fairn, Gregory D.; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Res Inst, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Fairn, GD (corresponding author), Hosp Sick Children, Cell Biol Program, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca		Fairn, Greg/0000-0001-6508-168X				Calderon F, 2008, J NEUROCHEM, V104, P1271, DOI 10.1111/j.1471-4159.2007.05079.x; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Saito K, 2007, DEV CELL, V13, P743, DOI 10.1016/j.devcel.2007.09.014; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	13	11	17	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					458	460		10.1126/science.1158173	http://dx.doi.org/10.1126/science.1158173			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436763				2022-12-28	WOS:000255249300024
J	Pavord, ID; Chung, KF				Pavord, Ian D.; Chung, Kian Fan			Chronic cough 2 - Management of chronic cough	LANCET			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY HEALTH SURVEY; CHRONIC PERSISTENT COUGH; IDIOPATHIC CHRONIC COUGH; AIRWAY SENSORY NERVES; GUINEA-PIG; GASTROESOPHAGEAL-REFLUX; EOSINOPHILIC BRONCHITIS; ANTITUSSIVE ACTIVITY; INHIBITS COUGH	Cough that remains unexplained after basic clinical assessment is a common reason for referral to secondary care. Much of the evidence about management of isolated chronic cough is derived from case series; this evidence suggests that isolated chronic cough is usually due to asthma, gastro-oesophageal reflux disease, and upper airway conditions, and that it can be cured in most people by treatment of these conditions. However, there is increasing recognition that satisfactory control of chronic cough is not achieved in a substantial number of patients seen in secondary care. Moreover, there is a concern that perpetuation of the belief that chronic cough is solely due to the effects of comorbid conditions is inhibiting research into the pathophysiology of an abnormally heightened cough reflex, and jeopardising development of improved treatments. We advocate a change in emphasis, which makes a clear distinction between cough due to corticosteroid-responsive eosinophilic airway diseases and corticosteroid-resistant non-eosinophilic cough. We recommend that some factors with weak evidence of an association with cough are best viewed as potential aggravating factors of an intrinsic abnormality of the cough reflex, rather than the cause. We call for more research into the basic mechanisms and pharmacological control of an abnormally heightened cough reflex, and recommend ways to assess the effects of potentially antitussive treatments.	[Pavord, Ian D.] Univ Hosp Leicester NHS Trust, Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Inst Lung Hlth, Leicester LE3 9QP, Leics, England; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Chung, Kian Fan] Royal Brompton Hosp, London SW3 6LY, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Imperial College London; Royal Brompton Hospital	Pavord, ID (corresponding author), Univ Hosp Leicester NHS Trust, Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Inst Lung Hlth, Leicester LE3 9QP, Leics, England.	ian.pavord@uhl-tr.nhs.uk	Chung, Kian Fan/I-8456-2019; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Pavord, Ian/0000-0002-4288-5973	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arai T, 2000, AM J HYPERTENS, V13, P1050, DOI 10.1016/S0895-7061(00)00301-0; Arai T, 1998, LANCET, V352, P1937, DOI 10.1016/S0140-6736(05)60437-0; AYLWARD M, 1984, EUR J RESPIR DIS, V65, P283; Barry Samantha J, 2006, Cough, V2, P8, DOI 10.1186/1745-9974-2-8; Bayer-Oglesby L, 2006, AM J EPIDEMIOL, V164, P1190, DOI 10.1093/aje/kwj338; Berry MA, 2005, CLIN EXP ALLERGY, V35, P598, DOI 10.1111/j.1365-2222.2005.02222.x; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; Birring SS, 2004, RESP MED, V98, P242, DOI 10.1016/j.rmed.2003.10.005; Birring SS, 2004, EUR RESPIR J, V23, P199, DOI 10.1183/09031936.03.00066403; Birring SS, 2004, AM J RESP CRIT CARE, V169, P15, DOI 10.1164/rccm.200308-1092OC; Birring SS, 2003, THORAX, V58, P1066, DOI 10.1136/thorax.58.12.1066; Birring SS, 2003, THORAX, V58, P533, DOI 10.1136/thorax.58.6.533; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Birring SS, 2006, RESP MED, V100, P1105, DOI 10.1016/j.rmed.2005.09.023; Birring Surinder S, 2007, Cough, V3, P7; BLANC P, 1991, CHEST, V99, P27, DOI 10.1378/chest.99.1.27; BOLSER DC, 1994, BRIT J PHARMACOL, V113, P1344, DOI 10.1111/j.1476-5381.1994.tb17145.x; Brightling CE, 2000, ANN MED, V32, P446, DOI 10.3109/07853890009002019; Brightling CE, 2000, EUR RESPIR J, V15, P682, DOI 10.1034/j.1399-3003.2000.15d10.x; Brightling CE, 1999, AM J RESP CRIT CARE, V160, P406, DOI 10.1164/ajrccm.160.2.9810100; Brightling CE, 2001, RESP MED, V95, P999, DOI 10.1053/rmed.2001.1195; Cain HC, 1998, CLIN CHEST MED, V19, P687, DOI 10.1016/S0272-5231(05)70110-6; Carney IK, 1997, AM J RESP CRIT CARE, V156, P211, DOI 10.1164/ajrccm.156.1.9605044; Caselli M, 1999, SCAND J GASTROENTERO, V34, P828, DOI 10.1080/003655299750025787; Chang AB, 2006, BMJ-BRIT MED J, V332, P11, DOI 10.1136/bmj.38677.559005.55; Chatkin JM, 1999, AM J RESP CRIT CARE, V159, P1810, DOI 10.1164/ajrccm.159.6.9809047; Chong CF, 2005, EMERG MED J, V22, P429, DOI 10.1136/emj.2004.015719; CHOUDRY NB, 1991, BRIT J CLIN PHARMACO, V32, P633, DOI 10.1111/j.1365-2125.1991.tb03966.x; Chung KF, 2006, RESP PHYSIOL NEUROBI, V152, P329, DOI 10.1016/j.resp.2006.02.001; Chung KF, 2006, LANCET, V367, P981, DOI 10.1016/S0140-6736(06)68415-8; Chung KF, 2005, EXPERT OPIN INV DRUG, V14, P19, DOI 10.1517/13543784.14.1.19; Coyle Michael A, 2005, Cough, V1, P3, DOI 10.1186/1745-9974-1-3; Dicpinigaitis PV, 2005, CHEST, V128, P196, DOI 10.1378/chest.128.1.196; Dicpinigaitis PV, 1997, CHEST, V111, P996, DOI 10.1378/chest.111.4.996; Dicpinigaitis PV, 2003, CHEST, V123, P685, DOI 10.1378/chest.123.3.685; Dicpinigaitis PV, 2003, PULM PHARMACOL THER, V16, P61, DOI 10.1016/S1094-5539(02)00149-9; EDDY NB, 1969, B WORLD HEALTH ORGAN, V40, P639; FAHY JV, 1995, AM J RESP CRIT CARE, V152, P879, DOI 10.1164/ajrccm.152.3.7663799; Featherstone RL, 1996, LUNG, V174, P269; Fox AJ, 1996, NAT MED, V2, P814, DOI 10.1038/nm0796-814; Fox AJ, 1997, J CLIN INVEST, V99, P513, DOI 10.1172/JCI119187; Freestone C, 1997, J PHARM PHARMACOL, V49, P1045, DOI 10.1111/j.2042-7158.1997.tb06039.x; French CT, 2002, CHEST, V121, P1123, DOI 10.1378/chest.121.4.1123; GEDDES DM, 1977, Q J MED, V46, P427; Gibson PG, 2004, AM J RESP CRIT CARE, V169, P1, DOI 10.1164/rccm.2310009; GIRARD V, 1995, EUR RESPIR J, V8, P1110, DOI 10.1183/09031936.95.08071110; GORDON SB, 1996, EUR RESPIR J, V9, P23; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; Harnden A, 2006, BRIT MED J, V333, P174, DOI 10.1136/bmj.38870.655405.AE; Hay DWP, 2002, J PHARMACOL EXP THER, V300, P314, DOI 10.1124/jpet.300.1.314; HOWARD P, 1977, BRIT J DIS CHEST, V71, P19, DOI 10.1016/0007-0971(77)90073-0; HSU JY, 1994, EUR RESPIR J, V7, P1246, DOI 10.1183/09031936.94.07071246; ING A J, 1992, American Review of Respiratory Disease, V145, pA11; Irwin R S, 1980, Clin Notes Respir Dis, V18, P11; Irwin RS, 2000, NEW ENGL J MED, V343, P1715, DOI 10.1056/NEJM200012073432308; IRWIN RS, 1993, CHEST, V104, P1511, DOI 10.1378/chest.104.5.1511; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; Jansen DF, 1999, AM J RESP CRIT CARE, V160, P259, DOI 10.1164/ajrccm.160.1.9811015; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; Janson C, 2001, EUR RESPIR J, V18, P647, DOI 10.1183/09031936.01.00098701; Jegoux F, 2002, LANCET, V360, P618, DOI 10.1016/S0140-6736(02)09786-6; Kanazawa H, 2003, CHEST, V123, P596, DOI 10.1378/chest.123.2.596; Kastelik JA, 2005, EUR RESPIR J, V25, P235, DOI 10.1183/09031936.05.00140803; Kastelik JA, 2003, THORAX, V58, P699, DOI 10.1136/thorax.58.8.699; Kern J, 2001, J OCCUP ENVIRON MED, V43, P905, DOI 10.1097/00043764-200110000-00010; Kiljander TO, 2000, EUR RESPIR J, V16, P633, DOI 10.1034/j.1399-3003.2000.16d11.x; Kotzer CJ, 2000, J PHARMACOL EXP THER, V292, P803; Koyama H, 1997, THORAX, V52, P915, DOI 10.1136/thx.52.10.915; Lalloo UG, 1998, EUR RESPIR J, V11, P702; LALLOO UG, 1995, J APPL PHYSIOL, V79, P1082, DOI 10.1152/jappl.1995.79.4.1082; Larsson ML, 2003, EUR RESPIR J, V21, P672, DOI 10.1183/09031936.03.00033702; Lu LR, 2003, CHEST, V124, P587, DOI 10.1378/chest.124.2.587; LUNDE H, 1994, BRIT MED J, V308, P18, DOI 10.1136/bmj.308.6920.18; Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548; MATTHYS H, 1983, J INT MED RES, V11, P92, DOI 10.1177/030006058301100206; McGarvey LPA, 1998, THORAX, V53, P738, DOI 10.1136/thx.53.9.738; McLeod RL, 1998, PHARMACOLOGY, V57, P57, DOI 10.1159/000028226; McLeod RL, 2001, BRIT J PHARMACOL, V132, P1175, DOI 10.1038/sj.bjp.0703954; Mello CJ, 1996, ARCH INTERN MED, V156, P997, DOI 10.1001/archinte.156.9.997; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Morita K, 2000, EUR J PHARMACOL, V395, P161, DOI 10.1016/S0014-2999(00)00197-7; MUNYARD P, 1994, PEDIATR PULM, V18, P178, DOI 10.1002/ppul.1950180310; OCONNELL F, 1994, AM J RESP CRIT CARE, V150, P374, DOI 10.1164/ajrccm.150.2.8049818; Ours TM, 1999, AM J GASTROENTEROL, V94, P3131, DOI 10.1111/j.1572-0241.1999.01504.x; Palombini BC, 1999, CHEST, V116, P279, DOI 10.1378/chest.116.2.279; Patel HJ, 2003, BRIT J PHARMACOL, V140, P261, DOI 10.1038/sj.bjp.0705435; Patterson RN, 2004, EUR RESPIR J, V24, P724, DOI 10.1183/09031936.04.00007404; Pavesi L, 2001, CHEST, V120, P1121, DOI 10.1378/chest.120.4.1121; Pavord ID, 2006, EUR RESPIR J, V27, P884, DOI 10.1183/09031936.06.00128105; Pavord ID, 2005, EUR RESPIR J, V25, P213, DOI 10.1183/09031936.05.00136504; Pierse N, 2006, THORAX, V61, P216, DOI 10.1136/thx.2004.036418; POE RH, 1989, CHEST, V95, P723, DOI 10.1378/chest.95.4.723; Prudon B, 2005, CHEST, V127, P550, DOI 10.1378/chest.127.2.550; REID DD, 1953, LANCET, V265, P1303; Ross AM, 2003, BRIT MED J, V326, P1036; Simpson G, 1999, THORAX, V54, P469; Smith J, 2006, J ALLERGY CLIN IMMUN, V117, P831, DOI 10.1016/j.jaci.2005.09.055; Smith J, 2006, CHEST, V130, P379, DOI 10.1016/S0012-3692(15)51851-5; SMYRNIOS NA, 1995, CHEST, V108, P991, DOI 10.1378/chest.108.4.991; Torrego A, 2006, THORAX, V61, P706, DOI 10.1136/thx.2005.049767; Trevisani M, 2004, THORAX, V59, P769, DOI 10.1136/thx.2003.012930; VENTRESCA PG, 1990, AM REV RESPIR DIS, V142, P143, DOI 10.1164/ajrccm/142.1.143; Vertigan AE, 2006, THORAX, V61, P1065, DOI 10.1136/thx.2006.064337; Watkin G, 2006, THORAX, V61, pII92; WYNDER EL, 1967, AM REV RESPIR DIS, V96, P645	111	83	91	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1375	1384		10.1016/S0140-6736(08)60596-6	http://dx.doi.org/10.1016/S0140-6736(08)60596-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424326				2022-12-28	WOS:000255208500028
J	Taylor, IW; Wrana, JL				Taylor, Ian W.; Wrana, Jeffrey L.			SnapShot: The TGF beta pathway interactome	CELL			English	Editorial Material							CELL-MEMBRANE; NUCLEUS		[Taylor, Ian W.; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Taylor, IW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Wrana, Jeffrey/F-8857-2013					Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; LAIHO M, 1992, Critical Reviews in Oncogenesis, V3, P1; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X	9	37	38	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2							378.e1	10.1016/j.cell.2008.04.007	http://dx.doi.org/10.1016/j.cell.2008.04.007			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423207	Bronze			2022-12-28	WOS:000255052000027
J	Gillies, CL; Lambert, PC; Abrams, KR; Sutton, AJ; Cooper, NJ; Hsu, RT; Davies, MJ; Khunti, K				Gillies, Clare L.; Lambert, Paul C.; Abrams, Keith R.; Sutton, Alex J.; Cooper, Nicola J.; Hsu, Ron T.; Davies, Melanie J.; Khunti, Kamlesh			Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; ECONOMIC-EVALUATION; PROGRESSION; RISK; POPULATION; METFORMIN; MELLITUS; PEOPLE; MODEL	Objective To compare four potential screening strategies, and subsequent interventions, for the prevention and treatment of type 2 diabetes: (a) screening for type 2 diabetes to enable early detection and treatment, (b) screening for type 2 diabetes and impaired glucose tolerance, intervening with lifestyle interventions in those with a diagnosis of impaired glucose tolerance to delay or prevent diabetes, (c) as for (b) but with pharmacological interventions, and (d) no screening. Design Cost effectiveness analysis based on development and evaluation of probabilistic, comprehensive economic decision analytic model, from screening to death. Setting A hypothetical population, aged 45 at time of screening, with above average risk of diabetes. Data sources Published clinical trials and epidemiological studies retrieved from electronic bibliographic databases; supplementary data obtained from the Department of Health statistics for England and Wales, the screening those at risk (STAR) study, and the Leicester division of the ADDITION study. Methods A hybrid decision tree/Markov model was developed to simulate the long term effects of each screening strategy, in terms of both clinical and cost effectiveness outcomes. The base case model assumed a 50 year time horizon with discounting of both costs and benefits at 3.5%. Sensitivity analyses were carried out to investigate assumptions of the model and to identify which model inputs had most impact on the results. Results Estimated costs for each quality adjusted life year (QALY) gained (discounted at 3.5% a year for both costs and benefits) were 14 pound 150 ((euro)17 560; $27 860) for screening for type 2 diabetes, 6242 pound for screening for diabetes and impaired glucose tolerance followed by lifestyle interventions, and 7023 pound for screening for diabetes and impaired glucose tolerance followed by pharmacological interventions, all compared with no screening. At a willingness-to-pay threshold of 20 pound 000 the probability of the intervention being cost effective was 49%, 93%, and 85% for each of the active screening strategies respectively. Conclusions Screening for type 2 diabetes and impaired glucose tolerance, with appropriate intervention for those with impaired glucose tolerance, in an above average risk population aged 45, seems to be cost effective. The cost effectiveness of a policy of screening for diabetes alone, which offered no intervention to those with impaired glucose tolerance, is still uncertain, and further research on the impact of early detection of diabetes is needed.	[Gillies, Clare L.; Lambert, Paul C.; Abrams, Keith R.; Sutton, Alex J.; Cooper, Nicola J.; Hsu, Ron T.] Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Davies, Melanie J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Khunti, Kamlesh] Univ Leicester, Div Gen Practice & Primary Hlth Care, Dept Hlth Sci, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester; University of Leicester	Gillies, CL (corresponding author), Univ Leicester, Ctr Biostat & Genet Epidemiol, Dept Hlth Sci, Leicester LE1 7RH, Leics, England.	clg13@le.ac.uk	/ABC-9527-2021; Abrams, Keith/AAA-2557-2020	Gillies, Clare/0000-0002-8417-9700; Davies, Melanie/0000-0002-9987-9371; Abrams, Keith/0000-0002-7557-1567; Lambert, Paul/0000-0002-5337-663X; Khunti, Kamlesh/0000-0003-2343-7099; Sutton, Alexander/0000-0002-8934-9940	MRC [G106/1170] Funding Source: UKRI; Medical Research Council [G106/1170] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Borch-Johnsen K, 1999, LANCET, V354, P617; Caro JJ, 2004, DIABETIC MED, V21, P1229, DOI 10.1111/j.1464-5491.2004.01330.x; Chen THH, 2001, DIABETES RES CLIN PR, V54, pS37; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Clarke PM, 2005, DIABETOLOGIA, V48, P868, DOI 10.1007/s00125-005-1717-3; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Cooper NJ, 2004, HEALTH ECON, V13, P203, DOI 10.1002/hec.804; Curtis L, 2006, UNIT COSTS HLTH SOCI; Davies M.J., 2005, DIABETIC MED, V22, P99; Davies MJ, 2004, DIABETIC MED, V21, P403, DOI 10.1111/j.1464-5491.2004.01176.x; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; Donnelly R, 2000, BRIT MED J, V320, P1062, DOI 10.1136/bmj.320.7241.1062; Eddy DM, 2005, ANN INTERN MED, V143, P251, DOI 10.7326/0003-4819-143-4-200508160-00006; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Eriksson JG, 2006, J INTERN MED, V259, P553, DOI 10.1111/j.1365-2796.2006.01633.x; Gilks W. R., 2003, BUGS BAYESIAN INFERE; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Glumer C, 2006, DIABETOLOGIA, V49, P1536, DOI 10.1007/s00125-006-0248-x; Gulliford MC, 2005, DIABETES CARE, V28, P47, DOI 10.2337/diacare.28.1.47; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Herman WH, 2005, ANN INTERN MED, V142, P323, DOI 10.7326/0003-4819-142-5-200503010-00007; Hoerger TJ, 2004, ANN INTERN MED, V140, P689, DOI 10.7326/0003-4819-140-9-200405040-00008; Icks A, 2007, DIABETIC MED, V24, P473, DOI 10.1111/j.1464-5491.2007.02108.x; Jacobs-van der Bruggen MAM, 2007, DIABETES CARE, V30, P128, DOI 10.2337/dc06-0690; JARRETT RJ, 1979, DIABETOLOGIA, V16, P25, DOI 10.1007/BF00423146; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Meigs JB, 2003, DIABETES, V52, P1475, DOI 10.2337/diabetes.52.6.1475; National Institute for Clinical Excellence, 2004, GUID METH TECHN APPR; Palmer AJ, 2004, CLIN THER, V26, P304, DOI 10.1016/S0149-2918(04)90029-X; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rasmussen SS, 2007, DIABETOLOGIA, V50, P293, DOI 10.1007/s00125-006-0530-y; Rossing P, 1996, BRIT MED J, V313, P779; Segal L, 1998, HEALTH PROMOT INT, V13, P197, DOI 10.1093/heapro/13.3.197; Srinivasan BT, 2007, DIABETIC MED, V24, P51; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UK NAT SCREEN COM, 2008, HDB VASC RISK ASS RI; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Wein P, 1999, AUST NZ J OBSTET GYN, V39, P162, DOI 10.1111/j.1479-828X.1999.tb03363.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	47	189	194	0	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2008	336	7654					1180	+		10.1136/bmj.39545.585289.25	http://dx.doi.org/10.1136/bmj.39545.585289.25			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308WJ	18426840	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000256420900042
J	Gulland, A				Gulland, Anne			Lessons from the battlefield	BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk							0	7	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1098	1100		10.1136/bmj.39568.496424.94	http://dx.doi.org/10.1136/bmj.39568.496424.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483051	Green Published			2022-12-28	WOS:000255975100033
J	Cannatella, DC				Cannatella, David C.			Comment on "Habitat split and the global decline of amphibians"	SCIENCE			English	Editorial Material									Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Cannatella, DC (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	catfish@mail.utexas.edu						Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Duellman W. E., 1986, BIOL AMPHIBIANS; Everitt B.S., 1977, ANAL CONTINGENCY TAB; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Sokal RR, 1995, BIOMETRY	6	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878								10.1126/science.1155114	http://dx.doi.org/10.1126/science.1155114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487175				2022-12-28	WOS:000255868300020
J	Neves, SR; Tsokas, P; Sarkar, A; Grace, EA; Rangamani, P; Taubenfeld, SM; Alberini, CM; Schaff, JC; Blitzer, RD; Moraru, II; Iyengar, R				Neves, Susana R.; Tsokas, Panayiotis; Sarkar, Anamika; Grace, Elizabeth A.; Rangamani, Padmini; Taubenfeld, Stephen M.; Alberini, Cristina M.; Schaff, James C.; Blitzer, Robert D.; Moraru, Ion I.; Iyengar, Ravi			Cell shape and negative links in regulatory motifs together control spatial information flow in signaling networks	CELL			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; QUANTITATIVE AUTORADIOGRAPHY; FLUORESCENT INDICATOR; SYNAPTIC PLASTICITY; MORPHOGEN GRADIENT; PTP-SL; CAMP; ACTIVATION; PHOSPHATASE	The role of cell size and shape in controlling local intracellular signaling reactions, and how this spatial information originates and is propagated, is not well understood. We have used partial differential equations to model the flow of spatial information from the beta-adrenergic receptor to MAPK1,2 through the cAMP/PKA/B-Raf/MAPK1,2 network in neurons using real geometries. The numerical simulations indicated that cell shape controls the dynamics of local biochemical activity of signal-modulated negative regulators, such as phosphodiesterases and protein phosphatases within regulatory loops to determine the size of microdomains of activated signaling components. The model prediction that negative regulators control the flow of spatial information to downstream components was verified experimentally in rat hippocampal slices. These results suggest a mechanism by which cellular geometry, the presence of regulatory loops with negative regulators, and key reaction rates all together control spatial information transfer and microdomain characteristics within cells.	[Neves, Susana R.; Tsokas, Panayiotis; Sarkar, Anamika; Grace, Elizabeth A.; Rangamani, Padmini; Blitzer, Robert D.; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Taubenfeld, Stephen M.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Schaff, James C.; Moraru, Ion I.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Connecticut	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	ravi.iyengar@mssm.edu		Moraru, Ion/0000-0002-3746-9676; tsokas, panayiotis/0000-0002-1679-8980; Neves-Zaph, Susana/0000-0002-3388-0054	NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, F31GM065065, R01GM054508, P50GM071558] Funding Source: NIH RePORTER; NEI NIH HHS [PN2 EY016586, PN2EY016586, PN2 EY016586-05S1] Funding Source: Medline; NIDDK NIH HHS [R01 DK038761, R01 DK038761-21, DK 38761] Funding Source: Medline; NIGMS NIH HHS [R01 GM072853-04, P50 GM071558, P50 GM071558-01A2, R01 GM054508, R01 GM072853, F31 GM065065, F31 GM065065-05, GM-65065, GM072853] Funding Source: Medline; PHS HHS [PSDGM071558] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BANKER G, 1998, CULTURING NERVE CELL; Berg, 2018, RANDOM WALKS BIOL; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Byron Bird R, 2007, TRANSPORT PHENOMENA, V2nd, DOI DOI 10.1002/AIC.690070245; Cancela JM, 2002, EMBO J, V21, P909, DOI 10.1093/emboj/21.5.909; CORBIN JD, 1977, J BIOL CHEM, V252, P3854; Craske ML, 2005, J CELL BIOL, V170, P1147, DOI 10.1083/jcb.200503118; DUNCAN GE, 1991, BRAIN RES, V561, P84, DOI 10.1016/0006-8993(91)90752-H; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Goentoro LA, 2006, DEV CELL, V11, P263, DOI 10.1016/j.devcel.2006.07.004; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; KEELY SL, 1979, MOL PHARMACOL, V15, P235; LEVENSPIEL O, 1995, CHEM REACTION ENG; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Loew LM, 2001, TRENDS BIOTECHNOL, V19, P401, DOI 10.1016/S0167-7799(01)01740-1; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MALETICSAVATIC M, 1995, J NEUROSCI, V15, P3840; Marsault R, 1997, EMBO J, V16, P1575, DOI 10.1093/emboj/16.7.1575; Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Nagai Y, 2000, NAT BIOTECHNOL, V18, P313, DOI 10.1038/73767; NEVES SR, 2006, THESIS MOUNT SINAI S; Nika K, 2004, BIOCHEM J, V378, P335, DOI 10.1042/BJ20031244; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Onsum MD, 2006, PHYS BIOL, V3, P190, DOI 10.1088/1478-3975/3/3/004; ORDWAY GA, 1988, J PHARMACOL EXP THER, V247, P379; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; Pulido R, 1998, EMBO J, V17, P7337, DOI 10.1093/emboj/17.24.7337; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; Remy S, 2007, P NATL ACAD SCI USA, V104, P17192, DOI 10.1073/pnas.0707919104; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; Slepchenko BM, 2002, ANNU REV BIOPH BIOM, V31, P423, DOI 10.1146/annurev.biophys.31.101101.140930; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	53	205	206	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					666	680		10.1016/j.cell.2008.04.025	http://dx.doi.org/10.1016/j.cell.2008.04.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485874	Green Accepted, Bronze			2022-12-28	WOS:000255903300021
J	Tang, Y; Zhao, WH; Chen, Y; Zhao, YM; Gu, W				Tang, Yi; Zhao, Wenhui; Chen, Yue; Zhao, Yingming; Gu, Wei			Acetylation is indispensable for p53 activation	CELL			English	Article							DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; NEGATIVE REGULATOR; TUMOR-SUPPRESSOR; CELL-SURVIVAL; IN-VIVO; MDM2; PHOSPHORYLATION	The activation of the tumor suppressor p53 facilitates the cellular response to genotoxic stress; however, the p53 response can only be executed if its interaction with its inhibitor Mdm2 is abolished. There have been conflicting reports on the question of whether p53 posttranslational modifications, such as phosphorylation or acetylation, are essential or only play a subtle, fine-tuning role in the p53 response. Thus, it remains unclear whether p53 modification is absolutely required for its activation. We have now identified all major acetylation sites of p53. Although unacetylated p53 retains its ability to induce the p53-Mdm2 feedback loop, loss of acetylation completely abolishes p53-dependent growth arrest and apoptosis. Notably, acetylation of p53 abrogates Mdm2-mediated repression by blocking the recruitment of Mdm2 to p53-responsive promoters, which leads to p53 activation independent of its phosphorylation status. Our study identifies p53 acetylation as an indispensable event that destabilizes the p53-Mdm2 and enables the p53-mediated stress response.	[Tang, Yi; Zhao, Wenhui; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Chen, Yue; Zhao, Yingming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Columbia University; Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA.	wg8@columbia.edu		ZHAO, WENHUI/0000-0002-7703-7106; Tang, Yi/0000-0002-3561-8447	NCI NIH HHS [R01 CA126832-01A1, R01 CA126832] Funding Source: Medline; NIDDK NIH HHS [R01 DK082664-01, R01 DK082664] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Aparicio O, 2004, CURR PROTOC CELL BIO, V17; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; EL DW, 1993, CELL, V75, P817; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; LUNA RMD, 1995, NATURE, V378, P203; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Prives C, 1999, J PATHOL, V187, P112; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wu ZQ, 2002, MOL CELL BIOL, V22, P2441, DOI 10.1128/MCB.22.8.2441-2449.2002; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zupnick A, 2006, J BIOL CHEM, V281, P20464, DOI 10.1074/jbc.M603387200	53	635	658	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					612	626		10.1016/j.cell.2008.03.025	http://dx.doi.org/10.1016/j.cell.2008.03.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485870	Bronze, Green Accepted			2022-12-28	WOS:000255903300017
J	Riddler, SA; Haubrich, R; DiRienzo, AG; Peeples, L; Powderly, WG; Klingman, KL; Garren, KW; George, T; Rooney, JF; Brizz, B; Lalloo, UG; Murphy, RL; Swindells, S; Havlir, D; Mellors, JW				Riddler, Sharon A.; Haubrich, Richard; DiRienzo, A. Gregory; Peeples, Lynne; Powderly, William G.; Klingman, Karin L.; Garren, Kevin W.; George, Tania; Rooney, James F.; Brizz, Barbara; Lalloo, Umesh G.; Murphy, Robert L.; Swindells, Susan; Havlir, Diane; Mellors, John W.		AIDS Clin Trials Grp Study A5142 T	Class-sparing regimens for initial treatment of HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; PROTEASE INHIBITORS; CLINICAL-TRIALS; PLUS STAVUDINE; EFAVIRENZ; LOPINAVIR/RITONAVIR; NELFINAVIR; LAMIVUDINE; RESISTANCE; THERAPY	Background: The use of either efavirenz or lopinavir-ritonavir plus two nucleoside reverse-transcriptase inhibitors (NRTIs) is recommended for initial therapy for patients with human immunodeficiency virus type 1 (HIV-1) infection, but which of the two regimens has greater efficacy is not known. The alternative regimen of lopinavir-ritonavir plus efavirenz may prevent toxic effects associated with NRTIs. Methods: In an open-label study, we compared three regimens for initial therapy: efavirenz plus two NRTIs (efavirenz group), lopinavir-ritonavir plus two NRTIs (lopinavir-ritonavir group), and lopinavir-ritonavir plus efavirenz (NRTI-sparing group). We randomly assigned 757 patients with a median CD4 count of 191 cells per cubic millimeter and a median HIV-1 RNA level of 4.8 log(10) copies per milliliter to the three groups. Results: At a median follow-up of 112 weeks, the time to virologic failure was longer in the efavirenz group than in the lopinavir-ritonavir group (P=0.006) but was not significantly different in the NRTI-sparing group from the time in either of the other two groups. At week 96, the proportion of patients with fewer than 50 copies of plasma HIV-1 RNA per milliliter was 89% in the efavirenz group, 77% in the lopinavir-ritonavir group, and 83% in the NRTI-sparing group (P=0.003 for the comparison between the efavirenz group and the lopinavir-ritonavir group). The groups did not differ significantly in the time to discontinuation because of toxic effects. At virologic failure, antiretroviral resistance mutations were more frequent in the NRTI-sparing group than in the other two groups. Conclusions: Virologic failure was less likely in the efavirenz group than in the lopinavir-ritonavir group. The virologic efficacy of the NRTI-sparing regimen was similar to that of the efavirenz regimen but was more likely to be associated with drug resistance. (ClinicalTrials.gov number, NCT00050895.).	[Riddler, Sharon A.; Mellors, John W.] Univ Pittsburgh, Pittsburgh, PA USA; [Haubrich, Richard] Univ Calif San Diego, San Diego, CA 92103 USA; [DiRienzo, A. Gregory; Peeples, Lynne] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Powderly, William G.] Univ Coll Dublin, Dublin 2, Ireland; [Klingman, Karin L.] NIAID, Div Aids, Bethesda, MD 20892 USA; [Garren, Kevin W.] Abbott Labs, Abbott Pk, IL 60064 USA; [George, Tania] Bristol Myers Squibb Co, Plainsboro, NJ USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Brizz, Barbara] Social & Sci Syst, Silver Spring, MD USA; [Lalloo, Umesh G.] Univ KwaZulu Natal, Durban, South Africa; [Murphy, Robert L.] Northwestern Univ, Chicago, IL 60611 USA; [Swindells, Susan] Univ Nebraska Med Ctr, Omaha, NE USA; [Havlir, Diane] Univ Calif San Francisco, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; University College Dublin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Abbott Laboratories; Bristol-Myers Squibb; Gilead Sciences; Social & Scientific Systems; University of Kwazulu Natal; Northwestern University; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California San Francisco	Riddler, SA (corresponding author), 613 Falk Bldg,3601 5th Ave, Pittsburgh, PA 15213 USA.	riddler@dom.pitt.edu		Murphy, Robert/0000-0003-3936-2052; Powderly, William/0000-0001-7808-3086	NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NCRR NIH HHS [RR 02635, RR 00075, RR 00047, RR 00051, M01 RR002635, RR 00096, M01 RR000044, RR 00052, M01 RR000051, M01 RR000039, M01 RR000047, RR 00032, M01 RR000096, M01 RR000046, RR 00039, RR 00044, M01 RR000052, M01 RR000032, RR 00046] Funding Source: Medline; NIAID NIH HHS [AI 069439, UM1 AI069419, U01 AI069411, AI 069418, U01 AI069424, U01 AI032782, UM1 AI069465, UM1 AI069532, UM1 AI069450, U01 AI025859, UM1 AI069502, AI 068636, P30 AI036214, AI 27661, U01 AI027673, AI 069450, U01 AI046381, AI 069432, UM1 AI069556, AI 069470, U01 AI069495, AI 45008, AI 069484, UM1 AI069452, U01 AI034853, UM1 AI069474, U01 AI068636, AI 069495, U01 AI046370, U01 AI038858, AI 25859, U01 AI069432, UM1 AI069477, AI 46376, UM1 AI069484, U01 AI069501, UM1 AI068634, UM1 AI069470, AI 069472, P30 AI045008, AI 064086, AI 50410, UM1 AI069439, U01 AI069532, AI 069501, AI 069411, U01 AI069418, AI 069471, U01 AI069556, U01 AI069439, AI 36214, UM1 AI069471, U01 AI069484, AI 069494, AI 069556, UM1 AI069495, U01 AI069470, AI 068634, UM1 AI069411, AI 069477, AI 46381, AI 069434, UM1 AI069432, K24 AI064086, AI 34853, UM1 AI069434, U01 AI069465, AI 32782, AI 069447, AI 069452, UM1 AI069424, AI 27673, AI 060354, AI 069423, U01 AI069434, AI 069465, UM1 AI069513, U01 AI069423, UM1 AI069501, U01 AI069447, U01 AI069474, UM1 AI069472, UM1 AI069423, UM1 AI069494, AI 069419, U01 AI069513, U01 AI069477, AI 069424, P30 AI060354, AI 069502, UM1 AI069418, AI 38858, P30 AI050410, U01 AI069419, AI 069532, U01 AI069494, UM1 AI068636, UM1 AI069447, U01 AI032783, AI 069513, U01 AI069471, U01 AI069472, AI 069474, U01 AI068634, U01 AI069452, AI 46370, U01 AI027661, U01 AI069502, AI 32783, U01 AI069450, U01 AI046376] Funding Source: Medline; NIDA NIH HHS [DA 12121] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635, M01RR000046, M01RR000096, M01RR000047, M01RR000039, M01RR000051, M01RR000044, M01RR000052, M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, UM1AI069419, U01AI046381, U01AI032782, U01AI027661, U01AI069556, U01AI069411, U01AI032783, U01AI069474, UM1AI069439, U01AI069452, UM1AI069513, U01AI069513, UM1AI069532, U01AI068636, U01AI069450, P30AI060354, UM1AI069502, UM1AI069501, UM1AI069447, UM1AI069432, U01AI046370, UM1AI069477, U01AI069477, UM1AI069471, U01AI034853, U01AI069471, U01AI038858, UM1AI068634, U01AI069495, U01AI069472, U01AI069423, UM1AI069424, U01AI069439, K24AI064086, UM1AI069423, U01AI068634, UM1AI069450, U01AI046376, P30AI045008, U01AI069484, U01AI069418, U01AI069470, U01AI069494, UM1AI069470, UM1AI069495, U01AI069434, U01AI069465, UM1AI069472, U01AI027673, U01AI069532, UM1AI069465, UM1AI069452, U01AI069419, UM1AI069474, U01AI069502, U01AI069447, P30AI036214, UM1AI068636, UM1AI069494, U01AI069432, UM1AI069556, UM1AI069418, U01AI025859, U01AI069501, UM1AI069434, UM1AI069411, U01AI069424, UM1AI069484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012121] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allavena C, 2005, JAIDS-J ACQ IMM DEF, V39, P300, DOI 10.1097/01.qai.0000165914.42827.bb; *BRIST MYERS SQUIB, 2006, SUST TABL; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; DiRienzo AG, 2003, CONTROL CLIN TRIALS, V24, P122, DOI 10.1016/S0197-2456(02)00321-5; Dube MP, 2005, AIDS, V19, P1807, DOI 10.1097/01.aids.0000183629.20041.bb; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HAUBRICH RH, 2007, 14 C RETR OPP INF LO; Hicks C, 2004, AIDS, V18, P775, DOI 10.1097/00002030-200403260-00008; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Murphy RL, 2001, AIDS, V15, pF1, DOI 10.1097/00002030-200101050-00002; *PAN CLIN PRACT TR, 2006, GUID US ANT AG HIV 1; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; STEIN JH, 2005, CIRCULATION, V112, P237; Vlahakis SR, 2007, CLIN PHARMACOL THER, V82, P294, DOI 10.1038/sj.clpt.6100140; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354	20	548	562	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2095	2106		10.1056/NEJMoa074609	http://dx.doi.org/10.1056/NEJMoa074609			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480202	Green Accepted			2022-12-28	WOS:000255849300003
J	Biegler, P				Biegler, Paul			Autonomy, stress, and treatment of depression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MAJOR DEPRESSION; LIFE EVENTS; EPISODES; NEED		Monash Univ, Sch Philosophy & Bioeth, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia; Sandringham Hosp, Emergency Dept, Sandringham, Vic, Australia	Monash University	Biegler, P (corresponding author), Monash Univ, Sch Philosophy & Bioeth, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia.	pbiegler@bigpond.net.au						ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; ANDERSEN SM, 1992, J PERS SOC PSYCHOL, V63, P711, DOI 10.1037/0022-3514.63.5.711; [Anonymous], 1986, HIST THEORY INFORM C; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; DIMIDJIAN S, 2004, COGNITIVE THERAPY LI, P477; ELLIOTT C, 2003, BETTER WELL AM MED M, P260; Ellis PM, 2004, AUST NZ J PSYCHIAT, V38, P389, DOI 10.1080/j.1440-1614.2004.01377.x; Fu T, 2005, J PSYCHOPATHOL BEHAV, V27, P243, DOI 10.1007/s10862-005-2404-x; Griffin J., 1986, WELL BEING ITS MEANI; Harmer CJ, 2004, AM J PSYCHIAT, V161, P1256, DOI 10.1176/appi.ajp.161.7.1256; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Holmes J, 2002, BRIT MED J, V324, P288, DOI 10.1136/bmj.324.7332.288; Kendler KS, 2000, AM J PSYCHIAT, V157, P1243, DOI 10.1176/appi.ajp.157.8.1243; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Lazarus RS., 1984, STRESS APPRAISAL COP; LAZARUS RS, 1994, NATURE EMOTION FUNDA, P208; MacLeod AK, 1997, CLIN PSYCHOL PSYCHOT, V4, P15, DOI 10.1002/(SICI)1099-0879(199703)4:1<15::AID-CPP112>3.0.CO;2-#; Matschinger H, 1996, SOC PSYCH PSYCH EPID, V31, P309, DOI 10.1007/BF00783418; Mitchell PB, 2003, J AFFECT DISORDERS, V73, P245, DOI 10.1016/S0165-0327(01)00479-7; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Nierenberg AA, 2000, PSYCHIAT CLIN N AM, V23, P731, DOI 10.1016/S0193-953X(05)70194-5; Scott J, 2006, BMJ-BRIT MED J, V332, P985, DOI 10.1136/bmj.332.7548.985; Van Praag HM, 2005, WORLD J BIOL PSYCHIA, V6, P5, DOI [10.1080/15622970510030018, 10.1016/j.pnpbp.2004.05.031]; Young Robert., 1986, PERSONAL AUTONOMY NE	26	5	6	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2008	336	7652					1046	1048		10.1136/bmj.39541.470023.AD	http://dx.doi.org/10.1136/bmj.39541.470023.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	304IN	18467412	Green Published			2022-12-28	WOS:000256103300026
J	Phares, CR; Lynfield, R; Farley, MM; Mohle-Boetani, J; Harrison, LH; Petit, S; Craig, AS; Schaffner, W; Zansky, SM; Gershman, K; Stefonek, KR; Albanese, BA; Zell, ER; Schuchat, A; Schrag, SJ				Phares, Christina R.; Lynfield, Ruth; Farley, Monica M.; Mohle-Boetani, Janet; Harrison, Lee H.; Petit, Susan; Craig, Allen S.; Schaffner, William; Zansky, Shelley M.; Gershman, Ken; Stefonek, Karen R.; Albanese, Bernadette A.; Zell, Elizabeth R.; Schuchat, Anne; Schrag, Stephanie J.			Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOXOID CONJUGATE VACCINE; RISK-FACTORS; IMMUNE-RESPONSE; PREGNANT-WOMEN; INFECTIONS; IMMUNOGENICITY; SURVEILLANCE; PREVENTION; ADULTS; STRATEGIES	Context Group B streptococcus is a leading infectious cause of morbidity in newborns and causes substantial disease in elderly individuals. Guidelines for prevention of perinatal disease through intrapartum chemoprophylaxis were revised in 2002. Candidate vaccines are under development. Objective To describe disease trends among populations that might benefit from vaccination and among newborns during a period of evolving prevention strategies. Design and Setting Analysis of active, population- based surveillance in 10 states participating in the Active Bacterial Core surveillance/ Emerging Infections Program Network. Main Outcome Measures Age- and race- specific incidence of invasive group B streptococcal disease. Results There were 14 573 cases of invasive group B streptococcal disease during 1999- 2005, including 1348 deaths. The incidence of invasive group B streptococcal disease among infants from birth through 6 days decreased from 0.47 per 1000 live births in 1999- 2001 to 0.34 per 1000 live births in 2003- 2005 ( P <. 001), a relative reduction of 27% ( 95% confidence interval [ CI], 16%- 37%). Incidence remained stable among infants aged 7 through 89 days ( mean, 0.34 per 1000 live births) and pregnant women ( mean, 0.12 per 1000 live births). Among persons aged 15 through 64 years, disease incidence increased from 3.4 per 100 000 population in 1999 to 5.0 per 100 000 in 2005 ( chi(2)(1) for trend, 57; P <. 001), a relative increase of 48% ( 95% CI, 32%-65%). Among adults 65 years or older, incidence increased from 21.5 per 100 000 to 26.0 per 100 000 ( chi(2)(1) for trend, 15; P <. 001), a relative increase of 20% ( 95% CI, 8%-35%). All 4882 isolates tested were susceptible to penicillin, ampicillin, and vancomycin, but 32% and 15% were resistant to erythromycin and clindamycin, respectively. Serotypes Ia, Ib, II, III, and V accounted for 96% of neonatal cases and 88% of adult cases. Conclusions Among infants from birth through 6 days, the incidence of group B streptococcal disease was lower in 2003- 2005 relative to 1999-2001. This reduction coincided with the release of revised disease prevention guidelines in 2002. However, the disease burden in adults is substantial and increased significantly during the study period.	[Phares, Christina R.] Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Off Workforce & Career Dev, Div Bacterial Dis,Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Phares, Christina R.; Schuchat, Anne; Schrag, Stephanie J.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Zell, Elizabeth R.] Ctr Dis Control & Prevent, Biostat & Informat Management Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Farley, Monica M.] Emory Univ, Sch Med, Atlanta, GA USA; [Farley, Monica M.] Vet Affairs Med Ctr, Georgia Emerging Infect Program, Atlanta, GA 30033 USA; [Mohle-Boetani, Janet] Calif Dept Hlth Serv, Infect Dis Branch, Richmond, CA USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Petit, Susan] Connecticut Dept Publ Hlth, Emerging Infect Program, Hartford, CT USA; [Craig, Allen S.] Tennessee Dept Hlth, Nashville, TN USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA; [Zansky, Shelley M.] New York State Dept Hlth, Albany, NY USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Stefonek, Karen R.] Oregon Publ Hlth Serv, Portland, OR USA; [Albanese, Bernadette A.] New Mexico Dept Hlth, Emerging Infect Program, Santa Fe, NM USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; California Department of Health Care Services; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tennessee Department Health; Vanderbilt University; State University of New York (SUNY) System; Colorado Department of Public Health & Environment; New Mexico Department of Health	Phares, CR (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv Program, Off Workforce & Career Dev, Div Bacterial Dis,Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop E-03, Atlanta, GA 30333 USA.	cphares@cdc.gov	Mohle-Boetani, Janet/AAH-4221-2019					*AM COLL OBST GYN, 1996, PREV EARL ONS GROUP; Baker CJ, 2007, VACCINE, V25, P55, DOI 10.1016/j.vaccine.2006.07.018; Baker CJ, 1999, J INFECT DIS, V179, P142, DOI 10.1086/314574; Baker CJ, 2004, J INFECT DIS, V189, P1103, DOI 10.1086/382193; Baker CJ, 2003, VACCINE, V21, P3468, DOI 10.1016/S0264-410X(03)00353-0; Baker CJ, 2003, J INFECT DIS, V188, P66, DOI 10.1086/375536; Baker CJ, 2000, J INFECT DIS, V182, P1129, DOI 10.1086/315839; Blumberg HM, 1996, J INFECT DIS, V173, P365, DOI 10.1093/infdis/173.2.365; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1205; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P679; Centers for Diseases Control and Prevention, 2006, ACT BACT COR SURV AB; Centre for Disease Control and Prevention [Internet], ACT BACT COR SURV SU; Davies HD, 2001, PEDIATR INFECT DIS J, V20, P879, DOI 10.1097/00006454-200109000-00011; DILLON HC, 1982, J INFECT DIS, V145, P794, DOI 10.1093/infdis/145.6.794; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Eisenberg E, 2005, PEDIATR INFECT DIS J, V24, P520, DOI 10.1097/01.inf.0000164765.12808.26; FARLEY MM, 1993, NEW ENGL J MED, V328, P1807, DOI 10.1056/NEJM199306243282503; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Halsey NA, 1997, PEDIATRICS, V99, P489, DOI 10.1542/peds.99.3.489; Harrison LH, 1998, J INFECT DIS, V177, P998, DOI 10.1086/515260; HEARD SR, 1993, J CLIN PATHOL, V46, P145, DOI 10.1136/jcp.46.2.145; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; JORDAN H, 2006, 44 ANN M INF DIS SOC, P169; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kaspar DL, 1996, J CLIN INVEST, V98, P2308, DOI 10.1172/JCI119042; Lin FYC, 2003, J INFECT DIS, V188, P267, DOI 10.1086/376457; Locksmith GJ, 1999, AM J OBSTET GYNECOL, V180, P416, DOI 10.1016/S0002-9378(99)70225-5; *NCCLS, 2002, NCCLS PERF STAND ANT; Newton ER, 1996, OBSTET GYNECOL, V88, P577, DOI 10.1016/0029-7844(96)00264-5; Palazzi DL, 2004, J INFECT DIS, V190, P558, DOI 10.1086/422010; Paoletti LC, 2001, INFECT IMMUN, V69, P6696, DOI 10.1128/IAI.69.11.6696-6701.2001; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reingold A., 2007, Morbidity and Mortality Weekly Report, V56, P701; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; SCHUCHAT A, 1990, J INFECT DIS, V162, P672, DOI 10.1093/infdis/162.3.672; SCHUCHAT A, 1994, EPIDEMIOL REV, V16, P374, DOI 10.1093/oxfordjournals.epirev.a036159; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; SCHWARTZ B, 1991, JAMA-J AM MED ASSOC, V266, P1112, DOI 10.1001/jama.266.8.1112; Slotved HC, 2003, J CLIN MICROBIOL, V41, P4445, DOI 10.1128/JCM.41.9.4445-4447.2003; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P1177, DOI 10.1128/JCM.43.3.1177-1186.2005; Tyrrell GJ, 2000, J INFECT DIS, V182, P168, DOI 10.1086/315699; Zaleznik DF, 2000, CLIN INFECT DIS, V30, P276, DOI 10.1086/313665	45	601	636	2	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2056	2065		10.1001/jama.299.17.2056	http://dx.doi.org/10.1001/jama.299.17.2056			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460666	Bronze			2022-12-28	WOS:000255552700022
J	Silberschmidt, G; Matheson, D; Kickbusch, I				Silberschmidt, Gaudenz; Matheson, Don; Kickbusch, Ilona			Creating a committee C of the World Health Assembly	LANCET			English	Editorial Material									[Silberschmidt, Gaudenz] Fed Hlth Publ Off, Fed Dept Home Affairs, CH-3011 Bern, Switzerland; [Matheson, Don] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Kickbusch, Ilona] Grad Inst Int & Dev Studies, Geneva, Switzerland	University of Otago	Silberschmidt, G (corresponding author), Fed Hlth Publ Off, Fed Dept Home Affairs, CH-3011 Bern, Switzerland.	gaudenz.silberschmidt@bag.admin.ch						Eiseman E, 2005, CHALLENGES CREATING; Garrett L, 2007, FOREIGN AFF, V86, P14; Kickbusch I, 2000, SOC SCI MED, V51, P979, DOI 10.1016/S0277-9536(00)00076-9; Kirton JJ, 2007, B WORLD HEALTH ORGAN, V85, P192, DOI 10.2471/BLT.06.039917; *UN JOINT INSP UN, 2006, UN HUM ASS PROGR DIS; World Health Organisation, WHO DOC; World Health Organization, 2006, BAS DOC; World Health Organization, 2005, WHO FRAM CONV TOB CO; World Health Organization (WHO), 2016, INT HLTH REG 2005	9	31	31	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1483	1486		10.1016/S0140-6736(08)60634-0	http://dx.doi.org/10.1016/S0140-6736(08)60634-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456086				2022-12-28	WOS:000255668300007
J	Winyard, G; Maynard, A				Winyard, Graham; Maynard, Alan			Does it matter that medical graduates don't get jobs as doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Maynard, Alan] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK		gwinyard@doctors.org.uk; akm3@york.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2008	336	7651					990	991		10.1136/bmj.39555.457060.AD	http://dx.doi.org/10.1136/bmj.39555.457060.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300EZ	18456628	Green Published			2022-12-28	WOS:000255808400035
J	Salzman, H; Lowell, L				Salzman, Hal; Lowell, Lindsay			Making the grade	NATURE			English	Editorial Material									[Salzman, Hal] Urban Inst, Washington, DC 20037 USA; [Lowell, Lindsay] Georgetown Univ, Inst Study Int Migrat, Washington, DC 20007 USA	Urban Institute; Georgetown University	Salzman, H (corresponding author), Urban Inst, 2100 M St NW, Washington, DC 20037 USA.							Boe EE, 2005, PHI DELTA KAPPAN, V86, P688, DOI 10.1177/003172170508600913; Kaiser D, 2006, SOC RES, V73, P1225; LIM M, 2007, INT AFFAIRS J U 0629; Lowell B.L., 2007, EYE STORM ASSESSING; Lynn L, 2006, ISSUES SCI TECHNOL, V22, P74; *OECD, 2008, PISA 2006 COMP TOM W; OECD, 2004, LEARN TOM WORLD 1 RE	7	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					28	30		10.1038/453028a	http://dx.doi.org/10.1038/453028a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451836	Bronze			2022-12-28	WOS:000255398800022
J	Zahn, LM; Hines, PJ; Pennisi, E; Travis, J				Zahn, Laura M.; Hines, Pamela J.; Pennisi, Elizabeth; Travis, John			Green genes - Introduction	SCIENCE			English	Editorial Material																			0	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					465	465		10.1126/science.320.5875.465	http://dx.doi.org/10.1126/science.320.5875.465			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436766				2022-12-28	WOS:000255249300027
J	Harrison, JL; Hoen, B; Prendergast, BD				Harrison, James L.; Hoen, Bruno; Prendergast, Bernard D.			Antibiotic prophylaxis for infective endocarditis	LANCET			English	Editorial Material							BACTEREMIA; PREVENTION; GUIDELINES; ADULTS; RISK		[Prendergast, Bernard D.] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; [Harrison, James L.] St Marys Hosp, Dept Cardiol, London W2 1NY, England; [Hoen, Bruno] Univ Franche Comte, Hop St Jacques, Serv Malad Infect & Trop, F-25030 Besancon, France	University of Oxford; Imperial College London; Universite de Franche-Comte; CHU Besancon	Prendergast, BD (corresponding author), John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England.	bernard.prendergast@orh.nhs.uk						AHLSTEDT S, 1984, ALLERGY, V39, P151, DOI 10.1111/j.1398-9995.1984.tb02619.x; Danchin N, 2005, HEART, V91, P715, DOI 10.1136/hrt.2003.033183; Duval X, 2006, CLIN INFECT DIS, V42, pE102, DOI 10.1086/504385; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Gould FK, 2006, J ANTIMICROB CHEMOTH, V57, P1035, DOI 10.1093/jac/dkl121; Hoen B, 2006, HEART, V92, P1694, DOI 10.1136/hrt.2005.072595; Lacassin F, 1995, EUR HEART J, V16, P1968, DOI 10.1093/oxfordjournals.eurheartj.a060855; Martin MV, 2007, BRIT DENT J, V203, DOI 10.1038/bdj.2007.123; Martin M, 2006, BRIT DENT J, V200, P471, DOI 10.1038/sj.bdj.4813621; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; NICE-Short_Clinical_Guidelines_Technical_Team, 2008, PROPH INF END ANT PR; OLIVER R, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003813.PUB2; Prendergast BD, 2006, HEART, V92, P879, DOI 10.1136/hrt.2005.067256; Roberts GJ, 2006, HEART, V92, P1274, DOI 10.1136/hrt.2004.046581; Roberts GJ, 1999, PEDIATR CARDIOL, V20, P317, DOI 10.1007/s002469900477; Strom BL, 1998, ANN INTERN MED, V129, P761, DOI 10.7326/0003-4819-129-10-199811150-00002; VANDERMEER JTM, 1992, LANCET, V339, P135, DOI 10.1016/0140-6736(92)90207-J; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	19	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1317	1319		10.1016/S0140-6736(08)60574-7	http://dx.doi.org/10.1016/S0140-6736(08)60574-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424310	Green Accepted			2022-12-28	WOS:000255208500007
J	Mukherjee, K; Sharma, M; Urlaub, H; Bourenkov, GP; Jahn, R; Sudhof, TC; Wahl, MC				Mukherjee, Konark; Sharma, Manu; Urlaub, Henning; Bourenkov, Gleb P.; Jahn, Reinhard; Suedhof, Thomas C.; Wahl, Markus C.			CASK functions as a Mg2+-independent neurexin kinase	CELL			English	Article							DEPENDENT PROTEIN-KINASE; SYNAPTIC VESICLE EXOCYTOSIS; BASOLATERAL MEMBRANE; ACTIVATION SEGMENT; NUCLEOTIDE-BINDING; ADHESION MOLECULE; CATALYTIC DOMAIN; EPITHELIAL-CELLS; CASK/LIN-2; COMPLEX	CASK is a unique MAGUK protein that contains an N-terminal CaM-kinase domain besides the typical MAGUK domains. The CASK CaM-kinase domain is presumed to be a catalytically inactive pseudokinase because it lacks the canonical DFG motif required for Mg2+ binding that is thought to be indispensable for kinase activity. Here we show, however, that CASK functions as an active protein kinase even without Mg2+ binding. High-resolution crystal structures reveal that the CASK CaM-kinase domain adopts a constitutively active conformation that binds ATP and catalyzes phosphotransfer without Mg2+. The CASK CaM-kinase domain phosphorylates itself and at least one physiological interactor, the synaptic protein neurexin-1, to which CASK is recruited via its PDZ domain. Thus, our data indicate that CASK combines the scaffolding activity of MAGUKs with an unusual kinase activity that phosphorylates substrates recuited by the scaffolding activity. Moreover, our study suggests that other pseudokinases (10% of the kinome) could also be catalytically active.	[Mukherjee, Konark; Sharma, Manu; Suedhof, Thomas C.] Univ Texas SW Med Ctr Dallas, Dept Nuerosci, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Mukherjee, Konark; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Res Grp Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Wahl, Markus C.] Max Planck Inst Biophys Chem, Res Grp Xray Crystallog, D-37077 Gottingen, Germany; [Wahl, Markus C.] Univ Gottingen, Dept Med, D-37077 Gottingen, Germany	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen	Mukherjee, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Nuerosci, Howard Hughes Med Inst, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	konark.mukherjee@utsouthwestern..edu; thomas.sudhof@utsouthwestern.edu; mwahl@gwdg.de	Wahl, Markus C./D-6365-2017; Bourenkov, Gleb P/C-7794-2017	Wahl, Markus C./0000-0002-2811-5307; Bourenkov, Gleb P/0000-0002-2617-5920; Jahn, Reinhard/0000-0003-1542-3498	NIMH NIH HHS [R37 MH052804-08, R37 MH52804-08, R37 MH052804] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Dimitratos SD, 1998, GENOMICS, V51, P308, DOI 10.1006/geno.1998.5404; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gotoh H, 1999, BRAIN RES, V828, P163, DOI 10.1016/S0006-8993(99)01298-6; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANLEY RM, 1988, BIOCHEM BIOPH RES CO, V152, P122, DOI 10.1016/S0006-291X(88)80688-0; Hata Y, 1996, J NEUROSCI, V16, P2488; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Hoskins R, 1996, DEVELOPMENT, V122, P97; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jauch R, 2006, EMBO J, V25, P4020, DOI 10.1038/sj.emboj.7601285; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; KWIATKOWSKI AP, 1987, BIOCHEMISTRY-US, V26, P7636, DOI 10.1021/bi00398a016; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lopes C, 2001, BIOCHEM BIOPH RES CO, V284, P1004, DOI 10.1006/bbrc.2001.5050; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Martinez-Estrada OM, 2001, J BIOL CHEM, V276, P9291, DOI 10.1074/jbc.M006991200; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olsen O, 2006, CURR OPIN CELL BIOL, V18, P223, DOI 10.1016/j.ceb.2006.02.010; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Tereshko V, 2001, NAT STRUCT BIOL, V8, P899, DOI 10.1038/nsb1001-899; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Waas WF, 2004, BBA-PROTEINS PROTEOM, V1697, P81, DOI 10.1016/j.bbapap.2003.11.015; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; Zordan MA, 2005, J NEUROPHYSIOL, V94, P1074, DOI 10.1152/jn.00954.2004	53	193	200	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					328	339		10.1016/j.cell.2008.02.036	http://dx.doi.org/10.1016/j.cell.2008.02.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423203	Bronze, Green Accepted			2022-12-28	WOS:000255052000021
J	Coustan, DR				Coustan, Donald R.			A 40-year-old woman with diabetes contemplating pregnancy after gastric bypass surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PIMA INDIAN WOMEN; CONGENITAL-MALFORMATIONS; PRECONCEPTION CARE; CLOMIPHENE CITRATE; INTERNAL HERNIA; INSULIN LISPRO; DOUBLE-BLIND; MELLITUS; METFORMIN; GLYBURIDE	Mrs T is a 40- year- old woman with type 2 diabetes and chronic hypertension who has had a gastric bypass procedure and is planning to conceive. She would like to know whether she can continue using metformin during the pregnancy and also is concerned about the effect of the gastric bypass surgery. This article discusses the management of diabetes prior to and during pregnancy, including appropriate preconception evaluation and the use of insulin and oral antidiabetic agents. The implications of gastric bypass surgery for pregnancy are also outlined. Important aspects include the need to optimize metabolic control prior to conception, to evaluate and treat vascular complications of diabetes prior to conception, and to provide the services of a health care team to gravid women with diabetes. Gastric bypass surgery with subsequent weight loss is likely to ameliorate type 2 diabetes, and special attention must be paid to nutrition when women who have undergone such procedures become pregnant.	Women & Infants Hosp Rhode Isl, Providence, RI 02905 USA; Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Women & Infants Hospital Rhode Island; Brown University	Coustan, DR (corresponding author), Women & Infants Hosp Rhode Isl, 101 Dudley St, Providence, RI 02905 USA.	dcoustan@wihri.org						ACOG Committee on Practice Bulletins, 2004, Obstet Gynecol, V104, P1449; Ahmed AR, 2006, OBES SURG, V16, P1246, DOI 10.1381/096089206778392310; *AM COLL OBST GYN, 2003, OBSTET GYNECOL, V102, P203; *AM COLL OBST GYN, 2004, OBSTET GYNECOL, V104, P203; *AM DIAB ASS, 2007, DIABETES CARE S1, V31, pS12; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS76; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], 2001, OBSTET GYNECOL, V98, P177; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boskovic R, 2003, DIABETES CARE, V26, P1390, DOI 10.2337/diacare.26.5.1390; Bouldin MJ, 2006, AM J MED SCI, V331, P183, DOI 10.1097/00000441-200604000-00004; Briggs GG, 2005, OBSTET GYNECOL, V105, P1437, DOI 10.1097/01.AOG.0000163249.65810.5b; BRIGGS GG, 2005, DRUGS PREGNANCY LACT, P1020; CARPENTER MW, 2004, DIABETES WOMEN, P283; CATALANO PM, 2004, DIABETES WOMEN, P129; *CDCP, PREV DIAGN DIAB PER; Chan LYS, 2005, FERTIL STERIL, V83, P955, DOI 10.1016/j.fertnstert.2004.10.045; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Conway D L, 2004, J Matern Fetal Neonatal Med, V15, P51; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Cousins L, 1992, J Perinatol, V12, P173; Coustan DR, 2007, DIABETES CARE, V30, pS206, DOI 10.2337/dc07-s217; COUSTAN DR, 2004, DIABETES WOMEN, P205; DEVECIANA M, 1995, NEW ENGL J MED, V333, P1237, DOI 10.1056/NEJM199511093331901; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; ELIXHAUSER A, 1993, DIABETES CARE, V16, P1146, DOI 10.2337/diacare.16.8.1146; ELLIOTT BD, 1991, AM J OBSTET GYNECOL, V165, P807, DOI 10.1016/0002-9378(91)90421-M; Feig DS, 2005, DIABETES CARE, V28, P1851, DOI 10.2337/diacare.28.8.1851; Fujioka K, 2005, DIABETES CARE, V28, P481, DOI 10.2337/diacare.28.2.481; Gabbe SG, 2003, OBSTET GYNECOL, V102, P857, DOI 10.1016/j.obstetgynecol.2003.07.001; Galan HL, 2004, DIABETES WOMEN, P159; Gurewitsch ED, 1996, OBSTET GYNECOL, V88, P658, DOI 10.1016/0029-7844(96)00187-1; HAGUE WM, METFORMIN CROSSES PL; Hale TW, 2002, DIABETOLOGIA, V45, P1509, DOI 10.1007/s00125-002-0939-x; Hebert MF, 2007, AM J OBSTET GYNECOL, V197, pS25, DOI 10.1016/j.ajog.2007.10.060; Jovanovic L, 1999, DIABETES CARE, V22, P1422, DOI 10.2337/diacare.22.9.1422; Jovanovic L, 2005, DIABETOLOGIA, V48, pA317; JOVANOVIC L, 2004, DIABETES WOMEN, P371; Jovanovic L, 2007, DIABETES CARE, V30, pS220, DOI 10.2337/dc07-s220; Kakarla N, 2005, OBSTET GYNECOL, V105, P1195, DOI 10.1097/01.AOG.0000152352.58688.27; KALHAN SC, 1975, J CLIN ENDOCR METAB, V40, P139, DOI 10.1210/jcem-40-1-139; Kitzmiller JL, 1996, DIABETES CARE, V19, P514, DOI 10.2337/diacare.19.5.514; KITZMILLER JL, 2004, DIABETES WOMEN, P383; Kitzmiller JL, 2008, DIABETES CARE, V31, P1060, DOI 10.2337/dc08-9020; KLEIN BEK, 1990, DIABETES CARE, V13, P34, DOI 10.2337/diacare.13.1.34; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; LANGER O, 1991, ISRAEL J MED SCI, V27, P516; LEGUIZAMON G, 2004, DIABETES WOMEN ADOLE, P425; Mathiesen ER, 2007, DIABETES CARE, V30, P771, DOI 10.2337/dc06-1887; MENON RK, 1990, NEW ENGL J MED, V323, P309, DOI 10.1056/NEJM199008023230505; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Moore KA, 2004, NEW ENGL J MED, V351, P721, DOI 10.1056/NEJM200408123510722; OH W, 2004, DIABETES WOMEN ADOLE, P451; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Palomba S, 2004, J CLIN ENDOCR METAB, V89, P4801, DOI 10.1210/jc.2004-0689; Pedersen J, 1977, PREGNANT DIABETIC HE, P211; PETTITT DJ, 1991, DIABETES, V40, P126, DOI 10.2337/diab.40.2.S126; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Quan A, 2006, EARLY HUM DEV, V82, P23, DOI 10.1016/j.earlhumdev.2005.11.001; Ray JG, 2001, QJM-INT J MED, V94, P435, DOI 10.1093/qjmed/94.8.435; The American College of Obstetricians and Gynecologists, 2005, OBSTET GYNECOL, V105, P675, DOI DOI 10.1097/00006250-200503000-00049; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vanky E, 2005, FERTIL STERIL, V83, P1575, DOI 10.1016/j.fertnstert.2004.11.051	66	3	3	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 4	2008	299	21					2550	2557		10.1001/jama.299.17.jrr80003	http://dx.doi.org/10.1001/jama.299.17.jrr80003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308AR	18460652				2022-12-28	WOS:000256361200027
J	Bierman, MJ; Lau, YKA; Kvit, AV; Schmitt, AL; Jin, S				Bierman, Matthew J.; Lau, Y. K. Albert; Kvit, Alexander V.; Schmitt, Andrew L.; Jin, Song			Dislocation-driven nanowire growth and Eshelby twist	SCIENCE			English	Article							MECHANISM; CRYSTALS	Hierarchical nanostructures of lead sulfide nanowires resembling pine trees were synthesized by chemical vapor deposition. Structural characterization revealed a screwlike dislocation in the nanowire trunks with helically rotating epitaxial branch nanowires. It is suggested that the screw component of an axial dislocation provides the self- perpetuating steps to enable one- dimensional crystal growth, in contrast to mechanisms that require metal catalysts. The rotating trunks and branches are the consequence of the Eshelby twist of screw dislocations with a dislocation Burgers vector along the < 110 > directions having an estimated magnitude of 6 +/- 2 angstroms for the screw component. The results confirm the Eshelby theory of dislocations, and the proposed nanowire growth mechanism could be general to many materials.	[Bierman, Matthew J.; Lau, Y. K. Albert; Schmitt, Andrew L.; Jin, Song] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Kvit, Alexander V.] Univ Wisconsin, Ctr Mat Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jin, S (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	jin@chem.wisc.edu	Bierman, Matthew J/C-2657-2013; Jin, Song/B-4300-2008	Bierman, Matthew J/0000-0002-9053-6356; Jin, Song/0000-0001-8693-7010				BAUSER E, 1981, J CRYST GROWTH, V51, P362, DOI 10.1016/0022-0248(81)90321-3; Bierman MJ, 2007, NANO LETT, V7, P2907, DOI 10.1021/nl071405l; BURTON WK, 1949, NATURE, V163, P398, DOI 10.1038/163398a0; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Dick KA, 2004, NAT MATER, V3, P380, DOI 10.1038/nmat1133; Dong A, 2007, J AM CHEM SOC, V129, P12254, DOI 10.1021/ja0737772; DRAGSDORF RD, 1958, J APPL PHYS, V29, P817, DOI 10.1063/1.1723291; ESHELBY JD, 1953, J APPL PHYS, V24, P176, DOI 10.1063/1.1721234; Fardy M, 2007, ADV MATER, V19, P3047, DOI 10.1002/adma.200602674; FOITZIK A, 1990, PHYS STATUS SOLIDI A, V121, P81, DOI 10.1002/pssa.2211210110; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Hirth J.P., 1968, THEORY DISLOCATIONS; Lieber CM, 2007, MRS BULL, V32, P99, DOI 10.1557/mrs2007.41; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Nabarro FRN, 1967, THEORY CRYSTAL DISLO; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Persson AI, 2004, NAT MATER, V3, P677, DOI 10.1038/nmat1220; SEARS GW, 1953, ACTA METALL MATER, V1, P457, DOI 10.1016/0001-6160(53)90131-X; SEARS GW, 1959, J CHEM PHYS, V31, P53, DOI 10.1063/1.1730336; SEARS GW, 1955, ACTA METALL MATER, V3, P361, DOI 10.1016/0001-6160(55)90041-9; TRENTLER TJ, 1995, SCIENCE, V270, P1791, DOI 10.1126/science.270.5243.1791; VEBLEN DR, 1983, AM MINERAL, V68, P790; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; WAGNER RS, 1964, J APPL PHYS, V35, P2993, DOI 10.1063/1.1713143; Wang D, 2004, NANO LETT, V4, P871, DOI 10.1021/nl049728u; Williams D B, 1996, TRANSMISSION ELECT M; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Zhu J, 2007, NANO LETT, V7, P1095, DOI 10.1021/nl0700393	28	436	441	9	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 23	2008	320	5879					1060	1063		10.1126/science.1157131	http://dx.doi.org/10.1126/science.1157131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18451264				2022-12-28	WOS:000256059800041
J	Grummt, I; Ladurner, AG				Grummt, Ingrid; Ladurner, Andreas G.			A metabolic throttle regulates the epigenetic state of rDNA	CELL			English	Review							POLYMERASE-I TRANSCRIPTION; HETEROCHROMATIN FORMATION; RNA-SYNTHESIS; COMPLEX; YEAST; HOMOLOG; PROTEIN; GENES	The synthesis of ribosomal RNA ( rRNA) is carefully tuned to match nutritional conditions. In this issue, Murayama et al. ( 2008) describe a mechanism that couples the energy status of the cell to heterochromatin formation and silencing of rRNA genes. They show that an altered NAD+/ NADH ratio in response to glucose starvation regulates the silencing activity of eNoSC, a complex consisting of the NAD(+)- dependent histone deacetylase SIRT1, the histone methyltransferase SUV39H1, and a new protein called nucleomethylin (NML). These results suggest a mechanism that links cell physiology to rDNA silencing, which in turn is a prerequisite for nucleolar integrity and cell survival.	[Grummt, Ingrid] DKFZ ZMBH Alliance, German Canc Res Ctr, Dept Mol Biol Cell II, D-69120 Heidelberg, Germany; [Ladurner, Andreas G.] European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Grummt, I (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr, Dept Mol Biol Cell II, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.	i.grummt@dkfz-heidelberg.de; ladurner@embl.de		Ladurner, Andreas/0000-0003-3835-232X				Bousquet-Antonelli C, 2000, RNA, V6, P826, DOI 10.1017/S1355838200992288; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; GRUMMT I, 1976, CELL, V7, P447, DOI 10.1016/0092-8674(76)90175-6; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	18	47	47	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					577	580		10.1016/j.cell.2008.04.026	http://dx.doi.org/10.1016/j.cell.2008.04.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485866	Bronze			2022-12-28	WOS:000255903300013
J	Holmes, E; Loo, RL; Stamler, J; Bictash, M; Yap, IKS; Chan, Q; Ebbels, T; De Iorio, M; Brown, IJ; Veselkov, KA; Daviglus, ML; Kesteloot, H; Ueshima, H; Zhao, LC; Nicholson, JK; Elliott, P				Holmes, Elaine; Loo, Ruey Leng; Stamler, Jeremiah; Bictash, Magda; Yap, Ivan K. S.; Chan, Queenie; Ebbels, Tim; De Iorio, Maria; Brown, Ian J.; Veselkov, Kirill A.; Daviglus, Martha L.; Kesteloot, Hugo; Ueshima, Hirotsugu; Zhao, Liancheng; Nicholson, Jeremy K.; Elliott, Paul			Human metabolic phenotype diversity and its association with diet and blood pressure	NATURE			English	Article							COMPLEX BIOLOGICAL MIXTURES; H-1-NMR; SPECTROSCOPY	Metabolic phenotypes are the products of interactions among a variety of factors-dietary, other lifestyle/environmental, gut microbial and genetic(1-3). We use a large-scale exploratory analytical approach to investigate metabolic phenotype variation across and within four human populations, based on H-1 NMR spectroscopy. Metabolites discriminating across populations are then linked to data for individuals on blood pressure, a major risk factor for coronary heart disease and stroke (leading causes of mortality worldwide(4)). We analyse spectra from two 24-hour urine specimens for each of 4,630 participants from the INTERMAP epidemiological study(5), involving 17 population samples aged 40-59 in China, Japan, UK and USA. We show that urinary metabolite excretion patterns for East Asian and western population samples, with contrasting diets, diet-related major risk factors, and coronary heart disease/stroke rates, are significantly differentiated (P < 10(-16)), as are Chinese/Japanese metabolic phenotypes, and subgroups with differences in dietary vegetable/animal protein and blood pressure(6). Among discriminatory metabolites, we quantify four and show association (P < 0.05 to P < 0.0001) of mean 24-hour urinary formate excretion with blood pressure in multiple regression analyses for individuals. Mean 24-hour urinary excretion of alanine (direct) and hippurate (inverse), reflecting diet and gut microbial activities(2,7), are also associated with blood pressure of individuals. Metabolic phenotyping applied to high-quality epidemiological data offers the potential to develop an area of aetiopathogenetic knowledge involving discovery of novel biomarkers related to cardiovascular disease risk.	[Holmes, Elaine; Loo, Ruey Leng; Bictash, Magda; Yap, Ivan K. S.; Ebbels, Tim; Veselkov, Kirill A.; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet SORA, London SW7 2AZ, England; [Loo, Ruey Leng; Bictash, Magda; Yap, Ivan K. S.; Chan, Queenie; De Iorio, Maria; Brown, Ian J.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Stamler, Jeremiah; Daviglus, Martha L.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Kesteloot, Hugo] Akad Ziekenhuis St Rafael, Dept Publ Hlth, Div Epidemiol, B-3000 Louvain, Belgium; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Shiga 5202192, Japan; [Zhao, Liancheng] Chinese Acad Med Sci, Dept Epidemiol, Fu Wai Hosp, Beijing 100037, Peoples R China; [Zhao, Liancheng] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100037, Peoples R China	Imperial College London; Imperial College London; Northwestern University; Feinberg School of Medicine; KU Leuven; Shiga University of Medical Science; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet SORA, S Kensington Campus, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk; p.elliott@imperial.ac.uk	Yap, Ivan Kok Seng/ABD-4843-2020; Ebbels, Tim/ABB-2627-2021; Holmes, Elaine/A-2189-2015; Holmes, Elaine/ABE-6606-2020; Chan, Queenie/C-5017-2011; Nicholson, Jeremy K/B-3395-2012	Yap, Ivan Kok Seng/0000-0002-7523-5352; Ebbels, Tim/0000-0002-3372-8423; Holmes, Elaine/0000-0002-0556-8389; Chan, Queenie/0000-0001-9278-230X; Nicholson, Jeremy K/0000-0002-8123-8349; De Iorio, Maria/0000-0003-3109-0478; Loo, Ruey Leng/0000-0001-5307-5709; Elliott, Paul/0000-0002-7511-5684; Veselkov, Kirill/0000-0002-1164-0359	NHLBI NIH HHS [R01 HL50490, R01 HL084228, R01 HL050490] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050490, R01HL084228] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHEN SH, 1971, SCIENCE, V173, P148, DOI 10.1126/science.173.3992.148; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; CONLAY LA, 1990, PHARMACOL TOXICOL, V66, P415, DOI 10.1111/j.1600-0773.1990.tb00771.x; Crockford DJ, 2005, ANAL CHEM, V77, P4556, DOI 10.1021/ac0503456; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; ELLIOTT P, 1988, BRIT MED J, V297, P319; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; ELLIOTT P, 2005, CORONARY HEART DIS E, P751; Elliott P, 2008, HYPERTENSION, V51, P669, DOI 10.1161/HYPERTENSIONAHA.107.103747; Elliott P, 2007, CIRCULATION, V116, P1563, DOI 10.1161/CIRCULATIONAHA.106.675579; Fekkes D, 2000, J CHROMATOGR B, V744, P183, DOI 10.1016/S0378-4347(00)00234-6; Grandits GA, 1997, AM J CLIN NUTR, V65, P211; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Lin SH, 2001, QJM-MON J ASSOC PHYS, V94, P133, DOI 10.1093/qjmed/94.3.133; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Mulder TP, 2005, AM J CLIN NUTR, V81, p256S, DOI 10.1093/ajcn/81.1.256S; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	30	796	828	12	284	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					396	U50		10.1038/nature06882	http://dx.doi.org/10.1038/nature06882			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18425110	Green Accepted			2022-12-28	WOS:000255868400053
J	Peng, RD; Chang, HH; Bell, ML; McDermott, A; Zeger, SL; Samet, JM; Dominici, F				Peng, Roger D.; Chang, Howard H.; Bell, Michelle L.; McDermott, Aidan; Zeger, Scott L.; Samet, Jonathan M.; Dominici, Francesca			Coarse particulate matter air pollution and hospital admissions for cardiovascular and respiratory diseases among medicare patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-RATE-VARIABILITY; DAILY MORTALITY; FINE PARTICLES; COACHELLA VALLEY; US CITIES; ADULTS; SIZE; LUNG	Context Health risks of fine particulate matter of 2.5 mu m or less in aerodynamic diameter ( PM2.5) have been studied extensively over the last decade. Evidence concerning the health risks of the coarse fraction of greater than 2.5 mu m and 10 mu m or less in aerodynamic diameter ( PM10-2.5) is limited. Objective To estimate risk of hospital admissions for cardiovascular and respiratory diseases associated with PM10-2.5 exposure, controlling for PM2.5. Design, Setting, and Participants Using a database assembled for 108 US counties with daily cardiovascular and respiratory disease admission rates, temperature and dew- point temperature, and PM10-2.5 and PM2.5 concentrations were calculated with monitoring data as an exposure surrogate from January 1, 1999, through December 31, 2005. Admission rates were constructed from the Medicare National Claims History Files, for a study population of approximately 12 million Medicare enrollees living on average 9 miles ( 14.4 km) from collocated pairs of PM10 and PM2.5 monitors. Main Outcome Measures Daily counts of county- wide emergency hospital admissions for primary diagnoses of cardiovascular or respiratory disease. Results There were 3.7 million cardiovascular disease and 1.4 million respiratory disease admissions. A 10-mu g/m(3) increase in PM10-2.5 was associated with a 0.36% ( 95% posterior interval [ PI], 0.05% to 0.68%) increase in cardiovascular disease admissions on the same day. However, when adjusted for PM2.5, the association was no longer statistically significant ( 0.25%; 95% PI, - 0.11% to 0.60%). A 10-mu g/m(3) increase in PM10-2.5 was associated with a nonstatistically significant unadjusted 0.33% ( 95% PI, - 0.21% to 0.86%) increase in respiratory disease admissions and with a 0.26% ( 95% PI, - 0.32% to 0.84%) increase in respiratory disease admissions when adjusted for PM2.5. The unadjusted associations of PM2.5 with cardiovascular and respiratory disease admissions were 0.71% ( 95% PI, 0.45%- 0.96%) for same- day exposure and 0.44% ( 95% PI, 0.06% to 0.82%) for exposure 2 days before hospital admission. Conclusion After adjustment for PM2.5, there were no statistically significant associations between coarse particulates and hospital admissions for cardiovascular and respiratory diseases.	[Peng, Roger D.; Chang, Howard H.; McDermott, Aidan; Zeger, Scott L.; Dominici, Francesca] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Samet, Jonathan M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Bell, Michelle L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University	Dominici, F (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St, Baltimore, MD 21205 USA.	fdominic@jhsph.edu	Bell, Michelle/Y-4608-2018	Bell, Michelle/0000-0002-3965-1359; Zeger, Scott/0000-0001-8907-1603	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012054, P30ES003819] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES003819, R01 ES012054, ES012054-03, R01 ES012054-03, P30 ES003819-22, P30 ES 03819] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bell ML, 2007, ENVIRON HEALTH PERSP, V115, P989, DOI 10.1289/ehp.9621; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; *BOARD TRUST FED H, 2007, ANN REP BOARDS TRUST; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Burnett RT, 1997, ENVIRON HEALTH PERSP, V105, P614, DOI 10.1289/ehp.97105614; Carroll RJ, 2006, MEASUREMENT ERROR NO; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Dominici F, 2000, J ROY STAT SOC A STA, V163, P263, DOI 10.1111/1467-985X.00170; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2005, J TOXICOL ENV HEAL A, V68, P1071, DOI 10.1080/15287390590935932; DUMOUCHEL WH, 1983, J AM STAT ASSOC, V78, P293, DOI 10.2307/2288631; Everson PJ, 2000, J ROY STAT SOC B, V62, P399, DOI 10.1111/1467-9868.00239; Gelman A., 2003, BAYESIAN DATA ANAL; Happo MS, 2007, INHAL TOXICOL, V19, P227, DOI 10.1080/08958370601067897; Health Effects Institute, 2003, REV AN NAT MORB MORT; Host S, 2008, OCCUP ENVIRON MED, V65, P544, DOI 10.1136/oem.2007.036194; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; LINDLEY DV, 1972, J ROY STAT SOC B, V34, P1; Lipsett MJ, 2006, ENVIRON HEALTH PERSP, V114, P1215, DOI 10.1289/ehp.8856; *NAT RES COUNC, 2004, RES PRIOR AIRB PART, V4; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Ostro BD, 2000, J EXPO ANAL ENV EPID, V10, P412, DOI 10.1038/sj.jea.7500094; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SAMET JM, 2000, NATL MORBIDITY MO 1; SAMET JM, 2000, NATL MORBIDITY MO 2; Schwartz J, 1996, J AIR WASTE MANAGE, V46, P927, DOI 10.1080/10473289.1996.10467528; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Schwartz J, 1999, ENVIRON HEALTH PERSP, V107, P339, DOI 10.2307/3434536; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; *US EPA, 2005, REV NAT AMB AIR QUAL; US-EPA, 2004, AIR QUAL CRIT PART M; VANDERPOOL R, 2004, MULTISITE EVALUATION; Venkataraman C, 1999, INHAL TOXICOL, V11, P151, DOI 10.1080/089583799197221; WHITBY KT, 1978, ATMOS ENVIRON, V12, P135, DOI 10.1016/0004-6981(78)90196-8; WILLEKE K, 1975, JAPCA J AIR WASTE MA, V25, P529, DOI 10.1080/00022470.1975.10470110; Wilson WE, 1997, J AIR WASTE MANAGE, V47, P1238, DOI 10.1080/10473289.1997.10464074; Yeatts K, 2007, ENVIRON HEALTH PERSP, V115, P709, DOI 10.1289/ehp.9499; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279; 2006, FED REG, V17, P2620	40	289	296	1	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2172	2179		10.1001/jama.299.18.2172	http://dx.doi.org/10.1001/jama.299.18.2172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477784	Bronze, Green Accepted			2022-12-28	WOS:000255790000024
J	Aboyans, V; Lacroix, P				Aboyans, Victor; Lacroix, Philippe			Carotid bruit: good for silent cardiovascular disease?	LANCET			English	Editorial Material							PERIPHERAL ARTERIAL-DISEASE; RISK		[Aboyans, Victor; Lacroix, Philippe] Dupuytren Univ Hosp, Vasc Unit, Dept Thorac & Cardiovasc Surg & Angiol, F-87042 Limoges, France	CHU Limoges	Aboyans, V (corresponding author), Dupuytren Univ Hosp, Vasc Unit, Dept Thorac & Cardiovasc Surg & Angiol, F-87042 Limoges, France.	victor.aboyans@unilim.fr	Aboyans, Victor/AAN-8308-2020					Aboyans V, 2007, J AM COLL CARDIOL, V49, P1540, DOI 10.1016/j.jacc.2006.09.055; Aboyans V, 2006, J CLIN EPIDEMIOL, V59, P547, DOI 10.1016/j.jclinepi.2005.11.002; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cournot M, 2007, J VASC SURG, V46, P1215, DOI 10.1016/j.jvs.2007.08.022; CRIQUI MH, 1985, CIRCULATION, V72, P768, DOI 10.1161/01.CIR.72.4.768; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Greenland P, 2000, CIRCULATION, V101, P723; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; HEYMAN A, 1980, NEW ENGL J MED, V302, P838, DOI 10.1056/NEJM198004103021504; Pickett CA, 2008, LANCET, V371, P1587, DOI 10.1016/S0140-6736(08)60691-1; Shaw LJ, 2003, PROG CARDIOVASC DIS, V46, P171, DOI 10.1016/S0033-0620(03)00085-9; USPSTF, 2007, ANN INTERN MED, V147, P854, DOI 10.7326/0003-4819-147-12-200712180-00005; *WORLD BANK, 2002, WORLD DEV IND	13	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1554	1556		10.1016/S0140-6736(08)60667-4	http://dx.doi.org/10.1016/S0140-6736(08)60667-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468527				2022-12-28	WOS:000255715400005
J	Mermelstein, R				Mermelstein, Robin			Moving tobacco prevention outside the classroom	LANCET			English	Editorial Material							PEER-LED INTERVENTION; ADOLESCENT; SMOKING; SMOKERS		[Mermelstein, Robin] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60608 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mermelstein, R (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60608 USA.	robinm@uic.edu			NCI NIH HHS [P01 CA098262] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA098262] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Audrey S, 2006, SOC SCI MED, V63, P320, DOI 10.1016/j.socscimed.2005.12.010; Avenevoli S, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1360-0443.98.s1.2.x; Campbell R, 2008, LANCET, V371, P1595, DOI 10.1016/S0140-6736(08)60692-3; Colby SM, 2000, DRUG ALCOHOL DEPEN, V59, pS83; EVANS N, 1995, J NATL CANCER I, V87, P1538, DOI 10.1093/jnci/87.20.1538; Grimshaw GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003289.pub4; Mercken L, 2007, ADDICTION, V102, P1483, DOI 10.1111/j.1360-0443.2007.01905.x; Thomas R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001293.pub2; Thomas RE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004493.pub2; Turner L, 2004, ANN NY ACAD SCI, V1021, P175, DOI 10.1196/annals.1308.023; *US DEP HHS, 1994, PREV TOB US YOUNG PE; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0	12	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1556	1557		10.1016/S0140-6736(08)60668-6	http://dx.doi.org/10.1016/S0140-6736(08)60668-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298VO	18468528				2022-12-28	WOS:000255715400006
J	Horner-Devine, MC; Martiny, AC				Horner-Devine, M. Claire; Martiny, Adam C.			Biogeochemistry - News about nitrogen	SCIENCE			English	Editorial Material							ANAEROBIC AMMONIUM OXIDATION; OXIDIZING BACTERIA; NITRIFICATION; PLANKTON; ARCHAEA; OCEAN; CRENARCHAEOTA; DIVERSITY; COMMUNITY; FIXATION		[Horner-Devine, M. Claire] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Martiny, Adam C.] Univ Calif Irvine, Irvine, CA 92697 USA	University of Washington; University of Washington Seattle; University of California System; University of California Irvine	Horner-Devine, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	mchd@u.washington.edu	Martiny, Adam/AAC-4459-2019	Martiny, Adam/0000-0003-2829-4314				Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Caffrey JM, 2007, ISME J, V1, P660, DOI 10.1038/ismej.2007.79; Carney KM, 2004, ECOL LETT, V7, P684, DOI 10.1111/j.1461-0248.2004.00628.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Graham DW, 2007, ISME J, V1, P385, DOI 10.1038/ismej.2007.45; Hawkes CV, 2005, ECOL LETT, V8, P976, DOI 10.1111/j.1461-0248.2005.00802.x; Horz HP, 2004, P NATL ACAD SCI USA, V101, P15136, DOI 10.1073/pnas.0406616101; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Knapp CW, 2007, FEMS MICROBIOL ECOL, V62, P195, DOI 10.1111/j.1574-6941.2007.00380.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Mehta MP, 2006, SCIENCE, V314, P1783, DOI 10.1126/science.1134772; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1111/j.1574-6941.1995.tb00281.x; Sohm JA, 2006, MAR ECOL PROG SER, V317, P21, DOI 10.3354/meps317021; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Webster G, 2005, ENVIRON MICROBIOL, V7, P676, DOI 10.1111/j.1462-2920.2005.00740.x; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	24	21	26	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					757	758		10.1126/science.1147012	http://dx.doi.org/10.1126/science.1147012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467581				2022-12-28	WOS:000255644400029
J	Kahn, MW				Kahn, Michael W.			Etiquette-based medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kahn, Michael W.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Kahn, Michael W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kahn, MW (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268	2	84	87	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					1988	1989		10.1056/NEJMp0801863	http://dx.doi.org/10.1056/NEJMp0801863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296WY	18463374				2022-12-28	WOS:000255577700002
J	Nogues-Bravo, D; Araujo, MB; Romdal, T; Rahbek, C				Nogues-Bravo, D.; Araujo, M. B.; Romdal, T.; Rahbek, C.			Scale effects and human impact on the elevational species richness gradients	NATURE			English	Article							LATITUDINAL GRADIENTS; SPATIAL SCALE; DIVERSITY; PATTERNS; AREA; BIODIVERSITY	Despite two centuries of effort in characterizing environmental gradients of species richness in search of universal patterns, surprisingly few of these patterns have been widely acknowledged(1-3). Species richness along altitudinal gradients was previously assumed to increase universally from cool highlands to warm lowlands, mirroring the latitudinal increase in species richness from cool to warm latitudes(1,4,5). However, since the more recent general acceptance of altitudinal gradients as model templates for testing hypotheses behind large- scale patterns of diversity(5-9), these gradients have been used in support of all the main diversity hypotheses, although little consensus has been achieved. Here we show that when resampling a data set comprising 400,000 records for 3,046 Pyrenean floristic species at different scales of analysis ( achieved by varying grain size and the extent of the gradients sampled), the derived species richness pattern changed progressively from hump- shaped to a monotonic pattern as the scale of extent diminished. Scale effects alone gave rise to as many conflicting patterns of species richness as had previously been reported in the literature, and scale effects lent significantly different statistical support to competing diversity hypotheses. Effects of scale on current studies may be affected by human activities, because montane ecosystems and human activities are intimately connected(10). This interdependence has led to a global reduction in natural lowland habitats, hampering our ability to detect universal patterns and impeding the search for universal diversity gradients to discover the mechanisms determining the distribution of biological diversity on Earth.	[Nogues-Bravo, D.; Araujo, M. B.] CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, E-28006 Madrid, Spain; [Nogues-Bravo, D.; Araujo, M. B.; Romdal, T.; Rahbek, C.] Univ Copenhagen, Inst Biol, Ctr Macroecol, DK-2100 Copenhagen O, Denmark; [Nogues-Bravo, D.] CSIC, Pyrenean Inst Ecol, E-50080 Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Copenhagen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE)	Nogues-Bravo, D (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodivers & Evolutionary Biol, C Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.	davidnogues@mncn.csic.es	Rahbek, Carsten/D-9372-2013; Araújo, Miguel B/B-6117-2008; Rahbek, Carsten/L-1129-2013	Araújo, Miguel B/0000-0002-5107-7265; Rahbek, Carsten/0000-0003-4585-0300; Nogues-Bravo, David/0000-0002-4060-0153				Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Brehm G, 2007, GLOBAL ECOL BIOGEOGR, V16, P205, DOI 10.1111/j.1466-8238.2006.00281.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; *CLARK LABS, 2004, IDR KIL VERS 14 02 G; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dunn RR, 2007, GLOBAL ECOL BIOGEOGR, V16, P305, DOI 10.1111/j.1466-8238.2006.00284.x; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MacArthur R.H., 1972, pvii; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; McCoy ED, 2002, OIKOS, V99, P189, DOI 10.1034/j.1600-0706.2002.990120.x; McNeill J. R., 1992, MOUNTAINS MEDITERRAN; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Romdal TS, 2007, ECOGRAPHY, V30, P440, DOI 10.1111/j.0906-7590.2007.04954.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	28	366	402	9	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					216	U8		10.1038/nature06812	http://dx.doi.org/10.1038/nature06812			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464741	Bronze			2022-12-28	WOS:000255592400038
J	Glasziou, PP; Irwig, L; Heritier, S; Simes, RJ; Tonkin, A				Glasziou, Paul P.; Irwig, Les; Heritier, Stephane; Simes, R. John; Tonkin, Andrew		Lipid Study Investigators	Monitoring cholesterol levels: Measurement error or true change?	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Cholesterol level monitoring is a common clinical activity, but the optimal monitoring interval is unknown and practice varies. Objective: To estimate, in patients receiving cholesterol-lowering medication, the variation in initial response to treatment, the long-term drift from initial response, and the detectability of long-term changes in on-treatment cholesterol level ("signal") given short-term, within-person variation ("noise"). Design: Analysis of cholesterol measurement data in the LIPID (Long-Term Intervention with Pravastatin in Ischaemic Disease) study. Setting: Randomized, placebo-controlled trial in Australia and New Zealand (June 1990 to May 1997). Patients: 9014 patients with past coronary heart disease who were randomly assigned to receive pravastatin or placebo. Measurements: Serial cholesterol concentrations at randomization, 6 months, and 12 months, and then annually to 5 years. Results: Both the placebo and pravastatin groups showed small increases in within-person variability over time. The estimated within-person SD increased from 0.40 mmol/L (15 mg/dL) (coefficient of variation, 7%) to 0.60 mmol/L (23 mg/dL) (coefficient of variation, 11 %), but it took almost 4 years for the long-term variation to exceed the short-term variation. This slow increase in variation and the modest increase in mean cholesterol level, about 2% per year, suggest that most of the variation in the study is due to short-term biological and analytic variability. Our calculations suggest that, for patients with levels that are 0.5 mmol/L or more (>= 19 mg/dL) under target, monitoring is likely to detect many more false-positive results than true-positive results for at least the first 3 years after treatment has commenced. Limitations: Patients may respond differently to agents other than pravastatin. Future values for nonadherent patients were imputed. Conclusion: The signal-noise ratio in cholesterol level monitoring is weak. The signal of a small increase in cholesterol level is difficult to detect against the background of a short-term variability of 7%. In annual rechecks in adherent patients, many apparent increases in cholesterol level may be false positive. Independent of the office visit schedule, the interval for monitoring patients who are receiving stable cholesterol-lowering treatment could be lengthened.	Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Oxford OX3 7LF, England; Univ Sydney, Sydney, NSW 2006, Australia; Monash Univ, Melbourne, Vic 3004, Australia	University of Oxford; University of Sydney; Monash University	Glasziou, PP (corresponding author), Univ Oxford, Dept Primary Hlth Care, Ctr Evidence Based Med, Old Rd Campus, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Simes, Robert John/P-1497-2014; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X				Bakx JC, 2000, PREV MED, V30, P138, DOI 10.1006/pmed.1999.0608; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HOGAN C, 2008, TRENDS MEDICARE CARR; IRWIG L, 1991, JAMA-J AM MED ASSOC, V266, P1678, DOI 10.1001/jama.266.12.1678; MacLaughlin EJ, 2005, DRUG AGING, V22, P231, DOI 10.2165/00002512-200522030-00005; *NAT HEART FDN CAR, 2005, POS STAT LIP MAN 200; *NAT LIB HLTH, CLIN KNOWL SUMM LIP; Pereira MA, 2004, INT J EPIDEMIOL, V33, P534, DOI 10.1093/ije/dyh057; Peterson GM, 2004, J CLIN PHARM THER, V29, P23, DOI 10.1046/j.1365-2710.2003.00532.x; ROTTERDAM EP, 1987, CLIN CHEM, V33, P1913; SHEPARD DS, 1981, J CHRON DIS, V34, P191, DOI 10.1016/0021-9681(81)90064-3; THOMPSON SG, 1990, J CLIN EPIDEMIOL, V43, P783, DOI 10.1016/0895-4356(90)90238-K; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; MEDICARE NATL COVERA	15	87	90	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					656	661		10.7326/0003-4819-148-9-200805060-00005	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458278				2022-12-28	WOS:000255731800003
J	Peebles, PJE; Unruh, WG				Peebles, P. James E.; Unruh, William G.			John Wheeler (1911-2008) - Obituary	NATURE			English	Biographical-Item									[Peebles, P. James E.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Unruh, William G.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	Princeton University; University of British Columbia	Peebles, PJE (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	pjep@princeton.edu; unruh@physics.ubc.ca							0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					50	50		10.1038/453050a	http://dx.doi.org/10.1038/453050a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451853				2022-12-28	WOS:000255398800036
J	Merico, A; Tyrrell, T; Wilson, PA				Merico, Agostino; Tyrrell, Toby; Wilson, Paul A.			Eocene/oligocene ocean de-acidification linked to Antarctic glaciation by sea-level fall	NATURE			English	Article							EOCENE-OLIGOCENE TRANSITION; ATMOSPHERIC CARBON-DIOXIDE; CALCITE COMPENSATION; CENOZOIC GLACIATION; BIPOLAR GLACIATION; OXYGEN ISOTOPES; CYCLE; PALEOCEANOGRAPHY; ACCUMULATION; INITIATION	One of the most dramatic perturbations to the Earth system during the past 100 million years was the rapid onset of Antarctic glaciation near the Eocene/ Oligocene epoch boundary(1-3) (similar to 34 million years ago). This climate transition was accompanied(3) by a deepening of the calcite compensation depth - the ocean depth at which the rate of calcium carbonate input from surface waters equals the rate of dissolution. Changes in the global carbon cycle(4), rather than changes in continental configuration(5), have recently been proposed as the most likely root cause of Antarctic glaciation, but the mechanism linking glaciation to the deepening of calcite compensation depth remains unclear. Here we use a global biogeochemical box model to test competing hypotheses put forward to explain the Eocene/ Oligocene transition. We find that, of the candidate hypotheses, only shelf to deep sea carbonate partitioning is capable of explaining the observed changes in both carbon isotope composition and calcium carbonate accumulation at the sea floor. In our simulations, glacioeustatic sea- level fall associated with the growth of Antarctic ice sheets permanently reduces global calcium carbonate accumulation on the continental shelves, leading to an increase in pelagic burial via permanent deepening of the calcite compensation depth. At the same time, fresh limestones are exposed to erosion, thus temporarily increasing global river inputs of dissolved carbonate and increasing seawater delta(13) C. Our work sheds new light on the mechanisms linking glaciation and ocean acidity change across arguably the most important climate transition of the Cenozoic era.	[Merico, Agostino; Tyrrell, Toby; Wilson, Paul A.] Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Merico, Agostino] GKSS Forschungszentrum Geesthacht GmbH, Inst Coastal Res, D-21502 Geesthacht, Germany	NERC National Oceanography Centre; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Merico, A (corresponding author), Natl Oceanog Ctr, European Way, Southampton SO14 3ZH, Hants, England.	agostino.merico@gkss.de	Merico, Agostino/C-1103-2013	Merico, Agostino/0000-0001-8095-8056; Wilson, Paul/0000-0001-6425-8906	NERC [soc010008] Funding Source: UKRI; Natural Environment Research Council [soc010008, NER/A/S/2003/00377] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Archer D, 1996, GLOBAL BIOGEOCHEM CY, V10, P511, DOI 10.1029/96GB01521; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; Chuck A, 2005, TELLUS B, V57, P70, DOI 10.1111/j.1600-0889.2005.00127.x; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DIESTERHAASS L, 1995, PALAEOGEOGR PALAEOCL, V113, P311, DOI 10.1016/0031-0182(95)00067-V; Dupont-Nivet G, 2007, NATURE, V445, P635, DOI 10.1038/nature05516; Edgar KM, 2007, NATURE, V448, P908, DOI 10.1038/nature06053; Eldrett JS, 2007, NATURE, V446, P176, DOI 10.1038/nature05591; GIBBS MT, 1994, PALEOCEANOGRAPHY, V9, P529, DOI 10.1029/94PA01009; Hofmann M, 1999, GLOBAL BIOGEOCHEM CY, V13, P873, DOI 10.1029/1999GB900063; JANSEN H, 2002, GLOB BIOGEOCHEM CYCL, V16; KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Kump L. R., 1997, TECTONIC UPLIFT CLIM, P399, DOI [DOI 10.1007/978-1-4615-5935-1, DOI 10.1007/978-1-4615-5935-1_18]; Lyle AO, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001230; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Munhoven G, 2002, GLOBAL PLANET CHANGE, V33, P155, DOI 10.1016/S0921-8181(02)00068-1; Opdyke BN, 1988, PALEOCEANOGRAPHY, V3, P685, DOI 10.1029/PA003i006p00685; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pekar SF, 2002, GEOLOGY, V30, P903, DOI 10.1130/0091-7613(2002)030<0903:CBEEFB>2.0.CO;2; Ravizza G, 2003, EARTH PLANET SC LETT, V210, P151, DOI 10.1016/S0012-821X(03)00137-7; Rea DK, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001064; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P87, DOI 10.5194/bg-4-87-2007; Rohling EJ, 1999, MODERN FORAMINIFERA, P239; Salamy KA, 1999, PALAEOGEOGR PALAEOCL, V145, P61, DOI 10.1016/S0031-0182(98)00093-5; Sigman DM, 1998, GLOBAL BIOGEOCHEM CY, V12, P409, DOI 10.1029/98GB01184; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Swart PK, 2005, SEDIMENT GEOL, V175, P115, DOI 10.1016/j.sedgeo.2004.12.029; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; WALKER JCG, 1992, GLOBAL PLANET CHANGE, V97, P151, DOI 10.1016/0921-8181(92)90009-Y; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1999, CHEM GEOL, V161, P165, DOI 10.1016/S0009-2541(99)00085-6; ZEEBE R, 2003, GEOCHEM GEOPHYS GEOS, V4	39	79	84	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					979	U6		10.1038/nature06853	http://dx.doi.org/10.1038/nature06853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432242				2022-12-28	WOS:000255208600036
J	Ito, K; Bernardi, R; Morotti, A; Matsuoka, S; Saglio, G; Ikeda, Y; Rosenblatt, J; Avigan, DE; Teruya-Feldstein, J; Pandolfi, PP				Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Matsuoka, Sahoko; Saglio, Giuseppe; Ikeda, Yasuo; Rosenblatt, Jacalyn; Avigan, David E.; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo			PML targeting eradicates quiescent leukaemia-initiating cells	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; HEMATOPOIETIC STEM-CELLS; IMATINIB MESYLATE; RETINOIC ACID; MYELOID-LEUKEMIA; ARSENIC TRIOXIDE; CANCER; DISCONTINUATION; REMISSION	The existence of a small population of 'cancer-initiating cells' responsible for tumour maintenance has been firmly demonstrated in leukaemia. This concept is currently being tested in solid tumours. Leukaemia-initiating cells, particularly those that are in a quiescent state, are thought to be resistant to chemotherapy and targeted therapies, resulting in disease relapse. Chronic myeloid leukaemia is a paradigmatic haematopoietic stem cell disease in which the leukaemia-initiating-cell pool is not eradicated by current therapy, leading to disease relapse on drug discontinuation. Here we define the critical role of the promyelocytic leukaemia protein (PML) tumour suppressor in haematopoietic stem cell maintenance, and present a new therapeutic approach for targeting quiescent leukaemia-initiating cells and possibly cancer-initiating cells by pharmacological inhibition of PML.	[Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02215 USA; [Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Pathol, Boston, MA 02215 USA; [Rosenblatt, Jacalyn; Avigan, David E.] Harvard Univ, Sch Med, Div Hematol & Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Ito, Keisuke; Bernardi, Rosa; Morotti, Alessandro; Teruya-Feldstein, Julie; Pandolfi, Pier Paolo] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Matsuoka, Sahoko; Ikeda, Yasuo] Keio Univ, Sch Med, Div Hematol, Dept Internal Med,Shinjuku Ku, Tokyo 1608582, Japan; [Saglio, Giuseppe] Univ Turin, Div Hematol & Internal Med, Dept Clin & Biol Sci, I-10043 Turin, Italy	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Keio University; University of Turin	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Canc Genet Program, Beth Israel Deaconess Canc Ctr,Dept Med, New Res Bldg,330 Brookline Ave, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Morotti, Alessandro/J-7590-2018; bernardi, rosa/B-1650-2013	Morotti, Alessandro/0000-0002-8407-2903; bernardi, rosa/0000-0002-3607-6336; Saglio, Giuseppe/0000-0002-1046-3514	NATIONAL CANCER INSTITUTE [R00CA139009, R37CA071692, K99CA139009] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA071692-12, R00 CA139009, K99 CA139009, R37 CA071692] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Aronson S M, 1994, R I Med, V77, P233; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bhatia R, 2003, BLOOD, V101, P4701, DOI 10.1182/blood-2002-09-2780; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Cortes J, 2004, BLOOD, V104, P2204, DOI 10.1182/blood-2004-04-1335; CROSS NCP, 1993, BRIT J HAEMATOL, V84, P67, DOI 10.1111/j.1365-2141.1993.tb03026.x; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Di Cristofano A, 2001, J EXP MED, V194, P275, DOI 10.1084/jem.194.3.275; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ghanima W, 2004, EUR J HAEMATOL, V72, P441, DOI 10.1111/j.1600-0609.2004.00257.x; Gurrieri C, 2004, BLOOD, V103, P2358, DOI 10.1182/blood-2003-07-2200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Higashi T, 2004, AM J HEMATOL, V76, P275, DOI 10.1002/ajh.20096; Holtz M, 2007, CANCER RES, V67, P1113, DOI 10.1158/0008-5472.CAN-06-2014; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jorgensen HG, 2005, EXP HEMATOL, V33, P1140, DOI 10.1016/j.exphem.2005.05.020; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; KLAASSEN CD, 1996, PHARMACOL BASIS THER, P1649; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Mauro MJ, 2004, LEUKEMIA RES, V28, pS71, DOI 10.1016/j.leukres.2003.10.017; Merante S, 2005, HAEMATOLOGICA, V90, P979; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Scadden DT, 2004, NAT IMMUNOL, V5, P701, DOI 10.1038/ni0704-701; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	45	437	465	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1072	U4		10.1038/nature07016	http://dx.doi.org/10.1038/nature07016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18469801	Green Accepted			2022-12-28	WOS:000256839900050
J	Tagkopoulos, I; Liu, YC; Tavazoie, S				Tagkopoulos, Ilias; Liu, Yir-Chung; Tavazoie, Saeed			Predictive behavior within microbial genetic networks	SCIENCE			English	Article							ESCHERICHIA-COLI; REGULATORY ROLE; EVOLUTION; ADAPTATION; OSCILLATORS; ROBUSTNESS; MICROARRAY; ORGANISMS; DYNAMICS; GENOME	The homeostatic framework has dominated our understanding of cellular physiology. We question whether homeostasis alone adequately explains microbial responses to environmental stimuli, and explore the capacity of intracellular networks for predictive behavior in a fashion similar to metazoan nervous systems. We show that in silico biochemical networks, evolving randomly under precisely defined complex habitats, capture the dynamical, multidimensional structure of diverse environments by forming internal representations that allow prediction of environmental change. We provide evidence for such anticipatory behavior by revealing striking correlations of Escherichia coli transcriptional responses to temperature and oxygen perturbations- precisely mirroring the covariation of these parameters upon transitions between the outside world and the mammalian gastrointestinal tract. We further show that these internal correlations reflect a true associative learning paradigm, because they show rapid decoupling upon exposure to novel environments.	[Tagkopoulos, Ilias; Liu, Yir-Chung; Tavazoie, Saeed] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Tagkopoulos, Ilias] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Liu, Yir-Chung; Tavazoie, Saeed] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Tavazoie, S (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tavazoie@genomics.princeton.edu	Tagkopoulos, Ilias/B-3468-2009	Tagkopoulos, Ilias/0000-0003-1104-7616	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM071508, P50 GM071508-01, P50 GM071508-06] Funding Source: Medline; NIH HHS [DP1 OD003787] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Cannon W.B., 1932, WISDOM BODY; Cheung KJ, 2003, GENOME RES, V13, P206, DOI 10.1101/gr.401003; Courcelle J, 2001, GENETICS, V158, P41; Dunne C, 2001, INFLAMM BOWEL DIS, V7, P136, DOI 10.1097/00054725-200105000-00010; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Francois P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100192; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Neidhardt F.C., 1996, ESCHERICHIA SALMONEL; Rodrigo G, 2007, CENT EUR J BIOL, V2, P233, DOI 10.2478/s11535-007-0016-z; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Soyer OS, 2006, J THEOR BIOL, V241, P223, DOI 10.1016/j.jtbi.2005.11.024; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Yura T, 1999, CURR OPIN MICROBIOL, V2, P153, DOI 10.1016/S1369-5274(99)80027-7	25	276	282	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 6	2008	320	5881					1313	1317		10.1126/science.1154456	http://dx.doi.org/10.1126/science.1154456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18467556	Green Accepted			2022-12-28	WOS:000256441100037
J	van den Heuvel, EPJ				van den Heuvel, Edward P. J.			Astronomy - An eccentric pulsar: Result of a threesome?	SCIENCE			English	Editorial Material							MILLISECOND PULSAR; NEUTRON-STAR; BINARY; ORIGIN		[van den Heuvel, Edward P. J.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [van den Heuvel, Edward P. J.] Univ Amsterdam, Ctr High Energy Astrophys, NL-1098 SJ Amsterdam, Netherlands; [van den Heuvel, Edward P. J.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA	University of Amsterdam; University of Amsterdam; University of California System; University of California Santa Barbara	van den Heuvel, EPJ (corresponding author), Univ Amsterdam, Astron Inst Anton Pannekoek, Kruislaan 403, NL-1098 SJ Amsterdam, Netherlands.	e.p.j.vandenheuvel@uva.nl	van den Heuvel, Edward P.J./C-1262-2018					ALPAR MA, 1982, NATURE, V300, P728, DOI 10.1038/300728a0; Chakrabarty D, 1998, NATURE, V394, P346, DOI 10.1038/28561; Champion DJ, 2008, SCIENCE, V320, P1309, DOI 10.1126/science.1157580; Edwards RT, 2001, ASTROPHYS J, V547, pL37, DOI 10.1086/318893; FLANNERY BP, 1975, ASTRON ASTROPHYS, V39, P61; GHOSH P, 2007, ROTATION ACCRETION P; Lewin W. H. G., 2006, COMPACT STELLAR XRAY; Lorimer D. R., 2012, HDB PULSAR ASTRONOMY; Lorimer DR, 2005, LIVING REV RELATIV, V8, DOI 10.12942/lrr-2005-7; RADHAKRISHNAN V, 1982, CURR SCI INDIA, V51, P1096; Stairs IH, 2004, SCIENCE, V304, P547, DOI 10.1126/science.1096986; van der Klis M., 2006, COMPACT STELLAR XRAY, P39; VANDENHEUVEL EPJ, 1984, ASTRON ASTROPHYS, V139, pL16; Wijnands R, 1998, NATURE, V394, P344, DOI 10.1038/28557	14	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 6	2008	320	5881					1298	1299		10.1126/science.1158738	http://dx.doi.org/10.1126/science.1158738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309DO	18483400				2022-12-28	WOS:000256441100030
J	Muers, MF; Stephens, RJ; Fisher, P; Darlison, L; Higgs, CMB; Lowry, E; Nicholson, AG; O'Brien, M; Peake, M; Rudd, R; Snee, M; Steele, J; Girling, DJ; Nankivell, M; Pugh, C; Parmar, MKB				Muers, Martin F.; Stephens, Richard J.; Fisher, Patricia; Darlison, Liz; Higgs, Christopher M. B.; Lowry, Erica; Nicholson, Andrew G.; O'Brien, Mary; Peake, Michael; Rudd, Robin; Snee, Michael; Steele, Jeremy; Girling, David J.; Nankivell, Matthew; Pugh, Cheryl; Parmar, Mahesh K. B.		MS01 Trial Management Grp	Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial	LANCET			English	Article							MVP MITOMYCIN-C; LUNG-CANCER; CISPLATIN CHEMOTHERAPY; CLINICAL-TRIALS; PHASE-III; VINORELBINE; VINBLASTINE; QLQ-C30	Background Malignant pleural mesothelioma is almost always fatal, and few treatment options are available. Although active symptom control (ASC) has been recommended for the management of this disease, no consensus exists for the role of chemotherapy. We investigated whether the addition of chemotherapy to ASC improved survival and quality of life. Methods 409 patients with malignant pleural mesothelioma, from 76 centres in the UK and two in Australia, were randomly assigned to ASC alone (treatment could include steroids, analgesic drugs, bronchodilators, palliative radiotherapy [n=136]); to ASC plus MVP (four cycles of mitomycin 6 mg/m(2), vinblastine 6 mg/m(2) and cisplatin 50 mg/m(2) every 3 weeks [n=137]); or to ASC plus vinorelbine (one injection of vinorelbine 30 mg/m(2) every week for 12 weeks [n=136]). Randomisation was done by minimisation, with stratification for WHO performance status, histology, and Centre. Follow-up was every 3 weeks to 21 weeks after randomisation, and every 8 weeks thereafter. Because of slow accrual, the two chemotherapy groups were combined and compared with ASC alone for the primary outcome of overall survival. Analysis was by intention to treat. This study is registered, number ISRCTN54469112. Findings At the time of analysis, 393 (96%) patients had died (ASC 132 [97%], ASC plus, MVP 132 [96%], ASC plus vinorelbine 129 [95%]). Compared with ASC alone, we noted a small, non-significant survival benefit for ASC plus chemotherapy (hazard ratio [HR] 0.89 [95% CI 0.72-1.10]; p=0.29). Median survival was 7.6 months in the ASC alone group and 8.5 months in the ASC plus chemotherapy group. Exploratory analyses suggested a survival advantage for ASC plus vinorelbine compared with ASC alone (HR 0.80 [0.63-1.02]; p=0.08), with a median survival of 9.5 months. There was no evidence of a survival benefit with ASC plus MVP (HR 0.99 [0.78-1.27]; p=0.95). We observed no between-group differences in four predefined quality-of-life subscales (physical functioning, pain, dyspnoea, and global health status) at any of the assessments in the first 6 months. Interpretation The addition of chemotherapy to ASC offers no significant benefits in terms of overall survival or quality of life. However, exploratory analyses suggested that vinorelbine merits further investigation.	[Stephens, Richard J.; Girling, David J.; Nankivell, Matthew; Pugh, Cheryl; Parmar, Mahesh K. B.] MRC, Clin Trials Unit, London NW1 2DA, England; [Muers, Martin F.] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Fisher, Patricia] Weston Pk Hosp, Sheffield, S Yorkshire, England; [Darlison, Liz; Peake, Michael] Univ Hosp Leicester, Leicester, Leics, England; [Higgs, Christopher M. B.] Dorothy House Hospice, Bath, Avon, England; [Lowry, Erica] Papworth Hosp, Papworth Everard, England; [Nicholson, Andrew G.] Royal Brompton Hosp, London SW3 6LY, England; [O'Brien, Mary] Royal Marsden Hosp, London SW3 6JJ, England; [Rudd, Robin; Steele, Jeremy] St Bartholomews Hosp, London, England; [Snee, Michael] Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England	Medical Research Council Clinical Trials Unit; Leeds General Infirmary; University of Leeds; Weston Park Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Papworth Hospital; Royal Brompton Hospital; Royal Marsden NHS Foundation Trust; University of London; Queen Mary University London; Cookridge Hospital	Stephens, RJ (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	rs@ctu.mrc.ac.uk	Ottensmeier, Christian H/E-8131-2012	Ottensmeier, Christian H/0000-0003-3619-1657; Sebag-Montefiore, David/0000-0002-5978-9259; Braybrooke, Jeremy/0000-0003-1943-7360; Lee, Siow Ming/0000-0002-1741-6235	MRC [MC_U122861375] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; Medical Research Council [MC_U122861375] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Andreopoulou E, 2004, ANN ONCOL, V15, P1406, DOI 10.1093/annonc/mdh356; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Byrne MJ, 1999, J CLIN ONCOL, V17, P25, DOI 10.1200/JCO.1999.17.1.25; Chapman A, 2008, THORAX, V63, P435, DOI 10.1136/thx.2007.081430; DEHAES JCJM, 1990, BRIT J CANCER, V62, P1034, DOI 10.1038/bjc.1990.434; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Gralla RJ, 2007, DRUGS, V67, P1403, DOI 10.2165/00003495-200767100-00003; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; LANGENDIJK H, 2004, MED RADIOL, P395; Middleton GW, 1998, ANN ONCOL, V9, P269, DOI 10.1023/A:1008236010868; Muers MF, 2004, THORAX, V59, P144, DOI 10.1136/thorax.2003.009290; Peto J, 1999, BRIT J CANCER, V79, P666, DOI 10.1038/sj.bjc.6690105; RUSCH VW, 1995, CHEST, V107, pS322, DOI 10.1378/chest.107.6_Supplement.322S; Ryan CW, 1998, CHEST, V113, p66S, DOI 10.1378/chest.113.1_Supplement.66S; Steele JPC, 2000, J CLIN ONCOL, V18, P3912, DOI 10.1200/JCO.2000.18.23.3912; Stephens RJ, 1999, BRIT J CANCER, V79, P538, DOI 10.1038/sj.bjc.6690085; Tanvetyanon T, 2007, J THORAC ONCOL, V2, P1091, DOI 10.1097/JTO.0b013e31815cff64; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tossavainen A, 2004, INT J OCCUP ENV HEAL, V10, P22, DOI 10.1179/oeh.2004.10.1.22; van Meerbeeck JP, 2006, J THORAC ONCOL, V1, P279, DOI 10.1097/01243894-200605000-00001; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; VOGELZANG NJ, 2002, P AM SOC CLIN ONCOL, V21; Wiggins J, 2001, THORAX, V56, P250	25	197	200	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1685	1694		10.1016/S0140-6736(08)60727-8	http://dx.doi.org/10.1016/S0140-6736(08)60727-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486741	Green Published			2022-12-28	WOS:000256002200027
J	DeWitt, N				DeWitt, Natalie			Regenerative medicine	NATURE			English	Editorial Material																			0	12	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					301	301		10.1038/453301a	http://dx.doi.org/10.1038/453301a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480809	Bronze			2022-12-28	WOS:000255868400035
J	McDermott, J				McDermott, Josh			The evolution of music	NATURE			English	Editorial Material									[McDermott, Josh] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	McDermott, J (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.								0	50	62	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					287	288		10.1038/453287a	http://dx.doi.org/10.1038/453287a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	301AI	18480798	Bronze			2022-12-28	WOS:000255868400025
J	Takahashi, H; Igawa, K; Arii, K; Kamihara, Y; Hirano, M; Hosono, H				Takahashi, Hiroki; Igawa, Kazumi; Arii, Kazunobu; Kamihara, Yoichi; Hirano, Masahiro; Hosono, Hideo			Superconductivity at 43 K in an iron-based layered compound LaO1-xFxFeAs	NATURE			English	Article								The iron- and nickel-based layered compounds LaOFeP (refs 1, 2) and LaONiP (ref. 3) have recently been reported to exhibit low-temperature superconducting phases with transition temperatures T-c of 3 and 5 K, respectively. Furthermore, a large increase in the midpoint T-c of up to similar to 26 K has been realized(4) in the isocrystalline compound LaOFeAs on doping of fluoride ions at the O2- sites (LaO1-xFxFeAs). Experimental observations(5,6) and theoretical studies(7-9) suggest that these transitions are related to a magnetic instability, as is the case for most superconductors based on transition metals. In the copper-based high-temperature superconductors, as well as in LaOFeAs, an increase in T-c is often observed as a result of carrier doping in the two-dimensional electronic structure through ion substitution in the surrounding insulating layers, suggesting that the application of external pressure should further increase T-c by enhancing charge transfer between the insulating and conducting layers. The effects of pressure on these iron oxypnictide superconductors may be more prominent than those in the copper-based systems, because the As ion has a greater electronic polarizability, owing to the covalency of the Fe-As chemical bond, and, thus, is more compressible than the divalent O2- ion. Here we report that increasing the pressure causes a steep increase in the onset T-c of F-doped LaOFeAs, to a maximum of similar to 43 K at similar to 4 GPa. With the exception of the copper-based high-T-c superconductors, this is the highest T-c reported to date. The present result, together with the great freedom available in selecting the constituents of isocrystalline materials with the general formula LnOTMPn (Ln, Y or rare-earth metal; TM, transition metal; Pn, group-V, 'pnicogen', element), indicates that the layered iron oxypnictides are promising as a new material platform for further exploration of high-temperature superconductivity.	[Takahashi, Hiroki; Igawa, Kazumi; Arii, Kazunobu] Nihon Univ, Dept Phys, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan; [Kamihara, Yoichi; Hirano, Masahiro; Hosono, Hideo] Tokyo Inst Technol, ERATO SORST, JST, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Hirano, Masahiro; Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Nihon University; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Tokyo Institute of Technology	Takahashi, H (corresponding author), Nihon Univ, Dept Phys, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan.	hiroki@chs.nihon-u.ac.jp	Kamihara, Yoichi/C-4471-2008; Hiroki, Takahashi/AAI-9862-2021; Hosono, HIdeo/J-3489-2013; Hosono, Hideo/T-1845-2019	Hosono, HIdeo/0000-0001-9260-6728; 				ISHIBASHI S, IN PRESS J PHYS SOC; Ishida K, 1998, NATURE, V396, P658, DOI 10.1038/25315; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kamihara Y, 2006, J AM CHEM SOC, V128, P10012, DOI 10.1021/ja063355c; KOHAMA Y, UNPUB PHYS REV LETT; KUROKI K, 2008, UNCONVENTIONAL SUPER; Liang CY, 2007, SUPERCOND SCI TECH, V20, P687, DOI 10.1088/0953-2048/20/7/017; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; MATSUMOTO T, 2002, REV HIGH PRESSURE SC, V12, P280, DOI DOI 10.4131/JSHPREVIEW.12.280; NAKAI Y, UNPUB PHYS REV LETT; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; Shimizu K, 2001, NATURE, V412, P316, DOI 10.1038/35085536; SINGH DJ, 2008, LOW CARRIER DENSITY; TAKAHASHI H, 1996, STUDIES HIGH TEMPERA, V16, P1; Uehara M, 1996, J PHYS SOC JPN, V65, P2764, DOI 10.1143/JPSJ.65.2764; Watanabe T, 2007, INORG CHEM, V46, P7719, DOI 10.1021/ic701200e; YANAGI H, UNPUB PHYS REV B	17	1022	1044	16	473	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					376	378		10.1038/nature06972	http://dx.doi.org/10.1038/nature06972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18432191				2022-12-28	WOS:000255868400048
J	Liu, H; Paige, NM; Goldzweig, CL; Wong, E; Zhou, A; Suttorp, MJ; Munjas, B; Orwoll, E; Shekelle, P				Liu, Hau; Paige, Nell M.; Goldzweig, Caroline L.; Wong, Elaine; Zhou, Annie; Suttorp, Marika J.; Munjas, Brett; Orwoll, Eric; Shekelle, Paul			Screening for osteoporosis in men: A systematic review for an American College of Physicians guideline	ANNALS OF INTERNAL MEDICINE			English	Review							BONE-MINERAL DENSITY; ANDROGEN DEPRIVATION THERAPY; X-RAY ABSORPTIOMETRY; SPINAL-CORD-INJURY; EUROPEAN PROSPECTIVE OSTEOPOROSIS; RISK-FACTORS; PROSTATE-CANCER; HIP FRACTURE; QUANTITATIVE ULTRASOUND; ELDERLY-MEN	Background: Screening for low bone mineral density (BMD) by dual-energy x-ray absorptiometry (DXA) is the primary way to identify asymptomatic men who might benefit from osteoporosis treatment. Identifying men at risk for low BMD and fracture can help clinicians determine which men should be tested. Purpose: To identify which asymptomatic men should receive DXA BMD testing, this systematic review evaluates 1) risk factors for osteoporotic fracture in men that may be mediated through low BMD and 2) the performance of non-DXA tests in identifying men with low BMD. Data Sources: Studies identified through the MEDLINE database (1990 to July 2007). Study Selection: Articles that assessed risk factors for osteoporotic fracture in men or evaluated a non-DXA screening test against a gold standard of DXA. Data Extraction: Researchers performed independent dual abstractions for each article, determined performance characteristics of screening tests, and assessed the quality of included articles. Data Synthesis: A published meta-analysis of 167 studies evaluating risk factors for low BMD-related fracture in men and women found high-risk factors to be increased age (>70 years), low body weight (body mass index <20 to 25 kg/m(2)), weight loss (>10%), physical inactivity, prolonged corticosteroid use, and previous osteoporotic fracture. An additional 102 studies assessing 15 other proposed risk factors were reviewed; most had insufficient evidence in men to draw conclusions. Twenty diagnostic study articles were reviewed. At a T-score threshold of -1.0, calcaneal ultrasonography had a sensitivity of 75% and specificity of 66% for identifying DXA-determined osteoporosis (DXA T-score, -2.5). At a risk score threshold of -1, the Osteoporosis Self-Assessment Screening Tool had a sensitivity of 81% and specificity of 68% to identify DXA-determined osteoporosis. Limitation: Data on other screening tests, including radiography, and bone geometry variables, were sparse. Conclusion: Key risk factors for low BMD-mediated fracture include increased age, low body weight, weight loss, physical inactivity, prolonged corticosteroid use, previous osteoporotic fracture, and androgen deprivation therapy. Non-DXA tests either are too insensitive or have insufficient data to reach conclusions.	Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Santa Clara Valley Medical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; Oregon Health & Science University	Liu, H (corresponding author), Santa Clara Valley Med Ctr, 751 S Baascon Ave, San Jose, CA 95128 USA.	hauliu@stanford.edu		Orwoll, Eric/0000-0002-8520-7355	AHRQ HHS [HS000028-19] Funding Source: Medline; NCRR NIH HHS [RR024140] Funding Source: Medline; NIAMS NIH HHS [AR45647] Funding Source: Medline; NIA NIH HHS [AG027810] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000028, T32HS000028] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG027810] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adler RA, 2003, CHEST, V123, P2012, DOI 10.1378/chest.123.6.2012; Adler RA, 2003, MAYO CLIN PROC, V78, P723, DOI 10.4065/78.6.723; Adler RR, 2001, J CLIN DENSITOM, V4, P225, DOI 10.1385/JCD:4:3:225; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bakhireva LN, 2004, AM J PREV MED, V26, P436, DOI 10.1016/j.ampere.2004.02.013; BARRETTCONNOR E, 1992, JAMA-J AM MED ASSOC, V268, P3333; Bateman C, 2006, SAMJ S AFR MED J, V96, P19; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; BAUER DC, 2004, AM SOC BON MIN RES 2, P1023; Benson BW, 2005, NICOTINE TOB RES, V7, P719, DOI 10.1080/14622200500259119; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Boonen S, 1997, J BONE MINER RES, V12, P2119, DOI 10.1359/jbmr.1997.12.12.2119; Brunader R, 2002, AM FAM PHYSICIAN, V65, P1357; Burger H, 1998, AM J EPIDEMIOL, V147, P871, DOI 10.1093/oxfordjournals.aje.a009541; Cankurtaran M, 2005, AGING CLIN EXP RES, V17, P108; Cauley JA, 2005, OSTEOPOROSIS INT, V16, P1525, DOI 10.1007/s00198-005-1866-8; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Chen Z, 2002, CANCER-AM CANCER SOC, V95, P2136, DOI 10.1002/cncr.10967; Cheng SL, 1997, J BONE MINER RES, V12, P1075, DOI 10.1359/jbmr.1997.12.7.1075; Cheung EYN, 2005, OSTEOPOROSIS INT, V16, P1481, DOI 10.1007/s00198-005-2000-7; Cohen-Solal ME, 1998, J BONE MINER RES, V13, P1909, DOI 10.1359/jbmr.1998.13.12.1909; Daniell HW, 2000, J UROLOGY, V163, P181, DOI 10.1016/S0022-5347(05)68000-7; Daniell HW, 1997, J UROLOGY, V157, P439, DOI 10.1016/S0022-5347(01)65165-6; De Laet CEDH, 1998, J BONE MINER RES, V13, P1587, DOI 10.1359/jbmr.1998.13.10.1587; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Demirel G, 1998, SPINAL CORD, V36, P822, DOI 10.1038/sj.sc.3100704; Deutschmann HA, 2002, J INTERN MED, V252, P389, DOI 10.1046/j.1365-2796.2002.01040.x; Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x; Diamond TH, 2004, J UROLOGY, V172, P529, DOI 10.1097/01.ju.0000130508.61020.66; Diaz MN, 1997, OSTEOPOROSIS INT, V7, P65, DOI 10.1007/BF01623463; Diaz MN, 1997, BONE, V20, P145, DOI 10.1016/S8756-3282(96)00331-6; Donaldson MMK, 1999, OSTEOPOROSIS INT, V10, P316, DOI 10.1007/s001980050234; ELLIOT JR, 1993, AUST NZ J MED, V23, P458, DOI 10.1111/j.1445-5994.1993.tb01830.x; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; GLYNN NW, 1995, J BONE MINER RES, V10, P1769; Gonnelli S, 2005, OSTEOPOROSIS INT, V16, P963, DOI 10.1007/s00198-004-1771-6; Grampp S, 2001, RADIOLOGY, V220, P400, DOI 10.1148/radiology.220.2.r01au05400; Gudmundsdottir SL, 2005, J CLIN DENSITOM, V8, P80, DOI 10.1385/JCD:8:1:080; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Hatano T, 2000, BJU INT, V86, P449, DOI 10.1046/j.1464-410X.2000.00774.x; Hatjimihail AT, 2006, EVID BASED MED, V11, P189; Haugeberg G, 2002, ARTHRITIS RHEUM-US, V46, P1720, DOI 10.1002/art.10408; Heijckmann AC, 2005, EUR J ENDOCRINOL, V153, P23, DOI 10.1530/eje.1.01933; Hoidrup S, 1999, AM J EPIDEMIOL, V149, P993; Hussain SA, 2003, BJU INT, V92, P690, DOI 10.1046/j.1464-410X.2003.04471.x; Iqbal F, 1999, CHEST, V116, P1616, DOI 10.1378/chest.116.6.1616; Izumotani K, 2003, J BONE MINER METAB, V21, P86, DOI 10.1007/s007740300014; Jones LM, 2002, SPINAL CORD, V40, P230, DOI 10.1038/sj.sc.3101286; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P799, DOI 10.1007/s00198-004-1755-6; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P581, DOI 10.1007/s00198-004-1780-5; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; Kaptoge S, 2004, J BONE MINER RES, V19, P1982, DOI 10.1359/JBMR.040901; Karadag F, 2003, J BONE MINER METAB, V21, P242, DOI 10.1007/s00774-002-0416-0; Karlsson KM, 1996, BONE, V18, P327, DOI 10.1016/8756-3282(96)00004-X; Kemppainen T, 1999, BONE, V24, P249, DOI 10.1016/S8756-3282(98)00178-1; Kiebzak GM, 2002, ARCH INTERN MED, V162, P2217, DOI 10.1001/archinte.162.19.2217; Kim Mi Jin, 2003, Korean J Intern Med, V18, P174; Koh LKH, 2001, OSTEOPOROSIS INT, V12, P699, DOI 10.1007/s001980170070; Kroger H, 1999, CALCIFIED TISSUE INT, V64, P191; Krupski TL, 2004, CANCER-AM CANCER SOC, V101, P541, DOI 10.1002/cncr.20388; Kung AWC, 2005, OSTEOPOROSIS INT, V16, P849, DOI 10.1007/s00198-004-1778-z; LAROCHE M, 1994, OSTEOPOROSIS INT, V4, P309, DOI 10.1007/BF01622188; Lau EMC, 2001, J BONE MINER RES, V16, P572, DOI 10.1359/jbmr.2001.16.3.572; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Lazo MG, 2001, SPINAL CORD, V39, P208, DOI 10.1038/sj.sc.3101139; Lewis CE, 2007, J BONE MINER RES, V22, P211, DOI 10.1359/JBMR.061017; Li-Yu JT, 2005, OSTEOPOROSIS INT, V16, P1789, DOI 10.1007/s00198-005-1929-x; Lim S, 2004, BONE, V35, P792, DOI 10.1016/j.bone.2004.05.016; Lin JD, 2001, BRIT J RADIOL, V74, P602, DOI 10.1259/bjr.74.883.740602; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Lopez AM, 2005, OSTEOPOROSIS INT, V16, P707, DOI 10.1007/s00198-004-1799-7; Lunt M, 2001, OSTEOPOROSIS INT, V12, P688, DOI 10.1007/s001980170069; Lynn HS, 2005, OSTEOPOROSIS INT, V16, P829, DOI 10.1007/s00198-004-1768-1; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; MALLMIN H, 1994, OSTEOPOROSIS INT, V4, P298, DOI 10.1007/BF01622186; Maugeri D, 1998, Eur Rev Med Pharmacol Sci, V2, P189; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Melton LJ, 2002, BONE, V31, P119, DOI 10.1016/S8756-3282(02)00788-3; Melton LJ, 2005, OSTEOPOROSIS INT, V16, P460, DOI 10.1007/s00198-004-1820-1; Melton LJ, 2003, J UROLOGY, V169, P1747, DOI 10.1097/01.ju.0000059281.67667.97; Mitchell BD, 2003, BONE, V33, P839, DOI 10.1016/S8756-3282(03)00246-1; Montagnani A, 2001, J CLIN DENSITOM, V4, P231, DOI 10.1385/JCD:4:3:231; Morris CA, 2004, J GEN INTERN MED, V19, P783, DOI 10.1111/j.1525-1497.2004.30240.x; Morris MS, 2005, BONE, V37, P234, DOI 10.1016/j.bone.2005.04.017; Moyad Mark A, 2002, Urol Nurs, V22, P276; Mulleman D, 2002, OSTEOPOROSIS INT, V13, P388, DOI 10.1007/s001980200044; Naves M, 2005, OSTEOPOROSIS INT, V16, P603, DOI 10.1007/s00198-004-1727-x; Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nguyen TV, 1996, AM J EPIDEMIOL, V144, P255, DOI 10.1093/oxfordjournals.aje.a008920; ODVINA CV, 1988, METABOLISM, V37, P221, DOI 10.1016/0026-0495(88)90099-6; Oefelein MG, 2001, J UROLOGY, V166, P1724, DOI 10.1016/S0022-5347(05)65661-3; Ohldin Andrea, 2003, J South Orthop Assoc, V12, P18; Orwin R.G., 1994, HDB RES SYNTHESIS; Orwoll ES, 2000, OSTEOPOROSIS INT, V11, P815, DOI 10.1007/s001980070039; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; PRAET JP, 1992, OSTEOPOROSIS INT, V2, P257, DOI 10.1007/BF01624152; ROBINSON B, 1987, MED J AUSTRALIA, V146, P297, DOI 10.5694/j.1326-5377.1987.tb120265.x; Rothenberg RJ, 2004, J CLIN DENSITOM, V7, P101, DOI 10.1385/JCD:7:1:101; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Rud B, 2007, OSTEOPOROSIS INT, V18, P1177, DOI 10.1007/s00198-006-0319-3; Sabo D, 2001, ARCH ORTHOP TRAUM SU, V121, P75, DOI 10.1007/s004020000162; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Schwartz AV, 2005, J BONE MINER RES, V20, P596, DOI 10.1359/JBMR.041219; Seeman E, 2004, CALCIFIED TISSUE INT, V75, P120, DOI 10.1007/s00223-004-4002-4; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Shaw C K, 1993, Ann Epidemiol, V3, P264; Shepherd AJ, 2007, ANN FAM MED, V5, P540, DOI 10.1370/afm.753; Shin A, 2004, OSTEOPOROSIS INT, V15, P639, DOI 10.1007/s00198-004-1587-4; Shin MH, 2005, J KOREAN MED SCI, V20, P1011, DOI 10.3346/jkms.2005.20.6.1011; Sin DD, 2003, AM J MED, V114, P10, DOI 10.1016/S0002-9343(02)01297-4; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908; SOROKO SB, 1994, J BONE MINER RES, V9, P761; STANLEY HL, 1991, J AM GERIATR SOC, V39, P766, DOI 10.1111/j.1532-5415.1991.tb02698.x; STEWART A, 1995, BRIT J RADIOL, V68, P614, DOI 10.1259/0007-1285-68-810-614; Stoch SA, 2001, J CLIN ENDOCR METAB, V86, P2787, DOI 10.1210/jc.86.6.2787; Tanaka T, 2001, OSTEOPOROSIS INT, V12, P942, DOI 10.1007/s001980170023; TRAVERSGUSTAFSON D, 1995, CALCIFIED TISSUE INT, V57, P267, DOI 10.1007/BF00298881; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; Varenna M, 2005, OSTEOPOROSIS INT, V16, P1749, DOI 10.1007/s00198-005-1914-4; Villareal MS, 1996, ANN ALLERG ASTHMA IM, V76, P369, DOI 10.1016/S1081-1206(10)60040-3; vonWowern N, 1996, JPEN-PARENTER ENTER, V20, P105, DOI 10.1177/0148607196020002105; Welch Ailsa, 2004, Osteoporos Int, V15, P217, DOI 10.1007/s00198-003-1410-7; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong PKK, 2003, INTERN MED J, V33, P505, DOI 10.1046/j.1445-5994.2003.00468.x; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P610, DOI 10.1007/s00198-004-1730-2; Yaturu S, 2006, PROSTATE CANCER P D, V9, P35, DOI 10.1038/sj.pcan.4500846; Yeh SS, 2002, J INVEST MED, V50, P452, DOI 10.1136/jim-50-06-05	137	97	108	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					685	701		10.7326/0003-4819-148-9-200805060-00009	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00009			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458282				2022-12-28	WOS:000255731800007
J	Turunen, JHO				Turunen, Juha H. O.			Depicting the pain profile with the diary-day method	LANCET			English	Editorial Material									Univ Kuopio, Dept Social Pharm, FI-70211 Kuopio, Finland	University of Eastern Finland	Turunen, JHO (corresponding author), Univ Kuopio, Dept Social Pharm, FI-70211 Kuopio, Finland.	juha.turunen@uku.fi		Turunen, Juha/0000-0002-9913-1240				Dysvik Elin, 2004, Pain Manag Nurs, V5, P66; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Turunen JHO, 2004, J PAIN, V5, P498, DOI 10.1016/j.jpain.2004.08.003; TURUNEN JHO, 2007, THESIS U KUOPIO; Verhaak PFM, 1998, PAIN, V77, P231, DOI 10.1016/S0304-3959(98)00117-1	6	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1482	1483		10.1016/S0140-6736(08)60633-9	http://dx.doi.org/10.1016/S0140-6736(08)60633-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456085				2022-12-28	WOS:000255668300006
J	Hsu, J; Fung, V; Price, M; Huang, J; Brand, R; Hui, R; Fireman, B; Newhouse, JP				Hsu, John; Fung, Vicki; Price, Mary; Huang, Jie; Brand, Richard; Hui, Rita; Fireman, Bruce; Newhouse, Joseph P.			Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-SURVEY; COVERAGE; CAPS	Context Medicare Part D drug benefits include substantial cost sharing. Objective To determine beneficiaries' knowledge of benefits and cost responses. Design, Setting, and Participants Telephone interviews were conducted in 2007 in a stratified random sample of community- dwelling Kaiser Permanente- Northern California Medicare Advantage beneficiaries aged 65 years or older, with a gap in coverage if they exceeded $ 2250 in drug costs ( N= 1040; 74.9% response rate). Half were selected to have reached the gap in 2006. In the source population of Medicare Advantage Prescription Drug plan beneficiaries, 8% entered the coverage gap in 2006. Models were adjusted for individual characteristics and weighted for sampling proportions. Main Outcome Measures Knowledge of cost sharing including awareness of the coverage gap, gap start and end amounts, and drug cost sharing before, during, and after the gap. Cost- related responses including cost- coping behaviors ( eg, switching to lower- cost medications), reduced adherence ( eg, not refilling prescriptions), and financial burden ( eg, going without necessities). Results An estimated 40% ( 95% confidence interval [ CI], 35%- 45%) of beneficiaries were aware that their drug plan in 2006 included a coverage gap; knowledge of the gap was greater among individuals who reached the gap during the year. Approximately 36% ( 95% CI, 32%- 41%) of beneficiaries reported at least 1 of the following responses to drug costs: cost- coping behavior ( 26%), reduced adherence ( 15%), or experiencing financial burden ( 7%). In multivariate analyses, beneficiaries with lower household income more frequently reported cost responses ( difference of 14.5 percentage points for <$ 40 000/ y vs >= $ 40 000/ y [ 95% CI, 3.6- 25.4 percentage points]). Compared with beneficiaries who were unaware of having a coverage gap, those who were aware more frequently reported any cost response ( difference of 11.3 percentage points [ 95% CI, 0.8- 21.9 percentage points]), but had fewer reports of borrowing money or going without necessities ( difference of 5.5 percentage points [ 95% CI, 1.1- 10.0 percentage points]). Conclusions Beneficiaries in this Medicare Advantage plan have limited knowledge of Part D cost sharing and often report behavioral responses to drug costs. Limited knowledge is associated with fewer reports of cost responses overall, but more reports of financial burden.	[Hsu, John; Fung, Vicki; Price, Mary; Huang, Jie; Fireman, Bruce] Kaiser Permanente Med Care Program, Ctr Hlth Policy Studies, Oakland, CA 94612 USA; [Hsu, John; Fung, Vicki; Price, Mary; Huang, Jie; Fireman, Bruce] Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94612 USA; [Hui, Rita] Kaiser Permanente Med Care Program, Drug Informat Serv, Pharm Outcomes Res Grp, Oakland, CA 94612 USA; [Brand, Richard] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Newhouse, Joseph P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Cambridge, MA 02138 USA; [Newhouse, Joseph P.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Cambridge, MA 02138 USA; [Newhouse, Joseph P.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Hsu, J (corresponding author), Kaiser Permanente Med Care Program, Ctr Hlth Policy Studies, 2000 Broadway,3rd Floor, Oakland, CA 94612 USA.	jth@dor.kaiser.org	Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022		AHRQ HHS [R01 HS013902] Funding Source: Medline; NIA NIH HHS [R01 AG029316] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029316] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2007, REP C MED PAYM POL M; *C BUDG OFF, FACT SHEET CBOS MARC; Cox ER, 2001, MED CARE, V39, P296, DOI 10.1097/00005650-200103000-00009; Cubanski J, 2007, HEALTH AFFAIR, V26, pW1, DOI 10.1377/hlthaff.26.1.w1; HEISS F, 2007, MIND GAPL CONS PERC; *HJ KAIS FAM FDN, 2007, FACT SHEET MED PRESC; *HJ KAIS FAM FDN, 2006, SEN MED PRESCR DRUG; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Lichtenberg FR, 2007, HEALTH AFFAIR, V26, P1735, DOI 10.1377/hlthaff.26.6.1735; *MED PAYM ADV COMM, 2006, REP C INCR VAL MED; Neuman P, 2007, HEALTH AFFAIR, V26, pW630, DOI 10.1377/hlthaff.26.5.w630; Newhouse JP, 1993, FREE ALL LESSONS RAN; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Pauly MV, 2004, NBER FR HLTH POL RES, P55; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Reed M, 2008, HEALTH SERV RES, V43, P785, DOI 10.1111/j.1475-6773.2007.00797.x; SAFRAN DG, 2005, HLTH AFF MILLWOOD S; Soumerai SB, 2006, ARCH INTERN MED, V166, P1829, DOI 10.1001/archinte.166.17.1829; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; Yin W, 2008, ANN INTERN MED, V148, P169, DOI 10.7326/0003-4819-148-3-200802050-00200	21	84	86	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1929	1936		10.1001/jama.299.16.1929	http://dx.doi.org/10.1001/jama.299.16.1929			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291AD	18430912	Bronze			2022-12-28	WOS:000255163800027
J	Czech, B; Malone, CD; Zhou, R; Stark, A; Schlingeheyde, C; Dus, M; Perrimon, N; Kellis, M; Wohlschlegel, JA; Sachidanandam, R; Hannon, GJ; Brennecke, J				Czech, Benjamin; Malone, Colin D.; Zhou, Rui; Stark, Alexander; Schlingeheyde, Catherine; Dus, Monica; Perrimon, Norbert; Kellis, Manolis; Wohlschlegel, James A.; Sachidanandam, Ravi; Hannon, Gregory J.; Brennecke, Julius			An endogenous small interfering RNA pathway in Drosophila	NATURE			English	Article							C-ELEGANS; MICRORNA MATURATION; ARGONAUTE PROTEINS; DISTINCT ROLES; BIOGENESIS; INITIATION; GERMLINE; ELEMENTS; REVEALS; VIRUSES	Drosophila endogenous small RNAs are categorized according to their mechanisms of biogenesis and the Argonaute protein to which they bind. MicroRNAs are a class of ubiquitously expressed RNAs of 22 nucleotides in length, which arise from structured precursors through the action of Drosha - Pasha and Dicer- 1-Loquacious complexes(1-7). These join Argonaute-1 to regulate gene expression(8,9). A second endogenous small RNA class, the Piwi-interacting RNAs, bind Piwi proteins and suppress transposons(10,11). Piwi- interacting RNAs are restricted to the gonad, and at least a subset of these arises by Piwi- catalysed cleavage of single-stranded RNAs(12,13). Here we show that Drosophila generates a third small RNA class, endogenous small interfering RNAs, in both gonadal and somatic tissues. Production of these RNAs requires Dicer- 2, but a subset depends preferentially on Loquacious(1,4,5) rather than the canonical Dicer- 2 partner, R2D2 ( ref. 14). Endogenous small interfering RNAs arise both from convergent transcription units and from structured genomic loci in a tissue- specific fashion. They predominantly join Argonaute- 2 and have the capacity, as a class, to target both protein- coding genes and mobile elements. These observations expand the repertoire of small RNAs in Drosophila, adding a class that blurs distinctions based on known biogenesis mechanisms and functional roles.	[Czech, Benjamin; Malone, Colin D.; Schlingeheyde, Catherine; Dus, Monica; Sachidanandam, Ravi; Hannon, Gregory J.; Brennecke, Julius] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Zhou, Rui; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, Boston, MA 02115 USA; [Stark, Alexander; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander; Kellis, Manolis] Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; [Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; brenneck@cshl.edu	sachidanandam, ravi/Q-6916-2019; Czech, Benjamin/AAJ-8592-2020; Brennecke, Julius/C-1626-2015; Hannon, Gregory/AAB-3568-2019; Stark, Alexander/D-1473-2012; Kellis, Manolis/ABE-7385-2020; Brennecke, Julius/T-5883-2019	sachidanandam, ravi/0000-0001-9844-4459; Czech, Benjamin/0000-0001-8471-0007; Brennecke, Julius/0000-0002-5141-0814; Stark, Alexander/0000-0003-2611-0841; Kellis, Manolis/0000-0001-7113-9630; Brennecke, Julius/0000-0002-5141-0814; Perrimon, Norbert/0000-0001-7542-472X	NHGRI NIH HHS [U54 HG004570-01, U54 HG004555-01, U01 HG004264-02, U54 HG004570, U54 HG004555, U01 HG004264] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, U54HG004555, U01HG004264] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Forsyth D, 1907, Q J MED, V1, P287; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; TAM OH, 2008, NATURE          0410; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WATANABE T, 2008, NATURE          0410; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	32	504	527	5	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					798	U7		10.1038/nature07007	http://dx.doi.org/10.1038/nature07007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463631	Green Accepted			2022-12-28	WOS:000256415300047
J	Natanson, C; Kern, SJ; Lurie, P; Banks, SM; Wolfe, SM				Natanson, Charles; Kern, Steven J.; Lurie, Peter; Banks, Steven M.; Wolfe, Sidney M.			Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POLYMERIZED BOVINE HEMOGLOBIN; ABDOMINAL AORTIC-ANEURYSM; NITRIC-OXIDE; OXYGEN CARRIER; PREOPERATIVE HEMODILUTION; ENDOTHELIAL-CELLS; HEMORRHAGIC-SHOCK; RANDOMIZED-TRIAL; CARDIAC-SURGERY; BLINDED TRIAL	Context Hemoglobin-based blood substitutes (HBBSs) are infusible oxygen-carrying liquids that have long shelf lives, have no need for refrigeration or cross-matching, and are ideal for treating hemorrhagic shock in remote settings. Some trials of HBBSs during the last decade have reported increased risks without clinical benefit. Objective To assess the safety of HBBSs in surgical, stroke, and trauma patients. Data Sources PubMed, EMBASE, and Cochrane Library searches for articles using hemoglobin and blood substitutes from 1980 through March 25, 2008; reviews of Food and Drug Administration (FDA) advisory committee meeting materials; and Internet searches for company press releases. Study Selection Randomized controlled trials including patients aged 19 years and older receiving HBBSs therapeutically. The database searches yielded 70 trials of which 13 met these criteria; in addition, data from 2 other trials were reported in 2 press releases, and additional data were included in 1 relevant FDA review. Data Extraction Data on death and myocardial infarction (MI) as outcome variables. Results Sixteen trials involving 5 different products and 3711 patients in varied patient populations were identified. A test for heterogeneity of the results of these trials was not significant for either mortality or MI (for both, I-2 = 0%, P >= .60), and data were combined using a fixed-effects model. Overall, there was a statistically significant increase in the risk of death (164 deaths in the HBBS-treated groups and 123 deaths in the control groups; relative risk [RR], 1.30; 95% confidence interval [CI], 1.05-1.61) and risk of MI (59 MIs in the HBBS-treated groups and 16 MIs in the control groups; RR, 2.71; 95% CI, 1.67-4.40) with these HBBSs. Subgroup analysis of these trials indicated the increased risk was not restricted to a particular HBBS or clinical indication. Conclusion Based on the available data, use of HBBSs is associated with a significantly increased risk of death and MI.	[Natanson, Charles; Kern, Steven J.; Banks, Steven M.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Lurie, Peter; Wolfe, Sidney M.] Hlth Res Grp, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Natanson, C (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, 10 Ctr Dr, Bethesda, MD 20892 USA.	cnatanson@cc.nih.gov						[Anonymous], RANDOMIZED DOUBLE BL; Bloomfield EL, 2004, MIL MED, V169, P546, DOI 10.7205/MILMED.169.7.546; Brauer P, 1998, J NEUROSURG ANESTH, V10, P146, DOI 10.1097/00008506-199807000-00004; BRESLOW NE, 1980, IARC SCI PUBL; Burton Thomas M, 2006, Wall St J (East Ed), pA3; Caron A, 1999, J APPL PHYSIOL, V86, P541, DOI 10.1152/jappl.1999.86.2.541; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; DAMLE A, 2007, POLICY STUDY CLIN TR; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; DORSEN N, 1977, REV PANEL NEW DRUG R; *FOOD DRUG ADM BLO, 2006, FOOD DRUG ADM BLOOD; *FOOD DRUG ADM CTR, 1999, WORKSH CRIT SAF EFF; Garrioch MA, 1999, BRIT J ANAESTH, V83, P702, DOI 10.1093/bja/83.5.702; Gonzalez P, 1997, J INVEST MED, V45, P258; Gould SA, 1998, J AM COLL SURGEONS, V187, P113, DOI 10.1016/S1072-7515(98)00095-7; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Greenburg AG, 2004, J AM COLL SURGEONS, V198, P373, DOI 10.1016/j.jamcollsurg.2003.11.020; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SE, 2002, J CARDIOTHOR VASC AN, V16, P695, DOI 10.1053/jcan.2002.128416; Jahr JS, 2005, ANESTH ANALG, V100, P431, DOI 10.1213/01.ANE.0000142116.42938.82; Kasper SM, 1996, ANESTH ANALG, V83, P921; Kasper SM, 1998, ANESTH ANALG, V87, P284, DOI 10.1097/00000539-199808000-00009; Kerner T, 2003, INTENS CARE MED, V29, P378, DOI 10.1007/s00134-002-1622-x; LaMuraglia GM, 2000, J VASC SURG, V31, P299, DOI 10.1016/S0741-5214(00)90161-7; Lamy ML, 2000, ANESTHESIOLOGY, V92, P646, DOI 10.1097/00000542-200003000-00007; Levy JH, 2002, J THORAC CARDIOV SUR, V124, P35, DOI 10.1067/mtc.2002.121505; Lin G, 2001, BIOCHEM BIOPH RES CO, V280, P824, DOI 10.1006/bbrc.2000.4167; Lowe KC, 2006, J MATER CHEM, V16, P4189, DOI 10.1039/b604923k; Lurie P, 2006, LAW CONTEMP PROBL, V68, P85; MANTEL N, 1959, J NATL CANCER I, V22, P719; Matheson B, 2002, J APPL PHYSIOL, V93, P1479, DOI 10.1152/japplphysiol.00191.2002; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Olofsson C, 2006, ANESTHESIOLOGY, V105, P1153, DOI 10.1097/00000542-200612000-00015; PHELAN M, 1995, J CLIN INVEST, V96, P1145, DOI 10.1172/JCI118102; Przybelski R J, 1999, Prehosp Disaster Med, V14, P251; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Saxena R, 1999, STROKE, V30, P993, DOI 10.1161/01.STR.30.5.993; Schubert A, 2003, ANESTH ANALG, V97, P323, DOI 10.1213/01.ANE.0000068888.02977.DA; Schubert A, 2002, ARTIF CELL BLOOD SUB, V30, P259, DOI 10.1081/BIO-120006118; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sprung J, 2002, ANESTH ANALG, V94, P799, DOI 10.1097/00000539-200204000-00006; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vandegriff KD, 2003, TRANSFUSION, V43, P509, DOI 10.1046/j.1537-2995.2003.00341.x; 2006, FOOD DRUG ADM PRESEN; SINGLE CTR STUDY EVA; ENHANCEMENT TISSUE P; PHASE 2 OPEN LABEL S	48	435	454	0	66	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 21	2008	299	19					2304	2312		10.1001/jama.299.19.jrv80007	http://dx.doi.org/10.1001/jama.299.19.jrv80007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302QN	18443023				2022-12-28	WOS:000255984500025
J	Lucken-Ardjomande, S; Martinou, JC				Lucken-Ardjomande, Safa; Martinou, Jean-Claude			Granzyme A, a stealth killer in the mitochondrion	CELL			English	Editorial Material							COMPLEX-I; CELL-DEATH; APOPTOSIS; CHAIN		[Lucken-Ardjomande, Safa; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva, Switzerland	University of Geneva	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	jean-claude.martinou@cellbio.unige.ch		Lucken Ardjomande Hasler, Safa/0000-0003-0845-3584; martinou, Jean-claude/0000-0002-9847-2051				Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008	10	5	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					568	570		10.1016/j.cell.2008.04.031	http://dx.doi.org/10.1016/j.cell.2008.04.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485862	Bronze			2022-12-28	WOS:000255903300009
J	Mani, SA; Guo, W; Liao, MJ; Eaton, EN; Ayyanan, A; Zhou, AY; Brooks, M; Reinhard, F; Zhang, CC; Shipitsin, M; Campbell, LL; Polyak, K; Brisken, C; Yang, J; Weinberg, RA				Mani, Sendurai A.; Guo, Wenjun; Liao, Mai-Jing; Eaton, Elinor Ng.; Ayyanan, Ayyakkannu; Zhou, Alicia Y.; Brooks, Mary; Reinhard, Ferenc; Zhang, Cheng Cheng; Shipitsin, Michail; Campbell, Lauren L.; Polyak, Kornelia; Brisken, Cathrin; Yang, Jing; Weinberg, Robert A.			The epithelial-mesenchymal transition generates cells with properties of stem cells	CELL			English	Article							BREAST-CANCER CELLS; TRANSCRIPTION FACTOR SNAIL; TUMOR PROGRESSION; E-CADHERIN; MAMMARY-GLAND; METASTASIS; EXPRESSION; TWIST; IDENTIFICATION; TRANSFORMATION	The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer invasion and metastasis. We here report that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers. Furthermore, we show that those cells have an increased ability to form mammospheres, a property associated with mammary epithelial stem cells. Independent of this, stem cell-like cells isolated from HMLE cultures form mammospheres and express markers similar to those of HMLEs that have undergone an EMT. Moreover, stem-like cells isolated either from mouse or human mammary glands or mammary carcinomas express EMT markers. Finally, transformed human mammary epithelial cells that have undergone an EMT form mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties.	[Mani, Sendurai A.; Guo, Wenjun; Liao, Mai-Jing; Eaton, Elinor Ng.; Zhou, Alicia Y.; Brooks, Mary; Reinhard, Ferenc; Zhang, Cheng Cheng; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zhou, Alicia Y.; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA; [Ayyanan, Ayyakkannu; Brisken, Cathrin] Swiss Inst Expt Canc Res, NCCR Mol Oncol, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland; [Shipitsin, Michail; Campbell, Lauren L.; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shipitsin, Michail; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Campbell, Lauren L.; Polyak, Kornelia] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Yang, Jing] Univ Calif San Diego, Sch Med, Dept Pediat & Pharmacol, La Jolla, CA 92093 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California San Diego	Mani, SA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	smani@mdanderson.org; weinberg@wi.mit.edu	Mani, Sendurai A./A-7244-2009; Zhang, Cheng/GRS-8698-2022; Sayan, A. Emre/H-7330-2012	Mani, Sendurai A./0000-0002-5918-4276; Brisken, Cathrin/0000-0002-6857-3230; Zhou, Alicia/0000-0003-0388-8909; Sayan, A. Emre/0000-0002-5291-1485	NCI NIH HHS [CA94074, P01 CA080111-09, CA89393, P50 CA089393-070014, P50 CA089393-080014, R01 CA116235, P50 CA089393, P01 CA080111, P0-CA080111, R01-CA078461, R01 CA116235-03, R01 CA116235-01A1, R01 CA078461-09, R01 CA094074, P50 CA089393-060014, R01 CA078461, R01 CA116235-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA116235, P50CA089393, P01CA080111, R01CA094074, R01CA078461] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Briegel KJ, 2006, IUBMB LIFE, V58, P123, DOI 10.1080/15216540600686870; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Davies JA, 1996, ACTA ANAT, V156, P187; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Hay ED, 1995, ACTA ANAT, V154, P8; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; LIAO MJ, 2007, IN PRESS CANC RES; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Pomares JM, 2002, ANAT RECORD, V268, P343, DOI 10.1002/ar.10165; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850	42	6363	6687	16	1014	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					704	715		10.1016/j.cell.2008.03.027	http://dx.doi.org/10.1016/j.cell.2008.03.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485877	Green Accepted, Bronze			2022-12-28	WOS:000255903300024
J	Huffman, JC; Park, LT; Welch, CA; Nierenberg, AA; Januzzi, JL; Pomerantz, SR				Huffman, Jeffery C.; Park, Lawrence T.; Welch, Charles A.; Nierenberg, Andrew A.; Januzzi, James L., Jr.; Pomerantz, Stuart R.			A man with anergia and anhedonia associated with cardiovascular surgery - Major depressive disorder (with features of vascular depression) in a patient with cardiovascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; ELECTROCONVULSIVE-THERAPY ECT; ARTERY-BYPASS-SURGERY; MYOCARDIAL-INFARCTION; RISK-FACTOR; ANTIDEPRESSANT; MORTALITY; TRIAL; METAANALYSIS; PREVALENCE		[Huffman, Jeffery C.; Park, Lawrence T.; Welch, Charles A.; Nierenberg, Andrew A.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Januzzi, James L., Jr.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Pomerantz, Stuart R.] Massachusetts Gen Hosp, Neuroradiol Div, Boston, MA 02114 USA; [Huffman, Jeffery C.; Park, Lawrence T.; Welch, Charles A.; Nierenberg, Andrew A.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Januzzi, James L., Jr.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Pomerantz, Stuart R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Huffman, JC (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Januzzi, James/Y-2436-2019					Alexopoulos GS, 1997, AM J PSYCHIAT, V154, P562; Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P98, DOI 10.1176/appi.ajgp.10.1.98; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P340; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Blumenthal JA, 2003, LANCET, V362, P604, DOI 10.1016/S0140-6736(03)14190-6; Bocchio-Chiavetto L, 2006, EUR NEUROPSYCHOPHARM, V16, P620, DOI 10.1016/j.euroneuro.2006.04.010; Carney RM, 2003, BIOL PSYCHIAT, V54, P241, DOI 10.1016/S0006-3223(03)00111-2; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; Connerney I, 2001, LANCET, V358, P1766, DOI 10.1016/S0140-6736(01)06803-9; Gonzalez M B, 1996, Depression, V4, P57, DOI 10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C; Husain MM, 2004, J CLIN PSYCHIAT, V65, P485; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LESPERANCE F, 2007, JAMA-J AM MED ASSOC, V298, P40; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; O'Brien J, 1998, BMJ-BRIT MED J, V317, P982, DOI 10.1136/bmj.317.7164.982; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Rush AJ, 2007, AM J PSYCHIAT, V164, P201, DOI 10.1176/appi.ajp.164.2.201; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Sanacora G, 2003, AM J PSYCHIAT, V160, P577, DOI 10.1176/appi.ajp.160.3.577; Skala JA, 2006, CAN J PSYCHIAT, V51, P738, DOI 10.1177/070674370605101203; Spijkerman TA, 2005, J PSYCHOSOM RES, V58, P425, DOI 10.1016/j.jpsychores.2005.02.005; Taragano FE, 2005, INT PSYCHOGERIATR, V17, P487, DOI 10.1017/S1041610205001493; Taylor CB, 2005, ARCH GEN PSYCHIAT, V62, P792, DOI 10.1001/archpsyc.62.7.792; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	27	2	6	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2051	2059		10.1056/NEJMcpc0801779	http://dx.doi.org/10.1056/NEJMcpc0801779			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463382				2022-12-28	WOS:000255577700011
J	Wang, B; Cote, AP; Furukawa, H; O'Keeffe, M; Yaghi, OM				Wang, Bo; Cote, Adrien P.; Furukawa, Hiroyasu; O'Keeffe, Michael; Yaghi, Omar M.			Colossal cages in zeolitic imidazolate frameworks as selective carbon dioxide reservoirs	NATURE			English	Article							METAL-ORGANIC FRAMEWORKS; GAS SEPARATION; DESIGN; POLYMERS; NETS	Zeolitic imidazolate frameworks ( ZIFs) are porous crystalline materials with tetrahedral networks that resemble those of zeolites: transition metals ( Zn, Co) replace tetrahedrally coordinated atoms ( for example, Si), and imidazolate links replace oxygen bridges(1). A striking feature of these materials is that the structure adopted by a given ZIF is determined by link - link interactions, rather than by the structure directing agents used in zeolite synthesis(2). As a result, systematic variations of linker substituents have yielded many different ZIFs that exhibit known or predicted zeolite topologies. The materials are chemically and thermally stable, yet have the long- sought- after design flexibility offered by functionalized organic links and a high density of transition metal ions(1-7) . Here we report the synthesis and characterization of two porous ZIFs-ZIF-95 and ZIF-100-with structures of a scale and complexity previously unknown in zeolites(8-10). The materials have complex cages that contain up to 264 vertices, and are constructed from as many as 7,524 atoms. As expected from the adsorption selectivity recently documented for other members of this materials family(3), both ZIFs selectively capture carbon dioxide from several different gas mixtures at room temperature, with ZIF-100 capable of storing 28 litres per litre of material at standard temperature and pressure. These characteristics, combined with their high thermal and chemical stability and ease of fabrication, make ZIFs promising candidate materials for strategies aimed at ameliorating increasing atmospheric carbon dioxide levels.	[Wang, Bo; Cote, Adrien P.; Furukawa, Hiroyasu; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Ctr Reticular Chem, Los Angeles, CA 90095 USA; [O'Keeffe, Michael] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe	Yaghi, OM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Ctr Reticular Chem, 607 E Charles E Young Dr, Los Angeles, CA 90095 USA.	yaghi@chem.ucla.edu	WANG, BO/D-9762-2012; Furukawa, Hiroyasu/C-5910-2008; Yaghi, Omar M/C-6749-2013; yarasi, soujanya/F-5531-2011	WANG, BO/0000-0001-9092-3252; Furukawa, Hiroyasu/0000-0002-6082-1738; Yaghi, Omar/0000-0002-5611-3325				Baerlocher C., DATABASE ZEOLITE STR; Banerjee R, 2008, SCIENCE, V319, P939, DOI 10.1126/science.1152516; Blatov VA, 2007, ACTA CRYSTALLOGR A, V63, P418, DOI 10.1107/S0108767307038287; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Hayashi H, 2007, NAT MATER, V6, P501, DOI 10.1038/nmat1927; Horike S, 2007, CHEM COMMUN, P3395, DOI 10.1039/b703502k; HOUGHTON JT, 1997, 4 IPCC; Huang XC, 2006, ANGEW CHEM INT EDIT, V45, P1557, DOI 10.1002/anie.200503778; Li H, 1998, J AM CHEM SOC, V120, P8571, DOI 10.1021/ja981669x; Liu YL, 2006, CHEM COMMUN, P1488, DOI 10.1039/b600188m; Maji TK, 2005, CHEM COMMUN, P2436, DOI 10.1039/b500971e; Malek A, 1996, AICHE J, V42, P3191, DOI 10.1002/aic.690421120; Millward AR, 2005, J AM CHEM SOC, V127, P17998, DOI 10.1021/ja0570032; *MOL SIM, 1999, CERIUS2 MOD ENV; Ockwig NW, 2005, ACCOUNTS CHEM RES, V38, P176, DOI 10.1021/ar020022l; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Park YK, 2007, ANGEW CHEM INT EDIT, V46, P8230, DOI 10.1002/anie.200702324; SASAKI A, 1993, IEEE T ENERGY CONVER, V8, P26, DOI 10.1109/60.207402; SIRCAR S, 1995, IND ENG CHEM RES, V34, P2881, DOI 10.1021/ie00047a042; Sircar S, 1996, CARBON, V34, P1, DOI 10.1016/0008-6223(95)00128-X; Sircar S, 2006, IND ENG CHEM RES, V45, P5435, DOI 10.1021/ie051056a; Surble S, 2006, J AM CHEM SOC, V128, P14889, DOI 10.1021/ja064343u; Thomas JM, 1999, ANGEW CHEM INT EDIT, V38, P3589; Tian YQ, 2004, INORG CHEM, V43, P4631, DOI 10.1021/ic049713z; Tian YQ, 2007, CHEM-EUR J, V13, P4146, DOI 10.1002/chem.200700181; Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	28	1280	1346	60	1199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					207	U6		10.1038/nature06900	http://dx.doi.org/10.1038/nature06900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464739	Bronze			2022-12-28	WOS:000255592400036
J	Giordani, B; Chervin, RD				Giordani, Bruno; Chervin, Ronald D.			Sleep-disordered breathing and neurobehavioral outcomes - In search of clear markers for children at risk - Abstract and commentary	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DAYTIME SLEEPINESS; APNEA SYNDROME; BEHAVIOR; DURATION		[Giordani, Bruno] Univ Michigan, Sch Med, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48105 USA; [Chervin, Ronald D.] Univ Michigan, Sch Med, Dept Neurol, Sleep Disorders Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Giordani, B (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, Neuropsychol Sect, 2101 Commonwealth Blvd,Ste C, Ann Arbor, MI 48105 USA.	giordani@umich.edu	Giordani, Bruno/AAR-1910-2021	Giordani, Bruno/0000-0001-5921-3455				Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Chervin RD, 2006, PEDIATRICS, V117, pE769, DOI 10.1542/peds.2005-1837; Chervin RD, 2005, SLEEP, V28, P1041, DOI 10.1093/sleep/28.9.1041; Chervin RD, 2005, SLEEP, V28, P885, DOI 10.1093/sleep/28.7.885; Chervin RD, 2004, SLEEP, V27, P110, DOI 10.1093/sleep/27.1.110; Golan N, 2004, SLEEP, V27, P261, DOI 10.1093/sleep/27.2.261; Gozal D, 2004, PEDIATR PULM, P166, DOI 10.1002/ppul.70094; Gregory AM, 2008, ARCH PEDIAT ADOL MED, V162, P330, DOI 10.1001/archpedi.162.4.330; Judge S, 2007, J SCHOOL HEALTH, V77, P672, DOI 10.1111/j.1746-1561.2007.00250.x; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Marcus CL, 2001, AM J RESP CRIT CARE, V164, P16, DOI 10.1164/ajrccm.164.1.2008171; Marcus CL, 2002, PEDIATRICS, V109, P704; Owens JA, 2008, ARCH PEDIAT ADOL MED, V162, P313, DOI 10.1001/archpedi.162.4.313; Quist JF, 2001, J AM ACAD CHILD PSY, V40, P253, DOI 10.1097/00004583-200102000-00022; Rosen CL, 2004, PEDIATR CLIN N AM, V51, P153, DOI 10.1016/S0031-3955(03)00183-4; Tauman R, 2006, J PEDIATR-US, V149, P803, DOI 10.1016/j.jpeds.2006.08.067; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305	17	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2078	2080		10.1001/jama.299.17.2078	http://dx.doi.org/10.1001/jama.299.17.2078			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18467967				2022-12-28	WOS:000255552700024
J	Mongelluzzo, J; Mohamad, Z; Ten Have, TR; Shah, SS				Mongelluzzo, Jillian; Mohamad, Zeinab; Ten Have, Thomas R.; Shah, Samir S.			Corticosteroids and mortality in children with bacterial meningitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPENSITY SCORES; DEXAMETHASONE TREATMENT; MENINGOCOCCAL DISEASE; ANALYTIC STRATEGIES; UNITED-STATES; OUTCOMES	Context In adults, adjuvant corticosteroids significantly reduce mortality associated with bacterial meningitis; however, in children, studies reveal conflicting results. Objective To determine the association between adjuvant corticosteroids and clinical outcomes in children with bacterial meningitis. Design, Setting, and Patients A retrospective cohort study conducted between January 1, 2001, and December 31, 2006, of 2780 children discharged with bacterial meningitis as their primary diagnosis from 27 tertiary care children's hospitals located in 18 US states and the District of Columbia that provide data to the Pediatric Health Information System's administrative database. Main Outcome Measures Propensity scores, constructed using patient demographics and markers of illness severity at presentation, were used to determine each child's likelihood of receiving adjuvant corticosteroids. Primary outcomes of interest, time to death and time to hospital discharge, were analyzed by using propensity- adjusted Cox proportional hazards regression models stratified by age categories. Results The median age was 9 months ( interquartile range, 0- 6 years); 57% of the patients were males. Streptococcus pneumoniae was the most commonly identified cause of meningitis. Adjuvant corticosteroids were administered to 248 children ( 8.9%). The overall mortality rate was 4.2% ( 95% confidence interval [ CI], 3.5%- 5.0%), and cumulative incidences were 2.2% and 3.1% at 7 days and 28 days, respectively, after admission. Adjuvant corticosteroids did not reduce mortality, regardless of age ( children < 1 year: hazard ratio [ HR], 1.09; 95% CI, 0.53- 2.24; 1- 5 years: HR, 1.28; 95% CI, 0.59- 2.78; and > 5 years: HR, 0.92; 95% CI, 0.38- 2.25). Adjuvant corticosteroids were also not associated with time to hospital discharge. In subgroup analyses, the results did not change in either children identified with pneumococcal or meningococcal meningitis or children with a cerebrospinal fluid culture performed at the admitting hospital. Conclusion In this multicenter observational study of children with bacterial meningitis, adjuvant corticosteroid therapy was not associated with time to death or time to hospital discharge.	[Mongelluzzo, Jillian; Mohamad, Zeinab; Shah, Samir S.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Mohamad, Zeinab; Shah, Samir S.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Ten Have, Thomas R.; Shah, Samir S.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Ten Have, Thomas R.; Shah, Samir S.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Shah, SS (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 34th St & Civ Ctr Blvd,Room 1526,North Campus, Philadelphia, PA 19104 USA.	shahs@email.chop.edu	; Shah, Samir/B-2661-2015	Ten Have, Thomas/0000-0003-0026-3073; Shah, Samir/0000-0001-7902-7000	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016946] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024132] Funding Source: NIH RePORTER; AHRQ HHS [U18HS016946] Funding Source: Medline; NCRR NIH HHS [KL1RR024132] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		*AM AC PED, 2006, RED BOOK 2006 REP CO, P530; Braitman LE, 2002, ANN INTERN MED, V137, P693, DOI 10.7326/0003-4819-137-8-200210150-00015; Cepeda MS, 2000, PHARMACOEPIDEM DR S, V9, P103, DOI 10.1002/(SICI)1099-1557(200003/04)9:2<103::AID-PDS477>3.0.CO;2-6; Chaudhuri A, 2004, LANCET NEUROL, V3, P54, DOI 10.1016/S1474-4422(03)00623-9; Daoud AS, 1999, EUR J PEDIATR, V158, P230, DOI 10.1007/s004310051056; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; FEIGIN RD, 2004, TXB PEDIAT INFECT DI, V1, P443; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Markovitz Barry P, 2005, Pediatr Crit Care Med, V6, P270, DOI 10.1097/01.PCC.0000160596.31238.72; McIntyre PB, 2005, ARCH DIS CHILD, V90, P391, DOI 10.1136/adc.2003.037523; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; O'Brien JA, 2006, VALUE HEALTH, V9, P236, DOI 10.1111/j.1524-4733.2006.00113.x; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peltola H, 2007, CLIN INFECT DIS, V45, P1277, DOI 10.1086/522534; Pelton SI, 2005, ARCH DIS CHILD, V90, P333, DOI 10.1136/adc.2004.052928; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; SCHELD WM, 1980, J CLIN INVEST, V66, P243, DOI 10.1172/JCI109850; Shah SS, 2006, CLIN INFECT DIS, V42, DOI 10.1086/498745; Sharip A, 2006, PEDIATR INFECT DIS J, V25, P191, DOI 10.1097/01.inf.0000202065.03366.0c; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; TAUBER MG, 1985, J INFECT DIS, V151, P528, DOI 10.1093/infdis/151.3.528; Theodoridou MN, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-101; Townsend GC, 1996, J ANTIMICROB CHEMOTH, V37, P1051, DOI 10.1093/jac/37.6.1051; van de Beek D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub2; Weitzen S, 2004, PHARMACOEPIDEM DR S, V13, P841, DOI 10.1002/pds.969	29	138	141	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2048	2055		10.1001/jama.299.17.2048	http://dx.doi.org/10.1001/jama.299.17.2048			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460665	Bronze			2022-12-28	WOS:000255552700021
J	Gainotti, S; Galeotti, F; Izzicupo, F; Petrini, C; Raschetti, R				Gainotti, Sabina; Galeotti, Francesca; Izzicupo, Fabio; Petrini, Carlo; Raschetti, Roberto			Antipsychotics in individuals with intellectual disability	LANCET			English	Letter									[Gainotti, Sabina; Galeotti, Francesca; Raschetti, Roberto] Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Izzicupo, Fabio] Univ G dAnnunzio, Inst Geriatr Med, Dept Med & Sci Aging, Chieti, Italy; [Petrini, Carlo] Natl Inst Hlth, Bioeth Unit, Off President, Rome, Italy	Istituto Superiore di Sanita (ISS); G d'Annunzio University of Chieti-Pescara; Istituto Superiore di Sanita (ISS)	Raschetti, R (corresponding author), Natl Inst Hlth, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy.	roberto.raschetti@iss.it	; gainotti, sabina/A-6651-2015	Petrini, Carlo Maria/0000-0002-7895-4440; gainotti, sabina/0000-0002-6006-9064				Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; SACHS GA, 2007, POSITION STATEMENT I; Tyrer P, 2008, LANCET, V371, P57, DOI 10.1016/S0140-6736(08)60072-0	3	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1501	1502		10.1016/S0140-6736(08)60648-0	http://dx.doi.org/10.1016/S0140-6736(08)60648-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456094				2022-12-28	WOS:000255668300019
J	Numasaki, M; Ohrui, T; Sato, A; He, M; Arai, H				Numasaki, Muneo; Ohrui, Takashi; Sato, Akihiro; He, Mei; Arai, Hiroyuki			Congenital tracheae stenosis and an anomalous origin of the right upper lobe bronchus	LANCET			English	Editorial Material									[Numasaki, Muneo; Ohrui, Takashi; He, Mei; Arai, Hiroyuki] Tohoku Univ, Sch Med, Dept Geriatr & Gerontol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Sato, Akihiro] Tohoku Univ, Sch Med, Dept Radiol, Sendai, Miyagi 9808574, Japan	Tohoku University; Tohoku University	Ohrui, T (corresponding author), Tohoku Univ, Sch Med, Dept Geriatr & Gerontol, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808574, Japan.	ohrui@geriat.med.tohoku.ac.jp							0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1526	1526		10.1016/S0140-6736(08)60657-1	http://dx.doi.org/10.1016/S0140-6736(08)60657-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456102				2022-12-28	WOS:000255668300029
J	Allesina, S; Alonso, D; Pascual, M				Allesina, Stefano; Alonso, David; Pascual, Mercedes			A general model for food web structure	SCIENCE			English	Article							BODY-SIZE; ECOLOGICAL NETWORKS	A central problem in ecology is determining the processes that shape the complex networks known as food webs formed by species and their feeding relationships. The topology of these networks is a major determinant of ecosystems' dynamics and is ultimately responsible for their responses to human impacts. Several simple models have been proposed for the intricate food webs observed in nature. We show that the three main models proposed so far fail to fully replicate the empirical data, and we develop a likelihood- based approach for the direct comparison of alternative models based on the full structure of the network. Results drive a new model that is able to generate all the empirical data sets and to do so with the highest likelihood.	[Allesina, Stefano; Alonso, David; Pascual, Mercedes] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Allesina, Stefano] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Alonso, David] Univ Groningen, Ctr Ecol & Evolutionary Studies, Community & Conservat Ecol Grp, NL-9750 AA Haren, Netherlands; [Pascual, Mercedes] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Michigan System; University of Michigan; National Center for Ecological Analysis & Synthesis; University of Groningen; The Santa Fe Institute	Allesina, S (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Nat Sci Bldg,830 North Univ, Ann Arbor, MI 48109 USA.	allesina@nceas.ucsb.edu	Allesina, Stefano/A-2255-2009; Alonso, David/A-5406-2008	Alonso, David/0000-0002-8888-1644; Allesina, Stefano/0000-0003-0313-8374				Bersier LF, 2006, SFI S SCI C, P91; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Caldarelli G, 1998, J THEOR BIOL, V193, P345, DOI 10.1006/jtbi.1998.0706; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; COHEN JE, 1977, P NATL ACAD SCI USA, V74, P4533, DOI 10.1073/pnas.74.10.4533; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P421, DOI 10.1098/rspb.1985.0042; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; DUNNE JA, 2006, ECOLOGICAL NETWORKS, pCH2; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; Martinez ND, 2006, SFI S SCI C, P87; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Montoya JM, 2003, ECOL LETT, V6, P587, DOI 10.1046/j.1461-0248.2003.00469.x; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Neubert MG, 2000, OECOLOGIA, V123, P241, DOI 10.1007/s004420051011; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; PIMM SL, 1982, FOOD WEBS; Rossberg AG, 2006, J THEOR BIOL, V241, P552, DOI 10.1016/j.jtbi.2005.12.021; Rossberg AG, 2005, ECOL COMPLEX, V2, P312, DOI 10.1016/j.ecocom.2005.04.007; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Williams RJ, 2004, EUR PHYS J B, V38, P297, DOI 10.1140/epjb/e2004-00122-1; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005	28	182	186	1	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					658	661		10.1126/science.1156269	http://dx.doi.org/10.1126/science.1156269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451301				2022-12-28	WOS:000255454300044
J	Clauset, A; Moore, C; Newman, MEJ				Clauset, Aaron; Moore, Cristopher; Newman, M. E. J.			Hierarchical structure and the prediction of missing links in networks	NATURE			English	Article							FOOD-WEB STRUCTURE; METABOLIC NETWORKS; COMPLEX NETWORKS; COMMUNITY STRUCTURE; SOCIAL NETWORKS; ORGANIZATION; MODULARITY	Networks have in recent years emerged as an invaluable tool for describing and quantifying complex systems in many branches of science(1-3). Recent studies suggest that networks often exhibit hierarchical organization, in which vertices divide into groups that further subdivide into groups of groups, and so forth over multiple scales. In many cases the groups are found to correspond to known functional units, such as ecological niches in food webs, modules in biochemical networks ( protein interaction networks, metabolic networks or genetic regulatory networks) or communities in social networks(4-7). Here we present a general technique for inferring hierarchical structure from network data and show that the existence of hierarchy can simultaneously explain and quantitatively reproduce many commonly observed topological properties of networks, such as right- skewed degree distributions, high clustering coefficients and short path lengths. We further show that knowledge of hierarchical structure can be used to predict missing connections in partly known networks with high accuracy, and for more general network structures than competing techniques(8). Taken together, our results suggest that hierarchy is a central organizing principle of complex networks, capable of offering insight into many network phenomena.	[Clauset, Aaron; Moore, Cristopher] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Moore, Cristopher] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Clauset, Aaron; Moore, Cristopher; Newman, M. E. J.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Newman, M. E. J.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Newman, M. E. J.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA	University of New Mexico; University of New Mexico; The Santa Fe Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Clauset, A (corresponding author), Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA.	aaronc@santafe.edu		CLAUSET, AARON/0000-0002-3529-8746; Moore, Cristopher/0000-0002-2062-1942				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2002, CONNECTIONS; Bryant D., 2003, BIOCONSENSUS, P163; Casella G, 2001, STAT INFERENCE, V2nd; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; COSENTINOLAGOMA.M, 2001, P NATL ACAD SCI USA, V104, P5516; DAWAH HA, 1995, J ANIM ECOL, V64, P708, DOI 10.2307/5850; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kleinberg J, 2002, ADV NEUR IN, V14, P431; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lakhina A, 2003, IEEE INFOCOM SER, P332; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Martinez ND, 1999, ECOLOGY, V80, P1044, DOI 10.1890/0012-9658(1999)080[1044:EOSEOC]2.0.CO;2; Newman M., 1999, MONTE CARLO METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Sprinzak E, 2003, J MOL BIOL, V327, P919, DOI 10.1016/S0022-2836(03)00239-0; Szilagyi A, 2005, PHYS BIOL, V2, pS1, DOI 10.1088/1478-3975/2/2/S01; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120	30	1266	1376	19	369	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					98	101		10.1038/nature06830	http://dx.doi.org/10.1038/nature06830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451861	Green Submitted, Green Published			2022-12-28	WOS:000255398800046
J	Psaty, BM; Ray, W				Psaty, Bruce M.; Ray, Wayne			FDA guidance on off-label promotion and the state of the literature from sponsors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; ROFECOXIB; DOCUMENTS; ESTROGEN		[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Ray, Wayne] Vanderbilt Univ, Sch Med, Vanderbilt Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; [Ray, Wayne] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN 37203 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087652, R01HL074745, R01HL080295, U01HL080295, R01HL085251] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL080295, HL085251, HL74745, HL087652] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Blackwell AE, 2003, FOOD DRUG LAW J, V58, P439; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P1365, DOI 10.1001/jama.292.11.1365; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sismondo S, 2007, PLOS MED, V4, P1429, DOI 10.1371/journal.pmed.0040286; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; *US FDA, 2008, FED REGISTER, V74, P9342; Waxman HA, 2003, FOOD DRUG LAW J, V58, P299	14	22	23	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1949	1951		10.1001/jama.299.16.1949	http://dx.doi.org/10.1001/jama.299.16.1949			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291AD	18430914				2022-12-28	WOS:000255163800029
J	Zink, TM				Zink, Therese M.			Thank goodness for my ass	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												zink0003@umn.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1879	1880		10.1001/jama.299.16.1879	http://dx.doi.org/10.1001/jama.299.16.1879			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291AD	18430899				2022-12-28	WOS:000255163800001
J	Gonzalez-Jose, R; Escapa, I; Neves, WA; Cuneo, R; Pucciarelli, HM				Gonzalez-Jose, Rolando; Escapa, Ignacio; Neves, Walter A.; Cuneo, Ruben; Pucciarelli, Hector M.			Cladistic analysis of continuous modularized traits provides phylogenetic signals in Homo evolution	NATURE			English	Article							INTEGRATION; CHARACTERS	Evolutionary novelties in the skeleton are usually expressed as changes in the timing of growth of features intrinsically integrated at different hierarchical levels of development(1). As a consequence, most of the shape- traits observed across species do vary quantitatively rather than qualitatively(2), in a multivariate space(3) and in a modularized way(4,5). Because most phylogenetic analyses normally use discrete, hypothetically independent characters(6), previous attempts have disregarded the phylogenetic signals potentially enclosed in the shape of morphological structures. When analysing low taxonomic levels, where most variation is quantitative in nature, solving basic requirements like the choice of characters and the capacity of using continuous, integrated traits is of crucial importance in recovering wider phylogenetic information. This is particularly relevant when analysing extinct lineages, where available data are limited to fossilized structures. Here we show that when continuous, multivariant and modularized characters are treated as such, cladistic analysis successfully solves relationships among main Homo taxa. Our attempt is based on a combination of cladistics, evolutionary- development- derived selection of characters, and geometric morphometrics methods. In contrast with previous cladistic analyses of hominid phylogeny, our method accounts for the quantitative nature of the traits, and respects their morphological integration patterns. Because complex phenotypes are observable across different taxonomic groups and are potentially informative about phylogenetic relationships, future analyses should point strongly to the incorporation of these types of trait.	[Gonzalez-Jose, Rolando] Consejo Nacl Invest Cient & Tecn, Unidad Invest Divers Sistemat & Evoluc, Ctr Nacl Patagonico, Consejo Nacl Invest Cient & Tecn, Puerto Madryn, Argentina; [Escapa, Ignacio; Cuneo, Ruben] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Consejo Nacl Invest Cient & Tecn, Trelew, Argentina; [Neves, Walter A.] Univ Sao Paulo, Lab Estud Evolut Humanos, Dept Genet & Biol Evolut, Inst Biociencias, BR-05422970 Sao Paulo, Brazil; [Pucciarelli, Hector M.] Natl Univ La Plata, Consejo Nacl Invest Cient & Tecn, CONICET, Dept Cientifico Antropol Museo La Plata, RA-1900 La Plata, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata	Gonzalez-Jose, R (corresponding author), Consejo Nacl Invest Cient & Tecn, Unidad Invest Divers Sistemat & Evoluc, Ctr Nacl Patagonico, Consejo Nacl Invest Cient & Tecn, Blvd Brown 2825,U9120ACF, Puerto Madryn, Argentina.	rolando@cenpat.edu.ar	E., Ignacio/AAA-3569-2021; Rohlf, F J/A-8710-2008; Neves, Walter A/Q-8316-2016	Neves, Walter A/0000-0001-9124-3937; Gonzalez-Jose, Rolando/0000-0002-8128-9381; Escapa, Ignacio/0000-0002-7042-7750				Ackermann RR, 2004, PHENOTYPIC INTEGRATION: STUDYING THE ECOLOGY AND EVOLUTION OF COMPLEX PHENOTYPES, P302; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Collard Mark, 2007, P1575, DOI 10.1007/978-3-540-33761-4_51; Curnoe D, 2003, HOMO, V53, P225, DOI 10.1078/0018-442X-00048; FARRIS JS, 1970, SYST ZOOL, V19, P172, DOI 10.2307/2412452; Felsenstein J., 2004, INFERRING PHYLOGENIE; FELSENSTEIN J, 2007, PHYLIP PHYLOGENY INF; Goloboff P. A., 2008, TREE ANAL USING NEW; GOLOBOFF PA, IN PRESS CLADISTICS; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Humphries Christopher John, 2002, VVolume 64, P8; Lalueza-Fox C, 2005, MOL BIOL EVOL, V22, P1077, DOI 10.1093/molbev/msi094; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; MacLeod Norman, 2002, VVolume 64, P1; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Polly P. David, 2004, Palaeontologia Electronica, V7, P1; Polly PD, 2003, J MAMMAL, V84, P369, DOI 10.1644/1545-1542(2003)084<0369:PTTOGD>2.0.CO;2; Rae TC, 1998, CLADISTICS, V14, P221, DOI 10.1111/j.1096-0031.1998.tb00335.x; Rightmire G. Philip, 2007, P1695, DOI 10.1007/978-3-540-33761-4_55; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; SKELTON RR, 1992, J HUM EVOL, V23, P309, DOI 10.1016/0047-2484(92)90070-P; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Strait DS, 2001, AM J PHYS ANTHROPOL, V114, P273, DOI 10.1002/ajpa.1041; STRAIT DS, 2007, HDB PALEOANTHROPOLOG, P1782; Stringer CB, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P524; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	31	72	79	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					775	U4		10.1038/nature06891	http://dx.doi.org/10.1038/nature06891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18454137				2022-12-28	WOS:000256415300042
J	Field, DJ; Dorling, JS; Manktelow, BN; Draper, ES				Field, David J.; Dorling, Jon S.; Manktelow, Bradley N.; Draper, Elizabeth S.			Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEVELOPMENTAL-DISABILITY; INFANTS BORN; MORBIDITY; DISCHARGE; OUTCOMES; AGE	Objective To assess changes in survival for infants born before 26 completed weeks of gestation. Design Prospective cohort study in a geographically defined population. Setting Former Trent health region of the United Kingdom. Subjects All infants born at 22 + 0 to 25+6 weeks' gestation to mothers living in the region. Terminations were excluded but all other births of babies alive at the on set of tabour or the delivery process were included. Main outcome measures Outcome for all infants was categorised as stillbirth, death without admission to neonatal intensive care, death before discharge from neonatal intensive care, and survival to discharge home in two time periods: 1994-9 and 2000-5 inclusive. Results The proportion of infants dying in delivery rooms was similar in the two periods, but a significant improvement was seen in the number of infants surviving to discharge (P<0.001). Of 497 infants admitted to neonatal intensive care in 2000-5, 236 (47%) survived to discharge compared with 174/490 (36%) in 1994. These changes were attributable to substantial improvements in the survival of infants born at 24 and 25 weeks. During the 12 years of the study none of the 150 infants born at 22 weeks' gestation survived. Of the infants born at 23 weeks who were admitted to intensive care, there was no significant improvement in survival to discharge in 2000-5 (12/65 (18%) in 2000-5 v 15/81 (19%) in 1994-9). Conclusions Survival of infants born at 24 and 25 weeks of gestation has significantly increased. Although over half the cohort of infants born at 23 weeks was admitted to neonatal intensive care, there was no improvement in survival at this gestation. Care for infants born at 22 weeks remained unsuccessful.	[Field, David J.; Manktelow, Bradley N.; Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Dorling, Jon S.] Univ Nottingham Hosp Trust, Neonatol Unit, Nottingham, England	University of Leicester; Nottingham University Hospital NHS Trust	Field, DJ (corresponding author), Leicester Royal Infirm, Neonatol Unit, Leicester LE1 5WW, Leics, England.	david.field@uhl-tr.nhs.uk	Draper, Elizabeth S/I-6304-2018; Dorling, Jon/B-7409-2015; Manktelow, Bradley N/G-2794-2011; Draper, Elizabeth/S-6874-2019	Draper, Elizabeth S/0000-0001-9340-8176; Dorling, Jon/0000-0002-1691-3221; Manktelow, Bradley N/0000-0002-3264-0323; Draper, Elizabeth/0000-0001-9340-8176				[Anonymous], 2004, PAEDIATR PERINAT EP, V18, P153; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Doyle LW, 2004, EARLY HUM DEV, V80, P103, DOI 10.1016/j.earlhumdev.2004.05.009; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; Hack M, 2000, Semin Neonatol, V5, P89, DOI 10.1053/siny.1999.0001; Larroque B, 2004, ARCH DIS CHILD-FETAL, V89, P139, DOI 10.1136/adc.2002.020396; Manktelow BN, 2001, ARCH DIS CHILD-FETAL, V85, pF33, DOI 10.1136/fn.85.1.F33; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; O'Dowd A, 2007, BRIT MED J, V335, P903, DOI 10.1136/bmj.39381.521481.DB; Riley K, 2008, ACTA PAEDIATR, V97, P159, DOI 10.1111/j.1651-2227.2007.00637.x; Smith LK, 2007, OBSTET GYNECOL, V110, P325, DOI 10.1097/01.AOG.0000270158.57566.2f; Stark AR, 2007, PEDIATRICS, V119, P401, DOI 10.1542/peds.2006-3180; Tommiska V, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e2; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; Vanhaesebrouck P, 2004, PEDIATRICS, V114, P663, DOI 10.1542/peds.2003-0903-L; Weindling AM, 2003, ARCH DIS CHILD, V88, P1034, DOI 10.1136/adc.88.12.1034; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	19	146	149	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2008	336	7655					1221	+		10.1136/bmj.39555.670718.BE	http://dx.doi.org/10.1136/bmj.39555.670718.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	311PS	18469017	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000256612700028
J	Boeger, H; Griesenbeck, J; Kornberg, RD				Boeger, Hinrich; Griesenbeck, Joachim; Kornberg, Roger D.			Nucleosome retention and the stochastic nature of promoter chromatin remodeling for transcription	CELL			English	Article							PHO5 PROMOTER; HISTONE ACETYLATION; DNA TRANSLOCATION; PH05 PROMOTER; IN-VIVO; YEAST; SWI/SNF; ACTIVATION; COMPLEX; REPLICATION	The rate-limiting step of transcriptional activation in eukaryotes, and thus the critical point for gene regulation, is unknown. Combining biochemical analyses of the chromatin transition at the transcriptionally induced PHO5 promoter in yeast with modeling based on a small number of simple assumptions, we demonstrate that random removal and reformation of promoter nucleosomes can account for stochastic and kinetic properties of PHO5 expression. Our analysis suggests that the disassembly of promoter nucleosomes is rate limiting for PHO5 expression, and supports a model for the underlying mechanism of promoter chromatin remodeling, which appears to conserve a single nucleosome on the promoter at all times.	[Boeger, Hinrich] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Griesenbeck, Joachim] Univ Regensburg, Lehrstuhl Biochem III, D-93080 Regensburg, Germany; [Kornberg, Roger D.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; University of Regensburg; Stanford University	Boeger, H (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	boeger@biology.ucsc.edu		Griesenbeck, Joachim/0000-0002-7817-6095	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036659, R01GM078111, R37GM036659] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078111-02, R01 GM036659, GM078111-01, R01 GM078111, GM36659, R37 GM036659] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chandy M, 2006, EUKARYOT CELL, V5, P1738, DOI 10.1128/EC.00165-06; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Feller W., 1957, INTRO PROBABILITY TH, VI; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Griesenbeck J, 2004, METHOD ENZYMOL, V375, P170; Griesenbeck J, 2003, MOL CELL BIOL, V23, P9275, DOI 10.1128/MCB.23.24.9275-9282.2003; Grimmett G. R., 2001, PROBABILITY RANDOM P; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; McAndrew PC, 1998, MOL CELL BIOL, V18, P5818, DOI 10.1128/MCB.18.10.5818; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; PRUNELL A, 1977, COLD SPRING HARB SYM, V42, P103, DOI 10.1101/SQB.1978.042.01.011; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; Vogelauer M, 2000, NATURE, V408, P495, DOI 10.1038/35044127; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Wykoff DD, 2007, MOL CELL, V27, P1005, DOI 10.1016/j.molcel.2007.07.022; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025	54	131	133	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					716	726		10.1016/j.cell.2008.02.051	http://dx.doi.org/10.1016/j.cell.2008.02.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485878	Bronze, Green Accepted			2022-12-28	WOS:000255903300025
J	Margaritis, T; Holstege, FCP				Margaritis, Thanasis; Holstege, Frank C. P.			Poised RNA polymerase II gives pause for thought	CELL			English	Review							EMBRYONIC STEM-CELLS; DROSOPHILA-MELANOGASTER; TRANSCRIPTION ELONGATION; HUMAN GENOME; P-TEFB; PROMOTER; GENES; ACTIVATION; ELEMENT; ESCAPE	Transcription by RNA polymerase II (Pol II) is thought to be predominantly regulated by recruitment of Pol II to promoters. Recent genome-wide analyses demonstrate that many genes are in fact regulated after recruitment of Pol II, by mechanisms such as pausing of Pol II proximal to promoters.	[Margaritis, Thanasis; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Sweg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@umcutrecht.nl	Holstege, Frank/AAM-9944-2021					Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Montanuy I, 2008, J BIOL CHEM, V283, P7368, DOI 10.1074/jbc.M706243200; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Wu CH, 2001, MOL CELL BIOL, V21, P1593, DOI 10.1128/MCB.21.5.1593-1602.2001; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	20	113	115	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					581	584		10.1016/j.cell.2008.04.027	http://dx.doi.org/10.1016/j.cell.2008.04.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485867	Bronze			2022-12-28	WOS:000255903300014
J	Swanson, CM; Malim, MH				Swanson, Chad M.; Malim, Michael H.			SnapShot: HIV-1 proteins	CELL			English	Editorial Material								Human immunodeficiency virus type-1 (HIV-1) is the etiologic agent of acquired immunodeficiency syndrome ( AIDS) and the prototypic member of the lentivirus genus of retroviruses. Lentivirus infections are considered as chronic or "slow" and, when pathogenic ( most notably, HIV-1 infection of humans), are associated with severe immunological and neurological dysfunction. HIV-1 has nine genes, with only the gag, pol, and env genes common to all replication-competent retroviruses. The pol gene encodes two enzymes that define the replicative strategy of the retrovirus: reverse transcriptase (RT) copies the viral RNA genome into DNA, and integrase ( IN) mediates the insertion of that DNA into the genomic DNA of an infected cell to establish the provirus ( and persistent infection). A third enzyme protease ( PR), also derived from pol, is necessary for maturation of virions into an infectious form. Of the remaining six regulatory/accessory genes of HIV-1, tat and rev are essential for virus replication, whereas vif, vpr, vpu, and nef are thought to modulate immune functions in vivo ( often in a species-specific fashion). Current frontline highly active antiretroviral therapy ( HAART) for treating AIDS includes combinations of small-molecule inhibitors of PR and RT ( nucleoside RT inhibitors, NRTIs; non-nucleoside RT inhibitors, NNRTIs). A peptide inhibitor of TM that inhibits viral entry is used in salvage therapy, and a small-molecule IN inhibitor, Raltegravir, was recently approved by the FDA. Three crucial viral enzymes are inhibited pharmacologically, but blocking remaining viral proteins and virus-host interactions is an important objective ( a CCR5 coreceptor antagonist, Maraviroc, received FDA approval in 2007).	[Swanson, Chad M.; Malim, Michael H.] Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Swanson, CM (corresponding author), Kings Coll London, Sch Med, Dept Infect Dis, London SE1 9RT, England.			Swanson, Chad/0000-0002-6650-3634; Malim, Michael/0000-0002-7699-2064	Medical Research Council [G0401570] Funding Source: Medline; MRC [G0401570] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Coffin J, 1997, RETROVIRUSES; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; *HIV 1, HIV 1 HUM PROT INT D; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033	8	32	36	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4							742.e1	10.1016/j.cell.2008.05.005	http://dx.doi.org/10.1016/j.cell.2008.05.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485880	Bronze			2022-12-28	WOS:000255903300027
J	Orton, GS; Yanamandra-Fisher, PA; Fisher, BM; Friedson, AJ; Parrish, PD; Nelson, JF; Bauermeister, AS; Fletcher, L; Gezari, DY; Varosi, F; Tokunaga, AT; Caldwell, J; Baines, KH; Hora, JL; Ressler, ME; Fujiyoshi, T; Fuse, T; Hagopian, H; Martin, TZ; Bergstralh, JT; Howett, C; Hoffmann, WF; Deutsch, LK; Van Cleve, JE; Noe, E; Adams, JD; Kassis, M; Tollestrup, E				Orton, Glenn S.; Yanamandra-Fisher, Padma A.; Fisher, Brendan M.; Friedson, A. James; Parrish, Paul D.; Nelson, Jesse F.; Bauermeister, Amber Swenson; Fletcher, Leigh; Gezari, Daniel Y.; Varosi, Frank; Tokunaga, Alan T.; Caldwell, John; Baines, Kevin H.; Hora, Joseph L.; Ressler, Michael E.; Fujiyoshi, Takuya; Fuse, Tetsuharu; Hagopian, Hagop; Martin, Terry Z.; Bergstralh, Jay T.; Howett, Carly; Hoffmann, William F.; Deutsch, Lynne K.; Van Cleve, Jeffrey E.; Noe, Eldar; Adams, Joseph D.; Kassis, Marc; Tollestrup, Eric			Semi-annual oscillations in Saturn's low-latitude stratospheric temperatures	NATURE			English	Article							JUPITERS STRATOSPHERE	Observations of oscillations of temperature and wind in planetary atmospheres provide a means of generalizing models for atmospheric dynamics in a diverse set of planets in the Solar System and elsewhere. An equatorial oscillation similar to one in the Earth's atmosphere(1,2) has been discovered in Jupiter(3-6). Here we report the existence of similar oscillations in Saturn's atmosphere, from an analysis of over two decades of spatially resolved observations of its 7.8-mu m methane and 12.2-mu m ethane stratospheric emissions, where we compare zonal- mean stratospheric brightness temperatures at planetographic latitudes of 3.6 degrees and 15.5 degrees in both the northern and the southern hemispheres. These results support the interpretation of vertical and meridional variability of temperatures in Saturn's stratosphere(7) as a manifestation of a wave phenomenon similar to that on the Earth and in Jupiter. The period of this oscillation is 14.8+/-1.2 terrestrial years, roughly half of Saturn's year, suggesting the influence of seasonal forcing, as is the case with the Earth's semi- annual oscillation(1).	[Orton, Glenn S.; Yanamandra-Fisher, Padma A.; Fisher, Brendan M.; Friedson, A. James; Fletcher, Leigh; Baines, Kevin H.; Ressler, Michael E.; Martin, Terry Z.; Noe, Eldar] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Parrish, Paul D.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; [Nelson, Jesse F.] Univ Maine, Dept Phys & Astron, Orono, ME 04469 USA; [Bauermeister, Amber Swenson] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Gezari, Daniel Y.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Varosi, Frank] Univ Florida, Dept Astron, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Tokunaga, Alan T.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Caldwell, John] York Univ, Dept Phys & Astron, Toronto, ON M3J 1P3, Canada; [Hora, Joseph L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Fujiyoshi, Takuya; Fuse, Tetsuharu] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Hagopian, Hagop] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Bergstralh, Jay T.] Langley Res Ctr, Hampton, VA 23681 USA; [Howett, Carly] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Hoffmann, William F.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Van Cleve, Jeffrey E.] Ball Aerosp & Technol Corp, Civil Space Syst, Boulder, CO 80306 USA; [Adams, Joseph D.] Dept Radiophys & Space Res, Ithaca, NY 14853 USA; [Kassis, Marc] WM Keck Observ, Kamuela, HI 96743 USA; [Tollestrup, Eric] NASA, Infrared Telescope Facil, Inst Astron, Hilo, HI 96822 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Edinburgh; University of Maine System; University of Maine Orono; University of California System; University of California Berkeley; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; State University System of Florida; University of Florida; University of Hawaii System; York University - Canada; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); University of California System; University of California Los Angeles; National Aeronautics & Space Administration (NASA); NASA Langley Research Center; University of Oxford; University of Arizona; Ball Aerospace & Technologies; National Aeronautics & Space Administration (NASA)	Orton, GS (corresponding author), CALTECH, Jet Prop Lab, MS 169-237,4800 Oak Grove Dr, Pasadena, CA 91109 USA.	glenn.orton@jpl.nasa.gov	Fletcher, Leigh/D-6093-2011; Orton, Glenn/AAD-9862-2020	Fletcher, Leigh/0000-0001-5834-9588; Ressler, Michael/0000-0001-5644-8830; Hora, Joseph/0000-0002-5599-4650; Tokunaga, Alan/0000-0001-8136-9704				Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; Deutsch LK, 2003, P SOC PHOTO-OPT INS, V4841, P106, DOI 10.1117/12.461436; Flasar FM, 2004, NATURE, V427, P132, DOI 10.1038/nature02142; Friedson AJ, 1999, ICARUS, V137, P34, DOI 10.1006/icar.1998.6038; GEZARI DY, 1989, NATURE, V342, P777, DOI 10.1038/342777a0; HOFFMANN WF, 1993, P SOC PHOTO-OPT INS, V1946, P449, DOI 10.1117/12.158697; Li X, 2000, PLANET SPACE SCI, V48, P637, DOI 10.1016/S0032-0633(00)00033-7; Orton GS, 2005, SCIENCE, V307, P696, DOI 10.1126/science.1105730; ORTON GS, 1991, SCIENCE, V252, P537, DOI 10.1126/science.252.5005.537; RESSLER ME, 1994, EXP ASTRON, V3, P277	12	67	67	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					196	199		10.1038/nature06897	http://dx.doi.org/10.1038/nature06897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464736	Bronze			2022-12-28	WOS:000255592400033
J	Warner, E; Messersmith, H; Causer, P; Eisen, A; Shumak, R; Plewes, D				Warner, Ellen; Messersmith, Hans; Causer, Petrina; Eisen, Andrea; Shumak, Rene; Plewes, Donald			Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer	ANNALS OF INTERNAL MEDICINE			English	Review							HIGH FAMILIAL RISK; HIGH GENETIC RISK; MUTATION CARRIERS; BRCA MUTATIONS; OVARIAN-CANCER; MAMMOGRAPHY; SURVEILLANCE; MRI; ULTRASOUND; CARCINOMA	Background: A sensitive and acceptable screening regimen for women at high risk for breast cancer is essential. Contrast-enhanced magnetic resonance imaging (MRI) of the breast is highly sensitive for diagnosis of breast cancer but has variable specificity. Purpose: To summarize the sensitivity, specificity, likelihood ratios, and posttest probability associated with adding MRI to annual mammography screening of women at very high risk for breast cancer. Data Sources: English-language literature search of the MEDLINE, EMBASE, and Cochrane databases from January 1995 to September 2007, supplemented by hand searches of pertinent articles. Study Selection: Prospective studies published after 1994 in which MRI and mammography (with or without additional tests) were used to screen women at very high risk for breast cancer. Data Extraction: Methods and potential biases of studies were assessed by 2 reviewers, and data were extracted and entered into 2 x 2 tables that compared American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) scores of MRI plus mammography, mammography alone, or MRI alone with results of breast tissue biopsies. Data Synthesis: Eleven relevant, prospective, nonrandomized studies that ranged from small single-center studies with only 1 round of patient screening to large multicenter studies with repeated rounds of annual screening were identified. Characteristics of women that varied across study samples included age range, history of breast cancer, and BRCA1 or BRCA2 mutation status. Studies used dynamic contrast-enhanced MRI with axial or coronal plane images (European studies) or sagittal images (North American studies) that were usually interpreted without knowledge of mammography results. The summary negative likelihood ratio and the probability of a BI-RADS-suspicious lesion (given negative test findings and assuming a 2% pretest probability of disease) were 0.70 (95% CI, 0.59 to 0.82) and 1.4% (CI, 1.2% to 1.6%) for mammography alone and 0.14 (CI, 0.05 to 0.42) and 0.3% (CI, 0.1% to 0.8%) for the combination of MRI plus mammography, using a BI-RADS score of 4 or higher as the definition of positive. Limitations: Differences in patient population, center experience, and criteria for positive screening results led to between-study heterogeneity. Data on patients with nonfamilial high risk were limited, and no data were available on recurrence or survival. Conclusion: Screening with both MRI and mammography might rule out cancerous lesions better than mammography alone in women who are known or likely to have an inherited predisposition to breast cancer.	McMaster Univ, Program Evidence Based Care, DTC, Hamilton, ON L8S 4L8, Canada; Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada; Canc Care Ontario, Toronto, ON, Canada	McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cancer Care Ontario	Messersmith, H (corresponding author), McMaster Univ, Program Evidence Based Care, DTC, 1280 Main St W,3rd Floor, Hamilton, ON L8S 4L8, Canada.	messers@mcmaster.ca		Messersmith, Hans/0000-0002-4585-9906				Arpino G, 2004, CANCER-AM CANCER SOC, V101, P242, DOI 10.1002/cncr.20318; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Brekelmans CTM, 2001, J CLIN ONCOL, V19, P924, DOI 10.1200/JCO.2001.19.4.924; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Hagen AI, 2007, BREAST, V16, P367, DOI 10.1016/j.breast.2007.01.006; Hartman AR, 2004, CANCER-AM CANCER SOC, V100, P479, DOI 10.1002/cncr.11926; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Komenaka IK, 2004, CANCER, V100, P2079, DOI 10.1002/cncr.20221; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kriege M, 2006, CANCER-AM CANCER SOC, V106, P2318, DOI 10.1002/cncr.21863; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lee AKC, 1997, CANCER-AM CANCER SOC, V79, P761, DOI 10.1002/(SICI)1097-0142(19970215)79:4<761::AID-CNCR13>3.3.CO;2-K; Lehman CD, 2005, CANCER, V103, P1898, DOI 10.1002/cncr.20971; Lehman CD, 2007, RADIOLOGY, V244, P381, DOI 10.1148/radiol.2442060461; LEITNER SP, 1995, CANCER-AM CANCER SOC, V76, P2266, DOI 10.1002/1097-0142(19951201)76:11<2266::AID-CNCR2820761114>3.0.CO;2-T; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; OREL SG, 1994, RADIOLOGY, V190, P485, DOI 10.1148/radiology.190.2.8284404; ROSEN PP, 1993, J CLIN ONCOL, V11, P2090, DOI 10.1200/JCO.1993.11.11.2090; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Tilanus-Linthorst MMA, 2005, EUR J CANCER, V41, P1610, DOI 10.1016/j.ejca.2005.02.034; Travis LB, 2003, JAMA-J AM MED ASSOC, V290, P465, DOI 10.1001/jama.290.4.465; Trecate G, 2006, TUMORI J, V92, P517, DOI 10.1177/030089160609200609; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vacek PM, 2004, CANCER EPIDEM BIOMAR, V13, P715; Vasen HFA, 2005, EUR J CANCER, V41, P549, DOI 10.1016/j.ejca.2004.10.029; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Warner E, 2001, J CLIN ONCOL, V19, P3524, DOI 10.1200/JCO.2001.19.15.3524; WEINREB JC, 1995, RADIOLOGY, V196, P593, DOI 10.1148/radiology.196.3.7644617	35	362	373	0	44	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					671	679		10.7326/0003-4819-148-9-200805060-00007	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458280				2022-12-28	WOS:000255731800005
J	Sherman, SE				Sherman, Scott E.			Quality improvement report - A framework for tobacco control: lessons learnt from Veterans Health Administration	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SMOKING-CESSATION; VITAL SIGN; CARE; INTERVENTION; INFORMATION; GUIDELINES; SMOKERS; TRENDS		[Sherman, Scott E.] NYU, Sch Med, VA New York Harbor Healthcare Syst, New York, NY 10010 USA	New York University	Sherman, SE (corresponding author), NYU, Sch Med, VA New York Harbor Healthcare Syst, New York, NY 10010 USA.	scott.sherman@med.nyu.edu		Sherman, Scott/0000-0003-1752-7303				Boyle R, 2004, ANN FAM MED, V2, P22, DOI 10.1370/afm.38; Bradley KA, 2006, AM J MANAG CARE, V12, P597; Conroy MB, 2005, NICOTINE TOB RES, V7, pS35, DOI 10.1080/14622200500078089; *DEP VET AFF, 2004, MAN TOB US VA DOD CL; Halpern J, 1996, MED CARE, V34, pMS55; HAMLETTBERRY K, 2004, SMOKING CESSATION PO; Jonk YC, 2005, AM J MANAG CARE, V11, P77; JOSEPH AM, 2002, RECRUITMENT VETERAN; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kizer KW, 1997, ANN EMERG MED, V30, P804, DOI 10.1016/S0196-0644(97)70053-2; Maizlish NA, 2006, AM J MED QUAL, V21, P169, DOI 10.1177/1062860606287190; Partin MR, 2006, AM J PREV MED, V31, P293, DOI 10.1016/j.amepre.2006.06.021; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Prochaska JO, 2004, PUBLIC HEALTH REP, V119, P244, DOI 10.1016/j.phr.2004.04.003; Sherman S. E., 2004, BEST PRACTICES TOBAC; Sherman Scott E, 2004, Jt Comm J Qual Saf, V30, P80; Sherman SE, 2006, MIL MED, V171, P80, DOI 10.7205/MILMED.171.1.80; Sherman SE, 2005, AM J MED QUAL, V20, P33, DOI 10.1177/1062860604273776	18	34	34	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2008	336	7651					1016	1019		10.1136/bmj.39510.805266.BE	http://dx.doi.org/10.1136/bmj.39510.805266.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300EZ	18456633	Green Published			2022-12-28	WOS:000255808400046
J	Lister, R; O'Malley, RC; Tonti-Filippini, J; Gregory, BD; Berry, CC; Millar, AH; Ecker, JR				Lister, Ryan; O'Malley, Ronan C.; Tonti-Filippini, Julian; Gregory, Brian D.; Berry, Charles C.; Millar, A. Harvey; Ecker, Joseph R.			Highly integrated single-base resolution maps of the epigenome in Arabidopsis	CELL			English	Article							DIRECTED DNA METHYLATION; CYTOSINE METHYLTRANSFERASE; EPIGENETIC INHERITANCE; CG METHYLATION; DE-NOVO; GENOME; THALIANA; GLYCOSYLASE/LYASE; MAINTENANCE; ARGONAUTE4	Deciphering the multiple layers of epigenetic regulation that control transcription is critical to understanding how plants develop and respond to their environment. Using sequencing-by-synthesis technology we directly sequenced the cytosine methylome (methylC-seq), transcriptome (mRNA-seq), and small RNA transcriptome (smRNA-seq) to generate highly integrated epigenome maps for wild-type Arabidopsis thaliana and mutants defective in DNA methyltransferase or demethylase activity. At singlebase resolution we discovered extensive, previously undetected DNA methylation, identified the context and level of methylation at each site, and observed local sequence effects upon methylation state. Deep sequencing of smRNAs revealed a direct relationship between the location of smRNAs and DNA methylation, perturbation of smRNA biogenesis upon loss of CpG DNA methylation, and a tendency for smRNAs to direct strand-specific DNA methylation in regions of RNA-DNA homology. Finally, strandspecific mRNA-seq revealed altered transcript abundance of hundreds of genes, transposons, and unannotated intergenic transcripts upon modification of the DNA methylation state.	[Lister, Ryan; O'Malley, Ronan C.; Gregory, Brian D.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Lister, Ryan; O'Malley, Ronan C.; Gregory, Brian D.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Berry, Charles C.] Univ Calif San Diego, Dept Family Prevent Med, La Jolla, CA 92093 USA; [Millar, A. Harvey] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia	Salk Institute; Salk Institute; University of California System; University of California San Diego; University of Western Australia	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Millar, A. Harvey/A-5452-2008; Lister, Ryan/B-5168-2012; Tonti-Filippini, Julian S/L-8020-2018; jia, xu/A-8386-2016; Gregory, Brian D/G-2890-2010	Ecker, Joseph R/0000-0001-5799-5895; Millar, A. Harvey/0000-0001-9679-1473; Lister, Ryan/0000-0001-6637-7239; Tonti-Filippini, Julian S/0000-0003-3464-0770; omalley, ronan/0000-0002-4907-0339	NHGRI NIH HHS [R01 HG003523-03, R01 HG003523-01, R01 HG003523, R01 HG003523-02] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aufsatz W, 2004, PLANT MOL BIOL, V54, P793, DOI 10.1007/s11103-004-0179-1; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fojtova M, 2001, PLANT SCI, V160, P585, DOI 10.1016/S0168-9452(00)00411-8; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yu ZH, 2000, GENETICS, V156, P2019; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	33	1693	1766	8	267	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					523	536		10.1016/j.cell.2008.03.029	http://dx.doi.org/10.1016/j.cell.2008.03.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18423832	Green Accepted, Bronze			2022-12-28	WOS:000255503900022
J	McKay, D; White, M; Pasienski, M; DeMarco, B				McKay, D.; White, M.; Pasienski, M.; DeMarco, B.			Phase-slip-induced dissipation in an atomic Bose-Hubbard system	NATURE			English	Article							SUPERCONDUCTING NANOWIRES; EINSTEIN CONDENSATE; INSULATOR; TRANSITION; SUPERFLUID	Phase- slips control dissipation in many bosonic systems, determining the critical velocity of superfluid helium(1) and the generation of resistance in thin superconducting wires(2). Technological interest has been largely motivated by applications involving nanoscale superconducting circuit elements, such as standards based on quantum phase- slip junctions(3). Although phase slips caused by thermal fluctuations at high temperatures are well understood(4), controversy remains over the role of phase slips in small- scale superconductors(5) - in solids, problems such as uncontrolled noise sources and disorder complicate their study and application(6). Here we show that phase slips can lead to dissipation in a clean and well- characterized Bose - Hubbard system, by experimentally studying the transport of ultracold atoms trapped in an optical lattice. In contrast to previous work, we explore a low- velocity regime described by the three- dimensional Bose Hubbard model that is unaffected by instabilities, and we measure the effect of temperature on the dissipation strength. The damping rate of atomic motion ( the analogue of electrical resistance in a solid) in the confining parabolic potential is well fitted by a model that includes finite damping at zero temperature. The low- temperature behaviour is consistent with the theory of quantum tunnelling of phase slips, whereas at higher temperatures a crossover consistent with a transition to thermal activation of phase slips is evident. Motion- induced features reminiscent of vortices and vortex rings associated with phase slips are also observed in time- of- flight imaging. These results clarify the role of phase slips in superfluid systems. They may also be of relevance in understanding the source of metallic phases observed in thin films(7,8), or serve as a test bed for theories of bosonic dissipation based upon variants of the Bose - Hubbard model(9).	[McKay, D.; White, M.; Pasienski, M.; DeMarco, B.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	DeMarco, B (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	bdemarco@uiuc.edu		DeMarco, Brian/0000-0002-2791-0413				Anderson BP, 2001, PHYS REV LETT, V86, P2926, DOI 10.1103/PhysRevLett.86.2926; Bezryadin A, 2000, NATURE, V404, P971, DOI 10.1038/35010060; Blakie PB, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.013603; Bollinger AT, 2006, EUROPHYS LETT, V76, P505, DOI 10.1209/epl/i2006-10275-5; Cataliotti FS, 2001, SCIENCE, V293, P843, DOI 10.1126/science.1062612; Cristiani M, 2004, OPT EXPRESS, V12, P4, DOI 10.1364/OPEX.12.000004; Cristiani M, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063612; De Sarlo L, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013603; Denschlag JH, 2002, J PHYS B-AT MOL OPT, V35, P3095, DOI 10.1088/0953-4075/35/14/307; Fallani L, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140406; Ferlaino F, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.011604; Fertig CD, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.120403; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Goldman AM, 2003, PHYSICA E, V18, P1, DOI 10.1016/S1386-9477(02)00932-3; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; Haljan PC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.210403; Henderson K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.150401; Ho TL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120404; LANGER JS, 1967, PHYS REV, V164, P498, DOI 10.1103/PhysRev.164.498; LANGER JS, 1967, PHYS REV LETT, V19, P560, DOI 10.1103/PhysRevLett.19.560; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; MCCUMBER DE, 1970, PHYS REV B-SOLID ST, V1, P1054, DOI 10.1103/PhysRevB.1.1054; Mooij JE, 2006, NAT PHYS, V2, P169, DOI 10.1038/nphys234; Mun J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150604; Phillips P, 2003, SCIENCE, V302, P243, DOI 10.1126/science.1088253; Plourde BLT, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.014503; Polkovnikov A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.063613; Rey AM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.023608; Stamper-Kurn DM, 1998, PHYS REV LETT, V81, P500, DOI 10.1103/PhysRevLett.81.500; Tinkham M, 1996, INTRO SUPERCONDUCTIV; VINEN WF, 1957, PROC R SOC LON SER-A, V242, P493, DOI 10.1098/rspa.1957.0191; White M, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.023616; Wu B, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/104	35	67	67	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					76	+		10.1038/nature06920	http://dx.doi.org/10.1038/nature06920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451857	Green Submitted			2022-12-28	WOS:000255398800041
J	Randau, L; Schroder, I; Soll, D				Randau, Lennart; Schroder, Imke; Soll, Dieter			Life without RNase P	NATURE			English	Article							NANOARCHAEUM-EQUITANS; RIBONUCLEASE-P; GENES; EVOLUTION; PROTEIN; GENOME; ENZYME; SEQUENCES; PROMOTER; SUBUNIT	The universality of ribonuclease P ( RNase P), the ribonucleoprotein essential for transfer RNA ( tRNA) 5' maturation(1,2), is challenged in the archaeon Nanoarchaeum equitans. Neither extensive computational analysis of the genome nor biochemical tests in cell extracts revealed the existence of this enzyme. Here we show that the conserved placement of its tRNA gene promoters allows the synthesis of leaderless tRNAs, whose presence was verified by the observation of 5' triphosphorylated mature tRNA species. Initiation of tRNA gene transcription requires a purine, which coincides with the finding that tRNAs with a cytosine in position 1 display unusually extended 5' termini with an extra purine residue. These tRNAs were shown to be substrates for their cognate aminoacyl- tRNA synthetases. These findings demonstrate how nature can cope with the loss of the universal and supposedly ancient RNase P through genomic rearrangement at tRNA genes under the pressure of genome condensation.	[Randau, Lennart; Soll, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Soll, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Schroder, Imke] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Yale University; Yale University; University of California System; University of California Los Angeles	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu		Randau, Lennart/0000-0002-2780-2076	NIGMS NIH HHS [R01 GM022854] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN S, 1993, FASEB J, V7, P7, DOI 10.1096/fasebj.7.1.7916700; ALTMAN S, 1989, GENE, V82, P63, DOI 10.1016/0378-1119(89)90030-9; Connolly SA, 2004, BIOCHEMISTRY-US, V43, P962, DOI 10.1021/bi035708f; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Farruggio D, 1996, MOL CELL BIOL, V16, P4248; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Fitz-Gibbon ST, 2002, P NATL ACAD SCI USA, V99, P984, DOI 10.1073/pnas.241636498; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; HAUSNER W, 2007, ARCHAEA EVOLUTION PH, P185; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Klein RJ, 2002, P NATL ACAD SCI USA, V99, P7542, DOI 10.1073/pnas.112063799; Kobayashi T, 2003, NAT STRUCT BIOL, V10, P425, DOI 10.1038/nsb934; Li Y, 2004, RNA, V10, P1533, DOI 10.1261/rna.7970404; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; NOREN CJ, 1990, NUCLEIC ACIDS RES, V18, P83, DOI 10.1093/nar/18.1.83; PALMER JR, 1995, J BACTERIOL, V177, P1844, DOI 10.1128/jb.177.7.1844-1849.1995; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; Randau L, 2005, NATURE, V433, P537, DOI 10.1038/nature03233; She Q, 2004, BIOCHEM SOC T, V32, P222, DOI 10.1042/BST0320222; SHUMAN S, 1980, J BIOL CHEM, V255, P1588; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tsai HY, 2006, P NATL ACAD SCI USA, V103, P16147, DOI 10.1073/pnas.0608000103; VOGELI G, 1975, P NATL ACAD SCI USA, V72, P4790, DOI 10.1073/pnas.72.12.4790; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Willkomm DK, 2002, BIOCHIMIE, V84, P713, DOI 10.1016/S0300-9084(02)01447-5	32	81	82	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					120	+		10.1038/nature06833	http://dx.doi.org/10.1038/nature06833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451863				2022-12-28	WOS:000255398800051
J	Kuiper, KF; Deino, A; Hilgen, FJ; Krijgsman, W; Renne, PR; Wijbrans, JR				Kuiper, K. F.; Deino, A.; Hilgen, F. J.; Krijgsman, W.; Renne, P. R.; Wijbrans, J. R.			Synchronizing rock clocks of Earth history	SCIENCE			English	Article							U-PB GEOCHRONOLOGY; 40AR/39AR AGES; ACAPULCO METEORITE; SYSTEMATIC-ERRORS; DECAY CONSTANTS; ABSOLUTE AGES; MELILLA BASIN; ASH BEDS; PALEOCENE; BOUNDARY	Calibration of the geological time scale is achieved by independent radioisotopic and astronomical dating, but these techniques yield discrepancies of similar to 1.0% or more, limiting our ability to reconstruct Earth history. To overcome this fundamental setback, we compared astronomical and 40Ar/39Ar ages of tephras in marine deposits in Morocco to calibrate the age of Fish Canyon sanidine, the most widely used standard in 40Ar/39Ar geochronology. This calibration results in a more precise older age of 28.201 +/- 0.046 million years ago ( Ma) and reduces the 40Ar/39Ar method's absolute uncertainty from similar to 2.5 to 0.25%. In addition, this calibration provides tight constraints for the astronomical tuning of pre- Neogene successions, resulting in a mutually consistent age of similar to 65.95 Ma for the Cretaceous/ Tertiary boundary.	[Kuiper, K. F.; Hilgen, F. J.; Krijgsman, W.] Univ Utrecht, Fac Geosci, Dept Earth Sci, NL-3584 CD Utrecht, Netherlands; [Kuiper, K. F.; Wijbrans, J. R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Inst Earth Sci, NL-1081 HV Amsterdam, Netherlands; [Deino, A.; Renne, P. R.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Renne, P. R.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Utrecht University; Vrije Universiteit Amsterdam; Berkeley Geochronolgy Center; University of California System; University of California Berkeley	Kuiper, KF (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.		Wijbrans, J.R./M-6067-2019; Wijbrans, Jan/Q-1914-2016	Wijbrans, Jan/0000-0002-8091-1239; Krijgsman, Wout/0000-0002-1472-1074; Renne, Paul/0000-0003-1769-5235; Hilgen, Frits/0000-0002-5683-259X				Bachmann O, 2007, CHEM GEOL, V236, P134, DOI 10.1016/j.chemgeo.2006.09.005; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Bouvier A, 2007, GEOCHIM COSMOCHIM AC, V71, P1583, DOI 10.1016/j.gca.2006.12.005; CANDE SC, 1992, J GEOPHYS RES-SOL EA, V97, P13917, DOI 10.1029/92JB01202; Coe RS, 2004, EARTH PLANET SC LETT, V222, P667, DOI 10.1016/j.epsl.2004.03.003; Dinares-Turell J, 2003, EARTH PLANET SC LETT, V216, P483, DOI 10.1016/S0012-821X(03)00557-0; Gradstein FM, 2004, GEOLOGIC TIME SCALE; Hilgen FJ, 1997, GEOPHYS RES LETT, V24, P2043, DOI 10.1029/97GL02029; IZETT GA, 1991, SCIENCE, V252, P1539, DOI 10.1126/science.252.5012.1539; JESSBERGER EK, 1980, ICARUS, V42, P380, DOI 10.1016/0019-1035(80)90103-7; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Kuiper KF, 2004, EARTH PLANET SC LETT, V222, P583, DOI 10.1016/j.epsl.2004.03.005; Kwon JY, 2002, MATH GEOL, V34, P457, DOI 10.1023/A:1015035228810; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LOURENS L, 2004, GEOLOGIC TIME SCALE, P409, DOI DOI 10.1017/CBO9780511536045.022; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; McCoy TJ, 1996, GEOCHIM COSMOCHIM AC, V60, P2681, DOI 10.1016/0016-7037(96)00109-3; Min KW, 2003, EARTH PLANET SC LETT, V209, P323, DOI 10.1016/S0012-821X(03)00080-3; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; MUNDIL R, 2006, EOS T AM GEOPH UN S, V87; NICHOLS RH, 1994, GEOCHIM COSMOCHIM AC, V58, P2553, DOI 10.1016/0016-7037(94)90031-0; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Palike H, 2004, GEOLOGY, V32, P929, DOI 10.1130/G20750.1; Renne PR, 1998, SCIENCE, V282, P1840, DOI 10.1126/science.282.5395.1840; Renne PR, 2000, EARTH PLANET SC LETT, V175, P13, DOI 10.1016/S0012-821X(99)00287-3; RENNE PR, 1994, GEOLOGY, V22, P783, DOI 10.1130/0091-7613(1994)022<0783:IOAART>2.3.CO;2; Renne PR, 1998, CHEM GEOL, V145, P117, DOI 10.1016/S0009-2541(97)00159-9; Roger S, 2000, EARTH PLANET SC LETT, V179, P101, DOI 10.1016/S0012-821X(00)00094-7; Schmitz MD, 2001, GEOCHIM COSMOCHIM AC, V65, P2571, DOI 10.1016/S0016-7037(01)00616-0; Schoene B, 2006, GEOCHIM COSMOCHIM AC, V70, P426, DOI 10.1016/j.gca.2005.09.007; Sierro FJ, 2001, PALAEOGEOGR PALAEOCL, V168, P141, DOI 10.1016/S0031-0182(00)00253-4; Simon JI, 2008, EARTH PLANET SC LETT, V266, P182, DOI 10.1016/j.epsl.2007.11.014; Steenbrink J, 1999, PALAEOGEOGR PALAEOCL, V152, P283, DOI 10.1016/S0031-0182(99)00044-9; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Swindle TD, 1998, METEORIT PLANET SCI, V33, P1147, DOI 10.1111/j.1945-5100.1998.tb01719.x; SWISHER CC, 1992, SCIENCE, V257, P954, DOI 10.1126/science.257.5072.954; SWISHER CC, 1993, CAN J EARTH SCI, V30, P1981, DOI 10.1139/e93-174; van Assen E, 2006, PALAEOGEOGR PALAEOCL, V238, P15, DOI 10.1016/j.palaeo.2006.03.014; Varadi F, 2003, ASTROPHYS J, V592, P620, DOI 10.1086/375560; Westerhold T, 2008, PALAEOGEOGR PALAEOCL, V257, P377, DOI 10.1016/j.palaeo.2007.09.016	40	1072	1098	5	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					500	504		10.1126/science.1154339	http://dx.doi.org/10.1126/science.1154339			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436783				2022-12-28	WOS:000255249300042
J	Tang, HB; Bowers, JE; Wang, XY; Ming, R; Alam, M; Paterson, AH				Tang, Haibao; Bowers, John E.; Wang, Xiyin; Ming, Ray; Alam, Maqsudul; Paterson, Andrew H.			Perspective - Synteny and collinearity in plant genomes	SCIENCE			English	Editorial Material							DUPLICATION; EVOLUTION; SEQUENCE; SORGHUM; GENE; SACCHAROMYCES; RECOMBINATION; CONSERVATION; ARABIDOPSIS; EVENTS	Correlated gene arrangements among taxa provide a valuable framework for inference of shared ancestry of genes and for the utilization of findings from model organisms to study less- well- understood systems. In angiosperms, comparisons of gene arrangements are complicated by recurring polyploidy and extensive genome rearrangement. New genome sequences and improved analytical approaches are clarifying angiosperm evolution and revealing patterns of differential gene loss after genome duplication and differential gene retention associated with evolution of some morphological complexity. Because of variability in DNA substitution rates among taxa and genes, deviation from collinearity might be a more reliable phylogenetic character.	[Tang, Haibao; Bowers, John E.; Wang, Xiyin; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Ming, Ray] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Alam, Maqsudul] Univ Hawaii, Adv Studies Genom Proteom & Bioinformat Unit, Honolulu, HI 96822 USA	University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; University of Hawaii System	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@uga.edu	Bowers, John/B-9245-2009; Bowers, John/AAD-7601-2019; Tang, Haibao/A-6715-2011	Bowers, John/0000-0001-8984-9796; Tang, Haibao/0000-0002-3460-8570; Bowers, John/0000-0001-5693-2796				BENNETT MD, 1991, PHILOS T R SOC B, V334, P309, DOI 10.1098/rstb.1991.0120; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowers JE, 2005, P NATL ACAD SCI USA, V102, P13206, DOI 10.1073/pnas.0502365102; Bowers JE, 2003, GENETICS, V165, P367; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; MING R, IN PRESS NATURE; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Soltis D, 2005, PHYLOGENY EVOLUTION; Spangler R, 1999, SYST BOT, V24, P267, DOI 10.2307/2419552; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Yogeeswaran K, 2005, GENOME RES, V15, P505, DOI 10.1101/gr.3436305	26	684	716	13	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					486	488		10.1126/science.1153917	http://dx.doi.org/10.1126/science.1153917			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436778				2022-12-28	WOS:000255249300037
J	Steffen, KK; MacKay, VL; Kerr, EO; Tsuchiya, M; Hu, D; Fox, LA; Dang, N; Johnston, ED; Oakes, JA; Tchao, BN; Pak, DN; Fields, S; Kennedy, BK; Kaeberlein, M				Steffen, Kristan K.; MacKay, Vivian L.; Kerr, Emily O.; Tsuchiya, Mitsuhiro; Hu, Di; Fox, Lindsay A.; Dang, Nick; Johnston, Elijah D.; Oakes, Jonathan A.; Tchao, Bie N.; Pak, Diana N.; Fields, Stanley; Kennedy, Brian K.; Kaeberlein, Matt			Yeast life span extension by depletion of 60S ribosomal subunits is mediated by Gcn4	CELL			English	Article							OPEN READING FRAMES; TOR-SIGNALING PATHWAY; GENE-EXPRESSION; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; TRANSLATIONAL REGULATION; CALORIE RESTRICTION; PROTEIN-SYNTHESIS; STRESS-RESPONSE	In nearly every organism studied, reduced caloric intake extends life span. In yeast, span extension from dietary restriction is thought to be mediated by the highly conserved, nutrient-responsive target of rapamycin (TOR), protein kinase A (PKA), and Sch9 kinases. These kinases coordinately regulate various cellular processes including stress responses, protein turnover, cell growth, and ribosome biogenesis. Here we show that a specific reduction of 60S ribosomal subunit levels slows aging in yeast. Deletion of genes encoding 60S subunit proteins or processing factors or treatment with a small molecule, which all inhibit 60S subunit biogenesis, are each sufficient to significantly increase replicative life span. One mechanism by which reduced 60S subunit levels leads to life span extension is through induction of Gcn4, a nutrient-responsive transcription factor. Genetic epistasis analyses suggest that dietary restriction, reduced 60S subunit abundance, and Gcn4 activation extend yeast life span by similar mechanisms.	[Steffen, Kristan K.; MacKay, Vivian L.; Kerr, Emily O.; Tsuchiya, Mitsuhiro; Hu, Di; Fox, Lindsay A.; Dang, Nick; Johnston, Elijah D.; Oakes, Jonathan A.; Tchao, Bie N.; Pak, Diana N.; Kennedy, Brian K.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Fields, Stanley] Univ Washington, Dept Genom Sci & Med, Seattle, WA 98195 USA; [Fields, Stanley] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kennedy, BK (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	bkenn@u.washington.edu; kaeber@u.washington.edu	Pak, Diana/GWZ-8091-2022	Kaeberlein, Matt/0000-0002-1311-3421; Kennedy, Brian/0000-0002-5754-1874	NATIONAL INSTITUTE ON AGING [P50AG005136, P30AG013280, R01AG025549, R01AG024287] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [P50 AG005136-25, R01 AG025549-03, R01 AG024287, R01 AG025549, P30 AG013280, P50 AG005136] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baldock C, 1998, BIOCHEM PHARMACOL, V55, P1541; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Carey J. R., 2003, LONGEVITY BIOL DEMOG, DOI [10.1515/9780691224084, DOI 10.1515/9780691224084]; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dilova I, 2002, CURR BIOL, V12, P389, DOI 10.1016/S0960-9822(02)00677-2; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jia MH, 2000, PHYSIOL GENOMICS, V3, P83, DOI 10.1152/physiolgenomics.2000.3.2.83; Jiang JC, 2000, FASEB J, V14, P2135; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2006, HDB MODELS HUMAN AGI, P109; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lebreton A, 2006, J CELL BIOL, V173, P349, DOI 10.1083/jcb.200510080; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; LUCCHINI G, 1984, MOL CELL BIOL, V4, P1326, DOI 10.1128/MCB.4.7.1326; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin-Marcos P, 2007, MOL CELL BIOL, V27, P5968, DOI 10.1128/MCB.00019-07; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Miyoshi K, 2002, J BIOL CHEM, V277, P18334, DOI 10.1074/jbc.M201667200; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Mueller PP, 1998, J BIOL CHEM, V273, P32870, DOI 10.1074/jbc.273.49.32870; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Pertschy B, 2004, MOL CELL BIOL, V24, P6476, DOI 10.1128/MCB.24.14.6476-6487.2004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009; Salas-Marco J, 2005, J MOL BIOL, V348, P801, DOI 10.1016/j.jmb.2005.03.025; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; TSAY YF, 1988, GENE DEV, V2, P664, DOI 10.1101/gad.2.6.664; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Valenzuela L, 2001, J BACTERIOL, V183, P2331, DOI 10.1128/JB.183.7.2331-2334.2001; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WEINDRUCH R, 1988, J GERONTOL, V43, pB40, DOI 10.1093/geronj/43.2.B40; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000; Zhang ZH, 2005, CURR GENET, V48, P77, DOI 10.1007/s00294-005-0001-x; Zhao Y, 2003, MOL CELL BIOL, V23, P699, DOI 10.1128/MCB.23.2.699-707.2003	70	336	339	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					292	302		10.1016/j.cell.2008.02.037	http://dx.doi.org/10.1016/j.cell.2008.02.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423200	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000255052000018
J	Kanasaki, K; Palmsten, K; Sugimoto, H; Ahmad, S; Hamano, Y; Xie, L; Parry, S; Augustin, HG; Gattone, VH; Folkman, J; Strauss, JF; Kalluri, R				Kanasaki, Keizo; Palmsten, Kristin; Sugimoto, Hikaru; Ahmad, Shakil; Hamano, Yuki; Xie, Liang; Parry, Samuel; Augustin, Hellmut G.; Gattone, Vincent H., Jr.; Folkman, Judah; Strauss, Jerome F.; Kalluri, Raghu			Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia	NATURE			English	Article							GROWTH-FACTOR RECEPTOR-1; INHIBITS ANGIOGENESIS; TUMOR-GROWTH; IN-VITRO; PREGNANCY; PLACENTA; 2-HYDROXYESTRADIOL; 2-METHOXYESTRADIOL; DIFFERENTIATION; PROTEINURIA	Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and oedema are the principal clinical features of this disease. It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/ placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia(1-5). However, pre-eclampsia does not develop in all women with high sFLT-1 or low PLGF levels, and it also occurs in some women with low sFLT-1 and high PLGF levels(5,6). Moreover, recent experiments strongly suggest that several soluble factors affecting the vasculature are probably elevated because of placental hypoxia in the pre-eclamptic women, indicating that upstream molecular defect(s) may contribute to pre-eclampsia. Here we show that pregnant mice deficient in catechol-O-methyltransferase (COMT) show a pre-eclampsia-like phenotype resulting from an absence of 2-methoxyoestradiol (2-ME), a natural metabolite of oestradiol that is elevated during the third trimester of normal human pregnancy. 2-ME ameliorates all pre-eclampsia-like features without toxicity in the Comt(-/-) pregnant mice and suppresses placental hypoxia, hypoxia-inducible factor-1 alpha expression and sFLT-1 elevation. The levels of COMT and 2-ME are significantly lower in women with severe pre-eclampsia. Our studies identify a genetic mouse model for pre-eclampsia and suggest that 2-ME may have utility as a plasma and urine diagnostic marker for this disease, and may also serve as a therapeutic supplement to prevent or treat this disorder.	[Kanasaki, Keizo; Palmsten, Kristin; Sugimoto, Hikaru; Hamano, Yuki; Xie, Liang; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med, Boston, MA 02215 USA; [Kanasaki, Keizo; Palmsten, Kristin; Sugimoto, Hikaru; Hamano, Yuki; Xie, Liang; Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Ahmad, Shakil] Univ Birmingham, Sch Med, Dept Reprod Biol, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England; [Ahmad, Shakil] Univ Birmingham, Sch Med, Dept Vasc Biol, Biomed Res Inst, Birmingham B15 2TT, W Midlands, England; [Ahmad, Shakil] Birmingham Womens Hosp, Birmingham B15 2TG, W Midlands, England; [Parry, Samuel] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Augustin, Hellmut G.] Univ Heidelberg, Joint Res Div Vasc Biol, Med Fac Mannheim, D-69120 Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Gattone, Vincent H., Jr.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Folkman, Judah] Childrens Hosp, Program Vasc Biol, Dept Surg Res, Boston, MA 02215 USA; [Strauss, Jerome F.] Virginia Commonwealth Univ, Sch Med, Richmond, VA 23298 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Birmingham; University of Birmingham; Birmingham Women's Hospital; University of Pennsylvania; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Boston Children's Hospital; Virginia Commonwealth University; Harvard University; Harvard University; Harvard Medical School	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Div Matrix Biol, Dept Med, Boston, MA 02215 USA.	rkalluri@bidmc.harvard.edu	Augustin, Hellmut/AAA-5246-2020; Ahmad, Shakil/A-9421-2008; Kalluri, Raghu/E-2677-2015	Augustin, Hellmut/0000-0002-7173-4242; Ahmad, Shakil/0000-0002-9294-0475; Kalluri, Raghu/0000-0002-2190-547X	MRC [G0700288] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061688, R01DK055001, R01DK062987] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Medical Research Council [G0700288] Funding Source: Medline; NIDDK NIH HHS [DK 62987, DK 61688, R01 DK055001, DK 55001, R01 DK061688, DK 13193] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; BARNEA ER, 1988, AM J PERINAT, V5, P121, DOI 10.1055/s-2007-999669; BERG D, 1983, ACTA ENDOCRINOL-COP, V103, P282, DOI 10.1530/acta.0.1030282; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; CASEY ML, 1983, AM J OBSTET GYNECOL, V145, P453, DOI 10.1016/0002-9378(83)90316-2; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Hata T, 1997, LANCET, V350, P1600, DOI 10.1016/S0140-6736(05)64016-0; Ireson CR, 2004, BRIT J CANCER, V90, P932, DOI 10.1038/sj.bjc.6601591; Krauss T, 2004, HYPERTENS PREGNANCY, V23, P101, DOI 10.1081/PRG-120028286; LABARRERE CA, 1988, PLACENTA, V9, P95, DOI 10.1016/0143-4004(88)90076-8; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; MACGILLIVRAY I, 1969, CLIN SCI, V37, P395; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Myatt L, 1997, HUM REPROD, V12, P167, DOI 10.1093/humrep/12.1.167; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; ROSING U, 1984, GYNECOL OBSTET INVES, V18, P199, DOI 10.1159/000299081; Sata F, 2006, PHARMACOGENET GENOM, V16, P775, DOI 10.1097/01.fpc.0000230116.49452.c0; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Senthilkumaran B, 2001, J ENDOCRINOL, V168, P239, DOI 10.1677/joe.0.1680239; Solomon CG, 2004, NEW ENGL J MED, V350, P641, DOI 10.1056/NEJMp038241; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P7321, DOI 10.1073/pnas.0601436103; Takanashi K, 2000, CLIN CHEM, V46, P373; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Zacharia LC, 2004, J PHARMACOL EXP THER, V309, P1093, DOI 10.1124/jpet.103.062505	33	300	317	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 19	2008	453	7198					1117	U12		10.1038/nature06951	http://dx.doi.org/10.1038/nature06951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18469803				2022-12-28	WOS:000256839900060
J	Brawley, OW; Cornelius, LJ; Edwards, LR; Gamble, VN; Green, BL; Inturrisi, C; James, AH; Laraque, D; Mendez, M; Montoya, CJ; Pollock, BH; Robinson, L; Scholnik, AP; Schori, M				Brawley, Otis W.; Cornelius, Llewellyn J.; Edwards, Linda R.; Gamble, Vanessa Northington; Green, Bettye L.; Inturrisi, Charles; James, Andra H.; Laraque, Danielle; Mendez, Magda; Montoya, Carolyn J.; Pollock, Brad H.; Robinson, Lawrence; Scholnik, Aaron P.; Schori, Melissa			National institutes of health consensus development conference statement: Hydroxyurea treatment for sickle cell disease	ANNALS OF INTERNAL MEDICINE			English	Article									Emory Univ, Atlanta, GA 30322 USA; Amer Canc Soc, Atlanta, GA 30329 USA; Univ Maryland, Sch Social Work, Baltimore, MD 21201 USA; Univ Florida, Coll Med, Jacksonville, FL USA; George Washington Univ, Washington, DC USA; St Joseph Regional Med Ctr, South Bend, IN USA; African Amer Women Touch, South Bend, IN USA; Cornell Univ, Weill Med Coll, New York, NY 10021 USA; Mt Sinai Sch Med, New York, NY USA; Lincoln Med & Mental Hlth Ctr, Bronx, NY 10451 USA; Duke Univ, Med Ctr, Durham, NC USA; Womens Hemostasis & Thrombosis Clin, Durham, NC USA; Univ New Mexico, Natl Assoc Pediatr Nurse Practitioners, Albuquerque, NM 87131 USA; Univ New Mexico, Coll Nursing, Albuquerque, NM 87131 USA; Univ Texas Hlth Sci Ctr San Antonio, Sch Med, San Antonio, TX 78229 USA; Philadelphia Dept Publ Hlth, Philadelphia, PA USA; Marquette Gen Hlth System, Canc Res Off, Marquette, MI USA; Princeton Healthcare System, Princeton, NJ USA	Emory University; American Cancer Society; University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; George Washington University; Cornell University; Icahn School of Medicine at Mount Sinai; Duke University; University of New Mexico; University of New Mexico; University of Texas System; University of Texas Health San Antonio	Brawley, OW (corresponding author), Emory Univ, Atlanta, GA 30322 USA.		Inturrisi, Charles/E-7365-2013	cornelius, llewellyn/0000-0002-3296-3894; James, Andra/0000-0003-4570-6595					0	179	186	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2008	148	12					932	+		10.7326/0003-4819-148-12-200806170-00220	http://dx.doi.org/10.7326/0003-4819-148-12-200806170-00220			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323DU	18458271				2022-12-28	WOS:000257425000005
J	Pocivavsek, L; Dellsy, R; Kern, A; Johnson, S; Lin, BH; Lee, KYC; Cerda, E				Pocivavsek, Luka; Dellsy, Robert; Kern, Andrew; Johnson, Sebastian; Lin, Binhua; Lee, Ka Yee C.; Cerda, Enrique			Stress and fold localization in thin elastic membranes	SCIENCE			English	Article							MONOLAYER SPREAD; TRANSITIONS; COLLAPSE	Thin elastic membranes supported on a much softer elastic solid or a fluid deviate from their flat geometries upon compression. We demonstrate that periodic wrinkling is only one possible solution for such strained membranes. Folds, which involve highly localized curvature, appear whenever the membrane is compressed beyond a third of its initial wrinkle wavelength. Eventually the surface transforms into a symmetry-broken state with flat regions of membrane coexisting with locally folded points, reminiscent of a crumpled, unsupported membrane. We provide general scaling laws for the wrinkled and folded states and proved the transition with numerical and experimental supported membranes. Our work provides insight into the interfacial stability of such diverse systems as biological membranes such as lung surfactant and nanoparticle thin films.	[Johnson, Sebastian; Cerda, Enrique] Univ Santiago, Dept Fis, Santiago, Chile; [Johnson, Sebastian; Cerda, Enrique] Univ Santiago, Ctr Invest Interdisciplinaria Avanzada Ciencias M, Santiago, Chile; [Pocivavsek, Luka; Kern, Andrew; Lee, Ka Yee C.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Pocivavsek, Luka; Kern, Andrew; Lee, Ka Yee C.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Dellsy, Robert; Lin, Binhua] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA	Universidad de Santiago de Chile; Universidad de Santiago de Chile; University of Chicago; University of Chicago; University of Chicago	Cerda, E (corresponding author), Univ Santiago, Dept Fis, Av Ecuador 3493, Santiago, Chile.	ecerda@lauca.usach.cl		Kern-Goldberger, Andrew/0000-0003-0610-4292				BOURDIEU L, 1994, PHYS REV LETT, V72, P1502, DOI 10.1103/PhysRevLett.72.1502; Bowden N, 1998, NATURE, V393, P146, DOI 10.1038/30193; Cerda E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.074302; Collier CP, 1998, ANNU REV PHYS CHEM, V49, P371, DOI 10.1146/annurev.physchem.49.1.371; Diamant H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.061602; Efimenko K, 2005, NAT MATER, V4, P293, DOI 10.1038/nmat1342; Gopal A, 2006, J PHYS CHEM B, V110, P10220, DOI 10.1021/jp0618983; Gopal A, 2001, J PHYS CHEM B, V105, P10348, DOI 10.1021/jp012532n; HERTZ H, 1884, WIEDEMANNS ANN PHYS, V22, P449; Huang J, 2007, SCIENCE, V317, P650, DOI 10.1126/science.1144616; Huang R, 2002, J APPL PHYS, V91, P1135, DOI 10.1063/1.1427407; Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367; LOBKOVSKY A, 1995, SCIENCE, V270, P1482, DOI 10.1126/science.270.5241.1482; Lu WX, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.146107; MILNER ST, 1989, EUROPHYS LETT, V9, P495, DOI 10.1209/0295-5075/9/5/015; Mueggenburg KE, 2007, NAT MATER, V6, P656, DOI 10.1038/nmat1965; NIKOMAROV ES, 1990, LANGMUIR, V6, P410, DOI 10.1021/la00092a021; RIES HE, 1955, J PHYS CHEM-US, V59, P94, DOI 10.1021/j150523a028; Saint-Jalmes A, 1998, J PHYS CHEM B, V102, P5810, DOI 10.1021/jp980541z; SAINTJALMES A, 1994, EUROPHYS LETT, V28, P565, DOI 10.1209/0295-5075/28/8/005; Schultz DG, 2006, J PHYS CHEM B, V110, P24522, DOI 10.1021/jp063820s; Vaia R, 2008, SCIENCE, V319, P420, DOI 10.1126/science.1152931; Vella D, 2004, EUROPHYS LETT, V68, P212, DOI 10.1209/epl/i2004-10202-x; Witten TA, 2007, REV MOD PHYS, V79, P643, DOI 10.1103/RevModPhys.79.643; Ybert C, 2002, J PHYS-CONDENS MAT, V14, P4753, DOI 10.1088/0953-8984/14/19/301; Zasadzinski JA, 2001, CURR OPIN COLLOID IN, V6, P506, DOI 10.1016/S1359-0294(01)00124-8	26	394	401	6	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					912	916		10.1126/science.1154069	http://dx.doi.org/10.1126/science.1154069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487188				2022-12-28	WOS:000255868300037
J	Hanikenne, M; Talke, IN; Haydon, MJ; Lanz, C; Nolte, A; Motte, P; Kroymann, J; Weigel, D; Kramer, U				Hanikenne, Marc; Talke, Ina N.; Haydon, Michael J.; Lanz, Christa; Nolte, Andrea; Motte, Patrick; Kroymann, Juergen; Weigel, Detlef; Kraemer, Ute			Evolution of metal hyperaccumulation required cis-regulatory changes and triplication of HMA4	NATURE			English	Article							ARABIDOPSIS-THALIANA; ZINC TOLERANCE; GENETIC-BASIS; COPY NUMBER; HOMEOSTASIS; PLANT; TRANSPORTER; EXPRESSION; SELECTION; CADMIUM	Little is known about the types of mutations underlying the evolution of species-specific traits. The metal hyperaccumulator Arabidopsis halleri has the rare ability to colonize heavy-metal-polluted soils, and, as an extremophile sister species of Arabidopsis thaliana, it is a powerful model for research on adaptation(1-3). A. halleri naturally accumulates and tolerates leaf concentrations as high as 2.2% zinc and 0.28% cadmium in dry biomass(4). On the basis of transcriptomics studies, metal hyperaccumulation in A. halleri has been associated with more than 30 candidate genes that are expressed at higher levels in A. halleri than in A. thaliana(4-6). Some of these genes have been genetically mapped to broad chromosomal segments of between 4 and 24 cM co-segregating with Zn and Cd hypertolerance(7-9). However, the in planta loss-of-function approaches required to demonstrate the contribution of a given candidate gene to metal hyperaccumulation or hypertolerance have not been pursued to date. Using RNA interference to downregulate HMA4 (HEAVY METAL ATPASE 4) expression, we show here that Zn hyperaccumulation and full hypertolerance to Cd and Zn in A. halleri depend on the metal pump HMA4. Contrary to a postulated global trans regulatory factor governing high expression of numerous metal hyperaccumulation genes, we demonstrate that enhanced expression of HMA4 in A. halleri is attributable to a combination of modified cis-regulatory sequences and copy number expansion, in comparison to A. thaliana. Transfer of an A. halleri HMA4 gene to A. thaliana recapitulates Zn partitioning into xylem vessels and the constitutive transcriptional upregulation of Zn deficiency response genes characteristic of Zn hyperaccumulators. Our results demonstrate the importance of cis-regulatory mutations and gene copy number expansion in the evolution of a complex naturally selected extreme trait(10). The elucidation of a natural strategy for metal hyperaccumulation enables the rational design of technologies for the clean-up of metal-contaminated soils and for bio-fortification.	[Hanikenne, Marc; Talke, Ina N.; Haydon, Michael J.; Nolte, Andrea; Kraemer, Ute] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Lanz, Christa; Weigel, Detlef] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Motte, Patrick] Univ Liege, Dept Life Sci, B-4000 Liege, Belgium; [Motte, Patrick] Univ Liege, Ctr Assistance Technol Microscopy, Dept Chem, B-4000 Liege, Belgium; [Kroymann, Juergen] Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Max Planck Society; Max Planck Society; University of Liege; University of Liege; Max Planck Society	Kramer, U (corresponding author), Heidelberg Univ, BIOQUANT Ctr, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany.	ute.kraemer@bioquant.uni-heidelberg.de	Weigel, Detlef/AAR-3312-2021; Kroymann, Juergen/AAY-8562-2021; Haydon, Michael/B-9326-2014; Kroymann, Juergen/B-4317-2013; Hanikenne, Marc/Y-4642-2019; Kraemer, Ute/C-5025-2008; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Kroymann, Juergen/0000-0002-4573-6498; Haydon, Michael/0000-0003-2486-9387; Hanikenne, Marc/0000-0002-8964-9601; Kraemer, Ute/0000-0001-7870-4508; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Talke, Ina/0000-0002-8319-1951				Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; Becher M, 2004, PLANT J, V37, P251, DOI 10.1046/j.1365-313X.2003.01959.x; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; Bert V, 2003, PLANT SOIL, V249, P9, DOI 10.1023/A:1022580325301; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Chateau S, 2000, J EXP BOT, V51, P1961, DOI 10.1093/jexbot/51.353.1961; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Clemens S, 2002, TRENDS PLANT SCI, V7, P309, DOI 10.1016/S1360-1385(02)02295-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Courbot M, 2007, PLANT PHYSIOL, V144, P1052, DOI 10.1104/pp.106.095133; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Drager DB, 2004, PLANT J, V39, P425, DOI 10.1111/j.1365-313X.2004.02143.x; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Lasat MM, 2000, J EXP BOT, V51, P71, DOI 10.1093/jexbot/51.342.71; Macnair MR, 1999, P ROY SOC B-BIOL SCI, V266, P2175, DOI 10.1098/rspb.1999.0905; Mitchell-Olds T, 2001, TRENDS ECOL EVOL, V16, P693, DOI 10.1016/S0169-5347(01)02291-1; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Sugino RP, 2006, TRENDS GENET, V22, P642, DOI 10.1016/j.tig.2006.09.014; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; VANCANNEYT G, 1990, MOL GEN GENET, V220, P245, DOI 10.1007/BF00260489; Walther D, 2001, GENOME RES, V11, P875, DOI 10.1101/gr.177901; Weber M, 2004, PLANT J, V37, P269, DOI 10.1046/j.1365-313X.2003.01960.x; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157; Willems G, 2007, GENETICS, V176, P659, DOI 10.1534/genetics.106.064485; Windsor AJ, 2006, PLANT PHYSIOL, V140, P1169, DOI 10.1104/pp.105.073981; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101	38	560	586	8	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					391	U44		10.1038/nature06877	http://dx.doi.org/10.1038/nature06877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18425111				2022-12-28	WOS:000255868400052
J	Mayer, SA; Brun, NC; Begtrup, K; Broderick, J; Davis, S; Diringer, MN; Skolnick, BE; Steiner, T				Mayer, Stephan A.; Brun, Nikolai C.; Begtrup, Kamilla; Broderick, Joseph; Davis, Stephen; Diringer, Michael N.; Skolnick, Brett E.; Steiner, Thorsten		FAST Trial Investigators	Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREDICTS HEMATOMA EXPANSION; HEMOSTATIC THERAPY; STROKE COUNCIL; GUIDELINES; VOLUME; SCALE; DETERMINANT; MANAGEMENT; GROWTH; BLOOD	Background: Intracerebral hemorrhage is the least treatable form of stroke. We performed this phase 3 trial to confirm a previous study in which recombinant activated factor VII (rFVIIa) reduced growth of the hematoma and improved survival and functional outcomes. Methods: We randomly assigned 841 patients with intracerebral hemorrhage to receive placebo (268 patients), 20 mu g of rFVIIa per kilogram of body weight (276 patients), or 80 mu g of rFVIIa per kilogram (297 patients) within 4 hours after the onset of stroke. The primary end point was poor outcome, defined as severe disability or death according to the modified Rankin scale 90 days after the stroke. Results: Treatment with 80 mu g of rFVIIa per kilogram resulted in a significant reduction in growth in volume of the hemorrhage. The mean estimated increase in volume of the intracerebral hemorrhage at 24 hours was 26% in the placebo group, as compared with 18% in the group receiving 20 mu g of rFVIIa per kilogram (P=0.09) and 11% in the group receiving 80 mu g (P<0.001). The growth in volume of intracerebral hemorrhage was reduced by 2.6 ml (95% confidence interval [CI], -0.3 to 5.5; P=0.08) in the group receiving 20 mu g of rFVIIa per kilogram and by 3.8 ml (95% CI, 0.9 to 6.7; P=0.009) in the group receiving 80 mu g, as compared with the placebo group. Despite this reduction in bleeding, there was no significant difference among the three groups in the proportion of patients with poor clinical outcome (24% in the placebo group, 26% in the group receiving 20 mu g of rFVIIa per kilogram, and 29% in the group receiving 80 mu g). The overall frequency of thromboembolic serious adverse events was similar in the three groups; however, arterial events were more frequent in the group receiving 80 mu g of rFVIIa than in the placebo group (9% vs. 4%, P=0.04). Conclusions: Hemostatic therapy with rFVIIa reduced growth of the hematoma but did not improve survival or functional outcome after intracerebral hemorrhage. (ClinicalTrials.gov number, NCT00127283.).	[Mayer, Stephan A.] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Mayer, Stephan A.] Columbia Univ, Coll Phys & Surg, Dept Neurosurg, New York, NY USA; [Brun, Nikolai C.; Begtrup, Kamilla] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; [Broderick, Joseph] Univ Cincinnati, Med Ctr, Cincinnati, OH 45267 USA; [Davis, Stephen] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; [Diringer, Michael N.] Washington Univ, Sch Med, St Louis, MO USA; [Skolnick, Brett E.] Novo Nordisk AS, Princeton, NJ USA; [Steiner, Thorsten] Heidelberg Univ, Heidelberg, Germany	Columbia University; Columbia University; Novo Nordisk; University System of Ohio; University of Cincinnati; Royal Melbourne Hospital; University of Melbourne; Washington University (WUSTL); Novo Nordisk; Ruprecht Karls University Heidelberg	Mayer, SA (corresponding author), Neurol Inst, 710 W 168Th St,Box 39, New York, NY 10032 USA.	sam14@columbia.edu	Davis, Stephen M/L-5260-2013; Iversen, Helle Klingenberg/B-9154-2009; Diringer, Michael N/C-1165-2008; Roos, Yvo BWEM/B-9843-2013; Gaines, Kenneth/D-4730-2011; Vanhooren, Geert/H-4433-2011; Steiner, Thorsten/A-7391-2014; Toni, Danilo/K-3151-2016; Tanne, David/F-2560-2010; Kasner, Scott/C-6109-2011; Demchuk, Andrew M/E-1103-2012; Egido, Jose/E-3837-2015	Davis, Stephen M/0000-0003-0962-2300; Diringer, Michael N/0000-0003-2337-5537; Vanhooren, Geert/0000-0001-6818-9346; Toni, Danilo/0000-0003-2735-8427; Tanne, David/0000-0002-6699-2220; Demchuk, Andrew M/0000-0002-4930-7789; Andersen, Grethe/0000-0001-6807-2500; Egido, Jose/0000-0003-1698-9127; Iversen, Helle Klingenberg/0000-0002-5880-6352; Tirschwell, David/0000-0002-8059-2901; Bleck, Thomas/0000-0002-8267-9787; samson, yves/0000-0002-8080-1427				Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; COUNSELL C, 1995, CEREBROVASC DIS, V5, P26, DOI 10.1159/000107814; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Diringer MN, 2008, STROKE, V39, P850, DOI 10.1161/STROKEAHA.107.493601; Dorman PJ, 1997, STROKE, V28, P1876, DOI 10.1161/01.STR.28.10.1876; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Haley EC, 2005, STROKE, V36, P1006, DOI 10.1161/01.STR.0000163053.77982.8d; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Lyden PD, 2007, STROKE, V38, P2262, DOI 10.1161/STROKEAHA.106.472746; MAHONEY F I, 1965, Md State Med J, V14, P61; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2003, STROKE, V34, P224, DOI 10.1161/01.STR.0000046458.67968.E4; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Steiner T, 2006, NEUROSURGERY, V59, P767, DOI 10.1227/01.NEU.0000232837.34992.32; TEASDALE G, 1974, LANCET, V2, P81; Tuhrim S, 1999, CRIT CARE MED, V27, P617, DOI 10.1097/00003246-199903000-00045; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zimmerman RD, 2006, AM J NEURORADIOL, V27, P666	25	849	886	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2127	2137		10.1056/NEJMoa0707534	http://dx.doi.org/10.1056/NEJMoa0707534			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480205	Green Submitted			2022-12-28	WOS:000255849300006
J	Holmes, JA				Holmes, Jonathan A.			Ecology - How the Sahara became dry	SCIENCE			English	Editorial Material							NORTHERN AFRICA; ABRUPT CHANGE; VEGETATION; FEEDBACKS; ECOSYSTEM; MONSOON; SAHEL		UCL, Environm Change Res Ctr, Dept Geog, London WC1E 6BT, England	University of London; University College London	Holmes, JA (corresponding author), UCL, Environm Change Res Ctr, Dept Geog, Mortimer St, London WC1E 6BT, England.	j.holmes@ucl.ac.uk						Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Hoelzmann P, 1998, GLOBAL BIOGEOCHEM CY, V12, P35, DOI 10.1029/97GB02733; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kutzbach J, 1996, NATURE, V384, P623, DOI 10.1038/384623a0; Kutzbach JE, 1997, SCIENCE, V278, P440, DOI 10.1126/science.278.5337.440; Liu Z, 2007, QUATERNARY SCI REV, V26, P1818, DOI 10.1016/j.quascirev.2007.03.002; Street-Perrott FA, 2000, HOLOCENE, V10, P293, DOI 10.1191/095968300678141274; van de Flierdt T, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2006PA001294; Waller MP, 2007, J BIOGEOGR, V34, P1575, DOI 10.1111/j.1365-2699.2007.01721.x	10	33	34	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					752	753		10.1126/science.1158105	http://dx.doi.org/10.1126/science.1158105			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467577				2022-12-28	WOS:000255644400025
J	Kamerow, D				Kamerow, Douglas			Who wrote that article? The latest revelations about ghost authorship of journal articles are truly frightening	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				2008, BMJ, V336, P849	1	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 3	2008	336	7651					989	989		10.1136/bmj.39563.567847.94	http://dx.doi.org/10.1136/bmj.39563.567847.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300EZ	18456627	Green Published			2022-12-28	WOS:000255808400034
J	Aronov, D; Andalman, AS; Fee, MS				Aronov, Dmitriy; Andalman, Aaron S.; Fee, Michale S.			A specialized forebrain circuit for vocal babbling in the juvenile songbird	SCIENCE			English	Article							EARLY MOTOR-ACTIVITY; MALE ZEBRA FINCHES; AXONAL CONNECTIONS; HUMAN INFANTS; NUCLEUS; BIRDSONG; LESIONS; BRAIN; MECHANISMS; BEHAVIOR	Young animals engage in variable exploratory behaviors essential for the development of neural circuitry and adult motor control, yet the neural basis of these behaviors is largely unknown. Juvenile songbirds produce subsong- a succession of primitive vocalizations akin to human babbling. We found that subsong production in zebra finches does not require HVC ( high vocal center), a key premotor area for singing in adult birds, but does require LMAN ( lateral magnocellular nucleus of the nidopallium), a forebrain nucleus involved in learning but not in adult singing. During babbling, neurons in LMAN exhibited premotor correlations to vocal output on a fast time scale. Thus, juvenile singing is driven by a circuit distinct from that which produces the adult behavior- a separation possibly general to other developing motor systems.	[Aronov, Dmitriy; Andalman, Aaron S.; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu	Andalman, Aaron S/C-7694-2011	Fee, Michale/0000-0001-7539-1745	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067105] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067105] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; ALVAREZBUYLLA A, 1992, J NEUROBIOL, V23, P396, DOI 10.1002/neu.480230406; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Doya K, 1996, ADV NEURAL INFORMATI, P101; EDELMAN GM, 1987, NEURAL DARWIMISM THE; Elowson AM, 1998, TRENDS COGN SCI, V2, P31, DOI 10.1016/S1364-6613(97)01115-7; Eyre JA, 2000, BRAIN, V123, P51, DOI 10.1093/brain/123.1.51; Fagen RM, 1981, ANIMAL PLAY BEHAV; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Forssberg H, 1999, CURR OPIN NEUROBIOL, V9, P676, DOI 10.1016/S0959-4388(99)00037-9; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Hadders-Algra M, 2000, DEV MED CHILD NEUROL, V42, P566, DOI 10.1017/S0012162200001067; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HERRMANN K, 1991, J NEUROSCI, V11, P2063; Imada T, 2006, NEUROREPORT, V17, P957, DOI 10.1097/01.wnr.0000223387.51704.89; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; Knornschild M, 2006, NATURWISSENSCHAFTEN, V93, P451, DOI 10.1007/s00114-006-0127-9; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; MARLER P, 1970, AM SCI, V58, P669; Marler P, 1997, J NEUROBIOL, V33, P501; Milh M, 2007, CEREB CORTEX, V17, P1582, DOI 10.1093/cercor/bhl069; MOONEY R, 1994, J NEUROSCI, V14, P6532; MOONEY R, 1992, J NEUROSCI, V12, P2464; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719; Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3; REISS D, 1993, J COMP PSYCHOL, V107, P301, DOI 10.1037/0735-7036.107.3.301; Robinson SR, 2000, BEHAV NEUROSCI, V114, P328, DOI 10.1037//0735-7044.114.2.328; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Thompson JA, 2007, DEV NEUROBIOL, V67, P205, DOI 10.1002/dneu.20287; Troyer TW, 2001, CURR OPIN NEUROBIOL, V11, P721, DOI 10.1016/S0959-4388(01)00275-6; Wallace PS, 2003, NEUROPSYCHOLOGIA, V41, P1912, DOI 10.1016/S0028-3932(03)00128-3; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	44	235	238	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					630	634		10.1126/science.1155140	http://dx.doi.org/10.1126/science.1155140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451295				2022-12-28	WOS:000255454300036
J	Bravo-Abad, J; Soljacic, M				Bravo-Abad, Jorge; Soljacic, Marin			Physics - A unified picture of laser physics	SCIENCE			English	Editorial Material									[Bravo-Abad, Jorge; Soljacic, Marin] MIT, Dept Phys, Cambridge, MA 02139 USA; [Bravo-Abad, Jorge; Soljacic, Marin] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bravo-Abad, J (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	jbravo@mit.edu	Soljacic, Marin/AAA-4868-2019; Bravo-Abad, Jorge/M-3493-2014	Bravo-Abad, Jorge/0000-0001-6876-8022				Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278; LAWANDY NM, 1994, NATURE, V368, P436, DOI 10.1038/368436a0; Siegman A. E., 1986, LASER; Tureci HE, 2008, SCIENCE, V320, P643, DOI 10.1126/science.1155311; van der Molen KL, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.143901; Vanneste C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.143902	8	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					623	624		10.1126/science.1157494	http://dx.doi.org/10.1126/science.1157494			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451291				2022-12-28	WOS:000255454300032
J	Howitz, KT; Sinclair, DA				Howitz, Konrad T.; Sinclair, David A.			Xenohormesis: Sensing the chemical cues of other species	CELL			English	Article							RESVERATROL; FLAVONOIDS; ACTIVATORS; SIRTUINS; MOLECULE	Many plant molecules interact with and modulate key regulators of mammalian physiology in ways that are beneficial to health, but why? We propose that heterotrophs (animals and fungi) are able to sense chemical cues synthesized by plants and other autotrophs in response to stress. These cues provide advance warning about deteriorating environmental conditions, allowing the heterotrophs to prepare for adversity while conditions are still favorable.	[Howitz, Konrad T.] BIOMOL Int LP, Plymouth Meeting, PA 19462 USA; [Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Howitz, KT (corresponding author), BIOMOL Int LP, 5120 Butler Pike, Plymouth Meeting, PA 19462 USA.	howitzkt@biomol.com; david_sinclair@hms.harvard.edu		Sinclair, David/0000-0002-9936-436X	NIA NIH HHS [P01 AG027916-020003, R01 AG019719, R01 AG028730-01A1, P01 AG027916, R01 AG028730] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072-01, R01 GM068072] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028730, P01AG027916, R01AG019719] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Dore S, 2005, NEUROSIGNALS, V14, P61, DOI 10.1159/000085386; GANGE AC, 1989, OECOLOGIA, V81, P38, DOI 10.1007/BF00377007; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Halliwell B, 2005, AM J CLIN NUTR, V81, p268S, DOI 10.1093/ajcn/81.1.268S; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kushiro T, 2003, NATURE, V422, P122, DOI 10.1038/422122a; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; Nandi A, 2003, PLANT CELL, V15, P2383, DOI 10.1105/tpc.015529; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; Schultz JC, 2002, INTEGR COMP BIOL, V42, P454, DOI 10.1093/icb/42.3.454; Soleas GJ, 1997, CLIN BIOCHEM, V30, P91, DOI 10.1016/S0009-9120(96)00155-5; STAFFORD HA, 1991, PLANT PHYSIOL, V96, P680, DOI 10.1104/pp.96.3.680; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Woo HH, 2005, BIOTECHNOL LETT, V27, P365, DOI 10.1007/s10529-005-1521-7; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yu CW, 2002, PHARM RES-DORDR, V19, P1907, DOI 10.1023/A:1021414129280	21	195	209	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					387	391		10.1016/j.cell.2008.04.019	http://dx.doi.org/10.1016/j.cell.2008.04.019			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455976	Green Accepted, Bronze			2022-12-28	WOS:000255503900006
J	Schenck, A; Goto-Silva, L; Collinet, C; Rhinn, M; Giner, A; Habermann, B; Brand, M; Zerial, M				Schenck, Annette; Goto-Silva, Livia; Collinet, Claudio; Rhinn, Muriel; Giner, Angelika; Habermann, Bianca; Brand, Michael; Zerial, Marino			The endosomal protein Appl1 mediates akt substrate specificity and cell survival in vertebrate development	CELL			English	Article							SIGNAL-TRANSDUCTION; ENDOCYTIC PATHWAY; RAB5 EFFECTORS; COMPLEX; GIPC; INTERACTS; TURNOVER; DOMAINS; CANCER; DEATH	During development of multicellular organisms, cells respond to extracellular cues through nonlinear signal transduction cascades whose principal components have been identified. Nevertheless, the molecular mechanisms underlying specificity of cellular responses remain poorly understood. Spatial distribution of signaling proteins may contribute to signaling specificity. Here, we tested this hypothesis by investigating the role of the Rab5 effector Appl1, an endosomal protein that interacts with transmembrane receptors and Akt. We show that in zebrafish, Appl1 regulates Akt activity and substrate specificity, controlling GSK-3 beta but not TSC2. Consistent with this pattern, Appl1 is selectively required for cell survival, most critically in highly expressing tissues. Remarkably, Appl1 function requires its endosomal localization. Indeed, Akt and GSK-3 beta, but not TSC2, dynamically associate with Appl1 endosomes upon growth factor stimulation. We propose that partitioning of Akt and selected effectors onto endosomal compartments represents a key mechanism contributing to the specificity of signal transduction in vertebrate development.	[Schenck, Annette; Goto-Silva, Livia; Collinet, Claudio; Giner, Angelika; Habermann, Bianca; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Rhinn, Muriel; Brand, Michael] Univ Technol Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Rhinn, Muriel; Brand, Michael] Univ Technol Dresden, Ctr Regenerat Therapies, D-01307 Dresden, Germany; [Habermann, Bianca] Scion Comp Innovat GmbH, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Brand, Michael/A-5509-2010; Habermann, Bianca/N-4886-2016; Schenck, Annette/E-4514-2012; Goto, Livia/I-3072-2012	Brand, Michael/0000-0001-5711-6512; Habermann, Bianca/0000-0002-2457-7504; Schenck, Annette/0000-0002-6918-3314; Collinet, Claudio/0000-0002-8532-2601; Rhinn, Muriel/0000-0002-1918-0246				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dumont JE, 2001, CELL SIGNAL, V13, P457, DOI 10.1016/S0898-6568(01)00168-1; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Hoeller D, 2005, CURR OPIN CELL BIOL, V17, P107, DOI 10.1016/j.ceb.2005.01.001; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Katoh M, 2002, INT J MOL MED, V9, P585; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Liu J, 2002, J BIOL CHEM, V277, P26281, DOI 10.1074/jbc.M204679200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Nechamen CA, 2004, BIOL REPROD, V71, P629, DOI 10.1095/biolreprod.103.025833; Nechamen CA, 2007, MOL CELL ENDOCRINOL, V260, P93, DOI 10.1016/j.mce.2006.08.014; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Polak P, 2006, DEV CELL, V11, P433, DOI 10.1016/j.devcel.2006.09.005; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Yang L, 2003, J BIOL CHEM, V278, P16820, DOI 10.1074/jbc.M213163200	48	249	260	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					486	497		10.1016/j.cell.2008.02.044	http://dx.doi.org/10.1016/j.cell.2008.02.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455989	Bronze			2022-12-28	WOS:000255503900019
J	Ibrahim, SF; Tu, JH				Ibrahim, Sherrif F.; Tu, John H.			Nevus sebaceus of Jadassohn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ibrahim, Sherrif F.; Tu, John H.] Univ Rochester, Rochester, NY 14642 USA	University of Rochester	Ibrahim, SF (corresponding author), Univ Rochester, 601 Elmwood Ave, Rochester, NY 14642 USA.	sherrif_ibrahim@umc.rochester.edu	Ibrahim, Sherrif/AAI-2946-2021						0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					E20	E20		10.1056/NEJMicm071445	http://dx.doi.org/10.1056/NEJMicm071445			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450599				2022-12-28	WOS:000255387900010
J	Guyatt, GH; Oxman, AD; Vist, GE; Kunz, R; Falck-Ytter, Y; Alonso-Coello, P; Schunemann, HJ				Guyatt, Gordon H.; Oxman, Andrew D.; Vist, Gunn E.; Kunz, Regina; Falck-Ytter, Yngve; Alonso-Coello, Pablo; Schuenemann, Holger J.		GRADE Working Grp	GRADE: an emerging consensus on rating quality of evidence and strength of recommendations	BRITISH MEDICAL JOURNAL			English	Editorial Material							ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; TRIAL; PREVENTION; THERAPY; DISEASE		[Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Oxman, Andrew D.; Vist, Gunn E.] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Kunz, Regina] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Falck-Ytter, Yngve] Case Western Reserve Univ, Case Med Ctr, Div Gastroenterol, Cleveland, OH 44106 USA; [Alonso-Coello, Pablo] Univ Autonoma Barcelona, Hosp St Pau, Serv Epidemiol Clin & Salud Publ, Iberoamer Cochrane Ctr, Barcelona 08041, Spain; [Schuenemann, Holger J.] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, Rome, Italy	McMaster University; Norwegian Knowledge Centre for Health Services; University of Basel; Case Western Reserve University; Autonomous University of Barcelona	Guyatt, GH (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Oxman, Andrew/Y-3004-2019; Yngve Falck-Ytter, AGAF/AAC-5362-2019; Djulbegovic, Benjamin/I-3661-2012; Falck-Ytter, Yngve/GZH-0993-2022; Fervers, Béatrice/AAD-1847-2022; Whittington, Craig/B-1380-2008	Oxman, Andrew/0000-0002-5608-5061; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Djulbegovic, Benjamin/0000-0003-0671-1447; Fervers, Béatrice/0000-0003-3498-6499; Whittington, Craig/0000-0002-1950-0334; Schunemann, Holger/0000-0003-3211-8479; Flottorp, Signe/0000-0003-2961-7461; Tuut, Mariska/0000-0002-0880-6215				ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Committee on Infectious Disease AAoP, 1982, PEDIATRICS, V69, P810; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; GRADY D, 1992, ANN INTERN MED, V117, P1038; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Lacchetti C., 2002, USERS GUIDES MED LIT; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321	9	10197	10562	12	290	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					924	926		10.1136/bmj.39489.470347.AD	http://dx.doi.org/10.1136/bmj.39489.470347.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18436948	Green Accepted, Green Published			2022-12-28	WOS:000255540900028
J	Hall, LJ; Coluci, VR; Galvao, DS; Kozlov, ME; Zhang, M; Dantas, SO; Baughman, RH				Hall, Lee J.; Coluci, Vitor R.; Galvao, Douglas S.; Kozlov, Mikhail E.; Zhang, Mei; Dantas, Socrates O.; Baughman, Ray H.			Sign change of Poisson's ratio for carbon nanotube sheets	SCIENCE			English	Article							NETWORK; MECHANICS; BUNDLES; PAPER	Most materials shrink laterally like a rubber band when stretched, so their Poisson's ratios are positive. Likewise, most materials contract in all directions when hydrostatically compressed and decrease density when stretched, so they have positive linear compressibilities. We found that the in- plane Poisson's ratio of carbon nanotube sheets ( buckypaper) can be tuned from positive to negative by mixing single- walled and multiwalled nanotubes. Density- normalized sheet toughness, strength, and modulus were substantially increased by this mixing. A simple model predicts the sign and magnitude of Poisson's ratio for buckypaper from the relative ease of nanofiber bending and stretch, and explains why the Poisson's ratios of ordinary writing paper are positive and much larger. Theory also explains why the negative in- plane Poisson's ratio is associated with a large positive Poisson's ratio for the sheet thickness, and predicts that hydrostatic compression can produce biaxial sheet expansion. This tunability of Poisson's ratio can be exploited in the design of sheet- derived composites, artificial muscles, gaskets, and chemical and mechanical sensors.	[Hall, Lee J.; Kozlov, Mikhail E.; Zhang, Mei; Baughman, Ray H.] Univ Texas Dallas, MacDiarmid NanoTech Inst, Richardson, TX 75083 USA; [Coluci, Vitor R.; Galvao, Douglas S.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083970 Campinas, SP, Brazil; [Dantas, Socrates O.] UFJF, Dept Fis, BR-36036330 Juiz De Fora, Minas Gerais, Brazil	University of Texas System; University of Texas Dallas; Universidade Estadual de Campinas; Universidade Federal de Juiz de Fora	Baughman, RH (corresponding author), Univ Texas Dallas, MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Coluci, Vitor R/E-1079-2012; Han, Jinhua/F-9464-2010; Baughman, Ray/A-8628-2018; Galvao, Douglas/J-6017-2013	Coluci, Vitor R/0000-0001-5179-6182; Baughman, Ray/0000-0001-5845-5137; Galvao, Douglas/0000-0003-0145-8358				Astrom JA, 2000, J APPL PHYS, V88, P5056, DOI 10.1063/1.1315622; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; BOAL DH, 1993, PHYS REV E, V48, P4274, DOI 10.1103/PhysRevE.48.4274; Bowick M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148103; BREZINSKI JP, 1982, TAPPI, V65, P114; Bronkhorst CA, 2003, INT J SOLIDS STRUCT, V40, P5441, DOI 10.1016/S0020-7683(03)00281-6; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; Cumings J, 2000, SCIENCE, V289, P602, DOI 10.1126/science.289.5479.602; Delince M, 2004, ACTA MATER, V52, P1013, DOI 10.1016/j.actamat.2003.10.035; DiBiasio CM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2741144; EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0; GIBSON LJ, 1981, P ROY SOC LOND A MAT, V377, P99, DOI 10.1098/rspa.1981.0117; GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088; Kis A, 2004, NAT MATER, V3, P153, DOI 10.1038/nmat1076; Lakes R, 2001, NATURE, V414, P503, DOI 10.1038/35107190; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; MILTON GW, 1992, J MECH PHYS SOLIDS, V40, P1105, DOI 10.1016/0022-5096(92)90063-8; Nikolaev P, 1999, CHEM PHYS LETT, V313, P91, DOI 10.1016/S0009-2614(99)01029-5; PERKINS RW, 1980, PAP SCI TECHN CUTT E, P89; Rinzler AG, 1998, APPL PHYS A-MATER, V67, P29, DOI 10.1007/s003390050734; UESAKA T, 1979, TAPPI, V62, P111; Yakobson BI, 2006, J NANOPART RES, V8, P105, DOI 10.1007/s11051-005-8335-3; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Yudasaka M, 2001, NANO LETT, V1, P487, DOI 10.1021/nl010037x; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhou W, 2004, APPL PHYS LETT, V84, P2172, DOI 10.1063/1.1689405	27	210	216	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					504	507		10.1126/science.1149815	http://dx.doi.org/10.1126/science.1149815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18440923				2022-12-28	WOS:000255249300043
J	Ajani, JA; Winter, KA; Gunderson, LL; Pedersen, J; Benson, AB; Thomas, CR; Mayer, RJ; Haddock, MG; Rich, TA; Willett, C				Ajani, Jaffer A.; Winter, Kathryn A.; Gunderson, Leonard L.; Pedersen, John; Benson, Al B., III; Thomas, Charles R., Jr.; Mayer, Robert J.; Haddock, Michael G.; Rich, Tyvin A.; Willett, Christopher			Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SQUAMOUS-CELL CARCINOMA; DOSE RADIATION-THERAPY; EPIDERMOID CARCINOMA; CHEMORADIATION THERAPY; EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; ONCOLOGY-GROUP; PHASE-II; CANCER; 5-FLUOROURACIL	Context Chemoradiation as definitive therapy is the preferred primary therapy for patients with anal canal carcinoma; however, the 5- year disease- free survival rate from concurrent fluorouracil/ mitomycin and radiation is only approximately 65%. Objective To compare the efficacy of cisplatin- based ( experimental) therapy vs mitomycin-based ( standard) therapy in treatment of anal canal carcinoma. Design, Setting, and Participants US Gastrointestinal Intergroup trial RTOG 9811, a multicenter, phase 3, randomized controlled trial comparing treatment with fluorouracil plus mitomycin and radiotherapy vs treatment with fluorouracil plus cisplatin and radiotherapy in 682 patients with anal canal carcinoma enrolled between October 31, 1998, and June 27, 2005. Stratifications included sex, clinical nodal status, and tumor diameter. Intervention Participants were randomly assigned to 1 of 2 intervention groups: ( 1) the mitomycin- based group ( n= 341), who received fluorouracil ( 1000 mg/ m(2) on days 1- 4 and 29- 32) plus mitomycin ( 10 mg/ m2 on days 1 and 29) and radiotherapy ( 45- 59 Gy) or ( 2) the cisplatin- based group ( n= 341), who received fluorouracil ( 1000 mg/ m2 on days 1- 4, 29- 32, 57- 60, and 85- 88) plus cisplatin ( 75 mg/ m2 on days 1, 29, 57, and 85) and radiotherapy ( 45- 59 Gy; start day= day 57). Main Outcome Measures The primary end point was 5- year disease- free survival; secondary end points were overall survival and time to relapse. Results A total of 644 patients were assessable. The median follow- up for all patients was 2.51 years. Median age was 55 years, 69% were women, 27% had a tumor diameter greater than 5 cm, and 26% had clinically positive nodes. The 5- year disease- free survival rate was 60% ( 95% confidence interval [ CI], 53%- 67%) in the mitomycin- based group and 54% ( 95% CI, 46%- 60%) in the cisplatin- based group ( P=. 17). The 5- year overall survival rate was75%( 95% CI, 67%- 81%) in the mitomycin-based group and 70% ( 95% CI, 63%- 76%) in the cisplatin- based group ( P=. 10). The 5- year local- regional recurrence and distant metastasis rates were 25% ( 95% CI, 20%-30%) and 15% ( 95% CI, 10%- 20%), respectively, for mitomycin- based treatment and 33%( 95% CI, 27%- 40%) and 19%( 95% CI, 14%- 24%), respectively, for cisplatin-based treatment. The cumulative rate of colostomy was significantly better for mitomycin-based than cisplatin- based treatment ( 10% vs 19%; P=. 02). Severe hematologic toxicity was worse with mitomycin- based treatment ( P <. 001). Conclusions In this population of patients with anal canal carcinoma, cisplatin-based therapy failed to improve disease- free- survival compared with mitomycinbased therapy, but cisplatin- based therapy resulted in a significantly worse colostomy rate. These findings do not support the use of cisplatin in place of mitomycin in combination with fluorouracil and radiotherapy in the treatment of anal canal carcinoma. Trial Registration clinicaltrials. gov Identifier: NCT00003596.	[Ajani, Jaffer A.] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Winter, Kathryn A.] Radiat Therapy Oncol Grp, Philadelphia, PA USA; [Gunderson, Leonard L.] Mayo Clin, Scottsdale, AZ USA; [Pedersen, John] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Benson, Al B., III] Northwestern Univ, Chicago, IL 60611 USA; [Thomas, Charles R., Jr.] Univ Oregon, Portland, OR USA; [Mayer, Robert J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Haddock, Michael G.] Mayo Clin, Rochester, MN USA; [Rich, Tyvin A.] Univ Virginia, Charlottesville, VA USA; [Willett, Christopher] Duke Univ, Durham, NC USA	University of Texas System; UTMD Anderson Cancer Center; Radiation Therapy Oncology Group (RTOG); Mayo Clinic; Mayo Clinic Phoenix; University of Alberta; Northwestern University; University of Oregon; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; University of Virginia; Duke University	Ajani, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, 1515 Holcombe Blvd,Mail Stop 426, Houston, TX 77030 USA.	jajani@mdanderson.org			NATIONAL CANCER INSTITUTE [U10CA032115, U10CA037422, U10CA021661] Funding Source: NIH RePORTER; NCI NIH HHS [U10 CA37422, U10 CA21661, U10 CA32115] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allal AS, 1999, CANCER, V86, P405, DOI 10.1002/(SICI)1097-0142(19990801)86:3<405::AID-CNCR7>3.0.CO;2-Q; Arnott SJ, 1996, LANCET, V348, P1049; Bartelink H, 1997, J CLIN ONCOL, V15, P2040, DOI 10.1200/JCO.1997.15.5.2040; BOMAN BM, 1984, CANCER-AM CANCER SOC, V54, P114, DOI 10.1002/1097-0142(19840701)54:1<114::AID-CNCR2820540124>3.0.CO;2-P; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; COX JD, 1995, INT J RADIAT ONCOL, V31, P1341, DOI 10.1016/0360-3016(95)00060-C; Cytel Software Corporation, 1992, E SOFTW PACK DES INT; DOCI R, 1992, ANN SURG, V215, P150, DOI 10.1097/00000658-199202000-00010; Flam M, 1996, J CLIN ONCOL, V14, P2527, DOI 10.1200/JCO.1996.14.9.2527; FROST DB, 1984, CANCER, V53, P1285, DOI 10.1002/1097-0142(19840315)53:6<1285::AID-CNCR2820530611>3.0.CO;2-N; Fuchshuber PR, 1997, J AM COLL SURGEONS, V185, P494, DOI 10.1016/S1072-7515(01)00967-X; Gerard JP, 1998, RADIOTHER ONCOL, V46, P249, DOI 10.1016/S0167-8140(97)00192-8; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; GREENALL MJ, 1985, SURG GYNECOL OBSTET, V161, P509; Greene FL, 2002, AJCC CANC STAGING HD; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; JOHN M, 1998, P AM SOC CLIN ONC 5; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KLOTZ RG, 1967, CANCER-AM CANCER SOC, V20, P1727, DOI 10.1002/1097-0142(196710)20:10<1727::AID-CNCR2820201024>3.0.CO;2-1; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Martenson JA, 1996, INT J RADIAT ONCOL, V35, P745, DOI 10.1016/0360-3016(96)00146-0; MEROPOL NJ, 2005, P ASCO GASTR S COMB; National Cancer Institute, 1999, COMM TOX CRIT VERS 2; NIGRO ND, 1983, CANCER, V51, P1826, DOI 10.1002/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PAPILLON J, 1987, DIS COLON RECTUM, V30, P324, DOI 10.1007/BF02555448; Peiffert D, 2001, ANN ONCOL, V12, P397, DOI 10.1023/A:1011107105538; PINTOR MP, 1989, BRIT J SURG, V76, P806, DOI 10.1002/bjs.1800760814; RICH TA, 1993, RADIOTHER ONCOL, V27, P209, DOI 10.1016/0167-8140(93)90076-K; Sato H, 2005, DIS COLON RECTUM, V48, P1301, DOI 10.1007/s10350-004-0934-z; SCHNEIDER TC, 1981, SURGERY, V90, P729; SINGH R, 1981, CANCER, V48, P411, DOI 10.1002/1097-0142(19810715)48:2<411::AID-CNCR2820480232>3.0.CO;2-Z; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	34	618	624	1	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 23	2008	299	16					1914	1921		10.1001/jama.299.16.1914	http://dx.doi.org/10.1001/jama.299.16.1914			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291AD	18430910	Bronze			2022-12-28	WOS:000255163800025
J	Jhunjhunwala, S; van Zelm, MC; Peak, MM; Cutchin, S; Riblet, R; van Dongen, JJM; Grosveld, FG; Knoch, TA; Murre, C				Jhunjhunwala, Suchit; van Zelm, Menno C.; Peak, Mandy M.; Cutchin, Steve; Riblet, Roy; van Dongen, Jacques J. M.; Grosveld, Frank G.; Knoch, Tobias A.; Murre, Cornelis			The 3D structure of the immunoglobulin heavy-chain locus: Implications for long-range genomic interactions	CELL			English	Article							IN-SITU HYBRIDIZATION; CHROMATIN; ENHANCER; REGION; GENES; REARRANGEMENT; ARCHITECTURE; EXPRESSION; CELLS	The immunoglobulin heavy-chain (Igh) locus is organized into distinct regions that contain multiple variable (V-H), diversity (D-H), joining (J(H)) and constant (C-H) coding elements. How the Igh locus is structured in 3D space is unknown. To probe the topography of the Igh locus, spatial distance distributions were determined between 12 genomic markers that span the entire Igh locus. Comparison of the distance distributions to computer simulations of alternative chromatin arrangements predicted that the Igh locus is organized into compartments containing clusters of loops separated by linkers. Trilateration and triple-point angle measurements indicated the mean relative 3D positions of the V-H, D-H, J(H), and C-H elements, showed compartmentalization and striking conformational changes involving V-H and D-H-J(H) elements during early B cell development. In pro-B cells, the entire repertoire of V-H regions (2 Mbp) appeared to have merged and juxtaposed to the D-H elements, mechanistically permitting long-range genomic interactions to occur with relatively high frequency.	[Grosveld, Frank G.; Knoch, Tobias A.] Erasmus MC, Dept Biophys Genom, NL-3015 GE Rotterdam, Netherlands; [Grosveld, Frank G.; Knoch, Tobias A.] Erasmus MC, Dept Cell Biol & Genet, NL-3015 GE Rotterdam, Netherlands; [Knoch, Tobias A.] Heidelberg Univ, Kirchhoff Inst Phys, Dept Biophys Genom, D-69120 Heidelberg, Germany; [Jhunjhunwala, Suchit; van Zelm, Menno C.; Peak, Mandy M.; Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Cutchin, Steve] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92037 USA; [Riblet, Roy] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [van Dongen, Jacques J. M.] Erasmus MC, Dept Immunol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Ruprecht Karls University Heidelberg; University of California System; University of California San Diego; University of California System; University of California San Diego; Torrey Pines Institute for Molecular Studies, California; Erasmus University Rotterdam; Erasmus MC	Knoch, TA (corresponding author), Erasmus MC, Dept Biophys Genom, Dr Molewaterplein 50, NL-3015 GE Rotterdam, Netherlands.	ta.knoch@taknoch.org; murre@biomail.ucsd.edu	Jhunjhunwala, Suchit/GNH-2256-2022; van Dongen, Jacques J.M./F-8537-2015; van Zelm, Menno C/O-4404-2015	Jhunjhunwala, Suchit/0000-0003-3484-0588; van Dongen, Jacques J.M./0000-0001-7686-0021; van Zelm, Menno C/0000-0003-4161-1919; Cutchin, Steven/0000-0002-6515-1905; van Dongen, Jacques J.M./0000-0002-3650-7087	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023548] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI023548-13, R01 AI023548-18, R01 AI023548-20A2, R01 AI023548-21, R01 AI023548-16, R01 AI023548-19, R01 AI023548-22, R01 AI023548-15, R01 AI023548-17A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Boveri T., 1909, ARCH ZELLFORSCH, V3, P181; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen YW, 2007, J PHYS CHEM B, V111, P7432, DOI 10.1021/jp068963t; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Eivazova ER, 2004, P NATL ACAD SCI USA, V101, P251, DOI 10.1073/pnas.0303919101; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GROSBERG AY, 1997, GIANT MOL, P78; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; HERENDEEN DR, 1992, SCIENCE, V256, P1298, DOI 10.1126/science.1598572; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Knoch TA, 2003, HIGH PERFORMANCE COMPUTING IN SCIENCE AND ENGINEERING'03, P421; Knoch TA, 2000, HIGH PERFORMANCE COMPUTING IN SCIENCE AND ENGINEERING '99, P229; KNOCH TA, 2002, VIVO QUANTIFICATION; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Love VA, 2000, MOL IMMUNOL, V37, P29, DOI 10.1016/S0161-5890(00)00023-7; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; OKADA TA, 1979, CHROMOSOMA, V72, P1, DOI 10.1007/BF00286426; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Paulson JR, 1988, CHROMOSOMES CHROMATI, VIII, P3; PIENTA KJ, 1984, J CELL SCI, P123; Rabl C, 1885, MORPHOL JB, V10, P214; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Rombel I, 1998, COLD SPRING HARB SYM, V63, P157, DOI 10.1101/sqb.1998.63.157; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TRASK BJ, 1991, AM J HUM GENET, V48, P1; WARRINGTON JA, 1994, GENOMICS, V24, P395, DOI 10.1006/geno.1994.1636; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239	41	212	217	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					265	279		10.1016/j.cell.2008.03.024	http://dx.doi.org/10.1016/j.cell.2008.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423198	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000255052000016
J	Chang, RSK; Tse, ACT; Mak, W; Cheung, RTF; Ho, SL				Chang, Richard S. K.; Tse, Alan C. T.; Mak, Windsor; Cheung, Raymond T. F.; Ho, Shu L.			From drugs to delirium	LANCET			English	Editorial Material									[Chang, Richard S. K.; Tse, Alan C. T.; Mak, Windsor; Cheung, Raymond T. F.; Ho, Shu L.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China	University of Hong Kong	Chang, RSK (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, 4-F Professorial Block, Hong Kong, Peoples R China.	richardcsk@gmail.com	Ho, Shu-Leong/AFK-8146-2022; Ho, Shu Leong/C-4136-2009					Meierkord H, 2007, LANCET NEUROL, V6, P329, DOI 10.1016/S1474-4422(07)70074-1; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; THOMAS P, 1992, NEUROLOGY, V42, P104, DOI 10.1212/WNL.42.1.104; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1722	1722		10.1016/S0140-6736(08)60730-8	http://dx.doi.org/10.1016/S0140-6736(08)60730-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486744				2022-12-28	WOS:000256002200030
J	Hatcher, S; Arroll, B				Hatcher, Simon; Arroll, Bruce			Assessment and management of medically unexplained symptoms	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL SOMATIC SYNDROMES; SOMATOFORM DISORDERS; PROSPECTIVE COHORT; PRIMARY-CARE; CHRONIC PAIN; SOMATIZATION; THERAPY; NEUROLOGY; FATIGUE		[Hatcher, Simon] Univ Auckland, Auckland 1, New Zealand; [Arroll, Bruce] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Auckland; University of Auckland	Hatcher, S (corresponding author), Univ Auckland, Private Bag 92019, Auckland 1, New Zealand.	s.hatcher@auckland.ac.nz		Hatcher, Simon/0000-0003-3117-2350				Aggarwal VR, 2006, INT J EPIDEMIOL, V35, P468, DOI 10.1093/ije/dyi265; Asano E, 2005, EPILEPSY RES, V66, P129, DOI 10.1016/j.eplepsyres.2005.07.012; Barsky AJ, 2005, ARCH GEN PSYCHIAT, V62, P903, DOI 10.1001/archpsyc.62.8.903; Carson AJ, 2003, J NEUROL NEUROSUR PS, V74, P897, DOI 10.1136/jnnp.74.7.897; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P207, DOI 10.1136/jnnp.68.2.207; Chen DK, 2005, NEUROLOGY, V65, P668, DOI 10.1212/01.wnl.0000178391.96957.d0; Craig TKJ, 2002, PSYCHOL MED, V32, P805, DOI 10.1017/S0033291702005846; Creed F, 2004, J PSYCHOSOM RES, V56, P391, DOI 10.1016/S0022-3999(03)00622-6; Crimlisk HL, 1998, BRIT MED J, V316, P582, DOI 10.1136/bmj.316.7131.582; FINK P, 1992, PSYCHOL MED, V22, P173, DOI 10.1017/S0033291700032827; GOULD R, 1986, J NERV MENT DIS, V174, P593, DOI 10.1097/00005053-198610000-00003; GUTHRIE E, 1993, BRIT J PSYCHIAT, V163, P315, DOI 10.1192/bjp.163.3.315; Hamilton WT, 2005, FAM PRACT, V22, P383, DOI 10.1093/fampra/cmi021; Hatcher S, 2003, PSYCHOL MED, V33, P1185, DOI 10.1017/S0033291703008274; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Howard L, 2005, J NEUROL NEUROSUR PS, V76, P1558, DOI 10.1136/jnnp.2004.057851; Khan AA, 2003, PSYCHOSOMATICS, V44, P471, DOI 10.1176/appi.psy.44.6.471; Kouyanou K, 1997, PSYCHOSOM MED, V59, P597, DOI 10.1097/00006842-199711000-00007; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; Kroenke K, 2007, PSYCHOSOM MED, V69, P881, DOI 10.1097/PSY.0b013e31815b00c4; Kroenke K, 2007, PSYCHOSOMATICS, V48, P277, DOI 10.1176/appi.psy.48.4.277; McGonigal A, 2002, J NEUROL NEUROSUR PS, V72, P549; Minhas FA, 2006, INT REV PSYCHIATR, V18, P55, DOI 10.1080/09540260500466949; O'Malley PG, 1999, J FAM PRACTICE, V48, P980; Petrie KJ, 2007, BRIT MED J, V334, P352, DOI 10.1136/bmj.39093.464190.55; Salmon P, 1999, BRIT MED J, V318, P372, DOI 10.1136/bmj.318.7180.372; Salmon P, 2007, PSYCHOSOM MED, V69, P571, DOI 10.1097/PSY.0b013e3180cabc85; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; SMITH GR, 1995, ARCH GEN PSYCHIAT, V52, P238; Sollner W, 2001, Z PSYCHOSOM MED PSYC, V47, P115; Stone J, 2005, BRIT MED J, V331, P989, DOI 10.1136/bmj.38628.466898.55; Stone J, 2003, J NEUROL NEUROSUR PS, V74, P591, DOI 10.1136/jnnp.74.5.591; Sumathipala A, 2000, PSYCHOL MED, V30, P747, DOI 10.1017/S0033291799002160; TAYLOR DC, 1986, BRIT J PSYCHIAT, V149, P37, DOI 10.1192/bjp.149.1.37; Viner R, 2005, BMJ-BRIT MED J, V330, P1012, DOI 10.1136/bmj.330.7498.1012; Vuilleumier P, 2005, PROG BRAIN RES, V150, P309, DOI 10.1016/S0079-6123(05)50023-2; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Ziv I, 1998, J NEUROL, V245, P797, DOI 10.1007/s004150050289; 2006, NY TIMES        0926; 2005, DAILY MAIL      0721	41	110	112	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1124	1128		10.1136/bmj.39554.592014.BE	http://dx.doi.org/10.1136/bmj.39554.592014.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483055	Green Published			2022-12-28	WOS:000255975100042
J	Papp, KA; Langley, RG; Lebwohl, M; Krueger, GG; Szapary, P; Yeilding, N; Guzzo, C; Hsu, MC; Wang, YH; Li, S; Dooley, LT; Reich, K				Papp, Kim A.; Langley, Richard G.; Lebwohl, Mark; Krueger, Gerald G.; Szapary, Philippe; Yeilding, Newman; Guzzo, Cynthia; Hsu, Ming-Chun; Wang, Yuhua; Li, Shu; Dooley, Lisa T.; Reich, Kristian		PHOENIX 2 Investigators	Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)	LANCET			English	Article							PATHOGENESIS; THERAPY; IL-12	Background Ustekinumab, a human monoclonal antibody against interleukins 12 and 23, has shown therapeutic potential for psoriasis. This study assessed the efficacy and safety of ustekinumab in psoriasis patients and assessed dosing intensification in partial responders. Methods In this multicentre, phase III, double-blind, placebo-controlled study, 1230 patients with moderate-to-severe psoriasis (defined by a psoriasis area and severity index [PASI] score >= 12, and at least 10% total body surface area involvement) were randomly assigned to receive ustekinumab 45 mg (n=409) or 90 mg (n=411) at weeks 0 and 4, then every 12 weeks, or placebo (n=410). Partial responders (ie, patients achieving >= 50% but < 75% improvement from baseline in PASI) were re-randomised at week 28 to continue dosing every 12 weeks or escalate to dosing every 8 weeks. Both randomisations were done with a minimisation method via a centralised interactive voice response. The primary endpoint was the proportion of patients achieving at least 75% improvement in PASI (PASI 75) at week 12. Analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00307437. Findings All randomised patients were included in the efficacy analysis. 273 (66.7%) patients receiving ustekinumab 45 mg, 311 (75.7%) receiving ustekinumab 90 mg, and 15 (3.7%) receiving placebo achieved the primary endpoint (difference in response rate 63.1%, 95% CI 58.2-68.0, p < 0.0001 for the 45 mg group vs placebo and 72.0% 67.5-76.5, p < 0.0001 for the 90 mg group vs placebo). More partial responders at week 28 who received ustekinumab 90 mg every 8 weeks achieved PASI 75 at week 52 than did those who continued to receive the same dose every 12 weeks (22 [68.8%] vs 11 [33.3%]; difference in response rate 35.4%, 95% CI 12.7-58.1, p=0.004). There was no such response to changes in dosing intensity in partial responders treated with ustekinumab 45 mg. During the placebo-controlled phase, 217 (53.1%) patients in the 45 mg group, 197 (47.9%) in the 90 mg group, and 204 (49.8%) in the placebo group experienced adverse events; serious adverse events were seen in eight (2.0%) patients in the 45 mg group, five (1.2%) in the 90 mg group, and eight (2.0%) in the placebo group. Interpretation Although treatment with ustekinumab every 12 weeks is effective for most patients with moderate-to-severe psoriasis, intensification of dosing to once every 8 weeks with ustekinumab 90 mg might be necessary to elicit a full response in patients who only partially respond to the initial regimen.	[Papp, Kim A.] Prob Med Res Inc, Waterloo, ON N2J 1C4, Canada; [Papp, Kim A.] Univ Western Ontario, London, ON, Canada; [Langley, Richard G.] Dalhousie Univ, Halifax, NS, Canada; [Lebwohl, Mark] Mt Sinai Sch Med, New York, NY USA; [Krueger, Gerald G.] Univ Utah, Salt Lake City, UT USA; [Szapary, Philippe; Yeilding, Newman; Guzzo, Cynthia; Hsu, Ming-Chun; Wang, Yuhua; Li, Shu; Dooley, Lisa T.] Centocor Inc, Malvern, PA 19355 USA; [Reich, Kristian] Dermatologikum Hamburg, Hamburg, Germany	Probity Medical Research Inc; Western University (University of Western Ontario); Dalhousie University; Icahn School of Medicine at Mount Sinai; Utah System of Higher Education; University of Utah; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Dermatologikum Hamburg	Papp, KA (corresponding author), Prob Med Res Inc, 135 Union St E, Waterloo, ON N2J 1C4, Canada.	kapapp@probitymedical.com		Vender, Ronald/0000-0002-2624-2724; Papp, Kim A./0000-0001-9557-3642				Carlin CS, 2004, J AM ACAD DERMATOL, V50, P859, DOI 10.1016/j.jaad.2003.09.014; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Geng D, 2005, J PHARMACEUT BIOMED, V39, P364, DOI 10.1016/j.jpba.2005.04.045; GOTTLIEB A, 2007, AM COLL RHEUM ANN M; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Hong K, 1999, J IMMUNOL, V162, P7480; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Richards HL, 2006, J EUR ACAD DERMATOL, V20, P370, DOI 10.1111/j.1468-3083.2006.01565.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Zaghloul SS, 2004, ARCH DERMATOL, V140, P408, DOI 10.1001/archderm.140.4.408	21	1101	1152	1	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1675	1684		10.1016/S0140-6736(08)60726-6	http://dx.doi.org/10.1016/S0140-6736(08)60726-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486740				2022-12-28	WOS:000256002200026
J	Martinvalet, D; Dykxhoorn, DM; Ferrini, R; Lieberman, J				Martinvalet, Denis; Dykxhoorn, Derek M.; Ferrini, Roger; Lieberman, Judy			Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death	CELL			English	Article							BOVINE HEART-MITOCHONDRIA; CYTOCHROME-C RELEASE; B-INDUCED APOPTOSIS; MEDIATED APOPTOSIS; OXIDATIVE STRESS; DNA-DAMAGE; ACTIVATION; IMPORT; SUPEROXIDE; SUBUNITS	The killer lymphocyte protease granzyme A (GzmA) triggers caspase-independent target cell death with morphological features of apoptosis. We previously showed that GzmA acts directly on mitochondria to generate reactive oxygen species (ROS) and disrupt the transmembrane potential (Delta Psi m) but does not permeabilize the mitochondrial outer membrane. Mitochondrial damage is critical to GzmA-induced cell death since cells treated with superoxide scavengers are resistant to GzmA. Here we find that GzmA accesses the mitochondrial matrix to cleave the complex I protein NDUFS3, an iron-sulfur subunit of the NADH: ubiquinone oxidoreductase complex I, after Lys56 to interfere with NADH oxidation and generate superoxide anions. Target cells expressing a cleavage site mutant of NDUFS3 are resistant to GzmA-mediated cell death but remain sensitive to GzmB.	[Martinvalet, Denis; Dykxhoorn, Derek M.; Ferrini, Roger; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Martinvalet, Denis; Dykxhoorn, Derek M.; Ferrini, Roger; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Dykxhoorn, Derek M/D-1357-2015; Lieberman, Judy/A-2717-2015		NHLBI NIH HHS [T32 HL66987, T32 HL066987] Funding Source: Medline; NIAID NIH HHS [R01 AI045587-10, R56 AI045587, R01 AI045587, AI45587] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045587, R01AI045587] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aronis A, 2003, CELL DEATH DIFFER, V10, P335, DOI 10.1038/sj.cdd.4401150; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Beresford PJ, 1998, J IMMUNOL, V161, P161; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Bredemeyer AJ, 2006, J BIOL CHEM, V281, P37130, DOI 10.1074/jbc.M607969200; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; DAUM G, 1982, J BIOL CHEM, V257, P3075; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Geissler A, 2001, MOL CELL BIOL, V21, P7097, DOI 10.1128/MCB.21.20.7097-7104.2001; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Heibein JA, 1999, J IMMUNOL, V163, P4683; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hostetter DR, 2007, J BIOL CHEM, V282, P27865, DOI 10.1074/jbc.M704312200; Huang G, 2007, CELL DEATH DIFFER, V14, P327, DOI 10.1038/sj.cdd.4402004; Johnson H, 2003, BLOOD, V101, P3093, DOI 10.1182/blood-2002-08-2485; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loeb CRK, 2006, J BIOL CHEM, V281, P28326, DOI 10.1074/jbc.M604544200; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Malassagne B, 2001, GASTROENTEROLOGY, V121, P1451, DOI 10.1053/gast.2001.29590; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Papa S, 2000, J BIOENERG BIOMEMBR, V32, P401, DOI 10.1023/A:1005584221456; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; SANDSTROM PA, 1994, J LEUKOCYTE BIOL, V55, P221, DOI 10.1002/jlb.55.2.221; Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Thomas DA, 2001, P NATL ACAD SCI USA, V98, P14985, DOI 10.1073/pnas.261581498; Wang GQ, 2001, J EXP MED, V194, P1325, DOI 10.1084/jem.194.9.1325; Yamaguchi M, 1998, J BIOL CHEM, V273, P8094, DOI 10.1074/jbc.273.14.8094; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhu PC, 2006, EMBO REP, V7, P431, DOI 10.1038/sj.embor.7400622	51	155	160	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					681	692		10.1016/j.cell.2008.03.032	http://dx.doi.org/10.1016/j.cell.2008.03.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485875	Green Accepted, Bronze			2022-12-28	WOS:000255903300022
J	Brook, RD				Brook, Robert D.			Potential health risks of air pollution beyond triggering acute cardiopulmonary events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; CORONARY ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; PREDICTION; ASSOCIATION; REDUCTION; MORTALITY; EXPOSURE; SMOKING		[Brook, Robert D.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan	Brook, RD (corresponding author), Univ Michigan, Div Cardiovasc Med, 24 Frank Lloyd Wright Dr,POB 322, Ann Arbor, MI 48106 USA.	robdbrok@umich.edu						Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook Robert D, 2007, J Clin Hypertens (Greenwich), V9, P629, DOI 10.1111/j.1524-6175.2007.07187.x; Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70; Brook RD, 2007, NEW ENGL J MED, V356, P2104; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; LOGAN WPD, 1953, LANCET, V264, P336; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; Tofler GH, 2006, CIRCULATION, V114, P1863, DOI 10.1161/CIRCULATIONAHA.105.596189; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zieske AW, 2005, ATHEROSCLEROSIS, V180, P87, DOI 10.1016/j.atherosclerosis.2004.10.039	19	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2194	2196		10.1001/jama.299.18.2194	http://dx.doi.org/10.1001/jama.299.18.2194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18484111				2022-12-28	WOS:000255790000027
J	Harrington, P				Harrington, Pamela			A patient's journey - Obsessive compulsive disorder with associated hypochondriasis	BRITISH MEDICAL JOURNAL			English	Editorial Material												pam.harrington@virgin.net							0	1	2	2	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1070	1071		10.1136/bmj.39555.608252.AD	http://dx.doi.org/10.1136/bmj.39555.608252.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18467416	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000256103300033
J	Sherrill, BM				Sherrill, Bradley M.			Physics - Designer atomic nuclei	SCIENCE			English	Editorial Material									[Sherrill, Bradley M.] Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA	Michigan State University	Sherrill, BM (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA.	sherril2@msu.edu	Sherrill, Bradley M/B-3378-2011; Sherrill, Bradley M/B-4098-2009	Sherrill, Bradley M/0000-0002-5093-8190; 				Bastin B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.022503; Bishop S, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.162501; Dworschak M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.072501; Geesaman DF, 2006, ANNU REV NUCL PART S, V56, P53, DOI 10.1146/annurev.nucl.55.090704.151604; Miernik K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.192501; *NAT RES COUNC RAR, 2007, SCI OPPT RAR IS FAC; Otsuka T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.082502; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; Sanchez R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.033002; Sneden C, 2003, SCIENCE, V299, P70, DOI 10.1126/science.1077506; Tanihata I, 1996, J PHYS G NUCL PARTIC, V22, P157, DOI 10.1088/0954-3899/22/2/004; Walter FM, 2006, NAT PHYS, V2, P443, DOI 10.1038/nphys349	12	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					751	752		10.1126/science.1151836	http://dx.doi.org/10.1126/science.1151836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467576				2022-12-28	WOS:000255644400024
J	Rowan, JA; Hague, WM; Gao, WZ; Battin, MR; Moore, MP				Rowan, Janet A.; Hague, William M.; Gao, Wanzhen; Battin, Malcolm R.; Moore, M. Peter		MiG Trial Investigators	Metformin versus insulin for the treatment of gestational diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYCYSTIC-OVARY-SYNDROME; PREGNANCY OUTCOMES; BIRTH-WEIGHT; WOMEN; MANAGEMENT; MELLITUS; GLYBURIDE; MOTHERS; POPULATION; TRIMESTER	Background: Metformin is a logical treatment for women with gestational diabetes mellitus, but randomized trials to assess the efficacy and safety of its use for this condition are lacking. Methods: We randomly assigned 751 women with gestational diabetes mellitus at 20 to 33 weeks of gestation to open treatment with metformin (with supplemental insulin if required) or insulin. The primary outcome was a composite of neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity. The trial was designed to rule out a 33% increase (from 30% to 40%) in this composite outcome in infants of women treated with metformin as compared with those treated with insulin. Secondary outcomes included neonatal anthropometric measurements, maternal glycemic control, maternal hypertensive complications, postpartum glucose tolerance, and acceptability of treatment. Results: Of the 363 women assigned to metformin, 92.6% continued to receive metformin until delivery and 46.3% received supplemental insulin. The rate of the primary composite outcome was 32.0% in the group assigned to metformin and 32.2% in the insulin group (relative risk, 1.00; 95% confidence interval, 0.90 to 1.10). More women in the metformin group than in the insulin group stated that they would choose to receive their assigned treatment again (76.6% vs. 27.2%, P<0.001). The rates of other secondary outcomes did not differ significantly between the groups. There were no serious adverse events associated with the use of metformin. Conclusions: In women with gestational diabetes mellitus, metformin (alone or with supplemental insulin) is not associated with increased perinatal complications as compared with insulin. The women preferred metformin to insulin treatment. (Australian New Zealand Clinical Trials Registry number, 12605000311651.).	[Rowan, Janet A.] Auckland City Hosp, Auckland, New Zealand; [Gao, Wanzhen] Auckland Univ Technol, Fac Hlth & Environm Sci, Natl Inst Publ Hlth & Mental Hlth Res, Auckland, New Zealand; [Battin, Malcolm R.] Univ Auckland, Auckland City Hosp, Dept Pediat, Auckland 1, New Zealand; [Moore, M. Peter] Christchurch Hosp, Ctr Diabet, Christchurch, New Zealand; [Hague, William M.] Univ Adelaide, Womens & Childrens Hosp, Dept Obstet, Adelaide, SA, Australia	Auckland City Hospital; Auckland University of Technology; Auckland City Hospital; University of Auckland; Christchurch Hospital New Zealand; University of Adelaide; Womens & Childrens Hospital Australia	Rowan, JA (corresponding author), Auckland City Hosp, SMO Room,9th Floor Support Bldg, Auckland, New Zealand.	jrowan@internet.co.nz	Lust, Karin/M-4037-2013; McIntyre, Harold D/F-1888-2010	McIntyre, Harold D/0000-0001-8819-5794				Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; Charles B, 2006, THER DRUG MONIT, V28, P67, DOI 10.1097/01.ftd.0000184161.52573.0e; COETZEE E J, 1985, Diabetes Research and Clinical Practice, V1, P281, DOI 10.1016/S0168-8227(86)80036-5; COETZEE EJ, 1979, DIABETOLOGIA, V16, P241, DOI 10.1007/BF01221950; COETZEE EJ, 1980, S AFR MED J, V58, P795; COETZEE EJ, 1984, S AFR MED J, V65, P635; Conway D L, 2004, J Matern Fetal Neonatal Med, V15, P51; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Ferrara A, 2004, OBSTET GYNECOL, V103, P799; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Gilbert C, 2006, FERTIL STERIL, V86, P658, DOI 10.1016/j.fertnstert.2006.02.098; Glueck CJ, 2004, HUM REPROD, V19, P1323, DOI 10.1093/humrep/deh263; Glueck CJ, 2002, HUM REPROD, V17, P2858, DOI 10.1093/humrep/17.11.2858; Glueck CJ, 2001, FERTIL STERIL, V75, P46, DOI 10.1016/S0015-0282(00)01666-6; Glueck CJ, 2004, DIABETIC MED, V21, P829, DOI 10.1111/j.1464-5491.2004.01251.x; Gutzin Sheryl J, 2003, Can J Clin Pharmacol, V10, P179; Hague WM, 2003, BMJ-BRIT MED J, V326, P762; Hawthorne G, 2006, DIABETIC MED, V23, P223, DOI 10.1111/j.1464-5491.2006.01856.x; Hellmuth E, 2000, DIABETIC MED, V17, P507, DOI 10.1046/j.1464-5491.2000.00314.x; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Hughes RCE, 2006, DIABETIC MED, V23, P318, DOI 10.1111/j.1464-5491.2006.01750.x; Jacobson GF, 2005, AM J OBSTET GYNECOL, V193, P118, DOI 10.1016/j.ajog.2005.03.018; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; Langer O, 2000, NEW ENGL J MED, V343, P1134, DOI 10.1056/NEJM200010193431601; McCowan L, 2004, AUST NZ J OBSTET GYN, V44, P428, DOI 10.1111/j.1479-828X.2004.00272.x; Rochon M, 2006, AM J OBSTET GYNECOL, V195, P1090, DOI 10.1016/j.ajog.2006.07.029; Ross S., 2007, AM J OBSTET GYNECOL, V196, pe1, DOI DOI 10.1016/J.AJ0G.2006.10.903; Ross S, 2007, AM J OBSTET GYNECOL, V196, p[119, e1]; Rowan JA, 2007, DIABETES CARE, V30, pS214, DOI 10.2337/dc07-s219; Schaefer-Graf UM, 2005, DIABETES CARE, V28, P1745, DOI 10.2337/diacare.28.7.1745; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347	35	554	599	1	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2003	2015		10.1056/NEJMoa0707193	http://dx.doi.org/10.1056/NEJMoa0707193			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463376	Bronze			2022-12-28	WOS:000255577700004
J	Chaitman, BR; Fromer, M				Chaitman, Bernard R.; Fromer, Martin			Should ECG be required in young athletes?	LANCET			English	Editorial Material							OF-CARDIOLOGY; SUDDEN-DEATH; PREPARTICIPATION; ELECTROCARDIOGRAM; ABNORMALITIES; STATEMENT; HEART		[Chaitman, Bernard R.] St Louis Univ, Sch Med, Dept Med, Div Cardiol, St Louis, MO 63117 USA; [Fromer, Martin] Univ Hosp CHUV, Dept Med, Serv Cardiol, Arrhythmia Unit, Lausanne, Switzerland	Saint Louis University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Chaitman, BR (corresponding author), St Louis Univ, Sch Med, Dept Med, Div Cardiol, St Louis, MO 63117 USA.	chaitman@slu.edu						Atchley AE, 2007, CARDIOL CLIN, V25, P371, DOI 10.1016/j.ccl.2007.06.009; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; FERST JA, 1984, SPORTS MED, V1, P390, DOI 10.2165/00007256-198401050-00004; *IOC MED COMM, 2004, SUDD CARD DEATH SPOR; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; Pelliccia A, 2000, CIRCULATION, V102, P278; Pelliccia A, 2008, NEW ENGL J MED, V358, P152, DOI 10.1056/NEJMoa060781; Pelliccia A, 2007, EUR HEART J, V28, P2703, DOI 10.1093/eurheartj/ehm455	12	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1489	1490		10.1016/S0140-6736(08)60636-4	http://dx.doi.org/10.1016/S0140-6736(08)60636-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456088	Green Published			2022-12-28	WOS:000255668300009
J	Guyatt, GH; Oxman, AD; Vist, GE; Kunz, R; Falck-Ytter, Y; Schunemann, H				Guyatt, Gordon H.; Oxman, Andrew D.; Vist, Gunn E.; Kunz, Regina; Falck-Ytter, Yngve; Schunemann, Holger		GRADE Working Grp	GRADE: what is "quality of evidence" and why is it important to clinicians?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; END-POINT; CONTROLLED-TRIAL; ADEQUATE RELIEF; PLACEBO; WOMEN; PERFORMANCE; IMPROVEMENT; VALIDATION; GUIDELINES		[Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Vist, Gunn E.] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Kunz, Regina] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Falck-Ytter, Yngve] Case Western Reserve Univ, Div Gastroenterol, Case Med Ctr, Cleveland, OH 44106 USA; [Schunemann, Holger] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, Rome, Italy	McMaster University; Norwegian Knowledge Centre for Health Services; University of Basel; Case Western Reserve University	Guyatt, GH (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Room 2C12,1200 Main St, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Djulbegovic, Benjamin/I-3661-2012; Whittington, Craig/B-1380-2008; Falck-Ytter, Yngve/GZH-0993-2022; Fervers, Béatrice/AAD-1847-2022; Oxman, Andrew/Y-3004-2019; Yngve Falck-Ytter, AGAF/AAC-5362-2019	Djulbegovic, Benjamin/0000-0003-0671-1447; Whittington, Craig/0000-0002-1950-0334; Fervers, Béatrice/0000-0003-3498-6499; Oxman, Andrew/0000-0002-5608-5061; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Flottorp, Signe/0000-0003-2961-7461; Schunemann, Holger/0000-0003-3211-8479; Tuut, Mariska/0000-0002-0880-6215				Allan LG, 2002, EVAL HEALTH PROF, V25, P410, DOI 10.1177/0163278702238054; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Benedetti F, 2005, J NEUROSCI, V25, P10390, DOI 10.1523/JNEUROSCI.3458-05.2005; Bengtsson M, 2006, PATIENT EDUC COUNS, V62, P118, DOI 10.1016/j.pec.2005.06.015; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Camilleri M, 2007, CLIN GASTROENTEROL H, V5, P534, DOI 10.1016/j.cgh.2007.03.004; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; DESAINTONGE DMC, 1994, LANCET, V344, P995, DOI 10.1016/S0140-6736(94)91647-0; Drossman DA, 2003, GASTROENTEROLOGY, V125, P19, DOI 10.1016/S0016-5085(03)00669-3; Drossman DA, 2000, AM J GASTROENTEROL, V95, P999; FLETCHER SW, 1980, ANN INTERN MED, V92, P253, DOI 10.7326/0003-4819-92-2-253; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Gordon S, 2003, DIGEST DIS SCI, V48, P1317, DOI 10.1023/A:1024159226274; Guyatt G., 2015, USERS GUIDES MED LIT; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Hrobjartsson A, 2002, J CLIN EPIDEMIOL, V55, P430, DOI 10.1016/S0895-4356(01)00496-6; Inadomi JM, 2003, ALIMENT PHARM THER, V18, P671, DOI 10.1046/j.1365-2036.2003.t01-1-01736.x; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Karanicolas PJ, 2007, ANN SURG ONCOL, V14, P1825, DOI 10.1245/s10434-006-9330-3; Keefer L, 2001, BEHAV RES THER, V39, P801, DOI 10.1016/S0005-7967(00)00078-4; Kleinhenz J, 1999, PAIN, V83, P235, DOI 10.1016/S0304-3959(99)00107-4; Lang EV, 2000, LANCET, V355, P1486, DOI 10.1016/S0140-6736(00)02162-0; Lembo T, 2001, AM J GASTROENTEROL, V96, P2662; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mangel AW, 2006, ALIMENT PHARM THERAP, V23, P879, DOI 10.1111/j.1365-2036.2006.02839.x; Mangel AW, 1998, J INT MED RES, V26, P76, DOI 10.1177/030006059802600203; MILLER FG, 2008, IN PRESS J ROY SOC M; MITCHELL CM, 1987, GASTROENTEROLOGY, V92, P1282, DOI 10.1016/S0016-5085(87)91099-7; MONCHER FJ, 1991, CLIN PSYCHOL REV, V11, P247, DOI 10.1016/0272-7358(91)90103-2; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Novick J, 2002, ALIMENT PHARM THER, V16, P1877, DOI 10.1046/j.1365-2036.2002.01372.x; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; OXMAN AD, 1988, CAN MED ASSOC J, V138, P697; PACHECOLOPEZ G, 2006, BRAIN BEHAV IMMUNOL, P403; Patel SM, 2005, NEUROGASTROENT MOTIL, V17, P332, DOI 10.1111/j.1365-2982.2005.00650.x; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Schunemann HJ, 2006, HEALTH RES POLICY SY, P4; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; Thompson WG, 1999, GUT, V45, P43; Vanner SJ, 1999, AM J GASTROENTEROL, V94, P2912	43	1811	1872	1	72	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2008	336	7651					995	999B		10.1136/bmj.39490.551019.BE	http://dx.doi.org/10.1136/bmj.39490.551019.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300EZ	18456631	Green Published			2022-12-28	WOS:000255808400041
J	Zhu, JK				Zhu, Jian-Kang			Epigenome sequencing comes of age	CELL			English	Editorial Material							DNA METHYLATION; ARABIDOPSIS GENOME; GLYCOSYLASE/LYASE; ROS1	Epigenetic states are responsive to developmental and environmental signals, and as a consequence a eukaryotic cell can have many different epigenomes. In this issue of Cell, Lister et al. (2008) present the floral epigenome of Arabidopsis using next-generation sequencing technology to analyze both DNA methylation at single-base resolution and the expression of small RNAs.	Univ Calif Riverside, Riverside, CA 92508 USA	University of California System; University of California Riverside	Zhu, JK (corresponding author), Univ Calif Riverside, Riverside, CA 92508 USA.	jian-kang.zhu@ucr.edu	Zhu, Jian-Kang/F-7658-2011	Zhu, Jian-Kang/0000-0001-5134-731X	NIGMS NIH HHS [R01 GM059138-15, R01 GM070795-09, R01 GM070795, R01 GM059138] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070795, R01GM059138] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	10	54	65	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					395	397		10.1016/j.cell.2008.04.016	http://dx.doi.org/10.1016/j.cell.2008.04.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455978	Green Accepted, Bronze			2022-12-28	WOS:000255503900008
J	Kidd, JM; Cooper, GM; Donahue, WF; Hayden, HS; Sampas, N; Graves, T; Hansen, N; Teague, B; Alkan, C; Antonacci, F; Haugen, E; Zerr, T; Yamada, NA; Tsang, P; Newman, TL; Tuzun, E; Cheng, Z; Ebling, HM; Tusneem, N; David, R; Gillett, W; Phelps, KA; Weaver, M; Saranga, D; Brand, A; Tao, W; Gustafson, E; McKernan, K; Chen, L; Malig, M; Smith, JD; Korn, JM; McCarroll, SA; Altshuler, DA; Peiffer, DA; Dorschner, M; Stamatoyannopoulos, J; Schwartz, D; Nickerson, DA; Mullikin, JC; Wilson, RK; Bruhn, L; Olson, MV; Kaul, R; Smith, DR; Eichler, EE				Kidd, Jeffrey M.; Cooper, Gregory M.; Donahue, William F.; Hayden, Hillary S.; Sampas, Nick; Graves, Tina; Hansen, Nancy; Teague, Brian; Alkan, Can; Antonacci, Francesca; Haugen, Eric; Zerr, Troy; Yamada, N. Alice; Tsang, Peter; Newman, Tera L.; Tuezuen, Eray; Cheng, Ze; Ebling, Heather M.; Tusneem, Nadeem; David, Robert; Gillett, Will; Phelps, Karen A.; Weaver, Molly; Saranga, David; Brand, Adrianne; Tao, Wei; Gustafson, Erik; McKernan, Kevin; Chen, Lin; Malig, Maika; Smith, Joshua D.; Korn, Joshua M.; McCarroll, Steven A.; Altshuler, David A.; Peiffer, Daniel A.; Dorschner, Michael; Stamatoyannopoulos, John; Schwartz, David; Nickerson, Deborah A.; Mullikin, James C.; Wilson, Richard K.; Bruhn, Laurakay; Olson, Maynard V.; Kaul, Rajinder; Smith, Douglas R.; Eichler, Evan E.			Mapping and sequencing of structural variation from eight human genomes	NATURE			English	Article							COPY NUMBER POLYMORPHISM; SEGMENTAL DUPLICATIONS; PREDISPOSES; INVERSION; VARIANTS; REVEALS; MAPS	Genetic variation among individual humans occurs on many different scales, ranging from gross alterations in the human karyotype to single nucleotide changes. Here we explore variation on an intermediate scale - particularly insertions, deletions and inversions affecting from a few thousand to a few million base pairs. We employed a clone- based method to interrogate this intermediate structural variation in eight individuals of diverse geographic ancestry. Our analysis provides a comprehensive overview of the normal pattern of structural variation present in these genomes, refining the location of 1,695 structural variants. We find that 50% were seen in more than one individual and that nearly half lay outside regions of the genome previously described as structurally variant. We discover 525 new insertion sequences that are not present in the human reference genome and show that many of these are variable in copy number between individuals. Complete sequencing of 261 structural variants reveals considerable locus complexity and provides insights into the different mutational processes that have shaped the human genome. These data provide the first high- resolution sequence map of human structural variation - a standard for genotyping platforms and a prelude to future individual genome sequencing projects.	[Kidd, Jeffrey M.; Cooper, Gregory M.; Alkan, Can; Antonacci, Francesca; Zerr, Troy; Newman, Tera L.; Tuezuen, Eray; Cheng, Ze; Weaver, Molly; Chen, Lin; Malig, Maika; Smith, Joshua D.; Dorschner, Michael; Stamatoyannopoulos, John; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kidd, Jeffrey M.; Cooper, Gregory M.; Alkan, Can; Antonacci, Francesca; Zerr, Troy; Newman, Tera L.; Tuezuen, Eray; Cheng, Ze; Weaver, Molly; Chen, Lin; Malig, Maika; Smith, Joshua D.; Dorschner, Michael; Stamatoyannopoulos, John; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Donahue, William F.; Ebling, Heather M.; Tusneem, Nadeem; David, Robert; Saranga, David; Brand, Adrianne; Tao, Wei; Gustafson, Erik; McKernan, Kevin; Smith, Douglas R.] Agencourt Biosci Corp, Beverly, MA 01915 USA; [Hayden, Hillary S.; Haugen, Eric; Gillett, Will; Phelps, Karen A.; Olson, Maynard V.; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Hayden, Hillary S.; Haugen, Eric; Gillett, Will; Phelps, Karen A.; Olson, Maynard V.; Kaul, Rajinder] Univ Washington, Univ Washington Genome Ctr, Seattle, WA 98195 USA; [Sampas, Nick; Yamada, N. Alice; Tsang, Peter; Bruhn, Laurakay] Agilent Technol, Santa Clara, CA 95051 USA; [Graves, Tina; Wilson, Richard K.] Washington Univ, Genome Sequencing Ctr, Sch Med, St Louis, MO 63108 USA; [Hansen, Nancy; Mullikin, James C.] NIH, Human Genome Res Inst, Bethesda, MD 20892 USA; [Teague, Brian; Schwartz, David] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Korn, Joshua M.; McCarroll, Steven A.; Altshuler, David A.] MIT, Broad Inst, Program Med & Populat Genet, Boston, MA 02114 USA; [Korn, Joshua M.; McCarroll, Steven A.; Altshuler, David A.] Harvard Univ, Broad Inst, Boston, MA 02114 USA; [Peiffer, Daniel A.] Illumina Inc, San Diego, CA 92121 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Agilent Technologies; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Illumina	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Antonacci, Francesca/F-5457-2013; Tuzun, Eray/B-5949-2018; Alkan, Can/D-2982-2009; Cooper, Gregory/D-6914-2011; Altshuler, David M/A-4476-2009; McCarroll, Steven A/A-8433-2009; Tuzun, Eray/AAD-7282-2021	Wilson, Richard K./0000-0002-1992-1358; Antonacci, Francesca/0000-0002-5833-6186; Tuzun, Eray/0000-0002-5550-7816; Alkan, Can/0000-0002-5443-0706; Cooper, Gregory/0000-0001-5509-9923; Altshuler, David M/0000-0002-7250-4107; Tuzun, Eray/0000-0002-5550-7816; /0000-0002-9833-2817; Kaul, Rajinder/0000-0002-7895-9284; Kidd, Jeffrey/0000-0002-9631-1465; Haugen, Eric/0000-0001-7444-8981; McKernan, Kevin/0000-0002-3908-1122	Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [HG004120, P01 HG004120, 3 U54 HG002043, U54 HG002043-07S1, P01 HG004120-01, U54 HG002043] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002043, P01HG004120, Z01HG200330] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; DONAHUE W, 2007, CURR PROTOCOLS HUM G, V5; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Gillett W, 1996, GENOMICS, V33, P389, DOI 10.1006/geno.1996.0215; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nguyen TV, 2006, WORLD J GASTROENTERO, V12, P6021, DOI 10.3748/wjg.v12.i37.6021; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nusbaum C, 2006, NATURE, V439, P331, DOI 10.1038/nature04406; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Wong GKS, 1997, P NATL ACAD SCI USA, V94, P5225, DOI 10.1073/pnas.94.10.5225; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	42	815	861	2	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					56	64		10.1038/nature06862	http://dx.doi.org/10.1038/nature06862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451855	Green Accepted			2022-12-28	WOS:000255398800038
J	DellaPenna, D; Last, RL				DellaPenna, Dean; Last, Robert L.			Perspective - Genome-enabled approaches shed new light on plant metabolism	SCIENCE			English	Editorial Material							ARABIDOPSIS MUTANT; BIOSYNTHESIS; GENE; EXPRESSION; TOCOPHEROL; DEFICIENT; PATHWAYS; SYNTHASE; FAMILY; OIL	Plant metabolism research has experienced a second golden age resulting from synergies between genome- enabled technologies and classical biochemistry. The rapid rate at which genomics data are being accumulated creates increased needs for robust metabolomic technologies and fast and accurate methods for identifying the activities of enzymes.	[DellaPenna, Dean; Last, Robert L.] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; [Last, Robert L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	DellaPenna, D (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.	dellapen@msu.edu	Last, Robert L/D-9197-2011	Last, Robert/0000-0001-6974-9587				Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Cheng ZG, 2003, PLANT CELL, V15, P2343, DOI 10.1105/tpc.013656; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Croteau RB, 2005, NATURWISSENSCHAFTEN, V92, P562, DOI 10.1007/s00114-005-0055-0; de Crecy-Lagard V, 2007, TRENDS MICROBIOL, V15, P563, DOI 10.1016/j.tim.2007.10.008; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; Dhugga KS, 2004, SCIENCE, V303, P363, DOI 10.1126/science.1090908; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Lange BM, 2000, P NATL ACAD SCI USA, V97, P2934, DOI 10.1073/pnas.97.6.2934; Last RL, 2007, NAT REV MOL CELL BIO, V8, P167, DOI 10.1038/nrm2098; Maeda H, 2007, CURR OPIN PLANT BIOL, V10, P260, DOI 10.1016/j.pbi.2007.04.006; Naoumkina M, 2007, P NATL ACAD SCI USA, V104, P17909, DOI 10.1073/pnas.0708697104; Nelson T, 2006, ANNU REV PLANT BIOL, V57, P181, DOI 10.1146/annurev.arplant.56.032604.144138; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHILMILLER AL, IN PRESS PLANT J; SOMERVILLE CR, 1980, P NATL ACAD SCI-BIOL, V77, P2684, DOI 10.1073/pnas.77.5.2684; Sweetlove LJ, 2008, BIOCHEM J, V409, P27, DOI 10.1042/BJ20071115; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Trethewey RN, 2004, CURR OPIN PLANT BIOL, V7, P196, DOI 10.1016/j.pbi.2003.12.003; Van Eenennaam AL, 2003, PLANT CELL, V15, P3007, DOI 10.1105/tpc.015875; Webb ME, 2007, NAT PROD REP, V24, P988, DOI 10.1039/b703105j	25	21	23	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					479	481		10.1126/science.1153715	http://dx.doi.org/10.1126/science.1153715			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436775				2022-12-28	WOS:000255249300034
J	Kaminski, JA; Sloutsky, VM; Heckler, AF				Kaminski, Jennifer A.; Sloutsky, Vladimir M.; Heckler, Andrew F.			Learning theory - The advantage of abstract examples in learning math	SCIENCE			English	Editorial Material							ANALOGICAL TRANSFER		[Kaminski, Jennifer A.; Sloutsky, Vladimir M.; Heckler, Andrew F.] Ohio State Univ, Ctr Cognit Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Kaminski, JA (corresponding author), Ohio State Univ, Ctr Cognit Sci, Columbus, OH 43210 USA.	kaminski.16@osu.edu	Heckler, Andrew/AAE-2597-2022; Heckler, Andrew F/A-7291-2010	Heckler, Andrew/0000-0001-5494-7855; Heckler, Andrew F/0000-0001-5494-7855				CATRAMBONE R, 1989, J EXP PSYCHOL LEARN, V15, P1147, DOI 10.1037/0278-7393.15.6.1147; Gentner D, 2003, J EDUC PSYCHOL, V95, P393, DOI 10.1037/0022-0663.95.2.393; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; Goldstone RL, 2003, COGNITIVE PSYCHOL, V46, P414, DOI 10.1016/S0010-0285(02)00519-4; Kaminski J. A., 2005, P 27 ANN C COGN SCI, P1090; Kaminski J.A., 2006, P 28 ANN C COGN SCI, P411; NOVICK LR, 1988, J EXP PSYCHOL LEARN, V14, P510, DOI 10.1037/0278-7393.14.3.510; NOVICK LR, 1991, J EXP PSYCHOL LEARN, V17, P387; REED SK, 1985, J EXP PSYCHOL LEARN, V11, P106, DOI 10.1037/0278-7393.11.1.106; Sloutsky VM, 2005, PSYCHON B REV, V12, P508, DOI 10.3758/BF03193796	10	177	177	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					454	455		10.1126/science.1154659	http://dx.doi.org/10.1126/science.1154659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436760				2022-12-28	WOS:000255249300021
J	Leitch, AR; Leitch, IJ				Leitch, A. R.; Leitch, I. J.			Perspective - Genomic plasticity and the diversity of polyploid plants	SCIENCE			English	Editorial Material							ALLOPOLYPLOID NICOTIANA; GENE-EXPRESSION; BRASSICA-NAPUS; MECHANISMS; EVOLUTION; PRODUCTS	Polyploidy, a change whereby the entire chromosome set is multiplied, arises through mitotic or meiotic misdivisions and frequently involves unreduced gametes and interspecific hybridization. The success of newly formed angiosperm polyploids is partly attributable to their highly plastic genome structure, as manifested by tolerance to changing chromosome numbers ( aneuploidy and polyploidy), genome size, ( retro) transposable element mobility, insertions, deletions, and epigenome restructuring. The ability to withstand large- scale changes, frequently within one or a few generations, is associated with a restructuring of the transcriptome, metabolome, and proteome and can result in an altered phenotype and ecology. Thus, polyploid- induced changes can generate individuals that are able to exploit new niches or to outcompete progenitor species. This process has been a major driving force behind the divergence of the angiosperms and their biodiversity.	[Leitch, A. R.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Leitch, I. J.] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England	University of London; Queen Mary University London; Royal Botanic Gardens, Kew	Leitch, AR (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	a.r.leitch@qmul.ac.uk; i.leitch@kew.edu	Leitch, Andrew R/J-6385-2014; Leitch, Ilia J/X-5449-2019; Leitch, Ilia J/D-6052-2011	Leitch, Andrew R/0000-0001-8574-302X; Leitch, Ilia J/0000-0002-3837-8186; Leitch, Ilia J/0000-0002-3837-8186	Natural Environment Research Council [NE/C511964/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; Albertin W, 2006, GENETICS, V173, P1101, DOI 10.1534/genetics.106.057554; Albertin W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-56; BEADLE NCW, 1962, ECOLOGY, V43, P281, DOI 10.2307/1931983; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Gaeta RT, 2007, PLANT CELL, V19, P3403, DOI 10.1105/tpc.107.054346; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Lim KY, 2007, NEW PHYTOL, V175, P756, DOI 10.1111/j.1469-8137.2007.02121.x; Lim KY, 2006, AM J BOT, V93, P875, DOI 10.3732/ajb.93.6.875; Lou Y, 2003, P NATL ACAD SCI USA, V100, P14581, DOI 10.1073/pnas.2135348100; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Pearse IS, 2006, PLANT J, V47, P196, DOI 10.1111/j.1365-313X.2006.02776.x; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Yang FT, 2004, CHROMOSOME RES, V12, P65, DOI 10.1023/B:CHRO.0000009298.02689.8a	27	594	614	6	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					481	483		10.1126/science.1153585	http://dx.doi.org/10.1126/science.1153585			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436776				2022-12-28	WOS:000255249300035
J	Hsieh, D; Qian, D; Wray, L; Xia, Y; Hor, YS; Cava, RJ; Hasan, MZ				Hsieh, D.; Qian, D.; Wray, L.; Xia, Y.; Hor, Y. S.; Cava, R. J.; Hasan, M. Z.			A topological Dirac insulator in a quantum spin Hall phase	NATURE			English	Article							MAGNETIC SUSCEPTIBILITY; BAND-STRUCTURE; GRAPHENE; BISMUTH; TRANSITION; WELLS; MODEL; GAS	When electrons are subject to a large external magnetic field, the conventional charge quantum Hall effect(1,2) dictates that an electronic excitation gap is generated in the sample bulk, but metallic conduction is permitted at the boundary. Recent theoretical models suggest that certain bulk insulators with large spin - orbit interactions may also naturally support conducting topological boundary states in the quantum limit(3-5), which opens up the possibility for studying unusual quantum Hall- like phenomena in zero external magnetic fields(6). Bulk Bi1-xSbx single crystals are predicted to be prime candidates(7,8) for one such unusual Hall phase of matter known as the topological insulator(9-11). The hallmark of a topological insulator is the existence of metallic surface states that are higher- dimensional analogues of the edge states that characterize a quantum spin Hall insulator(3-13). In addition to its interesting boundary states, the bulk of Bi1-xSbx is predicted to exhibit three- dimensional Dirac particles(14-17), another topic of heightened current interest following the new findings in two-dimensional graphene(18-20) and charge quantum Hall fractionalization observed in pure bismuth(21). However, despite numerous transport and magnetic measurements on the Bi1-xSbx family since the 1960s(17), no direct evidence of either topological Hall states or bulk Dirac particles has been found. Here, using incident- photon- energy- modulated angle- resolved photoemission spectroscopy ( IPEM- ARPES), we report the direct observation of massive Dirac particles in the bulk of Bi0.9Sb0.1, locate the Kramers points at the sample's boundary and provide a comprehensive mapping of the Dirac insulator's gapless surface electron bands. These findings taken together suggest that the observed surface state on the boundary of the bulk insulator is a realization of the 'topological metal'(9-11). They also suggest that this material has potential application in developing next- generation quantum computing devices that may incorporate 'light- like' bulk carriers and spin- textured surface currents.	[Hsieh, D.; Qian, D.; Wray, L.; Xia, Y.; Hasan, M. Z.] Princeton Univ, Dept Phys, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Hor, Y. S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Hasan, M. Z.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Hasan, MZ (corresponding author), Princeton Univ, Dept Phys, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	mzhasan@princeton.edu	HASAN, M. Zahid/D-8237-2012; Qian, Dong/O-1028-2015; San Hor, Yew/S-1429-2017	San Hor, Yew/0000-0002-1417-4357; Wray, L. Andrew/0000-0001-8977-0201				Ast CR, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245122; Ast CR, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.113102; Ast CR, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.177602; Behnia K, 2007, SCIENCE, V317, P1729, DOI 10.1126/science.1146509; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; BUOT FA, 1973, PHYS REV A, V8, P1570, DOI 10.1103/PhysRevA.8.1570; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Fu L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045302; FUKUYAMA H, 1970, J PHYS SOC JPN, V28, P570, DOI 10.1143/JPSJ.28.570; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; HEBEL LC, 1964, PHYS LETT, V10, P273, DOI 10.1016/0031-9163(64)90498-6; Hengsberger M, 2000, EUR PHYS J B, V17, P603, DOI 10.1007/s100510070097; Hirahara T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.153305; Hochst H, 2005, J ELECTRON SPECTROSC, V144, P351, DOI 10.1016/j.elspec.2005.01.163; Hofmann P, 2006, PROG SURF SCI, V81, P191, DOI 10.1016/j.progsurf.2006.03.001; Hufner S., 1995, PHOTOELECTRON SPECTR; Jezequel G, 1997, PHYS REV B, V56, P6620, DOI 10.1103/PhysRevB.56.6620; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Kopelevich Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165128; Lenoir B, 1996, PROCEEDINGS ICT '96 - FIFTEENTH INTERNATIONAL CONFERENCE ON THERMOELECTRICS, P1, DOI 10.1109/ICT.1996.553246; LIU Y, 1995, PHYS REV B, V52, P1566, DOI 10.1103/PhysRevB.52.1566; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Murakami S, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/356; Novoselov KS, 2007, SCIENCE, V315, P1379, DOI 10.1126/science.1137201; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; ROY R, 2006, 3 DIMENSIONAL TOPOLO; Sheng DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036808; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; WOLFF PA, 1964, J PHYS CHEM SOLIDS, V25, P1057, DOI 10.1016/0022-3697(64)90128-3; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhou SY, 2007, NAT MATER, V6, P770, DOI 10.1038/nmat2003	36	2617	2652	37	1340	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					970	U5		10.1038/nature06843	http://dx.doi.org/10.1038/nature06843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432240	Green Submitted, Green Accepted			2022-12-28	WOS:000255208600034
J	Fowlkes, CC; Luengo Hendriks, CL; Keranen, SVE; Weber, GH; Rubel, O; Huang, MY; Chatoor, S; DePace, AH; Simirenko, L; Henriquez, C; Beaton, A; Weiszmann, R; Celniker, S; Hamann, B; Knowles, DW; Biggin, MD; Eisen, MB; Malik, J				Fowlkes, Charless C.; Luengo Hendriks, Cris L.; Keraenen, Soile V. E.; Weber, Gunther H.; Ruebel, Oliver; Huang, Min-Yu; Chatoor, Sohail; DePace, Angela H.; Simirenko, Lisa; Henriquez, Clara; Beaton, Amy; Weiszmann, Richard; Celniker, Susan; Hamann, Bernd; Knowles, David W.; Biggin, Mark D.; Eisen, Michael B.; Malik, Jitendra			A quantitative spatiotemporal atlas of gene expression in the Drosophila blastoderm	CELL			English	Article							TRANSCRIPTIONAL REGULATION; 3-DIMENSIONAL MORPHOLOGY; POSITIONAL INFORMATION; EGG SIZE; EMBRYOGENESIS; MELANOGASTER; PATTERNS; EMBRYO; SPECIFICATION; EVOLUTION	To fully understand animal transcription networks, it is essential to accurately measure the spatial and temporal expression patterns of transcription factors and their targets. We describe a registration technique that takes image-based data from hundreds of Drosophila blastoderm embryos, each costained for a reference gene and one of a set of genes of interest, and builds a model VirtualEmbryo. This model captures in a common framework the average expression patterns for many genes in spite of significant variation in morphology and expression between individual embryos. We establish the method's accuracy by showing that relationships between a pair of genes' expression inferred from the model are nearly identical to those measured in embryos costained for the pair. We present a VirtualEmbryo containing data for 95 genes at six time cohorts. We show that known gene-regulatory interactions can be automatically recovered from this data set and predict hundreds of new interactions.	[Fowlkes, Charless C.; Luengo Hendriks, Cris L.; Keraenen, Soile V. E.; Weber, Gunther H.; Ruebel, Oliver; Huang, Min-Yu; Chatoor, Sohail; DePace, Angela H.; Simirenko, Lisa; Henriquez, Clara; Celniker, Susan; Hamann, Bernd; Knowles, David W.; Biggin, Mark D.; Eisen, Michael B.; Malik, Jitendra] Univ Calif Irvine, Berkeley Drosophila Transcript Network Project, Irvine, CA 92697 USA; [Fowlkes, Charless C.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Luengo Hendriks, Cris L.; Chatoor, Sohail; Celniker, Susan; Knowles, David W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Keraenen, Soile V. E.; DePace, Angela H.; Simirenko, Lisa; Henriquez, Clara; Beaton, Amy; Weiszmann, Richard; Biggin, Mark D.; Eisen, Michael B.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Weber, Gunther H.; Ruebel, Oliver; Huang, Min-Yu; Hamann, Bernd] Univ Calif Davis, Inst Data Anal & Visualizat IDAV, Davis, CA 95616 USA; [Ruebel, Oliver; Huang, Min-Yu; Chatoor, Sohail; Hamann, Bernd] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Malik, Jitendra] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Irvine, Berkeley Drosophila Transcript Network Project, Irvine, CA 92697 USA.	mbeisen@lbl.gov; malik@cs.berkeley.edu	Luengo Hendriks, Cris L./B-1097-2008; Weber, Gunther/AAA-9678-2019	Luengo Hendriks, Cris L./0000-0002-8279-1760; Weber, Gunther/0000-0002-1794-1398; Fowlkes, Charless/0000-0002-2990-1780; Eisen, Michael/0000-0002-7528-738X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070444] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002779, R01 HG002779-05, R01 HG002779-06] Funding Source: Medline; NIGMS NIH HHS [GM704403, R01 GM070444] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnosti DN, 1996, DEVELOPMENT, V122, P205; Azevedo RBR, 1996, EVOLUTION, V50, P2338, DOI [10.2307/2410702, 10.1111/j.1558-5646.1996.tb03621.x]; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Duchon J, 1977, CONSTRUCTIVE THEORY, P85, DOI DOI 10.1007/BFB0086566; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; ELDON ED, 1991, DEVELOPMENT, V111, P367; FOWLKES CC, 2006, UCBEECS2006142; Grace W., 1990, SPLINE MODELS OBSERV; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Keranen SVE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r124; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Laney JD, 1996, DEVELOPMENT, V122, P2303; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Mjolsness E, 2007, J BIOINF COMPUT BIOL, V5, P467, DOI 10.1142/S0219720007002874; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; RUBEL O, 2006, DATA VISUALIZATION 2; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Spirov AV, 2002, REAL-TIME IMAGING, V8, P507, DOI 10.1006/rtim.2002.0292; Struffi P, 2004, DEVELOPMENT, V131, P2419, DOI 10.1242/dev.01075; Tassy O, 2006, CURR BIOL, V16, P345, DOI 10.1016/j.cub.2005.12.044; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; TURNER FR, 1976, DEV BIOL, V50, P95, DOI 10.1016/0012-1606(76)90070-1; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Warren DC, 1924, GENETICS, V9, P41; Weber GH, 2009, IEEE ACM T COMPUT BI, V6, P296, DOI 10.1109/TCBB.2007.70249; Yuh CH, 2001, DEVELOPMENT, V128, P617; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97	35	185	188	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 18	2008	133	2					364	374		10.1016/j.cell.2008.01.053	http://dx.doi.org/10.1016/j.cell.2008.01.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423206	Bronze, Green Submitted			2022-12-28	WOS:000255052000024
J	Sekido, R; Lovell-Badge, R				Sekido, Ryohei; Lovell-Badge, Robin			Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer	NATURE			English	Article							CAMPOMELIC DYSPLASIA; TESTIS DEVELOPMENT; DISTINCT FUNCTIONS; DETERMINING REGION; MOUSE; GENE; MICE; DIFFERENTIATION; ACTIVATION; EXPRESSION	The mammalian Y chromosome acts as a dominant male determinant as a result of the action of a single gene, Sry, whose role in sex determination is to initiate testis rather than ovary development from early bipotential gonads(1-3). It does so by triggering the differentiation of Sertoli cells from supporting cell precursors, which would otherwise give follicle cells. The related autosomal gene Sox9 is also known from loss- of- function mutations in mice and humans to be essential for Sertoli cell differentiation(4,5); moreover, its abnormal expression in an XX gonad can lead to male development in the absence of Sry(6,7). These genetic data, together with the finding that Sox9 is upregulated in Sertoli cell precursors just after SRY expression begins(8,9), has led to the proposal that Sox9 could be directly regulated by SRY. However, the mechanism by which SRY action might affect Sox9 expression was not understood. Here we show that SRY binds to multiple elements within a Sox9 gonad- specific enhancer in mice, and that it does so along with steroidogenic factor 1 ( SF1, encoded by the gene Nr5a1 ( Sf1)), an orphan nuclear receptor. Mutation, co- transfection and sex-reversal studies all point to a feedforward, self- reinforcing pathway in which SF1 and SRY cooperatively upregulate Sox9 and then, together with SF1, SOX9 also binds to the enhancer to help maintain its own expression after that of SRY has ceased. Our results open up the field, permitting further characterization of the molecular mechanisms regulating sex determination and how they have evolved, as well as how they fail in cases of sex reversal.	[Sekido, Ryohei; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England	MRC National Institute for Medical Research	Sekido, R (corresponding author), Natl Inst Med Res, MRC, Div Dev Genet, Ridgeway,Mill Hill, London NW7 1AA, England.	rsekido@nimr.mrc.ac.uk; rlovell@nimr.mrc.ac.uk		Sekido, Ryohei/0000-0003-2364-1882; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Ikeda Y, 2001, DEV DYNAM, V220, P363, DOI 10.1002/dvdy.1116; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; LUO X, 1994, CELL, V77, P663; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Park SY, 2005, DEVELOPMENT, V132, P2415, DOI 10.1242/dev.01826; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Shen JHC, 2002, MOL ENDOCRINOL, V16, P529, DOI 10.1210/me.16.3.529; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102; Wunderle VM, 1998, P NATL ACAD SCI USA, V95, P10649, DOI 10.1073/pnas.95.18.10649	30	647	676	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 12	2008	453	7197					930	934		10.1038/nature06944	http://dx.doi.org/10.1038/nature06944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18454134				2022-12-28	WOS:000256632000046
J	Tilmes, S; Muller, R; Salawitch, R				Tilmes, Simone; Mueller, Rolf; Salawitch, Ross			The sensitivity of polar ozone depletion to proposed geoengineering schemes	SCIENCE			English	Article								The large burden of sulfate aerosols injected into the stratosphere by the eruption of Mount Pinatubo in 1991 cooled Earth and enhanced the destruction of polar ozone in the subsequent few years. The continuous injection of sulfur into the stratosphere has been suggested as a "geoengineering" scheme to counteract global warming. We use an empirical relationship between ozone depletion and chlorine activation to estimate how this approach might influence polar ozone. An injection of sulfur large enough to compensate for surface warming caused by the doubling of atmospheric CO2 would strongly increase the extent of Arctic ozone depletion during the present century for cold winters and would cause a considerable delay, between 30 and 70 years, in the expected recovery of the Antarctic ozone hole.	[Tilmes, Simone] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Mueller, Rolf] KFA Julich, Forschungszentrum, D-52425 Julich, Germany; [Salawitch, Ross] Univ Maryland, College Pk, MD 20742 USA	National Center Atmospheric Research (NCAR) - USA; Helmholtz Association; University System of Maryland; University of Maryland College Park	Tilmes, S (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	tilmes@ucar.edu	Müller, Rolf/ABA-8213-2021; Salawitch, Ross/B-4605-2009; Müller, Rolf/A-6669-2013	Müller, Rolf/0000-0002-5024-9977; Salawitch, Ross/0000-0001-8597-5832; Müller, Rolf/0000-0002-5024-9977; Tilmes, Simone/0000-0002-6557-3569				Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; CHIPPERFIELD MP, 2007, SCI ASSESSMENT OZONE, pCH3; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; DRDLA K, 2005, AM GEOPH UN FALL M S; HOFMANN DJ, 1993, J GEOPHYS RES-ATMOS, V98, P18555, DOI 10.1029/93JD02092; Jin JJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026752; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Newman PA, 2007, ATMOS CHEM PHYS, V7, P4537, DOI 10.5194/acp-7-4537-2007; Rasch PJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032179; Rex M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026731; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; Solomon S, 1996, J GEOPHYS RES-ATMOS, V101, P6713, DOI 10.1029/95JD03353; Stenchikov G, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002090; Tabazadeh A, 2002, P NATL ACAD SCI USA, V99, P2609, DOI 10.1073/pnas.052518199; Thomason L.W., 2006, ASSESSMENT STRATOSPH; Tilmes S, 2008, ATMOS CHEM PHYS, V8, P1897, DOI 10.5194/acp-8-1897-2008; Tilmes S, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008334; Tilmes S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026925; von Hobe M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026945; Wigley TML, 2006, SCIENCE, V314, P452, DOI 10.1126/science.1131728	20	187	196	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2008	320	5880					1201	1204		10.1126/science.1153966	http://dx.doi.org/10.1126/science.1153966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18436741				2022-12-28	WOS:000256233000034
J	Turnbull, F; Neal, B; Ninomiya, T; Algerl, C; Arima, H; Barzi, F; Bulpitt, C; Chalmers, J; Fagard, R; Gleason, A; Heritier, S; Li, N; Perkovic, V; Woodward, M; MacMahon, S				Turnbull, F.; Neal, B.; Ninomiya, T.; Algerl, C.; Arima, H.; Barzi, F.; Bulpitt, C.; Chalmers, J.; Fagard, R.; Gleason, A.; Heritier, S.; Li, N.; Perkovic, V.; Woodward, M.; MacMahon, S.		Blood Pressure Lowering Treatment	Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger people: meta-analysis of randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONVERTING-ENZYME-INHIBITORS; PLACEBO-CONTROLLED TRIAL; CORONARY-ARTERY-DISEASE; DOUBLE-BLIND; ANTIHYPERTENSIVE DRUGS; HYPERTENSIVE PATIENTS; CALCIUM-ANTAGONIST; MORBIDITY; MORTALITY; OUTCOMES	Objective To quantify the relative risk reductions achieved with different regimens to lower blood pressure in younger and older adults. Design Meta-analyses and meta-regression analyses used to compare the effects on the primary outcome between two age groups (< 65 v >= 65 years). Evidence for an interaction between age and the effects of treatment sought by fitting age as a continuous variable and estimating overall effects across trials. Main outcome measures Primary outcome: total major cardiovascular events. Results 31 trials, with 190 606 participants, were included. The meta-analyses showed no clear difference between age groups in the effects of lowering blood pressure or any difference between the effects of the drug classes on major cardiovascular events (all P >= 0.24). Neither was there any significant interaction between age and treatment when age was fitted as a continuous variable (all P > 0.09). The meta-regressions also showed no difference in effects between the two age groups for the outcome of major cardiovascular events (< 65 v >= 65; P=0.38). Conclusions Reduction of blood pressure produces benefits in younger (< 65 years) and older (>= 65 years) adults, with no strong evidence that protection against major vascular events afforded by different drug classes varies substantially with age.	[Turnbull, F.] Univ Sydney, Blood Pressure Lowering Treatment Trialists Colla, George Inst Int Hlth, Sydney, NSW 2050, Australia	University of Sydney	Turnbull, F (corresponding author), Univ Sydney, Blood Pressure Lowering Treatment Trialists Colla, George Inst Int Hlth, POB M201, Sydney, NSW 2050, Australia.	fturnbull@george.org.au	Woodward, Mark/D-8492-2015; Barzi, Federica/AAI-7465-2021; Woodward, Mark/L-6817-2017; Barzi, Federica/L-3553-2013; de Zeeuw, Dick/E-9080-2014; Remuzzi, Giuseppe/V-9766-2017	Barzi, Federica/0000-0001-7427-0167; de Zeeuw, Dick/0000-0003-3434-7777; Gleason, Andrew/0000-0001-5386-2948; Yusuf, Salim/0000-0003-4776-5601; Remuzzi, Giuseppe/0000-0002-6194-3446; Chalmers, John/0000-0002-9931-0580; Woodward, Mark/0000-0001-9800-5296; Neal, Bruce/0000-0002-0490-7465				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; BECKETT N, 2008, N ENGL J MED    0331; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Brown MJ, 2003, J HUM HYPERTENS, V17, P81, DOI 10.1038/sj.jhh.1001511; Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dens JA, 2001, AM J CARDIOL, V87, P28, DOI 10.1016/S0002-9149(00)01267-4; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fox KM, 2003, LANCET, V362, P782; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Qizilbash N, 1995, LANCET, V346, P1647; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Teo KK, 2000, CIRCULATION, V102, P1748; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; *US CENS BUR, 2002, WP02 US CENS BUR; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yui Y, 2004, HYPERTENS RES, V27, P181, DOI 10.1291/hypres.27.181; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zanchetti A, 1998, J HYPERTENS, V16, P1667, DOI 10.1097/00004872-199816110-00014; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	54	545	570	2	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1121	1123		10.1136/bmj.39548.738368.BE	http://dx.doi.org/10.1136/bmj.39548.738368.BE			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18480116	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000255975100041
J	Galloway, JN; Townsend, AR; Erisman, JW; Bekunda, M; Cai, ZC; Freney, JR; Martinelli, LA; Seitzinger, SP; Sutton, MA				Galloway, James N.; Townsend, Alan R.; Erisman, Jan Willem; Bekunda, Mateete; Cai, Zucong; Freney, John R.; Martinelli, Luiz A.; Seitzinger, Sybil P.; Sutton, Mark A.			Transformation of the nitrogen cycle: Recent trends, questions, and potential solutions	SCIENCE			English	Review							FUTURE; CONSEQUENCES; PERSPECTIVE; DEPOSITION; CLIMATE; CASCADE; SYSTEM	Humans continue to transform the global nitrogen cycle at a record pace, reflecting an increased combustion of fossil fuels, growing demand for nitrogen in agriculture and industry, and pervasive inefficiencies in its use. Much anthropogenic nitrogen is lost to air, water, and land to cause a cascade of environmental and human health problems. Simultaneously, food production in some parts of the world is nitrogen-deficient, highlighting inequities in the distribution of nitrogen-containing fertilizers. Optimizing the need for a key human resource while minimizing its negative consequences requires an integrated interdisciplinary approach and the development of strategies to decrease nitrogen-containing waste.	[Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Townsend, Alan R.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Townsend, Alan R.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Erisman, Jan Willem] ECN, Energy Res Ctr Netherlands, NL-1755 ZG Petten, Netherlands; [Bekunda, Mateete] Makerere Univ, Fac Agr, Kampala, Uganda; [Cai, Zucong] Chinese Acad Sci, Inst Soil Sci, Nanjing 210008, Peoples R China; [Freney, John R.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia; [Martinelli, Luiz A.] Univ Sao Paulo, Ctr Energia Nucl Agr, Piracicaba, SP, Brazil; [Seitzinger, Sybil P.] Rutgers State Univ, Inst Marine & Coastal Sci, Natl Ocean & Atmospher Adm Cooperat Marine Educ &, New Brunswick, NJ 08901 USA; [Sutton, Mark A.] Ctr Ecol & Hydrol, Edinburgh Res Stn, Penicuik EH26 0QB, Midlothian, Scotland	University of Virginia; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Makerere University; Chinese Academy of Sciences; Institute of Soil Science, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade de Sao Paulo; National Oceanic Atmospheric Admin (NOAA) - USA; Rutgers State University New Brunswick; UK Centre for Ecology & Hydrology (UKCEH)	Galloway, JN (corresponding author), Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA.	jng@virginia.edu	Galloway, James N/C-2769-2013; Freney, John/E-9462-2011; Martinelli, Luiz Antonio/F-7870-2011; Erisman, Jan Willem/N-5093-2019; Townsend, Alan/AAE-9602-2019; Sutton, Mark/K-2700-2012; Erisman, Jan Willem/C-6900-2008	Galloway, James N/0000-0001-7676-8698; Martinelli, Luiz Antonio/0000-0002-7103-7551; Erisman, Jan Willem/0000-0001-5058-7012; Sutton, Mark/0000-0002-1342-2072; Freney, John/0000-0001-7545-6529	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Achermann B., 2003, EMPIRICAL; [Anonymous], 2007, STAT REV WORLD EN; Boyer EW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002537; Cofala J, 2007, ATMOS ENVIRON, V41, P8486, DOI 10.1016/j.atmosenv.2007.07.010; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; DELWICHE CC, 1970, SCI AM, V223, P136, DOI 10.1038/scientificamerican0970-136; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Erisman JW, 2005, SCI CHINA SER C, V48, P827, DOI 10.1007/BF03187122; Erisman JW, 2004, BIOSCIENCE, V54, P286, DOI 10.1641/0006-3568(2004)054[0286:TNDOMO]2.0.CO;2; Food and Agriculture Organization, 2006, FAO STAT DAT; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Howarth R, 2005, MILLENNIUM ECOSYSTEM; Howarth RW, 2006, BIOGEOCHEMISTRY, V79, P163, DOI 10.1007/s10533-006-9010-1; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; *INT PAN CLIM CHAN, 2007, WORK GROUP 1 REP PHY; Jin XC, 2005, SCI CHINA SER C, V48, P948, DOI 10.1360/062005-286; Lara LBLS, 2001, ATMOS ENVIRON, V35, P4937, DOI 10.1016/S1352-2310(01)00198-4; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; McKenzie VJ, 2007, ECOHEALTH, V4, P384, DOI 10.1007/s10393-007-0131-3; Naylor R, 2005, SCIENCE, V310, P1621, DOI 10.1126/science.1117856; PRUDHOMME M, 2007, GLOBAL FERTILIZERS R, P2007; Sanchez PA, 2005, LANCET, V365, P442, DOI 10.1016/S0140-6736(05)17834-9; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Smil V., 2001, ENRICHING EARTH F HA; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Sutton MA, 2007, ENVIRON POLLUT, V150, P125, DOI 10.1016/j.envpol.2007.04.014; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Trivelin PCO, 2002, PESQUI AGROPECU BRAS, V37, P193, DOI 10.1590/S0100-204X2002000200011; *UN ENV PROGR WOOD, 2007, REACT NITR ENV TOO M; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Volk M, 2006, GLOBAL CHANGE BIOL, V12, P74, DOI 10.1111/j.1365-2486.2005.01083.x; Ward MH, 2005, ENVIRON HEALTH PERSP, V113, P1607, DOI 10.1289/ehp.8043; Zhu ZL, 2005, SCI CHINA SER C, V48, P729, DOI 10.1360/062005-266	40	3991	4480	288	4325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					889	892		10.1126/science.1136674	http://dx.doi.org/10.1126/science.1136674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487183	Green Submitted			2022-12-28	WOS:000255868300031
J	Berg, WA; Blume, JD; Cormack, JB; Mendelson, EB; Lehrer, D; Bohm-Velez, M; Pisano, ED; Jong, RA; Evans, WP; Morton, MJ; Mahoney, MC; Larsen, LH; Barr, RG; Farria, DM; Marques, HS; Boparai, K				Berg, Wendie A.; Blume, Jeffrey D.; Cormack, Jean B.; Mendelson, Ellen B.; Lehrer, Daniel; Bohm-Velez, Marcela; Pisano, Etta D.; Jong, Roberta A.; Evans, W. Phil; Morton, Marilyn J.; Mahoney, Mary C.; Larsen, Linda Hovanessian; Barr, Richard G.; Farria, Dione M.; Marques, Helga S.; Boparai, Karan		ACRIN 6666 Investigators	Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DENSE BREASTS; LESION DETECTION; TUMOR SIZE; US; PERFORMANCE; SONOGRAPHY; CARCINOMA; SURVEILLANCE; MR; MULTICENTER	Context Screening ultrasound may depict small, node- negative breast cancers not seen on mammography. Objective To compare the diagnostic yield, defined as the proportion of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer. Design, Setting, and Participants From April 2004 to February 2006, 2809 women, with at least heterogeneously dense breast tissue in at least 1 quadrant, were recruited from 21 sites to undergo mammographic and physician- performed ultrasonographic examinations in randomized order by a radiologist masked to the other examination results. Reference standard was defined as a combination of pathology and 12- month follow-up and was available for 2637 ( 96.8%) of the 2725 eligible participants. Main Outcome Measures Diagnostic yield, sensitivity, specificity, and diagnostic accuracy ( assessed by the area under the receiver operating characteristic curve) of combined mammography plus ultrasound vs mammography alone and the positive predictive value of biopsy recommendations for mammography plus ultrasound vs mammography alone. Results Forty participants ( 41 breasts) were diagnosed with cancer: 8 suspicious on both ultrasound and mammography, 12 on ultrasound alone, 12 on mammography alone, and 8 participants ( 9 breasts) on neither. The diagnostic yield for mammography was 7.6 per 1000 women screened ( 20 of 2637) and increased to 11.8 per 1000 ( 31 of 2637) for combined mammography plus ultrasound; the supplemental yield was 4.2 per 1000 women screened ( 95% confidence interval [ CI], 1.1- 7.2 per 1000; P=. 003 that supplemental yield is 0). The diagnostic accuracy for mammography was 0.78 ( 95% CI, 0.67- 0.87) and increased to 0.91 ( 95% CI, 0.84- 0.96) for mammography plus ultrasound ( P=. 003 that difference is 0). Of 12 supplemental cancers detected by ultrasound alone, 11 ( 92%) were invasive with a median size of 10 mm( range, 5- 40 mm; mean [ SE], 12.6 [ 3.0] mm) and 8 of the 9 lesions ( 89%) reported had negative nodes. The positive predictive value of biopsy recommendation after full diagnostic workup was 19 of 84 for mammography ( 22.6%; 95% CI, 14.2%- 33%), 21 of 235 for ultrasound ( 8.9%, 95% CI, 5.6%- 13.3%), and 31 of 276 for combined mammography plus ultrasound ( 11.2%; 95% CI. 7.8%- 15.6%). Conclusions Adding a single screening ultrasound to mammography will yield an additional 1.1 to 7.2 cancers per 1000 high- risk women, but it will also substantially increase the number of false positives. Trial Registration clinicaltrials. gov Identifier: NCT00072501.	[Berg, Wendie A.] Amer Radiol Serv Inc, John Hopkins Green Spring, Lutherville Timonium, MD USA; [Blume, Jeffrey D.; Cormack, Jean B.; Marques, Helga S.] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Mendelson, Ellen B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Lehrer, Daniel] CERIM, Buenos Aires, DF, Argentina; [Bohm-Velez, Marcela] Weinstein Imaging Assoc, Pittsburgh, PA USA; [Pisano, Etta D.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Jong, Roberta A.] Univ Toronto, Sunnybrook & Womens Hosp, Toronto, ON, Canada; [Evans, W. Phil] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Morton, Marilyn J.] Mayo Clin, Rochester, MN USA; [Mahoney, Mary C.] Univ Cincinnati, Cincinnati, OH USA; [Larsen, Linda Hovanessian] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Barr, Richard G.] Western Reserve Care Syst, Youngstown, OH USA; [Farria, Dione M.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Boparai, Karan] Amer Coll Radiol, Philadelphia, PA USA	Johns Hopkins University; Johns Hopkins Medicine; Brown University; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; University System of Ohio; University of Cincinnati; University of Southern California; Case Western Reserve University; Washington University (WUSTL); American College of Radiology	Berg, WA (corresponding author), 10755 Falls Rd,Suite 440, Lutherville Timonium, MD 21093 USA.	wendieberg@gmail.com	Soo, Mary S C/B-1580-2017; Barr, Richard G./AEN-6134-2022	Barr, Richard G./0000-0001-8021-0072; Marques, Helga/0000-0003-2029-9241	NCI NIH HHS [U10 CA080098, U01 CA080098-10, CA 80098, U10 CA079778, U01 CA079778, U01 CA080098, CA 79778] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA080098, U01CA080098, U01CA079778, U10CA079778] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x; Berg WA, 2006, RADIOLOGY, V239, P693, DOI 10.1148/radiol.2393051069; Berg WA, 2004, AM J ROENTGENOL, V182, P34; Berg WA, 2004, RADIOL CLIN N AM, V42, P845, DOI 10.1016/j.rcl.2004.04.003; Berg WA, 2007, RADIOL CLIN N AM, V45, P895, DOI 10.1016/j.rcl.2007.06.001; Berg WA, 2006, RADIOLOGY, V241, P355, DOI 10.1148/radiol.2412051710; Bondy Melissa L., 2003, Cancer, V97, P230, DOI 10.1002/cncr.11018; Booi RC, 2008, ULTRASOUND MED BIOL, V34, P12, DOI 10.1016/j.ultrasmedbio.2007.07.003; Bosch AM, 2003, BRIT J RADIOL, V76, P328, DOI 10.1259/bjr/17252624; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Buchberger W, 2000, SEMIN ULTRASOUND CT, V21, P325, DOI 10.1016/S0887-2171(00)90027-1; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Corsetti V, 2006, RADIOL MED, V111, P440, DOI 10.1007/s11547-006-0040-5; Crystal P, 2003, AM J ROENTGENOL, V181, P177, DOI 10.2214/ajr.181.1.1810177; D'Orsi C, 2003, BREAST IMAGING REPOR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Farria DM, 2005, CANCER-AM CANCER SOC, V104, P491, DOI 10.1002/cncr.21304; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; GORDON PB, 1995, CANCER, V76, P626, DOI 10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z; Harvey JA, 2004, RADIOLOGY, V230, P29, DOI 10.1148/radiol.2301020870; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Kaplan SS, 2001, RADIOLOGY, V221, P641, DOI 10.1148/radiol.2213010364; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Kolb TM, 1998, RADIOLOGY, V207, P191, DOI 10.1148/radiology.207.1.9530316; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Leconte I, 2003, AM J ROENTGENOL, V180, P1675, DOI 10.2214/ajr.180.6.1801675; Lehman CD, 2007, RADIOLOGY, V244, P381, DOI 10.1148/radiol.2442060461; Leisenring W, 2000, BIOMETRICS, V56, P345, DOI 10.1111/j.0006-341X.2000.00345.x; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Mendelson EB, 2003, BREAST IMAGING REPOR; Menell JH, 2005, BREAST J, V11, P382, DOI 10.1111/j.1075-122X.2005.00121.x; Metz CE, 1984, INFORMATION PROCESSI; Michaelson JS, 2003, CANCER, V98, P2133, DOI 10.1002/cncr.11765; Michaelson JS, 2002, CANCER, V95, P713, DOI 10.1002/cncr.10742; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Rosenberg RD, 2006, RADIOLOGY, V241, P55, DOI 10.1148/radiol.2411051504; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schell MJ, 2007, RADIOLOGY, V243, P681, DOI 10.1148/radiol.2433060372; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Stomper PC, 1996, AM J ROENTGENOL, V167, P1261, DOI 10.2214/ajr.167.5.8911192; Swan JS, 2006, MED DECIS MAKING, V26, P347, DOI 10.1177/0272989X06290490; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tabar L., 2007, RADIOGRAPHICS, V27, pS5; Warner E, 2004, JAMA-J AM MED ASSOC, V292, P1317, DOI 10.1001/jama.292.11.1317; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	47	972	1008	1	65	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2151	2163		10.1001/jama.299.18.2151	http://dx.doi.org/10.1001/jama.299.18.2151			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477782	Green Accepted, Bronze			2022-12-28	WOS:000255790000022
J	Potts, M; Halperin, DT; Kirby, D; Swidler, A; Marseille, E; Klausner, JD; Hearst, N; Wamai, RG; Kahn, JG; Walsh, J				Potts, Malcolm; Halperin, Daniel T.; Kirby, Douglas; Swidler, Ann; Marseille, Elliot; Klausner, Jeffrey D.; Hearst, Norman; Wamai, Richard G.; Kahn, James G.; Walsh, Julia			Public health - Reassessing HIV prevention	SCIENCE			English	Editorial Material							MALE CIRCUMCISION; BEHAVIOR-CHANGE; INFECTION; REDUCTION; COUNTRIES		[Halperin, Daniel T.; Wamai, Richard G.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Potts, Malcolm; Walsh, Julia] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Kirby, Douglas] ETR Assoc, Scotts Valley, CA 95066 USA; [Swidler, Ann] Univ Calif Berkeley, Dept Sociol, Berkeley, CA 94720 USA; [Marseille, Elliot; Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, San Francisco, CA 94103 USA; [Hearst, Norman] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; San Francisco Department of Public Health; University of California System; University of California San Francisco	Halperin, DT (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	daniel_halperin@harvard.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA015612, R01 DA015612-08] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Carter MW, 2007, AIDS BEHAV, V11, P822, DOI 10.1007/s10461-006-9203-6; Cassell MM, 2007, LANCET INFECT DIS, V7, P491, DOI 10.1016/S1473-3099(07)70114-7; Cohen J, 2008, SCIENCE, V319, P888, DOI 10.1126/science.319.5865.888; Corbett EL, 2007, AIDS, V21, P483, DOI 10.1097/QAD.0b013e3280115402; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; EPSTEIN H, 2007, INVISIBLE CURE AFRIC; Gray RH, 2007, LANCET, V370, P200, DOI 10.1016/S0140-6736(07)61058-7; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Halperin DT, 2007, S AFR J HIV MED, P19; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Hearst N, 2004, STUD FAMILY PLANN, V35, P39, DOI 10.1111/j.1728-4465.2004.00004.x; Klausner Jeffrey D, 2008, Futur HIV Ther, V2, P1, DOI 10.2217/17469600.2.1.1; Maman S, 2003, AIDS BEHAV, V7, P373, DOI 10.1023/B:AIBE.0000004729.89102.d4; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; *SDAC, 2006, EXP THINK TANK M HIV; Shelton JD, 2007, LANCET, V370, P1809, DOI 10.1016/S0140-6736(07)61755-3; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; *UNAIDS, 2007, UNAIDS PUBL; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; 2007, ECONOMIST       0628, P95	26	159	160	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					749	750		10.1126/science.1153843	http://dx.doi.org/10.1126/science.1153843			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	297VB	18467575	Green Accepted			2022-12-28	WOS:000255644400023
J	DasGupta, S				DasGupta, Sayantani			The question	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sd2030@columbia.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2003	2004		10.1001/jama.299.17.2003	http://dx.doi.org/10.1001/jama.299.17.2003			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460654				2022-12-28	WOS:000255552700001
J	Fiore, MC; Jaen, CR				Fiore, Michael C.; Jaen, Carlos Roberto			A clinical blueprint to accelerate the elimination of tobacco use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING-CESSATION; HEALTH-CARE		[Fiore, Michael C.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Madison, WI 53706 USA; [Jaen, Carlos Roberto] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA	University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio	Fiore, MC (corresponding author), Univ Wisconsin, Ctr Tobacco Res & Intervent, 1300 Univ Ave, Madison, WI 53706 USA.	mcf@ctri.medicine.wisc.edu		Jaen, Carlos Roberto/0000-0001-5904-4719				Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Bellows NM, 2007, MED CARE, V45, P350, DOI 10.1097/01.mlr.0000254610.90363.dc; Curry SJ, 2006, AM J PREV MED, V31, P269, DOI 10.1016/j.amepre.2006.05.003; Fiore MC, 1996, SMOKING CESSATION CL; Fiore MC, 2008, TREATING TOBACCO USE; FIORE MC, 2000, TREATING TOBACCO USE; Fiore MC, 2007, AM J PREV MED, V33, pS349, DOI 10.1016/j.amepre.2007.09.001; Keller PA, 2005, NICOTINE TOB RES, V7, pS5, DOI 10.1080/14622200500077966; McPhillips-Tangum Carol, 2006, Prev Chronic Dis, V3, pA87; Orleans CT, 2007, AM J PREV MED, V33, pS340, DOI 10.1016/j.amepre.2007.09.003; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Steinberg MB, 2006, AM J HEALTH BEHAV, V30, P375, DOI 10.5993/AJHB.30.4.4	12	100	101	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2083	2085		10.1001/jama.299.17.2083	http://dx.doi.org/10.1001/jama.299.17.2083			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460668				2022-12-28	WOS:000255552700026
J	Garnero, EJ; McNamara, AK				Garnero, Edward J.; McNamara, Allen K.			Structure and dynamics of Earth's lower mantle	SCIENCE			English	Review							POST-PEROVSKITE PHASE; VELOCITY STRUCTURE; D''; TRANSITION; BOUNDARY; BENEATH; CORE; TOMOGRAPHY; MGSIO3; WAVE	Processes within the lowest several hundred kilometers of Earth's rocky mantle play a critical role in the evolution of the planet. Understanding Earth's lower mantle requires putting recent seismic and mineral physics discoveries into a self- consistent, geodynamically feasible context. Two nearly antipodal large low- shear- velocity provinces in the deep mantle likely represent chemically distinct and denser material. High- resolution seismological studies have revealed laterally varying seismic velocity discontinuities in the deepest few hundred kilometers, consistent with a phase transition from perovskite to post- perovskite. In the deepest tens of kilometers of the mantle, isolated pockets of ultralow seismic velocities may denote Earth's deepest magma chamber.	[Garnero, Edward J.; McNamara, Allen K.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Garnero, EJ (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Box 871404, Tempe, AZ 85287 USA.	garnero@asu.edu	McNamara, Allen/P-3144-2014	McNamara, Allen/0000-0003-3866-9503				Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Buffett BA, 2000, SCIENCE, V290, P1338, DOI 10.1126/science.290.5495.1338; CHRISTENSEN UR, 1994, J GEOPHYS RES-SOL EA, V99, P19867, DOI 10.1029/93JB03403; Davaille A, 2005, EARTH PLANET SC LETT, V239, P233, DOI 10.1016/j.epsl.2005.07.024; Garnero EJ, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003004; GARNERO EJ, 2007, ORIGIN MELTING ANOMA, P79; Grand SP., 1997, GSA TODAY, V7, P1; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Hirose K, 2005, EARTH PLANET SC LETT, V237, P239, DOI 10.1016/j.epsl.2005.06.035; Hutko AR, 2006, NATURE, V441, P333, DOI 10.1038/nature04757; Jellinek AM, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000144; Kito T, 2007, GEOPHYS J INT, V169, P631, DOI 10.1111/j.1365-246X.2007.03350.x; KNITTLE E, 1991, SCIENCE, V251, P1438, DOI 10.1126/science.251.5000.1438; Lay T, 1998, GEODYNAMICS, V28, P299; LAY T, 1983, GEOPHYS J ROY ASTR S, V75, P799, DOI 10.1111/j.1365-246X.1983.tb05010.x; Lay T, 2007, GEOPHYS MONOGR SER, V174, P129, DOI 10.1029/174GM11; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; Lin JF, 2007, SCIENCE, V317, P1740, DOI 10.1126/science.1144997; Mao WL, 2006, SCIENCE, V312, P564, DOI 10.1126/science.1123442; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Merkel S, 2007, SCIENCE, V316, P1729, DOI 10.1126/science.1140609; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Nakagawa T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020648; Ni SD, 2002, SCIENCE, V296, P1850, DOI 10.1126/science.1070698; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ritsema J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002610; Rost S, 2005, NATURE, V435, P666, DOI 10.1038/nature03620; TACKLEY PJ, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI DOI 10.1029/2001BC000167; Tan E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024190; Thomas C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003013; Thorne MS, 2004, PHYS EARTH PLANET IN, V146, P47, DOI 10.1016/j.pepi.2003.09.026; Thorne MS, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003010; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; van der Hilst RD, 2006, GEOPHYS J INT, V167, P1211, DOI 10.1111/J.1365-246X.2006.03211.x; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; Wallace M, 2005, PHYS EARTH PLANET IN, V151, P115, DOI 10.1016/j.pepi.2005.02.001; Wang Y, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004483; WEBER M, 1990, GEOPHYS J INT, V102, P231, DOI 10.1111/j.1365-246X.1990.tb00544.x; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345; Wysession ME, 1998, GEODYNAMICS, V28, P273	42	297	313	2	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					626	628		10.1126/science.1148028	http://dx.doi.org/10.1126/science.1148028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451293				2022-12-28	WOS:000255454300034
J	Kurant, E; Axelrod, S; Leaman, D; Gaul, U				Kurant, Estee; Axelrod, Sofia; Leaman, Dan; Gaul, Ulrike			Six-microns-under acts upstream of draper in the glial phagocytosis of apoptotic neurons	CELL			English	Article							PROGRAMMED CELL-DEATH; CAENORHABDITIS-ELEGANS; HOMOLOGOUS RECOMBINATION; DROSOPHILA METAMORPHOSIS; ENGULFMENT RECEPTOR; SCAVENGER RECEPTOR; CORPSE ENGULFMENT; NERVOUS-SYSTEM; C-ELEGANS; CLEARANCE	The removal of apoptotic cells by phagocytic neighbors is essential for metazoan development but remains poorly characterized. Here we report the discovery of a Drosophila phagocytosis receptor, Six-microns-under (SIMU), which is expressed in highly phagocytic cell types during development and required for efficient apoptotic cell clearance by glia in the nervous system and by macrophages elsewhere. SIMU is part of a conserved family of proteins that includes CED-1 and Draper (DRPR). Phenotypic analysis reveals that simu acts upstream of drpr in the same pathway and affects the recognition and engulfment of apoptotic cells, while drpr affects their subsequent degradation. SIMU strongly binds to apoptotic cells, presumably through its EMILIN-like domain, but requires no membrane anchoring, suggesting that it can function as a bridging molecule. Our study introduces an important factor in tissue-resident apoptotic clearance and underscores the prominent role of glia as "semiprofessional'' phagocytes in the nervous system.	[Kurant, Estee; Axelrod, Sofia; Leaman, Dan; Gaul, Ulrike] Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10065 USA	Rockefeller University	Gaul, U (corresponding author), Rockefeller Univ, Lab Dev Neurogenet, 1230 York Ave, New York, NY 10065 USA.	gaul@mail.rockefeller.edu	Kurant, Estee/ADQ-6246-2022	Kurant, Estee/0000-0003-4795-4074; Axelrod, Sofia/0000-0003-4024-8521	NEI NIH HHS [R01 EY011560-10, R01 EY011560, EY011560] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011560, R55EY011560] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Adachi H, 1997, J BIOL CHEM, V272, P31217, DOI 10.1074/jbc.272.50.31217; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Callebaut I, 2003, BIOCHEM BIOPH RES CO, V300, P619, DOI 10.1016/S0006-291X(02)02904-2; Finn JT, 2000, J NEUROSCI, V20, P1333; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li W, 2007, CELL, V129, P1215, DOI 10.1016/j.cell.2007.03.054; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Mergliano J, 2003, DEVELOPMENT, V130, P5779, DOI 10.1242/dev.00824; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Silva E, 2007, IMMUNITY, V27, P585, DOI 10.1016/j.immuni.2007.08.016; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; TRUMAN JW, 1992, J NEUROBIOL, V23, P1295, DOI 10.1002/neu.480230917; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wood W, 2000, DEVELOPMENT, V127, P5245; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	46	121	124	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					498	509		10.1016/j.cell.2008.02.052	http://dx.doi.org/10.1016/j.cell.2008.02.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455990	Green Accepted, Bronze			2022-12-28	WOS:000255503900020
J	Giustino, F; Cohen, ML; Louie, SG				Giustino, Feliciano; Cohen, Marvin L.; Louie, Steven G.			Small phonon contribution to the photoemission kink in the copper oxide superconductors	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; CUPRATE SUPERCONDUCTORS; ENERGY; DISPERSION; STATE	Despite over two decades of intense research efforts, the origin of high- temperature superconductivity in the copper oxides remains elusive. Angle- resolved photoemission spectroscopy experiments(1,2) have revealed a kink in the dispersion relations ( energy versus wavevector) of electronic states in the copper oxides at binding energies of 50-80 meV, raising the hope that this anomaly could be a key to understanding high- temperature superconductivity. The kink is often interpreted in terms of interactions between the electrons and a bosonic field. Although there is no consensus on the nature of the bosons ( or even whether a boson model is appropriate), both phonons(1) and spin fluctuations(2) have been proposed as possible candidates. Here we report first- principles calculations of the role of phonons and the electron - phonon interaction in the photoemission spectra of La2-xSrxCuO4. Our calculations within the standard formalism demonstrate that the phonon- induced renormalization of the electron energies and the Fermi velocity is almost one order of magnitude smaller than the effect observed in photoemission experiments. Therefore, our result rules out electron - phonon interaction in bulk La2-xSrxCuO4 as the exclusive origin of the measured kink. Our conclusions are consistent with those reached independently in a recent study(3) of the related compound YBa2Cu3O7.	[Giustino, Feliciano; Cohen, Marvin L.; Louie, Steven G.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Giustino, Feliciano; Cohen, Marvin L.; Louie, Steven G.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Louie, SG (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	sglouie@berkeley.edu	Giustino, Feliciano/AAM-2551-2020; Giustino, Feliciano/F-6343-2013; Giustino, Feliciano/ABD-5408-2021	Giustino, Feliciano/0000-0001-9293-1176				ALLEN PB, 1982, SOLID STATE PHYS, V37, P1; Baroni S, 2001, REV MOD PHYS, V73, P515, DOI 10.1103/RevModPhys.73.515; Bohnen KP, 2003, EUROPHYS LETT, V64, P104, DOI 10.1209/epl/i2003-00143-x; CHEN XK, 1994, PHYS REV LETT, V73, P3290, DOI 10.1103/PhysRevLett.73.3290; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Eschrig M, 2000, PHYS REV LETT, V85, P3261, DOI 10.1103/PhysRevLett.85.3261; Falter C, 2005, PHYS STATUS SOLIDI B, V242, P78, DOI 10.1002/pssb.200404953; Farid B, 2004, PHILOS MAG, V84, P909, DOI 10.1080/14786430310001627403; Giustino F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165108; Giustino F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.047005; Grimvall G., 1981, ELECT PHONON INTERAC; Hedin L., 1969, SOLID STATE PHYS, V15, P1; HEID R, IN PRESS PHYS REV LE; IHM J, 1979, J PHYS C SOLID STATE, V12, P4409, DOI 10.1088/0022-3719/12/21/009; Ino A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.094504; Johnson PD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.177007; Lanzara A, 2001, NATURE, V412, P510, DOI 10.1038/35087518; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; McQueeney RJ, 1999, PHYS REV LETT, V82, P628, DOI 10.1103/PhysRevLett.82.628; McQueeney RJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.077001; Meevasana W, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.157003; PERDEW JP, 1992, PHYS REV B, V46, P12947, DOI 10.1103/PhysRevB.46.12947; Phillips JC, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.214503; PICKETT WE, 1989, REV MOD PHYS, V61, P433, DOI 10.1103/RevModPhys.61.433; PINTSCHOVIUS L, 1991, PHYSICA C, V185, P156, DOI 10.1016/0921-4534(91)91965-7; Sahrakorpi S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.157601; Savrasov SY, 1996, PHYS REV LETT, V77, P4430, DOI 10.1103/PhysRevLett.77.4430; Valla T, 2006, SCIENCE, V314, P1914, DOI 10.1126/science.1134742; Zhou XJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.187001	29	134	134	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					975	978		10.1038/nature06874	http://dx.doi.org/10.1038/nature06874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432241				2022-12-28	WOS:000255208600035
J	Stayrook, S; Jaru-Ampornpan, P; Ni, J; Hochschild, A; Lewis, M				Stayrook, Steven; Jaru-Ampornpan, Peera; Ni, Jenny; Hochschild, Ann; Lewis, Mitchell			Crystal structure of the lambda repressor and a model for pairwise cooperative operator binding	NATURE			English	Article							BACTERIOPHAGE-LAMBDA; LEXA; CLEAVAGE; DOMAIN; CRYSTALLOGRAPHY; RECOGNITION; PROTEIN; DIMERS	Bacteriophage lambda has for many years been a model system for understanding mechanisms of gene regulation(1). A 'genetic switch' enables the phage to transition from lysogenic growth to lytic development when triggered by specific environmental conditions. The key component of the switch is the cI repressor, which binds to two sets of three operator sites on the lambda chromosome that are separated by about 2,400 base pairs (bp)(2,3). A hallmark of the lambda system is the pairwise cooperativity of repressor binding(4). In the absence of detailed structural information, it has been difficult to understand fully how repressor molecules establish the cooperativity complex. Here we present the X- ray crystal structure of the intact lambda cI repressor dimer bound to a DNA operator site. The structure of the repressor, determined by multiple isomorphous replacement methods, reveals an unusual overall architecture that allows it to adopt a conformation that appears to facilitate pairwise cooperative binding to adjacent operator sites.	[Stayrook, Steven; Jaru-Ampornpan, Peera; Ni, Jenny; Lewis, Mitchell] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19102 USA; [Hochschild, Ann] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Pennsylvania; Harvard University; Harvard Medical School	Lewis, M (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 37th & Hamilton Walk, Philadelphia, PA 19102 USA.	lewis@mail.med.upenn.edu		Stayrook, Steven/0000-0002-1677-8293	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044025] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Bell CE, 2001, J MOL BIOL, V314, P1127, DOI 10.1006/jmbi.2000.5196; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang G, 1997, ACTA CRYSTALLOGR D, V53, P279, DOI 10.1107/S0907444996014990; Dodd IB, 2001, GENE DEV, V15, P3013, DOI 10.1101/gad.937301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; MANIATIS T, 1975, CELL, V5, P109, DOI 10.1016/0092-8674(75)90018-5; MANIATIS T, 1973, P NATL ACAD SCI USA, V70, P1531, DOI 10.1073/pnas.70.5.1531; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PTASHNE M, 2004, GENETIC SWITCH; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; ROLAND KL, 1992, J MOL BIOL, V228, P395, DOI 10.1016/0022-2836(92)90829-9; SAUER RT, 1982, J BIOL CHEM, V257, P4458; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WHIPPLE FW, 1994, GENE DEV, V8, P1212, DOI 10.1101/gad.8.10.1212; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235	23	71	73	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					1022	U12		10.1038/nature06831	http://dx.doi.org/10.1038/nature06831			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432246				2022-12-28	WOS:000255208600045
J	Tombe, M				Tombe, Martin			Hemoglobinuria with malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tombe, Martin] Mpilo Hosp, Bulawayo, Zimbabwe		Tombe, M (corresponding author), Mpilo Hosp, Bulawayo, Zimbabwe.	mtombe@mweb.co.zw							0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1837	1837		10.1056/NEJMicm070121	http://dx.doi.org/10.1056/NEJMicm070121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434653				2022-12-28	WOS:000255209200010
J	Li, LB; Yu, ZM; Teng, XY; Bonini, NM				Li, Ling-Bo; Yu, Zhenming; Teng, Xiuyin; Bonini, Nancy M.			RNA toxicity is a component of ataxin-3 degeneration in Drosophila	NATURE			English	Article							POLYGLUTAMINE-INDUCED DISEASE; MYOTONIC-DYSTROPHY TYPE-1; SCA1 TRANSGENIC MICE; MUSCLEBLIND PROTEINS; BINDING PROTEIN; NUCLEAR FOCI; NEURODEGENERATION; REPEATS; AGGREGATION; INCLUSIONS	Polyglutamine (polyQ) diseases are a class of dominantly inherited neurodegenerative disorders caused by the expansion of a CAG repeat encoding glutamine within the coding region of the respective genes(1). The molecular and cellular pathways underlying polyQ-induced neurodegeneration are the focus of much research, and it is widely considered that toxic activities of the protein, resulting from the abnormally long polyQ tract, cause pathogenesis(2,3). Here we provide evidence for a pathogenic role of the CAG repeat RNA in polyQ toxicity using Drosophila. In a Drosophila screen for modifiers of polyQ degeneration induced by the spinocerebellar ataxia type 3 (SCA3) protein ataxin-3, we isolated an upregulation allele of muscleblind (mbl), a gene implicated in the RNA toxicity of CUG expansion diseases(4-6). Further analysis indicated that there may be a toxic role of the RNA in polyQ-induced degeneration. We tested the role of the RNA by altering the CAG repeat sequence to an interrupted CAACAG repeat within the polyQ-encoding region; this dramatically mitigated toxicity. In addition, expression of an untranslated CAG repeat of pathogenic length conferred neuronal degeneration. These studies reveal a role for the RNA in polyQ toxicity, highlighting common components in RNA-based and polyQ-protein-based trinucleotide repeat expansion diseases.	[Li, Ling-Bo; Yu, Zhenming; Teng, Xiuyin; Bonini, Nancy M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Yu, Zhenming; Teng, Xiuyin; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania	Bonini, NM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu		Bonini, Nancy/0000-0003-0226-5291	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS043578-04, R01 NS043578-02, R01 NS043578-03, R01 NS043578-01A1, R01 NS043578, R01 NS043578-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043578] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Garcia-Casado Z, 2002, GENESIS, V34, P111, DOI 10.1002/gene.10147; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Goti D, 2004, J NEUROSCI, V24, P10266, DOI 10.1523/JNEUROSCI.2734-04.2004; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; Jin P, 2003, NEURON, V39, P739, DOI 10.1016/S0896-6273(03)00533-6; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McLeod CJ, 2005, HUM MOL GENET, V14, P1041, DOI 10.1093/hmg/ddi096; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Tapscott SJ, 2001, SCIENCE, V293, P816, DOI 10.1126/science.1063517; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064	30	234	238	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1107	U9		10.1038/nature06909	http://dx.doi.org/10.1038/nature06909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18449188	Green Accepted			2022-12-28	WOS:000256839900058
J	Graupera, M; Guillermet-Guibert, J; Foukas, LC; Phng, LK; Cain, RJ; Salpekar, A; Pearce, W; Meek, S; Millan, J; Cutillas, PR; Smith, AJH; Ridley, AJ; Ruhrberg, C; Gerhardt, H; Vanhaesebroeck, B				Graupera, Mariona; Guillermet-Guibert, Julie; Foukas, Lazaros C.; Phng, Li-Kun; Cain, Robert J.; Salpekar, Ashreena; Pearce, Wayne; Meek, Stephen; Millan, Jaime; Cutillas, Pedro R.; Smith, Andrew J. H.; Ridley, Anne J.; Ruhrberg, Christiana; Gerhardt, Holger; Vanhaesebroeck, Bart			Angiogenesis selectively requires the p110 alpha isoform of PI3K to control endothelial cell migration	NATURE			English	Article							GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; P110 DELTA; B-CELL; EXPRESSION; MICE; TRAFFICKING	Phosphoinositide 3- kinases ( PI3Ks) signal downstream of multiple cell- surface receptor types. Class IA PI3K isoforms(1) couple to tyrosine kinases and consist of a p110 catalytic subunit ( p110 alpha, p110 beta or p110 delta), constitutively bound to one of five distinct p85 regulatory subunits. PI3Ks have been implicated in angiogenesis(2-5), but little is known about potential selectivity among the PI3K isoforms and their mechanism of action in endothelial cells during angiogenesis in vivo. Here we show that only p110 alpha activity is essential for vascular development. Ubiquitous or endothelial cell- specific inactivation of p110 alpha led to embryonic lethality at mid- gestation because of severe defects in angiogenic sprouting and vascular remodelling. p110 alpha exerts this critical endothelial cell- autonomous function by regulating endothelial cell migration through the small GTPase RhoA. p110 alpha activity is particularly high in endothelial cells and preferentially induced by tyrosine kinase ligands ( such as vascular endothelial growth factor ( VEGF)- A). In contrast, p110 delta in endothelial cells signals downstream of G- protein- coupled receptor ( GPCR) ligands such as SDF-1 alpha, whereas p110 delta is expressed at low level and contributes only minimally to PI3K activity in endothelial cells. These results provide the first in vivo evidence for p110- isoform	[Phng, Li-Kun; Gerhardt, Holger] Canc Res UK London Res Inst, Vasc Biol Lab, London WC2A 3PX, England; [Graupera, Mariona; Guillermet-Guibert, Julie; Foukas, Lazaros C.; Salpekar, Ashreena; Pearce, Wayne; Cutillas, Pedro R.; Vanhaesebroeck, Bart] Queen Mary Univ London, Ctr Cell Signalling, Inst Canc, London EC1M 6BQ, England; [Cain, Robert J.; Millan, Jaime; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Meek, Stephen; Smith, Andrew J. H.] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Ruhrberg, Christiana] UCL, Dept Cell Biol, Inst Ophthalmol, London EC1V 9EL, England	Cancer Research UK; University of London; Queen Mary University London; University of London; King's College London; University of Edinburgh; University of London; University College London	Gerhardt, H (corresponding author), Canc Res UK London Res Inst, Vasc Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	Holger.gerhardt@cancer.org.uk; bart.vanh@qmul.ac.uk	Graupera, Mariona/J-1122-2017; Ruhrberg, Christiana/C-6404-2009; Phng, Li-Kun/L-7346-2013; Guillermet-Guibert, Julie/D-2317-2014; Gerhardt, Holger/G-4610-2011; Gerhardt, Holger/G-4610-2011	Graupera, Mariona/0000-0003-4608-4185; Ruhrberg, Christiana/0000-0002-3212-9381; Guillermet-Guibert, Julie/0000-0003-3173-4907; Gerhardt, Holger/0000-0002-3030-0384; Rodriguez Cutillas, Pedro/0000-0002-3426-2274; Pearce, Wayne/0000-0001-5407-4767; Gerhardt, Holger/0000-0001-9228-7472; Ridley, Anne/0000-0001-8186-5708; Millan, Jaime/0000-0003-3107-147X	Biotechnology and Biological Sciences Research Council [BB/C505659/1, BB/C505659/2] Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [G0700711, G0601093, G0601093(79633)] Funding Source: Medline; MRC [G0601093, G0700711] Funding Source: UKRI; Medical Research Council [G0700711B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bilancio A, 2006, BLOOD, V107, P642, DOI 10.1182/blood-2005-07-3041; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cutillas PR, 2006, P NATL ACAD SCI USA, V103, P8959, DOI 10.1073/pnas.0602101103; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Geng L, 2004, CANCER RES, V64, P4893, DOI 10.1158/0008-5472.CAN-03-3955; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; Gerhardt H, 2005, EXP SUPPL, V94, P3; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gille H, 2000, EMBO J, V19, P4064, DOI 10.1093/emboj/19.15.4064; GUILLERMETGUIBE.J, IN PRESS P NATL ACAD; Hughes S, 2000, MICROCIRCULATION, V7, P317, DOI 10.1038/sj.mn.7300119; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lelievre E, 2005, BLOOD, V105, P3935, DOI 10.1182/blood-2004-10-3955; Lidington EA, 2002, AM J PHYSIOL-CELL PH, V282, pC67, DOI 10.1152/ajpcell.2002.282.1.C67; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Okkenhaug K, 2002, SCIENCE, V297, P1031; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sawyer C, 2003, CANCER RES, V63, P1667; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wells Claire M., 2004, V294, P31; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	31	390	447	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					662	666		10.1038/nature06892	http://dx.doi.org/10.1038/nature06892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18449193				2022-12-28	WOS:000256185200046
J	Wrammert, J; Smith, K; Miller, J; Langley, WA; Kokko, K; Larsen, C; Zheng, NY; Mays, I; Garman, L; Helms, C; James, J; Air, GM; Capra, JD; Ahmed, R; Wilson, PC				Wrammert, Jens; Smith, Kenneth; Miller, Joe; Langley, William A.; Kokko, Kenneth; Larsen, Christian; Zheng, Nai-Ying; Mays, Israel; Garman, Lori; Helms, Christina; James, Judith; Air, Gillian M.; Capra, J. Donald; Ahmed, Rafi; Wilson, Patrick C.			Rapid cloning of high-affinity human monoclonal antibodies against influenza virus	NATURE			English	Article							MEMORY B-CELLS; IMMUNE-RESPONSE; VACCINATION; DIVERSITY; INFECTION; VACCINES; HEAVY	Pre- existing neutralizing antibody provides the first line of defence against pathogens in general. For influenza virus, annual vaccinations are given to maintain protective levels of antibody against the currently circulating strains. Here we report that after booster vaccination there was a rapid and robust influenza-specific IgG(+) antibody- secreting plasma cell ( ASC) response that peaked at approximately day 7 and accounted for up to 6% of peripheral blood B cells. These ASCs could be distinguished from influenza- specific IgG(+) memory B cells that peaked 14 - 21 days after vaccination and averaged 1% of all B cells. Importantly, as much as 80% of ASCs purified at the peak of the response were influenza specific. This ASC response was characterized by a highly restricted B- cell receptor ( BCR) repertoire that in some donors was dominated by only a few B- cell clones. This pauciclonal response, however, showed extensive intraclonal diversification from accumulated somatic mutations. We used the immunoglobulin variable regions isolated from sorted single ASCs to produce over 50 human monoclonal antibodies ( mAbs) that bound to the three influenza vaccine strains with high affinity. This strategy demonstrates that we can generate multiple high-affinity mAbs from humans within a month after vaccination. The panel of influenza- virus- specific human mAbs allowed us to address the issue of original antigenic sin ( OAS): the phenomenon where the induced antibody shows higher affinity to a previously encountered influenza virus strain compared with the virus strain present in the vaccine(1). However, we found that most of the influenza- virus- specific mAbs showed the highest affinity for the current vaccine strain. Thus, OAS does not seem to be a common occurrence in normal, healthy adults receiving influenza vaccination.	[Smith, Kenneth; Zheng, Nai-Ying; Mays, Israel; Garman, Lori; Helms, Christina; Wilson, Patrick C.] Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, Oklahoma City, OK 73104 USA; [Wrammert, Jens; Miller, Joe; Langley, William A.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Wrammert, Jens; Miller, Joe; Langley, William A.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Kokko, Kenneth; Larsen, Christian] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Kokko, Kenneth; Larsen, Christian] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [James, Judith] Oklahoma Med Res Fdn, Arthritis & Immunol Res Program, Oklahoma City, OK 73104 USA; [Capra, J. Donald] Oklahoma Med Res Fdn, Mol Immunogenet Res Program, Oklahoma City, OK 73104 USA; [James, Judith; Wilson, Patrick C.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [James, Judith] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Air, Gillian M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Capra, J. Donald; Wilson, Patrick C.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Emory University; Emory University; Emory University; Emory University; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Wilson, PC (corresponding author), Oklahoma Med Res Fdn, Immunobiol & Canc Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	wilsonp@omrf.org	Larsen, Christian P./B-6906-2012; Wilson, Patrick/HGC-3157-2022	Larsen, Christian P./0000-0001-6573-2649; Air, Gillian/0000-0001-5724-3108	NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NCRR NIH HHS [P20 RR018758-057588, P20 RR018758] Funding Source: Medline; NIAID NIH HHS [R01 AI050933, HHSN266200700006C, U19 AI057266-04, HHSN266200500026C, N01-AI-50025-02, N01AI50025, U19-AI057266-04, U19 AI057266] Funding Source: Medline; NIAMS NIH HHS [P30 AR053483] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI050933, N01AI050025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BROKSTAD KA, 1995, J INFECT DIS, V171, P198, DOI 10.1093/infdis/171.1.198; Brokstad KA, 2002, J INFECT DIS, V185, P878, DOI 10.1086/339710; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; COOK WD, 1977, P NATL ACAD SCI USA, V74, P5687, DOI 10.1073/pnas.74.12.5687; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; LLEWELYN MB, 1992, BMJ-BRIT MED J, V305, P1269, DOI 10.1136/bmj.305.6864.1269; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Meijer PJ, 2006, J MOL BIOL, V358, P764, DOI 10.1016/j.jmb.2006.02.040; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Poulsen TR, 2007, J IMMUNOL, V179, P3841, DOI 10.4049/jimmunol.179.6.3841; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WEBSTER RG, 2002, WHO MANUAL ANIMAL IN; Wilson PC, 2000, J EXP MED, V191, P1881, DOI 10.1084/jem.191.11.1881; Zheng NY, 2005, J EXP MED, V201, P1467, DOI 10.1084/jem.20042483; Zheng NY, 2004, J CLIN INVEST, V113, P1188, DOI 10.1172/JCI200420255	28	754	893	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 29	2008	453	7195					667	U10		10.1038/nature06890	http://dx.doi.org/10.1038/nature06890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18449194	Green Accepted, Bronze			2022-12-28	WOS:000256185200047
J	Argiris, A; Karamouzis, MV; Raben, D; Ferris, RL				Argiris, Athanassios; Karamouzis, Michalis V.; Raben, David; Ferris, Robert L.			Head and neck cancer	LANCET			English	Review							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; LOCOREGIONALLY ADVANCED HEAD; CISPLATIN PLUS FLUOROURACIL; QUALITY-OF-LIFE; PHASE-III TRIAL; GROWTH-FACTOR RECEPTOR; 2ND PRIMARY TUMORS; RADIATION-THERAPY; HUMAN-PAPILLOMAVIRUS	Most head and neck cancers are squamous cell carcinomas that develop in the upper aerodigestive epithelium after exposure to carcinogens such as tobacco and alcohol. Human papillomavirus has also been strongly implicated as a causative agent in a subset of these cancers. The complex anatomy and vital physiological role of the tumour-involved structures dictate that the goals of treatment are not only to improve survival outcomes but also to preserve organ function. Major improvements have been accomplished in surgical techniques and radiotherapy delivery. Moreover, systemic therapy including chemotherapy and molecularly targeted agents-namely, the epidermal growth factor receptor inhibitors-has been successfully integrated into potentially curative treatment of locally advanced squamous-cell carcinoma of the head and neck. In deciding which treatment strategy would be suitable for an individual patient, important considerations include expected functional outcomes, ability to tolerate treatment, and comorbid illnesses. The collaboration of many specialties is the key for optimum assessment and decision making. We review the epidemiology, molecular pathogenesis, diagnosis and staging, and the latest multimodal management of squamous cell carcinoma of the head and neck.	[Argiris, Athanassios; Karamouzis, Michalis V.] Univ Pittsburgh, Div Hematol Oncol, Dept Med, Pittsburgh, PA 15232 USA; [Argiris, Athanassios; Karamouzis, Michalis V.; Ferris, Robert L.] Univ Pittsburgh, Pittsburgh Canc Inst, Head & Neck Canc Program, Pittsburgh, PA USA; [Raben, David] Univ Colorado, Dept Radiat Oncol, Denver, CO 80202 USA; [Ferris, Robert L.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Ferris, Robert L.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Ferris, Robert L.] Univ Pittsburgh, Pittsburgh Canc Inst, Canc Immunol Immunotherapy & Immunoprevent Progra, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; University of Colorado System; University of Colorado Denver; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Argiris, A (corresponding author), Univ Pittsburgh, Div Hematol Oncol, Dept Med, UPMC Canc Pavil,5th Floor, Pittsburgh, PA 15232 USA.	argirisae@upmc.edu	Karamouzis, Michalis/AAD-2860-2020	Argiris, Athanassios/0000-0003-4075-8812	NATIONAL CANCER INSTITUTE [P50CA097190] Funding Source: NIH RePORTER; NCI NIH HHS [P50CA097190, P50 CA097190] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abendstein H, 2005, LARYNGOSCOPE, V115, P2183, DOI 10.1097/01.MLG.0000181507.69620.14; Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Allal AS, 2003, HEAD NECK-J SCI SPEC, V25, P833, DOI 10.1002/hed.10302; Ambrosch Petra, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P82, DOI 10.1097/MOO.0b013e3280147336; Annertz K, 2002, INT J CANCER, V101, P95, DOI 10.1002/ijc.10577; [Anonymous], 2006, SEER CANC STAT REV 1; Argiris A, 2003, CANC TREAT, V114, P15; Argiris A, 2004, HEAD NECK-J SCI SPEC, V26, P447, DOI 10.1002/hed.10394; Argiris A, 2004, CLIN CANCER RES, V10, P1956, DOI 10.1158/1078-0432.CCR-03-1077; Argiris A, 2003, ANN ONCOL, V14, P1306, DOI 10.1093/annonc/mdg330; Argiris Athanassios, 2005, J Natl Compr Canc Netw, V3, P393; Bachaud JM, 1996, INT J RADIAT ONCOL, V36, P999, DOI 10.1016/S0360-3016(96)00430-0; Balz V, 2003, CANCER RES, V63, P1188; Bentzen SM, 2003, INT J RADIAT BIOL, V79, P581, DOI 10.1080/09553000310001597002; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2005, NAT CLIN PRACT ONCOL, V2, P305, DOI 10.1038/ncponc0201; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bese NS, 2007, INT J RADIAT ONCOL, V68, P654, DOI 10.1016/j.ijrobp.2007.03.010; BLOT WJ, 1988, CANCER RES, V48, P3282; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bourhis J, 2004, J CLIN ONCOL, V22, p489S; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Branstetter BF, 2005, RADIOLOGY, V235, P580, DOI 10.1148/radiol.2352040134; Brennan M, 2007, ORAL SURG ORAL MED O, V103, pS19, DOI 10.1016/j.tripleo.2006.10.015; Brizel DM, 1998, NEW ENGL J MED, V338, P1798, DOI 10.1056/NEJM199806183382503; Brockstein B, 2004, ANN ONCOL, V15, P1179, DOI 10.1093/annonc/mdh308; Budach V, 2005, J CLIN ONCOL, V23, P1125, DOI 10.1200/JCO.2005.07.010; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Calais G, 2006, J CLIN ONCOL, V24, p281S; Calais G, 1999, J NATL CANCER I, V91, P2081, DOI 10.1093/jnci/91.24.2081; Califano J, 1996, CANCER RES, V56, P2488; Capaccio P, 2000, HEAD NECK-J SCI SPEC, V22, P234, DOI 10.1002/(SICI)1097-0347(200005)22:3<234::AID-HED5>3.0.CO;2-3; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cohen EEW, 2004, J CLIN ONCOL, V22, P1743, DOI 10.1200/JCO.2004.06.147; Colevas AD, 2006, J CLIN ONCOL, V24, P2644, DOI 10.1200/JCO.2005.05.3348; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; COOPER JS, 2006, ANN M AM SOC THER RA; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; DEANDRES L, 1995, J CLIN ONCOL, V13, P1493, DOI 10.1200/JCO.1995.13.6.1493; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Dey P, 2002, COCHRANE DB SYST REV, V2; Ding MS, 2005, OTOLARYNG CLIN N AM, V38, P371, DOI 10.1016/j.otc.2004.10.009; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Do KA, 2003, CANCER CAUSE CONTROL, V14, P131, DOI 10.1023/A:1023060315781; Domenge C, 2000, BRIT J CANCER, V83, P1594, DOI 10.1054/bjoc.2000.1512; Duvvuri U, 2004, LARYNGOSCOPE, V114, P2228, DOI 10.1097/01.mlg.0000149464.73080.20; Eisbruch A, 2004, INT J RADIAT ONCOL, V59, P28, DOI 10.1016/j.ijrobp.2003.10.032; Ferlito A, 2006, ORAL ONCOL, V42, P14, DOI 10.1016/j.oraloncology.2005.03.009; FERRARA N, 2005, ONCOLOGY S3, V69, pS11; Ferris RL, 2005, IMMUNOL RES, V33, P113, DOI 10.1385/IR:33:2:113; Ferris RL, 2005, CANCER RES, V65, P2147, DOI 10.1158/0008-5472.CAN-04-3717; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; FORASTIERE AA, 1992, J CLIN ONCOL, V10, P1245, DOI 10.1200/JCO.1992.10.8.1245; Forastiere AA, 2006, J CLIN ONCOL, V24, P5517; Foulkes WD, 1996, BMJ-BRIT MED J, V313, P716, DOI 10.1136/bmj.313.7059.716; Fu KK, 2000, INT J RADIAT ONCOL, V48, P7, DOI 10.1016/S0360-3016(00)00663-5; Garavello W, 2006, ANN ONCOL, V17, P1459, DOI 10.1093/annonc/mdl166; Garden Adam S, 2006, Curr Oncol Rep, V8, P140, DOI 10.1007/s11912-006-0049-x; Garden AS, 2004, J CLIN ONCOL, V22, P2856, DOI 10.1200/JCO.2004.12.012; Gibson MK, 2005, J CLIN ONCOL, V23, P3562, DOI 10.1200/JCO.2005.01.057; Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573; GRANDIS JR, 1993, CANCER RES, V53, P3579; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Greenberg JS, 2003, CANCER, V98, P508, DOI 10.1002/cncr.11526; Ha PK, 2006, LANCET ONCOL, V7, P77, DOI 10.1016/S1470-2045(05)70540-4; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPI-05-0710; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Hitt R, 2005, J CLIN ONCOL, V23, P8636, DOI 10.1200/JCO.2004.00.1990; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; Huguenin P, 2004, J CLIN ONCOL, V22, P4665, DOI 10.1200/JCO.2004.12.193; JANOT F, 2006, J CLIN ONCOL S18, V24, P5508; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeremic B, 1997, RADIOTHER ONCOL, V43, P29, DOI 10.1016/S0167-8140(97)00048-0; Jeremic B, 2000, J CLIN ONCOL, V18, P1458, DOI 10.1200/JCO.2000.18.7.1458; Jones AS, 2004, HEAD NECK-J SCI SPEC, V26, P127, DOI 10.1002/hed.10361; Karamouzis MV, 2007, JAMA-J AM MED ASSOC, V298, P70, DOI 10.1001/jama.298.1.70; Kendal WS, 2007, ANN ONCOL, V18, P381, DOI 10.1093/annonc/mdl385; Khuri FR, 2006, JNCI-J NATL CANCER I, V98, P441, DOI 10.1093/jnci/djj091; Konski A, 2006, INT J RADIAT ONCOL, V66, P408, DOI 10.1016/j.ijrobp.2006.04.049; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kuss I, 2004, CLIN CANCER RES, V10, P3755, DOI 10.1158/1078-0432.CCR-04-0054; LARAMORE GE, 1992, INT J RADIAT ONCOL, V23, P705, DOI 10.1016/0360-3016(92)90642-U; Le QTX, 1997, INT J RADIAT ONCOL, V39, P115, DOI 10.1016/S0360-3016(97)00284-8; Lee JJ, 2000, CLIN CANCER RES, V6, P1702; Lefebvre JL, 2006, LANCET ONCOL, V7, P747, DOI 10.1016/S1470-2045(06)70860-9; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lippman SM, 2006, CLIN CANCER RES, V12, P3109, DOI 10.1158/1078-0432.CCR-05-2636; List MA, 1999, J CLIN ONCOL, V17, P1020, DOI 10.1200/JCO.1999.17.3.1020; List MA, 2000, J CLIN ONCOL, V18, P877, DOI 10.1200/JCO.2000.18.4.877; Lodi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001829.pub3; Lopez-Albaitero A, 2006, J IMMUNOL, V176, P3402, DOI 10.4049/jimmunol.176.6.3402; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; McCaul JA, 2002, LANCET ONCOL, V3, P280, DOI 10.1016/S1470-2045(02)00729-5; Mendenhall WM, 2006, AM J CLIN ONCOL-CANC, V29, P290, DOI 10.1097/01.coc.0000209510.19360.f9; Mendenhall WM, 2004, CANCER-AM CANCER SOC, V100, P1786, DOI 10.1002/cncr.20181; MORTON RP, 1985, CANCER CHEMOTH PHARM, V15, P283; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; MYERS EN, 1994, ANN OTO RHINOL LARYN, V103, P28, DOI 10.1177/000348949410300104; Nakamura K, 2006, INT J RADIAT ONCOL, V65, P1045, DOI 10.1016/j.ijrobp.2006.02.001; Ng SH, 2006, J CLIN ONCOL, V24, P4371, DOI 10.1200/JCO.2006.05.7349; Nguyen LN, 2002, LANCET ONCOL, V3, P693, DOI 10.1016/S1470-2045(02)00906-3; Olmi P, 2003, INT J RADIAT ONCOL, V55, P78, DOI 10.1016/S0360-3016(02)03792-6; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel SG, 2005, CA-CANCER J CLIN, V55, P242, DOI 10.3322/canjclin.55.4.242; Pavia M, 2006, AM J CLIN NUTR, V83, P1126, DOI 10.1093/ajcn/83.5.1126; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; PETERS LJ, 1993, INT J RADIAT ONCOL, V26, P3, DOI 10.1016/0360-3016(93)90167-T; Pfister DG, 2006, J CLIN ONCOL, V24, P3693, DOI 10.1200/JCO.2006.07.4559; Pfister DG, 2006, J CLIN ONCOL, V24, P1072, DOI 10.1200/JCO.2004.00.1792; Pignataro L, 1998, J CLIN ONCOL, V16, P3069, DOI 10.1200/JCO.1998.16.9.3069; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Proia NK, 2006, CANCER EPIDEM BIOMAR, V15, P1061, DOI 10.1158/1055-9965.EPI-05-0983; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Roepman P, 2006, CANCER RES, V66, P2361, DOI 10.1158/0008-5472.CAN-05-3960; Rosenthal DI, 2006, J CLIN ONCOL, V24, P2636, DOI 10.1200/JCO.2006.06.0079; Ryu JK, 2007, INT J RADIAT ONCOL, V67, P643, DOI 10.1016/j.ijrobp.2006.09.043; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Saraiya M, 2007, J CLIN ONCOL, V25; Schmalbach Cecelia E, 2007, Curr Oncol Rep, V9, P139, DOI 10.1007/s11912-007-0012-5; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Semrau R, 2006, INT J RADIAT ONCOL, V64, P1308, DOI 10.1016/j.ijrobp.2005.10.039; Shangina O, 2006, AM J EPIDEMIOL, V164, P367, DOI 10.1093/aje/kwj208; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Simental AA, 2006, ANN OTO RHINOL LARYN, V115, P846, DOI 10.1177/000348940611501109; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Smith BD, 2000, J CLIN ONCOL, V18, P2046, DOI 10.1200/JCO.2000.18.10.2046; Staar S, 2001, INT J RADIAT ONCOL, V50, P1161, DOI 10.1016/S0360-3016(01)01544-9; STEWART S, 2007, ANN M AM ASS CANC RE; Sturgis EM, 2002, CURR OPIN ONCOL, V14, P310, DOI 10.1097/00001622-200205000-00010; Suarez C, 2006, ORAL ONCOL, V42, P965, DOI 10.1016/j.oraloncology.2006.03.002; Suwinski R, 2003, INT J RADIAT ONCOL, V56, P399, DOI 10.1016/S0360-3016(02)04469-3; Suzuki M, 2006, RADIOTHER ONCOL, V78, P283, DOI 10.1016/j.radonc.2006.03.006; TRIZNA Z, 1992, OTOLARYNG CLIN N AM, V25, P1089; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403; Vermorken J, 2007, J CLIN ONCOL S, V25, P6091; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; VOKES EE, 1990, J CLIN ONCOL, V8, P911, DOI 10.1200/JCO.1990.8.5.911; Voynov G, 2006, TECHNOL CANCER RES T, V5, P529, DOI 10.1177/153303460600500510; Warnakulasuriya S, 2002, ADDICT BIOL, V7, P127, DOI 10.1080/13556210120091491; Weber RS, 2003, ARCH OTOLARYNGOL, V129, P44, DOI 10.1001/archotol.129.1.44; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wendt TG, 1998, J CLIN ONCOL, V16, P1318, DOI 10.1200/JCO.1998.16.4.1318; Witcher TP, 2007, BRIT J ORAL MAX SURG, V45, P19, DOI 10.1016/j.bjoms.2006.03.018; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; Zorat PL, 2004, JNCI-J NATL CANCER I, V96, P1714, DOI 10.1093/jnci/djh306; [No title captured]	153	1373	1407	0	167	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1695	1709		10.1016/S0140-6736(08)60728-X	http://dx.doi.org/10.1016/S0140-6736(08)60728-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486742	Green Accepted			2022-12-28	WOS:000256002200028
J	Christakis, NA				Christakis, Nicholas A.			Medicine may change our genes	BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Mt Auburn Hosp, Cambridge, MA 02138 USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; Christakis, Nicholas A/B-6690-2008						0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1101	1101		10.1136/bmj.39580.445856.59	http://dx.doi.org/10.1136/bmj.39580.445856.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483052	Green Published			2022-12-28	WOS:000255975100034
J	Pace, N; Seal, A; Costello, A				Pace, Noemi; Seal, Andrew; Costello, Anthony			Food commodity derivatives: a new cause of malnutrition?	LANCET			English	Editorial Material									[Pace, Noemi; Seal, Andrew; Costello, Anthony] Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1N 1EH, England	University of London; University College London	Pace, N (corresponding author), Inst Child Hlth, UCL Ctr Int Hlth & Dev, London WC1N 1EH, England.	n.pace@ich.ucl.ac.uk	Seal, Andrew/C-8550-2014	Seal, Andrew/0000-0003-3656-4054; Pace, Noemi/0000-0001-6413-4890				BLAS J, 2008, FT COM          0507; *CHIC BOARD TRAD, ROUGH RIC COMM TRAD; *CME GROUP, 2008, MONTHL AGR GRAINS UP; Dodd R., 2003, CONSEQUENCES LIBERAL; JEEHOON L, 2008, JOONGANG DAILY  0407; Sahi G. S., 2006, COMMODITY FUTURES MA; Sahi Gurpreet S, 2006, INFLUENCE COMMODITY; SHENK M, 2008, BLOOMBERG COM   0418; STEWART H, 2008, GUARDIAN        0420; *USDA, 2003, DAT SETS INT FOOD CO; Yang J, 2005, J BUS FINAN ACCOUNT, V32, P297, DOI 10.1111/j.0306-686X.2005.00595.x; 2007, ECONOMIST       1206; 2008, ECONOMIST       0427	13	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1648	1650		10.1016/S0140-6736(08)60707-2	http://dx.doi.org/10.1016/S0140-6736(08)60707-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486729	Green Submitted			2022-12-28	WOS:000256002200009
J	Baerenfaller, K; Grossmann, J; Grobei, MA; Hull, R; Hirsch-Hoffmann, M; Yalovsky, S; Zimmermann, P; Grossniklaus, U; Gruissem, W; Baginsky, S				Baerenfaller, Katja; Grossmann, Jonas; Grobei, Monica A.; Hull, Roger; Hirsch-Hoffmann, Matthias; Yalovsky, Shaul; Zimmermann, Philip; Grossniklaus, Ueli; Gruissem, Wilhelm; Baginsky, Sacha			Genome-scale proteomics reveals Arabidopsis thaliana gene models and proteome dynamics	SCIENCE			English	Article							PREDICTION; ANNOTATION; ABUNDANCE; PRIDE	We have assembled a proteome map for Arabidopsis thaliana from high-density, organ-specific proteome catalogs that we generated for different organs, developmental stages, and undifferentiated cultured cells. We matched 86,456 unique peptides to 13,029 proteins and provide expression evidence for 57 gene models that are not represented in the TAIR7 protein database. Analysis of the proteome identified organ-specific biomarkers and allowed us to compile an organ-specific set of proteotypic peptides for 4105 proteins to facilitate targeted quantitative proteomics surveys. Quantitative information for the identified proteins was used to establish correlations between transcript and protein accumulation in different plant organs. The Arabidopsis proteome map provides information about genome activity and proteome assembly and is available as a resource for plant systems biology.	[Baerenfaller, Katja; Grossmann, Jonas; Hirsch-Hoffmann, Matthias; Zimmermann, Philip; Gruissem, Wilhelm; Baginsky, Sacha] ETH, Swiss Fed Inst Technol, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Baerenfaller, Katja; Grossmann, Jonas; Grobei, Monica A.; Grossniklaus, Ueli; Gruissem, Wilhelm; Baginsky, Sacha] Univ Zurich, Ctr Model Organism Proteomes, CH-8057 Zurich, Switzerland; [Grossmann, Jonas; Gruissem, Wilhelm] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Grobei, Monica A.; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Hull, Roger] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Yalovsky, Shaul] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University of Manchester; Tel Aviv University	Baerenfaller, K (corresponding author), ETH, Swiss Fed Inst Technol, Inst Plant Sci, Universitatstr 2, CH-8092 Zurich, Switzerland.	kbaerenfaller@ethz.ch; wgruissem@ethz.ch; sbaginsky@ethz.ch	Baerenfaller, Katja/D-8799-2017; Grossniklaus, Ueli/A-2736-2012; Baerenfaller, Katja/Z-5765-2019; Gruissem, Wilhelm/H-1752-2013; Hull, Roger/B-4080-2013; Grossniklaus, Ueli/E-9995-2016; Zimmermann, Philip/J-4488-2012	Baerenfaller, Katja/0000-0002-1904-9440; Grossniklaus, Ueli/0000-0002-0522-8974; Gruissem, Wilhelm/0000-0002-1872-2998; Hirsch-Hoffmann, Matthias/0000-0002-4802-754X; Grossmann, Jonas/0000-0002-6899-9020; Baginsky, Sacha/0000-0002-5440-3898				Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Baginsky S, 2005, J PROTEOME RES, V4, P637, DOI 10.1021/pr049764u; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Eriksson J, 2007, NAT BIOTECHNOL, V25, P651, DOI 10.1038/nbt1315; Foissac S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-25; Gallardo K, 2007, MOL CELL PROTEOMICS, V6, P2165, DOI 10.1074/mcp.M700171-MCP200; Jones P, 2008, NUCLEIC ACIDS RES, V36, pD878, DOI 10.1093/nar/gkm1021; Jones P, 2006, NUCLEIC ACIDS RES, V34, pD659, DOI 10.1093/nar/gkj138; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; King NL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r106; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kuster B, 2005, NAT REV MOL CELL BIO, V6, P577, DOI 10.1038/nrm1683; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Nesvizhskii A.I., 2007, METHODS MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Roos FF, 2007, BIOINFORMATICS, V23, P3016, DOI 10.1093/bioinformatics/btm417; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	27	396	404	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					938	941		10.1126/science.1157956	http://dx.doi.org/10.1126/science.1157956			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18436743				2022-12-28	WOS:000255868300044
J	Bromberg, KD; Ma'ayan, A; Neves, SR; Iyengar, R				Bromberg, Kenneth D.; Ma'ayan, Avi; Neves, Susana R.; Iyengar, Ravi			Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth	SCIENCE			English	Article							BRCA1; DATABASE; ACTIVATION; CANCER; PROTEINS; UPDATE; ROLES; CNS	Cannabinoid receptor 1 (CB1R) regulates neuronal differentiation. To understand the logic underlying decision-making in the signaling network controlling CB1R-induced neurite outgrowth, we profiled the activation of several hundred transcription factors after cell stimulation. We assembled an in silico signaling network by connecting CB1R to 23 activated transcription factors. Statistical analyses of this network predicted a role for the breast cancer 1 protein BRCA1 in neuronal differentiation and a new pathway from CB1R through phosphoinositol 3-kinase to the transcription factor paired box 6 (PAX6). Both predictions were experimentally confirmed. Results of transcription factor activation experiments that used pharmacological inhibitors of kinases revealed a network organization of partial OR gates regulating kinases stacked above AND gates that control transcription factors, which together allow for distributed decision-making in CB1R-induced neurite outgrowth.	[Bromberg, Kenneth D.; Ma'ayan, Avi; Neves, Susana R.; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	Ma'ayan, Avi/AAG-3131-2019	Ma'ayan, Avi/0000-0002-6904-1017	NCI NIH HHS [T32 CA088796, R24 CA095823, 5R24 CA095823-04, T32 CA88796] Funding Source: Medline; NCRR NIH HHS [1 S10 RR0 9145-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM054508-21, P50 GM071558-01A2, R01 GM054508, P50 GM071558-030007, R01 GM072853, P50 GM071558, GM54508, P50 GM071558-02, R01 GM072853-04, P50 GM071558-01A20007, GM072853, P50 GM071558-020007] Funding Source: Medline; PHS HHS [P50-071558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA088796, R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, R01GM072853, P50GM071558] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Centonze D, 2007, TRENDS PHARMACOL SCI, V28, P180, DOI 10.1016/j.tips.2007.02.004; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; Dubrovska A, 2005, ONCOGENE, V24, P2289, DOI 10.1038/sj.onc.1208443; Eccles D, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028084; Eccles D M, 2003, J Med Genet, V40, pe24, DOI 10.1136/jmg.40.3.e24; Gao B, 2001, FEBS LETT, V488, P179, DOI 10.1016/S0014-5793(00)02430-3; Garcia-Campmany L, 2007, DEVELOPMENT, V134, P65, DOI 10.1242/dev.02702; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Houvras Y, 2000, J BIOL CHEM, V275, P36230, DOI 10.1074/jbc.M002539200; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Miralem T, 2003, MOL CELL BIOL, V23, P579, DOI 10.1128/MCB.23.2.579-593.2003; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239; Yan Q, 2007, J BIOL CHEM, V282, P13954, DOI 10.1074/jbc.M611476200; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	37	107	109	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					903	909		10.1126/science.1152662	http://dx.doi.org/10.1126/science.1152662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487186	Green Accepted			2022-12-28	WOS:000255868300035
J	Bereiter, J				Bereiter, Jeanne			Crying for my grandmother	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jbereiter@salud.unm.edu							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2129	2130		10.1001/jama.299.18.2129	http://dx.doi.org/10.1001/jama.299.18.2129			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477773				2022-12-28	WOS:000255790000001
J	Delamothe, T; Brilliant, L				Delamothe, Tony; Brilliant, Larry			Twenty first century native	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 3	2008	336	7651					986	988		10.1136/bmj.39548.369977.AD	http://dx.doi.org/10.1136/bmj.39548.369977.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300EZ	18456626	Green Published			2022-12-28	WOS:000255808400033
J	Hochstim, C; Deneen, B; Lukaszewicz, A; Zhou, Q; Anderson, DJ				Hochstim, Christian; Deneen, Benjamin; Lukaszewicz, Agnes; Zhou, Qiao; Anderson, David J.			Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code	CELL			English	Article							PROGENITOR-CELL IDENTITY; REELIN SIGNALING PATHWAY; DEVELOPING SPINAL-CORD; VENTRAL NEURAL-TUBE; RAT OPTIC-NERVE; TRANSCRIPTION FACTOR; MOTOR-NEURON; OLIGODENDROCYTE DIFFERENTIATION; PREGANGLIONIC NEURONS; IN-VITRO	Astrocytes constitute the most abundant cell type in the central nervous system (CNS) and play diverse functional roles, but the ontogenetic origins of this phenotypic diversity are poorly understood. We have investigated whether positional identity, a fundamental organizing principle governing the generation of neuronal subtype diversity, is also relevant to astrocyte diversification. We identified three positionally distinct subtypes of white-matter astrocytes (WMA) in the spinal cord, which can be distinguished by the combinatorial expression of Reelin and Slit1. These astrocyte subtypes derive from progenitor domains expressing the homeodomain transcription factors Pax6 and Nkx6.1, respectively. Loss- and gain-of-function experiments indicate that the positional identity of these astrocyte subtypes is controlled by Pax6 and Nkx6.1 in a combinatorial manner. Thus, positional identity is an organizing principle underlying astrocyte, as well as neuronal, subtype diversification and is controlled by a homeodomain transcriptional code whose elements are reutilized following the specification of neuronal identity earlier in development.	[Hochstim, Christian; Deneen, Benjamin; Lukaszewicz, Agnes; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Deneen, Benjmain/0000-0002-6335-1081; Zhou, Qiao/0000-0002-0099-3909	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS023476, R01 NS023476-22, 1R01-NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fu H, 2003, J COMP NEUROL, V456, P237, DOI 10.1002/cne.10481; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gauthier BR, 2007, BIOCHEM J, V403, P593, DOI 10.1042/BJ20070053; Goulding M, 2000, CURR BIOL, V10, pR565, DOI 10.1016/S0960-9822(00)00615-1; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kubasak MD, 2004, J COMP NEUROL, V468, P165, DOI 10.1002/cne.10946; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; LIUZZI FJ, 1987, BRAIN RES, V403, P385, DOI 10.1016/0006-8993(87)90081-3; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; McMahon AP, 2000, GENE DEV, V14, P2261, DOI 10.1101/gad.840800; MILLER RH, 1984, J NEUROSCI, V4, P585; MILLER RH, 1994, PERSPECT DEV NEUROBI, V2, P225; MORI S, 1969, J COMP NEUROL, V137, P197, DOI 10.1002/cne.901370206; Mukouyama Y, 2006, P NATL ACAD SCI USA, V103, P1551, DOI 10.1073/pnas.0510658103; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Qi YC, 2001, DEVELOPMENT, V128, P2723; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Sharif A, 2004, NEUROSCIENCE, V126, P263, DOI 10.1016/j.neuroscience.2004.02.039; Shibata T, 1997, J NEUROSCI, V17, P9212; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Takahashi M, 2002, DEVELOPMENT, V129, P1327; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; VAUGHN JE, 1967, J COMP NEUROL, V131, P143, DOI 10.1002/cne.901310206; Yip YP, 2007, J COMP NEUROL, V502, P635, DOI 10.1002/cne.21318; Yip YP, 2004, J COMP NEUROL, V475, P564, DOI 10.1002/cne.20212; Yip YP, 2004, J COMP NEUROL, V470, P210, DOI 10.1002/cne.20001; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	55	237	242	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					510	522		10.1016/j.cell.2008.02.046	http://dx.doi.org/10.1016/j.cell.2008.02.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455991	Green Accepted, Bronze			2022-12-28	WOS:000255503900021
J	Sun, HH; Gong, S; Carmody, RJ; Hilliard, A; Li, L; Sun, J; Kong, L; Xu, LY; Hilliard, B; Hu, SM; Shen, H; Yang, XL; Chen, YHH				Sun, Honghong; Gong, Shunyou; Carmody, Ruaidhri J.; Hilliard, Anja; Li, Li; Sun, Jing; Kong, Li; Xu, Lingyun; Hilliard, Brendan; Hu, Shimin; Shen, Hao; Yang, Xiaolu; Chen, Youhai H.			TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis	CELL			English	Article							NF-KAPPA-B; CELL-CYCLE PROGRESSION; DEATH DOMAIN PROTEIN; AUTOIMMUNE INFLAMMATION; T-LYMPHOCYTES; FAS LIGAND; ACTIVATION; CASPASE-8; APOPTOSIS; PATHWAY	Immune homeostasis is essential for the normal functioning of the immune system, and its breakdown leads to fatal inflammatory diseases. We report here the identification of a member of the tumor necrosis factor-alpha-induced protein-8 (TNFAIP8) family, designated TIPE2, that is required for maintaining immune homeostasis. TIPE2 is preferentially expressed in lymphoid tissues, and its deletion in mice leads to multiorgan inflammation, splenomegaly, and premature death. TIPE2-deficient animals are hypersensitive to septic shock, and TIPE2-deficient cells are hyper-responsive to Toll-like receptor (TLR) and T cell receptor (TCR) activation. Importantly, TIPE2 binds to caspase-8 and inhibits activating protein-1 and nuclear factor-kappa B activation while promoting Fas-induced apoptosis. Inhibiting caspase-8 significantly blocks the hyper-responsiveness of TIPE2-deficient cells. These results establish that TIPE2 is an essential negative regulator of TLR and TCR function, and its selective expression in the immune system prevents hyperresponsiveness and maintains immune homeostasis.	[Sun, Honghong; Gong, Shunyou; Carmody, Ruaidhri J.; Hilliard, Anja; Li, Li; Sun, Jing; Kong, Li; Hilliard, Brendan; Chen, Youhai H.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hu, Shimin; Yang, Xiaolu] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Shen, Hao] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Chen, YHH (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yhc@mail.med.upenn.edu	Hu, Shimin/H-3427-2019; shen, hao/HGF-0551-2022; Carmody, Ruaidhri/H-5396-2019; Gong, Shunyou/ABE-1345-2021; Chen, Youhai/AAJ-4031-2021	Hu, Shimin/0000-0001-7110-3814; Hilliard, Brendan/0000-0002-4689-6821; Gong, Shunyou/0000-0002-7883-4879	NIAID NIH HHS [R01 AI050059, R01 AI055934, R56 AI050059, AI50059, R01 AI050059-05, R01 AI055934-04, R01 AI050059-04, AI069289, R01 AI136945, R01 AI069289, R01 AI050059-03, R01 AI055934-05] Funding Source: Medline; NIDDK NIH HHS [R01 DK070691, R01 DK070691-02, DK070691] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050059, R01AI055934, R01AI069289, R01AI050059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070691] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Carmody RJ, 2002, J NEUROIMMUNOL, V133, P95, DOI 10.1016/S0165-5728(02)00366-1; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chaudhary PM, 1999, J BIOL CHEM, V274, P19211, DOI 10.1074/jbc.274.27.19211; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dudley E, 1999, EUR J IMMUNOL, V29, P878, DOI 10.1002/(SICI)1521-4141(199903)29:03<878::AID-IMMU878>3.0.CO;2-9; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Hua ZC, 2003, IMMUNITY, V18, P513, DOI 10.1016/S1074-7613(03)00083-9; Hueber AO, 2000, J BIOL CHEM, V275, P10453, DOI 10.1074/jbc.275.14.10453; KABELITZ D, 1993, IMMUNOL TODAY, V14, P338, DOI 10.1016/0167-5699(93)90231-9; Kumar D, 2004, ONCOGENE, V23, P612, DOI 10.1038/sj.onc.1207123; Kumar D, 2000, J BIOL CHEM, V275, P2973, DOI 10.1074/jbc.275.4.2973; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; Patel S, 1997, ORAL ONCOL, V33, P197, DOI 10.1016/S0964-1955(96)00065-6; Rivera-Walsh I, 2000, J BIOL CHEM, V275, P25222, DOI 10.1074/jbc.M000444200; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Van Parijs L, 1998, SCIENCE, V280, P243; Wahl SM, 2006, IMMUNOL REV, V213, P213, DOI 10.1111/j.1600-065X.2006.00437.x; Yoshinaga-Hirabayashi T, 2001, MARC MALPIG SYMP SER, V7, P51; Zhang CB, 2006, MOL THER, V13, P947, DOI 10.1016/j.ymthe.2005.11.020	29	274	328	0	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					415	426		10.1016/j.cell.2008.03.026	http://dx.doi.org/10.1016/j.cell.2008.03.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455983	Green Accepted, Bronze			2022-12-28	WOS:000255503900013
J	Lammermann, T; Bader, BL; Monkley, SJ; Worbs, T; Wedlich-Soldner, R; Hirsch, K; Keller, M; Forster, R; Critchley, DR; Fassler, R; Sixt, M				Laemmermann, Tim; Bader, Bernhard L.; Monkley, Susan J.; Worbs, Tim; Wedlich-Soeldner, Roland; Hirsch, Karin; Keller, Markus; Foerster, Reinhold; Critchley, David R.; Faessler, Reinhard; Sixt, Michael			Rapid leukocyte migration by integrin-independent flowing and squeezing	NATURE			English	Article							DENDRITIC CELLS; BLOOD-VESSELS; ADHESION; MOUSE; BETA-1-INTEGRIN; MOTILITY; COLLAGEN; FORCE; LINKS; TALIN	All metazoan cells carry transmembrane receptors of the integrin family, which couple the contractile force of the actomyosin cytoskeleton to the extracellular environment. In agreement with this principle, rapidly migrating leukocytes use integrin- mediated adhesion when moving over two- dimensional surfaces. As migration on two- dimensional substrates naturally overemphasizes the role of adhesion, the contribution of integrins during three- dimensional movement of leukocytes within tissues has remained controversial. We studied the interplay between adhesive, contractile and protrusive forces during interstitial leukocyte chemotaxis in vivo and in vitro. We ablated all integrin heterodimers from murine leukocytes, and show here that functional integrins do not contribute to migration in three- dimensional environments. Instead, these cells migrate by the sole force of actin- network expansion, which promotes protrusive flowing of the leading edge. Myosin II- dependent contraction is only required on passage through narrow gaps, where a squeezing contraction of the trailing edge propels the rigid nucleus.	[Laemmermann, Tim; Hirsch, Karin; Faessler, Reinhard; Sixt, Michael] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Wedlich-Soeldner, Roland] Max Planck Inst Biochem, Jr Res Grp Cellular Dynam & Cell Patterning, D-82152 Martinsried, Germany; [Bader, Bernhard L.; Keller, Markus] Tech Univ Munich, Dept Med Nutr, D-85350 Freising Weihenstephan, Germany; [Monkley, Susan J.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Worbs, Tim; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Max Planck Society; Max Planck Society; Technical University of Munich; University of Leicester; Hannover Medical School	Sixt, M (corresponding author), Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany.	sixt@biochem.mpg.de	Keller, Markus/A-2823-2009; Förster, Reinhold/D-6770-2011; Lämmermann, Tim/AAD-7453-2022; Sixt, Michael/F-3925-2010	Forster, Reinhold/0000-0001-6190-7923; Worbs, Tim/0000-0001-9945-3103; Sixt, Michael/0000-0002-6620-9179; Monkley, Susan/0000-0001-9174-6278	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; BERG DJ, 1995, J EXP MED, V182, P99, DOI 10.1084/jem.182.1.99; Bottino D, 2002, J CELL SCI, V115, P367; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; DEBRUYN PPH, 1946, ANAT REC, V95, P177, DOI 10.1002/ar.1090950209; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Morin NA, 2008, J EXP MED, V205, P195, DOI 10.1084/jem.20071543; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pittet MJ, 2008, IMMUNOL REV, V221, P107, DOI 10.1111/j.1600-065X.2008.00584.x; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; Vanni S, 2003, BIOPHYS J, V84, P2715, DOI 10.1016/S0006-3495(03)75077-2; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; WILSON RW, 1993, J IMMUNOL, V151, P1571; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	45	962	977	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					51	+		10.1038/nature06887	http://dx.doi.org/10.1038/nature06887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451854	Green Published			2022-12-28	WOS:000255398800037
J	Marscher, AP; Jorstad, SG; D'Arcangelo, FD; Smith, PS; Williams, GG; Larionov, VM; Oh, H; Olmstead, AR; Aller, MF; Aller, HD; McHardy, IM; Lahteenmaki, A; Tornikoski, M; Valtaoja, E; Hagen-Thorn, VA; Kopatskaya, EN; Gear, WK; Tosti, G; Kurtanidze, O; Nikolashvili, M; Sigua, L; Miller, HR; Ryle, WT				Marscher, Alan P.; Jorstad, Svetlana G.; D'Arcangelo, Francesca D.; Smith, Paul S.; Williams, G. Grant; Larionov, Valeri M.; Oh, Haruki; Olmstead, Alice R.; Aller, Margo F.; Aller, Hugh D.; McHardy, Ian M.; Lahteenmaki, Anne; Tornikoski, Merja; Valtaoja, Esko; Hagen-Thorn, Vladimir A.; Kopatskaya, Eugenia N.; Gear, Walter K.; Tosti, Gino; Kurtanidze, Omar; Nikolashvili, Maria; Sigua, Lorand; Miller, H. Richard; Ryle, Wesley T.			The inner jet of an active galactic nucleus as revealed by a radio-to-gamma-ray outburst	NATURE			English	Article							BL-LACERTAE; POLARIZATION; EMISSION; ENERGY; FLARES	Blazars are the most extreme active galactic nuclei. They possess oppositely directed plasma jets emanating at near light speeds from accreting supermassive black holes. According to theoretical models, such jets are propelled by magnetic fields twisted by differential rotation of the black hole's accretion disk or inertial-frame-dragging ergosphere(1-3). The flow velocity increases outward along the jet in an acceleration and collimation zone containing a coiled magnetic field(4,5). Detailed observations of outbursts of electromagnetic radiation, for which blazars are famous, can potentially probe the zone. It has hitherto not been possible to either specify the location of the outbursts or verify the general picture of jet formation. Here we report sequences of high- resolution radio images and optical polarization measurements of the blazar BL Lacertae. The data reveal a bright feature in the jet that causes a double flare of radiation from optical frequencies to TeV gamma-ray energies, as well as a delayed outburst at radio wavelengths. We conclude that the event starts in a region with a helical magnetic field that we identify with the acceleration and collimation zone predicted by the theories. The feature brightens again when it crosses a standing shock wave corresponding to the bright 'core' seen on the images.	[Marscher, Alan P.; Jorstad, Svetlana G.; D'Arcangelo, Francesca D.; Oh, Haruki; Olmstead, Alice R.] Boston Univ, Inst Astrophys Res, Boston, MA 02215 USA; [Jorstad, Svetlana G.; Larionov, Valeri M.; Hagen-Thorn, Vladimir A.; Kopatskaya, Eugenia N.] St Petersburg State Univ, Astron Inst, St Petersburg 198504, Russia; [Smith, Paul S.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Williams, G. Grant] Univ Arizona, Multiple Mirror Telescope Observ, Tucson, AZ 85721 USA; [Aller, Margo F.; Aller, Hugh D.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [McHardy, Ian M.] Univ Southampton, Dept Phys & Astron, Southampton SO17 1BJ, Hants, England; [Lahteenmaki, Anne; Tornikoski, Merja] Aalto Univ, TKK, Metsahovi Radio Observ, Kylmala 02540, Finland; [Valtaoja, Esko] Tuorla Observ, Piikkio 21500, Finland; [Valtaoja, Esko] Univ Turku, Dept Phys, Turku 20014, Finland; [Gear, Walter K.] Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3YB, Wales; [Tosti, Gino] Univ Perugia, Dept Phys, I-06123 Perugia, Italy; [Kurtanidze, Omar; Nikolashvili, Maria; Sigua, Lorand] Abastumani Astrophys Observ, Mt Kanobili, Abastumani, Georgia; [Miller, H. Richard; Ryle, Wesley T.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30303 USA	Boston University; Saint Petersburg State University; University of Arizona; University of Arizona; University of Michigan System; University of Michigan; University of Southampton; Aalto University; University of Turku; University of Turku; Cardiff University; University of Perugia; Ilia State University; University System of Georgia; Georgia State University	Marscher, AP (corresponding author), Boston Univ, Inst Astrophys Res, 725 Commonwealth Ave, Boston, MA 02215 USA.	marscher@bu.edu	Hagen-Thorn, Vladimir/H-3983-2013; Tosti, Gino/E-9976-2013; Larionov, Valeri M/H-1349-2013; Jorstad, Svetlana G/H-6913-2013; Kurtanidze, Omar M/J-6237-2014; Kopatskaya, Evgenia/AAN-1057-2021; Jorstad, Svetlana/AAM-3279-2021; Lähteenmäki, Anne/L-5987-2013	Hagen-Thorn, Vladimir/0000-0002-6431-8590; Larionov, Valeri M/0000-0002-4640-4356; Jorstad, Svetlana G/0000-0001-9522-5453; Kopatskaya, Evgenia/0000-0001-9518-337X; Jorstad, Svetlana/0000-0001-6158-1708; Chanishvili, Revaz/0000-0002-6410-1084; Gear, Walter/0000-0001-6789-6196; Kurtanidze, Omar/0000-0001-5385-0576; Nikolashvili, Mariam/0000-0003-0408-7177	Science and Technology Facilities Council [PP/D001013/1] Funding Source: researchfish; STFC [PP/D001013/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Albert J, 2007, ASTROPHYS J, V666, pL17, DOI 10.1086/521550; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Bottcher M, 2003, ASTROPHYS J, V596, P847, DOI 10.1086/378156; D'Arcangelo FD, 2007, ASTROPHYS J, V659, pL107, DOI 10.1086/517525; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Hawley JF, 2006, ASTROPHYS J, V641, P103, DOI 10.1086/500385; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; Jorstad SG, 2001, ASTROPHYS J, V556, P738, DOI 10.1086/321605; Junor W, 1999, NATURE, V401, P891, DOI 10.1038/44780; KIKUCHI S, 1988, ASTRON ASTROPHYS, V190, pL8; Lahteenmaki A, 2003, ASTROPHYS J, V590, P95, DOI 10.1086/374883; Laing RA, 1999, MON NOT R ASTRON SOC, V306, P513, DOI 10.1046/j.1365-8711.1999.02548.x; Lyutikov M, 2005, MON NOT R ASTRON SOC, V360, P869, DOI 10.1111/j.1365-2966.2005.08954.x; McKinney JC, 2007, MON NOT R ASTRON SOC, V375, P531, DOI 10.1111/j.1365-2966.2006.11220.x; Meier DL, 2001, SCIENCE, V291, P84, DOI 10.1126/science.291.5501.84; Melia F, 2002, ASTROPHYS J, V567, P811, DOI 10.1086/338579; MOORE RL, 1982, ASTROPHYS J, V260, P415, DOI 10.1086/160266; SILLANPAA A, 1993, ASTROPHYS SPACE SCI, V206, P55, DOI 10.1007/BF00658383; Tanihata C, 2000, ASTROPHYS J, V543, P124, DOI 10.1086/317086; Vlahakis N, 2004, ASTROPHYS J, V605, P656, DOI 10.1086/382670; Vlahakis N., 2006, ASP C SER, V350, P169	22	506	508	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					966	969		10.1038/nature06895	http://dx.doi.org/10.1038/nature06895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432239	Green Published			2022-12-28	WOS:000255208600033
J	Fuller, BG; Lampson, MA; Foley, EA; Rosasco-Nitcher, S; Le, KV; Tobelmann, P; Brautigan, DL; Stukenberg, PT; Kapoor, TM				Fuller, Brian G.; Lampson, Michael A.; Foley, Emily A.; Rosasco-Nitcher, Sara; Le, Kim V.; Tobelmann, Page; Brautigan, David L.; Stukenberg, P. Todd; Kapoor, Tarun M.			Midzone activation of aurora B in anaphase produces an intracellular phosphorylation gradient	NATURE			English	Article							IN-SITU; SPINDLE; MICROTUBULES; CYTOKINESIS; CLEAVAGE; REVEALS	Proper partitioning of the contents of a cell between two daughters requires integration of spatial and temporal cues. The anaphase array of microtubules that self-organize at the spindle midzone contributes to positioning the cell-division plane midway between the segregating chromosomes(1). How this signalling occurs over length scales of micrometres, from the midzone to the cell cortex, is not known. Here we examine the anaphase dynamics of protein phosphorylation by aurora B kinase, a key mitotic regulator, using fluorescence resonance energy transfer (FRET)-based sensors in living HeLa cells and immunofluorescence of native aurora B substrates. Quantitative analysis of phosphorylation dynamics, using chromosome- and centromere-targeted sensors, reveals that changes are due primarily to position along the division axis rather than time. These dynamics result in the formation of a spatial phosphorylation gradient early in anaphase that is centred at the spindle midzone. This gradient depends on aurora B targeting to a subpopulation of microtubules that activate it. Aurora kinase activity organizes the targeted microtubules to generate a structure-based feedback loop. We propose that feedback between aurora B kinase activation and midzone microtubules generates a gradient of post-translational marks that provides spatial information for events in anaphase and cytokinesis.	[Fuller, Brian G.; Rosasco-Nitcher, Sara; Tobelmann, Page; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem, Charlottesville, VA 22908 USA; [Fuller, Brian G.; Rosasco-Nitcher, Sara; Tobelmann, Page; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Mol Genet, Charlottesville, VA 22908 USA; [Lampson, Michael A.; Le, Kim V.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Foley, Emily A.; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10021 USA; [Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Pennsylvania; Rockefeller University; University of Virginia	Stukenberg, PT (corresponding author), Univ Virginia, Sch Med, Dept Biochem, Charlottesville, VA 22908 USA.	lampson@sas.upenn.edu; pts7h@virginia.edu		Stukenberg, Todd/0000-0002-6788-2111	NIGMS NIH HHS [R01 GM083988-01, R01 GM063045, R01 GM063045-08, R01 GM083988, R01 GM065933-06, R01 GM065933] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933, R01GM083988, R01GM063045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alsop GB, 2004, J CELL SCI, V117, P1591, DOI 10.1242/jcs.01007; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gruneberg U, 2004, J CELL BIOL, V166, P167, DOI 10.1083/jcb.200403084; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peters U, 2006, NAT CHEM BIOL, V2, P618, DOI 10.1038/nchembio826; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SU TT, 1998, GENE DEV, V21, P495; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zeitlin SG, 2001, J CELL SCI, V114, P653	27	271	273	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 19	2008	453	7198					1132	U14		10.1038/nature06923	http://dx.doi.org/10.1038/nature06923			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WM	18463638	Green Accepted			2022-12-28	WOS:000256839900063
J	Graves, AR; Curran, PK; Smith, CL; Mindell, JA				Graves, Austin R.; Curran, Patricia K.; Smith, Carolyn L.; Mindell, Joseph A.			The Cl(-)/H(+) antiporter ClC-7 is the primary chloride permeation pathway in lysosomes	NATURE			English	Article							OSTEOPETROSIS TYPE-II; FUNCTIONAL RECONSTITUTION; TORPEDO-CALIFORNICA; PROTON PUMP; CHANNEL; PROTEINS; MUTATION; DISEASE; LEADS	Lysosomes are the stomachs of the cell - terminal organelles on the endocytic pathway where internalized macromolecules are degraded. Containing a wide range of hydrolytic enzymes, lysosomes depend on maintaining acidic luminal pH values for efficient function. Although acidification is mediated by a V- type proton ATPase, a parallel anion pathway is essential to allow bulk proton transport(1,2). The molecular identity of this anion transporter remains unknown. Recent results of knockout experiments raise the possibility that ClC- 7, a member of the CLC family of anion channels and transporters, is a contributor to this pathway in an osteoclast lysosome- like compartment, with loss of ClC- 7 function causing osteopetrosis(3). Several mammalian members of the CLC family have been characterized in detail; some ( including ClC- 0, ClC- 1 and ClC- 2) function as Cl(-) -conducting ion channels(4), whereas others act as Cl(-)/H(+) antiporters ( ClC- 4 and ClC-5) (5,6). However, previous attempts at heterologous expression of ClC- 7 have failed to yield evidence of functional protein, so it is unclear whether ClC- 7 has an important function in lysosomal biology, and also whether this protein functions as a Cl(-) channel, a Cl(-)/H(+) antiporter, or as something else entirely. Here we directly demonstrate an anion transport pathway in lysosomes that has the defining characteristics of a CLC Cl(-)/H(+) antiporter and show that this transporter is the predominant route for Cl(-) through the lysosomal membrane. Furthermore, knockdown of ClC- 7 expression by short interfering RNA can essentially ablate this lysosomal Cl(-)/H(+) antiport activity and can strongly diminish the ability of lysosomes to acidify in vivo, demonstrating that ClC- 7 is a Cl(-)/H(+) antiporter, that it constitutes the major Cl(-) permeability of lysosomes, and that it is important in lysosomal acidification.	[Graves, Austin R.; Curran, Patricia K.; Mindell, Joseph A.] Natl Inst Neurol Disorders & Stroke, Membrane Transport Biophys Unit, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Smith, Carolyn L.] Natl Inst Neurol Disorders & Stroke, Light Microscopy Facil, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), Natl Inst Neurol Disorders & Stroke, Membrane Transport Biophys Unit, Porter Neurosci Res Ctr, NIH, 35 Convent Dr,Bldg 35,MSC 3701, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017	Mindell, Joseph/0000-0002-6952-8247; Graves, Austin/0000-0003-1087-3684	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003015, Z01NS003015] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; DELLANTONE P, 1979, BIOCHEM BIOPH RES CO, V86, P180, DOI 10.1016/0006-291X(79)90398-X; GARTY H, 1983, J BIOL CHEM, V258, P3094; GOLDBERG AFX, 1991, J MEMBRANE BIOL, V124, P199, DOI 10.1007/BF01994354; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Graham JM., 2000, CURRENT PROTOCOLS CE; Henriksen K, 2004, AM J PATHOL, V164, P1537, DOI 10.1016/S0002-9440(10)63712-1; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 1999, PFLUG ARCH EUR J PHY, V437, P783, DOI 10.1007/s004240050847; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2006, J CLIN ENDOCR METAB, V91, P995, DOI 10.1210/jc.2005-2017; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Letizia C, 2004, CALCIFIED TISSUE INT, V74, P42, DOI 10.1007/s00223-002-1087-5; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; OHKUMA S, 1982, P NATL ACAD SCI-BIOL, V79, P2758, DOI 10.1073/pnas.79.9.2758; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; WHITE MM, 1979, J BIOL CHEM, V254, P161	22	253	267	7	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					788	792		10.1038/nature06907	http://dx.doi.org/10.1038/nature06907			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18449189				2022-12-28	WOS:000256415300045
J	Ayoub, N; Jeyasekharan, AD; Bernal, JA; Venkitaraman, AR				Ayoub, Nabieh; Jeyasekharan, Anand D.; Bernal, Juan A.; Venkitaraman, Ashok R.			HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response	NATURE			English	Article							PROTEIN-KINASE CK2; DOUBLE-STRAND BREAKS; HETEROCHROMATIN PROTEIN-1; MAMMALIAN-CELLS; HISTONE H2AX; PHOSPHORYLATION; HP1; DYNAMICS; ATM; MOBILITY	Minutes after DNA damage, the variant histone H2AX is phosphorylated by protein kinases of the phosphoinositide kinase family, including ATM, ATR or DNA- PK1. Phosphorylated (gamma)-H2AX - which recruits molecules that sense or signal the presence of DNA breaks, activating the response that leads to repair(2,3) - is the earliest known marker of chromosomal DNA breakage. Here we identify a dynamic change in chromatin that promotes H2AX phosphorylation in mammalian cells. DNA breaks swiftly mobilize heterochromatin protein 1 (HP1)-beta ( also called CBX1), a chromatin factor bound to histone H3 methylated on lysine 9 ( H3K9me). Local changes in histone- tail modifications are not apparent. Instead, phosphorylation of HP1-beta on amino acid Thr 51 accompanies mobilization, releasing HP1-beta from chromatin by disrupting hydrogen bonds that fold its chromodomain around H3K9me. Inhibition of casein kinase 2 ( CK2), an enzyme implicated in DNA damage sensing and repair(4-6), suppresses Thr 51 phosphorylation and HP1-beta mobilization in living cells. CK2 inhibition, or a constitutively chromatin- bound HP1-beta mutant, diminishes H2AX phosphorylation. Our findings reveal an unrecognized signalling cascade that helps to initiate the DNA damage response, altering chromatin by modifying a histone- code mediator protein, HP1, but not the code itself.	[Ayoub, Nabieh; Jeyasekharan, Anand D.; Bernal, Juan A.; Venkitaraman, Ashok R.] Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Cambridge CB2 0XZ, England		Venkitaraman, AR (corresponding author), Hutchison MRC Res Ctr, Med Res Council Canc Cell Unit, Hills Rd, Cambridge CB2 0XZ, England.	arv22@cam.ac.uk	Jeyasekharan, Anand/O-3398-2019; Bernal, Juan A/N-4544-2014; Ayoub, Nabieh/AFK-5616-2022; Ayoub, Nabieh/AAG-4076-2022	Bernal, Juan A/0000-0002-9933-5550; Ayoub, Nabieh/0000-0002-9549-9929; Jeyasekharan, Anand/0000-0001-9816-6137	MRC [G0700651, G0600332, MC_U105359877, G9900064] Funding Source: UKRI; Medical Research Council [G0600332, G9900064, MC_U105359877, G0700651] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allende-Vega N, 2005, MOL CELL BIOCHEM, V274, P85, DOI 10.1007/s11010-005-3074-4; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Canton DA, 2001, BIOCHEM J, V358, P87, DOI 10.1042/0264-6021:3580087; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Formby B, 1998, MOL CELL BIOCHEM, V187, P23, DOI 10.1023/A:1006865721693; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ruzzene M, 2002, BIOCHEM J, V364, P41, DOI 10.1042/bj3640041; Schmiedeberg L, 2004, MOL BIOL CELL, V15, P2819, DOI 10.1091/mbc.E03-11-0827; Zhao T, 1999, J BIOL CHEM, V274, P15095, DOI 10.1074/jbc.274.21.15095; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	26	327	337	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					682	U14		10.1038/nature06875	http://dx.doi.org/10.1038/nature06875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18438399				2022-12-28	WOS:000256185200050
J	Tsaousis, AD; Kunji, ERS; Goldberg, AV; Lucocq, JM; Hirt, RP; Embley, TM				Tsaousis, Anastasios D.; Kunji, Edmund R. S.; Goldberg, Alina V.; Lucocq, John M.; Hirt, Robert P.; Embley, T. Martin			A novel route for ATP acquisition by the remnant mitochondria of Encephalitozoon cuniculi	NATURE			English	Article							RICKETTSIA-PROWAZEKII; ATP/ADP TRANSLOCASES; MICROSPORIDIA; TRANSPORT; PROTEINS; EVOLUTION; PROTOZOA; ARABIDOPSIS; CHLAMYDIAE; BIOLOGY	Mitochondria use transport proteins of the eukaryotic mitochondrial carrier family (MCF) to mediate the exchange of diverse substrates, including ATP, with the host cell cytosol. According to classical endosymbiosis theory, insertion of a host-nuclear-encoded MCF transporter into the protomitochondrion was the key step that allowed the host cell to harvest ATP from the enslaved endosymbiont(1). Notably the genome of the microsporidian Encephalitozoon cuniculi has lost all of its genes for MCF proteins(2). This raises the question of how the recently discovered microsporidian remnant mitochondrion, called a mitosome, acquires ATP to support protein import and other predicted ATP-dependent activities(2-4). The E. cuniculi genome does contain four genes for an unrelated type of nucleotide transporter used by plastids and bacterial intracellular parasites, such as Rickettsia and Chlamydia, to import ATP from the cytosol of their eukaryotic host cells(5-7). The inference is that E. cuniculi also uses these proteins to steal ATP from its eukaryotic host to sustain its lifestyle as an obligate intracellular parasite. Here we show that, consistent with this hypothesis, all four E. cuniculi transporters can transport ATP, and three of them are expressed on the surface of the parasite when it is living inside host cells. The fourth transporter co-locates with mitochondrial Hsp70 to the E. cuniculi mitosome. Thus, uniquely among eukaryotes, the traditional relationship between mitochondrion and host has been subverted in E. cuniculi, by reductive evolution and analogous gene replacement. Instead of the mitosome providing the parasite cytosol with ATP, the parasite cytosol now seems to provide ATP for the organelle.	[Tsaousis, Anastasios D.; Goldberg, Alina V.; Hirt, Robert P.; Embley, T. Martin] Univ Newcastle, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Tsaousis, Anastasios D.] Univ Newcastle, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kunji, Edmund R. S.] MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; [Lucocq, John M.] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Dundee	Hirt, RP (corresponding author), Univ Newcastle, Inst Cell & Mol Biosci, Catherine Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	r.p.hirt@ncl.ac.uk; ek@mrc-dunn.cam.ac.uk	Hirt, Robert/R-5429-2017; Kunji, Edmund/AAH-2362-2020	Hirt, Robert/0000-0002-3760-9958; Kunji, Edmund/0000-0002-0610-4500; lucocq, john/0000-0002-5191-0093; Embley, Thomas Martin/0000-0002-1484-340X; Tsaousis, Anastasios/0000-0002-5424-1905	MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Audia JP, 2006, J BACTERIOL, V188, P6261, DOI 10.1128/JB.00371-06; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Farthing MJG, 2006, NAT CLIN PRACT GASTR, V3, P436, DOI 10.1038/ncpgasthep0557; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haferkamp I, 2006, MOL MICROBIOL, V60, P1534, DOI 10.1111/j.1365-2958.2006.05193.x; Hollister WS, 1996, J EUKARYOT MICROBIOL, V43, pS104, DOI 10.1111/j.1550-7408.1996.tb05026.x; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mohlmann T, 1998, EUR J BIOCHEM, V252, P353, DOI 10.1046/j.1432-1327.1998.2520353.x; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Richards TA, 2003, PROTIST, V154, P17, DOI 10.1078/143446103764928468; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Taupin V, 2006, PARASITOL RES, V99, P708, DOI 10.1007/s00436-006-0231-y; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Vavra J, 2005, FOLIA PARASIT, V52, P193, DOI 10.14411/fp.2005.024; Vossbrinck CR, 2005, FOLIA PARASIT, V52, P131, DOI 10.14411/fp.2005.017; WEIDNER E, 1999, MICROSPORIDIA MICROS; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6; Zheng L, 2007, PLOS BIOL, V5, P1530, DOI 10.1371/journal.pbio.0050170	26	176	196	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 22	2008	453	7194					553	U11		10.1038/nature06903	http://dx.doi.org/10.1038/nature06903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303EL	18449191				2022-12-28	WOS:000256023700049
J	Metcalfe, S; Burgess, C; Laking, G; Evans, J; Wells, S; Crausaz, S				Metcalfe, Scott; Burgess, Carl; Laking, George; Evans, Jackie; Wells, Susan; Crausaz, Steffan			Trastuzumab: possible publication bias	LANCET			English	Editorial Material							BREAST-CANCER; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIALS; DOXORUBICIN; PACLITAXEL; THERAPY		[Metcalfe, Scott; Evans, Jackie; Crausaz, Steffan] Pharmaceut Management Agcy PHARMAC, Wellington 6143, New Zealand; [Burgess, Carl] Univ Otago, Wellington Sch Med & Hlth Sci, Wellington, New Zealand; [Laking, George] Auckland Dist Hlth Board, Dept Med Oncol, Reg Canc & Blood Serv, Auckland, New Zealand; [Wells, Susan] Univ Auckland, Epidemiol & Biostat Sect, Sch Populat Hlth, Auckland 1, New Zealand	University of Otago; Auckland District Health Board; University of Auckland	Metcalfe, S (corresponding author), Pharmaceut Management Agcy PHARMAC, Wellington 6143, New Zealand.	scott.metcalfe@pharmac.govt.nz		Laking, George/0000-0002-7749-8922				[Anonymous], 2005, LANCET, V366, P1673; *FOOD DRUG ADM, 103792 FDA BLA; Geddes John, 2004, Evid Based Ment Health, V7, P98; Hind D, 2007, LANCET, V369, P3, DOI 10.1016/S0140-6736(07)60004-X; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Metcalfe Scott, 2007, N Z Med J, V120, pU2593; Perez EA, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.09.3849; PEREZ EA, 2005, 45 ANN M AM SOC CLIN; Perez EA, 2008, J CLIN ONCOL, V26, P1231, DOI 10.1200/JCO.2007.13.5467; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Schulz KF, 2005, LANCET, V365, P1348, DOI 10.1016/S0140-6736(05)61034-3; SLEDGE GW, 2005, 45 ANN M AM SOC CLIN; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Spielmann M, 2007, SAN ANT BREAST CANC; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091	17	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1646	1648		10.1016/S0140-6736(08)60706-0	http://dx.doi.org/10.1016/S0140-6736(08)60706-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486728				2022-12-28	WOS:000256002200008
J	Condon, MA; Scheffer, SJ; Lewis, ML; Swensen, SM				Condon, Marty A.; Scheffer, Sonja J.; Lewis, Matthew L.; Swensen, Susan M.			Hidden neotropical diversity: Greater than the sum of its parts	SCIENCE			English	Article							BLEPHARONEURA DIPTERA; HERBIVOROUS INSECTS; SPECIES RICHNESS; FRUIT-FLIES; TEPHRITIDAE; DIVERSIFICATION; CUCURBITACEAE; SPECIATION; RADIATION; PATTERNS	The diversity of tropical herbivorous insects has been explained as a direct function of plant species diversity. Testing that explanation, we reared 2857 flies from flowers and seeds of 24 species of plants from 34 neotropical sites. Samples yielded 52 morphologically similar species of flies and documented highly conserved patterns of specificity to host taxa and host parts. Widespread species of plants can support 13 species of flies. Within single populations of plants, we typically found one or more fly species specific to female flowers and multiple specialists on male flowers. We suggest that neotropical herbivorous insect diversity is not simply a function of plant taxonomic and architectural diversity, but also reflects the geographic distribution of hosts and the age and area of the neotropics.	[Condon, Marty A.] Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA; [Condon, Marty A.; Scheffer, Sonja J.] Smithsonian Inst, Natl Museum Amer Hist, Dept Entomol, Washington, DC 20560 USA; [Scheffer, Sonja J.; Lewis, Matthew L.] USDA ARS, Syst Entomol Lab, Beltsville, MD 20705 USA; [Scheffer, Sonja J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Swensen, Susan M.] Ithaca Coll, Dept Biol, Ithaca, NY 14850 USA	Cornell University; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park	Condon, MA (corresponding author), Cornell Coll, Dept Biol, Mt Vernon, IA 52314 USA.	mcondon@cornellcollege.edu						Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Condon MA, 1997, BIOL J LINN SOC, V60, P443, DOI 10.1006/bijl.1996.0106; CONDON MA, 1988, AM J BOT, V75, P875, DOI 10.2307/2444007; Condon M, 2008, BIOL J LINN SOC, V93, P779, DOI 10.1111/j.1095-8312.2007.00943.x; CORNELL HV, 1985, ECOLOGY, V66, P1247, DOI 10.2307/1939178; CRACRAFT J, 1988, EVOLUTION, V42, P603, DOI 10.1111/j.1558-5646.1988.tb04164.x; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hubbell Stephen P., 2001, V32, pi; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Joy JB, 2007, EVOLUTION, V61, P784, DOI 10.1111/j.1558-5646.2007.00069.x; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; Norton DA, 2007, SCIENCE, V315, P1666, DOI 10.1126/science.1137249; Novotny V, 2005, J TROP ECOL, V21, P67, DOI 10.1017/S0266467404002044; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; SOUTHWOOD TRE, 1961, J ANIM ECOL, V30, P1, DOI 10.2307/2109; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; THOMAS CD, 1990, NATURE, V347, P237, DOI 10.1038/347237a0; Thompson J.N., 2005, INTERSPEC INTERACT; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	27	53	56	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					928	931		10.1126/science.1155832	http://dx.doi.org/10.1126/science.1155832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487192				2022-12-28	WOS:000255868300041
J	Daniels, R; Normark, S				Daniels, Robert; Normark, Staffan			Twin ushers guide pili across the bacterial outer membrane	CELL			English	Editorial Material							BIOGENESIS; COMPLEX		[Daniels, Robert; Normark, Staffan] Swedish Inst Infect Dis Control, S-17182 Solna, Sweden; [Daniels, Robert; Normark, Staffan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet	Normark, S (corresponding author), Swedish Inst Infect Dis Control, S-17182 Solna, Sweden.	staffan.normark@smi.ki.se		daniels, Robert/0000-0002-5988-2920				JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Li HL, 2004, J MOL BIOL, V344, P1397, DOI 10.1016/j.jmb.2004.10.008; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x	9	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					574	576		10.1016/j.cell.2008.04.032	http://dx.doi.org/10.1016/j.cell.2008.04.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485865	Bronze			2022-12-28	WOS:000255903300012
J	Ho, DD; Bieniasz, PD				Ho, David D.; Bieniasz, Paul D.			HIV-1 at 25	CELL			English	Article							INFECTION; RECEPTOR; PROTEIN; VIRUS; GENE; LYMPHOCYTES; RETROVIRUS; TURNOVER; PLASMA; AIDS		[Ho, David D.; Bieniasz, Paul D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA	Rockefeller University	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	dho@adarc.org						BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277; MUESING MA, 2008, NATURE, V451, P425; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; POPOVIC M, 1984, SCIENCE, V224, P500; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	20	22	25	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					561	565		10.1016/j.cell.2008.05.003	http://dx.doi.org/10.1016/j.cell.2008.05.003			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485860	Bronze			2022-12-28	WOS:000255903300007
J	Loulergue, L; Schilt, A; Spahni, R; Masson-Delmotte, V; Blunier, T; Lemieux, B; Barnola, JM; Raynaud, D; Stocker, TF; Chappellaz, J				Loulergue, Laetitia; Schilt, Adrian; Spahni, Renato; Masson-Delmotte, Valerie; Blunier, Thomas; Lemieux, Benedicte; Barnola, Jean-Marc; Raynaud, Dominique; Stocker, Thomas F.; Chappellaz, Jerome			Orbital and millennial-scale features of atmospheric CH4 over the past 800,000 years	NATURE			English	Article							CLIMATE VARIABILITY; TERRESTRIAL PLANTS; METHANE EMISSIONS; ICE CORES; SENSITIVITY; GREENLAND	Atmospheric methane is an important greenhouse gas and a sensitive indicator of climate change and millennial-scale temperature variability(1). Its concentrations over the past 650,000 years have varied between similar to 350 and similar to 800 parts per 10 9 by volume ( p. p. b. v.) during glacial and interglacial periods, respectively(2). In comparison, present-day methane levels of,1,770 p. p. b. v. have been reported(3). Insights into the external forcing factors and internal feedbacks controlling atmospheric methane are essential for predicting the methane budget in a warmer world(3). Here we present a detailed atmospheric methane record from the EPICA Dome C ice core that extends the history of this greenhouse gas to 800,000 yr before present. The average time resolution of the new data is similar to 380 yr and permits the identification of orbital and millennial-scale features. Spectral analyses indicate that the long-term variability in atmospheric methane levels is dominated by,100,000 yr glacial - interglacial cycles up to,400,000 yr ago with an increasing contribution of the precessional component during the four more recent climatic cycles. We suggest that changes in the strength of tropical methane sources and sinks ( wetlands, atmospheric oxidation), possibly influenced by changes in monsoon systems and the position of the intertropical convergence zone, controlled the atmospheric methane budget, with an additional source input during major terminations as the retreat of the northern ice sheet allowed higher methane emissions from extending periglacial wetlands. Millennial-scale changes in methane levels identified in our record as being associated with Antarctic isotope maxima events(1,4) are indicative of ubiquitous millennial-scale temperature variability during the past eight glacial cycles.	[Loulergue, Laetitia; Lemieux, Benedicte; Barnola, Jean-Marc; Raynaud, Dominique; Chappellaz, Jerome] Univ Grenoble 1, CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; [Schilt, Adrian; Spahni, Renato; Blunier, Thomas; Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Masson-Delmotte, Valerie] Univ Versailles St Quentin, Lab Sci Climat & Environm, Inst Pierre Simon Laplace, CE Saclay,CEA CNRS, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Bern; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Chappellaz, J (corresponding author), Univ Grenoble 1, CNRS, Lab Glaciol & Geophys Environm, 54 Rue Moliere, F-38402 St Martin Dheres, France.	jerome@lgge.obs.ujf-grenoble.fr	Masson-Delmotte, Valerie L/G-1995-2011; Stocker, Thomas/B-1273-2013; Raynaud, Dominique/H-9626-2016; Chappellaz, Jérôme A./A-4872-2011; Blunier, Thomas/M-4609-2014; raynaud, dominique/ABG-4718-2020	Masson-Delmotte, Valerie L/0000-0001-8296-381X; Blunier, Thomas/0000-0002-6065-7747; Schilt, Adrian/0000-0001-6312-7947				Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Blunier T, 2007, CLIM PAST, V3, P325, DOI 10.5194/cp-3-325-2007; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; Clement AC, 2004, CLIM DYNAM, V22, P327, DOI 10.1007/s00382-003-0375-8; Delmotte M, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004417; Dueck TA, 2007, NEW PHYTOL, V175, P29, DOI 10.1111/j.1469-8137.2007.02103.x; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kaplan JO, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002590; Kennett JP, 2000, SCIENCE, V288, P128, DOI 10.1126/science.288.5463.128; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu Z, 2003, J CLIMATE, V16, P2472, DOI 10.1175/1520-0442(2003)016<2472:CCSOTE>2.0.CO;2; Loulergue L, 2007, CLIM PAST, V3, P527, DOI 10.5194/cp-3-527-2007; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Prigent C, 2001, GEOPHYS RES LETT, V28, P4631, DOI 10.1029/2001GL013263; Schmidt GA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021083; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Spahni R, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017093; Sun Y, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001287; Thonicke K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002278; Walter BP, 2000, GLOBAL BIOGEOCHEM CY, V14, P745, DOI 10.1029/1999GB001204	27	593	625	15	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					383	386		10.1038/nature06950	http://dx.doi.org/10.1038/nature06950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480822	Bronze			2022-12-28	WOS:000255868400050
J	Cummings, JRF; Keshav, S; Travis, SPL				Cummings, J. R. Fraser; Keshav, Satish; Travis, Simon P. L.			Medical management of Crohn's dsease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFLAMMATORY-BOWEL-DISEASE; SERIOUS INFECTIONS; RANDOMIZED-TRIAL; THERAPY; MAINTENANCE; ASSOCIATION; INFLIXIMAB; ADALIMUMAB; REMISSION; CHARM		[Cummings, J. R. Fraser; Keshav, Satish; Travis, Simon P. L.] John Radcliffe Hosp, Gastroenterol Unit, Oxford OX3 9DU, England	University of Oxford	Travis, SPL (corresponding author), John Radcliffe Hosp, Gastroenterol Unit, Oxford OX3 9DU, England.	simon.travis@ndm.ox.ac.uk		Travis, Simon/0000-0002-2690-4361; Cummings, Fraser/0000-0002-9659-3247; Keshav, Satish/0000-0003-0508-8665				Akobeng AK, 2008, ALIMENT PHARM THER, V27, P11, DOI 10.1111/j.1365-2036.2007.03536.x; Akobeng AK, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003715.pub2; Bassi A, 2004, GUT, V53, P1471, DOI 10.1136/gut.2004.041616; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; CASPERSEN S, IN PRESS CLIN GASTRO; Clark M, 2007, GASTROENTEROLOGY, V133, P312, DOI 10.1053/j.gastro.2007.05.006; Colombel JF, 2007, GASTROENTEROLOGY, V132, P52, DOI 10.1053/j.gastro.2006.11.041; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Feagan BG, 2007, GASTROENTEROLOGY, V132, pA513; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; Lichtenstein GR, 2006, CLIN GASTROENTEROL H, V4, P621, DOI 10.1016/j.cgh.2006.03.002; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; LOLY C, IN PRESS SCAND J GAS; Markowitz J, 2000, GASTROENTEROLOGY, V119, P895, DOI 10.1053/gast.2000.18144; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Polle SW, 2007, NAT CLIN PRACT GASTR, V4, P324, DOI 10.1038/ncpgasthep0839; Rampton DS, 2005, GUT, V54, P1360, DOI 10.1136/gut.2005.076034; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Selby W, 2007, GASTROENTEROLOGY, V132, P2313, DOI 10.1053/j.gastro.2007.03.031; TRAVIS SP, 2006, GUT               S1, V55, P1; Viget N, 2008, GUT, V57, P549, DOI 10.1136/gut.2006.114660	26	38	40	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2008	336	7652					1062	1066		10.1136/bmj.39547.603218.AE	http://dx.doi.org/10.1136/bmj.39547.603218.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18467414	Green Published			2022-12-28	WOS:000256103300031
J	Kim, AY; Tang, ZX; Liu, Q; Patel, KN; Maag, D; Geng, YX; Dong, XZ				Kim, Andrew Y.; Tang, Zongxiang; Liu, Qin; Patel, Kush N.; Maag, David; Geng, Yixun; Dong, Xinzhong			Pirt, a phosphoinositide-binding protein, functions as a regulatory subunit of TRPV1	CELL			English	Article							CAPSAICIN RECEPTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ION-CHANNEL; TRPA1; DESENSITIZATION; SENSITIVITY; NOCICEPTION; MODULATION; ACTIVATION; DOMAIN	Transient receptor potential vanilloid 1 (TRPV1) is a molecular sensor of noxious heat and capsaicin. Its channel activity can be modulated by several mechanisms. Here we identify a membrane protein, Pirt, as a regulator of TRPV1. Pirt is expressed in most nociceptive neurons in the dorsal root ganglia (DRG) including TRPV1-positive cells. Pirt null mice show impaired responsiveness to noxious heat and capsaicin. Noxious heat- and capsaicin-sensitive currents in Pirt-deficient DRG neurons are significantly attenuated. Heterologous expression of Pirt strongly enhances TRPV1-mediated currents. Furthermore, the C terminus of Pirt binds to TRPV1 and several phosphoinositides, including phosphatidylinositol-4,5-bisphosphate (PIP(2)), and can potentiate TRPV1. The PIP(2) binding is dependent on the cluster of basic residues in the Pirt C terminus and is crucial for Pirt regulation of TRPV1. Importantly, the enhancement of TRPV1 by PIP(2) requires Pirt. Therefore, Pirt is a key component of the TRPV1 complex and positively regulates TRPV1 activity.	[Kim, Andrew Y.; Tang, Zongxiang; Liu, Qin; Patel, Kush N.; Maag, David; Geng, Yixun; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	xdong2@jhmi.edu			NEI NIH HHS [T32 EY017203] Funding Source: Medline; NINDS NIH HHS [R01 NS054791-01A1, R01 NS054791-02, R01 NS054791, NS054791, R01 NS054791-03, R01 NS054791-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DHAKA A, 2007, CELL, V106, P619; Guler AD, 2002, J NEUROSCI, V22, P6408; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Huang JJ, 2006, SEMIN CELL DEV BIOL, V17, P638, DOI 10.1016/j.semcdb.2006.11.002; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Lo LC, 2002, DEVELOPMENT, V129, P1553; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; MONTELL C, 2005, SCI STKE, P272; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Scott SA, 1992, SENSORY NEURONS DIVE; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsai RYL, 1997, BIOTECHNIQUES, V23, P794, DOI 10.2144/97235bm06; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200	27	134	137	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					475	485		10.1016/j.cell.2008.02.053	http://dx.doi.org/10.1016/j.cell.2008.02.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455988	Green Accepted, Bronze			2022-12-28	WOS:000255503900018
J	Paul, R; Jaeger, T; Abel, S; Wiederkehr, I; Folcher, M; Biondi, EG; Laub, MT; Jenal, U				Paul, Ralf; Jaeger, Tina; Abel, Soeren; Wiederkehr, Irene; Folcher, Marc; Biondi, Emanuele G.; Laub, Michael T.; Jenal, Urs			Allosteric regulation of histidine kinases by their cognate response regulator determines cell fate	CELL			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; CAULOBACTER-CRESCENTUS; DYNAMIC LOCALIZATION; CYCLE PROGRESSION; TYROSINE KINASE; PROTEIN-KINASE; DIFFERENTIATION; DIVISION; PHOSPHORYLATION; MORPHOGENESIS	The two-component phosphorylation network is of critical importance for bacterial growth and physiology. Here, we address plasticity and interconnection of distinct signal transduction pathways within this network. In Caulobacter crescentus antagonistic activities of the PleC phosphatase and DivJ kinase localized at opposite cell poles control the phosphorylation state and subcellular localization of the cell fate determinator protein DivK. We show that DivK functions as an allosteric regulator that switches PleC from a phosphatase into an autokinase state and thereby mediates a cyclic di-GMP-dependent morphogenetic program. Through allosteric activation of the DivJ autokinase, DivK also stimulates its own phosphorylation and polar localization. These data suggest that DivK is the central effector of an integrated circuit that operates via spatially organized feedback loops to control asymmetry and cell fate determination in C. crescentus. Thus, single domain response regulators can facilitate crosstalk, feedback control, and long-range communication among members of the two-component network.	[Paul, Ralf; Jaeger, Tina; Abel, Soeren; Wiederkehr, Irene; Folcher, Marc; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Biondi, Emanuele G.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA	University of Basel; Massachusetts Institute of Technology (MIT)	Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	urs.jenal@unibas.ch		Abel, Soren/0000-0002-4041-6989; Laub, Michael/0000-0002-8288-7607	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082899] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM082899, R01 GM082899-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; BETSCHINGER J, 2004, NATURE, V444, P899; Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; OHTA N, 1992, P NATL ACAD SCI USA, V89, P10297, DOI 10.1073/pnas.89.21.10297; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sciochetti SA, 2005, MOL MICROBIOL, V56, P1467, DOI 10.1111/j.1365-2958.2005.04652.x; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; SOMMER JM, 1991, GENETICS, V129, P623; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X	35	117	121	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					452	461		10.1016/j.cell.2008.02.045	http://dx.doi.org/10.1016/j.cell.2008.02.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455986	Green Accepted, Bronze			2022-12-28	WOS:000255503900016
J	Eckel, RH				Eckel, Robert H.			Nonsurgical management of obesity in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEIGHT-LOSS MAINTENANCE; LONG-TERM MANAGEMENT; LOW-FAT DIET; PHYSICAL-ACTIVITY; BODY-WEIGHT; BEHAVIORAL TREATMENT; BARIATRIC SURGERY; RANDOMIZED-TRIAL; LOW-CARBOHYDRATE; HEART-DISEASE		[Eckel, Robert H.] Univ Colorado Denver, Div Endocrinol Diabet & Metab, Aurora, CO 80045 USA; [Eckel, Robert H.] Univ Colorado Denver, Div Cardiol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Eckel, RH (corresponding author), Univ Colorado Denver, Div Endocrinol Diabet & Metab, Anschutz Med Campus,MS 8106,RC1 South,Rm 7107,128, Aurora, CO 80045 USA.	robert.eckel@uchsc.edu						ADAMS SO, 1986, J AM DIET ASSOC, V86, P485; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Ashley JM, 2001, ARCH INTERN MED, V161, P1599, DOI 10.1001/archinte.161.13.1599; Boudreaux ED, 2003, AM J HEALTH PROMOT, V17, P329, DOI 10.4278/0890-1171-17.5.329; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Butryn ML, 2007, OBESITY, V15, P3091, DOI 10.1038/oby.2007.368; Christensen R, 2008, LANCET, V371, P558; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; Due A, 2004, INT J OBESITY, V28, P1283, DOI 10.1038/sj.ijo.0802767; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V298, P627; Ebbeling CB, 2007, JAMA-J AM MED ASSOC, V297, P2092, DOI 10.1001/jama.297.19.2092; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Foster GD, 2005, AM J CLIN NUTR, V82, p230S, DOI 10.1093/ajcn/82.1.230S; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Frank A, 2004, OBES RES, V12, P1821, DOI 10.1038/oby.2004.226; GARDNER CD, 2007, JAMA-J AM MED ASSOC, V298, P178; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Halford JCG, 2006, CURR OPIN INVEST DR, V7, P312; Heymsfield SB, 2003, INT J OBESITY, V27, P537, DOI 10.1038/sj.ijo.0802258; Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005; Howarth NC, 2001, NUTR REV, V59, P129, DOI 10.1111/j.1753-4887.2001.tb07001.x; Hvizdos KM, 1999, DRUGS, V58, P743, DOI 10.2165/00003495-199958040-00015; Kaplan LM, 2005, GASTROENTEROL CLIN N, V34, P91, DOI 10.1016/j.gtc.2004.12.002; Klein S, 2001, OBES RES, V9, p354S, DOI 10.1038/oby.2001.142; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; Mancini MC, 2006, EXPERT OPIN INV DRUG, V15, P897, DOI 10.1517/13543784.15.8.897; Miller WC, 1997, INT J OBESITY, V21, P941, DOI 10.1038/sj.ijo.0800499; Noakes M, 2005, AM J CLIN NUTR, V81, P1298; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Perri MG, 2001, J CONSULT CLIN PSYCH, V69, P722, DOI 10.1037/0022-006X.69.4.722; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Poston WSC, 2000, AM FAM PHYSICIAN, V61, P3615; Raatz SK, 2005, J NUTR, V135, P2387, DOI 10.1093/jn/135.10.2387; SCHLUNDT DG, 1992, AM J CLIN NUTR, V55, P645, DOI 10.1093/ajcn/55.3.645; Schoeller DA, 1997, AM J CLIN NUTR, V66, P551, DOI 10.1093/ajcn/66.3.551; Shick SM, 1998, J AM DIET ASSOC, V98, P408, DOI 10.1016/S0002-8223(98)00093-5; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Svetkey LP, 2008, JAMA-J AM MED ASSOC, V299, P1139, DOI 10.1001/jama.299.10.1139; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Torgerson JS, 2004, DIABETES CARE, V27, P856; Truby H, 2006, BRIT MED J, V332, P1418; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; van Baak MA, 2003, AM J CLIN NUTR, V78, P209; Vogels N, 2005, AM J CLIN NUTR, V82, P740, DOI 10.1093/ajcn/82.4.740; Wadden TA, 2003, ENDOCRIN METAB CLIN, V32, P981, DOI 10.1016/S0889-8529(03)00072-0; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2000, OBES RES, V8, P431, DOI 10.1038/oby.2000.53; Westerterp-Plantenga MS, 2005, APPETITE, V45, P187, DOI 10.1016/j.appet.2005.02.005; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Wilmore JH, 1999, AM J CLIN NUTR, V70, P346; Wing RR, 2006, NEW ENGL J MED, V355, P1563, DOI 10.1056/NEJMoa061883; WOOD PD, 1994, MED SCI SPORT EXER, V26, P838; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; 1998, OBES RES, V6, P464	64	106	110	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1941	1950		10.1056/NEJMcp0801652	http://dx.doi.org/10.1056/NEJMcp0801652			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450605				2022-12-28	WOS:000255387900008
J	Marcucci, G; Radmacher, MD; Maharry, K; Mrozek, K; Ruppert, AS; Paschka, P; Vukosavljevic, T; Whitman, SP; Baldus, CD; Langer, C; Liu, CG; Carroll, AJ; Powell, BL; Garzon, R; Croce, CM; Kolitz, JE; Caligiuri, MA; Larson, RA; Bloomfield, CD				Marcucci, Guido; Radmacher, Michael D.; Maharry, Kati; Mrozek, Krzysztof; Ruppert, Amy S.; Paschka, Peter; Vukosavljevic, Tamara; Whitman, Susan P.; Baldus, Claudia D.; Langer, Christian; Liu, Chang-Gong; Carroll, Andrew J.; Powell, Bayard L.; Garzon, Ramiro; Croce, Carlo M.; Kolitz, Jonathan E.; Caligiuri, Michael A.; Larson, Richard A.; Bloomfield, Clara D.			MicroRNA expression in cytogenetically normal acute myeloid leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYELOGENOUS LEUKEMIA; BLOCKS INTERLEUKIN-1-BETA-INDUCED ACTIVATION; ETS-RELATED GENE; NF-KAPPA-B; INHIBITS PROLIFERATION; NORMAL KARYOTYPE; CANCER; ADULT; CELLS; PROGNOSIS	Background: A role of microRNAs in cancer has recently been recognized. However, little is known about the role of microRNAs in acute myeloid leukemia (AML). Methods: Using microRNA expression profiling, we studied samples of leukemia cells from adults under the age of 60 years who had cytogenetically normal AML and high-risk molecular features - that is, an internal tandem duplication in the fms-related tyrosine kinase 3 gene (FLT3-ITD), a wild-type nucleophosmin (NPM1), or both. A microRNA signature that was associated with event-free survival was derived from a training group of 64 patients and tested in a validation group of 55 patients. For the latter, a microRNA compound covariate predictor (called a microRNA summary value) was computed on the basis of weighted levels of the microRNAs forming the outcome signature. Results: Of 305 microRNA probes, 12 (including 5 representing microRNA-181 family members) were associated with event-free survival in the training group (P<0.005). In the validation group, the microRNA summary value was inversely associated with event-free survival (P=0.03). In multivariable analysis, the microRNA summary value remained associated with event-free survival (P=0.04) after adjustment for the allelic ratio of FLT3-ITD to wild-type FLT3 and for the white-cell count. Using results of gene-expression microarray analysis, we found that expression levels of the microRNA-181 family were inversely correlated with expression levels of predicted target genes encoding proteins involved in pathways of innate immunity mediated by toll-like receptors and interleukin-1 beta. Conclusions: A microRNA signature in molecularly defined, high-risk, cytogenetically normal AML is associated with the clinical outcome and with target genes encoding proteins involved in specific innate-immunity pathways.	[Marcucci, Guido; Radmacher, Michael D.; Maharry, Kati; Mrozek, Krzysztof; Ruppert, Amy S.; Paschka, Peter; Vukosavljevic, Tamara; Whitman, Susan P.; Langer, Christian; Liu, Chang-Gong; Garzon, Ramiro; Croce, Carlo M.; Caligiuri, Michael A.; Bloomfield, Clara D.] Ohio State Univ, Ctr Comprehens Canc, Div Hematol & Oncol, Columbus, OH 43210 USA; [Radmacher, Michael D.; Maharry, Kati; Ruppert, Amy S.] Duke Univ, Med Ctr, Ctr Stat, Canc & Leukemia Grp B, Durham, NC USA; [Baldus, Claudia D.] Charite Univ Med Berlin, Berlin, Germany; [Carroll, Andrew J.] Univ Alabama, Birmingham, AL USA; [Powell, Bayard L.] Wake Forest Univ, Ctr Comprehens Canc, Winston Salem, NC 27109 USA; [Kolitz, Jonathan E.] N Shore Univ Hosp, Manhasset, NY USA; [Larson, Richard A.] Univ Chicago, Chicago, IL 60637 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Duke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Alabama System; University of Alabama Birmingham; Wake Forest University; Northwell Health; North Shore University Hospital; University of Chicago	Marcucci, G (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Div Hematol & Oncol, Suite A434,Starling Loving Hall,320 W 10th Ave, Columbus, OH 43210 USA.	guido.marcucci@osumc.edu	Young, Richard A/F-6495-2012; Mrózek, Krzysztof/A-3142-2008; Garzon, Ramiro/E-3104-2011; Larson, Richard A./AAE-7223-2019	Young, Richard A/0000-0001-8855-8647; Larson, Richard A./0000-0001-9168-3203	NCI NIH HHS [U10 CA035279, U10 CA101140, CA31946, CA35279, CA03927, CA114725, CA16058, CA33601, CA102031, CA101140, UG1 CA189850, P30 CA016058, CA41287, CA77658, U10 CA003927, U10 CA077658] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA114725, UG1CA189850, U10CA033601, U10CA031946, U10CA077658, U10CA035279, U10CA101140, U10CA003927, U10CA041287, P30CA016058, R01CA102031] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Awomoyi AA, 2007, FEMS IMMUNOL MED MIC, V49, P324, DOI 10.1111/j.1574-695X.2007.00231.x; Baldus CD, 2003, BLOOD, V102, P1613, DOI 10.1182/blood-2003-02-0359; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Calin GA, 2006, NEW ENGL J MED, V355, P533; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Dohner K, 2005, BLOOD, V106, P3740, DOI 10.1182/blood-2005-05-2164; Estrov Z, 1999, BLOOD, V94, P2844, DOI 10.1182/blood.V94.8.2844.420k43_2844_2853; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Kobayashi R, 2007, CLIN IMMUNOL, V125, P149, DOI 10.1016/j.clim.2007.07.008; Kobayashi Y, 2000, J PATHOL, V192, P263; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; Kolitz JE, 2005, BLOOD, V106, p122A; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Marcucci G, 2005, J CLIN ONCOL, V23, P9234, DOI 10.1200/JCO.2005.03.6137; Marcucci G, 2007, J CLIN ONCOL, V25, P3337, DOI 10.1200/JCO.2007.10.8720; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Radmacher MD, 2006, BLOOD, V108, P1677, DOI 10.1182/blood-2006-02-005538; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Turzanski J, 2004, LEUKEMIA, V18, P1662, DOI 10.1038/sj.leu.2403457; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	34	361	407	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1919	1928		10.1056/NEJMoa074256	http://dx.doi.org/10.1056/NEJMoa074256			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294ER	18450603				2022-12-28	WOS:000255387900006
J	Marvier, M; Carriere, Y; Ellstrand, N; Gepts, P; Kareiva, P; Rosi-Marshall, E; Tabashnik, BE; Wolfenbarger, LL				Marvier, Michelle; Carriere, Yves; Ellstrand, Norman; Gepts, Paul; Kareiva, Peter; Rosi-Marshall, Emma; Tabashnik, Bruce E.; Wolfenbarger, L. LaReesa			Ecology - Harvesting data from genetically engineered crops	SCIENCE			English	Editorial Material							TRANSGENIC CROPS; COTTON		[Marvier, Michelle; Kareiva, Peter] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Carriere, Yves; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Ellstrand, Norman] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Gepts, Paul] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kareiva, Peter] Nature Conservancy, Seattle, WA 98105 USA; [Rosi-Marshall, Emma] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Wolfenbarger, L. LaReesa] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Santa Clara University; University of Arizona; University of California System; University of California Riverside; University of California System; University of California Davis; Nature Conservancy; Loyola University Chicago; University of Nebraska System	Marvier, M (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	mmarvier@scu.edu	Gepts, Paul/O-8229-2019; Ellstrand, Norman/F-7665-2011; Rosi-Marshall, Emma J/F-1777-2011	Gepts, Paul/0000-0002-1056-4665; Rosi-Marshall, Emma J/0000-0002-3476-6368; Marvier, Michelle/0000-0001-8360-9265				Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; *CAL DEP PEST REG, 2000, OV CAL UN FULL REP S; Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; *EPA, 1998, EPA PUBL; *EPA, 2007, EPAS REP ENV ROE SCI; Ervin DE, 2003, AGR ECOSYST ENVIRON, V99, P1, DOI 10.1016/S0167-8809(03)00145-2; FOURNIER A, 2007, COTTON COLL AGR REP, V151, P155; *NASS, 2007, ACR DAT; Siegfried Blair D., 2007, American Entomologist, V53, P208; *USDA ERS, 2002, AER810 USDA ERS	12	15	17	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					452	453		10.1126/science.1154521	http://dx.doi.org/10.1126/science.1154521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436759				2022-12-28	WOS:000255249300020
J	Mercer, J; Helenius, A				Mercer, Jason; Helenius, Ari			Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells	SCIENCE			English	Article							PLASMA-MEMBRANE; ENTRY; PHOSPHATIDYLSERINE; ENDOCYTOSIS; INHIBITION; PATHWAYS; KINASE; DEATH	Viruses employ many different strategies to enter host cells. Vaccinia virus, a prototype poxvirus, enters cells in a pH- dependent fashion. Live cell imaging showed that fluorescent virus particles associated with and moved along filopodia to the cell body, where they were internalized after inducing the extrusion of large transient membrane blebs. p21- activated kinase 1 ( PAK1) was activated by the virus, and the endocytic process had the general characteristics of macropinocytosis. The induction of blebs, the endocytic event, and infection were all critically dependent on the presence of exposed phosphatidylserine in the viral membrane, which suggests that vaccinia virus uses apoptotic mimicry to enter cells.	[Mercer, Jason; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Mercer, Jason; Helenius, Ari] ETH Honggerberg, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH, Inst Biochem, Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch		Mercer, Jason/0000-0003-1466-9541				Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; FISHKIND DJ, 1991, J CELL BIOL, V114, P967, DOI 10.1083/jcb.114.5.967; Harrison SC, 2004, P NATL ACAD SCI USA, V101, P11178, DOI 10.1073/pnas.0403600101; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; ICHIHASHI Y, 1983, VIROLOGY, V130, P306, DOI 10.1016/0042-6822(83)90085-5; ICHIHASHI Y, 1984, J VIROL, V50, P929, DOI 10.1128/JVI.50.3.929-938.1984; Knipe D. M., 2007, FIELDS VIROLOGY, V5; Lehmann MJ, 2005, J CELL BIOL, V170, P317, DOI 10.1083/jcb.200503059; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; OIE M, 1985, VIROLOGY, V142, P299, DOI 10.1016/0042-6822(85)90338-1; Parrini MC, 2005, BIOCHEM SOC T, V33, P646, DOI 10.1042/BST0330646; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Valderrama F, 2006, SCIENCE, V311, P377, DOI 10.1126/science.1122411; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; ZWARTOUW HT, 1964, J GEN MICROBIOL, V34, P115, DOI 10.1099/00221287-34-1-115	25	557	584	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					531	535		10.1126/science.1155164	http://dx.doi.org/10.1126/science.1155164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436786				2022-12-28	WOS:000255249300051
J	Zhang, XY				Zhang, Xiaoyu			Perspective - The epigenetic landscape of plants	SCIENCE			English	Editorial Material							GENOME-WIDE ANALYSIS; DNA-METHYLATION; TRANSPOSABLE ELEMENTS; CG METHYLATION; RNA-POLYMERASE; GENE; HISTONE; MICRORNAS; METHYLTRANSFERASES; PARAMUTATION	In plants, DNA methylation, histone modifications, and RNA interference play critically important roles in regulating chromatin structure, thereby profoundly affecting transcription and other molecular events. Recent advances in microarray and high- throughput sequencing technologies have enabled genome- wide studies of these pathways in great detail. The vast amounts of "epigenomic" data generated so far have provided new insights into the mechanisms and functions of these pathways and have broadened our understanding of the structure and organization of plant chromatin as a whole.	[Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Zhang, XY (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	xiaoyu@plantbio.uga.edu	Zhang, xiaoyu/GXA-3206-2022					Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Devos KM, 2005, P NATL ACAD SCI USA, V102, P19243, DOI 10.1073/pnas.0509473102; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; MARTIENSSEN R, 1994, GENETICS, V136, P1157; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pfluger J, 2007, CURR OPIN PLANT BIOL, V10, P645, DOI 10.1016/j.pbi.2007.07.013; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinders J, 2008, GENOME RES, V18, P469, DOI 10.1101/gr.7073008; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vaillant I, 2007, CURR OPIN PLANT BIOL, V10, P528, DOI 10.1016/j.pbi.2007.06.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	53	161	168	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					489	492		10.1126/science.1153996	http://dx.doi.org/10.1126/science.1153996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436779				2022-12-28	WOS:000255249300038
J	Kurz, WA; Dymond, CC; Stinson, G; Rampley, GJ; Neilson, ET; Carroll, AL; Ebata, T; Safranyik, L				Kurz, W. A.; Dymond, C. C.; Stinson, G.; Rampley, G. J.; Neilson, E. T.; Carroll, A. L.; Ebata, T.; Safranyik, L.			Mountain pine beetle and forest carbon feedback to climate change	NATURE			English	Article							DISTURBANCE; OUTBREAK; ECOSYSTEM	The mountain pine beetle ( Dendroctonus ponderosae Hopkins, Coleoptera: Curculionidae, Scolytinae) is a native insect of the pine forests of western North America, and its populations periodically erupt into large- scale outbreaks(1-3). During outbreaks, the resulting widespread tree mortality reduces forest carbon uptake and increases future emissions from the decay of killed trees. The impacts of insects on forest carbon dynamics, however, are generally ignored in large- scale modelling analyses. The current outbreak in British Columbia, Canada, is an order of magnitude larger in area and severity than all previous recorded outbreaks(4). Here we estimate that the cumulative impact of the beetle outbreak in the affected region during 2000 - 2020 will be 270 megatonnes ( Mt) carbon ( or 36 g carbon m(-2) yr(-1) on average over 374,000 km 2 of forest). This impact converted the forest from a small net carbon sink to a large net carbon source both during and immediately after the outbreak. In the worst year, the impacts resulting from the beetle outbreak in British Columbia were equivalent to similar to 75% of the average annual direct forest fire emissions from all of Canada during 1959 - 1999. The resulting reduction in net primary production was of similar magnitude to increases observed during the 1980s and 1990s as a result of global change(5). Climate change has contributed to the unprecedented extent and severity of this outbreak(6). Insect outbreaks such as this represent an important mechanism by which climate change may undermine the ability of northern forests to take up and store atmospheric carbon, and such impacts should be accounted for in large- scale modelling analyses.	[Kurz, W. A.; Dymond, C. C.; Stinson, G.; Rampley, G. J.; Neilson, E. T.; Carroll, A. L.; Safranyik, L.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC V8Z 1M5, Canada; [Ebata, T.] British Columbia Minist Forests & Range, Victoria, BC V8W 9C2, Canada	Natural Resources Canada; Canadian Forest Service	Kurz, WA (corresponding author), Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC V8Z 1M5, Canada.	wkurz@nrcan.gc.ca	Dymond, Caren/P-6981-2019; Lukeš, Petr/B-1771-2010	Dymond, Caren/0000-0003-4542-0773; Kurz, Werner/0000-0003-4576-7849				Amiro BD, 2001, CAN J FOREST RES, V31, P512, DOI 10.1139/cjfr-31-3-512; Amman G.D., 1983, GTRINT145 USDA FOR S; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Berg EE, 2006, FOREST ECOL MANAG, V227, P219, DOI 10.1016/j.foreco.2006.02.038; Berryman A. A., 1988, DYNAMICS FOREST INSE; Bond-Lamberty B, 2007, NATURE, V450, P89, DOI 10.1038/nature06272; Canadell Josep G., 2007, P1; Carroll AL, 2004, PACIF FOR C, V399, P223; Environment Canada, 2007, NAT INV REP 1990 200; Hamann A, 2006, ECOLOGY, V87, P2773, DOI 10.1890/0012-9658(2006)87[2773:PEOCCO]2.0.CO;2; Kull S., 2006, OPERATIONAL SCALE CA; Kurz W.A., 1995, BIOTIC FEEDBACKS GLO, P119; Kurz WA, 1999, ECOL APPL, V9, P526, DOI 10.1890/1051-0761(1999)009[0526:AYRAOC]2.0.CO;2; KURZ WA, 1992, NORX326 FOR CAN NW R; Kurz WA, 2008, PHILOS T R SOC B, V363, P2261, DOI 10.1098/rstb.2007.2198; Logan J.A., 2001, AM ENTOMOL, V47, P160; MATTSON WJ, 1975, SCIENCE, V190, P515, DOI 10.1126/science.190.4214.515; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Parkins JR, 2007, GLOBAL ENVIRON CHANG, V17, P460, DOI 10.1016/j.gloenvcha.2007.01.003; Safranyik L, 1974, MANAGEMENT LODGEPOLE; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Taylor Steve W., 2006, P67; Taylor SW, 2004, PACIF FOR C, V399, P41; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; WALTON A, 2007, PROVINCIAL LEVEL PRO; Westfall J., 2007, 2006 SUMMARY FOREST; Williams DW, 2002, AGR FOREST ENTOMOL, V4, P87, DOI 10.1046/j.1461-9563.2002.00124.x; WULDER MA, 2001, FOREST ECOL MANAG, V221, P27	30	1258	1298	17	816	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					987	990		10.1038/nature06777	http://dx.doi.org/10.1038/nature06777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432244				2022-12-28	WOS:000255208600038
J	Ming, R; Hou, SB; Feng, Y; Yu, QY; Dionne-Laporte, A; Saw, JH; Senin, P; Wang, W; Ly, BV; Lewis, KLT; Salzberg, SL; Feng, L; Jones, MR; Skelton, RL; Murray, JE; Chen, CX; Qian, WB; Shen, JG; Du, P; Eustice, M; Tong, E; Tang, HB; Lyons, E; Paull, RE; Michael, TP; Wall, K; Rice, DW; Albert, H; Wang, ML; Zhu, YJ; Schatz, M; Nagarajan, N; Acob, RA; Guan, PZ; Blas, A; Wai, CM; Ackerman, CM; Ren, Y; Liu, C; Wang, JM; Wang, JP; Na, JK; Shakirov, EV; Haas, B; Thimmapuram, J; Nelson, D; Wang, XY; Bowers, JE; Gschwend, AR; Delcher, AL; Singh, R; Suzuki, JY; Tripathi, S; Neupane, K; Wei, HR; Irikura, B; Paidi, M; Jiang, N; Zhang, WL; Presting, G; Windsor, A; Navajas-Perez, R; Torres, MJ; Feltus, FA; Porter, B; Li, YJ; Burroughs, AM; Luo, MC; Liu, L; Christopher, DA; Mount, SM; Moore, PH; Sugimura, T; Jiang, JM; Schuler, MA; Friedman, V; Mitchell-Olds, T; Shippen, DE; dePamphilis, CW; Palmer, JD; Freeling, M; Paterson, AH; Gonsalves, D; Wang, L; Alam, M				Ming, Ray; Hou, Shaobin; Feng, Yun; Yu, Qingyi; Dionne-Laporte, Alexandre; Saw, Jimmy H.; Senin, Pavel; Wang, Wei; Ly, Benjamin V.; Lewis, Kanako L. T.; Salzberg, Steven L.; Feng, Lu; Jones, Meghan R.; Skelton, Rachel L.; Murray, Jan E.; Chen, Cuixia; Qian, Wubin; Shen, Junguo; Du, Peng; Eustice, Moriah; Tong, Eric; Tang, Haibao; Lyons, Eric; Paull, Robert E.; Michael, Todd P.; Wall, Kerr; Rice, Danny W.; Albert, Henrik; Wang, Ming-Li; Zhu, Yun J.; Schatz, Michael; Nagarajan, Niranjan; Acob, Ricelle A.; Guan, Peizhu; Blas, Andrea; Wai, Ching Man; Ackerman, Christine M.; Ren, Yan; Liu, Chao; Wang, Jianmei; Wang, Jianping; Na, Jong-Kuk; Shakirov, Eugene V.; Haas, Brian; Thimmapuram, Jyothi; Nelson, David; Wang, Xiyin; Bowers, John E.; Gschwend, Andrea R.; Delcher, Arthur L.; Singh, Ratnesh; Suzuki, Jon Y.; Tripathi, Savarni; Neupane, Kabi; Wei, Hairong; Irikura, Beth; Paidi, Maya; Jiang, Ning; Zhang, Wenli; Presting, Gernot; Windsor, Aaron; Navajas-Perez, Rafael; Torres, Manuel J.; Feltus, F. Alex; Porter, Brad; Li, Yingjun; Burroughs, A. Max; Luo, Ming-Cheng; Liu, Lei; Christopher, David A.; Mount, Stephen M.; Moore, Paul H.; Sugimura, Tak; Jiang, Jiming; Schuler, Mary A.; Friedman, Vikki; Mitchell-Olds, Thomas; Shippen, Dorothy E.; dePamphilis, Claude W.; Palmer, Jeffrey D.; Freeling, Michael; Paterson, Andrew H.; Gonsalves, Dennis; Wang, Lei; Alam, Maqsudul			The draft genome of the transgenic tropical fruit tree papaya (Carica papaya Linnaeus)	NATURE			English	Article							ARABIDOPSIS-THALIANA; RINGSPOT VIRUS; Y-CHROMOSOME; GENE; SEQUENCE; PROTEIN; DNA; EVOLUTION; FAMILIES; PLANTS	Papaya, a fruit crop cultivated in tropical and subtropical regions, is known for its nutritional benefits and medicinal applications. Here we report a 33 draft genome sequence of 'SunUp' papaya, the first commercial virus- resistant transgenic fruit tree(1) to be sequenced. The papaya genome is three times the size of the Arabidopsis genome, but contains fewer genes, including significantly fewer disease- resistance gene analogues. Comparison of the five sequenced genomes suggests a minimal angiosperm gene set of 13,311. A lack of recent genome duplication, atypical of other angiosperm genomes sequenced so far(2-5), may account for the smaller papaya gene number in most functional groups. Nonetheless, striking amplifications in gene number within particular functional groups suggest roles in the evolution of tree- like habit, deposition and remobilization of starch reserves, attraction of seed dispersal agents, and adaptation to tropical daylengths. Transgenesis at three locations is closely associated with chloroplast insertions into the nuclear genome, and with topoisomerase I recognition sites. Papaya offers numerous advantages as a system for fruit- tree functional genomics, and this draft genome sequence provides the foundation for revealing the basis of Carica's distinguishing morpho- physiological, medicinal and nutritional properties.	[Hou, Shaobin; Dionne-Laporte, Alexandre; Saw, Jimmy H.; Senin, Pavel; Ly, Benjamin V.; Lewis, Kanako L. T.; Alam, Maqsudul] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Ming, Ray; Yu, Qingyi; Jones, Meghan R.; Skelton, Rachel L.; Murray, Jan E.; Eustice, Moriah; Tong, Eric; Wang, Ming-Li; Zhu, Yun J.; Acob, Ricelle A.; Guan, Peizhu; Blas, Andrea; Wai, Ching Man; Ackerman, Christine M.; Singh, Ratnesh; Paidi, Maya] Hawaii Agr Res Ctr, Aiea, HI 96701 USA; [Ming, Ray; Murray, Jan E.; Chen, Cuixia; Wang, Jianping; Na, Jong-Kuk; Gschwend, Andrea R.; Li, Yingjun] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Feng, Yun; Wang, Wei; Feng, Lu; Qian, Wubin; Ren, Yan; Liu, Chao; Wang, Jianmei; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin Econ Technol Dev Area, Tianjin 300457, Peoples R China; [Feng, Yun; Feng, Lu; Shen, Junguo; Du, Peng; Wang, Lei] Tianjin Res Ctr Funct Genom & Biochip, Tianjin Econ Technol Dev Area, Tianjin 300457, Peoples R China; [Wang, Wei; Feng, Lu; Wang, Lei] Nankai Univ, Coll Life Sci, Minist Educ, Key Lab Mol Microbiol & Technol, Tianjin 300071, Peoples R China; [Salzberg, Steven L.; Schatz, Michael; Nagarajan, Niranjan; Delcher, Arthur L.; Burroughs, A. Max; Mount, Stephen M.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Eustice, Moriah; Acob, Ricelle A.; Guan, Peizhu; Blas, Andrea; Singh, Ratnesh; Paidi, Maya; Presting, Gernot; Porter, Brad; Christopher, David A.] Univ Hawaii, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Tang, Haibao; Wang, Xiyin; Bowers, John E.; Navajas-Perez, Rafael; Torres, Manuel J.; Feltus, F. Alex; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Lyons, Eric; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Paull, Robert E.; Wai, Ching Man; Irikura, Beth] Univ Hawaii, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Wall, Kerr; dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Rice, Danny W.; Palmer, Jeffrey D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Albert, Henrik; Suzuki, Jon Y.; Tripathi, Savarni; Moore, Paul H.; Gonsalves, Dennis] ARS, USDA, Pacific Basin Agr Res Ctr, Hilo, HI 96720 USA; [Shakirov, Eugene V.; Shippen, Dorothy E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Haas, Brian] Inst Genom Res, Rockville, MD 20850 USA; [Thimmapuram, Jyothi; Liu, Lei] Univ Illinois, WM Keck Ctr Comparat & Funct Genom, Urbana, IL 61801 USA; [Nelson, David] Univ Tennessee, Dept Mol Sci, Memphis, TN 38163 USA; [Neupane, Kabi] Univ Hawaii, Leeward Community Coll, Pearl City, HI 96782 USA; [Wei, Hairong] Wicell Res Inst, Madison, WI 53707 USA; [Jiang, Ning] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Zhang, Wenli; Jiang, Jiming] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Windsor, Aaron; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Luo, Ming-Cheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Mount, Stephen M.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Sugimura, Tak] Maui High Performance Comp Ctr, Kihei, HI 96753 USA; [Schuler, Mary A.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Schuler, Mary A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Schuler, Mary A.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Friedman, Vikki] Appl Biosyst Inc, Foster City, CA 94404 USA	University of Hawaii System; University of Illinois System; University of Illinois Urbana-Champaign; Nankai University; Nankai University; University System of Maryland; University of Maryland College Park; University of Hawaii System; University System of Georgia; University of Georgia; University of California System; University of California Berkeley; University of Hawaii System; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Indiana University System; Indiana University Bloomington; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Tennessee System; University of Tennessee Health Science Center; University of Hawaii System; WiCell Research Institute; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; Duke University; University of California System; University of California Davis; University System of Maryland; University of Maryland College Park; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Thermo Fisher Scientific; Applied Biosystems	Alam, M (corresponding author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.	wanglei@nankai.edu.cn; alam@hawaii.edu	feng, lu/M-5113-2015; Mitchell-Olds, Thomas/K-8121-2012; Jiang, Jiming/V-6060-2019; Palmer, Jeffrey/P-6747-2014; Jiang, Jiming/A-9614-2009; Bowers, John/AAD-7601-2019; Singh, Ratnesh/A-9739-2011; wei, hairong/GNM-7061-2022; Schatz, Michael/L-2690-2019; Wang, Lei/C-5176-2009; Salzberg, Steven/Q-6514-2019; Luo, Ming-Cheng/C-5600-2011; Singh, Ratnesh/I-1392-2015; Tang, Haibao/A-6715-2011; Saw, Jimmy/J-1360-2019; Bowers, John/B-9245-2009; Tripathi, Savarni/A-6910-2009; Saw, Jimmy HW/A-9972-2009; Liu, Chao/O-7322-2018; Shakirov, Eugene V/A-1363-2012; Salzberg, Steven L/F-6162-2011; Jiang, Ning/G-6546-2012; dePamphilis, Claude W/P-6652-2016; Yu, Qingyi/E-8899-2019; Wang, Jianmei/HHZ-0585-2022; Navajas-Pérez, Rafael/F-7122-2012	Mitchell-Olds, Thomas/0000-0003-3439-9921; Jiang, Jiming/0000-0002-6435-6140; Palmer, Jeffrey/0000-0002-4626-2220; Jiang, Jiming/0000-0002-6435-6140; wei, hairong/0000-0002-3551-4998; Schatz, Michael/0000-0002-4118-4446; Wang, Lei/0000-0003-4427-0881; Salzberg, Steven/0000-0002-8859-7432; Luo, Ming-Cheng/0000-0002-9744-5887; Singh, Ratnesh/0000-0001-5647-3390; Tang, Haibao/0000-0002-3460-8570; Saw, Jimmy/0000-0001-8353-3854; Bowers, John/0000-0001-8984-9796; Tripathi, Savarni/0000-0002-1814-2117; Saw, Jimmy HW/0000-0001-8353-3854; Liu, Chao/0000-0003-1303-1175; Shakirov, Eugene V/0000-0003-2689-7410; Salzberg, Steven L/0000-0002-8859-7432; Yu, Qingyi/0000-0001-5393-5764; Navajas-Pérez, Rafael/0000-0002-6147-3640; Burroughs, A. Max/0000-0002-2229-8771; Nelson, David/0000-0003-0583-5421; Michael, Todd/0000-0001-6272-2875; Feltus, Frank/0000-0002-2123-6114; Nagarajan, Niranjan/0000-0003-0850-5604; Lyons, Eric/0000-0002-3348-8845; Bowers, John/0000-0001-5693-2796; Wang, Wei/0000-0002-6660-8540; Senin, Pavel/0000-0001-5517-7768; Mount, Steve/0000-0003-2748-8205; Rice, Danny/0000-0002-1123-4617; Gschwend, Andrea/0000-0002-6208-2457	NIGMS NIH HHS [R01 GM083873-05, R01 GM083873] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083873] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Ehlting J, 2005, PLANT J, V42, P618, DOI 10.1111/j.1365-313X.2005.02403.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FITCH MMM, 1992, BIO-TECHNOL, V10, P1466, DOI 10.1038/nbt1192-1466; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANDER E S, 1988, Genomics, V2, P231; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; PAULL RE, 1983, PLANT PHYSIOL, V72, P382, DOI 10.1104/pp.72.2.382; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sawasaki T, 1998, GENE, V218, P27, DOI 10.1016/S0378-1119(98)00388-6; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Storey W. B., 1969, Miscellaneous Papers. Landbouwhogeschool Wageningen, P389; Thomas BC, 2007, P NATL ACAD SCI USA, V104, P3348, DOI 10.1073/pnas.0611574104; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Yu QY, 2008, PLANT J, V53, P124, DOI 10.1111/j.1365-313X.2007.03329.x; Yu QY, 2007, MOL GENET GENOMICS, V278, P177, DOI 10.1007/s00438-007-0243-z; Zhou LL, 2001, J AM SOC HORTIC SCI, V126, P351, DOI 10.21273/JASHS.126.3.351; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	51	721	843	5	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2008	452	7190					991	U7		10.1038/nature06856	http://dx.doi.org/10.1038/nature06856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432245	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000255208600039
J	Tullus, K; Brennan, E; Hamilton, G; Lord, R; McLaren, CA; Marks, SD; Roebuck, DJ				Tullus, Kjell; Brennan, Eileen; Hamilton, George; Lord, Rozanne; McLaren, Clare A.; Marks, Stephen D.; Roebuck, Derek J.			Renovascular hypertension in children	LANCET			English	Review							RENAL-ARTERY STENOSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ABDOMINAL AORTIC COARCTATION; TRANS-LUMINAL ANGIOPLASTY; MIDAORTIC SYNDROME; FIBROMUSCULAR DYSPLASIA; DUPLEX ULTRASONOGRAPHY; CAPTOPRIL RENOGRAPHY; BALLOON ANGIOPLASTY; CENTER EXPERIENCE	Renovascular disease is an uncommon but important cause of hypertension in children. it is usually diagnosed after a long delay because blood pressure is infrequently measured in children and high values are generally dismissed as inaccurate. Many children with renovascular disease have abnormalities of other blood vessels (aorta, cerebral, intestinal, or iliac). Individuals suspected of having the disorder can be investigated further with CT, MRI, or renal scintigraphy done before and after administration of an angiotensin-converting-enzyme inhibitor, but angiography is still the gold standard. Most children with renovascular disease will need interventional or surgical treatment. Endovascular treatment with or without stenting will cure or reduce high blood pressure in more than half of all affected children. Surgical intervention, if needed, should be delayed preferably until an age when the child is fully grown. Modern treatment provided by a multidisciplinary team of paediatric nephrologists, interventional radiologists, and vascular surgeons offers good long-term treatment results.	[Tullus, Kjell; Brennan, Eileen; Hamilton, George; Lord, Rozanne; McLaren, Clare A.; Marks, Stephen D.; Roebuck, Derek J.] Great Ormond St Hosp Sick Children, Dept Paediat Nephrol, London WC1N 3JH, England; [Hamilton, George; Lord, Rozanne] Royal Free Hampstead NHS Trust, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Tullus, K (corresponding author), Great Ormond St Hosp Sick Children, Dept Paediat Nephrol, Great Ormond St, London WC1N 3JH, England.	tulluk@gosh.nhs.uk	Marks, Stephen/AAH-6303-2019; hamilton, george/K-4764-2013; Marks, Stephen D/C-6818-2008; Tullus, Kjell/C-6589-2008; Roebuck, Derek/ABB-8690-2021	Marks, Stephen D/0000-0001-9850-8352; Roebuck, Derek/0000-0003-1734-2536	Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish	Great Ormond Street Hospital Childrens Charity		ADELMAN RD, 1978, PEDIATR CLIN N AM, V25, P99; Adwani S, 1996, PEDIATR CARDIOL, V17, P346, DOI 10.1007/s002469900077; ALVESTRAND A, 1977, ACTA MED SCAND, V202, P231; ARAR MY, 1994, PEDIATR NEPHROL, V8, P186, DOI 10.1007/BF00865475; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Arora P, 1997, KIDNEY BLOOD PRESS R, V20, P285, DOI 10.1159/000174160; Ashida A, 2006, EUR J PEDIATR, V165, P336, DOI 10.1007/s00431-005-0048-1; Baum MA, 1997, PEDIATR NEPHROL, V11, P499, DOI 10.1007/s004670050327; Bleacher J, 1997, J PEDIATR SURG, V32, P248, DOI 10.1016/S0022-3468(97)90188-3; Bofinger A, 2001, J HUM HYPERTENS, V15, P185, DOI 10.1038/sj.jhh.1001144; Brun P, 1997, PEDIATR NEPHROL, V11, P27, DOI 10.1007/s004670050227; Brzezinska-Rajszys G, 1999, HEART, V81, P166, DOI 10.1136/hrt.81.2.166; CASALINI E, 1995, INVEST RADIOL, V30, P40, DOI 10.1097/00004424-199501000-00006; Conkbayir I, 2003, CLIN IMAG, V27, P256, DOI 10.1016/S0899-7071(02)00547-8; Cordeiro NJV, 2006, DEV MED CHILD NEUROL, V48, P58, DOI 10.1017/S001262206000119; Courtel JV, 1998, PEDIATR RADIOL, V28, P59, DOI 10.1007/s002470050294; Criado E, 2002, ANN VASC SURG, V16, P363, DOI 10.1007/s10016-001-0098-4; Cura MA, 2002, J VASC INTERV RADIOL, V13, P1167, DOI 10.1016/S1051-0443(07)61960-5; D'Souza SJA, 1998, J PEDIATR-US, V132, P1016, DOI 10.1016/S0022-3476(98)70401-9; DANIELS SR, 1987, PEDIATRICS, V80, P698; DEAL JE, 1990, ARCH DIS CHILD, V65, P269, DOI 10.1136/adc.65.3.269; DEAL JE, 1992, J PEDIATR-US, V121, P378, DOI 10.1016/S0022-3476(05)81789-5; DILLON MJ, 1975, BMJ-BRIT MED J, V4, P316, DOI 10.1136/bmj.4.5992.316; DONDI M, 1991, AM J HYPERTENS, V4, pS737, DOI 10.1093/ajh/4.12.737S; Eklof H, 2006, ACTA RADIOL, V47, P764, DOI 10.1080/02841850600849092; Eliason J L, 2001, Vasc Surg, V35, P397, DOI 10.1177/153857440103500511; ELLIS D, 1995, PEDIATR NEPHROL, V9, P259, DOI 10.1007/BF02254180; Estepa R, 2001, SCAND J UROL NEPHROL, V35, P388; FALLO F, 1985, INT J PED NEPHROL, V6, P261; FOMMEI E, 1993, EUR J NUCL MED, V20, P617; Fossali E, 2000, PEDIATR NEPHROL, V14, P806, DOI 10.1007/s004679900260; Foster BJ, 2000, ARCH DIS CHILD, V83, P253, DOI 10.1136/adc.83.3.253; FRY WJ, 1973, ARCH SURG-CHICAGO, V107, P692; Gao J, 2006, CLIN IMAG, V30, P140, DOI 10.1016/j.clinimag.2005.06.033; GAREL L, 1995, RADIOLOGY, V195, P401, DOI 10.1148/radiology.195.2.7724758; GILL DG, 1976, ARCH DIS CHILD, V51, P951, DOI 10.1136/adc.51.12.951; Goonasekera CDA, 2002, PEDIATR NEPHROL, V17, P945, DOI 10.1007/s00467-002-0954-7; Guia JM, 2001, REV ESP CARDIOL, V54, P1332, DOI 10.1016/S0300-8932(01)76505-0; Hacklander T, 2004, J COMPUT ASSIST TOMO, V28, P823, DOI 10.1097/00004728-200411000-00016; Hari P, 2000, Indian Pediatr, V37, P268; Hegde S, 2007, ARCH DIS CHILD-FETAL, V92, P305, DOI 10.1136/adc.2006.104927; HINER LB, 1993, PEDIATR CLIN N AM, V40, P123; Hirai H, 2005, PEDIATR NEPHROL, V20, P831, DOI 10.1007/s00467-004-1774-8; Hughes RJ, 2004, CARDIOVASC INTER RAD, V27, P435; Imamura H, 1998, ANGIOLOGY, V49, P69; ING FF, 1995, CARDIOVASC INTER RAD, V18, P414, DOI 10.1007/BF00338313; Ishijima H, 1997, CARDIOVASC INTER RAD, V20, P383, DOI 10.1007/s002709900173; Isobe N, 2005, NEUROL MED-CHIR, V45, P476, DOI 10.2176/nmc.45.476; Johansson M, 2000, KIDNEY INT, V58, P774, DOI 10.1046/j.1523-1755.2000.00226.x; Karanikas G, 2002, EUR J NUCL MED MOL I, V29, P312, DOI 10.1007/s00259-001-0707-z; Khan MS, 2000, CATHETER CARDIO INTE, V50, P445, DOI 10.1002/1522-726X(200008)50:4<445::AID-CCD17>3.0.CO;2-1; Konez O, 2001, CARDIOVASC INTER RAD, V24, P343, DOI 10.1007/s00270-001-0027-5; Konig K, 2006, PEDIATR NEPHROL, V21, P663, DOI 10.1007/s00467-006-0010-0; KOSKIMIES O, 1982, BRIT MED J, V285, P996, DOI 10.1136/bmj.285.6347.996; Koyanagi T, 2002, UROL INT, V68, P24, DOI 10.1159/000048413; Kumar P, 1996, NEPHROL DIAL TRANSPL, V11, P1261; Kurien A, 1997, ARCH DIS CHILD, V76, P454, DOI 10.1136/adc.76.5.454; Lenz T, 1999, J HUM HYPERTENS, V13, P431, DOI 10.1038/sj.jhh.1000860; LEWIS VD, 1988, RADIOLOGY, V167, P111, DOI 10.1148/radiology.167.1.2964673; Li JC, 2006, J ULTRAS MED, V25, P735, DOI 10.7863/jum.2006.25.6.735; Liang Chi Di, 2002, J Invasive Cardiol, V14, P32; Lillehei CW, 2001, J PEDIATR SURG, V36, P1252, DOI 10.1053/jpsu.2001.25787; MALI WPTM, 1987, RADIOLOGY, V165, P391, DOI 10.1148/radiology.165.2.2958896; McCulloch M, 2003, PEDIATR RADIOL, V33, P230, DOI 10.1007/s00247-002-0817-1; McLaren Clare A, 2003, Tech Vasc Interv Radiol, V6, P150, DOI 10.1053/j.tvir.2003.10.007; MCLEAN AG, 1992, NEPHROL DIAL TRANSPL, V7, P211, DOI 10.1093/oxfordjournals.ndt.a092107; McLeary MS, 1996, AM J ROENTGENOL, V167, P521, DOI 10.2214/ajr.167.2.8686641; McTaggart SJ, 2000, PEDIATR NEPHROL, V14, P1022, DOI 10.1007/s004670050066; Michaely HJ, 2006, RADIOLOGY, V238, P586, DOI 10.1148/radiol.2382041553; Mickley V, 1998, J VASC SURG, V28, P206, DOI 10.1016/S0741-5214(98)70156-9; MINTY I, 1993, EUR J NUCL MED, V20, P699; Mustafa AE, 2006, PEDIATR RADIOL, V36, P158, DOI 10.1007/s00247-005-0017-x; NANNI GS, 1983, AM J ROENTGENOL, V140, P1239, DOI 10.2214/ajr.140.6.1239; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ng CS, 1997, NUCL MED COMMUN, V18, P1017, DOI 10.1097/00006231-199711000-00004; O'Shaughnessy BA, 2005, J NEUROSURG, V102, P338, DOI 10.3171/ped.2005.102.3.0338; Ognjanovic MV, 2002, ARCH DIS CHILD, V86, P127, DOI 10.1136/adc.86.2.127; ONEILL JA, 1995, J PEDIATR SURG, V30, P164, DOI 10.1016/0022-3468(95)90555-3; Ozen S, 2006, ANN RHEUM DIS, V65, P936, DOI 10.1136/ard.2005.046300; Panayiotopoulos YP, 1996, BRIT J SURG, V83, P235, DOI 10.1046/j.1365-2168.1996.02101.x; Patzer L, 2002, PEDIATR NEPHROL, V17, P193, DOI 10.1007/s00467-001-0799-5; Prakken FJ, 2006, PEDIATR RADIOL, V36, P57, DOI 10.1007/s00247-005-0007-z; PROESMANS W, 1982, ANN PEDIATR-PARIS, V29, P671; Quiros-Tejeira RE, 1999, J PEDIATR GASTR NUTR, V29, P431, DOI 10.1097/00005176-199910000-00011; Roebuck DJ, 2001, IMAGING, V13, P302; Roques X, 1988, Ann Vasc Surg, V2, P138, DOI 10.1016/S0890-5096(06)60796-6; Rose C, 2001, EUR J PEDIATR, V160, P655, DOI 10.1007/s004310100835; ROZENBLIT GN, 1999, TECH VASC INTERV RAD, V2, P84; RUSHTON AR, 1980, ARCH INTERN MED, V140, P233, DOI 10.1001/archinte.140.2.233; Sadowski RH, 1996, AM J KIDNEY DIS, V27, P305, DOI 10.1016/S0272-6386(96)90351-0; Sandmanm W, 2000, ANN VASC SURG, V14, P496, DOI 10.1007/s100169910095; Shahdadpuri J, 2000, PEDIATR NEPHROL, V14, P816, DOI 10.1007/PL00013441; Shokeir AA, 2005, PEDIATR TRANSPLANT, V9, P33, DOI 10.1111/j.1399-3046.2005.00244.x; Shroff R, 2006, PEDIATRICS, V118, P268, DOI 10.1542/peds.2005-2642; Slovut DP, 2004, NEW ENGL J MED, V350, P1862, DOI 10.1056/NEJMra032393; Sozen H, 2006, TRANSPL P, V38, P426, DOI 10.1016/j.transproceed.2006.01.014; Stanley JC, 2006, J VASC SURG, V44, P1219, DOI 10.1016/j.jvs.2006.08.009; STANLEY JC, 1995, J VASC SURG, V21, P212, DOI 10.1016/S0741-5214(95)70263-6; STANLEY P, 1984, RADIOLOGY, V153, P101, DOI 10.1148/radiology.153.1.6236476; Teigen C L, 1992, J Vasc Interv Radiol, V3, P111, DOI 10.1016/S1051-0443(92)72202-7; Towbin RB, 2007, J VASC INTERV RADIOL, V18, P663, DOI 10.1016/j.jvir.2007.02.014; Tyagi S, 1997, PEDIATRICS, V99, P44, DOI 10.1542/peds.99.1.44; Vade A, 2002, PEDIATR NEPHROL, V17, P741, DOI 10.1007/s00467-002-0921-3; Vasbinder GBC, 2004, ANN INTERN MED, V141, P674, DOI 10.7326/0003-4819-141-9-200411020-00007; Vo NJ, 2006, PEDIATR RADIOL, V36, P1032, DOI 10.1007/s00247-006-0253-8; Wada Hiromi, 2002, J Atheroscler Thromb, V9, P224; WATSON AR, 1985, J PEDIATR-US, V106, P366, DOI 10.1016/S0022-3476(85)80658-2; Wong H, 2006, J HYPERTENS, V24, P597, DOI 10.1097/01.hjh.0000209994.33680.11; WYSZYNSKA T, 1992, ACTA PAEDIATR, V81, P244, DOI 10.1111/j.1651-2227.1992.tb12213.x; Zeltser I, 2003, PEDIATRICS, V111, P1437, DOI 10.1542/peds.111.6.1437	110	153	164	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1453	1463		10.1016/S0140-6736(08)60626-1	http://dx.doi.org/10.1016/S0140-6736(08)60626-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440428				2022-12-28	WOS:000255440600027
J	Kirschner, N; Pauker, SG; Stubbs, JW				Kirschner, Neil; Pauker, Stephen G.; Stubbs, Joseph W.		Amer Coll Phys	Information on cost-effectiveness: An essential product of a national comparative effectiveness program	ANNALS OF INTERNAL MEDICINE			English	Review							HEALTH-CARE; QUALITY	The American College of Physicians recently highlighted the need to provide increased information comparing the effectiveness of health care interventions to ensure the rational and effective practice of medicine. Comparative effectiveness refers to the evaluation of the relative clinical effectiveness, safety, and cost of 2 or more medical services, drugs, devices, therapies, or procedures used to treat the same condition. The College further recommended the establishment of an adequately funded, trusted national entity that should prioritize, sponsor, or produce both comparative clinical and cost-effectiveness data. This article addresses the need for the proposed entity to develop cost-effectiveness information. It examines the current reluctance to develop and use cost-effectiveness in the United States; it argues for the importance of this information for all health care stakeholders; and it makes specific recommendations regarding how this information can best be made available and used for the good of the public and our patients.	Amer Coll Physicians, Philadelphia, PA 19106 USA	American College of Physicians	Kirschner, N (corresponding author), Amer Coll Physicians, Philadelphia, PA 19106 USA.		Hersh, William/AAH-6106-2019	Hersh, William/0000-0002-4114-5148				Anderson G, 2001, HEALTH AFFAIR, V20, P219, DOI 10.1377/hlthaff.20.3.219; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; [Anonymous], 2020, RES C DE LIST OFF PA; [Anonymous], 2007, MPA COMMITTEE REPORT; Bloom BS, 2004, AM J MANAG CARE, V10, P329; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P1057, DOI 10.1001/jama.299.9.1057; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; Garber AM, 2001, HEALTH AFFAIR, V20, P62, DOI 10.1377/hlthaff.20.5.62; GARBER AM, 2004, HLTH AFF MILLWOOD S; GINSBURG ME, 2004, HLTH AFF MILLWOOD S; Ginsburg PB, 2006, HEALTH AFFAIR, V25, pW486, DOI 10.1377/hlthaff.25.w486; Gold MR, 1996, COST EFFECTIVENESS H; HIATT HH, 1975, NEW ENGL J MED, V293, P235, DOI 10.1056/NEJM197507312930506; *HJ KAIS FAM FDN, 2007, MED MED ADV FACT SHE; Institute of Medicine, 2002, CAR COV TOO LITTL TO; Institute of Medicine, 2008, KNOW WHAT WORKS HEAL; Jena AB, 2007, HEALTH AFFAIR, V26, P696, DOI 10.1377/hlthaff.26.3.696; *KAIS COMM MED UN, 2002, MED PURCH PRESCR DRU; *KAIS COMM MED UN, 2007, UN PRIM; KASSIRER JP, 1994, NEW ENGL J MED, V331, P669, DOI 10.1056/NEJM199409083311009; Kirschner N, 2008, IMPROVING AVAILABILI; *MED PAYM ADV COMM, 2007, MED PAYM ADV COMM PU; *MED PAYM ADV COMM, 2006, REP C INCR VAL MED; Medicare Payment Advisory Commission, 2005, REP C ISS MOD MED PR; Neumann PJ, 2008, AM J MANAG CARE, V14, P185; Neumann PJ, 2005, VALUE HEALTH, V8, P3, DOI 10.1111/j.1524-4733.2005.04010.x; Neumann PJ, 2005, USING COST EFFECTIVE; Pearson SD, 2005, JAMA-J AM MED ASSOC, V294, P2618, DOI 10.1001/jama.294.20.2618; *SOC MED DEC MAK, 2008, SOC MED DEC MAK URG; *SOC SEC MED BOARD, 2007, STAT SOC SEC MED PRO; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Tunis SR, 2004, NEW ENGL J MED, V350, P2196, DOI 10.1056/NEJMe048091; Wilensky GR, 2006, HEALTH AFFAIR, V25, pW572, DOI 10.1377/hlthaff.25.w572	33	84	84	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 17	2008	148	12					956	961		10.7326/0003-4819-148-12-200806170-00222	http://dx.doi.org/10.7326/0003-4819-148-12-200806170-00222			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323DU	18483128				2022-12-28	WOS:000257425000007
J	Soutoglou, E; Misteli, T				Soutoglou, Evi; Misteli, Tom			Activation of the cellular DNA damage response in the absence of DNA lesions	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; MDC1; CHECKPOINT; ATM; PHOSPHORYLATION; 53BP1; RECOGNITION; MACHINERY; RETENTION	The cellular DNA damage response (DDR) is initiated by the rapid recruitment of repair factors to the site of DNA damage to form a multiprotein repair complex. How the repair complex senses damaged DNA and then activates the DDR is not well understood. We show that prolonged binding of DNA repair factors to chromatin can elicit the DDR in an ATM (ataxia telangiectasia mutated)- and DNAPK (DNA-dependent protein kinase)-dependent manner in the absence of DNA damage. Targeting of single repair factors to chromatin revealed a hierarchy of protein interactions within the repair complex and suggests amplification of the damage signal. We conclude that activation of the DDR does not require DNA damage and stable association of repair factors with chromatin is likely a critical step in triggering, amplifying, and maintaining the DDR signal.	[Soutoglou, Evi; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Soutoglou, E (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	soutogle@mail.nih.gov; mistelit@mail.nih.gov		Soutoglou, Evi/0000-0002-3724-5613	NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Lukas J, 2004, CELL, V118, P666, DOI 10.1016/j.cell.2004.09.006; Monier K, 2007, J CELL SCI, V120, P101, DOI 10.1242/jcs.03326; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Shiloh Y, 2003, CELL CYCLE, V2, P116, DOI 10.4161/cc.2.2.342; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038	21	234	236	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 13	2008	320	5882					1507	1510		10.1126/science.1159051	http://dx.doi.org/10.1126/science.1159051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	312MV	18483401	Green Accepted			2022-12-28	WOS:000256676400048
J	Hsu, M; Anen, C; Quartz, SR				Hsu, Ming; Anen, Cedric; Quartz, Steven R.			The right and the good: Distributive justice and neural encoding of equity and efficiency	SCIENCE			English	Article							INEQUALITY AVERSION; MAXIMIN PREFERENCES; REWARD; RESPONSES; TRUST; BRAIN; RISK; GAME	Distributive justice concerns how individuals and societies distribute benefits and burdens in a just or moral manner. We combined distribution choices with functional magnetic resonance imaging to investigate the central problem of distributive justice: the trade- off between equity and efficiency. We found that the putamen responds to efficiency, whereas the insula encodes inequity, and the caudate/ septal subgenual region encodes a unified measure of efficiency and inequity ( utility). Notably, individual differences in inequity aversion correlate with activity in inequity and utility regions. Against utilitarianism, our results support the deontological intuition that a sense of fairness is fundamental to distributive justice but, as suggested by moral sentimentalists, is rooted in emotional processing. More generally, emotional responses related to norm violations may underlie individual differences in equity considerations and adherence to ethical rules.	[Anen, Cedric; Quartz, Steven R.] CALTECH, Social Cognit Neurosci Lab, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA; [Hsu, Ming] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Hsu, Ming] Univ Illinois, Dept Econ, Urbana, IL 61801 USA	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Quartz, SR (corresponding author), CALTECH, Social Cognit Neurosci Lab, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA.	steve@hss.caltech.edu	sarinopoulos, isidoros/B-5453-2010					AMIEL Y, 1999, THINIKING INQUALITY; [Anonymous], 1984, COLLECTIVE CHOICE SO; Aristotle, 1980, NICOMACHEAN ETHICS; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Engelmann D, 2004, AM ECON REV, V94, P857, DOI 10.1257/0002828042002741; Fehr E, 2006, AM ECON REV, V96, P1912, DOI 10.1257/aer.96.5.1912; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harsanyi J.C., 1976, ESSAYS ETHICS SOCIAL; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Kohlberg L, 1981, PHILOS MORAL DEV MOR, V1; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Loeber R, 2000, J AM ACAD CHILD PSY, V39, P1468, DOI 10.1097/00004583-200012000-00007; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Rawls J., 1972, SOCIAL JUSTICE LIBER; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Smith Adam., 1812, THEORY MORAL SENTIME	27	221	235	5	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 23	2008	320	5879					1092	1095		10.1126/science.1153651	http://dx.doi.org/10.1126/science.1153651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303RY	18467558				2022-12-28	WOS:000256059800050
J	Murayama, A; Ohmori, K; Fujimura, A; Minami, H; Yasuzawa-Tanaka, K; Kuroda, T; Oie, S; Daitoku, H; Okuwaki, M; Nagata, K; Fukamizu, A; Kimura, K; Shimizu, T; Yanagisawa, J				Murayama, Akiko; Ohmori, Kazuji; Fujimura, Akiko; Minami, Hiroshi; Yasuzawa-Tanaka, Kayoko; Kuroda, Takao; Oie, Shohei; Daitoku, Hiroaki; Okuwaki, Mitsuru; Nagata, Kyosuke; Fukamizu, Akiyoshi; Kimura, Keiji; Shimizu, Toshiyuki; Yanagisawa, Junn			Epigenetic control of rDNA loci in response to intracellular energy status	CELL			English	Article							RNA-POLYMERASE-I; HISTONE METHYLTRANSFERASE; HETEROCHROMATIN FORMATION; NUCLEOLAR DOMINANCE; CALORIE RESTRICTION; GENE-TRANSCRIPTION; LYSINE METHYLATION; CATALYTIC DOMAIN; CELL-SURVIVAL; YEAST	Intracellular energy balance is important for cell survival. In eukaryotic cells, the most energy-consuming process is ribosome biosynthesis, which adapts to changes in intracellular energy status. However, the mechanism that links energy status and ribosome biosynthesis is largely unknown. Here, we describe eNoSC, a protein complex that senses energy status and controls rRNA transcription. eNoSC contains Nucleomethylin, which binds histone H3 dimethylated Lys9 in the rDNA locus, in a complex with SIRT1 and SUV39H1. Both SIRT1 and SUV39H1 are required for energy-dependent transcriptional repression, suggesting that a change in the NAD(+)/NADH ratio induced by reduction of energy status could activate SIRT1, leading to deacetylation of histone H3 and dimethylation at Lys9 by SUV39H1, thus establishing silent chromatin in the rDNA locus. Furthermore, eNoSC promotes restoration of energy balance by limiting rRNA transcription, thus protecting cells from energy deprivation-dependent apoptosis. These findings provide key insight into the mechanisms of energy homeostasis in cells.	[Murayama, Akiko; Ohmori, Kazuji; Fujimura, Akiko; Yasuzawa-Tanaka, Kayoko; Kuroda, Takao; Oie, Shohei; Kimura, Keiji; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Murayama, Akiko; Daitoku, Hiroaki; Fukamizu, Akiyoshi] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058572, Japan; [Okuwaki, Mitsuru; Nagata, Kyosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058572, Japan; [Okuwaki, Mitsuru; Nagata, Kyosuke] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058572, Japan; [Minami, Hiroshi; Shimizu, Toshiyuki] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa 2300045, Japan; [Murayama, Akiko; Ohmori, Kazuji] JST, PRESTO, Saitama, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba; Yokohama City University; Japan Science & Technology Agency (JST)	Yanagisawa, J (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	junny@agbi.tsukuba.ac.jp	Okuwaki, Mitsuru/R-3038-2019; fukamizu, akiyoshi/J-5350-2012	Okuwaki, Mitsuru/0000-0003-2118-442X; fukamizu, akiyoshi/0000-0002-8786-6020				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bousquet-Antonelli C, 2000, RNA, V6, P826, DOI 10.1017/S1355838200992288; Buck SW, 2002, CELL, V111, P1003, DOI 10.1016/S0092-8674(02)01193-5; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; MURAMATSU M, 1964, CANCER RES, V24, P1028; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Oakes ML, 2006, MOL CELL BIOL, V26, P3889, DOI 10.1128/MCB.26.10.3889-3901.2006; Preuss S, 2007, BBA-GENE STRUCT EXPR, V1769, P383, DOI 10.1016/j.bbaexp.2007.02.005; ROUSSEL P, 1993, J CELL SCI, V104, P327; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Yang TL, 2006, TRENDS ENDOCRIN MET, V17, P186, DOI 10.1016/j.tem.2006.04.002; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	42	288	292	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					627	639		10.1016/j.cell.2008.03.030	http://dx.doi.org/10.1016/j.cell.2008.03.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485871	Bronze			2022-12-28	WOS:000255903300018
J	Egger, M; Boulle, A				Egger, Matthias; Boulle, Andrew			Population effect of scaling up ART in resource-poor settings	LANCET			English	Editorial Material							ANTIRETROVIRAL TREATMENT; THERAPY		[Egger, Matthias; Boulle, Andrew] Univ Cape Town, IeDEA, Infect Dis Epidemiol Unit, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Egger, Matthias] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland	University of Cape Town; University of Bern	Egger, M (corresponding author), Univ Cape Town, IeDEA, Infect Dis Epidemiol Unit, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	egger@ispm.unibe.ch	Boulle, Andrew/C-1413-2008	Boulle, Andrew/0000-0002-7713-8062; Egger, Matthias/0000-0001-7462-5132	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI069924] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*ART LINC COLL IED, 2008, TROP MED INT HLTH; BOULLE A, IN PRESS B WHO; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Desvarieux M, 2005, AM J PUBLIC HEALTH, V95, P1117, DOI 10.2105/AJPH.2003.034249; Egger M, 2005, INT J EPIDEMIOL, V34, P509, DOI 10.1093/ije/dyi110; EGGER M, 2007, 14 C RETR OPP INF LO, V22; FINE PEM, 1986, LANCET, V2, P499, DOI 10.1016/S0140-6736(86)90367-3; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; HERBST K, 2007, 3 S AFR AIDS C DURB; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; LAUBSCHER R, 2007, 3 S AFR AIDS C DURB; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; TANSFER F, 2007, INT J EPIDEMIOL	13	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 10	2008	371	9624					1558	1559		10.1016/S0140-6736(08)60669-8	http://dx.doi.org/10.1016/S0140-6736(08)60669-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468529				2022-12-28	WOS:000255715400007
J	Fushman, I; Englund, D; Faraon, A; Stoltz, N; Petroff, P; Vuckovic, J				Fushman, Ilya; Englund, Dirk; Faraon, Andrei; Stoltz, Nick; Petroff, Pierre; Vuckovic, Jelena			Controlled phase shifts with a single quantum dot	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; PHOTONIC CRYSTAL; COMPUTATION; QUBITS	Optical nonlinearities enable photon- photon interaction and lie at the heart of several proposals for quantum information processing, quantum nondemolition measurements of photons, and optical signal processing. To date, the largest nonlinearities have been realized with single atoms and atomic ensembles. We show that a single quantum dot coupled to a photonic crystal nanocavity can facilitate controlled phase and amplitude modulation between two modes of light at the single- photon level. At larger control powers, we observed phase shifts up to pi/4 and amplitude modulation up to 50%. This was accomplished by varying the photon number in the control beam at a wavelength that was the same as that of the signal, or at a wavelength that was detuned by several quantum dot linewidths from the signal. Our results present a step toward quantum logic devices and quantum nondemolition measurements on a chip.	[Vuckovic, Jelena] Stanford Univ, Stanford, CA 94305 USA; [Fushman, Ilya; Englund, Dirk; Faraon, Andrei] Stanford Univ, Stanford, CA 94305 USA; [Stoltz, Nick; Petroff, Pierre] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	Stanford University; Stanford University; University of California System; University of California Santa Barbara	Vuckovic, J (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	jela@stanford.edu	Petroff, Pierre/M-9840-2019; Englund, Dirk Robert/GNH-1681-2022; Vuckovic, Jelena/A-7335-2019	Englund, Dirk Robert/0000-0002-1043-3489; Vuckovic, Jelena/0000-0002-4603-9686				Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; Altug H, 2005, OPT LETT, V30, P982, DOI 10.1364/OL.30.000982; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Boyd R. W., 2003, NONLINEAR OPTICS; CHUANG IL, 1995, PHYS REV A, V52, P3489, DOI 10.1103/PhysRevA.52.3489; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Englund D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.013904; Englund D, 2007, NATURE, V450, P857, DOI 10.1038/nature06234; Englund D, 2007, OPT EXPRESS, V15, P5550, DOI 10.1364/OE.15.005550; Faraon A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2472534; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; IMOTO N, 1985, PHYS REV A, V32, P2287, DOI 10.1103/PhysRevA.32.2287; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; POIZAT JP, 1993, PHYS REV LETT, V70, P271, DOI 10.1103/PhysRevLett.70.271; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; Waks E, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.041803; Waks E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.153601; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835	25	357	381	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					769	772		10.1126/science.1154643	http://dx.doi.org/10.1126/science.1154643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467584	Green Submitted			2022-12-28	WOS:000255644400032
J	Burks, AW				Burks, A. Wesley			Peanut allergy	LANCET			English	Review							TREE NUT ALLERGY; FOOD-INDUCED ANAPHYLAXIS; DIAL TELEPHONE SURVEY; SKIN PRICK TESTS; T-CELL PEPTIDES; ARA-H-II; ORAL TOLERANCE; MURINE MODEL; IGE-BINDING; SUBLINGUAL IMMUNOTHERAPY	Peanut allergy has become a major health concern worldwide, especially in developed countries. However, the reasons this increasing prevalence over the past several decades are not well understood. Because of the potentially severe health consequences of peanut allergy, those suspected of having had an allergic reaction to peanuts deserve a thorough evaluation. All patients with peanut allergy should be given an emergency management plan, as well as epinephrine and antihistamines to have on hand at all times. Patients and families should be taught to recognise early allergic reactions to peanuts and how to implement appropriate peanut-avoidance strategies. It is imperative that severe, or potentially severe, reactions be treated promptly with intramuscular epinephrine and oral antihistamines. Patients who have had such a reaction should be kept under observation in a hospital emergency department or equivalent for up to 4 h because of the possible development of the late-phase allergic response. This Seminar looks at the changing epidemiology of this allergy-and theories as to the rise in prevalence, diagnosis, and management of the allergy, and potential new treatments and prevention strategies under development.	[Burks, A. Wesley] Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Burks, AW (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.	wesley.burks@duke.edu						Alexander C, 2005, ALLERGY, V60, P1269, DOI 10.1111/j.1398-9995.2005.00885.x; Arbes SJ, 2005, J ALLERGY CLIN IMMUN, V116, P377, DOI 10.1016/j.jaci.2005.05.017; Astier C, 2006, J ALLERGY CLIN IMMUN, V118, P250, DOI 10.1016/j.jaci.2006.04.053; Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Beyer K, 2003, J ALLERGY CLIN IMMUN, V112, P202, DOI 10.1067/mai.2003.1621; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Buchanan A, 2006, J ALLERGY CLIN IMMUN, V117, pS327, DOI 10.1016/j.jaci.2005.12.1290; Buchanan AD, 2007, J ALLERGY CLIN IMMUN, V119, P199, DOI 10.1016/j.jaci.2006.09.016; BURKS AW, 1995, J ALLERGY CLIN IMMUN, V95, P607, DOI 10.1016/S0091-6749(95)70323-3; Burks AW, 1999, INT ARCH ALLERGY IMM, V118, P313, DOI 10.1159/000024114; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Burks W, 2004, CLIN REV ALLERG IMMU, V27, P191, DOI 10.1385/CRIAI:27:3:191; Burks W, 2003, J CLIN INVEST, V111, P950, DOI 10.1172/JCI200318233; Burks Wesley, 2004, Clin Allergy Immunol, V18, P319; Busse PJ, 2002, NEW ENGL J MED, V347, P1535, DOI 10.1056/NEJM200211073471921; Chehade M, 2005, J ALLERGY CLIN IMMUN, V115, P3, DOI 10.1016/j.jaci.2004.11.008; Chung SY, 1999, J AGR FOOD CHEM, V47, P5227, DOI 10.1021/jf9904416; Dalal I, 2002, ALLERGY, V57, P362, DOI 10.1034/j.1398-9995.2002.1s3412.x; Dreskin SC, 2006, ANN ALLERG ASTHMA IM, V96, P766, DOI 10.1016/S1081-1206(10)61337-3; Eigenmann PA, 2006, PEDIATR ALLERGY IMMU, V17, P601, DOI 10.1111/j.1399-3038.2006.00455.x; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; Fleischer DM, 2004, J ALLERGY CLIN IMMUN, V114, P1195, DOI 10.1016/j.jaci.2004.08.035; Fleischer DM, 2003, J ALLERGY CLIN IMMUN, V112, P183, DOI 10.1067/mai.2003.1517; Frank L, 1999, PEDIATR ALLERGY IMMU, V10, P27, DOI 10.1034/j.1399-3038.1999.101010.x; Frick OL, 2005, ALLERGY, V60, P243, DOI 10.1111/j.1398-9995.2004.00711.x; Furlong TJ, 2001, J ALLERGY CLIN IMMUN, V108, P867, DOI 10.1067/mai.2001.119157; Glaspole IN, 2005, ALLERGY, V60, P35, DOI 10.1111/j.1398-9995.2004.00608.x; Gleich GJ, 2000, J ALLERGY CLIN IMMUN, V105, P651, DOI 10.1067/mai.2000.105712; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Hourihane JO, 1997, BRIT MED J, V314, P1084, DOI 10.1136/bmj.314.7087.1084; Hourihane JO, 1998, BRIT MED J, V316, P1271, DOI 10.1136/bmj.316.7140.1271; Hourihane JO, 2007, J ALLERGY CLIN IMMUN, V119, P1197, DOI 10.1016/j.jaci.2006.12.670; Kagan R, 2003, ANN ALLERG ASTHMA IM, V90, P640, DOI 10.1016/S1081-1206(10)61869-8; Kagan RS, 2003, J ALLERGY CLIN IMMUN, V112, P1223, DOI 10.1016/j.jaci.2003.09.026; Kelso JM, 2003, J ALLERGY CLIN IMMUN, V111, P650, DOI 10.1067/mai.2003.100; Khakoo A, 2004, CURR ALLERGY ASTHM R, V4, P36, DOI 10.1007/s11882-004-0041-1; King N, 2005, MOL NUTR FOOD RES, V49, P963, DOI 10.1002/mnfr.200500073; Koppelman SJ, 2003, ALLERGY, V58, P1144, DOI 10.1034/j.1398-9995.2003.00259.x; Kopper RA, 2004, J ALLERGY CLIN IMMUN, V114, P614, DOI 10.1016/j.jaci.2004.05.012; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 1996, BRIT MED J, V313, P300, DOI 10.1136/bmj.313.7052.300; Lee LA, 2006, ANNU REV NUTR, V26, P539, DOI 10.1146/annurev.nutr.26.061505.111211; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Leung TF, 2002, J ASTHMA, V39, P523, DOI 10.1081/JAS-120004922; Levy Y, 2003, ALLERGY, V58, P1206, DOI 10.1046/j.1398-9995.2003.00307.x; Li Xiu-Min, 2004, Clin Allergy Immunol, V18, P663; Li XM, 2003, J ALLERGY CLIN IMMUN, V112, P159, DOI 10.1067/mai.2003.1622; Li XM, 2003, J ALLERGY CLIN IMMUN, V111, P1140, DOI 10.1067/mai.2003.1494; Li XM, 2003, J IMMUNOL, V170, P3289, DOI 10.4049/jimmunol.170.6.3289; Li XM, 2001, J ALLERGY CLIN IMMUN, V108, P639, DOI 10.1067/mai.2001.118787; Lin RY, 2000, J ALLERGY CLIN IMMUN, V106, P65, DOI 10.1067/mai.2000.107600; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Mansfield L, 2006, ANN ALLERG ASTHMA IM, V97, P266, DOI 10.1016/S1081-1206(10)60026-9; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Moneret-Vautrin DA, 1999, J ALLERGY CLIN IMMUN, V104, P883, DOI 10.1016/S0091-6749(99)70303-9; Moneret-Vautrin DA, 1998, CLIN EXP ALLERGY, V28, P1113, DOI 10.1046/j.1365-2222.1998.00370.x; Moseley BEB, 2001, ALLERGY, V56, P61, DOI 10.1034/j.1398-9995.2001.00100.x-i1; Namiki M, 1988, Adv Food Res, V32, P115, DOI 10.1016/S0065-2628(08)60287-6; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; OPPENHEIMER JJ, 1992, J ALLERGY CLIN IMMUN, V90, P256, DOI 10.1016/0091-6749(92)90080-L; Palmer K, 2006, CURR OPIN ALLERGY CL, V6, P202, DOI 10.1097/01.all.0000225161.60274.31; Patriarca G, 2006, DIGEST DIS SCI, V51, P471, DOI 10.1007/s10620-006-3157-4; Perry TT, 2004, J ALLERGY CLIN IMMUN, V114, P144, DOI 10.1016/j.jaci.2004.04.009; Pons L, 2004, J ALLERGY CLIN IMMUN, V114, P915, DOI 10.1016/j.jaci.2004.06.049; Prioult G, 2005, IMMUNOL REV, V206, P204, DOI 10.1111/j.0105-2896.2005.00277.x; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Rance F, 2002, J ALLERGY CLIN IMMUN, V109, P1027, DOI 10.1067/mai.2002.124775; Roberts G, 2005, J ALLERGY CLIN IMMUN, V115, P1291, DOI 10.1016/j.jaci.2005.02.038; Sampson HA, 1998, ALLERGY, V53, P125, DOI 10.1111/j.1398-9995.1998.tb04982.x; Sampson HA, 2002, NEW ENGL J MED, V346, P1294, DOI 10.1056/NEJMcp012667; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Sampson Hugh A, 2004, Novartis Found Symp, V257, P161; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Shreffler WG, 2006, ANN ALLERG ASTHMA IM, V96, P865, DOI 10.1016/S1081-1206(10)61351-8; Shreffler WG, 2004, J ALLERGY CLIN IMMUN, V113, P776, DOI 10.1016/j.jaci.2003.12.588; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V106, P53, DOI [10.1067/mai.2000.108105, 10.1067/mai.2000.110158]; Sicherer SH, 2003, J ALLERGY CLIN IMMUN, V112, P1203, DOI 10.1016/S0091-6749(03)02026-8; Sicherer SH, 2006, J ALLERGY CLIN IMMUN, V117, pS470, DOI 10.1016/j.jaci.2005.05.048; Sicherer SH, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e6; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P128, DOI 10.1067/mai.2001.115755; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V103, P559, DOI 10.1016/S0091-6749(99)70224-1; Sicherer SH, 1999, J ALLERGY CLIN IMMUN, V104, P186, DOI 10.1016/S0091-6749(99)70133-8; Simons FER, 1998, J ALLERGY CLIN IMMUN, V101, P33, DOI 10.1016/S0091-6749(98)70190-3; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129; Srivastava KD, 2005, J ALLERGY CLIN IMMUN, V115, P171, DOI 10.1016/j.jaci.2004.10.003; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x; Strobel S, 2006, CURR OPIN ALLERGY CL, V6, P207, DOI 10.1097/01.all.0000225162.98391.81; Taylor SL, 2006, CURR OPIN ALLERGY CL, V6, P186, DOI 10.1097/01.all.0000225158.75521.ad; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Verhoef A, 2005, PLOS MED, V2, P253, DOI 10.1371/journal.pmed.0020078; Warner JO, 2005, PEDIATR ALLERGY IMMU, V16, P1, DOI 10.1111/j.1399-3038.2005.00260.x; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; Yocum MW, 1999, J ALLERGY CLIN IMMUN, V104, P452, DOI 10.1016/S0091-6749(99)70392-1; Yu JW, 2006, J ALLERGY CLIN IMMUN, V118, P466, DOI 10.1016/j.jaci.2006.04.024	104	156	165	1	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1538	1546		10.1016/S0140-6736(08)60659-5	http://dx.doi.org/10.1016/S0140-6736(08)60659-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456104				2022-12-28	WOS:000255668300031
J	Jacobs, LR				Jacobs, Lawrence R.			1994 all over again? Public opinion and health care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jacobs, Lawrence R.] Univ Minnesota, Hubert H Humphrey Inst Publ Affairs, Ctr Study Polit & Governance, Minneapolis, MN 55455 USA; [Jacobs, Lawrence R.] Univ Minnesota, Dept Polit Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jacobs, LR (corresponding author), Univ Minnesota, Hubert H Humphrey Inst Publ Affairs, Ctr Study Polit & Governance, Minneapolis, MN 55455 USA.							Cappella J.N., 1997, SPIRAL CYNICISM PRES; Jacobs Lawrence R., 2000, POLITICIANS DONT PAN; Jacobs Lawrence R., 1993, HLTH NATIONS PUBLIC	3	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1881	1883		10.1056/NEJMp0802361	http://dx.doi.org/10.1056/NEJMp0802361			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294ER	18450600				2022-12-28	WOS:000255387900001
J	Hawkes, N				Hawkes, Nigel			They're digging up the trees they've just planted	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes@thetimes.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					919	919		10.1136/bmj.39556.604572.94	http://dx.doi.org/10.1136/bmj.39556.604572.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18436946	Green Published			2022-12-28	WOS:000255540900026
J	Schweitzer, SO				Schweitzer, Stuart O.			Trying times at the FDA - The challenge of ensuring the safety of imported pharmaceuticals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Schweitzer, SO (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA.							BARNES K, 2006, US EU PHARMA TRADE B; BOGDANICH W, 2008, NY TIMES        0320; BOGDANICH W, 2008, NY TIMES        0229; *COMM EN COMM, 2007, GAO08224T; *FOOD DRUG ADM, 2004, RISK BAS METH PRIOR	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1773	+		10.1056/NEJMp0802041	http://dx.doi.org/10.1056/NEJMp0802041			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434648				2022-12-28	WOS:000255209200001
J	Fergusson, DA; Hebert, PC; Mazer, CD; Fremes, S; MacAdams, C; Murkin, JM; Teoh, K; Duke, PC; Arellano, R; Blajchman, MA; Bussieres, JS; Cote, D; Karski, J; Martineau, R; Robblee, JA; Rodger, M; Wells, G; Clinch, J; Pretorius, R				Fergusson, Dean A.; Hebert, Paul C.; Mazer, C. David; Fremes, Stephen; MacAdams, Charles; Murkin, John M.; Teoh, Kevin; Duke, Peter C.; Arellano, Ramiro; Blajchman, Morris A.; Bussieres, Jean S.; Cote, Dany; Karski, Jacek; Martineau, Raymond; Robblee, James A.; Rodger, Marc; Wells, George; Clinch, Jennifer; Pretorius, Roanda		BART Investigators	A comparison of aprotinin and lysine analogues in high-risk cardiac surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-LOSS; CARDIOPULMONARY BYPASS; TRANEXAMIC ACID; METAANALYSIS; TRANSFUSION; TECHNOLOGIES; PREVENTION; OUTCOMES	Background: Antifibrinolytic agents are commonly used during cardiac surgery to minimize bleeding and to reduce exposure to blood products. We sought to determine whether aprotinin was superior to either tranexamic acid or aminocaproic acid in decreasing massive postoperative bleeding and other clinically important consequences. Methods: In this multicenter, blinded trial, we randomly assigned 2331 high-risk cardiac surgical patients to one of three groups: 781 received aprotinin, 770 received tranexamic acid, and 780 received aminocaproic acid. The primary outcome was massive postoperative bleeding. Secondary outcomes included death from any cause at 30 days. Results: The trial was terminated early because of a higher rate of death in patients receiving aprotinin. A total of 74 patients (9.5%) in the aprotinin group had massive bleeding, as compared with 93 (12.1%) in the tranexamic acid group and 94 (12.1%) in the aminocaproic acid group (relative risk in the aprotinin group for both comparisons, 0.79; 95% confidence interval [CI], 0.59 to 1.05). At 30 days, the rate of death from any cause was 6.0% in the aprotinin group, as compared with 3.9% in the tranexamic acid group (relative risk, 1.55; 95% CI, 0.99 to 2.42) and 4.0% in the aminocaproic acid group (relative risk, 1.52; 95% CI, 0.98 to 2.36). The relative risk of death in the aprotinin group, as compared with that in both groups receiving lysine analogues, was 1.53 (95% CI, 1.06 to 2.22). Conclusions: Despite the possibility of a modest reduction in the risk of massive bleeding, the strong and consistent negative mortality trend associated with aprotinin, as compared with the lysine analogues, precludes its use in high-risk cardiac surgery. (Current Controlled Trials number, ISRCTN15166455.).	[Fergusson, Dean A.; Hebert, Paul C.; Rodger, Marc; Clinch, Jennifer; Pretorius, Roanda] Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON K1H 8L6, Canada; [Fergusson, Dean A.; Hebert, Paul C.; Robblee, James A.; Rodger, Marc; Wells, George] Univ Ottawa, Inst Heart, Ottawa, ON K1N 6N5, Canada; [Mazer, C. David; Fremes, Stephen; Karski, Jacek] Univ Toronto, Toronto, ON, Canada; [Mazer, C. David] St Michaels Hosp, Keenan Ctr, Li Ka Shing Inst, Toronto, ON M5B 1W8, Canada; [Fremes, Stephen] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Karski, Jacek] Toronto Gen Hosp, Toronto, ON, Canada; [MacAdams, Charles] Univ Calgary, Calgary, AB, Canada; [MacAdams, Charles] Foothills Med Ctr, Calgary, AB, Canada; [MacAdams, Charles] Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Murkin, John M.] Univ Western Ontario, London, ON, Canada; [Teoh, Kevin] Hamilton Hlth Sci Ctr, Hamilton, ON, Canada; [Teoh, Kevin; Blajchman, Morris A.] McMaster Univ, Hamilton, ON, Canada; [Blajchman, Morris A.] Canadian Blood Serv, Hamilton, ON, Canada; [Duke, Peter C.] Univ Manitoba, Winnipeg, MB, Canada; [Duke, Peter C.] Hlth Sci Ctr, Winnipeg, MB, Canada; [Arellano, Ramiro] Queens Univ, Kingston, ON, Canada; [Bussieres, Jean S.; Cote, Dany] Univ Laval, Hop Laval, Inst Univ Cardiol & Pneumol, Laval, PQ, Canada; [Martineau, Raymond] Inst Cardiol Montreal, Montreal, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa Heart Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; Western University (University of Western Ontario); McMaster University; McMaster University; Canadian Blood Services; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; Queens University - Canada; Laval University; Universite de Montreal; Institut de Cardiologie de Montreal	Hebert, PC (corresponding author), Ottawa Hlth Res Inst, Clin Epidemiol Program, Gen Campus,Box 208,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	paul.hebert@cma.ca	Fremes, Stephen E/P-7928-2015; Rapchuk, Ivan/E-2243-2011	Fremes, Stephen E/0000-0003-1723-3049; Rapchuk, Ivan/0000-0001-5644-2543; Rodger, Marc/0000-0001-8166-3487; Hardy, Jean-Francois/0000-0002-8254-3011; Mazer, Cyril David/0000-0003-2566-4308; Fergusson, Dean/0000-0002-3389-2485				BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Carless Paul A, 2005, BMC Cardiovasc Disord, V5, P19, DOI 10.1186/1471-2261-5-19; Fergusson, 2000, INT J TECHNOL ASSESS, V16, P296; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Fergusson D, 1999, INT J TECHNOL ASSESS, V15, P717, DOI 10.1017/S0266462399154114; FREMES SE, 1994, ANN THORAC SURG, V58, P1580, DOI 10.1016/0003-4975(94)91636-5; Graham ID, 2000, INT J TECHNOL ASSESS, V16, P228, DOI 10.1017/S0266462300161197; HARDY JF, 1991, CAN J ANAESTH, V38, P511, DOI 10.1007/BF03007591; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Herbertson M, 2004, BLOOD COAGUL FIBRIN, V15, pS31, DOI 10.1097/00001721-200405001-00007; Karski J M, 1993, J Cardiothorac Vasc Anesth, V7, P431; KARSKI JM, 1995, J THORAC CARDIOV SUR, V110, P835, DOI 10.1016/S0022-5223(95)70118-4; Karski JM, 1998, J CARDIOTHOR VASC AN, V12, P642, DOI 10.1016/S1053-0770(98)90235-X; Laupacis A, 1997, ANESTH ANALG, V85, P1258, DOI 10.1097/00000539-199712000-00014; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; LYTLE BW, 1987, J THORAC CARDIOV SUR, V93, P847; Machiraju VR, 2002, J CARDIAC SURG, V17, P20; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; Umscheid CA, 2007, CURR OPIN HEMATOL, V14, P455, DOI 10.1097/MOH.0b013e328270b89e	25	749	785	1	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 29	2008	358	22					2319	2331		10.1056/NEJMoa0802395	http://dx.doi.org/10.1056/NEJMoa0802395			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307GF	18480196				2022-12-28	WOS:000256306700003
J	Damber, JE; Aus, G				Damber, Jan-Erik; Aus, Gunnar			Prostate cancer	LANCET			English	Review							BICALUTAMIDE 150 MG; MEDIAN FOLLOW-UP; PHASE-III TRIAL; RADICAL PROSTATECTOMY; RADIATION-THERAPY; ANDROGEN SUPPRESSION; STANDARD CARE; CONFORMAL RADIOTHERAPY; INTERNATIONAL TRENDS; METASTATIC CARCINOMA	In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor. Clinically, prostate cancer is diagnosed as local or advanced, and treatments range from surveillance to radical local treatment or androgen-deprivation treatment. Androgen deprivation reduces symptoms in about 70-80% of patients with advanced prostate cancer, but most tumours relapse within 2 years to an incurable androgen-independent state. The recorded incidence of prostate cancer has substantially increased in the past two decades, probably because of the introduction of screening with prostate-specific antigen, the use of improved biopsy techniques for diagnosis, and increased public awareness. Trends in mortality from the disease are less clearcut. Mortality changes are not of the same magnitude as the changes in incidence, and in some countries mortality has been stable or even decreased. The disparity between reported incidence and mortality rates leads to the probable conclusion that only a small proportion of diagnosed low-risk prostate cancers will progress to life-threatening disease during the lifetime of the patient.	[Damber, Jan-Erik; Aus, Gunnar] Sahlgrens Univ Hosp, Dept Urol, SE-41345 Gothenburg, Sweden	Sahlgrenska University Hospital	Damber, JE (corresponding author), Sahlgrens Univ Hosp, Dept Urol, Brunastr 11, SE-41345 Gothenburg, Sweden.	jan-erik.damber@urology.gu.se						Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albrecht W, 2003, EUR UROL, V44, P505, DOI 10.1016/S0302-2838(03)00375-0; Amin M, 2005, SCAND J UROL NEPHROL, V39, P20, DOI 10.1080/03008880510030923; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Andersson SO, 1997, JNCI-J NATL CANCER I, V89, P385, DOI 10.1093/jnci/89.5.385; Andriole G, 2004, J UROLOGY, V172, P1314, DOI 10.1097/01.ju.0000139320.78673.2a; ANDRIOLE G, 2006, J UROLOGY, V176, P408; [Anonymous], 1997, Br J Urol, V79, P235; Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857; Aus G, 2005, SCAND J UROL NEPHROL, V39, P124, DOI 10.1080/00365590510007784; Aus G, 2003, EUR UROL, V43, P627, DOI 10.1016/S0302-2838(03)00156-8; Aus G, 2005, EUR UROL, V48, P546, DOI 10.1016/j.eururo.2005.06.001; AUS G, EAU GUIDELINES PROST; Aus G, 2007, EUR UROL, V51, P659, DOI 10.1016/j.eururo.2006.07.012; Aus G, 2006, EUR UROL, V50, P927, DOI 10.1016/j.eururo.2006.07.011; Baade PD, 2004, CANCER CAUSE CONTROL, V15, P237, DOI 10.1023/B:CACO.0000024212.66334.26; Beard C, 2005, UROLOGY, V66, P1020, DOI 10.1016/j.urology.2005.05.039; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; BOYLE P, 2001, P C AM UR ASS AN JUN; Brasso K, 2006, PROSTATE, V66, P503, DOI 10.1002/pros.20311; BRUCHOVSKY N, 1990, CANCER RES, V50, P2275; BYAR DP, 1973, CANCER, V32, P1126, DOI 10.1002/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C; Cannon L., 1982, CANCER SURV, V1, P47; Crawford D, 2002, J UROLOGY, V167, P99; D'Amico AV, 2005, JAMA-J AM MED ASSOC, V294, P440, DOI 10.1001/jama.294.4.440; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2001, J UROLOGY, V166, P2185, DOI 10.1016/S0022-5347(05)65531-0; D'Amico AV, 2003, J NATL CANCER I, V95, P1376, DOI 10.1093/jnci/djg043; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x; Damber JE, 2004, BJU INT, V93, P695, DOI 10.1111/j.1464-410X.2003.04713.x; de Koning HJ, 2002, INT J CANCER, V98, P268, DOI 10.1002/ijc.10188; Dearnaley DP, 2007, LANCET ONCOL, V8, P475, DOI 10.1016/S1470-2045(07)70143-2; Deutsch E, 2004, LANCET ONCOL, V5, P303, DOI 10.1016/S1470-2045(04)01468-8; Dong JT, 2006, J CELL BIOCHEM, V97, P433, DOI 10.1002/jcb.20696; Dorff TB, 2006, EXPERT REV ANTICANC, V6, P1639, DOI 10.1586/14737140.6.11.1639; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Dunn IB, 2000, BJU INT, V86, P304, DOI 10.1046/j.1464-410x.2000.00298.x; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Etminan M, 2004, CANCER EPIDEM BIOMAR, V13, P340; Ferlay J, 2001, CANC INCIDENCE MORTA; Friedenreich CM, 2001, CANCER CAUSE CONTROL, V12, P461, DOI 10.1023/A:1011210121901; Gerber GS, 1997, EUR UROL, V32, P385, DOI 10.1159/000480794; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Graefen M, 2004, J UROLOGY, V171, P200, DOI 10.1097/01.ju.0000099161.70713.c8; Granfors T, 2006, J UROLOGY, V176, P544, DOI 10.1016/j.juro.2006.03.092; Greene KL, 2006, J UROLOGY, V175, P125, DOI 10.1016/S0022-5347(05)00056-X; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Hartman TJ, 1998, CANCER EPIDEM BIOMAR, V7, P335; Herrmann TR, 2007, WORLD J UROL, V25, P149, DOI 10.1007/s00345-007-0164-9; HODGE KK, 1989, J UROLOGY, V142, P71, DOI 10.1016/S0022-5347(17)38664-0; Hoeksema MJ, 1996, J NATL CANCER I, V88, P1706, DOI 10.1093/jnci/88.23.1706; Hsu CY, 2007, EUR UROL, V51, P121, DOI 10.1016/j.eururo.2006.05.024; Huggins C, 1941, CANCER RES, V1, P293; Hugosson J, 2004, CANCER-AM CANCER SOC, V100, P1397, DOI 10.1002/cncr.20126; *IARC WORK GROUP E, 2002, IARC HDB CANC PREV, V6, P117; ISAACS JT, 1984, PROSTATE, V5, P1, DOI 10.1002/pros.2990050102; Ito K, 2003, PROSTATE, V57, P8, DOI 10.1002/pros.10268; Iversen P, 2004, J UROLOGY, V172, P1871, DOI 10.1097/01.ju.0000139719.99825.54; Iversen P, 2006, SCAND J UROL NEPHROL, V40, P441, DOI 10.1080/00365590601017329; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; JORGENSEN T, 1995, EUR UROL, V28, P40; Kantoff P, 2005, ONCOLOGY-NY, V19, P631; Kiper A, 2006, INT UROL NEPHROL, V38, P571, DOI 10.1007/s11255-006-0096-0; Kirkham APS, 2006, EUR UROL, V50, P1163, DOI 10.1016/j.eururo.2006.06.025; KLEEMOLA P, PUBLICATIONS NATL PU; Klein EA, 2000, PROSTATE CANCER P D, V3, P145, DOI 10.1038/sj.pcan.4500412; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kopper L, 2005, PATHOL ONCOL RES, V11, P197, DOI 10.1007/BF02893851; Kroepfl I, 2006, BJU INT, V97, P985, DOI 10.1111/j.1464-410X.2006.06129.x; Kumar S, 2006, COCHRANE DB SYST REV, V4; LABRIE F, 1985, J STEROID BIOCHEM, V23, P833, DOI 10.1016/S0022-4731(85)80024-8; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Ma J, 1998, CANCER EPIDEM BIOMAR, V7, P385; Maffezzini M, 2007, EUR UROL, V51, P605, DOI 10.1016/j.eururo.2006.10.062; Mangar SA, 2005, EUR J CANCER, V41, P908, DOI 10.1016/j.ejca.2004.12.028; Messing EM, 1999, NEW ENGL J MED, V341, P1781, DOI 10.1056/NEJM199912093412401; Mettlin C, 2000, MICROSC RES TECHNIQ, V51, P415, DOI 10.1002/1097-0029(20001201)51:5<415::AID-JEMT2>3.0.CO;2-B; Mettlin CJ, 1996, CANCER, V77, P2162; Morote J, 2005, INT J BIOL MARKER, V20, P209, DOI 10.1177/172460080502000403; Muller H, 2006, CLIN CHEM, V52, P562, DOI 10.1373/clinchem.2005.062919; Nilsson S, 2004, ACTA ONCOL, V43, P316, DOI 10.1080/02841860410030661; Oberaigner W, 2006, AM J EPIDEMIOL, V164, P376, DOI 10.1093/aje/kwj213; Ohori M, 2004, J UROLOGY, V171, P1844, DOI 10.1097/01.ju.0000121693.05077.3d; Oliver SE, 2001, INT J CANCER, V92, P893, DOI 10.1002/ijc.1260; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARKIN DM, 1997, CANC INCIDENCE 5 CON, V7, P120; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Pickles Tom, 2006, Can J Urol, V13 Suppl 2, P68; Pilepich MV, 1997, J CLIN ONCOL, V15, P1013, DOI 10.1200/JCO.1997.15.3.1013; Plaskon LA, 2003, CANCER EPIDEM BIOMAR, V12, P604; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Porkka KP, 2004, EUR UROL, V45, P683, DOI 10.1016/j.eururo.2004.01.012; Potosky AL, 2001, EPIDEMIOL REV, V23, P181, DOI 10.1093/oxfordjournals.epirev.a000787; PUKKALA E, 1987, ATLAS CANC INCIDENCE, P37; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Sarma Aruna V, 2002, Semin Urol Oncol, V20, P3, DOI 10.1053/suro.2002.30390; Schaid DJ, 2005, PROSTATE, V63, P276, DOI 10.1002/pros.20198; SCHMITT B, 2004, COCHRANE LIB, V4; Schroder FH, 2004, J UROLOGY, V172, P923, DOI 10.1097/01.ju.0000135742.13171.d2; See WA, 2001, UROL ONCOL, V6, P43, DOI 10.1016/S1078-1439(00)00118-6; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; Simmons MN, 2007, EUR UROL, V51, P1175, DOI 10.1016/j.eururo.2007.01.015; Small EJ, 2006, J CLIN ONCOL, V24, P3089, DOI 10.1200/JCO.2005.04.5252; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; Sobin, 2009, UICC TNM CLASSIFICAT; Sonoda T, 2004, CANCER SCI, V95, P238, DOI 10.1111/j.1349-7006.2004.tb02209.x; Sowery Richard D, 2007, Curr Urol Rep, V8, P53, DOI 10.1007/s11934-007-0021-9; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Stenman UH, 2005, SCAND J UROL NEPHROL, V39, P64, DOI 10.1080/03008880510030941; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Torti DC, 2004, SPORTS MED, V34, P363, DOI 10.2165/00007256-200434060-00003; TRACHTENBERG J, 1987, J UROLOGY, V137, P785, DOI 10.1016/S0022-5347(17)44211-X; van der Cruijsen-Koeter IW, 2005, J UROLOGY, V174, P121, DOI 10.1097/01.ju.0000162061.40533.0f; VARENHORST E, 1988, NEW DEV BIOSCIENCES, V4, P105; WAK C, 2002, J UROLOGY, V168, P995; Wiklund F, 2004, CLIN CANCER RES, V10, P7150, DOI 10.1158/1078-0432.CCR-04-0982; Wirth MP, 2004, J UROLOGY, V172, P1865, DOI 10.1097/01.ju.0000140159.94703.80; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	133	384	396	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2008	371	9625					1710	1721		10.1016/S0140-6736(08)60729-1	http://dx.doi.org/10.1016/S0140-6736(08)60729-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486743				2022-12-28	WOS:000256002200029
J	Murakami, M; Kouyama, T				Murakami, Midori; Kouyama, Tsutomu			Crystal structure of squid rhodopsin	NATURE			English	Article							PROTEIN-COUPLED RECEPTOR; OUTER SEGMENT MEMBRANES; PHOTORECEPTOR MICROVILLI; CEPHALOPOD RHODOPSIN; POLARIZED-LIGHT; ACTIVATION; VERTEBRATE; SYSTEM; PHOTOISOMERIZATION; CRYSTALLOGRAPHY	Invertebrate phototransduction uses an inositol-1,4,5-trisphosphate signalling cascade in which photoactivated rhodopsin stimulates a G(q)-type G protein, that is, a class of G protein that stimulates membrane-bound phospholipase C beta. The same cascade is used by many G-protein-coupled receptors, indicating that invertebrate rhodopsin is a prototypical member. Here we report the crystal structure of squid (Todarodes pacificus) rhodopsin at 2.5 angstrom resolution. Among seven transmembrane alpha-helices, helices V and VI extend into the cytoplasmic medium and, together with two cytoplasmic helices, they form a rigid protrusion from the membrane surface. This peculiar structure, which is not seen in bovine rhodopsin, seems to be crucial for the recognition of G(q)-type G proteins. The retinal Schiff base forms a hydrogen bond to Asn 87 or Tyr 111; it is far from the putative counterion Glu 180. In the crystal, a tight association is formed between the amino-terminal polypeptides of neighbouring monomers; this intermembrane dimerization may be responsible for the organization of hexagonally packed microvillar membranes in the photoreceptor rhabdom.	[Murakami, Midori; Kouyama, Tsutomu] Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Kouyama, Tsutomu] RIKEN Harima Inst, SPring 8, Sayo, Hyogo 6795148, Japan	Nagoya University; Japan Synchrotron Radiation Research Institute; RIKEN	Kouyama, T (corresponding author), Nagoya Univ, Dept Phys, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.	kouyama@bio.phys.nagoya-u.ac.jp	murakami, midori/AAL-1023-2021					Ashida A, 2004, ZOOL SCI, V21, P245, DOI 10.2108/zsj.21.245; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167; DeLano W.L, PYMOL MOL GRAPHICS S; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HARANISHIMURA I, 1993, FEBS LETT, V317, P5, DOI 10.1016/0014-5793(93)81480-N; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; JANDER R, 1963, Z VERGL PHYSIOL, V46, P383, DOI 10.1007/BF00340466; KITO Y, 1982, METHOD ENZYMOL, V81, P167; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Matsui Y, 2002, J MOL BIOL, V324, P469, DOI 10.1016/S0022-2836(02)01110-5; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; NAITO T, 1981, VISION RES, V21, P935, DOI 10.1016/0042-6989(81)90195-4; Nakagawa M, 1999, P NATL ACAD SCI USA, V96, P6189, DOI 10.1073/pnas.96.11.6189; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ota T, 2006, BIOCHEMISTRY-US, V45, P2845, DOI 10.1021/bi051937l; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; SAIBIL H, 1987, J CELL BIOL, V105, P19, DOI 10.1083/jcb.105.1.19; SAIBIL HR, 1982, J MOL BIOL, V158, P435, DOI 10.1016/0022-2836(82)90208-X; Saidel WM, 2005, COMP BIOCHEM PHYS A, V142, P340, DOI 10.1016/j.cbpa.2005.08.003; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; SUZUKI T, 1976, BIOCHIM BIOPHYS ACTA, V428, P321, DOI 10.1016/0304-4165(76)90040-4; Terakita A, 1998, FEBS LETT, V439, P110, DOI 10.1016/S0014-5793(98)01340-4; Urizar E, 2005, J BIOL CHEM, V280, P17135, DOI 10.1074/jbc.M414678200; VENIENBRYAN C, 1995, FEBS LETT, V359, P45, DOI 10.1016/0014-5793(94)01449-B; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; YARFITZ S, 1994, J BIOL CHEM, V269, P14329	40	392	406	5	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					363	U33		10.1038/nature06925	http://dx.doi.org/10.1038/nature06925			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480818				2022-12-28	WOS:000255868400045
J	Applbaum, AI; Tilburt, JC; Collins, MT; Wendler, D				Applbaum, Arthur Isak; Tilburt, Jon C.; Collins, Michael T.; Wendler, David			A family's request for complementary medicine after patient brain death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; FUTILITY	A 19- year- old woman living with relatives in the United States who was admitted for elective cranial surgery for complications related to a congenital disorder developed an acute intracranial hemorrhage 10 days after surgery. The patient was declared dead following repeat negative apnea tests. The patient's father requested that the treating team administer an unverified traditional medicinal substance to the patient. Because of the unusual nature of this request, the treating team called an ethics consultation. The present article reviews this case and discusses other cases that share key features to determine whether and when it is appropriate to accommodate requests for interventions on patients who have been declared dead.	[Wendler, David] NIH, Dept Bioeth, Bethesda, MD 20892 USA; [Applbaum, Arthur Isak] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Applbaum, Arthur Isak] Harvard Univ, Edmond J Safra Fdn Ctr Eth, Cambridge, MA 02138 USA; [Tilburt, Jon C.] Mayo Clin, Rochester, MN USA; [Collins, Michael T.] NIDR, Clin Studies Unit, Cranial Facial & Skeletal Dis Branch, Bethesda, MD 20892 USA; [Collins, Michael T.] Natl Inst Craniofacial Res, Clin Studies Unit, Cranial Facial & Skeletal Dis Branch, Bethesda, MD USA; [Wendler, David] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; Harvard University; Harvard University; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Wendler, D (corresponding author), NIH, Dept Bioeth, 1C-119 Bldg 10, Bethesda, MD 20892 USA.	dwendler@cc.nih.gov			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000649] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DE000649-13] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Crawley LM, 2002, ANN INTERN MED, V136, P673, DOI 10.7326/0003-4819-136-9-200205070-00010; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; *NEW YORK STAT DEP, GUID DET BRAIN DEATH; Rawls J, 1993, POLITICAL LIBERALISM; SCHAUER F, 1985, HARVARD LAW REV, V99, P361, DOI 10.2307/1341127; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Truog RD, 2007, J LAW MED ETHICS, V35, P273, DOI 10.1111/j.1748-720X.2007.00136.x; von Gunten CF, 2000, JAMA-J AM MED ASSOC, V284, P3051, DOI 10.1001/jama.284.23.3051	9	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2188	2193		10.1001/jama.299.18.2188	http://dx.doi.org/10.1001/jama.299.18.2188			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477786	Green Accepted			2022-12-28	WOS:000255790000026
J	Abbondanzieri, EA; Bokinsky, G; Rausch, JW; Zhang, JX; Le Grice, SFJ; Zhuang, XW				Abbondanzieri, Elio A.; Bokinsky, Gregory; Rausch, Jason W.; Zhang, Jennifer X.; Le Grice, Stuart F. J.; Zhuang, Xiaowei			Dynamic binding orientations direct activity of HIV reverse transcriptase	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DEPENDENT DNA-POLYMERASE; RNASE-H-FUNCTION; ANGSTROM RESOLUTION; PRIMED INITIATION; CRYSTAL-STRUCTURE; ENERGY-TRANSFER; RNA/DNA HYBRID; MECHANISM; COMPLEX	The reverse transcriptase of human immunodeficiency virus ( HIV) catalyses a series of reactions to convert the single- stranded RNA genome of HIV into double- stranded DNA for host- cell integration. This task requires the reverse transcriptase to discriminate a variety of nucleic- acid substrates such that active sites of the enzyme are correctly positioned to support one of three catalytic functions: RNA- directed DNA synthesis, DNA- directed DNA synthesis and DNA- directed RNA hydrolysis. However, the mechanism by which substrates regulate reverse transcriptase activities remains unclear. Here we report distinct orientational dynamics of reverse transcriptase observed on different substrates with a single- molecule assay. The enzyme adopted opposite binding orientations on duplexes containing DNA or RNA primers, directing its DNA synthesis or RNA hydrolysis activity, respectively. On duplexes containing the unique polypurine RNA primers for plus- strand DNA synthesis, the enzyme can rapidly switch between the two orientations. The switching kinetics were regulated by cognate nucleotides and non- nucleoside reverse transcriptase inhibitors, a major class of anti- HIV drugs. These results indicate that the activities of reverse transcriptase are determined by its binding orientation on substrates.	[Abbondanzieri, Elio A.; Bokinsky, Gregory; Zhang, Jennifer X.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Rausch, Jason W.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21702 USA	Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhuang, XW (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NATIONAL CANCER INSTITUTE [ZIABC010493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z01 BC010493-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM068518-05, GM 068518, R01 GM068518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR A, 1992, J VIROL, V66, P2464, DOI 10.1128/JVI.66.4.2464-2472.1992; ARNOLD E, 1992, NATURE, V357, P85, DOI 10.1038/357085a0; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; CHAMPOUX JJ, 1993, REVERSE TRANSCRIPTAS, P103; Ding JP, 1998, J MOL BIOL, V284, P1095, DOI 10.1006/jmbi.1998.2208; El Safadi Y, 2007, APPL MICROBIOL BIOT, V75, P723, DOI 10.1007/s00253-007-0919-7; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; Goff S, 2001, FIELDS VIROLOGY, P1871; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Grobler JA, 2007, J BIOL CHEM, V282, P8005, DOI 10.1074/jbc.M608274200; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HOSTOMSKY Z, 1992, J VIROL, V66, P3179, DOI 10.1128/JVI.66.5.3179-3182.1992; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUBER HE, 1990, J BIOL CHEM, V265, P10565; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KATI WM, 1992, J BIOL CHEM, V267, P25988; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LEIS JP, 1973, P NATL ACAD SCI USA, V70, P466, DOI 10.1073/pnas.70.2.466; METZGER W, 1993, P NATL ACAD SCI USA, V90, P5909, DOI 10.1073/pnas.90.13.5909; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; OMER CA, 1984, J VIROL, V50, P465, DOI 10.1128/JVI.50.2.465-470.1984; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rausch JW, 2000, J BIOL CHEM, V275, P16015, DOI 10.1074/jbc.M909808199; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; Schultz SJ, 2000, J BIOL CHEM, V275, P32299, DOI 10.1074/jbc.M000021200; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Venezia CF, 2006, BIOCHEMISTRY-US, V45, P2779, DOI 10.1021/bi051915z; Wisniewski M, 2000, P NATL ACAD SCI USA, V97, P11978, DOI 10.1073/pnas.210392297	41	143	147	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					184	U2		10.1038/nature06941	http://dx.doi.org/10.1038/nature06941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464735	Green Accepted, Bronze			2022-12-28	WOS:000255592400031
J	Kishimoto, TK; Viswanathan, K; Ganguly, T; Elankumaran, S; Smith, S; Pelzer, K; Lansing, JC; Sriranganathan, N; Zhao, GL; Galcheva-Gargova, Z; Al-Hakim, A; Bailey, GS; Fraser, B; Roy, S; Rogers-Cotrone, T; Buhse, L; Whary, M; Fox, J; Nasr, M; Dal Pan, GJ; Shriver, Z; Langer, RS; Venkataraman, G; Austen, KF; Woodcock, J; Sasisekharan, R				Kishimoto, Takashi Kei; Viswanathan, Karthik; Ganguly, Tanmoy; Elankumaran, Subbiah; Smith, Sean; Pelzer, Kevin; Lansing, Jonathan C.; Sriranganathan, Nammalwar; Zhao, Ganlin; Galcheva-Gargova, Zoya; Al-Hakim, Ali; Bailey, Gregory Scott; Fraser, Blair; Roy, Sucharita; Rogers-Cotrone, Thomas; Buhse, Lucinda; Whary, Mark; Fox, James; Nasr, Moheb; Dal Pan, Gerald J.; Shriver, Zachary; Langer, Robert S.; Venkataraman, Ganesh; Austen, K. Frank; Woodcock, Janet; Sasisekharan, Ram			Contaminated heparin associated with adverse clinical events and activation of the contact system	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HAGEMAN-FACTOR; PLASMA KALLIKREIN; DEXTRAN SULFATE; FACTOR-XII; ALTERNATIVE PATHWAY; COMPLEMENT; ANTITHROMBIN; INHIBITION; COFACTOR; RABBIT	Background: There is an urgent need to determine whether oversulfated chondroitin sulfate (OSCS), a compound contaminating heparin supplies worldwide, is the cause of the severe anaphylactoid reactions that have occurred after intravenous heparin administration in the United States and Germany. Methods: Heparin procured from the Food and Drug Administration, consisting of suspect lots of heparin associated with the clinical events as well as control lots of heparin, were screened in a blinded fashion both for the presence of OSCS and for any biologic activity that could potentially link the contaminant to the observed clinical adverse events. In vitro assays for the activation of the contact system and the complement cascade were performed. In addition, the ability of OSCS to recapitulate key clinical manifestations in vivo was tested in swine. Results: The OSCS found in contaminated lots of unfractionated heparin, as well as a synthetically generated OSCS reference standard, directly activated the kinin-kallikrein pathway in human plasma, which can lead to the generation of bradykinin, a potent vasoactive mediator. In addition, OSCS induced generation of C3a and C5a, potent anaphylatoxins derived from complement proteins. Activation of these two pathways was unexpectedly linked and dependent on fluid-phase activation of factor XII. Screening of plasma samples from various species indicated that swine and humans are sensitive to the effects of OSCS in a similar manner. OSCS-containing heparin and synthetically derived OSCS induced hypotension associated with kallikrein activation when administered by intravenous infusion in swine. Conclusions: Our results provide a scientific rationale for a potential biologic link between the presence of OSCS in suspect lots of heparin and the observed clinical adverse events. An assay to assess the amidolytic activity of kallikrein can supplement analytic tests to protect the heparin supply chain by screening for OSCS and other highly sulfated polysaccharide contaminants of heparin that can activate the contact system.	[Viswanathan, Karthik; Whary, Mark; Fox, James; Shriver, Zachary; Langer, Robert S.; Venkataraman, Ganesh; Sasisekharan, Ram] MIT, Dept Biol Engn, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kishimoto, Takashi Kei; Ganguly, Tanmoy; Smith, Sean; Lansing, Jonathan C.; Zhao, Ganlin; Galcheva-Gargova, Zoya; Bailey, Gregory Scott; Roy, Sucharita; Shriver, Zachary; Venkataraman, Ganesh] Momenta Pharmaceut, Cambridge, MA USA; [Elankumaran, Subbiah; Pelzer, Kevin; Sriranganathan, Nammalwar; Rogers-Cotrone, Thomas] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Al-Hakim, Ali; Fraser, Blair; Buhse, Lucinda; Nasr, Moheb; Dal Pan, Gerald J.; Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Austen, K. Frank] Brigham & Womens Hosp, Boston, MA 02115 USA; [Austen, K. Frank] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Virginia Polytechnic Institute & State University; US Food & Drug Administration (FDA); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sasisekharan, R (corresponding author), MIT, Dept Biol Engn, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, 77 Massachusetts Ave,16-561, Cambridge, MA 02139 USA.	rams@mit.edu	Subbiah, Elankumaran/E-9277-2010; Pelzer, Kevin/S-3556-2016	Subbiah, Elankumaran/0000-0003-4135-9477; Pelzer, Kevin/0000-0001-6688-4986; Lansing, Jonathan/0000-0003-2041-190X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057073, R37GM057073] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL080278, HL080278-01] Funding Source: Medline; NIGMS NIH HHS [GM57073, R37 GM057073, R01 GM057073] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*BAXT, 2008, BAXT PROV UPD HEP IN; DISCIPIO RG, 1982, IMMUNOLOGY, V45, P587; *FOOD DRUG ADM, 2008, INF HEP SOD INJ; *FOOD DRUG ADM, 2008, INF ADV EV REP HEP; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; GUERRINI M, IN PRESS NAT BIOTECH; Henry SP, 1997, J PHARMACOL EXP THER, V281, P810; HOJIMA Y, 1984, BLOOD, V63, P1453; KAPLAN AP, 1971, J EXP MED, V133, P696, DOI 10.1084/jem.133.4.696; OLSON ST, 1993, BIOCHEMISTRY-US, V32, P12136, DOI 10.1021/bi00096a026; PIXLEY RA, 1991, THROMB HAEMOSTASIS, V66, P540; Schaiff WT, 1997, CORONARY ARTERY DIS, V8, P9, DOI 10.1097/00019501-199701000-00002; SIEBECK M, 1994, J APPL PHYSIOL, V77, P2675, DOI 10.1152/jappl.1994.77.6.2675; SILVERBERG M, 1987, BIOCHEM J, V248, P715, DOI 10.1042/bj2480715; SILVERBERG M, 1980, J BIOL CHEM, V255, P7281; STEAD N, 1976, J BIOL CHEM, V251, P6481; Verhamme IM, 2004, J BIOL CHEM, V279, P9785, DOI 10.1074/jbc.M313962200; WIGGINS RC, 1981, J EXP MED, V153, P1391, DOI 10.1084/jem.153.6.1391; WIGGINS RC, 1986, CIRC RES, V58, P595, DOI 10.1161/01.RES.58.4.595; 2008, MMWR MORB MORTAL WKL, V57, P124	20	466	490	0	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 5	2008	358	23					2457	2467		10.1056/NEJMoa0803200	http://dx.doi.org/10.1056/NEJMoa0803200			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308HY	18434646	Green Accepted			2022-12-28	WOS:000256380700005
J	Haas, AL; Wilkinson, KD				Haas, Arthur L.; Wilkinson, Keith D.			DeTeKting ubiquitination of APC/C substrates	CELL			English	Editorial Material									[Wilkinson, Keith D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Haas, Arthur L.] Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Emory University; Louisiana State University System	Wilkinson, KD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	genekdw@emory.edu						Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	9	2	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					570	572		10.1016/j.cell.2008.04.034	http://dx.doi.org/10.1016/j.cell.2008.04.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485863	Bronze			2022-12-28	WOS:000255903300010
J	Niu, YL				Niu, Yaoling			Geochemistry - The origin of alkaline lavas	SCIENCE			English	Editorial Material							HEAT-FLOW; MANTLE; VOLCANISM; BASALTS; MAGMAS; CRUST; MODEL; AGE		[Niu, Yaoling] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England	Durham University	Niu, YL (corresponding author), Univ Durham, Dept Earth Sci, Durham DH1 3LE, England.	yaoling.niu@durham.ac.uk	Niu, Yaoling/GPW-9211-2022; Niu, Yaoling/A-5448-2008	Niu, Yaoling/0000-0001-9488-2304				FITTON JG, 1987, GEOL SOC SPEC PUBL, V30; GREEN DH, 1976, TECTONOPHYSICS, V32, P61, DOI 10.1016/0040-1951(76)90086-X; GREEN DH, 1971, PHILOS TR R SOC S-A, V268, P707, DOI 10.1098/rsta.1971.0022; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Inoue T, 1998, PHYS EARTH PLANET IN, V107, P221, DOI 10.1016/S0031-9201(97)00135-0; Lloyd F.E., 1975, PHYS CHEM EARTH, V9, P389, DOI DOI 10.1016/0079-1946(75)90030-0; Niu YL, 2007, GEOCHIM COSMOCHIM AC, V71, pA721; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; PARSONS B, 1977, J GEOPHYS RES, V82, P803, DOI 10.1029/JB082i005p00803; Pilet S, 2008, SCIENCE, V320, P916, DOI 10.1126/science.1156563; RINGWOOD AE, 1992, EARTH PLANET SC LETT, V113, P521, DOI 10.1016/0012-821X(92)90129-J; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; SUN SS, 1975, CONTRIB MINERAL PETR, V52, P77, DOI 10.1007/BF00395006; WYLLIE PJ, 1987, GEOCHEM SOC SPEC PUB, V1, P107	15	66	76	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					883	884		10.1126/science.1158378	http://dx.doi.org/10.1126/science.1158378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487180				2022-12-28	WOS:000255868300028
J	Voesenek, LACJ; Pierik, R				Voesenek, Laurentius A. C. J.; Pierik, Ronald			Plant science - Plant stress profiles	SCIENCE			English	Editorial Material							SUBMERGENCE; RESPONSES; COMBINATION; SIGNALS; RICE		[Voesenek, Laurentius A. C. J.; Pierik, Ronald] Univ Utrecht, Inst Environm Biol, NL-3584 CA Utrecht, Netherlands	Utrecht University	Voesenek, LACJ (corresponding author), Univ Utrecht, Inst Environm Biol, Sorbonnelaan 16, NL-3584 CA Utrecht, Netherlands.	l.a.c.j.voesenek@uu.nl	Voesenek, Laurentius A.C.J./B-9661-2011; Pierik, Ronald/B-9591-2011	Pierik, Ronald/0000-0002-5320-6817; Voesenek, Laurentius/0000-0002-3361-3837				Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Colmer TD, 2008, NEW PHYTOL, V177, P918, DOI 10.1111/j.1469-8137.2007.02318.x; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Lasanthi-Kudahettige R, 2007, PLANT PHYSIOL, V144, P218, DOI 10.1104/pp.106.093997; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mommer L, 2005, PLANT PHYSIOL, V139, P497, DOI 10.1104/pp.105.064725; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920	15	23	24	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					880	881		10.1126/science.1158720	http://dx.doi.org/10.1126/science.1158720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487178				2022-12-28	WOS:000255868300026
J	Wu, C				Wu, Corinna			Scientists without borders	CELL			English	Editorial Material																			0	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					559	560		10.1016/j.cell.2008.05.001	http://dx.doi.org/10.1016/j.cell.2008.05.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485859	Bronze			2022-12-28	WOS:000255903300006
J	Stewart, GC; Nohria, A				Stewart, Garrick C.; Nohria, Anju			Giant left atrium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stewart, Garrick C.; Nohria, Anju] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Stewart, GC (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	anohria@partners.org	Nohria, Anju/AAD-4925-2022						0	1	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2050	2050		10.1056/NEJMicm070272	http://dx.doi.org/10.1056/NEJMicm070272			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463381				2022-12-28	WOS:000255577700009
J	Elliott, MR; Ravichandran, KS				Elliott, Michael R.; Ravichandran, Kodi S.			Death in the CNS: Six-microns-under	CELL			English	Editorial Material							DROSOPHILA; ENGULFMENT; PHAGOCYTOSIS; RECEPTOR; DRAPER	During embryonic development, large numbers of apoptotic cells are rapidly cleared by phagocytes. In this issue, Kurant et al. (2008) describe a new phagocytic receptor, called six-microns-under (SIMU), that promotes engulfment of apoptotic neurons by glial cells in the developing nervous system of Drosophila.	[Elliott, Michael R.; Ravichandran, Kodi S.] Univ Virginia, Carter Immunol Ctr, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Carter Immunol Ctr, MR4-Rm4072D,Box 801386,Lane Rd, Charlottesville, VA 22908 USA.	ravi@virginia.edu		Ravichandran, Kodi/0000-0001-9049-1410; Elliott, Michael/0000-0002-0642-482X	NIAID NIH HHS [T32 AI055432] Funding Source: Medline; NIGMS NIH HHS [R01 GM064709-06, R01 GM064709-07, R01 GM069998, R01 GM069998-03, R01 GM069998-04, R01 GM064709] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069998, R01GM064709] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; SONNENFELD MJ, 1995, J COMP NEUROL, V359, P644, DOI 10.1002/cne.903590410	7	5	5	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					393	395		10.1016/j.cell.2008.04.014	http://dx.doi.org/10.1016/j.cell.2008.04.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455977	Bronze, Green Accepted			2022-12-28	WOS:000255503900007
J	Guo, XJ; Silva, SRP				Guo, Xiaojun; Silva, S. R. P.			Engineering - High-performance transistors by design	SCIENCE			English	Editorial Material							THIN-FILM TRANSISTORS; SEMICONDUCTORS; ELECTRONICS		[Guo, Xiaojun; Silva, S. R. P.] Univ Surrey, Adv Technol Inst, Surrey GU2 7XH, England	University of Surrey	Guo, XJ (corresponding author), Univ Surrey, Adv Technol Inst, Surrey GU2 7XH, England.	s.silva@surrey.ac.uk	Silva, S. Ravi P/J-9210-2014	Silva, S. Ravi P/0000-0002-0356-1319	Engineering and Physical Sciences Research Council [GR/S72320/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bhattacharyya S, 2006, NAT MATER, V5, P19, DOI 10.1038/nmat1551; Duan XF, 2003, NATURE, V425, P274, DOI 10.1038/nature01996; GUO X, 2008, IN PRESS IEEE SPECIA; Ishii T, 2004, IEEE T ELECTRON DEV, V51, P1805, DOI 10.1109/TED.2004.836546; Kim CH, 1997, J APPL PHYS, V81, P8084, DOI 10.1063/1.365416; Lu ZH, 2002, APPL PHYS LETT, V80, P255, DOI 10.1063/1.1433166; Reuss RH, 2005, P IEEE, V93, P1239, DOI 10.1109/JPROC.2005.851237; Shannon JM, 2003, IEEE ELECTR DEVICE L, V24, P405, DOI 10.1109/LED.2003.813379; Shannon JM, 2007, IEEE T ELECTRON DEV, V54, P354, DOI 10.1109/TED.2006.888753; Shaw JM, 2001, IBM J RES DEV, V45, P3, DOI 10.1147/rd.451.0003; Stauth SA, 2006, P NATL ACAD SCI USA, V103, P13922, DOI 10.1073/pnas.0602893103; Sun YG, 2004, NANO LETT, V4, P1953, DOI 10.1021/nl048835l; Sun YG, 2007, ADV MATER, V19, P1897, DOI 10.1002/adma.200602223; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; Walker AJ, 2004, IEEE T ELECTRON DEV, V51, P1856, DOI 10.1109/TED.2004.837388; Yuan HC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397038	16	13	14	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					618	619		10.1126/science.1156327	http://dx.doi.org/10.1126/science.1156327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451287				2022-12-28	WOS:000255454300028
J	Wender, PA; Kee, JM; Warrington, JM				Wender, Paul A.; Kee, Jung-Min; Warrington, Jeffrey M.			Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PHORBOL ESTER; TUMOR PROMOTERS; SEED OIL; ACTIVATION; EXPRESSION; REACTIVATION; CHEMISTRY; RESERVOIR	Although antiretroviral therapies have been effective in decreasing active viral loads in AIDS patients, the persistence of latent viral reservoirs prevents eradication of the virus. Prostratin and DPP ( 12- deoxyphorbol- 13- phenylacetate) activate the latent virus and thus represent promising adjuvants for antiviral therapy. Their limited supply and the challenges of accessing related structures have, however, impeded therapeutic development and the search for clinically superior analogs. Here we report a practical synthesis of prostratin and DPP starting from phorbol or crotophorbolone, agents readily available from renewable sources, including a biodiesel candidate. This synthesis reliably supplies gram quantities of the therapeutically promising natural products, hitherto available only in low and variable amounts from natural sources, and opens access to a variety of new analogs.	[Wender, Paul A.; Kee, Jung-Min; Warrington, Jeffrey M.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Wender, Paul A.; Kee, Jung-Min; Warrington, Jeffrey M.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Wender, PA (corresponding author), Stanford Univ, Dept Chem, 337 Campus Dr, Stanford, CA 94305 USA.	wenderp@stanford.edu	Kee, Jung-Min/H-4798-2016; Chen, Yao/AAJ-2409-2020	Warrington, Jeff/0000-0002-2851-3110	NCI NIH HHS [R37 CA031845-28, CA31841, R37 CA031845, R01 CA031841-28, R01 CA031841, CA31845] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA031841, R37CA031845, R01CA031841, R01CA031845] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTSCH H, 1969, Z NATURFORSCH PT B, VB 24, P91, DOI 10.1515/znb-1969-0120; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Black H, 2004, SCIENTIST, V18, P59; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; BOWRY VW, 1992, J AM CHEM SOC, V114, P4992, DOI 10.1021/ja00039a006; BROWN SJ, 2004, 15 INT AIDS C BANGK; BUSTON JEH, 1995, J CHEM SOC PERK T 2, P639, DOI 10.1039/p29950000639; CAIRNES DA, 1981, CANCER LETT, V14, P85, DOI 10.1016/0304-3835(81)90013-6; CASHMORE AR, 1976, TETRAHEDRON LETT, P1737, DOI 10.1016/S0040-4039(00)92940-X; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cox PA, 2001, PHARM BIOL, V39, P33, DOI [10.1076/phbi.39.7.33.5875, 10.1076/phbi.39.s1.33.0001]; ENGEL PS, 1974, CAN J CHEM, V52, P4040, DOI 10.1139/v74-602; EVANS FJ, 1979, ACTA PHARMACOL TOX, V45, P181; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; FREEMAN JP, 1964, J ORG CHEM, V29, P1379, DOI 10.1021/jo01029a027; GSCHWEND.M, 1970, TETRAHEDRON LETT, P567; Gulakowski RJ, 1997, ANTIVIR RES, V33, P87, DOI 10.1016/S0166-3542(96)01004-2; GUSTAFSON KR, 1992, J MED CHEM, V35, P1978, DOI 10.1021/jm00089a006; Haas W, 2002, J NAT PROD, V65, P1434, DOI 10.1021/np020060d; Hezareh Marjan, 2004, Antiviral Chemistry & Chemotherapy, V15, P207; HIROTA M, 1988, CANCER RES, V48, P5800; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hook BDA, 2005, J ORG CHEM, V70, P7558, DOI 10.1021/jo050705p; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2004, AIDS RES HUM RETROV, V20, P497, DOI 10.1089/088922204323087741; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; LAURENCE J, 1990, BIOCHEM BIOPH RES CO, V166, P349, DOI 10.1016/0006-291X(90)91952-O; MIANA GA, 1985, PLANTA MED, V51, P353, DOI 10.1055/s-2007-969515; Polley H. Wayne, 2007, Ecological Society of America Annual Meeting Abstracts; Roebuck KA, 1996, AIDS, V10, P819, DOI 10.1097/00002030-199607000-00004; Rullas J, 2004, ANTIVIR THER, V9, P545; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; SZALLASI Z, 1993, CANCER RES, V53, P2507; THIELMANN HW, 1969, LIEBIGS ANN CHEM, V728, P158; Trushin SA, 2005, J VIROL, V79, P9821, DOI 10.1128/JVI.79.15.9821-9830.2005; TSENG SS, 1977, J ORG CHEM, V42, P3645, DOI 10.1021/jo00443a002; *UNAIDS WHO, AIDS EP UPD DEC 2007; Wender PA, 1997, J AM CHEM SOC, V119, P7897, DOI 10.1021/ja9706256; WENDER PA, 1990, J AM CHEM SOC, V112, P4956, DOI 10.1021/ja00168a050; WENDER PA, 1989, J AM CHEM SOC, V111, P8957, DOI 10.1021/ja00206a050; Wender Paul A, 2004, Curr Drug Discov Technol, V1, P1, DOI 10.2174/1570163043484888; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Witvrouw Myriam, 2003, Antiviral Chemistry & Chemotherapy, V14, P321; Yang QE, 2004, MED SCI MONITOR, V10, pRA155	44	151	169	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					649	652		10.1126/science.1154690	http://dx.doi.org/10.1126/science.1154690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	295DD	18451298	Green Accepted			2022-12-28	WOS:000255454300041
J	Zhao, SM; Guan, KL				Zhao, Shimin; Guan, Kun-Liang			Substrate selectivity APPLies to Akt	CELL			English	Editorial Material							RICTOR-MTOR COMPLEX; PHOSPHORYLATION; SURVIVAL; AKT/PKB	The protein kinase Akt occupies a central position in multiple signaling pathways. Although numerous Akt substrates have been identified, less is known about the factors that regulate specific cellular responses to Akt signaling. In this issue, Schenck et al. (2008) demonstrate that the endosomal protein Appl1 modulates Akt's substrate selectivity to promote cell survival during zebrafish development.	[Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Zhao, Shimin] Fudan Univ, Inst Biomed Sci, Mol & Cellular Biol Lab, Shanghai 200032, Peoples R China	University of California System; University of California San Diego; University of California System; University of California San Diego; Fudan University	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022					Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148	9	6	9	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					399	400		10.1016/j.cell.2008.04.015	http://dx.doi.org/10.1016/j.cell.2008.04.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455980	Bronze			2022-12-28	WOS:000255503900010
J	Glantz, LH; Annas, GJ				Glantz, Leonard H.; Annas, George J.			The FDA, preemption, and the supreme court	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Glantz, Leonard H.; Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Glantz, LH (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831; Glantz, Leonard/0000-0003-4591-2305					0	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 1	2008	358	18					1883	1885		10.1056/NEJMp0802108	http://dx.doi.org/10.1056/NEJMp0802108			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294ER	18450601				2022-12-28	WOS:000255387900002
J	Tye, KM; Stuber, GD; de Ridder, B; Bonci, A; Janak, PH				Tye, Kay M.; Stuber, Garret D.; de Ridder, Bram; Bonci, Antonello; Janak, Patricia H.			Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning	NATURE			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; PREFRONTAL CORTEX; VENTRAL STRIATUM; FEAR; PLASTICITY; NEURONS; STIMULI; RAT; PROJECTIONS	What neural changes underlie individual differences in goal-directed learning? The lateral amygdala ( LA) is important for assigning emotional and motivational significance to discrete environmental cues(1-4), including those that signal rewarding events(5-8). Recognizing that a cue predicts a reward enhances an animal's ability to acquire that reward; however, the cellular and synaptic mechanisms that underlie cue - reward learning are unclear. Here we show that marked changes in both cue- induced neuronal firing and input- specific synaptic strength occur with the successful acquisition of a cue - reward association within a single training session. We performed both in vivo and ex vivo electrophysiological recordings in the LA of rats trained to self- administer sucrose. We observed that reward- learning success increased in proportion to the number of amygdala neurons that responded phasically to a reward- predictive cue. Furthermore, cue - reward learning induced an AMPA (alpha-amino- 3- hydroxy- 5- methyl-isoxazole propionic acid)- receptor- mediated increase in the strength of thalamic, but not cortical, synapses in the LA that was apparent immediately after the first training session. The level of learning attained by individual subjects was highly correlated with the degree of synaptic strength enhancement. Importantly, intra-LA NMDA ( N- methyl- D- aspartate)- receptor blockade impaired reward- learning performance and attenuated the associated increase in synaptic strength. These findings provide evidence of a connection between LA synaptic plasticity and cue - reward learning, potentially representing a key mechanism underlying goal-directed behaviour.	[Tye, Kay M.; Stuber, Garret D.; de Ridder, Bram; Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Stuber, Garret D.; Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bonci, Antonello; Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Janak, PH (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.	pjanak@gallo.ucsf.edu	Tye, Kay/J-6158-2013; Stuber, Garret/E-1160-2011	Tye, Kay/0000-0002-2435-0182; Stuber, Garret/0000-0003-1730-4855; Janak, Patricia/0000-0002-3333-9049	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA115096, R01 DA015096, R01 DA015096-06] Funding Source: Medline; NIDDK NIH HHS [DP2 DK102256] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AZUMA S, 1984, EXP BRAIN RES, V56, P12; Baldwin AE, 2000, BEHAV NEUROSCI, V114, P84, DOI 10.1037/0735-7044.114.1.84; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; BURNS LH, 1994, BEHAV NEURAL BIOL, V61, P242, DOI 10.1016/S0163-1047(05)80007-X; CADOR M, 1989, NEUROSCIENCE, V30, P77, DOI 10.1016/0306-4522(89)90354-0; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; DAVIS M, 1992, P255; Doron NN, 1999, J COMP NEUROL, V412, P383; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McDonald AJ, 1998, PROG NEUROBIOL, V55, P257, DOI 10.1016/S0301-0082(98)00003-3; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Nakashima M, 2000, NEUROSCI RES, V36, P297, DOI 10.1016/S0168-0102(99)00129-7; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, NATURE, V417, P282, DOI 10.1038/417282a; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Samson RD, 2006, NEUROSCIENCE, V141, P1599, DOI 10.1016/j.neuroscience.2006.04.077; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shin RM, 2006, NEURON, V52, P883, DOI 10.1016/j.neuron.2006.10.010; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; UWANO T, 1995, NEUROSCIENCE, V68, P339, DOI 10.1016/0306-4522(95)00125-3	30	155	155	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 26	2008	453	7199					1253	U56		10.1038/nature06963	http://dx.doi.org/10.1038/nature06963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318FA	18469802	Green Accepted			2022-12-28	WOS:000257075800046
J	Kawamura, Y; Saito, K; Kin, T; Ono, Y; Asai, K; Sunohara, T; Okada, TN; Siomi, MC; Siomi, H				Kawamura, Yoshinori; Saito, Kuniaki; Kin, Taishin; Ono, Yukiteru; Asai, Kiyoshi; Sunohara, Takafumi; Okada, Tomoko N.; Siomi, Mikiko C.; Siomi, Haruhiko			Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells	NATURE			English	Article							PIWI-INTERACTING RNAS; DISTINCT ROLES; INTERFERENCE; GERMLINE; PATHWAYS; PROTEINS; HETEROCHROMATIN; ELEMENTS; SIRNAS; GENOME	RNA silencing is a conserved mechanism in which small RNAs trigger various forms of sequence- specific gene silencing by guiding Argonaute complexes to target RNAs by means of base pairing(1,2). RNA silencing is thought to have evolved as a form of nucleic- acid- based immunity to inactivate viruses and transposable elements. Although the activity of transposable elements in animals has been thought largely to be restricted to the germ line, recent studies have shown that they may also actively transpose in somatic cells, creating somatic mosaicism in animals(3). In the Drosophila germ line, Piwi- interacting RNAs arise from repetitive intergenic elements including retrotransposons by a Dicer-independent pathway and function through the Piwi subfamily of Argonautes to ensure silencing of retrotransposons(4-9). Here we show that, in cultured Drosophila S2 cells, Argonaute 2 ( AGO2), an AGO subfamily member of Argonautes, associates with endogenous small RNAs of 20 - 22 nucleotides in length, which we have collectively named endogenous short interfering RNAs ( esiRNAs). esiRNAs can be divided into two groups: one that mainly corresponds to a subset of retrotransposons, and the other that arises from stem - loop structures. esiRNAs are produced in a Dicer- 2-dependent manner from distinctive genomic loci, are modified at their 39 ends and can direct AGO2 to cleave target RNAs. Mutations in Dicer- 2 caused an increase in retrotransposon transcripts. Together, our findings indicate that different types of small RNAs and Argonautes are used to repress retrotransposons in germline and somatic cells in Drosophila.	[Kawamura, Yoshinori; Saito, Kuniaki; Sunohara, Takafumi; Okada, Tomoko N.; Siomi, Mikiko C.; Siomi, Haruhiko] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Saito, Kuniaki; Okada, Tomoko N.; Siomi, Mikiko C.; Siomi, Haruhiko] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; [Kin, Taishin; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo 1350664, Japan; [Ono, Yukiteru] Informat & Math Sci Lab Inc, Tokyo 1120012, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Siomi, Mikiko C.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Tokushima University; Keio University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; Japan Science & Technology Agency (JST)	Siomi, MC (corresponding author), Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan.	siomim@sc.itc.keio.ac.jp; awa403@sc.itc.keio.ac.jp	Asai, Kiyoshi/AAT-8344-2020; Saito, Kuniaki/A-6967-2015; Siomi, Haruhiko/A-7020-2015	Asai, Kiyoshi/0000-0003-0909-4982; Saito, Kuniaki/0000-0001-8233-9283; Siomi, Haruhiko/0000-0001-8690-3822				Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CELNIKER SE, 2002, GENOME BIOL, V0003; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Muotri AR, 2007, HUM MOL GENET, V16, pR159, DOI 10.1093/hmg/ddm196; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	29	331	349	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					793	U5		10.1038/nature06938	http://dx.doi.org/10.1038/nature06938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463636				2022-12-28	WOS:000256415300046
J	Talbot, K; Davies, KE				Talbot, Kevin; Davies, Kay E.			Is good housekeeping the key to motor neuron survival?	CELL			English	Editorial Material							SPINAL MUSCULAR-ATROPHY; SMN		[Talbot, Kevin; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genet Unit, Oxford OX1 3QX, England	University of Oxford	Talbot, K (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genet Unit, Oxford OX1 3QX, England.	kevin.talbot@clneuro.ox.ac.uk; kay.davies@dpag.ox.ac.uk	Talbot, Kevin/F-7361-2011	Talbot, Kevin/0000-0001-5490-1697				Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Kolb SJ, 2007, J CHILD NEUROL, V22, P990, DOI 10.1177/0883073807305666; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	5	11	11	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					572	574		10.1016/j.cell.2008.05.002	http://dx.doi.org/10.1016/j.cell.2008.05.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485864	Bronze			2022-12-28	WOS:000255903300011
J	Gurtner, GC; Werner, S; Barrandon, Y; Longaker, MT				Gurtner, Geoffrey C.; Werner, Sabine; Barrandon, Yann; Longaker, Michael T.			Wound repair and regeneration	NATURE			English	Review							GROWTH-FACTOR-BETA; STEM-CELLS; HAIR-FOLLICLES; TISSUE-REPAIR; TRANSCRIPTIONAL CONTROL; KERATINOCYTE MIGRATION; EPITHELIAL REPAIR; PPAR-BETA; C-JUN; SKIN	The repair of wounds is one of the most complex biological processes that occur during human life. After an injury, multiple biological pathways immediately become activated and are synchronized to respond. In human adults, the wound repair process commonly leads to a non-functioning mass of fibrotic tissue known as a scar. By contrast, early in gestation, injured fetal tissues can be completely recreated, without fibrosis, in a process resembling regeneration. Some organisms, however, retain the ability to regenerate tissue throughout adult life. Knowledge gained from studying such organisms might help to unlock latent regenerative pathways in humans, which would change medical practice as much as the introduction of antibiotics did in the twentieth century.	[Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Dept Surg,Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Werner, Sabine] ETH, Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Barrandon, Yann] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Barrandon, Yann] Ecole Polytech Fed Lausanne, Sch Life Sci LDCS, Stn 15, CH-1015 Lausanne, Switzerland	Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gurtner, GC (corresponding author), Stanford Univ, Sch Med, Div Plast & Reconstruct Surg, Dept Surg,Inst Stem Cell Biol & Regenerat Med, 257 Campus Dr, Stanford, CA 94305 USA.	ggurtner@stanford.edu; longaker@stanford.edu		Werner, Sabine/0000-0001-7397-8710				Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; ALVARADO AS, 2006, CELL, V124, P241, DOI DOI 10.1016/J.CELL.2006.01.012; Amendt C, 2002, J CELL SCI, V115, P2189; Anderson Robert N, 2003, Natl Vital Stat Rep, V52, P1; [Anonymous], MORB MORT 2002 CHART; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bluff JE, 2007, EXP HEMATOL, V35, P500, DOI 10.1016/j.exphem.2006.10.016; Braun S, 2004, PHILOS T R SOC B, V359, P753, DOI 10.1098/rstb.2004.1464; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chernyavsky AI, 2004, J CELL BIOL, V166, P261, DOI 10.1083/jcb.200401034; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x; Colwell AS, 2003, FRONT BIOSCI-LANDMRK, V8, pS1240, DOI 10.2741/1183; Cooper L, 2005, GENOME BIOL, V6; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; GHAHARY A, 1993, J LAB CLIN MED, V122, P465; Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147; Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.082405.095329; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klein L, 2003, AM J CARDIOL, V91, p18F, DOI 10.1016/S0002-9149(02)03336-2; Konigova R, 2000, Acta Chir Plast, V42, P91; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; LEVENSON SM, 1965, ANN SURG, V161, P293, DOI 10.1097/00000658-196502000-00019; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; LIN RY, 1995, ANN SURG, V222, P146, DOI 10.1097/00000658-199508000-00006; Lovvorn HN, 1999, J PEDIATR SURG, V34, P218, DOI 10.1016/S0022-3468(99)90261-0; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Martin P, 2003, CURR BIOL, V13, P1122, DOI 10.1016/S0960-9822(03)00396-8; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Mescher AL, 2005, ADV BIOCHEM ENG BIOT, V93, P39, DOI 10.1007/b99966; Metcalfe AD, 2008, CELL MOL LIFE SCI, V65, P24, DOI 10.1007/s00018-007-7427-x; Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Opalenik SR, 2005, FASEB J, V19, P1561, DOI 10.1096/fj.04-2978fje; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; Pullar CE, 2006, J BIOL CHEM, V281, P21225, DOI 10.1074/jbc.M601007200; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Reynolds AJ, 1999, NATURE, V402, P33, DOI 10.1038/46938; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Samakovlis C, 1996, DEVELOPMENT, V122, P3531; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Suzuki M, 2005, DEV BIOL, V286, P361, DOI 10.1016/j.ydbio.2005.08.021; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trent Jennifer T, 2003, Adv Skin Wound Care, V16, P31, DOI 10.1097/00129334-200301000-00014; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Wood W, 2002, NAT CELL BIOL, V4, P907, DOI 10.1038/ncb875; Woolley K, 2000, BIOESSAYS, V22, P911; Woolner S, 2005, DEV BIOL, V282, P163, DOI 10.1016/j.ydbio.2005.03.005; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925	85	3575	3729	106	1246	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					314	321		10.1038/nature07039	http://dx.doi.org/10.1038/nature07039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480812	Green Submitted			2022-12-28	WOS:000255868400038
J	Decaux, G; Soupart, A; Vassart, G				Decaux, Guy; Soupart, Alain; Vassart, Gilbert			Non-peptide arginine-vasopressin antagonists: the vaptans	LANCET			English	Article							V-1A RECEPTOR ANTAGONIST; WORSENING HEART-FAILURE; LONG-TERM TREATMENT; ANTIDIURETIC-HORMONE; DOUBLE-BLIND; PHARMACOLOGICAL CHAPERONES; INAPPROPRIATE SECRETION; UTERINE CONTRACTIONS; NEPHROGENIC SYNDROME; AQUARETIC AGENT	Arginine-vasopressin is a hormone that plays an important part in circulatory and water homoeostasis. The three arginine-vasopressin-receptor subtypes-V1a, V1b, and V2-all belong to the large rhodopsin-like G-protein-coupled receptor family. The vaptans are orally and intravenously active non-peptide vasopressin receptor antagonists that are in development. Relcovaptan is a selective V1a-receptor antagonist, which has shown initial positive results in the treatment of Raynaud's disease, dysmenorrhorea, and tocolysis. SSR-149415 is a selective V1b-receptor antagonist, which could have beneficial effects in the treatment of psychiatric disorders. V2-receptor antagonists-mozavaptan, lixivaptan, satavaptan, and tolvaptan-induce a highly hypotonic diuresis without substantially affecting the excretion of electrolytes (by contrast with the effects of diuretics). These drugs are all effective in the treatment of euvolaemic and hypervolaemic hyponatraemia. Conivaptan is a V1a/V2 non-selective vasopressin-receptor antagonist that has been approved by the US Food and Drug Administration as an intravenous infusion for the inhospital treatment of euvolaemic or hypervolaemic hyponatraemia.	[Decaux, Guy] Erasmus Univ Hosp, Dept Internal Med, B-1070 Brussels, Belgium; [Soupart, Alain] Tubize Jolimont Hosp, Dept Internal Med, Tubize, Belgium; [Vassart, Gilbert] Free Univ Brussels, Inst Rech Interdisciplinaire IRIBHM, Brussels, Belgium; [Vassart, Gilbert] Free Univ Brussels, Dept Med Genet, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Groupe Jolimont; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Decaux, G (corresponding author), Erasmus Univ Hosp, Dept Internal Med, Route Lennik 808, B-1070 Brussels, Belgium.	guy.decaux@skynet.be						Abraham WT, 2006, J AM COLL CARDIOL, V47, P1615, DOI 10.1016/j.jacc.2005.11.071; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Akerlund M, 1999, BRIT J OBSTET GYNAEC, V106, P1047, DOI 10.1111/j.1471-0528.1999.tb08112.x; Bankir L, 2001, CARDIOVASC RES, V51, P372, DOI 10.1016/S0008-6363(01)00328-5; Bemana I, 1997, ACT NEUR S, V70, P194; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Chen S, 2007, NAT CLIN PRACT NEPHR, V3, P82, DOI 10.1038/ncpneph0401; CLUITMANS FHM, 1990, AM J MED, V88, P161, DOI 10.1016/0002-9343(90)90467-R; Daidoh H, 1998, CLIN ENDOCRINOL, V49, P403; De Luca L, 2005, AM J CARDIOL, V96, p19L, DOI 10.1016/j.amjcard.2005.09.066; Decaux G, 2003, AM J MED SCI, V326, P25, DOI 10.1097/00000441-200307000-00004; Decaux G, 2001, AM J MED, V110, P582, DOI 10.1016/S0002-9343(01)00678-7; Decaux G, 2007, J AM SOC NEPHROL, V18, P606, DOI 10.1681/ASN.2006090987; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Folny V, 2003, AM J PHYSIOL-ENDOC M, V285, pE566, DOI 10.1152/ajpendo.00148.2003; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gerbes AL, 2003, GASTROENTEROLOGY, V124, P933, DOI 10.1053/gast.2003.50143; Ghali JK, 2006, J CLIN ENDOCR METAB, V91, P2145, DOI 10.1210/jc.2005-2287; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2005, AM J CARDIOL, V96, p3L, DOI 10.1016/j.amjcard.2005.09.059; Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Greenberg A, 2006, KIDNEY INT, V69, P2124, DOI 10.1038/sj.ki.5000432; Griebel G, 2002, P NATL ACAD SCI USA, V99, P6370, DOI 10.1073/pnas.092012099; Hayoz D, 2000, RHEUMATOLOGY, V39, P1132, DOI 10.1093/rheumatology/39.10.1132; JACKSON EK, 2006, GOODMAN GILMANS PHAR, P771; KLEIN L, 2005, CIRCULATION, V111, P1; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Kumar S, 1998, LANCET, V352, P220, DOI 10.1016/S0140-6736(97)12169-9; Lacheretz F, 2000, J OCUL PHARMACOL TH, V16, P203, DOI 10.1089/jop.2000.16.203; Laszlo FA, 1999, EUR J PHARMACOL, V364, P115, DOI 10.1016/S0014-2999(98)00836-X; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lemmens-Gruber R, 2006, CELL MOL LIFE SCI, V63, P1766, DOI 10.1007/s00018-006-6054-2; Licata G, 2003, AM HEART J, V145, P459, DOI 10.1067/mhj.2003.166; Macion-Dazard R, 2006, J PHARMACOL EXP THER, V316, P564, DOI 10.1124/jpet.105.095554; Matsuhisa A, 1997, CHEM PHARM BULL, V45, P1870; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Naito A, 2002, BIOL PHARM BULL, V25, P251, DOI 10.1248/bpb.25.251; OHNISHI A, 1993, J CLIN INVEST, V92, P2653, DOI 10.1172/JCI116881; Pequeux C, 2004, ENDOCR-RELAT CANCER, V11, P871, DOI 10.1677/erc.1.00803; Quittnat F, 2006, SEMIN NEPHROL, V26, P234, DOI 10.1016/j.semnephrol.2006.02.003; Renneboog B, 2006, AM J MED, V119, P71, DOI [10.1016/j.amjmed.2005.09.026, DOI 10.1016/J.AMJMED.2005.09.026]; Ring RH, 2005, CURR PHARM DESIGN, V11, P205, DOI 10.2174/1381612053382241; ROSE BD, 1986, AM J MED, V81, P1033, DOI 10.1016/0002-9343(86)90401-8; Saito T, 1997, J CLIN ENDOCR METAB, V82, P1054, DOI 10.1210/jc.82.4.1054; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Schwarz Ernst R, 2006, Expert Rev Cardiovasc Ther, V4, P17, DOI 10.1586/14779072.4.1.17; Serradeil-Le Gal C, 2002, PROG BRAIN RES, V139, P197; Serradeil-Le Gal C, 2002, J PHARMACOL EXP THER, V300, P1122; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; SerradeilLeGal C, 1996, J CLIN INVEST, V98, P2729, DOI 10.1172/JCI119098; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Sonino Nicoletta, 2005, Treat Endocrinol, V4, P87, DOI 10.2165/00024677-200504020-00003; Soupart A, 2006, CLIN J AM SOC NEPHRO, V1, P1154, DOI 10.2215/CJN.00160106; Steinwall M, 2005, GYNECOL ENDOCRINOL, V20, P104, DOI 10.1080/09513590400021144; Steinwall M, 2004, ACTA OBSTET GYN SCAN, V83, P12, DOI 10.1111/j.1600-0412.2004.00320.x; STERNS RH, 1994, J AM SOC NEPHROL, V4, P1522; Tahara A, 1997, J PHARMACOL EXP THER, V282, P301; Tahtaoui C, 2003, J BIOL CHEM, V278, P40010, DOI 10.1074/jbc.M301128200; Takeda T, 2003, HEARING RES, V182, P9, DOI 10.1016/S0378-5955(03)00135-7; TERZIAN C, 1994, J GEN INTERN MED, V9, P89, DOI 10.1007/BF02600208; Thibonnier M, 2001, ANNU REV PHARMACOL, V41, P175, DOI 10.1146/annurev.pharmtox.41.1.175; Torres VE, 2005, KIDNEY INT, V68, P2405, DOI 10.1111/j.1523-1755.2005.00703.x; Trandafir CC, 2004, CLIN EXP PHARMACOL P, V31, P261, DOI 10.1111/j.1440-1681.2004.03986.x; Udelson JE, 2007, J AM COLL CARDIOL, V49, P2151, DOI 10.1016/j.jacc.2007.01.091; Udelson JE, 2001, CIRCULATION, V104, P2417, DOI 10.1161/hc4501.099313; VERBALIS JG, 1989, CLIN RES, V37, pA586; Verbalis JG, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290001; Wada K, 2005, EUR J PHARMACOL, V507, P145, DOI 10.1016/j.ejphar.2004.11.022; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Wong F, 2003, HEPATOLOGY, V37, P182, DOI 10.1053/jhep.2003.50021; Wu CC, 2006, CLIN NEPHROL, V65, P28; YAMAMURA Y, 1991, SCIENCE, V252, P572, DOI 10.1126/science.1850553; YAMAMURA Y, 1992, BRIT J PHARMACOL, V105, P787, DOI 10.1111/j.1476-5381.1992.tb09058.x; Yeates KE, 2006, AM J NEPHROL, V26, P348, DOI 10.1159/000094539; Zeltser D, 2007, AM J NEPHROL, V27, P447, DOI 10.1159/000106456	78	250	266	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1624	1632		10.1016/S0140-6736(08)60695-9	http://dx.doi.org/10.1016/S0140-6736(08)60695-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468546				2022-12-28	WOS:000255715400030
J	Pickett, CA; Jackson, JL; Hemann, BA; Atwood, JE				Pickett, Christopher A.; Jackson, Jeffrey L.; Hemann, Brian A.; Atwood, J. Edwin			Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis	LANCET			English	Article							ASYMPTOMATIC CERVICAL BRUIT; PUBLICATION BIAS; PRESSURE INDEX; FOLLOW-UP; RISK; ENDARTERECTOMY; STROKE; ARTERY; POPULATION; STRATEGIES	Background Although carotid bruits are deemed to be markers of generalised atherosclerosis, they are poor predictors of cerebrovascular events. We investigated whether a carotid bruit predicts myocardial infarction and cardiovascular death. Methods in this meta-analysis, we searched Medline (1966 to August, 2007) and Embase (1974 to August, 2007) with the terms "carotid" and "bruit". Bibliographies of all the retrieved articles were also searched. Articles were included if they reported the incidence of myocardial infarction or cardiovascular death in adults. Outcome variables were extracted in duplicate and included the rate of myocardial infarction and cardiovascular mortality. Quality of the articles was independently assessed with the Hayden rating scheme. Data were pooled with a random effects model. Findings Of the 22 articles included, 20 (91%) used prospective cohorts. Our analysis included 17295 patients with 62413.5 patient-years of follow-up, with a median sample size of 273 patients (range 38-4736) followed up for 4 years (2-7). The rate of myocardial infarction in patients with carotid bruits was 3.69 (95% CI 2.97-5.40) per 100 patient-years (eight studies) compared with 1.86 (0.24-3.48) per 100 patient-years in those without bruits (two studies). Yearly rates of cardiovascular death were also higher in patients with bruits (16 studies) than in those without (four studies) (2 . 85 [2.16-3.54] per 100 patient-years vs 1 . 11 [0 . 45-1.76] per 100 patient-years). in the four trials in which direct comparisons of patients with and without bruits were possible, the odds ratio for myocardial infarction was 2.15 (1.67-2.78) and for cardiovascular death 2.27 (1.49-3.49). Interpretation Auscultation for carotid bruits in patients at risk for heart disease could help select those who might benefit the most from an aggressive modification strategy for cardiovascular risk.	[Pickett, Christopher A.; Jackson, Jeffrey L.; Hemann, Brian A.; Atwood, J. Edwin] Walter Reed Army Med Ctr, Dept Med, Washington, DC 20307 USA; [Hemann, Brian A.; Atwood, J. Edwin] Walter Reed Army Med Ctr, Dept Cardiol, Washington, DC 20307 USA; [Jackson, Jeffrey L.; Atwood, J. Edwin] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Pickett, CA (corresponding author), Walter Reed Army Med Ctr, Dept Med, 6900 Georgia Ave NW, Washington, DC 20307 USA.	christopher.pickett1@us.army.mil	Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				Akcakaya HR, 2002, ANIM CONSERV, V5, P333, DOI 10.1017/S1367943002004092; BEGG CB, 1989, J NATL CANCER I, V81, P107, DOI 10.1093/jnci/81.2.107; BOGOUSSLAVSKY J, 1986, NEUROLOGY, V36, P861, DOI 10.1212/WNL.36.6.861; BURKE PA, 1982, ARCH SURG-CHICAGO, V117, P1222; CHAMBERS BR, 1986, NEW ENGL J MED, V315, P860, DOI 10.1056/NEJM198610023151404; CHAMBERS BR, 1985, NEUROLOGY, V35, P742, DOI 10.1212/WNL.35.5.742; CLAGETT GP, 1984, SURGERY, V96, P823; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cote R, 2000, STROKE, V31, P1856, DOI 10.1161/01.STR.31.8.1856; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; CULLEN SJ, 1983, CIRCULATION, V68, P83; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DORAZIO RA, 1980, AM J SURG, V140, P212, DOI 10.1016/0002-9610(80)90008-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELLIS MR, 1987, J VASC SURG, V5, P869, DOI 10.1067/mva.1987.avs0050869; ENDEAN ED, 1991, J CARDIOVASC SURG, V32, P620; FORD CS, 1986, ARCH NEUROL-CHICAGO, V43, P219, DOI 10.1001/archneur.1986.00520030011004; Frost PH, 1996, CIRCULATION, V94, P26, DOI 10.1161/01.CIR.94.1.26; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; GUTIERREZ IZ, 1985, AM SURGEON, V51, P388; HANKEY GJ, 1991, BMJ-BRIT MED J, V302, P499, DOI 10.1136/bmj.302.6775.499; HANKEY GJ, 1990, BMJ-BRIT MED J, V300, P1485, DOI 10.1136/bmj.300.6738.1485; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; HEYMAN A, 1980, NEW ENGL J MED, V302, P838, DOI 10.1056/NEJM198004103021504; HOWARD VJ, 1989, STROKE, V20, P1331, DOI 10.1161/01.STR.20.10.1331; Leng GC, 1996, BMJ-BRIT MED J, V313, P1440, DOI 10.1136/bmj.313.7070.1440; Mackey AE, 1997, NEUROLOGY, V48, P896, DOI 10.1212/WNL.48.4.896; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Moll F L, 1987, Eur J Vasc Surg, V1, P33, DOI 10.1016/S0950-821X(87)80021-X; *NCEP ATPIII, 2002, NIH PUBL; NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485; ROPPER AH, 1982, NEW ENGL J MED, V307, P1388, DOI 10.1056/NEJM198211253072207; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Shorr RI, 1998, J GEN INTERN MED, V13, P86, DOI 10.1046/j.1525-1497.1998.00023.x; Sonecha TN, 2006, INT J CARDIOL, V107, P225, DOI 10.1016/j.ijcard.2005.03.026; TABET S, 1996, US PREVENTIVE SERVIC, P53; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; THOMPSON JE, 1978, ANN SURG, V188, P308, DOI 10.1097/00000658-197809000-00005; VANRUISWYK J, 1990, ANN INTERN MED, V112, P340, DOI 10.7326/0003-4819-112-5-340; VOGT MT, 1993, JAMA-J AM MED ASSOC, V270, P465, DOI 10.1001/jama.270.4.465; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; WIEBERS DO, 1990, STROKE, V21, P984, DOI 10.1161/01.STR.21.7.984; Wilczynski NL, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-23; WOLF PA, 1981, JAMA-J AM MED ASSOC, V245, P1442, DOI 10.1001/jama.245.14.1442; Yusuf S, 2000, NEW ENGL J MED, V342, P145	49	82	82	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1587	1594		10.1016/S0140-6736(08)60691-1	http://dx.doi.org/10.1016/S0140-6736(08)60691-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468542				2022-12-28	WOS:000255715400026
J	Bertaina, S; Gambarelli, S; Mitra, T; Tsukerblat, B; Muller, A; Barbara, B				Bertaina, S.; Gambarelli, S.; Mitra, T.; Tsukerblat, B.; Mueller, A.; Barbara, B.			Quantum oscillations in a molecular magnet	NATURE			English	Article							WEAK FERROMAGNETISM; MAGNETIZATION; V-15; CLUSTER; RELAXATION; QUBITS; PHASE	The term 'molecular magnet' generally refers to a molecular entity containing several magnetic ions whose coupled spins generate a collective spin, S ( ref. 1). Such complex multi- spin systems provide attractive targets for the study of quantum effects at the mesoscopic scale. In these molecules, the large energy barriers between collective spin states can be crossed by thermal activation or quantum tunnelling, depending on the temperature or an applied magnetic field(2-4). There is the hope that these mesoscopic spin states can be harnessed for the realization of quantum bits 'qubits', the basic building blocks of a quantum computer - based on molecular magnets(5-8). But strong decoherence(9) must be overcome if the envisaged applications are to become practical. Here we report the observation and analysis of Rabi oscillations ( quantum oscillations resulting from the coherent absorption and emission of photons driven by an electromagnetic wave(10)) of a molecular magnet in a hybrid system, in which discrete and well-separated magnetic V-15(IV) clusters are embedded in a self- organized non- magnetic environment. Each cluster contains 15 antiferromagnetically coupled S = 1/ 2 spins, leading to an S = 1/ 2 collective ground state(11-13). When this system is placed into a resonant cavity, the microwave field induces oscillatory transitions between the ground and excited collective spin states, indicative of long-lived quantum coherence. The present observation of quantum oscillations suggests that low- dimension self- organized qubit networks having coherence times of the order of 100 mu s ( at liquid helium temperatures) are a realistic prospect.	[Bertaina, S.; Barbara, B.] CNRS, Inst Neel, F-38042 Grenoble 9, France; [Gambarelli, S.; Barbara, B.] CEA Grenoble, INAC, UMR CEA UJF E3, Lab Chim Inorgan & Biol, F-38054 Grenoble 9, France; [Mitra, T.; Mueller, A.] Univ Bielefeld, Fak Chem, D-33501 Bielefeld, Germany; [Tsukerblat, B.] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Bielefeld; Ben Gurion University	Barbara, B (corresponding author), CNRS, Inst Neel, 25 Ave Martyrs,BP166, F-38042 Grenoble 9, France.	a.mueller@uni-bielefeld.de; bernard.barbara@grenoble.cnrs.fr	Mitra, Tamoghna/L-7358-2017; Bertaina, Sylvain/B-6841-2008	Mitra, Tamoghna/0000-0002-1649-6667; Bertaina, Sylvain/0000-0002-6466-8830; Muller, Achim/0000-0003-0117-4021				Ardavan A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057201; Barbara B, 2003, J MOL STRUCT, V656, P135, DOI 10.1016/S0022-2860(03)00362-4; BARBARA B, 1995, J MAGN MAGN MATER, V140, P1825, DOI 10.1016/0304-8853(94)00585-0; Bertaina S, 2007, NAT NANOTECHNOL, V2, P39, DOI 10.1038/nnano.2006.174; Chaboussant G, 2004, EUROPHYS LETT, V66, P423, DOI 10.1209/epl/i2004-10008-x; Chiorescu I, 2000, PHYS REV LETT, V84, P3454, DOI 10.1103/PhysRevLett.84.3454; De Raedt H, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064401; DZYALOSHINSKY I, 1958, J PHYS CHEM SOLIDS, V4, P241, DOI 10.1016/0022-3697(58)90076-3; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; GATTESCHI D, 1991, NATURE, V354, P463, DOI 10.1038/354463a0; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; HartmannBoutron F, 1996, INT J MOD PHYS B, V10, P2577, DOI 10.1142/S0217979296001148; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Mehring M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.153001; Morello A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.207206; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Morton JJL, 2006, NAT PHYS, V2, P40, DOI 10.1038/nphys192; MULLER A, 1988, ANGEW CHEM INT EDIT, V27, P1721, DOI 10.1002/anie.198817211; Nellutla S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137601; Prokof'ev NV, 2000, REP PROG PHYS, V63, P669, DOI 10.1088/0034-4885/63/4/204; Prokofev NV, 1996, J LOW TEMP PHYS, V104, P143, DOI 10.1007/BF00754094; Rabi II, 1937, PHYS REV, V51, P0652, DOI 10.1103/PhysRev.51.652; Stamp PCE, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014401; Tarantul A, 2007, INORG CHEM, V46, P161, DOI 10.1021/ic061394j; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Tsukerblat B, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2227390; Volkmer D, 2000, J AM CHEM SOC, V122, P1995, DOI 10.1021/ja992350v; Wernsdorfer W, 2004, EUROPHYS LETT, V66, P861, DOI 10.1209/epl/i2004-10033-9; Wernsdorfer W, 2007, NAT MATER, V6, P174, DOI 10.1038/nmat1852	30	305	306	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					203	U5		10.1038/nature06962	http://dx.doi.org/10.1038/nature06962			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464738	Green Published, Bronze			2022-12-28	WOS:000255592400035
J	Peter, JV; John, P; Graham, PL; Moran, JL; George, IA; Bersten, A				Peter, John Victor; John, Preeta; Graham, Petra L.; Moran, John L.; George, Ige Abraham; Bersten, Andrew			Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MIGRATION INHIBITORY FACTOR; HIGH-DOSE CORTICOSTEROIDS; OUTCOME SELECTION BIAS; ACUTE LUNG INJURY; STEROID-THERAPY; SEPTIC SHOCK; METHYLPREDNISOLONE; MORTALITY; TRIALS; GLUCOCORTICOIDS	Objective To systematically review the efficacy of steroids, in the prevention of acute respiratory distress syndrome (ARDS) in critically ill adults, and in treatment for established ARDS. Data sources Search of randomised controlled trials (1966-April 2007) of PubMed, Cochrane central register of controlled trials, Cochrane database of systematic reviews, American College of Physicians Journal Club, health technology assessment database, and database of abstracts of reviews of effects. Data extraction Two investigators independently assessed trials for inclusion and extracted data into standardised forms; differences were resolved by consensus. Data synthesis. Steroid efficacy was assessed through a Bayesian hierarchical model for comparing the odds of developing ARDS and mortality (both expressed as odds ratio with 95% credible interval) and duration of ventilator free days, assessed as mean difference. Bayesian outcome probabilities were calculated as the probability that the odds ratio would be >= 1 or the probability that the mean difference would be >= 0. Nine randomised trials using variable dose and duration of steroids were identified. Preventive steroids (four studies) were associated with a trend to increase both the odds of patients developing ARDS (odds ratio 1.55, 95% credible interval 0.58 to 4.05; P(odds ratio >= 1)=86.6%), and the risk of mortality in those who subsequently developed ARDS (three studies, odds ratio 1.52, 95% credible interval 0.30 to 5.94; P(odds ratio >= 1) = 72.8%). Steroid administration after onset of ARDS (five studies) was associated with a trend towards reduction in mortality (odds ratio. 0.62, 95% credible interval 0.23 to 1.26; P(odds ratio >= 1)=6.8%). Steroid therapy increased the number of ventilator free days compared with controls (three studies, mean difference 4.05 days, 95% credible interval 0.22 to 8.71; P(mean difference, >= 0)=97.9%). Steroids were not associated with increase in risk of infection. Conclusions A definitive,role of corticosteroids in the treatment of ARDS in adults is not established. A possibility of reduced mortality and increased ventilator free days with steroids Started after the on. set of ARDS was suggested. Preventive steroids possibly increase the incidence of ARDS in critically ill adults.	[Moran, John L.] Queen Elizabeth Hosp, Dept Intens Care, Woodville, SA 5011, Australia; [Peter, John Victor] Christian Med Coll & Hosp, Dept Med Intens Care, Vellore 632004, Tamil Nadu, India; [John, Preeta] Christian Med Coll & Hosp, Dept Surg Crit Care & Anaesthesia, Vellore 632004, Tamil Nadu, India; [Graham, Petra L.] Macquarie Univ, Dept Stat, Div Econ & Financial Studies, Sydney, NSW 2109, Australia; [George, Ige Abraham] Christian Med Coll & Hosp, Dept Med, Vellore 632004, Tamil Nadu, India; [Bersten, Andrew] Flinders Univ S Australia, Dept Crit Care Med, Flinders Med Ctr, Bedford Pk, SA 5042, Australia; [Bersten, Andrew] Flinders Univ S Australia, Dept Crit Care Med, Sch Med, Bedford Pk, SA 5042, Australia	Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore; Macquarie University; Christian Medical College & Hospital (CMCH) Vellore; Flinders Medical Centre; Flinders University South Australia; Flinders University South Australia	Moran, JL (corresponding author), Queen Elizabeth Hosp, Dept Intens Care, Woodville, SA 5011, Australia.	john.moran@adelaide.edu.au	Graham, Petra/V-8136-2019; Peter, John Victor/R-7700-2019	Graham, Petra/0000-0003-2890-2447; Bersten, Andrew/0000-0001-9908-394X				Abraham E, 1999, INTENS CARE MED, V25, P556, DOI 10.1007/s001340050903; Adhikari N, 2004, COCHRANE DB SYST REV; Agarwal R, 2007, RESPIROLOGY, V12, P585, DOI 10.1111/j.1440-1843.2007.01060.x; ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Annane D, 2007, CHEST, V131, P945, DOI 10.1378/chest.06-3005; Bassler D, 2007, J CLIN EPIDEMIOL, V60, P869, DOI 10.1016/j.jclinepi.2006.12.006; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; DUTOIT HJ, 1984, S AFR MED J, V65, P1049; Fernandes ABS, 2005, BRAZ J MED BIOL RES, V38, P147, DOI 10.1590/S0100-879X2005000200003; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; GREENLAND S, 1994, AM J EPIDEMIOL, V140, P290, DOI 10.1093/oxfordjournals.aje.a117248; HAN J, 1990, J EXP MED, V172, P391, DOI 10.1084/jem.172.1.391; Keel JBP, 1998, RESPIRATION, V65, P258, DOI 10.1159/000029273; Kevill KA, 2008, J IMMUNOL, V180, P601, DOI 10.4049/jimmunol.180.1.601; Kirsch I, 2007, CONTEMP CLIN TRIALS, V28, P348, DOI 10.1016/j.cct.2006.10.012; Leaver SK, 2007, BMJ-BRIT MED J, V335, P389, DOI 10.1136/bmj.39293.624699.AD; Lee HS, 2005, ANN THORAC SURG, V79, P405, DOI 10.1016/j.athoracsur.2004.07.079; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MANCILLA J, 1993, INFECT IMMUN, V61, P926, DOI 10.1128/IAI.61.3.926-932.1993; Maxime V, 2005, J INFECT DIS, V191, P138, DOI 10.1086/426401; Meduri GU, 2008, INTENS CARE MED, V34, P61, DOI 10.1007/s00134-007-0933-3; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Meduri GU, 2006, CRIT CARE MED, V34, P236, DOI 10.1097/01.CCM.0000196088.75067.4C; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Moran JL, 2005, INTENS CARE MED, V31, P227, DOI 10.1007/s00134-004-2506-z; NAKANE A, 1988, INFECT IMMUN, V56, P2563, DOI 10.1128/IAI.56.10.2563-2569.1988; National Research Council, 1992, STAT ISS OPP RES; Panageas KS, 2007, J NATL CANCER I, V99, P428, DOI 10.1093/jnci/djk091; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Sampath S, 2007, CRIT CARE MED, V35, P2516, DOI 10.1097/01.CCM.0000284503.88148.6F; SCHEIN RMH, 1987, CHEST, V91, P850, DOI 10.1378/chest.91.6.850; Smith BJ, 2005, BAYESIAN OUTPUT ANAL; Smith BJ, 2005, BAYESIAN OUTPUT ANAL; Smith CT, 2005, J EVAL CLIN PRACT, V11, P468, DOI 10.1111/j.1365-2753.2005.00559.x; Spruance SL, 2004, ANTIMICROB AGENTS CH, V48, P2787, DOI 10.1128/AAC.48.8.2787-2792.2004; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Suter PM, 2006, NEW ENGL J MED, V354, P1739, DOI 10.1056/NEJMe068033; SVENNEVIG JL, 1984, INJURY, V16, P80, DOI 10.1016/S0020-1383(84)80002-9; VANDERMERWE CJ, 1985, S AFR MED J, V67, P279; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; Zotti G C, 1988, Ital J Surg Sci, V18, P369	62	238	264	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2008	336	7651					1006	1009		10.1136/bmj.39537.939039.BE	http://dx.doi.org/10.1136/bmj.39537.939039.BE			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300EZ	18434379	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000255808400044
J	Yamazaki, Y; Sugiura, T; Kurokawa, K				Yamazaki, Yuu; Sugiura, Tomohito; Kurokawa, Katsumi			Sinister hiccups	LANCET			English	Editorial Material							PNEUMONIA		[Yamazaki, Yuu; Sugiura, Tomohito; Kurokawa, Katsumi] Hiroshima City Asa Hosp, Hiroshima, Japan		Yamazaki, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Neurosci & Therapeut, Div Integrated Med Sci,Programs Biomed Res,Minami, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	yuu-y@axel.ocn.ne.jp		Yamazaki, Yu/0000-0002-0806-4960				Burdette SD, 2004, SOUTH MED J, V97, P915, DOI 10.1097/01.SMJ.0000125174.62424.C6; Kahrilas PJ, 1997, GUT, V41, P712, DOI 10.1136/gut.41.5.712; LAUNOIS S, 1993, EUR RESPIR J, V6, P563; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908	4	9	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1550	1550		10.1016/S0140-6736(08)60660-1	http://dx.doi.org/10.1016/S0140-6736(08)60660-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456105				2022-12-28	WOS:000255668300033
J	Freundt, EC; Bidere, N; Lenardo, MJ				Freundt, Eric C.; Bidere, Nicolas; Lenardo, Michael J.			A different TIPE of immune homeostasis	CELL			English	Editorial Material							CELL-DEATH; ACTIVATION; PROLIFERATION; APOPTOSIS; KINASE; MICE	Proteins with death effector domains (DED) are key signal transducers involved in cell death and inflammation. In this issue of Cell, Sun et al. (2008) describe TIPE2, a DED protein that negatively regulates both T cell receptor and Toll-like receptor signaling. These findings reveal a new element critical to the maintenance of homeostasis in both the adaptive and innate immune systems.	[Freundt, Eric C.; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Bidere, Nicolas] Univ Paris 11, Hop Paul Brousse, INSERM, Unite 542, F-94804 Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	mlenardo@nih.gov	Bidère, Nicolas/K-8887-2015	Bidère, Nicolas/0000-0001-9177-0008	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000718-13] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Chugh P, 2005, P NATL ACAD SCI USA, V102, P12885, DOI 10.1073/pnas.0408577102; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Lens SMA, 2002, MOL CELL BIOL, V22, P5419, DOI 10.1128/MCB.22.15.5419-5433.2002; Liu L, 2002, J BIOL CHEM, V277, P13745, DOI 10.1074/jbc.M110480200; Tibbetts MD, 2003, NAT IMMUNOL, V4, P404, DOI 10.1038/ni0503-404; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	8	77	90	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					401	402		10.1016/j.cell.2008.04.017	http://dx.doi.org/10.1016/j.cell.2008.04.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455981	Bronze, Green Accepted			2022-12-28	WOS:000255503900011
J	Schlosshauer, M				Schlosshauer, Maximilian			Lifting the fog from the north	NATURE			English	Editorial Material																			0	2	2	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2008	453	7191					39	39		10.1038/453039a	http://dx.doi.org/10.1038/453039a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451845	Bronze			2022-12-28	WOS:000255398800028
J	Johnson, DL; Johnson, SAS				Johnson, Deborah L.; Johnson, Sandra A. S.			Cell biology - RNA metabolism and oncogenesis	SCIENCE			English	Editorial Material							POLYMERASE-III TRANSCRIPTION; TATA-BINDING PROTEIN; RETINOBLASTOMA PROTEIN; TRANSFORMATION; EXPRESSION; TFIIIB		[Johnson, Deborah L.; Johnson, Sandra A. S.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA	University of Southern California	Johnson, DL (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	johnsond@hsc.usc.edu			NCI NIH HHS [R01 CA074138] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074138] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Crighton D, 2003, EMBO J, V22, P2810, DOI 10.1093/emboj/cdg265; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dieci G, 2007, TRENDS GENET, V23, P614, DOI 10.1016/j.tig.2007.09.001; Felton-Edkins ZA, 2003, EMBO J, V22, P2422, DOI 10.1093/emboj/cdg240; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Larminie CGC, 1997, EMBO J, V16, P2061, DOI 10.1093/emboj/16.8.2061; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; Thumma SC, 2007, CANCER LETT, V258, P1, DOI 10.1016/j.canlet.2007.08.022; Wang HD, 1997, MOL CELL BIOL, V17, P6838, DOI 10.1128/MCB.17.12.6838; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; WOIWODE A, 2008, MOL CELL BIOL; Zhong SP, 2004, MOL CELL BIOL, V24, P5119, DOI 10.1128/MCB.24.12.5119-5129.2004	15	39	39	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					461	462		10.1126/science.1158680	http://dx.doi.org/10.1126/science.1158680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436765				2022-12-28	WOS:000255249300026
J	Whitham, TG; DiFazio, SP; Schweitzer, JA; Shuster, SM; Allan, GJ; Bailey, JK; Woolbright, SA				Whitham, Thomas G.; DiFazio, Stephen P.; Schweitzer, Jennifer A.; Shuster, Stephen M.; Allan, Gery J.; Bailey, Joseph K.; Woolbright, Scott A.			Perspective - Extending genomics to natural communities and ecosystems	SCIENCE			English	Editorial Material							POPULUS-FREMONTII; COTTONWOOD; ANGUSTIFOLIA; CONSEQUENCES; HERITABILITY; RESISTANCE; INSIGHTS; GENETICS; TRAIT	An important step in the integration of ecology and genomics is the progression from molecular studies of relatively simple model systems to complex field systems. The recent availability of sequenced genomes from key plants is leading to a new understanding of the molecular drivers of community composition and ecosystem processes. As genome sequences accumulate for species that form intimate associations in nature, a detailed view may emerge as to how these associations cause changes among species at the nucleotide level. This advance could dramatically alter views about the structure and evolution of communities and ecosystems.	[Whitham, Thomas G.; Shuster, Stephen M.; Allan, Gery J.; Woolbright, Scott A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Whitham, Thomas G.; Shuster, Stephen M.; Allan, Gery J.; Woolbright, Scott A.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [DiFazio, Stephen P.] W Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	Northern Arizona University; Northern Arizona University; West Virginia University; University of Tennessee System; University of Tennessee Knoxville	Whitham, TG (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Thomas.Whitham@nau.edu	Woolbright, Scott/B-4354-2012	Woolbright, Scott/0000-0002-7886-1009; DiFazio, Stephen/0000-0003-4077-1590				Antonovics J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P426; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Bangert RK, 2008, HEREDITY, V100, P121, DOI 10.1038/sj.hdy.6800914; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Freeman JS, 2008, NEW PHYTOL, V178, P846, DOI 10.1111/j.1469-8137.2008.02417.x; Hanley SJ, 2007, TREE GENET GENOMES, V3, P35, DOI 10.1007/s11295-006-0049-x; Harding SA, 2005, TREE PHYSIOL, V25, P1475, DOI 10.1093/treephys/25.12.1475; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; MORAN NA, 1988, EVOLUTION, V42, P717, DOI 10.1111/j.1558-5646.1988.tb02490.x; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Rae AM, 2007, NEW PHYTOL, V175, P59, DOI 10.1111/j.1469-8137.2007.02091.x; Rehill B, 2005, BIOCHEM SYST ECOL, V33, P125, DOI 10.1016/j.bse.2004.06.004; Schweitzer JA, 2004, ECOL LETT, V7, P127, DOI 10.1111/j.1461-0248.2003.00562.x; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Shuster SM, 2006, EVOLUTION, V60, P991, DOI 10.1111/j.0014-3820.2006.tb01177.x; Thompson J.N., 2005, INTERSPEC INTERACT; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Woolbright SA, 2008, HEREDITY, V100, P59, DOI 10.1038/sj.hdy.6801063; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308	24	152	154	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					492	495		10.1126/science.1153918	http://dx.doi.org/10.1126/science.1153918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436780				2022-12-28	WOS:000255249300039
J	Ehrenfeld, E; Glass, RI; Agol, VI; Chumakov, K; Dowdle, W; John, TJ; Katz, SL; Miller, M; Breman, JG; Modlin, J; Wright, P				Ehrenfeld, Ellie; Glass, Roger I.; Agol, Vadim I.; Chumakov, Konstantin; Dowdle, Walter; John, T. Jacob; Katz, Samuel L.; Miller, Mark; Breman, Joel G.; Modlin, John; Wright, Peter			Immunisation against poliomyelitis: moving forward	LANCET			English	Editorial Material							POLIOVIRUS VACCINES		[Glass, Roger I.; Miller, Mark; Breman, Joel G.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Ehrenfeld, Ellie] NIAID, NIH, Bethesda, MD 20892 USA; [Agol, Vadim I.] Inst Poliomyelitis & Viral Encephalitides, Moscow, Russia; [Chumakov, Konstantin] US FDA, PHHS, Rockville, MD 20857 USA; [Dowdle, Walter] Task Force Child Survival & Dev, Atlanta, GA USA; [John, T. Jacob] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Katz, Samuel L.] Duke Univ, Sch Med, Durham, NC USA; [Modlin, John; Wright, Peter] Dartmouth Med Sch, Hanover, NH USA; [Wright, Peter] Vanderbilt Univ Sch Med, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; US Food & Drug Administration (FDA); Christian Medical College & Hospital (CMCH) Vellore; Duke University; Dartmouth College; Vanderbilt University	Glass, RI (corresponding author), NIH, Fogarty Int Ctr, 31 Ctr Dr,MSC 2220, Bethesda, MD 20892 USA.	glassr@mail.nih.gov	Agol, Vadim I./E-1941-2013					Agol VI, 2006, BIOLOGICALS, V34, P103, DOI 10.1016/j.biologicals.2006.02.007; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Asturias EJ, 2007, J INFECT DIS, V196, P692, DOI 10.1086/520546; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; *CDC, 2007, MMWR-MORBID MORTAL W, V56, P996; Cello J, 2002, SCIENCE, V297, P1016, DOI 10.1126/science.1072266; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; *COMM DEV POL ANT, EXPL ROL ANT DRUGS E; Dragunsky EM, 2004, J INFECT DIS, V190, P1404, DOI 10.1086/424524; Fine P E, 2001, Dev Biol (Basel), V105, P129; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Macadam AJ, 2006, J VIROL, V80, P8653, DOI 10.1128/JVI.00370-06; Shulman LM, 2006, ISR MED ASSOC J, V8, P312; Simizu B, 2006, BIOLOGICALS, V34, P151, DOI 10.1016/j.biologicals.2006.02.010; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388	20	18	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1385	1387		10.1016/S0140-6736(08)60597-8	http://dx.doi.org/10.1016/S0140-6736(08)60597-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424327				2022-12-28	WOS:000255208500029
J	Chambers, RG; Gupta, RK; Ghebreyesus, TA				Chambers, Raymond G.; Gupta, Rajat K.; Ghebreyesus, Tedros Adhanom			Responding to the challenge to end malaria deaths in Africa	LANCET			English	Editorial Material									[Gupta, Rajat K.] Global Fund Fight AIDS TB & Malaria, New York, NY 10022 USA; [Chambers, Raymond G.] UN, New York, NY 10017 USA; [Ghebreyesus, Tedros Adhanom] Fed Democrat Republ Ethiopia, Addis Ababa, Ethiopia; [Ghebreyesus, Tedros Adhanom] Roll Back Malaria Partnership, Addis Ababa, Ethiopia		Gupta, RK (corresponding author), Global Fund Fight AIDS TB & Malaria, New York, NY 10022 USA.	rajat_gupta@mckinsey.com						Roll Back Malaria Partnership, 2000, AB DECL PLAN ACT; *WHO, 2008, IMP LONG LAST INS NE; *WORLD BANK, 2006, ETH PROT BAS SERV PR	3	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1399	1401		10.1016/S0140-6736(08)60609-1	http://dx.doi.org/10.1016/S0140-6736(08)60609-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294XW	18440416				2022-12-28	WOS:000255440600009
J	Ziegenfuss, JS; Biswas, R; Avery, MA; Hong, K; Sheehan, AE; Yeung, YG; Stanley, ER; Freeman, MR				Ziegenfuss, Jennifer S.; Biswas, Romi; Avery, Michelle A.; Hong, Kyoungja; Sheehan, Amy E.; Yeung, Yee-Guide; Stanley, E. Richard; Freeman, Marc R.			Draper-dependent glial phagocytic activity is mediated by Src and Syk family kinase signalling	NATURE			English	Article							EMBRYONIC DORSAL CLOSURE; CELL CORPSE ENGULFMENT; APOPTOTIC CELLS; C-ELEGANS; DROSOPHILA METAMORPHOSIS; TYROSINE KINASE; RECEPTOR; PROTEIN; REMOVAL; CED-1	The cellular machinery promoting phagocytosis of corpses of apoptotic cells is well conserved from worms to mammals. An important component is the Caenorhabditis elegans engulfment receptor CED- 1 ( ref. 1) and its Drosophila orthologue, Draper(2). The CED- 1/ Draper signalling pathway is also essential for the phagocytosis of other types of 'modified self' including necrotic cells(3), developmentally pruned axons(4,5) and dendrites(6), and axons undergoing Wallerian degeneration(7). Here we show that Drosophila Shark, a non- receptor tyrosine kinase similar to mammalian Syk and Zap- 70, binds Draper through an immunoreceptor tyrosine- based activation motif ( ITAM) in the Draper intracellular domain. We show that Shark activity is essential for Draper-mediated signalling events in vivo, including the recruitment of glial membranes to severed axons and the phagocytosis of axonal debris and neuronal cell corpses by glia. We also show that the Src family kinase ( SFK) Src42A can markedly increase Draper phosphorylation and is essential for glial phagocytic activity. We propose that ligand- dependent Draper receptor activation initiates the Src42A- dependent tyrosine phosphorylation of Draper, the association of Shark and the activation of the Draper pathway. These Draper - Src42A - Shark interactions are strikingly similar to mammalian immunoreceptor - SFK - Syk signalling events in mammalian myeloid and lymphoid cells(8,9). Thus, Draper seems to be an ancient immunoreceptor with an extracellular domain tuned to modified self, and an intracellular domain promoting phagocytosis through an ITAM- domain - SFK - Syk- mediated signalling cascade.	[Ziegenfuss, Jennifer S.; Avery, Michelle A.; Sheehan, Amy E.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Biswas, Romi; Hong, Kyoungja; Yeung, Yee-Guide; Stanley, E. Richard] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	University of Massachusetts System; University of Massachusetts Worcester; Yeshiva University; Albert Einstein College of Medicine	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	rstanley@aecom.yu.edu; marc.freeman@umassmed.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065; Freeman, Marc/0000-0003-3481-3715	NCI NIH HHS [R37 CA026504-30, 1R01CA26504, R01 CA026504, R37 CA026504] Funding Source: Medline; NIGMS NIH HHS [1R01GM55293] Funding Source: Medline; NINDS NIH HHS [R01 NS053538, 1R01NS053538] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA026504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Biswas R, 2006, DEVELOPMENT, V133, P217, DOI 10.1242/dev.02198; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cox D, 2001, SEMIN IMMUNOL, V13, P339, DOI 10.1006/smim.2001.0330; ELLIS RE, 1991, GENETICS, V129, P79; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fernandez R, 2000, GENE DEV, V14, P604; FERRANTE AW, 1995, P NATL ACAD SCI USA, V92, P1911, DOI 10.1073/pnas.92.6.1911; Fodor S, 2006, IMMUNOL LETT, V104, P29, DOI 10.1016/j.imlet.2005.11.001; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hengartner MO, 1999, RECENT PROG HORM RES, V54, P213; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Keegan K, 1996, ONCOGENE, V12, P1537; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; LI W, 1991, J BIOL CHEM, V266, P6808; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Pitcher LA, 2003, TRENDS IMMUNOL, V24, P554, DOI 10.1016/j.it.2003.08.003; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	32	143	147	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 12	2008	453	7197					935	U68		10.1038/nature06901	http://dx.doi.org/10.1038/nature06901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311WV	18432193	Green Accepted			2022-12-28	WOS:000256632000047
J	Okamura, K; Chung, WJ; Ruby, JG; Guo, HL; Bartel, DP; Lai, EC				Okamura, Katsutomo; Chung, Wei-Jen; Ruby, J. Graham; Guo, Huili; Bartel, David P.; Lai, Eric C.			The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs	NATURE			English	Article							DOUBLE-STRANDED-RNA; PASSENGER-STRAND; DISTINCT ROLES; MICRORNAS; EXPRESSION; GERMLINE; CLEAVAGE; COMPLEXES; DICER-1; PLANTS	In contrast to microRNAs and Piwi- associated RNAs, short interfering RNAs ( siRNAs) are seemingly dispensable for host- directed gene regulation in Drosophila. This notion is based on the fact that mutants lacking the core siRNA- generating enzyme Dicer- 2 or the predominant siRNA effector Argonaute 2 are viable, fertile and of relatively normal morphology(1,2). Moreover, endogenous Drosophila siRNAs have not yet been identified. Here we report that siRNAs derived from long hairpin RNA genes ( hpRNAs) programme Slicer complexes that can repress endogenous target transcripts. The Drosophila hpRNA pathway is a hybrid mechanism that combines canonical RNA interference factors ( Dicer- 2, Hen1 ( known as CG12367) and Argonaute 2) with a canonical microRNA factor ( Loquacious) to generate similar to 21- nucleotide siRNAs. These novel regulatory RNAs reveal unexpected complexity in the sorting of small RNAs, and open a window onto the biological usage of endogenous RNA interference in Drosophila.	[Okamura, Katsutomo; Chung, Wei-Jen; Lai, Eric C.] Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 521, New York, NY 10065 USA; [Ruby, J. Graham; Guo, Huili; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Ruby, J. Graham; Guo, Huili; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ruby, J. Graham; Guo, Huili; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Lai, EC (corresponding author), Sloan Kettering Inst, Dept Dev Biol, Rockefeller Res Labs 521, 1275 York Ave,Box 252, New York, NY 10065 USA.	laie@mskcc.org	Lai, Eric C/A-3412-2008; Lai, Eric/AAO-1143-2021	Lai, Eric/0000-0002-8432-5851; Guo, Huili/0000-0002-2294-5684	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM067031-01, R01 GM083300, R01 GM067031, GM067031, GM083300, R01 GM083300-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, R01GM083300] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Forsyth D, 1907, Q J MED, V1, P287; GHILDIYAL M, 2008, SCIENCE; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Harris PV, 1996, MOL CELL BIOL, V16, P5764; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Liu X, 2007, RNA, V13, P2324, DOI 10.1261/rna.723707; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930	28	287	302	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					803	U8		10.1038/nature07015	http://dx.doi.org/10.1038/nature07015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18463630	Green Accepted			2022-12-28	WOS:000256415300048
J	Vogelzang, NJ				Vogelzang, Nicholas J.			Chemotherapy for malignant pleural mesothelioma	LANCET			English	Editorial Material							LUNG-CANCER; PHASE-III; CISPLATIN		Nevada Canc Inst, Las Vegas, NV 89135 USA	University of California System; University of California San Diego	Vogelzang, NJ (corresponding author), Nevada Canc Inst, Las Vegas, NV 89135 USA.	nvogelzang@nvcancer.org						Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Karrison T, 2007, J CLIN ONCOL, V25; Muers MF, 2008, LANCET, V371, P1685, DOI 10.1016/S0140-6736(08)60727-8; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Steele JPC, 2000, J CLIN ONCOL, V18, P3912, DOI 10.1200/JCO.2000.18.23.3912; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136	7	20	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1640	1642		10.1016/S0140-6736(08)60703-5	http://dx.doi.org/10.1016/S0140-6736(08)60703-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486725				2022-12-28	WOS:000256002200005
J	Harrisingh, MC; Nitabach, MN				Harrisingh, Marie C.; Nitabach, Michael N.			Circadian rhythms - Integrating circadian timekeeping with cellular physiology	SCIENCE			English	Editorial Material							SUPRACHIASMATIC NUCLEUS; KAIC PHOSPHORYLATION; PACEMAKER NEURONS; CLOCK; FEEDBACK; CA2+; ARABIDOPSIS; OSCILLATION		[Harrisingh, Marie C.; Nitabach, Michael N.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Harrisingh, MC (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.	michael.nitabach@yale.edu						Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nomura K, 2003, J NEUROSCI RES, V72, P384, DOI 10.1002/jnr.10581; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Tang RH, 2007, SCIENCE, V315, P1423, DOI 10.1126/science.1134457; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540	15	20	21	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					879	880		10.1126/science.1158619	http://dx.doi.org/10.1126/science.1158619			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487177				2022-12-28	WOS:000255868300025
J	Prakash, M; Quere, D; Bush, JWM				Prakash, Manu; Quere, David; Bush, John W. M.			Surface tension transport of prey by feeding shorebirds: The capillary ratchet	SCIENCE			English	Article							SIZE DIMORPHISM; BEHAVIOR; BILL; PHALAROPES; MORPHOLOGY; VIBRATION; STABILITY; PARALLEL; MOTION; DROPS	The variability of bird beak morphology reflects diverse foraging strategies. One such feeding mechanism in shorebirds involves surface tension-induced transport of prey in millimetric droplets: By repeatedly opening and closing its beak in a tweezering motion, the bird moves the drop from the tip of its beak to its mouth in a stepwise ratcheting fashion. We have analyzed the subtle physical mechanism responsible for drop transport and demonstrated experimentally that the beak geometry and the dynamics of tweezering may be tuned to optimize transport efficiency. We also highlight the critical dependence of the capillary ratchet on the beak's wetting properties, thus making clear the vulnerability of capillary feeders to surface pollutants.	[Prakash, Manu] MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA; [Quere, David] ESPCI, CNRS, UMR 7636, F-75005 Paris, France; [Bush, John W. M.] MIT, Dept Math, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; Massachusetts Institute of Technology (MIT)	Prakash, M (corresponding author), MIT, Ctr Bits & Atoms, 20 Ames St, Cambridge, MA 02139 USA.			Prakash, Manu/0000-0002-8046-8388				Barbosa A, 1999, AUK, V116, P712; Bouasse H., 1924, CAPILLARITE PHENOMEN; BROCHARD F, 1989, LANGMUIR, V5, P432, DOI 10.1021/la00086a025; CHEN TY, 1992, J COLLOID INTERF SCI, V151, P49, DOI 10.1016/0021-9797(92)90237-G; Concus P, 1998, PHYS FLUIDS, V10, P39, DOI 10.1063/1.869547; Daniel S, 2005, LANGMUIR, V21, P4240, DOI 10.1021/la046886s; Daniel S, 2002, LANGMUIR, V18, P3404, DOI 10.1021/la025505c; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; DETTRE R, 1964, ADV CHEM SERIES, V43; DUSSAN EB, 1983, J FLUID MECH, V137, P1, DOI 10.1017/S002211208300227X; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; EPPLEY ZA, 1989, NATURE, V340, P513, DOI 10.1038/340513a0; Estrella SM, 2007, AUK, V124, P1244, DOI 10.1642/0004-8038(2007)124[1244:SPFAOS]2.0.CO;2; Estrella SM, 2007, J EXP BIOL, V210, P3757, DOI 10.1242/jeb.007690; Gennes P.-G.d., 2003, CAPILLARITY WETTING, V2004 ed.; HAUKSBEE F., 1710, PHILOS T, V27, P395, DOI DOI 10.1098/RSTL.1710.0036; Humphries S, 2007, PLOS BIOL, V5, P1647, DOI 10.1371/journal.pbio.0050204; KAMATH YK, 1978, J APPL POLYM SCI, V22, P2295, DOI 10.1002/app.1978.070220821; LOWRY BJ, 1995, P R SOC-MATH PHYS SC, V449, P411, DOI 10.1098/rspa.1995.0051; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; Obst BS, 1996, NATURE, V384, P121, DOI 10.1038/384121a0; Prakash M, 2007, SCIENCE, V315, P832, DOI 10.1126/science.1136907; Rubega MA, 1996, J MORPHOL, V228, P45, DOI 10.1002/(SICI)1097-4687(199604)228:1<45::AID-JMOR4>3.0.CO;2-O; RUBEGA MA, 1993, AUK, V110, P169; Rubega MA, 1997, IBIS, V139, P488, DOI 10.1111/j.1474-919X.1997.tb04663.x; RUBEGA MA, 1993, THESIS U CALIFORNIA; Stephenson R, 1997, ENVIRON CONSERV, V24, P121, DOI 10.1017/S0376892997000180; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; ZWEERS G, 1991, ACTA BIOTHEOR, V39, P15, DOI 10.1007/BF00046405	29	324	336	38	389	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					931	934		10.1126/science.1156023	http://dx.doi.org/10.1126/science.1156023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487193				2022-12-28	WOS:000255868300042
J	Remaut, H; Tang, C; Henderson, NS; Pinkner, JS; Wang, T; Hultgren, SJ; Thanassi, DG; Waksman, G; Li, HL				Remaut, Han; Tang, Chunyan; Henderson, Nadine S.; Pinkner, Jerome S.; Wang, Tao; Hultgren, Scott J.; Thanassi, David G.; Waksman, Gabriel; Li, Huilin			Fiber formation across the bacterial outer membrane by the chaperone/usher pathway	CELL			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; ASSEMBLY PLATFORM FIMD; PILUS BIOGENESIS; STRUCTURAL BASIS; TYPE-1 PILI; SUBUNIT COMPLEXES; CRYSTAL-STRUCTURE; ADHESIN COMPLEX; USHER PATHWAY; DIFFRACTION	Gram-negative pathogens commonly exhibit adhesive pili on their surfaces that mediate specific attachment to the host. A major class of pili is assembled via the chaperone/usher pathway. Here, the structural basis for pilus fiber assembly and secretion performed by the outer membrane assembly platform the usher-is revealed by the crystal structure of the translocation domain of the P pilus usher PapC and single particle cryo-electron microscopy imaging of the FimD usher bound to a translocating type 1 pilus assembly intermediate. These structures provide molecular snapshots of a twinned-pore translocation machinery in action. Unexpectedly, only one pore is used for secretion, while both usher protomers are used for chaperone-subunit complex recruitment. The translocating pore itself comprises 24 beta strands and is occluded by a folded plug domain, likely gated by a conformationally constrained beta-hairpin. These structures capture the secretion of a virulence factor across the outer membrane of Gram-negative bacteria.	[Pinkner, Jerome S.; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Remaut, Han; Waksman, Gabriel] UCL, Inst Struct Mol Sci, London WC1E 7HX, England; [Remaut, Han; Waksman, Gabriel] Birkbeck Coll, Inst Struct Mol Biol, London WC1E 7HX, England; [Tang, Chunyan; Wang, Tao; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Washington University (WUSTL); University of London; University College London; University of London; Birkbeck University London; United States Department of Energy (DOE); Brookhaven National Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu; david.thanassi@stonybrook.edu; g.waksman@mail.cryst.bbk.ac.uk; hli@bnl.gov	Tang, Chunyan/E-8352-2010	Pinkner, Jerome/0000-0002-7389-7440; Remaut, Han/0000-0002-9775-4102; Li, Huilin/0000-0001-8085-8928	Medical Research Council [58149, G0800002] Funding Source: Medline; NIAID NIH HHS [R37 AI048689, AI049950, R37 AI029549, R01 AI029549, R01 AI049950, R01 AI048689-08, AI48689, AI029549, R01 AI048689] Funding Source: Medline; NIGMS NIH HHS [GM062987, R01 GM062987, GM074985, R01 GM074985] Funding Source: Medline; MRC [G0800002] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689, R37AI029549, R01AI049950, R01AI029549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985, R01GM062987] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bann JG, 2004, P NATL ACAD SCI USA, V101, P17389, DOI 10.1073/pnas.0408072101; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Capitani G, 2006, PROTEINS, V65, P816, DOI 10.1002/prot.21147; *CCP4 SUIT, 1994, COMPUTATIONAL PROJ D, V50, P760; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dodson KW, 2001, CELL, V105, P733, DOI 10.1016/S0092-8674(01)00388-9; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 2006, 3 DIMENSIONAL ELECT; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knight S, 1997, ACTA CRYSTALLOGR D, V53, P207, DOI 10.1107/S0907444996011511; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Li HL, 2004, J MOL BIOL, V344, P1397, DOI 10.1016/j.jmb.2004.10.008; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Thanassi DG, 2002, J BACTERIOL, V184, P6260, DOI 10.1128/JB.184.22.6260-6269.2002; Topf M, 2005, J STRUCT BIOL, V149, P191, DOI 10.1016/j.jsb.2004.11.004; Verger D, 2007, PLOS PATHOG, V3, P674, DOI 10.1371/journal.ppat.0030073; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	45	173	176	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					640	652		10.1016/j.cell.2008.03.033	http://dx.doi.org/10.1016/j.cell.2008.03.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485872	Bronze, Green Accepted			2022-12-28	WOS:000255903300019
J	Chidgey, AP; Layton, D; Trounson, A; Boyd, RL				Chidgey, Ann P.; Layton, Daniel; Trounson, Alan; Boyd, Richard L.			Tolerance strategies for stem-cell-based therapies	NATURE			English	Review							REGULATORY T-CELLS; KERATINOCYTE GROWTH-FACTOR; PROMISCUOUS GENE-EXPRESSION; MARROW STROMAL CELLS; IMMUNE RECONSTITUTION; DENDRITIC CELLS; EPITHELIAL-CELLS; DIFFERENTIATION; TRANSPLANTATION; REGENERATION	There is much interest in using embryonic stem cells to regenerate tissues and organs. For this approach to succeed, these stem cells or their derivatives must engraft in patients over the long term. Unless a cell transplant is derived from the patient's own cells, however, the cells will be targeted for rejection by the immune system. Although standard methods for suppressing the immune system achieve some success, rejection of the transplant is inevitable. Emerging approaches to address this issue include 're-educating' the immune system to induce tolerance to foreign cells and reducing the immune targeting of the transplant by administering 'self stem cells' instead of foreign cells, but each of these approaches has associated challenges.	[Chidgey, Ann P.; Layton, Daniel; Trounson, Alan; Boyd, Richard L.] Monash Univ, Monash Immunol & Stem Cell Labs, STRIP, Clayton, Vic 3800, Australia	Monash University	Chidgey, AP (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, STRIP, Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia.	ann.chidgey@med.monash.edu.au	Layton, Danie/E-1629-2013; Layton, Daniel S/J-6117-2017; Chidgey, Ann P/I-2737-2014	Chidgey, Ann P/0000-0001-7442-6125; Trounson, Alan/0000-0001-5469-0500				Alexander SI, 2008, NEW ENGL J MED, V358, P369, DOI 10.1056/NEJMoa0707255; Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; BAO S, 1990, IMMUNOL CELL BIOL, V68, P235, DOI 10.1038/icb.1990.33; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Burt RK, 2004, J EXP MED, V199, P895, DOI 10.1084/jem.20031916; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Drukker M, 2004, TRENDS BIOTECHNOL, V22, P136, DOI 10.1016/j.tibtech.2004.01.003; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Fandrich F, 2002, NAT MED, V8, P171, DOI 10.1038/nm0202-171; Flores KG, 1999, J CLIN INVEST, V104, P1031, DOI 10.1172/JCI7558; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; French AJ, 2006, STEM CELL REV, V2, P265, DOI 10.1007/BF02698053; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gabler J, 2007, EUR J IMMUNOL, V37, P3363, DOI 10.1002/eji.200737131; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Goldberg GL, 2007, J IMMUNOL, V178, P7473, DOI 10.4049/jimmunol.178.11.7473; Goldberg GL, 2005, TRANSPLANTATION, V80, P1604, DOI 10.1097/01.tp.0000183962.64777.da; GOULBURN A, 2008, CELL THERAPY, P169; GREENSTEIN BD, 1987, J ENDOCRINOL, V112, P345, DOI 10.1677/joe.0.1120345; Grinnemo KH, 2006, REPROD BIOMED ONLINE, V13, P712, DOI 10.1016/S1472-6483(10)60663-3; GUERETTE B, 1994, TRANSPLANT P, V26, P3461; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Hince M, 2008, CELL IMMUNOL, V252, P122, DOI 10.1016/j.cellimm.2007.10.007; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; ILDSTAD ST, 1985, J EXP MED, V162, P231, DOI 10.1084/jem.162.1.231; ILDSTAD ST, 1984, NATURE, V307, P168, DOI 10.1038/307168a0; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lee K, 2004, J IMMUNOL, V172, P6539, DOI 10.4049/jimmunol.172.11.6539; Li L, 2004, STEM CELLS, V22, P448, DOI 10.1634/stemcells.22-4-448; MANTEGAZZA R, 1991, NEUROLOGY, V41, P1128, DOI 10.1212/WNL.41.7.1128; MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7; McLaren FH, 2001, J NEUROIMMUNOL, V112, P35, DOI 10.1016/S0165-5728(00)00410-0; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Min DL, 2002, BLOOD, V99, P4592, DOI 10.1182/blood.V99.12.4592; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; Okamoto Y, 2002, BLOOD, V99, P2851, DOI 10.1182/blood.V99.8.2851; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olsen NJ, 2001, IMMUNOL RES, V23, P281, DOI 10.1385/IR:23:2-3:281; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Romieu-Mourez R, 2007, J IMMUNOL, V179, P1549, DOI 10.4049/jimmunol.179.3.1549; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Rossi SW, 2007, BLOOD, V109, P3803, DOI 10.1182/blood-2006-10-049767; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Seggewiss R, 2007, BLOOD, V110, P441, DOI 10.1182/blood-2006-12-065623; Simpson E, 2001, EUR J IMMUNOGENET, V28, P505, DOI 10.1046/j.0960-7420.2001.00252.x; Spence PJ, 2008, P NATL ACAD SCI USA, V105, P973, DOI 10.1073/pnas.0709071105; Sutherland JS, 2008, CLIN CANCER RES, V14, P1138, DOI 10.1158/1078-0432.CCR-07-1784; Sutherland JS, 2005, J IMMUNOL, V175, P2741, DOI 10.4049/jimmunol.175.4.2741; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; TREMBLAY JP, 1993, CELL TRANSPLANT, V2, P99, DOI 10.1177/096368979300200203; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Verda L, 2008, STEM CELLS, V26, P381, DOI 10.1634/stemcells.2006-0262; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wils EJ, 2007, J IMMUNOL, V178, P3551, DOI 10.4049/jimmunol.178.6.3551; WONG GHW, 1984, NATURE, V310, P688, DOI 10.1038/310688a0; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhan XC, 2004, LANCET, V364, P163, DOI 10.1016/S0140-6736(04)16629-4; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	87	87	91	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					330	337		10.1038/nature07041	http://dx.doi.org/10.1038/nature07041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480814				2022-12-28	WOS:000255868400040
J	Maeda, K; Henbest, KB; Cintolesi, F; Kuprov, I; Rodgers, CT; Liddell, PA; Gust, D; Timmel, CR; Hore, PJ				Maeda, Kiminori; Henbest, Kevin B.; Cintolesi, Filippo; Kuprov, Ilya; Rodgers, Christopher T.; Liddell, Paul A.; Gust, Devens; Timmel, Christiane R.; Hore, P. J.			Chemical compass model of avian magnetoreception	NATURE			English	Article							RADICAL-PAIR MECHANISM; WEAK MAGNETIC-FIELDS; ARABIDOPSIS-THALIANA; CHARGE SEPARATION; EPR SPECTROSCOPY; MIGRATORY BIRDS; EUROPEAN ROBINS; RECOMBINATION; CRYPTOCHROME; ORIENTATION	Approximately 50 species, including birds, mammals, reptiles, amphibians, fish, crustaceans and insects, are known to use the Earth's magnetic field for orientation and navigation(1). Birds in particular have been intensively studied, but the biophysical mechanisms that underlie the avian magnetic compass are still poorly understood. One proposal, based on magnetically sensitive free radical reactions(2,3), is gaining support(4-11) despite the fact that no chemical reaction in vitro has been shown to respond to magnetic fields as weak as the Earth's (similar to 50 mu T) or to be sensitive to the direction of such a field. Here we use spectroscopic observation of a carotenoid-porphyrin-fullerene model system to demonstrate that the lifetime of a photochemically formed radical pair is changed by application of <= 50 mu T magnetic fields, and to measure the anisotropic chemical response that is essential for its operation as a chemical compass sensor. These experiments establish the feasibility of chemical magnetoreception and give insight into the structural and dynamic design features required for optimal detection of the direction of the Earth's magnetic field.	[Cintolesi, Filippo; Kuprov, Ilya; Rodgers, Christopher T.; Hore, P. J.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Maeda, Kiminori; Henbest, Kevin B.; Timmel, Christiane R.] Univ Oxford, Inorgan Chem Lab, Dept Chem, Oxford OX1 3QR, England; [Liddell, Paul A.; Gust, Devens] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA	University of Oxford; University of Oxford; Arizona State University; Arizona State University-Tempe	Hore, PJ (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, S Parks Rd, Oxford OX1 3QZ, England.	christiane.timmel@chem.ox.ac.uk; peter.hore@chem.ox.ac.uk	Rodgers, Christopher T./AAD-3344-2019; Timmel, Christiane/GLU-4087-2022; Maeda, Kiminori/A-3500-2012; Hore, Peter/R-1923-2017	Rodgers, Christopher T./0000-0003-1275-1197; Hore, Peter/0000-0002-8863-570X; Timmel, Christiane/0000-0003-1828-7700	Engineering and Physical Sciences Research Council [EP/D048559/1, GR/T05424/01, EP/F065205/1] Funding Source: researchfish; EPSRC [EP/D048559/1, EP/F065205/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahmad M, 2007, PLANTA, V225, P615, DOI 10.1007/s00425-006-0383-0; Brocklehurst B, 2002, CHEM SOC REV, V31, P301, DOI 10.1039/b107250c; Buchachenko AL, 2005, P NATL ACAD SCI USA, V102, P10793, DOI 10.1073/pnas.0504876102; Cintolesi F, 2003, CHEM PHYS, V294, P385, DOI 10.1016/S0301-0104(03)00320-3; Efimova O, 2008, BIOPHYS J, V94, P1565, DOI 10.1529/biophysj.107.119362; Henbest KB, 2004, J AM CHEM SOC, V126, P8102, DOI 10.1021/ja048220q; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kodis G, 2004, J PHYS ORG CHEM, V17, P724, DOI 10.1002/poc.787; Kuciauskas D, 1998, J AM CHEM SOC, V120, P10880, DOI 10.1021/ja981848e; Liddell PA, 1997, J AM CHEM SOC, V119, P1400, DOI 10.1021/ja9631054; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Poluektov OG, 2005, J AM CHEM SOC, V127, P11910, DOI 10.1021/ja053315t; Prabhakar R, 2002, J PHYS CHEM B, V106, P3742, DOI 10.1021/jp014013q; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rodgers CT, 2007, J AM CHEM SOC, V129, P6746, DOI 10.1021/ja068209l; Rodgers CT, 2005, J PHYS CHEM A, V109, P5035, DOI 10.1021/jp050765z; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Solov'yov IA, 2007, BIOPHYS J, V92, P2711, DOI 10.1529/biophysj.106.097139; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; Timmel CR, 1998, MOL PHYS, V95, P71, DOI 10.1080/00268979809483134; Timmel CR, 2004, PHILOS T ROY SOC A, V362, P2573, DOI 10.1098/rsta.2004.1459; van Dijk B, 1998, J PHYS CHEM B, V102, P464, DOI 10.1021/jp9721816; Wang K, 2006, PHYS BIOL, V3, P220, DOI 10.1088/1478-3975/3/3/007; Weaver JC, 2000, NATURE, V405, P707, DOI 10.1038/35015128; Weber S, 2005, BBA-BIOENERGETICS, V1707, P1, DOI 10.1016/j.bbabio.2004.02.010; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko W, 2001, J EXP BIOL, V204, P3295	29	357	362	10	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					387	U38		10.1038/nature06834	http://dx.doi.org/10.1038/nature06834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18449197				2022-12-28	WOS:000255868400051
J	Pronovost, PJ; Goeschel, CA; Wachter, RM				Pronovost, Peter J.; Goeschel, Christine A.; Wachter, Robert M.			The wisdom and justice of not paying for "preventable complications"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL-CARE; PERFORMANCE; INFECTIONS; TRAUMA; RATES		[Pronovost, Peter J.; Goeschel, Christine A.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Goeschel, Christine A.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA; [Wachter, Robert M.] Univ Calif San Francisco, Div Hosp Med, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco	Pronovost, PJ (corresponding author), Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, 1909T Hames St,2nd Floor, Baltimore, MD 21231 USA.	ppronov1@jhmi.edu	Goeschel, Christine/AAA-6783-2020					Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Haut ER, 2007, J TRAUMA, V63, P1132, DOI 10.1097/TA.0b013e31814856ad; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; Klompas M, 2007, ANN INTERN MED, V147, P803, DOI 10.7326/0003-4819-147-11-200712040-00013; Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Swoboda Sandra M, 2006, Surg Infect (Larchmt), V7, P331, DOI 10.1089/sur.2006.7.331; Wachter RM, 2008, JT COMM J QUAL PATIE, V34, P116, DOI 10.1016/S1553-7250(08)34014-8; Wald HL, 2007, JAMA-J AM MED ASSOC, V298, P2782, DOI 10.1001/jama.298.23.2782; Zhan CL, 2007, JT COMM J QUAL PATIE, V33, P326, DOI 10.1016/S1553-7250(07)33037-7	14	106	106	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2197	2199		10.1001/jama.299.18.2197	http://dx.doi.org/10.1001/jama.299.18.2197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477787				2022-12-28	WOS:000255790000028
J	England, R				England, Roger			The writing is on the wall for UNAIDS	BRITISH MEDICAL JOURNAL			English	Editorial Material												roger.england@healthsystemsworkshop.org							0	54	54	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1072	1072		10.1136/bmj.39569.497708.94	http://dx.doi.org/10.1136/bmj.39569.497708.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	304IN	18467417	Green Published			2022-12-28	WOS:000256103300034
J	Jahn, A; Floyd, S; Crampin, AC; Mwaungulu, F; Mvula, H; Munthali, F; McGrath, N; Mwafilaso, J; Mwinuka, V; Mangongo, B; Fine, PEM; Zaba, B; Glynn, JR				Jahn, Andreas; Floyd, Sian; Crampin, Amelia C.; Mwaungulu, Frank; Mvula, Hazzie; Munthali, Fipson; McGrath, Nuala; Mwafilaso, Johnbosco; Mwinuka, Venance; Mangongo, Bernard; Fine, Paul E. M.; Zaba, Basia; Glynn, Judith R.			Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi	LANCET			English	Article							KARONGA DISTRICT; SOUTH-AFRICA; PREVALENCE; LEPROSY; EPIDEMIC; IMPACT	Background Malawi, which has about 80000 deaths from AIDS every year, made free antiretroviral therapy available to more than 80000 patients between 2004 and 2006. We aimed to investigate mortality in a population before and after the introduction of free antiretroviral therapy, and therefore to assess the effects of such programmes on survival at the population level. Methods We used a demographic surveillance system to measure mortality in a population of 32 000 in northern Malawi, from August, 2002, when free antiretroviral therapy was not available in the study district, until February, 2006, 8 months after a clinic opened. Causes of death were established through verbal autopsies (retrospective interviews). Patients who registered for antiretroviral therapy at the clinic were identified and linked to the population under surveillance. Trends in mortality were analysed by age, sex, cause of death, and zone of residence. Findings Before antiretroviral therapy became available in June, 2005, mortality in adults (aged 15-59 years) was 9.8 deaths for 1000 person-years of observation (95% CI 8.9-10.9). The probability of dying between the ages of 15 and 60 years was 43% (39-49) for men and 43% (38-47) for women; 229 of 352 deaths (65 . 1%) were attributed to AIDS. 8 months after the clinic that provided antiretroviral therapy opened, 107 adults from the study population had accessed treatment, out of an estimated 334 in need of treatment. Overall mortality in adults had decreased by 10% from 10 . 2 to 8.7 deaths for 1000 person-years of observation (adjusted rate ratio 0 . 90, 95% Cl 0 . 70-1.14). Mortality was reduced by 35% (adjusted rate ratio 0 . 65, 0.46.0 . 92) in adults near the main road, where mortality before antiretroviral therapy was highest (from 13.2 to 8.5 deaths per 1000 person-years of observation before and after antiretroviral therapy). Mortality in adults aged 60 years or older did not change. Interpretation Our findings of a reduction in mortality in adults aged between 15 and 59 years, with no change in those older than 60 years, suggests that deaths from AIDS were averted by the rapid scale-up of free antiretroviral therapy in rural Malawi, which led to a decline in adult mortality that was detectable at the population level. Funding Wellcome Trust and British Leprosy Relief Association.	[Jahn, Andreas; Floyd, Sian; Crampin, Amelia C.; McGrath, Nuala; Fine, Paul E. M.; Zaba, Basia; Glynn, Judith R.] Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; [Mwaungulu, Frank; Mvula, Hazzie; Munthali, Fipson; Mwafilaso, Johnbosco; Mwinuka, Venance; Mangongo, Bernard] Karonga Prevent Study, Karonga, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Jahn, A (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.	andreas.jahn@lshtm.ac.uk	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [075886, 079828] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Blacker J, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200406002-00003; BLACKER J, 1997, HLTH T REV S2, V7, P45; BOERMA JT, 1998, AIDS S1, V12, P3; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chan KCW, 2006, HIV MED, V7, P186, DOI 10.1111/j.1468-1293.2006.00352.x; CHIMZIZI R, 2003, REPORT COUNTRY WIDE; CHIPETA J, 2005, MALAWI DEMOGRAPHIC H, P225; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; FINE PEM, 1988, T ROY SOC TROP MED H, V82, P810, DOI 10.1016/0035-9203(88)90003-X; FINE PEM, 1986, LANCET, V2, P499, DOI 10.1016/S0140-6736(86)90367-3; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; *INDEPTH NETW, 2003, INDEPTH STAND VERB A; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kamali A, 1996, INT J EPIDEMIOL, V25, P679, DOI 10.1093/ije/25.3.679; Libamba E, 2006, B WORLD HEALTH ORGAN, V84, P320; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; *MAL NAT AIDS COMM, 2003, NAT EST HIV AIDS MAL; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; *MIN HLTH POP, 2007, ART PUBL SECT MAL RE; *MIN HTH POP, 2007, ART PUBL SECT MAL RE; *NAT STAT OFF, 2005, INT HOUS SURV 2004 2, V1, P73; NGOM P, 2003, WORKSH HIV AIDS AD M; PONNIGHAUS JM, 1988, LEPROSY REV, V59, P97; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; SANKOH O, 2002, POPULATION HLTH DEV, P356; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; UNAIDS/WHO, 2006, 2006 REP GLOB AIDS E; *UNAIDS WHO, 2006, ANN 1 COUNTR PROF 20, P412; Urassa M, 2001, AIDS, V15, P2017, DOI 10.1097/00002030-200110190-00015; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; Whiting DR, 2006, B WORLD HEALTH ORGAN, V84, P940, DOI 10.2471/BLT.05.028910; Zaba B, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200406002-00001	40	187	188	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1603	1611		10.1016/S0140-6736(08)60693-5	http://dx.doi.org/10.1016/S0140-6736(08)60693-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468544	Green Published, Green Accepted			2022-12-28	WOS:000255715400028
J	Sekhri, N; Timmis, A; Chen, RL; Junghans, C; Walsh, N; Zaman, J; Eldridge, S; Hemingway, H; Feder, G				Sekhri, Neha; Timmis, Adam; Chen, Ruoling; Junghans, Cornelia; Walsh, Niamh; Zaman, Justin; Eldridge, Sandra; Hemingway, Harry; Feder, Gene			Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary angiography for suspected stable angina pectoris	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; CHEST-PAIN; CARDIAC-CATHETERIZATION; ETHNIC-DIFFERENCES; SEX-DIFFERENCES; REVASCULARIZATION; MANAGEMENT; DISPARITIES; GENDER; RACE	Objectives To determine whether coronary angiography for suspected stable angina pectoris is underused in older patients, women, south Asian patients, and those from socioeconomically deprived areas, and, if it is, whether this is associated with higher coronary event rates. Design Multicentre cohort with five year follow-up. Setting Six ambulatory care clinics in England. Participants 1375 consecutive patients in whom coronary angiography was individually rated-as appropriate with the Rand consensus method. Main outcome measures Receipt of angiography (420 procedures); coronary mortality and acute coronary syndrome events. Results In a multivariable analysis, angiography,was less likely to be performed in patients aged over 64 compared with those aged under 50 (hazard ratio 0.60, 95% confidence interval 0.38 to 0.96), women compared with men (0.42, 0.35 to 0.50), south Asians compared with white people (0.48, 0.34 to 0.67), and patients in the most deprived fifth compared with the other four fifths (0.66, 0.40 to 1.08). Not undergoing angiography when it was deemed appropriate was associated with higher rates of coronary event. Conclusions At an early stage after presentation with suspected angina, coronary angiography is underused in older people, women, south Asians, and people from deprived areas. Not receiving appropriate angiography was associated with a higher risk of coronary events in all groups. Interventions based on clinical guidance that supports individualised management decisions might improve access and outcomes.	[Feder, Gene] Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS8 2AA, Avon, England; [Sekhri, Neha; Timmis, Adam] Barts & London NHS Trust, Cardiac Directorate, London, England; [Chen, Ruoling; Junghans, Cornelia; Zaman, Justin; Hemingway, Harry] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London W1N 8AA, England; [Walsh, Niamh; Eldridge, Sandra] Univ London, Ctr Hlth Sci, Barts & London Queen Marys Sch Med & Dent, London E1 4NS, England	University of Bristol; Barts Health NHS Trust; University of London; University College London; UCL Medical School; University of London; Queen Mary University London	Feder, G (corresponding author), Univ Bristol, Acad Unit Primary Hlth Care, Bristol BS8 2AA, Avon, England.	gene.feder@bristol.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; Chen, Ruoling/0000-0002-3033-8753; Feder, Gene/0000-0002-7890-3926; Junghans, Cornelia/0000-0002-0663-3090				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 1995, J Clin Epidemiol, V48, P1441; Bhopal R, 1998, AM J PUBLIC HEALTH, V88, P1303, DOI 10.2105/AJPH.88.9.1303; Bond Matthew, 2003, J Health Serv Res Policy, V8, P40, DOI 10.1258/13558190360468218; Bowling A, 2001, HEART, V85, P680, DOI 10.1136/heart.85.6.680; Britton A, 2004, BMJ-BRIT MED J, V329, P318, DOI 10.1136/bmj.38156.690150.AE; Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; Chen J, 2001, NEW ENGL J MED, V344, P1443, DOI 10.1056/NEJM200105103441906; Daly C, 2006, CIRCULATION, V113, P490, DOI 10.1161/CIRCULATIONAHA.105.561647; Department of Health, 1997, NEW NHS MOD DEP; Epstein AM, 2003, MED CARE, V41, P1240, DOI 10.1097/01.MLR.0000093423.38746.8C; Feder G, 2002, BRIT MED J, V324, P511, DOI 10.1136/bmj.324.7336.511; Harding S, 2008, HEART, V94, P463, DOI 10.1136/hrt.2007.122044; Heidenreich PA, 2002, AM J MED, V113, P200, DOI 10.1016/S0002-9343(02)01221-4; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hippisley-Cox J, 2000, BRIT J GEN PRACT, V50, P449; *I COMM HLTH SCI R, 2001, SYST REV ACC UPT HLT; Jones M, 2004, BRIT J GEN PRACT, V54, P423; Junghans C, 2007, ARCH INTERN MED, V167, P195, DOI 10.1001/archinte.167.2.195; Lurie N, 2005, NEW ENGL J MED, V353, P727, DOI 10.1056/NEJMe058143; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; Morris RW, 2005, HEART, V91, P635, DOI 10.1136/hrt.2004.037507; Murphy NF, 2006, HEART, V92, P1047, DOI 10.1136/hrt.2005.069419; Rathore SS, 2002, ANN INTERN MED, V137, P487, DOI 10.7326/0003-4819-137-6-200209170-00008; Ray S, 1998, J ROY COLL PHYS LOND, V32, P420; Redberg RF, 2005, J AM COLL CARDIOL, V46, P1852, DOI 10.1016/j.jacc.2005.07.043; Sekhri N, 2007, HEART, V93, P458, DOI 10.1136/hrt.2006.090894; Sekhri N, 2006, QJM-INT J MED, V99, P135, DOI 10.1093/qjmed/hcl013; Somerville C, 2008, SOC SCI MED, V66, P1497, DOI 10.1016/j.socscimed.2007.12.010; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; TAYLOR GL, 2007, HEART           1004; Tenkorang JN, 2006, HEART, V92, P1084, DOI 10.1136/hrt.2005.079376; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341	35	39	39	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2008	336	7652					1058	+		10.1136/bmj.39534.571042.BE	http://dx.doi.org/10.1136/bmj.39534.571042.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18436918	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000256103300030
J	Drin, G; Morello, V; Casella, JF; Gounon, P; Antonny, B				Drin, Guillaume; Morello, Vincent; Casella, Jean-Francois; Gounon, Pierre; Antonny, Bruno			Asymmetric tethering of flat and curved lipid membranes by a golgin	SCIENCE			English	Article							CIS-GOLGI; RETROGRADE TRANSPORT; ARF-GAP; CURVATURE; APPARATUS; VESICLES; DOMAINS; PROTEINS; MOTIF; ER	Golgins, long stringlike proteins, tether cisternae and transport vesicles at the Golgi apparatus. We examined the attachment of golgin GMAP-210 to lipid membranes. GMAP- 210 connected highly curved liposomes to flatter ones. This asymmetric tethering relied on motifs that sensed membrane curvature both in the N terminus of GMAP- 210 and in ArfGAP1, which controlled the interaction of the C terminus of GMAP- 210 with the small guanine nucleotide-binding protein Arf1. Because membrane curvature constantly changes during vesicular trafficking, this mode of tethering suggests a way to maintain the Golgi architecture without compromising membrane flow.	[Drin, Guillaume; Morello, Vincent; Casella, Jean-Francois; Antonny, Bruno] Univ Nice, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Drin, Guillaume; Morello, Vincent; Casella, Jean-Francois; Antonny, Bruno] CNRS, F-06560 Valbonne, France; [Gounon, Pierre] Ctr Commun Microscopie Appl, F-06108 Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Antonny, B (corresponding author), Univ Nice, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; DRIN, Guillaume/0000-0002-3484-4581				Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Chan YHM, 2007, P NATL ACAD SCI USA, V104, P18913, DOI 10.1073/pnas.0706114104; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088; Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x; Liu YW, 2005, MOL BIOL CELL, V16, P4024, DOI 10.1091/mbc.E05-01-0023; Lu L, 2006, TRAFFIC, V7, P1399, DOI 10.1111/j.1600-0854.2006.00473.x; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pernet-Gallay K, 2002, TRAFFIC, V3, P822, DOI 10.1034/j.1600-0854.2002.31107.x; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Rios RM, 2004, CELL, V118, P323; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001	22	139	140	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					670	673		10.1126/science.1155821	http://dx.doi.org/10.1126/science.1155821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451304				2022-12-28	WOS:000255454300048
J	Mili, S; Moissoglu, K; Macara, IG				Mili, Stavroula; Moissoglu, Konstadinos; Macara, Ian G.			Genome-wide screen reveals APC-associated RNAs enriched in cell protrusions	NATURE			English	Article							ADENOMATOUS POLYPOSIS-COLI; ACTIN MESSENGER-RNA; DROSOPHILA OOCYTES; F-ACTIN; LOCALIZATION; MIGRATION; MICROTUBULES; OSKAR; TRANSPORT; MEMBRANE	RNA localization is important for the establishment and maintenance of polarity in multiple cell types. Localized RNAs are usually transported along microtubules or actin filaments(1) and become anchored at their destination to some underlying subcellular structure. Retention commonly involves actin or actin- associated proteins(2-7), although cytokeratin filaments and dynein anchor certain RNAs8,9. RNA localization is important for diverse processes ranging from cell fate determination to synaptic plasticity; however, so far there have been few comprehensive studies of localized RNAs in mammalian cells. Here we have addressed this issue, focusing on migrating fibroblasts that polarize to form a leading edge and a tail in a process that involves asymmetric distribution of RNAs10-12. We used a fractionation scheme(13) combined with microarrays to identify, on a genome- wide scale, RNAs that localize in protruding pseudopodia of mouse fibroblasts in response to migratory stimuli. We find that a diverse group of RNAs accumulates in such pseudopodial protrusions. Through their 39 untranslated regions these transcripts are anchored in granules concentrated at the plus ends of detyrosinated microtubules. RNAs in the granules associate with the adenomatous polyposis coli ( APC) tumour suppressor and the fragile X mental retardation protein ( FMRP). APC is required for the accumulation of transcripts in protrusions. Our results suggest a new type of RNA anchoring mechanism as well as a new, unanticipated function for APC in localizing RNAs.	[Mili, Stavroula; Macara, Ian G.] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Moissoglu, Konstadinos] Univ Virginia, Hlth Sci Ctr, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Macara, IG (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	sm2ju@virginia.edu; igm9c@virginia.edu	Mili, Stavroula/AAI-7076-2021	Mili, Stavroula/0000-0002-9161-8660; Moissoglu, Konstadinos/0000-0001-7211-4320	NIGMS NIH HHS [R01 GM070902-05, R01 GM070902] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070902] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Alarcon VB, 2001, J CELL SCI, V114, P1731; Babu K, 2004, GENE DEV, V18, P138, DOI 10.1101/gad.282604; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blower MD, 2007, J CELL BIOL, V179, P1365, DOI 10.1083/jcb.200705163; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Condeelis J, 2005, BIOL CELL, V97, P97; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Infante AS, 2000, J CELL SCI, V113, P3907; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jankovics F, 2002, CURR BIOL, V12, P2060, DOI 10.1016/S0960-9822(02)01256-3; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Liu G, 2002, MOL BIOL CELL, V13, P579, DOI 10.1091/mbc.01-03-0140; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160	30	210	213	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					115	+		10.1038/nature06888	http://dx.doi.org/10.1038/nature06888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451862	Green Accepted			2022-12-28	WOS:000255398800050
J	Strukov, DB; Snider, GS; Stewart, DR; Williams, RS				Strukov, Dmitri B.; Snider, Gregory S.; Stewart, Duncan R.; Williams, R. Stanley			The missing memristor found	NATURE			English	Article							MEMORY; RESISTANCE; REDUCTION	Anyone who ever took an electronics laboratory class will be familiar with the fundamental passive circuit elements: the resistor, the capacitor and the inductor. However, in 1971 Leon Chua reasoned from symmetry arguments that there should be a fourth fundamental element, which he called a memristor ( short for memory resistor)(1). Although he showed that such an element has many interesting and valuable circuit properties, until now no one has presented either a useful physical model or an example of a memristor. Here we show, using a simple analytical example, that memristance arises naturally in nanoscale systems in which solid- state electronic and ionic transport are coupled under an external bias voltage. These results serve as the foundation for understanding a wide range of hysteretic current - voltage behaviour observed in many nanoscale electronic devices(2-19) that involve the motion of charged atomic or molecular species, in particular certain titanium dioxide cross- point switches(20-22).	[Strukov, Dmitri B.; Snider, Gregory S.; Stewart, Duncan R.; Williams, R. Stanley] HP Labs, Palo Alto, CA 94304 USA	Hewlett-Packard	Williams, RS (corresponding author), HP Labs, 1501 Page Mill Rd, Palo Alto, CA 94304 USA.	stan.williams@hp.com	Strukov, Dmitri B/B-2689-2009; Williams, R. Stanley/A-8281-2009	Williams, R. Stanley/0000-0003-0213-4259; , Dmitri/0000-0002-4526-4347				Beck A, 2000, APPL PHYS LETT, V77, P139, DOI 10.1063/1.126902; Blackstock JJ, 2007, J PHYS CHEM C, V111, P16, DOI 10.1021/jp066266v; BLANC J, 1971, PHYS REV B, V4, P3548, DOI 10.1103/PhysRevB.4.3548; CHUA LO, 1976, P IEEE, V64, P209, DOI 10.1109/PROC.1976.10092; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Collier CP, 2000, SCIENCE, V289, P1172, DOI 10.1126/science.289.5482.1172; DEARNALEY G, 1970, REP PROG PHYS, V33, P1129, DOI 10.1088/0034-4885/33/3/306; Dietrich S, 2007, IEEE J SOLID-ST CIRC, V42, P839, DOI 10.1109/JSSC.2007.892207; Hamaguchi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193328; HICKMOTT TW, 1962, J APPL PHYS, V33, P2669, DOI 10.1063/1.1702530; Jameson JR, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769961; Jeong DS, 2007, ELECTROCHEM SOLID ST, V10, pG51, DOI 10.1149/1.2742989; Kozicki MN, 2005, IEEE T NANOTECHNOL, V4, P331, DOI 10.1109/TNANO.2005.846936; Kuekes PJ, 2005, SCI AM, V293, P72, DOI 10.1038/scientificamerican1105-72; Lai QX, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191874; Oligschlaeger R, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2162860; Richter CA, 2005, APPL PHYS A-MATER, V80, P1355, DOI 10.1007/s00339-004-3169-x; Sawa A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211147; Scott JC, 2007, ADV MATER, V19, P1452, DOI 10.1002/adma.200602564; Smits JHA, 2005, ADV MATER, V17, P1169, DOI 10.1002/adma.200401534; Stewart DR, 2004, NANO LETT, V4, P133, DOI 10.1021/nl034795u; Strukov DB, 2007, J NANOSCI NANOTECHNO, V7, P151, DOI 10.1166/jnn.2007.013; Szot K, 2006, NAT MATER, V5, P312, DOI 10.1038/nmat1614; Terabe K, 2005, NATURE, V433, P47, DOI 10.1038/nature03190; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Zhitenev NB, 2007, NAT NANOTECHNOL, V2, P237, DOI 10.1038/nnano.2007.75	26	7160	7473	124	2282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					80	83		10.1038/nature06932	http://dx.doi.org/10.1038/nature06932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451858				2022-12-28	WOS:000255398800042
J	Zarivach, R; Deng, WY; Vuckovic, M; Felise, HB; Nguyen, HV; Miller, SI; Finlay, BB; Strynadka, NCJ				Zarivach, Raz; Deng, Wanyin; Vuckovic, Marija; Felise, Heather B.; Nguyen, Hai V.; Miller, Samuel I.; Finlay, B. Brett; Strynadka, Natalie C. J.			Structural analysis of the essential self-cleaving type III secretion proteins EscU and SpaS	NATURE			English	Article							SUCCINIMIDE FORMATION; ESCHERICHIA-COLI; ASPARAGINYL; SALMONELLA; ASPARTYL; EXPORT; FLHB; DEGRADATION; COMPONENTS; MECHANISM	During infection by Gram- negative pathogenic bacteria, the type III secretion system ( T3SS) is assembled to allow for the direct transmission of bacterial virulence effectors into the host cell(1). The T3SS system is characterized by a series of prominent multicomponent rings in the inner and outer bacterial membranes, as well as a translocation pore in the host cell membrane. These are all connected by a series of polymerized tubes that act as the direct conduit for the T3SS proteins to pass through to the host cell. During assembly of the T3SS, as well as the evolutionarily related flagellar apparatus(2), a post- translational cleavage event within the inner membrane proteins EscU/FlhB is required to promote a secretion- competent state. These proteins have long been proposed to act as a part of a molecular switch, which would regulate the appropriate chronological secretion of the various T3SS apparatus components during assembly and subsequently the transported virulence effectors. Here we show that a surface type II beta- turn in the Escherichia coli protein EscU undergoes auto-cleavage by a mechanism involving cyclization of a strictly conserved asparagine residue(3). Structural and in vivo analysis of point and deletion mutations illustrates the subtle conformational effects of auto- cleavage in modulating the molecular features of a highly conserved surface region of EscU, a potential point of interaction with other T3SS components at the inner membrane. In addition, this work provides new structural insight into the distinct conformational requirements for a large class of self-cleaving reactions involving asparagine cyclization.	[Zarivach, Raz; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Zarivach, Raz; Vuckovic, Marija; Strynadka, Natalie C. J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada; [Deng, Wanyin; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Felise, Heather B.; Nguyen, Hai V.; Miller, Samuel I.] Dept Microbiol & Med, Seattle, WA 98195 USA	University of British Columbia; University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca	ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, R01AI030479] Funding Source: NIH RePORTER; NIAID NIH HHS [5R01 AI030479, U54 AI057141, U19 AI107775, R01 AI030479] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; CLARKE S, 1987, INT J PEPT PROT RES, V30, P808, DOI 10.1111/j.1399-3011.1987.tb03390.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; *DELANO SCI, 2002, PYMOL V 1; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; GEIGER T, 1987, J BIOL CHEM, V262, P785; Hodges JA, 2006, ORG LETT, V8, P4695, DOI 10.1021/ol061569t; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shemella P, 2007, BIOPHYS J, V92, P847, DOI 10.1529/biophysj.106.092049; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	28	112	112	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					124	+		10.1038/nature06832	http://dx.doi.org/10.1038/nature06832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451864				2022-12-28	WOS:000255398800052
J	Phillips, SM; Gallagher, M; Buchan, H				Phillips, Susan M.; Gallagher, Martin; Buchan, Heather			Change page - Use graduated compression stockings postoperatively to prevent deep vein thrombosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Phillips, Susan M.; Buchan, Heather] Natl Hlth & Med Res Council, Natl Inst Clin Studies, Res Implementat Program, Melbourne, Vic 3004, Australia; [Gallagher, Martin] George Inst Int Hlth, Sydney, NSW, Australia	University of Sydney	Phillips, SM (corresponding author), Natl Hlth & Med Res Council, Natl Inst Clin Studies, Res Implementat Program, Melbourne, Vic 3004, Australia.	sue.phillips@nhmrc.gov.au		Gallagher, Martin/0000-0001-9187-6187; Phillips, Susan/0000-0001-7336-2190				Amaragiri SV, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001484; Brady D, 2007, CRIT CARE NURS Q, V30, P255, DOI 10.1097/01.CNQ.0000278926.67562.2f; Hayes Joan M, 2002, Medsurg Nurs, V11, P163; May V, 2006, Br J Nurs, V15, P263; *NAT I CLIN STUD, 2007, STOP CLOT GUID INT V; *NAT I CLIN STUD, EV PRACT GAPS REP, V1; National Institute for Health and Clinical Excellence, 2007, CLIN GUID; Roderick P., 2005, HLTH TECHNOLOGY ASSE, V9; Tooher R, 2005, ANN SURG, V241, P397, DOI 10.1097/01.sla.0000154120.96169.99	9	6	6	2	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					943	944		10.1136/bmj.39513.642789.AD	http://dx.doi.org/10.1136/bmj.39513.642789.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18436950	Green Published			2022-12-28	WOS:000255540900033
J	He, J; Ma, LM; Kim, S; Nakai, J; Yu, CR				He, Jie; Ma, Limei; Kim, SangSeong; Nakai, Junichi; Yu, C. Ron			Encoding gender and individual information in the mouse vomeronasal organ	SCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MAJOR URINARY PROTEINS; MULTIGENE FAMILY; SENSORY NEURONS; GENE REPERTOIRE; MUTANT MICE; MAMMALS; RECOGNITION; SYSTEM; PEPTIDES	The mammalian vomeronasal organ detects complex chemical signals that convey information about gender, strain, and the social and reproductive status of an individual. How these signals are encoded is poorly understood. We developed transgenic mice expressing the calcium indicator G- CaMP2 and analyzed population responses of vomeronasal neurons to urine from individual animals. A substantial portion of cells was activated by either male or female urine, but only a small population of cells responded exclusively to gender- specific cues shared across strains and individuals. Female cues activated more cells and were subject to more complex hormonal regulations than male cues. In contrast to gender, strain and individual information was encoded by the combinatorial activation of neurons such that urine from different individuals activated distinctive cell populations.	[He, Jie; Ma, Limei; Kim, SangSeong; Yu, C. Ron] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Nakai, Junichi] RIKEN Brain Sci Inst, Lab Memory & Learning, Wako, Saitama 3510198, Japan	Stowers Institute for Medical Research; RIKEN	Yu, CR (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	cry@stowers-institute.org	Nakai, Junichi/GQZ-6415-2022		NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008003] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC008003, R01 DC008003-03] Funding Source: Medline; PHS HHS [NIDCD 008003] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 2014, PHEROMONES ANIMAL BE; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Birch M.C., 1974, PHEROMONES; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; Ji GJ, 2004, J BIOL CHEM, V279, P21461, DOI 10.1074/jbc.M401084200; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; VANDENBERGH JG, 1976, BIOL REPROD, V15, P260, DOI 10.1095/biolreprod15.2.260; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	31	118	120	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					535	538		10.1126/science.1154476	http://dx.doi.org/10.1126/science.1154476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436787	Green Accepted			2022-12-28	WOS:000255249300052
J	Kyrle, PA; Eichinger, S				Kyrle, Paul A.; Eichinger, Sabine			New diagnostic strategies for pulmonary embolism	LANCET			English	Editorial Material							RECURRENT VENOUS THROMBOEMBOLISM; COMPUTED-TOMOGRAPHY; D-DIMER; THERAPY; RISK; THROMBOSIS; EMERGENCY; DISEASE		[Kyrle, Paul A.; Eichinger, Sabine] Med Univ Vienna, Dept Med, A-1090 Vienna, Austria	Medical University of Vienna	Kyrle, PA (corresponding author), Med Univ Vienna, Dept Med, A-1090 Vienna, Austria.	paul.kyrle@meduniwien.ac.at						[Anonymous], 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001100.pub2, DOI 10.1002/14651858.CD001100.PUB2]; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Douketis JD, 2007, ANN INTERN MED, V147, P766, DOI 10.7326/0003-4819-147-11-200712040-00007; Douma RA, 2007, SEMIN THROMB HEMOST, V33, P821, DOI 10.1055/s-2007-1000371; Eichinger S, 2004, ARCH INTERN MED, V164, P92, DOI 10.1001/archinte.164.1.92; Hron G, 2006, JAMA-J AM MED ASSOC, V296, P397, DOI 10.1001/jama.296.4.397; Kaufman John A, 2006, Surg Obes Relat Dis, V2, P200, DOI 10.1016/j.soard.2006.03.009; Kuipers S, 2007, PLOS MED, V4, P1508, DOI 10.1371/journal.pmed.0040290; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010	19	9	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 19	2008	371	9621					1312	1315		10.1016/S0140-6736(08)60572-3	http://dx.doi.org/10.1016/S0140-6736(08)60572-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424308				2022-12-28	WOS:000255208500005
J	Righini, M; Le Gal, G; Aujesky, D; Roy, PM; Sanchez, O; Verschuren, F; Rutschmann, O; Nonent, M; Cornuz, J; Thys, F; Le Manach, CP; Revel, MP; Poletti, PA; Meyer, G; Mottier, D; Perneger, T; Bounameaux, H; Perrier, A				Righini, Marc; Le Gal, Gregoire; Aujesky, Drahomir; Roy, Pierre-Marie; Sanchez, Olivier; Verschuren, Franck; Rutschmann, Olivier; Nonent, Michel; Cornuz, Jacques; Thys, Frederic; Le Manach, Cedric Petit; Revel, Marie-Pierre; Poletti, Pierre-Alexandre; Meyer, Guy; Mottier, Dominique; Perneger, Thomas; Bounameaux, Henri; Perrier, Arnaud			Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial	LANCET			English	Article							HELICAL COMPUTED-TOMOGRAPHY; D-DIMER; CLINICAL PROBABILITY; OUTPATIENTS; STRATEGIES; PREDICTION; MANAGEMENT	Background Multislice CT (MSCT) combined with D-dimer measurement can safely exclude pulmonary embolism in patients with a low or intermediate clinical probability of this disease. We compared this combination with a strategy in which both a negative venous ultrasonography of the leg and MSCT were needed to exclude pulmonary embolism. Methods We included 1819 consecutive outpatients with clinically suspected pulmonary embolism in a multicentre non-inferiority randomised controlled trial comparing two strategies: clinical probability assessment and either D-dimer measurement and MSCT (DD-CT strategy [n=903]) or D-dimer measurement, venous compression ultrasonography of the leg, and MSCT (DD-US-CT strategy [n=916]). Randomisation was by computer-generated blocks with stratification according to Centre. Patients with a high clinical probability according to the revised Geneva score and a negative work-up for pulmonary embolism were further investigated in both groups. The primary outcome was the 3-month thromboembolic risk in patients who were left untreated on the basis of the exclusion of pulmonary embolism by diagnostic strategy. Clinicians assessing outcome were blinded to group assignment. Analysis was per protocol. This study is registered with ClinicalTrials.gov, number NCT00117169. Findings The prevalence of pulmonary embolism was 20.6% in both groups (189 cases in DD-US-CT group and 186 in DD-CT group). We analysed 855 patients in the DD-US-CT group and 838 in the DD-CT group per protocol. The 3-month thromboembolic risk was 0 . 3% (95% Cl 0 . 1-1 . 1) in the DD-US-CT group and 0 - 3% (0.1-1.2) in the DD-CT group (difference 0 . 0% [-0 . 9 to 0 . 8]). In the DD-US-CT group, ultrasonography showed a deep-venous thrombosis in 53 (9% [7-12]) of 574 patients, and thus MSCT was not undertaken. Interpretation The strategy combining D-dimer and MSCT is as safe as the strategy using D-dimer followed by venous compression ultrasonography of the leg and MSCT for exclusion of pulmonary embolism. An ultrasound could be of use in patients with a contraindication to CT. Funding Swiss National Research Foundation, Projets Hospitaliers de Recherche Clinique (France), Pneumologie Developpement (France).	[Righini, Marc; Bounameaux, Henri] Univ Hosp Geneva, Dept Internal Med, Div Angiol & Hemostasis, CH-1211 Geneva 14, Switzerland; [Rutschmann, Olivier; Perrier, Arnaud] Univ Hosp Geneva, Dept Internal Med, Div Gen Internal Med, CH-1211 Geneva 14, Switzerland; [Poletti, Pierre-Alexandre] Univ Hosp Geneva, Dept Radiol, CH-1211 Geneva 14, Switzerland; [Perneger, Thomas] Univ Hosp Geneva, Dept Clin Epidemiol, CH-1211 Geneva 14, Switzerland; [Righini, Marc] Fac Med, CH-1211 Geneva 14, Switzerland; [Le Gal, Gregoire; Nonent, Michel; Mottier, Dominique] Brest Univ Hosp, Dept Internal Med & Chest Dis, EA GETBO 3878, Brest, France; [Aujesky, Drahomir; Cornuz, Jacques] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Verschuren, Franck; Thys, Frederic] St Luc Univ Hosp, Emergency Dept, Brussels, Belgium; [Roy, Pierre-Marie; Le Manach, Cedric Petit] Angers Univ Hosp, Emergency Dept, Angers, France; [Sanchez, Olivier; Meyer, Guy] Hop Europeen Georges Pompidou, Serv Pneumol, Paris, France; [Revel, Marie-Pierre] Hop Europeen Georges Pompidou, Serv Radiol, Paris, France	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; CHU Brest; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Righini, M (corresponding author), Univ Hosp Geneva, Dept Internal Med, Div Angiol & Hemostasis, 24 Rue Micheli du Crest, CH-1211 Geneva 14, Switzerland.	Marc.Righini@hcuge.ch	Righini, Marc/AAX-8731-2020; Roy, Pierre-Marie/AAA-7737-2022; Perrier, Arnaud/M-2263-2014; LE GAL, Gregoire/K-1077-2012	SANCHEZ, Olivier/0000-0003-1633-8391; Thys, Frederic/0000-0002-4147-5948; revel, marie-pierre/0000-0001-8213-7817; LE GAL, Gregoire/0000-0002-9253-248X; NONENT, Michel/0000-0002-1317-8997				Altman D.G., 2000, STAT CONFIDENCE, Vsecond; BOUNAMEAUX H, 1991, LANCET, V337, P196, DOI 10.1016/0140-6736(91)92158-X; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; deMoerloose P, 1996, THROMB HAEMOSTASIS, V75, P11; Ghanima W, 2005, J THROMB HAEMOST, V3, P1926, DOI 10.1111/j.1538-7836.2005.01544.x; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Klok FA, 2008, J THROMB HAEMOST, V6, P40, DOI 10.1111/j.1538-7836.2007.02820.x; Kruip MJHA, 2003, ANN INTERN MED, V138, P941, DOI 10.7326/0003-4819-138-12-200306170-00005; Le Gal G, 2006, J THROMB HAEMOST, V4, P724, DOI 10.1111/j.1538-7836.2006.01819.x; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Mullins MD, 2000, ARCH INTERN MED, V160, P293, DOI 10.1001/archinte.160.3.293; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 2004, AM J MED, V116, P291, DOI 10.1016/j.amjmed.2003.09.041; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Rathbun SW, 2000, ANN INTERN MED, V132, P227, DOI 10.7326/0003-4819-132-3-200002010-00009; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Righini M, 2007, J THROMB HAEMOST, V5, P1869, DOI 10.1111/j.1538-7836.2007.02667.x; Schoepf UJ, 2002, RADIOLOGY, V222, P483, DOI 10.1148/radiol.2222001802; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Turkstra F, 1997, ANN INTERN MED, V126, P775, DOI 10.7326/0003-4819-126-10-199705150-00005; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	27	284	291	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2008	371	9621					1343	1352		10.1016/S0140-6736(08)60594-2	http://dx.doi.org/10.1016/S0140-6736(08)60594-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424324				2022-12-28	WOS:000255208500025
J	Xavier, D; Pais, P; Devereaux, PJ; Xie, CC; Prabhakaran, D; Reddy, KS; Gupta, R; Joshi, P; Kerkar, P; Thanikachalam, S; Haridas, KK; Jaison, TM; Naik, S; Maity, AK; Yusuf, S				Xavier, Denis; Pais, Prem; Devereaux, P. J.; Xie, Changchun; Prabhakaran, D.; Reddy, K. Srinath; Gupta, Rajeev; Joshi, Prashant; Kerkar, Prafulla; Thanikachalam, S.; Haridas, K. K.; Jaison, T. M.; Naik, Sudhir; Maity, A. K.; Yusuf, Salim		CREATE Registry Investigators	Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data	LANCET			English	Article							INVASIVE CARDIAC PROCEDURES; ACUTE MYOCARDIAL-INFARCTION; EURO HEART SURVEY; RISK-FACTORS; CARDIOVASCULAR-DISEASES; SOCIOECONOMIC-STATUS; MEDITERRANEAN BASIN; GLOBAL REGISTRY; BURDEN; EVENTS	Background India has the highest burden of acute coronary syndromes in the world, yet little is known about the treatments and outcomes of these diseases. We aimed to document the characteristics, treatments, and outcomes of patients with acute coronary syndromes who were admitted to hospitals in India. Methods We did a prospective registry study in 89 centres from 10 regions and 50 cities in India. Eligible patients had suspected acute myocardial infarction with definite electrocardiograph changes (whether elevated ST [STEMI] or non-STEMI or unstable angina), or had suspected myocardial infarction without ECG changes but with prior evidence of ischaemic heart disease. We recorded a range of clinical outcomes, and all-cause mortality at 30 days. Findings We enrolled 20937 patients. Of the 20468 patients who were given a definite diagnosis, 12405 (60.6%) had STEMI. The mean age of these patients was 57.5 (SD 12.1) years; patients with STEMI were younger (56.3 [12.1] years) than were those with non-STEMI or unstable angina (59.3 [11.8] years). Most patients were from lower middle 10 737 (52.5%) and poor 3999 (19.6%) social classes. The median time from symptoms to hospital was 360 (IQR 123-1317) min, with 50 (25-68) min from hospital to thrombolysis. 6226 (30.4%) patients had diabetes; 7720 (37.7%) had hypertension; and 8242 (40.2%) were smokers. Treatments for STEMI differed from those for non-STEMI or unstable angina. More patients with STEMI than with non-STEMI were given anti-platelet drugs (98.2% vs 97.4%); angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB) (60.5% vs 51.2%); and percutaneous coronary interventions (8 . 0% vs 6.7%, p<0. 0001 for all comparisons). Thrombolytics (96.3% streptokinase) were used for 58.5% of patients with STEMI. Conversely, fewer patients with STEMI than those with non-STEMI or unstable angina were given P blockers (57.5% vs 61.9%); lipid-lowering drugs (50.8% vs 53.9%); and coronary bypass graft surgery (1 . 9% vs 4.4%, p<0. 0001 for all comparisons). The 30-day outcomes for patients with STEMI were death (8.6%), reinfarction (2.3%), and stroke (0.7%). Outcomes for those with non-STEMI or unstable angina were better: death (3.7%), reinfarction (1 . 2%), and stroke (0 . 3%, p<0. 0001 for all comparisons). Use of key treatments also differed by socioeconomic status: more rich patients than poor patients were given thrombolytics (60 . 6% vs 52.3%), P blockers (58.8% vs 49.6%), lipid-lowering drugs (61.2% vs 36.0%), ACE inhibitors or ARB (63.2% vs 54.1%), percutaneous coronary intervention (15.3% vs 2 . 0%), and coronary artery bypass graft surgery (7.5% vs 0 . 7%, p<0. 0001 for all comparisons). Mortality was higher for poor patients than for rich patients (8.2% vs 5.5%, p<0 .0001). Adjustment for treatments (but not risk factors and baseline characteristics) eliminated this difference in mortality. Interprettion Patients in India who have acute coronary syndromes have a higher rate of STEMI than do patients in developed countries. Since most of these patients were poor, less likely to get evidence-based treatments, and had greater 30-day mortality, reduction of delays in access to hospital and provision of affordable treatments could reduce morbidity and mortality. Funding Division of Clinical Trials, St John's Research Institute, Bangalore, India; Population Health Research Institute (PHRI), McMaster University, Canada; Sanofi-Aventis India.	[Devereaux, P. J.; Xie, Changchun; Yusuf, Salim] McMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Devereaux, P. J.; Xie, Changchun; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Xavier, Denis; Pais, Prem] St Johns Med Coll, Bangalore, Karnataka, India; [Xavier, Denis; Pais, Prem] St Johns Res Inst, Bangalore, Karnataka, India; [Prabhakaran, D.; Reddy, K. Srinath] All India Inst Hlth Sci, New Delhi, India; [Gupta, Rajeev] Monilek Hosp & Res Ctr, Jaipur, Rajasthan, India; [Joshi, Prashant] Govt Med Coll, Nagpur, Maharashtra, India; [Kerkar, Prafulla] King Edward Mem Hosp, Bombay, Maharashtra, India; [Thanikachalam, S.] Sri Ramachandra Med Coll, Madras, Tamil Nadu, India; [Haridas, K. K.] Amrita Inst Med Sci, Kochi, India; [Jaison, T. M.] Christian Med Coll & Hosp, Ludhiana, Punjab, India; [Naik, Sudhir] Mediciti Hosp, Hyderabad, Andhra Pradesh, India; [Maity, A. K.] SSKM Hosp, Kolkata, India	McMaster University; Population Health Research Institute; McMaster University; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Research Institute; Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Sri Ramachandra Institute of Higher Education & Research; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Yusuf, S (corresponding author), McMaster Univ, Hamilton Gen Hosp, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Devereaux, PJ/AAY-1757-2021; Prabhakaran, Dorairaj/B-4147-2011; Devereaux, PJ/AAF-2862-2019	Prabhakaran, Dorairaj/0000-0002-3172-834X; Devereaux, PJ/0000-0003-2935-637X; Yusuf, Salim/0000-0003-4776-5601; Govind, Satish/0000-0001-6106-687X				Alter DA, 2004, JAMA-J AM MED ASSOC, V291, P1100, DOI 10.1001/jama.291.9.1100; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Budaj A, 2003, AM HEART J, V146, P999, DOI 10.1016/S0002-8703(03)00509-X; Canto JG, 2000, ARCH INTERN MED, V160, P817, DOI 10.1001/archinte.160.6.817; FOX KA, 2006, BMJ-BRIT MED J, V333, P1091, DOI DOI 10.1136/BMJ.38985.646481.55; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; George E, 2001, J Assoc Physicians India, V49, P320; George E, 1999, Indian Heart J, V51, P161; Ghaffar A, 2004, BMJ-BRIT MED J, V328, P807, DOI 10.1136/bmj.328.7443.807; Gibson CM, 2004, AM HEART J, V148, pS29, DOI 10.1016/j.ahj.2004.09.012; Govt. of India, 2001, CENS IND 2001 PROV P; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Jose V Jacob, 2004, Indian Heart J, V56, P210; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mandelzweig L, 2006, EUR HEART J, V27, P2285, DOI 10.1093/eurheartj/ehl196; Mohan V, 2001, J AM COLL CARDIOL, V38, P682, DOI 10.1016/S0735-1097(01)01415-2; Prabhakaran Dorairaj, 2005, Indian Heart J, V57, P217; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Rogers WJ, 2000, J AM COLL CARDIOL, V35, P371, DOI 10.1016/S0735-1097(99)00505-7; Rogers WJ, 2000, J AM COLL CARDIOL, V36, P2056, DOI 10.1016/S0735-1097(00)00996-7; Salomaa V, 2001, J EPIDEMIOL COMMUN H, V55, P475, DOI 10.1136/jech.55.7.475; Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	26	331	337	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1435	1442		10.1016/S0140-6736(08)60623-6	http://dx.doi.org/10.1016/S0140-6736(08)60623-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440425				2022-12-28	WOS:000255440600024
J	Yudkin, JS; Owens, G; Martineau, F; Rowson, M; Finer, S				Yudkin, John S.; Owens, Gemma; Martineau, Fred; Rowson, Mike; Finer, Sarah			Global health-worker crisis: the UK could learn from Cuba	LANCET			English	Editorial Material									[Yudkin, John S.; Owens, Gemma; Martineau, Fred; Rowson, Mike] UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London N7 0AG, England; [Finer, Sarah] Barts & London Queen Marys Sch Med & Dent, London, England	University of London; University College London; University of London; Queen Mary University London	Yudkin, JS (corresponding author), UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London N7 0AG, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008	Owens, Gemma/0000-0003-3471-4370; Martineau, Fred/0000-0001-7137-8252; Finer, Sarah/0000-0002-2684-4653	Medical Research Council [G0800441] Funding Source: researchfish; MRC [G0800441] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2007, GLOB HLTH ATL; *BBC NEWS, 2007, RESC PACK DOCT LEAK; Brown C, 2007, LANCET, V370, P655, DOI 10.1016/S0140-6736(07)61339-7; Crisp N., 2007, GLOBAL HLTH PARTNERS; *DEP HLTH, 2008, GLOB HLTH PART UK CO; Department of Health, 2008, SECR STAT HLTH RESP; *GLOB HLTH WORKF A, 2008, KAMP DECL AG GLOB AC; Mullan F, 2004, NEW ENGL J MED, V351, P2680, DOI 10.1056/NEJMp048270; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Tooke JE., 2008, ASPIRING EXCELLENCE; Yudkin JS, 2003, LANCET, V362, P822, DOI 10.1016/S0140-6736(03)14276-6	11	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1397	1399		10.1016/S0140-6736(08)60608-X	http://dx.doi.org/10.1016/S0140-6736(08)60608-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294XW	18440415				2022-12-28	WOS:000255440600008
J	Dian, BC; Brown, GG; Douglass, KO; Pate, BH				Dian, Brian C.; Brown, Gordon G.; Douglass, Kevin O.; Pate, Brooks H.			Measuring picosecond isomerization kinetics via broadband microwave spectroscopy	SCIENCE			English	Article							VIBRATIONAL-ENERGY REDISTRIBUTION; PHASE-SPACE BOTTLENECKS; MIXED QUANTUM STATE; ROTATIONAL SPECTRUM; RESONANCE-SPECTROSCOPY; ROOM-TEMPERATURE; LOW BARRIERS; GAS-PHASE; DYNAMICS; CYCLOPROPANECARBOXALDEHYDE	The rotational spectrum of a highly excited molecule is qualitatively different from its pure rotational spectrum and contains information about the intramolecular dynamics. We have developed a broadband Fourier transform microwave spectrometer that uses chirped-pulse excitation to measure a rotational spectrum in the 7.5- to 18.5-gigahertz range in a single shot and thereby reduces acquisition time sufficiently to couple molecular rotational spectroscopy with tunable laser excitation. After vibrationally exciting a single molecular conformation of cyclopropane carboxaldehyde above the barrier to C - C single-bond isomerization, we applied line-shape analysis of the dynamic rotational spectrum to reveal a product yield and picosecond reaction rate that were significantly different from statistical predictions. The technique should be widely applicable to dynamical studies of radical intermediates, molecular complexes, and conformationally flexible molecules with biological interest.	[Dian, Brian C.; Brown, Gordon G.; Douglass, Kevin O.; Pate, Brooks H.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA	University of Virginia	Pate, BH (corresponding author), Univ Virginia, Dept Chem, McCormick Rd, Charlottesville, VA 22904 USA.	brookspate@virginia.edu						ANDERSON PW, 1954, J PHYS SOC JPN, V9, P316, DOI 10.1143/JPSJ.9.316; Baer T, 2000, J PHYS CHEM A, V104, P9397, DOI 10.1021/jp000173a; Baer T., 1996, UNIMOLECULAR REACTIO; BALLE TJ, 1981, REV SCI INSTRUM, V52, P33, DOI 10.1063/1.1136443; BORCHARDT DB, 1986, J CHEM PHYS, V85, P4980, DOI 10.1063/1.451712; Brown GG, 2006, J MOL SPECTROSC, V238, P200, DOI 10.1016/j.jms.2006.05.003; Cocinero EJ, 2007, CHEM PHYS LETT, V435, P336, DOI 10.1016/j.cplett.2006.12.067; DAVIS MJ, 1986, J CHEM PHYS, V84, P5389, DOI 10.1063/1.449948; Dian BC, 2002, SCIENCE, V296, P2369, DOI 10.1126/science.1071563; Douglass KO, 2006, J MOL SPECTROSC, V239, P29, DOI 10.1016/j.jms.2006.05.015; DURIG JR, 1992, STRUCT CHEM, V3, P417, DOI 10.1007/BF00672016; Elles CG, 2004, J CHEM PHYS, V120, P6973, DOI 10.1063/1.1676292; Frisch M.J., 2016, GAUSSIAN16 REV B01; GRAY SK, 1987, J CHEM PHYS, V86, P2020, DOI 10.1063/1.452152; Keske J, 2000, INT REV PHYS CHEM, V19, P363, DOI 10.1080/01442350050034171; KUBO R, 1954, J PHYS SOC JPN, V9, P888, DOI 10.1143/JPSJ.9.888; Leitner DM, 1997, CHEM PHYS LETT, V280, P411, DOI 10.1016/S0009-2614(97)01120-2; McCarthy MC, 2006, ASTROPHYS J, V652, pL141, DOI 10.1086/510238; MCGURK JC, 1974, J CHEM PHYS, V60, P4181, DOI 10.1063/1.1680886; MUKAMEL S, 1984, CHEM PHYS LETT, V105, P134, DOI 10.1016/0009-2614(84)85636-5; Nesbitt DJ, 1996, J PHYS CHEM-US, V100, P12735, DOI 10.1021/jp960698w; Pate BH, 1998, J CHEM PHYS, V109, P4396, DOI 10.1063/1.477043; Pate BH, 1999, J CHEM PHYS, V110, P1990, DOI 10.1063/1.477864; Schanz R, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1834567; Suma K, 2005, SCIENCE, V308, P1885, DOI 10.1126/science.1112233; Tang J, 2002, SCIENCE, V297, P2030, DOI 10.1126/science.1073718; VOLLTRAU.HN, 1971, J CHEM PHYS, V54, P260, DOI 10.1063/1.1674602; von Benten R, 2004, J PHYS CHEM A, V108, P363, DOI 10.1021/jp030974o; WIBERG KB, 1995, J ORG CHEM, V60, P6327, DOI 10.1021/jo00125a018; Yoo HS, 2004, J PHYS CHEM A, V108, P1348, DOI 10.1021/jp027543a; Zheng JR, 2006, SCIENCE, V313, P1951, DOI 10.1126/science.1132178	31	115	121	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					924	928		10.1126/science.1155736	http://dx.doi.org/10.1126/science.1155736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487191				2022-12-28	WOS:000255868300040
J	Kholodenko, BN; Kolch, W				Kholodenko, Boris N.; Kolch, Walter			Giving space to cell signaling	CELL			English	Editorial Material							TRANSDUCTION; GRADIENTS; PATHWAYS		[Kholodenko, Boris N.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kolch, Walter] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Kolch, Walter] Univ Glasgow, Sir Henry Wellcome Funct Genom Facil, Glasgow G12 8QQ, Lanark, Scotland	Jefferson University; Beatson Institute; University of Glasgow	Kholodenko, BN (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	boris.kholodenko@jefferson.edu	Admin, SBI/HGB-2738-2022; Kolch, Walter/ABF-2102-2021	Kolch, Walter/0000-0001-5777-5016; Kholodenko, Boris/0000-0002-9483-4975				Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; FELL DA, 1980, J THEOR BIOL, V84, P361, DOI 10.1016/S0022-5193(80)80011-7; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Peletier MA, 2003, J THEOR BIOL, V225, P477, DOI 10.1016/S0022-5193(03)00289-3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615	8	21	21	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					566	567		10.1016/j.cell.2008.04.033	http://dx.doi.org/10.1016/j.cell.2008.04.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485861	Bronze			2022-12-28	WOS:000255903300008
J	Melnik, DG; Miller, TA				Melnik, Dmitry G.; Miller, Terry A.			Chemistry - The changing shapes of molecules	SCIENCE			English	Editorial Material							MIXED QUANTUM STATE; ROTATIONAL SPECTRUM; RESONANCE-SPECTROSCOPY		[Melnik, Dmitry G.; Miller, Terry A.] Ohio State Univ, Laser Spect Facil, Dept Chem, Columbus, OH 43210 USA	Ohio State University	Melnik, DG (corresponding author), Ohio State Univ, Laser Spect Facil, Dept Chem, Columbus, OH 43210 USA.	tamiller+@osu.edu	Miller, Terry A/F-6607-2014	Miller, Terry A/0000-0003-0731-8006				BALLE TJ, 1981, REV SCI INSTRUM, V52, P33, DOI 10.1063/1.1136443; Brown GG, 2006, J MOL SPECTROSC, V238, P200, DOI 10.1016/j.jms.2006.05.003; Demtroder W., 2003, LASER SPECTROSCOPY B; Dian BC, 2008, SCIENCE, V320, P924, DOI 10.1126/science.1155736; Douglass KO, 2006, J MOL SPECTROSC, V239, P29, DOI 10.1016/j.jms.2006.05.015; EDWARD HJ, 2008, FATTY ACIDS FOODS TH, P757; Pate BH, 1998, J CHEM PHYS, V109, P4396, DOI 10.1063/1.477043; Pate BH, 1999, J CHEM PHYS, V110, P1990, DOI 10.1063/1.477864; Petkie DT, 1997, REV SCI INSTRUM, V68, P1675, DOI 10.1063/1.1147970; Quack M., 2006, MODELLING MOL STRUCT, P3; Townes CH., 1955, MICROWAVE SPECTROSCO, V1	11	6	6	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					881	882		10.1126/science.1157668	http://dx.doi.org/10.1126/science.1157668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487179				2022-12-28	WOS:000255868300027
J	Luthi, D; Le Floch, M; Bereiter, B; Blunier, T; Barnola, JM; Siegenthaler, U; Raynaud, D; Jouzel, J; Fischer, H; Kawamura, K; Stocker, TF				Luethi, Dieter; Le Floch, Martine; Bereiter, Bernhard; Blunier, Thomas; Barnola, Jean-Marc; Siegenthaler, Urs; Raynaud, Dominique; Jouzel, Jean; Fischer, Hubertus; Kawamura, Kenji; Stocker, Thomas F.			High-resolution carbon dioxide concentration record 650,000-800,000 years before present	NATURE			English	Article							PAST 800,000 YEARS; 8 GLACIAL CYCLES; C ICE CORE; ATMOSPHERIC CO2; CLIMATE VARIABILITY; BIPOLAR SEESAW; ANTARCTICA; MODEL; CIRCULATION; GREENLAND	Changes in past atmospheric carbon dioxide concentrations can be determined by measuring the composition of air trapped in ice cores from Antarctica. So far, the Antarctic Vostok and EPICA Dome C ice cores have provided a composite record of atmospheric carbon dioxide levels over the past 650,000 years(1-4). Here we present results of the lowest 200m of the Dome C ice core, extending the record of atmospheric carbon dioxide concentration by two complete glacial cycles to 800,000 yr before present. From previously published data(1-8) and the present work, we find that atmospheric carbon dioxide is strongly correlated with Antarctic temperature throughout eight glacial cycles but with significantly lower concentrations between 650,000 and 750,000 yr before present. Carbon dioxide levels are below 180 parts per million by volume ( p. p. m. v.) for a period of 3,000 yr during Marine Isotope Stage 16, possibly reflecting more pronounced oceanic carbon storage. We report the lowest carbon dioxide concentration measured in an ice core, which extends the pre-industrial range of carbon dioxide concentrations during the late Quaternary by about 10 p. p. m. v. to 172-300 p. p. m. v.	[Luethi, Dieter; Bereiter, Bernhard; Blunier, Thomas; Siegenthaler, Urs; Kawamura, Kenji; Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Luethi, Dieter; Bereiter, Bernhard; Blunier, Thomas; Siegenthaler, Urs; Kawamura, Kenji; Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Le Floch, Martine; Barnola, Jean-Marc; Raynaud, Dominique] Univ Grenoble 1, CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; [Jouzel, Jean] Univ Versailles St Quentin, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, CEA CNRS,CE Saclay, F-91191 Gif Sur Yvette, France; [Fischer, Hubertus] Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	University of Bern; University of Bern; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Luthi, D (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	luethi@climate.unibe.ch	raynaud, dominique/ABG-4718-2020; Fischer, Hubertus/A-1211-2014; Kawamura, Kenji/C-7660-2011; Raynaud, Dominique/H-9626-2016; Blunier, Thomas/M-4609-2014; Stocker, Thomas/B-1273-2013	Fischer, Hubertus/0000-0002-2787-4221; Kawamura, Kenji/0000-0003-1163-700X; Blunier, Thomas/0000-0002-6065-7747; 				Ahn JH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029551; Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kohler P, 2006, CLIM PAST, V2, P57; Kohler P, 2005, CLIM DYNAM, V25, P689, DOI 10.1007/s00382-005-0058-8; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Loulergue L, 2007, CLIM PAST, V3, P527, DOI 10.5194/cp-3-527-2007; Marchal O, 1999, CLIM DYNAM, V15, P341, DOI 10.1007/s003820050286; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Pepin L, 2001, J GEOPHYS RES-ATMOS, V106, P31885, DOI 10.1029/2001JD900117; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Raynaud D, 2005, NATURE, V436, P39, DOI 10.1038/43639b; Siddall M, 2006, QUATERNARY SCI REV, V25, P3185, DOI 10.1016/j.quascirev.2005.12.014; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Wang PX, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000991; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614	26	1266	1353	19	516	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					379	382		10.1038/nature06949	http://dx.doi.org/10.1038/nature06949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480821	Green Published, Bronze			2022-12-28	WOS:000255868400049
J	Shulkin, DJ				Shulkin, David J.			Like night and day - Shedding light on off-hours care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WEEKENDS		Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; Albert Einstein Coll Med, New York, NY USA	Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Shulkin, DJ (corresponding author), Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.							Arabi Y, 2006, CRIT CARE MED, V34, P605, DOI 10.1097/01.CCM.0000203947.60552.DD; Bendavid E, 2007, AM J MED, V120, P422, DOI 10.1016/j.amjmed.2006.05.067; Hendey GW, 2005, ACAD EMERG MED, V12, P629, DOI 10.1197/j.aem.2005.02.009; Luyt CE, 2007, CRIT CARE MED, V35, P3, DOI 10.1097/01.CCM.0000249832.36518.11; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea	5	41	42	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2091	2093		10.1056/NEJMp0707144	http://dx.doi.org/10.1056/NEJMp0707144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300TY	18480201				2022-12-28	WOS:000255849300002
J	Brabin, L; Roberts, SA; Stretch, R; Baxter, D; Chambers, G; Kitchener, H; McCann, R				Brabin, Loretta; Roberts, Stephen A.; Stretch, Rebecca; Baxter, David; Chambers, Gloria; Kitchener, Henry; McCann, Rosemary			Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PARENTAL ATTITUDES; HPV VACCINATION; RUBELLA VACCINE; MEASLES; MUMPS	Objective To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls. Design Prospective cohort study. Setting 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom. Participants 2817 schoolgirls in year 8 (12 and 13 Year olds). Intervention Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year. Main outcome measures Vaccine-uptake for doses 1 and 2 of a three dose schedule. Results Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second close. Uptake was significantly tower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported. Conclusion Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.	[Brabin, Loretta; Stretch, Rebecca; Kitchener, Henry] Univ Manchester, St Marys Hosp, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England; [Roberts, Stephen A.] Univ Manchester, Hlth Methodol Res Grp, Manchester M13 9PL, Lancs, England; [Baxter, David] Stockport Primary Care Trust, Dept Publ Hlth, Stockport, Lancs, England; [Chambers, Gloria] Bury Primary Care Trust, Dept Publ Hlth, Bury St Edmunds, Suffolk, England; [McCann, Rosemary] Greater Manchester Hlth Protect Unit, Eccles, Lancs, England	University of Manchester; University of Manchester	Brabin, L (corresponding author), Univ Manchester, St Marys Hosp, Acad Unit Obstet & Gynaecol, Manchester M13 0JH, Lancs, England.	loretta.brabin@manchester.ac.uk	Bujan, Miren Karmele/F-5542-2014	Brabin, Loretta/0000-0003-4478-6503; Roberts, Steve/0000-0002-7477-7731				Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; *DEP HLTH, HPV VACC REC NHS IMM; Kohli M, 2007, BRIT J CANCER, V96, P143, DOI 10.1038/sj.bjc.6603501; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; Mixer RE, 2007, J EPIDEMIOL COMMUN H, V61, P797, DOI 10.1136/jech.2005.045633; Raffle AE, 2007, BMJ-BRIT MED J, V335, P375, DOI 10.1136/bmj.39273.458322.BE; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; VALLELY LA, 2008, VACCINE; Wallace LA, 2004, ARCH DIS CHILD, V89, P1041, DOI 10.1136/adc.2003.043687; Zimet GD, 2006, VACCINE, V24, P201, DOI 10.1016/j.vaccine.2006.06.017; 2008, CANADIAN NATL P 0219	12	155	155	0	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 10	2008	336	7652					1056	1058		10.1136/bmj.39541.534109.BE	http://dx.doi.org/10.1136/bmj.39541.534109.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18436917	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000256103300029
J	Cox, PM; Harris, PP; Huntingford, C; Betts, RA; Collins, M; Jones, CD; Jupp, TE; Marengo, JA; Nobre, CA				Cox, Peter M.; Harris, Phil P.; Huntingford, Chris; Betts, Richard A.; Collins, Matthew; Jones, Chris D.; Jupp, Tim E.; Marengo, Jose A.; Nobre, Carlos A.			Increasing risk of Amazonian drought due to decreasing aerosol pollution	NATURE			English	Article							SEA-SURFACE TEMPERATURE; CLIMATE-CHANGE; TROPICAL ATLANTIC; RAINY-SEASON; RAINFALL; MODEL; VARIABILITY; BASIN; TRENDS; FUTURE	The Amazon rainforest plays a crucial role in the climate system, helping to drive atmospheric circulations in the tropics by absorbing energy and recycling about half of the rainfall that falls on it. This region ( Amazonia) is also estimated to contain about one-tenth of the total carbon stored in land ecosystems, and to account for one-tenth of global, net primary productivity(1). The resilience of the forest to the combined pressures of deforestation and global warming is therefore of great concern(2), especially as some general circulation models ( GCMs) predict a severe drying of Amazonia in the twenty- first century(3-5). Here we analyse these climate projections with reference to the 2005 drought in western Amazonia, which was associated(6) with unusually warm North Atlantic sea surface temperatures ( SSTs). We show that reduction of dry-season ( July - October) rainfall in western Amazonia correlates well with an index of the north - south SST gradient across the equatorial Atlantic ( the 'Atlantic N - S gradient'). Our climate model is unusual among current GCMs in that it is able to reproduce this relationship and also the observed twentieth- century multidecadal variability in the Atlantic N - S gradient(7), provided that the effects of aerosols are included in the model(8). Simulations for the twenty- first century using the same model(3,8) show a strong tendency for the SST conditions associated with the 2005 drought to become much more common, owing to continuing reductions in reflective aerosol pollution in the Northern Hemisphere(9).	[Cox, Peter M.; Jupp, Tim E.] Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England; [Cox, Peter M.; Betts, Richard A.; Collins, Matthew; Jones, Chris D.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Harris, Phil P.; Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Marengo, Jose A.; Nobre, Carlos A.] INPE, CPTEC, Brazilian Ctr Weather Forecasting & Climate Studi, Sao Paulo, Brazil	University of Exeter; Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH); Instituto Nacional de Pesquisas Espaciais (INPE)	Cox, PM (corresponding author), Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk	Cox, Peter Michae;/B-3299-2012; Harris, Phil P/A-1933-2010; Marengo, Jose A/J-9382-2012; Jones, Chris/I-2983-2014; Collins, Matthew/F-8473-2011; Betts, Richard A/P-8976-2015; Huntingford, Christopher/A-4307-2008	Cox, Peter Michae;/0000-0002-0679-2219; Harris, Phil P/0000-0002-4834-7746; Marengo, Jose A/0000-0002-8154-2762; Jones, Chris/0000-0002-7141-9285; Collins, Matthew/0000-0003-3785-6008; Betts, Richard A/0000-0002-4929-0307; Huntingford, Christopher/0000-0002-5941-7770; Jupp, Timothy/0000-0002-2036-9476	NERC [earth010002, earth010004] Funding Source: UKRI; Natural Environment Research Council [earth010004, earth010002, ceh010023] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Cox P., 2001, 24 MET OFF HADL CTR; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Essery RLH, 2003, J HYDROMETEOROL, V4, P530, DOI 10.1175/1525-7541(2003)004<0530:EROSHI>2.0.CO;2; Folland CK, 2001, J CLIMATE, V14, P1937, DOI 10.1175/1520-0442(2001)014&lt;1937:PONBRA&gt;2.0.CO;2; Fu R, 2001, J CLIMATE, V14, P4003, DOI 10.1175/1520-0442(2001)014<4003:HDTSST>2.0.CO;2; Good P, 2008, PHILOS T R SOC B, V363, P1761, DOI 10.1098/rstb.2007.0024; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Harris PP, 2008, PHILOS T R SOC B, V363, P1753, DOI 10.1098/rstb.2007.0037; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Jones CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016867; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Li WH, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006355; Liebmann B, 2001, J CLIMATE, V14, P4308, DOI 10.1175/1520-0442(2001)014<4308:IVOTRS>2.0.CO;2; Marengo JA, 2004, THEOR APPL CLIMATOL, V78, P79, DOI 10.1007/S00704-004-0045-8; Marengo JA, 2001, J CLIMATE, V14, P833, DOI 10.1175/1520-0442(2001)014<0833:OAEOTR>2.0.CO;2; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Nakicenovic N., 2000, SPECIAL REPORT EMISS; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nobre P, 1996, J CLIMATE, V9, P2464, DOI 10.1175/1520-0442(1996)009<2464:VOSSTW>2.0.CO;2; Palmer JR, 2001, DEEP-SEA RES PT I, V48, P1169, DOI 10.1016/S0967-0637(00)00080-7; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Rotstayn LD, 2002, J CLIMATE, V15, P2103, DOI 10.1175/1520-0442(2002)015&lt;2103:TRTATI&gt;2.0.CO;2; SATO M, 1993, J GEOPHYS RES-ATMOS, V98, P22987, DOI 10.1029/93JD02553; Stevenson DS, 2000, GEOPHYS RES LETT, V27, P2073, DOI 10.1029/1999GL010887; Tian H, 2000, GLOBAL ECOL BIOGEOGR, V9, P315, DOI 10.1046/j.1365-2699.2000.00198.x	29	263	269	3	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					212	U7		10.1038/nature06960	http://dx.doi.org/10.1038/nature06960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464740	Bronze, Green Accepted			2022-12-28	WOS:000255592400037
J	Fouchet, T; Guerlet, S; Strobel, DF; Simon-Miller, AA; Bezard, B; Flasar, FM				Fouchet, T.; Guerlet, S.; Strobel, D. F.; Simon-Miller, A. A.; Bezard, B.; Flasar, F. M.			An equatorial oscillation in Saturn's middle atmosphere	NATURE			English	Article							QUASI-BIENNIAL OSCILLATION; JUPITERS STRATOSPHERE; MODEL; TEMPERATURES; TROPOSPHERE; PLANETS; SYSTEM; WINDS; TIME	The middle atmospheres of planets are driven by a combination of radiative heating and cooling, mean meridional motions, and vertically propagating waves ( which originate in the deep troposphere). It is very difficult to model these effects and, therefore, observations are essential to advancing our understanding of atmospheres. The equatorial stratospheres of Earth and Jupiter oscillate quasi- periodically on timescales of about two and four years, respectively, driven by wave- induced momentum transport(1-5). On Venus and Titan, waves originating from surface atmosphere interaction and inertial instability are thought to drive the atmosphere to rotate more rapidly than the surface ( superrotation). However, the relevant wave modes have not yet been precisely identified. Here we report infrared observations showing that Saturn has an equatorial oscillation like those found on Earth and Jupiter, as well as a mid- latitude subsidence that may be associated with the equatorial motion. The latitudinal extent of Saturn's oscillation shows that it obeys the same basic physics as do those on Earth and Jupiter. Future highly resolved observations of the temperature profile together with modelling of these three different atmospheres will allow us determine the wave mode, the wavelength and the wave amplitude that lead to middle atmosphere oscillation.	[Fouchet, T.; Guerlet, S.; Bezard, B.] Univ Paris 06, Observ Paris, CNRS, LESIA, F-92195 Meudon, France; [Strobel, D. F.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Strobel, D. F.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Simon-Miller, A. A.; Flasar, F. M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Johns Hopkins University; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Fouchet, T (corresponding author), Univ Paris 06, Observ Paris, CNRS, LESIA, F-92195 Meudon, France.	thierry.fouchet@obspm.fr	Simon, Amy/C-8020-2012; Strobel, Darrell5/AAO-6643-2021; Flasar, F Michael/C-8509-2012; Fouchet, Thierry/C-6374-2017	Simon, Amy/0000-0003-4641-6186; Strobel, Darrell5/0000-0002-0944-8675; Fouchet, Thierry/0000-0001-9040-8285; Guerlet, Sandrine/0000-0001-5019-899X; Bezard, Bruno/0000-0002-5433-5661				Achterberg RK, 1996, ICARUS, V119, P350, DOI 10.1006/icar.1996.0024; Andrews D. G., 1987, MIDDLE ATMOSPHERE DY; Baldwin MP, 2001, REV GEOPHYS, V39, P179, DOI 10.1029/1999RG000073; BARNET CD, 1992, ICARUS, V98, P94, DOI 10.1016/0019-1035(92)90210-X; BEEBE RF, 1992, ICARUS, V95, P163, DOI 10.1016/0019-1035(92)90035-6; BEZARD B, 1985, ICARUS, V61, P296, DOI 10.1016/0019-1035(85)90110-1; CONRATH BJ, 1990, ICARUS, V83, P255, DOI 10.1016/0019-1035(90)90068-K; DUNKERTON TJ, 1991, J ATMOS SCI, V48, P236, DOI 10.1175/1520-0469(1991)048<0236:NPOZWI>2.0.CO;2; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; Flasar FM, 2004, NATURE, V427, P132, DOI 10.1038/nature02142; Friedson AJ, 1999, ICARUS, V137, P34, DOI 10.1006/icar.1998.6038; GRAY LJ, 1989, J ATMOS SCI, V46, P203, DOI 10.1175/1520-0469(1989)046<0203:ATDMOT>2.0.CO;2; Greathouse TK, 2005, ICARUS, V177, P18, DOI 10.1016/j.icarus.2005.02.016; HOLTON JR, 1972, J ATMOS SCI, V29, P1076, DOI 10.1175/1520-0469(1972)029<1076:AUTFTQ>2.0.CO;2; Li X, 2000, PLANET SPACE SCI, V48, P637, DOI 10.1016/S0032-0633(00)00033-7; LINDZEN RS, 1968, J ATMOS SCI, V25, P1095, DOI 10.1175/1520-0469(1968)025<1095:ATOTQB>2.0.CO;2; Moses JI, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002450; ORTON GS, 1991, SCIENCE, V252, P537, DOI 10.1126/science.252.5005.537; Sanchez-Lavega A, 2002, ICARUS, V158, P272, DOI 10.1006/icar.2002.6864; SCHINDER PJ, 2005, AGU FALL M; Simon-Miller AA, 2007, ICARUS, V186, P192, DOI 10.1016/j.icarus.2006.08.009	23	79	79	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					200	202		10.1038/nature06912	http://dx.doi.org/10.1038/nature06912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464737	Bronze			2022-12-28	WOS:000255592400034
J	Ciferri, C; Pasqualato, S; Screpanti, E; Varetti, G; Santaguida, S; Dos Reis, G; Maiolica, A; Polka, J; De Luca, JG; De Wulf, P; Salek, M; Rappsilber, J; Moores, CA; Salmon, ED; Musacchio, A				Ciferri, Claudio; Pasqualato, Sebastiano; Screpanti, Emanuela; Varetti, Gianluca; Santaguida, Stefano; Dos Reis, Gabriel; Maiolica, Alessio; Polka, Jessica; De Luca, Jennifer G.; De Wulf, Peter; Salek, Mogjiborahman; Rappsilber, Juri; Moores, Carolyn A.; Salmon, Edward D.; Musacchio, Andrea			Implications for kinetochore-microtubule attachment from the structure of an engineered Ndc80 complex	CELL			English	Article							MOLECULAR ARCHITECTURE; CENTROMERIC NUCLEOSOME; OUTER PLATE; CENP-A; CHECKPOINT; COMPONENTS; NETWORK; PROTEIN; SPACE	Kinetochores are proteinaceous assemblies that mediate the interaction of chromosomes with the mitotic spindle. The 180 kDa Ndc80 complex is a direct point of contact between kinetochores and microtubules. Its four subunits contain coiled coils and form an elongated rod structure with functional globular domains at either end. We crystallized an engineered "bonsai'' Ndc80 complex containing a shortened rod domain but retaining the globular domains required for kinetochore localization and microtubule binding. The structure reveals a microtubule-binding interface containing a pair of tightly interacting calponin-homology (CH) domains with a previously unknown arrangement. The interaction with microtubules is cooperative and predominantly electrostatic. It involves positive charges in the CH domains and in the N-terminal tail of the Ndc80 subunit and negative charges in tubulin C-terminal tails and is regulated by the Aurora B kinase. We discuss our results with reference to current models of kinetochore-microtubule attachment and centromere organization.	[Ciferri, Claudio; Pasqualato, Sebastiano; Screpanti, Emanuela; Varetti, Gianluca; Santaguida, Stefano; Dos Reis, Gabriel; Maiolica, Alessio; De Wulf, Peter; Musacchio, Andrea] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Polka, Jessica; Salmon, Edward D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [De Luca, Jennifer G.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Salek, Mogjiborahman] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Moores, Carolyn A.] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England; [Musacchio, Andrea] Italian Inst Technol Fdn, Res Unit, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO); University of North Carolina; University of North Carolina Chapel Hill; Colorado State University; University of Oxford; University of Edinburgh; University of London; Birkbeck University London; Istituto Italiano di Tecnologia - IIT	Musacchio, A (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	andrea.musacchio@ifom-ieo-campus.it	Rappsilber, Juri/ABF-3328-2020; Santaguida, Stefano/ABH-5433-2020; Pasqualato, Sebastiano/G-1032-2011; Rappsilber, Juri/B-7265-2015; santaguida, stefano/G-2716-2010; Moores, Carolyn/A-4942-2010; Moores, Carolyn A/R-2497-2019	Santaguida, Stefano/0000-0002-1501-6190; Rappsilber, Juri/0000-0001-5999-1310; Moores, Carolyn A/0000-0001-5686-6290; Salek, Mogjiborahman/0000-0002-6664-4752; Polka, Jessica/0000-0001-6610-9293; Pasqualato, Sebastiano/0000-0002-9038-7768; De Wulf, Peter/0000-0001-9772-5881; Musacchio, Andrea/0000-0003-2362-8784	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; NCI NIH HHS [K01 CA125051] Funding Source: Medline; NIGMS NIH HHS [R37 GM024364] Funding Source: Medline; Telethon [GGP06044] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA125051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024364] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cassimeris L, 2001, INT REV CYTOL, V210, P163; CASTRESANA J, 1995, FEBS LETT, V374, P149, DOI 10.1016/0014-5793(95)01098-Y; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cowtan K, 2000, ACTA CRYSTALLOGR D, V56, P1612, DOI 10.1107/S0907444900013263; COWTAN K, 2006, J CELL BIOL, V111, P1069; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Dougherty GW, 2005, CELL MOTIL CYTOSKEL, V62, P141, DOI 10.1002/cm.20093; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Kline-Smith SL, 2005, CURR OPIN CELL BIOL, V17, P35, DOI 10.1016/j.ceb.2004.12.009; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterman-Storer CM, 1998, BIOPHYS J, V75, P2059, DOI 10.1016/S0006-3495(98)77648-9; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102	53	383	388	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 2	2008	133	3					427	439		10.1016/j.cell.2008.03.020	http://dx.doi.org/10.1016/j.cell.2008.03.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455984	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000255503900014
J	Jansen, JO; Yule, SR; Loudon, MA				Jansen, Jan O.; Yule, Steven R.; Loudon, Malcolm A.			Investigation of blunt abdominal trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COMPUTED TOMOGRAPHIC SCAN; FOCUSED ASSESSMENT; ULTRASOUND; INJURY; SONOGRAPHY; MANAGEMENT; CT; GUIDELINES		[Jansen, Jan O.; Loudon, Malcolm A.] Aberdeen Royal Infirm, Dept Surg, Aberdeen AB25 2ZN, Scotland; [Yule, Steven R.] Aberdeen Royal Infirm, Dept Radiol, Aberdeen AB25 2ZN, Scotland	University of Aberdeen; University of Aberdeen	Jansen, JO (corresponding author), Aberdeen Royal Infirm, Dept Surg, Aberdeen AB25 2ZN, Scotland.	jan.jansen@nhs.net						*AM ASS SURG TRAUM, INJ SCAL SCOR SYST; Bain IM, 1998, INJURY, V29, P65, DOI 10.1016/S0020-1383(97)00166-6; Boulanger BR, 2000, AM SURGEON, V66, P1049; Boulanger BR, 1996, J TRAUMA, V40, P867, DOI 10.1097/00005373-199606000-00003; Brody JM, 2000, RADIOGRAPHICS, V20, P1525, DOI 10.1148/radiographics.20.6.g00nv021525; Gilroy D, 2005, INJURY, V36, P47, DOI 10.1016/j.injury.2004.04.015; Haan JM, 2005, J TRAUMA, V58, P492, DOI 10.1097/01.TA.0000154575.49388.74; Healey MA, 1996, J TRAUMA, V40, P875, DOI 10.1097/00005373-199606000-00004; Heetveld MJ, 2004, WORLD J SURG, V28, P904, DOI 10.1007/s00268-004-7357-9; Heetveld MJ, 2004, ANZ J SURG, V74, P520, DOI 10.1111/j.1445-2197.2004.03074.x; Hoff WS, 2002, J TRAUMA, V53, P602, DOI 10.1097/00005373-200209000-00038; Isenhour JL, 2007, EMERG MED CLIN N AM, V25, P713, DOI 10.1016/j.emc.2007.06.002; Livingston DH, 1998, J TRAUMA, V44, P273, DOI 10.1097/00005373-199802000-00005; Myers J, 2007, J TRAUMA, V62, pS28, DOI 10.1097/TA.0b013e3180654052; Nagy KK, 2000, INJURY, V31, P479, DOI 10.1016/S0020-1383(00)00010-3; National Confidential Enquiry into Patient Outcome and Death, 2007, TRAUM WHO CAR; Rodriguez C, 2002, J TRAUMA, V53, P79, DOI 10.1097/00005373-200207000-00016; Rozycki GS, 1998, ANN SURG, V228, P557, DOI 10.1097/00000658-199810000-00012; ROZYCKI GS, 1993, J TRAUMA, V34, P516, DOI 10.1097/00005373-199304000-00008; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Scalea TM, 1999, J TRAUMA, V46, P466, DOI 10.1097/00005373-199903000-00022; Shanmuganathan K, 2004, SEMIN ULTRASOUND CT, V25, P180, DOI 10.1016/j.sult.2004.02.002; SHUMAN WP, 2005, BLUNT ABDOMINAL TRAU; Stein Deborah M, 2006, J Intensive Care Med, V21, P296, DOI 10.1177/0885066606290854; Stengel D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004446.pub2; Stengel D, 2001, BRIT J SURG, V88, P901, DOI 10.1046/j.0007-1323.2001.01777.x; The Royal College of Radiologists, 2007, MAK BEST US CLIN RAD; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P844, DOI 10.1001/archsurg.138.8.844; Yao DC, 2002, AM J ROENTGENOL, V178, P17, DOI 10.2214/ajr.178.1.1780017	29	47	56	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2008	336	7650					938	942		10.1136/bmj.39534.686192.80	http://dx.doi.org/10.1136/bmj.39534.686192.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18436949	Green Published			2022-12-28	WOS:000255540900032
J	Mahadevan, A; Thomas, LN; Tandon, A				Mahadevan, Amala; Thomas, Leif N.; Tandon, Amit			Comment on "eddy/wind interactions stimulate extraordinary mid-ocean plankton blooms"	SCIENCE			English	Editorial Material							OCEAN FRONTS; MESOSCALE; PHYTOPLANKTON; MECHANISMS; EDDY; PART		[Mahadevan, Amala] Boston Univ, Dept Earth Sci, Boston, MA 02215 USA; [Thomas, Leif N.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Tandon, Amit] Univ Massachusetts, Dept Phys, N Dartmouth, MA 02747 USA; [Tandon, Amit] Univ Massachusetts, Dept Estuarine & Ocean Sci, N Dartmouth, MA 02747 USA	Boston University; Woods Hole Oceanographic Institution; University of Massachusetts System; University Massachusetts Dartmouth; University of Massachusetts System; University Massachusetts Dartmouth	Mahadevan, A (corresponding author), Boston Univ, Dept Earth Sci, Boston, MA 02215 USA.	amala@bu.edu	Tandon, Amit/ABA-4855-2021	Tandon, Amit/0000-0001-7124-1512				Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Capet X, 2008, J PHYS OCEANOGR, V38, P29, DOI 10.1175/2007JPO3671.1; Giordani H, 2006, OCEAN DYNAM, V56, P513, DOI 10.1007/s10236-005-0050-1; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Levy ML, 2004, P ROY SOC A-MATH PHY, V460, P1673, DOI 10.1098/rspa.2003.1219; Mahadevan A, 2006, OCEAN MODEL, V14, P241, DOI 10.1016/j.ocemod.2006.05.006; Martin AP, 2001, DEEP-SEA RES PT II, V48, P757, DOI 10.1016/S0967-0645(00)00096-5; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; NIILER PP, 1969, J GEOPHYS RES, V74, P7048, DOI 10.1029/JC074i028p07048; SAWYER JS, 1956, PROC R SOC LON SER-A, V234, P346, DOI 10.1098/rspa.1956.0039; Stern M.E., 1965, DEEP SEA RES OCEANOG, V12, P355, DOI [10.1016/0011-7471(65)90007-0, DOI 10.1016/0011-7471(65)90007-0]; Thomas LN, 2005, J PHYS OCEANOGR, V35, P1086, DOI 10.1175/JPO2737.1; Thomas LN, 2002, J FLUID MECH, V473, P211, DOI 10.1017/S0022112002002367	13	127	131	5	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875								10.1126/science.1152111	http://dx.doi.org/10.1126/science.1152111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436758				2022-12-28	WOS:000255249300017
J	Cook, JA				Cook, Joseph A.			Eliminating binding trachoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLINDING TRACHOMA		Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cook, JA (corresponding author), Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA.							GRADLE HS, 1940, SIGHT SAVING REV, V10, P13; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Kuper H, 2003, LANCET INFECT DIS, V3, P372, DOI 10.1016/S1473-3099(03)00659-5; La Guardia Fiorello H., 1961, MAKING INSURGENT AUT; Mecaskey JW, 2003, LANCET INFECT DIS, V3, P728, DOI 10.1016/S1473-3099(03)00807-7	5	12	15	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1777	1779		10.1056/NEJMp0708546	http://dx.doi.org/10.1056/NEJMp0708546			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434650				2022-12-28	WOS:000255209200003
J	Wood, AJJ				Wood, Alastair J. J.			Playing "Kick the FDA" - Risk-free to players but hazardous to public health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wood, Alastair J. J.] Symphony Capital, New York, NY USA; [Wood, Alastair J. J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Wood, AJJ (corresponding author), Symphony Capital, New York, NY USA.							Food and Drug Administration Science Board, 2007, FDA SCI MISS RISK RE; MATHEWS AW, 2008, WALL STREET J   0320, pA4; 2005, SEATTLE TIMES   1021	3	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1774	1775		10.1056/NEJMp0802227	http://dx.doi.org/10.1056/NEJMp0802227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434649				2022-12-28	WOS:000255209200002
J	Alberti, FB				Alberti, Fay Bound			Historical keyword - The body	LANCET			English	Editorial Material									Univ Lancaster, Dept Hist, Lancaster, England	Lancaster University	Alberti, FB (corresponding author), Univ Lancaster, Dept Hist, Lancaster, England.	f.boundalberti@lancaster.ac.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 19	2008	371	9621					1329	1329		10.1016/S0140-6736(08)60581-4	http://dx.doi.org/10.1016/S0140-6736(08)60581-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424314				2022-12-28	WOS:000255208500012
J	Eagle, K				Eagle, Kim			Coronary artery disease in India: challenges and opportunities	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; RISK-FACTORS; COUNTRIES; MORTALITY		Univ Michigan, Med Ctr, Div Cardiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eagle, K (corresponding author), Univ Michigan, Med Ctr, Div Cardiol, Ann Arbor, MI 48109 USA.	keagle@umich.edu						Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Eagle KA, 2005, J AM COLL CARDIOL, V46, P1242, DOI 10.1016/j.jacc.2004.12.083; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Joshi P, 2007, JAMA-J AM MED ASSOC, V297, P286, DOI 10.1001/jama.297.3.286; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MULLERNORDHORN J, 2008, EUR HEART J     0206, DOI DOI 10.1093/EURHEARTJ/EHM604; Reddy KS, 2007, P NATL ACAD SCI USA, V104, P16263, DOI 10.1073/pnas.0700933104; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	11	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1394	1395		10.1016/S0140-6736(08)60606-6	http://dx.doi.org/10.1016/S0140-6736(08)60606-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440413				2022-12-28	WOS:000255440600006
J	Moore, DM; Mermin, J				Moore, David M.; Mermin, Jonathan			Monitoring antiretroviral failure in resource-poor settings	LANCET			English	Editorial Material							HIV-1-INFECTED PATIENTS; THERAPY		[Moore, David M.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6T 1Y6, Canada; [Mermin, Jonathan] US Ctr Dis Control & Prevent, Coordinating Ctr Global Hlth, Nairobi, Kenya	B.C. Centre for Excellence in HIV/AIDS	Moore, DM (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6T 1Y6, Canada.	dmoore@cfenet.ubc.ca	Mermin, Jonathan/J-9847-2012					Bisson GP, 2006, AIDS, V20, P1613, DOI 10.1097/01.aids.0000238407.00874.dc; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; COUTINHO A, 2007, 15 C RETR OPP INF 20, P125; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; HOSSEINIPOUR M, 2007, 4 INT AIDS SOC C HIV; Kagaayi J, 2007, AIDS, V21, P1208, DOI 10.1097/QAD.0b013e32810c8dce; Martinson N, 2005, 3 IAS C HIV PATH TRE; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moore DM, 2006, JAIDS-J ACQ IMM DEF, V43, P436, DOI 10.1097/01.qai.0000243105.80393.42; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; World Health Organization, 2006, ANT THER HIV INF AD	12	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1396	1397		10.1016/S0140-6736(08)60607-8	http://dx.doi.org/10.1016/S0140-6736(08)60607-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294XW	18440414				2022-12-28	WOS:000255440600007
J	Lund, JM; Hsing, L; Pham, TT; Rudensky, AY				Lund, Jennifer M.; Hsing, Lianne; Pham, Thuy T.; Rudensky, Alexander Y.			Coordination of early protective immunity to viral infection by regulatory T cells	SCIENCE			English	Article							TRANSCRIPTION FACTOR FOXP3; SIMPLEX-VIRUS TYPE-2; DENDRITIC CELLS; PERSISTENCE; RESPONSES; DISEASE; MICE	Suppression of immune responses by regulatory T cells ( Tregs) is thought to limit late stages of pathogen- specific immunity as a means of minimizing associated tissue damage. We examined a role for Tregs during mucosal herpes simplex virus infection in mice, and observed an accelerated fatal infection with increased viral loads in the mucosa and central nervous system after ablation of Tregs. Although augmented interferon production was detected in the draining lymph nodes ( dLNs) in Treg- deprived mice, it was profoundly reduced at the infection site. This was associated with a delay in the arrival of natural killer cells, dendritic cells, and T cells to the site of infection and a sharp increase in proinflammatory chemokine levels in the dLNs. Our results suggest that Tregs facilitate early protective responses to local viral infection by allowing a timely entry of immune cells into infected tissue.	[Lund, Jennifer M.; Hsing, Lianne; Pham, Thuy T.; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Lund, Jennifer M.; Hsing, Lianne; Pham, Thuy T.; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	aruden@u.washington.edu		Lund, Jennifer/0000-0003-3284-979X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Harandi AM, 2003, J VIROL, V77, P953, DOI 10.1128/JVI.77.2.953-962.2003; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; MILLIGAN GN, 1995, VIROLOGY, V212, P481, DOI 10.1006/viro.1995.1506; Parr MB, 1999, VIROLOGY, V258, P282, DOI 10.1006/viro.1999.9739; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Suvas S, 2003, J EXP MED, V198, P889, DOI 10.1084/jem.20030171; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	17	338	352	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 30	2008	320	5880					1220	1224		10.1126/science.1155209	http://dx.doi.org/10.1126/science.1155209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18436744	Green Accepted			2022-12-28	WOS:000256233000040
J	Richard, DJ; Bolderson, E; Cubeddu, L; Wadsworth, RIM; Savage, K; Sharma, GG; Nicolette, ML; Tsvetanov, S; McIlwraith, MJ; Pandita, RK; Takeda, S; Hay, RT; Gautier, J; West, SC; Paull, TT; Pandita, TK; White, MF; Khanna, KK				Richard, Derek J.; Bolderson, Emma; Cubeddu, Liza; Wadsworth, Ross I. M.; Savage, Kienan; Sharma, Girdhar G.; Nicolette, Matthew L.; Tsvetanov, Sergie; McIlwraith, Michael J.; Pandita, Raj K.; Takeda, Shunichi; Hay, Ronald T.; Gautier, Jean; West, Stephen C.; Paull, Tanya T.; Pandita, Tej K.; White, Malcolm F.; Khanna, Kum Kum			Single-stranded DNA-binding protein hSSB1 is critical for genomic stability	NATURE			English	Article							MAMMALIAN-CELLS; RAD52 PROTEIN; BREAK REPAIR; S-PHASE; DAMAGE; ATM; PHOSPHORYLATION; RECOMBINATION; ACTIVATION; CHECKPOINT	Single- strand DNA ( ssDNA)- binding proteins ( SSBs) are ubiquitous and essential for a wide variety of DNA metabolic processes, including DNA replication, recombination, DNA damage detection and repair(1). SSBs have multiple roles in binding and sequestering ssDNA, detecting DNA damage, stimulating nucleases, helicases and strand- exchange proteins, activating transcription and mediating protein - protein interactions. In eukaryotes, the major SSB, replication protein A ( RPA), is a heterotrimer(1). Here we describe a second human SSB ( hSSB1), with a domain organization closer to the archaeal SSB than to RPA. Ataxia telangiectasia mutated ( ATM) kinase phosphorylates hSSB1 in response to DNA double- strand breaks ( DSBs). This phosphorylation event is required for DNA damage- induced stabilization of hSSB1. Upon induction of DNA damage, hSSB1 accumulates in the nucleus and forms distinct foci independent of cell- cycle phase. These foci co-localize with other known repair proteins. In contrast to RPA, hSSB1 does not localize to replication foci in S- phase cells and hSSB1 deficiency does not influence S- phase progression. Depletion of hSSB1 abrogates the cellular response to DSBs, including activation of ATM and phosphorylation of ATM targets after ionizing radiation. Cells deficient in hSSB1 exhibit increased radiosensitivity, defective checkpoint activation and enhanced genomic instability coupled with a diminished capacity for DNA repair. These findings establish that hSSB1 influences diverse end-points in the cellular DNA damage response.	[Richard, Derek J.; Bolderson, Emma; Savage, Kienan; Tsvetanov, Sergie; Khanna, Kum Kum] Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia; [Cubeddu, Liza; Wadsworth, Ross I. M.; White, Malcolm F.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Cubeddu, Liza] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Savage, Kienan] Univ Queensland, Cent Clin Div, Sch Med, Brisbane, Qld 4072, Australia; [Sharma, Girdhar G.; Pandita, Raj K.; Pandita, Tej K.] Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63108 USA; [Nicolette, Matthew L.; Paull, Tanya T.] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto 6068501, Japan; [Hay, Ronald T.] Univ Dundee, Div Gene Regulat & Express, Wellcome Bioctr, Dundee DD1 5EH, Scotland; [Gautier, Jean] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA	QIMR Berghofer Medical Research Institute; University of St Andrews; University of Sydney; University of Queensland; Washington University (WUSTL); University of Texas System; University of Texas Austin; Cancer Research UK; Kyoto University; University of Dundee; Columbia University	Khanna, KK (corresponding author), Queensland Inst Med Res, Signal Transduct Lab, Brisbane, Qld 4029, Australia.	mfw2@st-and.ac.uk; kumkumK@qimr.edu.au	Hay, Ronald/S-3233-2019; Pandita, Tej K/AAM-9188-2020; Richard, Derek/J-1338-2012; Hay, Ronald T/F-9338-2011; Khanna, Kum Kum/I-1747-2013; White, Malcolm F/A-6055-2010; Bolderson, Emma/B-8743-2013	Hay, Ronald/0000-0001-7113-9024; Richard, Derek/0000-0002-4839-8471; Hay, Ronald T/0000-0001-7113-9024; White, Malcolm F/0000-0003-1543-9342; Mcilwraith, Michael/0000-0003-1559-4369; Savage, Kienan/0000-0002-4898-899X; Paull, Tanya/0000-0002-2991-651X; Khanna, Kum Kum/0000-0001-8650-5381; Bolderson, Emma/0000-0002-2849-1177; West, Stephen/0000-0001-8848-9418	Biotechnology and Biological Sciences Research Council [BB/C000110/1] Funding Source: Medline; NCI NIH HHS [CA92245, CA10445, CA123232] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA092245, R01CA123232] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aparicio O. M., 2005, CURRENT PROTOCOLS MO; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Dodson GE, 2004, J BIOL CHEM, V279, P34010, DOI 10.1074/jbc.C400242200; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Gatei M, 2000, CANCER RES, V60, P3299; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lisby M, 2004, CURR OPIN CELL BIOL, V16, P328, DOI 10.1016/j.ceb.2004.03.011; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; New JH, 2002, J BIOL CHEM, V277, P26171, DOI 10.1074/jbc.M203670200; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; SLAVOTINEK A, 1994, EUR J CANCER, V30A, P1376, DOI 10.1016/0959-8049(94)90189-9; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WOLD MS, 1997, ANNU REV BIOCHEM, V66, P3050; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	27	183	193	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 29	2008	453	7195					677	U13		10.1038/nature06883	http://dx.doi.org/10.1038/nature06883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305NN	18449195				2022-12-28	WOS:000256185200049
J	Burn, J				Burn, John			Can a cell have a soul?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Burn, John] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Burn, J (corresponding author), Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England.	john.burn@newcastle.ac.uk		Burn, John/0000-0002-9823-2322					0	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1132	1132		10.1136/bmj.39581.436875.94	http://dx.doi.org/10.1136/bmj.39581.436875.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483057	Green Published			2022-12-28	WOS:000255975100044
J	Hanna, JB; Schmitt, D; Griffin, TM				Hanna, Jandy B.; Schmitt, Daniel; Griffin, Timothy M.			The energetic cost of climbing in primates	SCIENCE			English	Article							ORIGINS		[Hanna, Jandy B.; Schmitt, Daniel; Griffin, Timothy M.] Duke Univ, Med Ctr, Dept Surg, Orthopaed Bioengn Lab, Durham, NC 27710 USA	Duke University	Hanna, JB (corresponding author), W Virginia Sch Osteopath Med, Lewisburg, WV 24901 USA.	jhanna@wvsom.edu	Griffin, Timothy M./V-8838-2019	Griffin, Timothy M./0000-0001-8840-9940; Hanna, Jandy/0000-0003-1543-973X	NCRR NIH HHS [P40-RR001254] Funding Source: Medline; NIAMS NIH HHS [AR051672] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051672] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Booth J, 1999, BRIT J SPORT MED, V33, P14, DOI 10.1136/bjsm.33.1.14; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; FULL RJ, 1990, J EXP BIOL, V149, P307; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; Soligo C, 2006, J HUM EVOL, V50, P414, DOI 10.1016/j.jhevol.2005.11.001; TAYLOR CR, 1972, SCIENCE, V178, P1096, DOI 10.1126/science.178.4065.1096	7	50	50	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					898	898		10.1126/science.1155504	http://dx.doi.org/10.1126/science.1155504			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487185				2022-12-28	WOS:000255868300033
J	Peacock, WF; De Marco, T; Fonarow, GC; Diercks, D; Wynne, J; Apple, FS; Wu, AHB				Peacock, W. Frank; De Marco, Teresa; Fonarow, Gregg C.; Diercks, Deborah; Wynne, Janet; Apple, Fred S.; Wu, Alan H. B.		ADHERE Investigators	Cardiac troponin and outcome in acute heart failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; NATRIURETIC PEPTIDE; RISK STRATIFICATION; MORTALITY; DYSFUNCTION	Background: Cardiac troponin provides diagnostic and prognostic information in acute coronary syndromes, but its role in acute decompensated heart failure is unclear. The purpose of our study was to describe the association between elevated cardiac troponin levels and adverse events in hospitalized patients with acute decompensated heart failure. Methods: We analyzed hospitalizations for acute decompensated heart failure between October 2001 and January 2004 that were recorded in the Acute Decompensated Heart Failure National Registry (ADHERE). Entry criteria included a troponin level that was obtained at the time of hospitalization in patients with a serum creatinine level of less than 2.0 mg per deciliter (177 micromol per liter). A positive troponin test was defined as a cardiac troponin I level of 1.0 mu g per liter or higher or a cardiac troponin T level of 0.1 mu g per liter or higher. Results: Troponin was measured at the time of admission in 84,872 of 105,388 patients (80.5%) who were hospitalized for acute decompensated heart failure. Of these patients, 67,924 had a creatinine level of less than 2.0 mg per deciliter. Cardiac troponin I was measured in 61,379 patients, and cardiac troponin T in 7880 patients (both proteins were measured in 1335 patients). Overall, 4240 patients (6.2%) were positive for troponin. Patients who were positive for troponin had lower systolic blood pressure on admission, a lower ejection fraction, and higher in-hospital mortality (8.0% vs. 2.7%, P<0.001) than those who were negative for troponin. The adjusted odds ratio for death in the group of patients with a positive troponin test was 2.55 (95% confidence interval, 2.24 to 2.89; P<0.001 by the Wald test). Conclusions: In patients with acute decompensated heart failure, a positive cardiac troponin test is associated with higher in-hospital mortality, independently of other predictive variables. (ClinicalTrials.gov number, NCT00366639.).	[Peacock, W. Frank] Cleveland Clin Fdn, Dept Emergency Med, Cleveland, OH 44195 USA; [De Marco, Teresa] Univ Calif San Francisco, Div Cardiol, San Francisco, CA 94143 USA; [Wu, Alan H. B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Diercks, Deborah] Univ Calif Davis, Dept Emergency Med, Sacramento, CA 95817 USA; [Wynne, Janet] Scios, Dept Stat, Mountain View, CA USA; [Apple, Fred S.] Hennepin Cty Med Ctr, Dept Lab Med & Pathol, Minneapolis, MN 55415 USA; [Apple, Fred S.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	Cleveland Clinic Foundation; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Davis; Scios; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Peacock, WF (corresponding author), Cleveland Clin Fdn, Dept Emergency Med E19, 9500 Euclid Ave, Cleveland, OH 44195 USA.	peacocw@ccf.org	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Angheloiu GO, 2004, RESUSCITATION, V63, P195, DOI 10.1016/j.resuscitation.2004.05.018; Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048; Burkhardt J, 2005, ACAD EMERG MED, V12, P869, DOI 10.1197/j.aem.2005.03.534; Del Carlo CH, 1999, AM HEART J, V138, P646, DOI 10.1016/S0002-8703(99)70178-X; Diercks DB, 2006, AM J EMERG MED, V24, P319, DOI 10.1016/j.ajem.2005.11.014; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 4, pS20; Gattis WA, 2004, AM J CARDIOL, V93, P1436, DOI 10.1016/j.amjcard.2004.02.051; Goto T, 2003, HEART, V89, P1303, DOI 10.1136/heart.89.11.1303; Horwich TB, 2003, CIRCULATION, V108, P833, DOI 10.1161/01.CIR.0000084543.79097.34; Ishii J, 2002, AM J CARDIOL, V89, P691, DOI 10.1016/S0002-9149(01)02341-4; Lowbeer C, 2004, SCAND J CLIN LAB INV, V64, P667, DOI 10.1080/00365510410003002; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; Peacock W Frank, 2003, Congest Heart Fail, V9, P303, DOI 10.1111/j.1527-5299.2003.02036.x; Perna ER, 2004, MED SCI MONITOR, V10, pCR90; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Xue CC, 2003, CHINESE MED J-PEKING, V116, P469; You JJ, 2007, AM HEART J, V153, P462, DOI 10.1016/j.ahj.2007.01.027	21	487	667	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2117	2126		10.1056/NEJMoa0706824	http://dx.doi.org/10.1056/NEJMoa0706824			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480204	Bronze			2022-12-28	WOS:000255849300005
J	Donnan, GA; Fisher, M; Macleod, M; Davis, SM				Donnan, Geoffrey A.; Fisher, Marc; Macleod, Malcolm; Davis, Stephen M.			Stroke	LANCET			English	Review							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; CAPSULAR WARNING SYNDROME; MIDDLE CEREBRAL-ARTERY; HIGH-RISK; BLOOD-PRESSURE; HEMORRHAGIC TRANSFORMATION; INTRACEREBRAL HEMORRHAGE; POOLED ANALYSIS; SUBARACHNOID HEMORRHAGE	Stroke is the second most common cause of death and major cause of disability worldwide. Because of the ageing population, the burden will increase greatly during the next 20 years, especially in developing countries. Advances have occurred in the prevention and treatment of stroke during the past decade. For patients with acute stroke, management in a stroke care unit, intravenous tissue plasminogen activator within 3 h or aspirin within 48 h of stroke onset, and decompressive surgery for supratentorial malignant hemispheric cerebral infarction are interventions of proven benefit; several other interventions are being assessed. Proven secondary prevention strategies are warfarin for patients with atrial fibrillation, endarterectomy for symptomatic carotid stenosis, antiplatelet agents, and cholesterol reduction. The most important intervention is the management of patients in stroke care units because these provide a framework within which further study might be undertaken. These advances have exposed a worldwide shortage of stroke health-care workers, especially in developing countries.	[Donnan, Geoffrey A.] Univ Melbourne, Natl Stroke Res Inst, Austin Hosp, Melbourne, Vic, Australia; [Fisher, Marc] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Macleod, Malcolm] Stirling Royal Infirm, Dept Neurol, Stirling, Scotland; [Davis, Stephen M.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Massachusetts System; University of Massachusetts Worcester; Royal Melbourne Hospital; University of Melbourne	Donnan, GA (corresponding author), Univ Melbourne, Natl Stroke Res Inst, Austin Hosp, 300 Waterdale Rd, Heidelberg Hts, Vic 3081, Australia.	gdonnan@unimelb.edu.au	Macleod, Malcolm Robert/B-2052-2010	Macleod, Malcolm Robert/0000-0001-9187-9839; Brown, Martin M/0000-0002-3273-1356; Donnan, Geoffrey/0000-0001-6324-3403				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Agyeman O, 2006, STROKE, V37, P963, DOI 10.1161/01.STR.0000206546.76860.6b; Akins PT, 2007, STROKE, V38, P874, DOI 10.1161/01.STR.0000258004.64840.0b; Albers GW, 2003, LANCET, V362, P1691; Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Algra A, 1996, J NEUROL NEUROSUR PS, V60, P197, DOI 10.1136/jnnp.60.2.197; *AM HEART ASS, 1997, HEART STROK FACTS ST; Amarenco P, 2005, CURR OPIN LIPIDOL, V16, P614, DOI 10.1097/01.mol.0000194127.99968.ca; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 1987, Lancet, V2, P1351; Auer RN, 2005, CAN J NEUROL SCI, V32, pS3; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; BOGOUSSLAVSKY J, 1984, STROKE, V15, P536, DOI 10.1161/01.STR.15.3.536; BONITA R, 1987, NEW ZEAL MED J, V100, P454; BONITA R, 1986, BRIT MED J, V292, P191, DOI 10.1136/bmj.292.6514.191; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; BONITA R, 1989, HYPERTENSION S1, V13, P169; Bornstein N, 2006, CLIN EXP HYPERTENS, V28, P317, DOI 10.1080/10641960600549405; Broderick J, 2004, STROKE, V35, P904, DOI 10.1161/01.STR.0000121641.77121.98; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brown MM, 2001, LANCET, V357, P1729; Cadilhac DA, 2004, STROKE, V35, P1035, DOI 10.1161/01.STR.0000125709.17337.5d; *CAN COOP STUD GRO, 1978, NEW ENGL J MED, V299, P53; Chambers BR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001923.pub2; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Collins R, 2003, LANCET, V361, P2005; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; De Cristobal J, 2001, J NEUROCHEM, V79, P456, DOI 10.1046/j.1471-4159.2001.00600.x; Dewey H, 2001, J CLIN NEUROSCI, V8, P14, DOI 10.1054/jocn.2000.0786; Dewey HM, 2001, STROKE, V32, P2409, DOI 10.1161/hs1001.097222; Diener HC, 2006, INT J STROKE, V1, P4, DOI 10.1111/j.1747-4949.2005.00016.x; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Donnan GA, 2003, STROKE, V34, P372, DOI 10.1161/01.STR.0000054670.86396.96; Donnan GA, 1996, CEREBROVASC DIS, V6, P202, DOI 10.1159/000108022; Donnan GA, 2002, LANCET NEUROL, V1, P417, DOI 10.1016/S1474-4422(02)00189-8; DONNAN GA, 1993, NEUROLOGY, V43, P957, DOI 10.1212/WNL.43.5.957; DONNAN GA, 1989, LANCET, V2, P643; Donnan GA, 2007, ISCHEMIC PENUMBRA, P7; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; Donnan GA, 2006, STROKE, V37, P2521, DOI 10.1161/01.STR.0000239696.61545.4b; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Fiorelli M, 1999, STROKE, V30, P2280, DOI 10.1161/01.STR.30.11.2280; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Fisher M, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000074790; Fisher M, 1996, NEUROLOGY, V47, P884, DOI 10.1212/WNL.47.4.884; Fisher M, 2006, INT J STROKE, V1, P52, DOI 10.1111/j.1747-4949.2006.00025.x; FRANK JI, 1995, NEUROLOGY, V45, P1286, DOI 10.1212/WNL.45.7.1286; Furlan A, 1999, JAMA-J AM MED ASSOC, V282, P2003, DOI 10.1001/jama.282.21.2003; Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; Furlan AJ, 2005, STROKE, V36, P398, DOI 10.1161/01.STR.0000153057.07181.94; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gerstein HC, 2000, LANCET, V355, P253; Gilligan AK, 2005, CEREBROVASC DIS, V20, P239, DOI 10.1159/000087705; Gulyas B, 1999, J NEUROIMAGING, V9, P217, DOI 10.1111/jon199994217; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 2004, LANCET, V363, P768; Halkes PHA, 2006, LANCET, V367, P1665; Hankey GJ, 1999, LANCET, V354, P1457, DOI 10.1016/S0140-6736(99)04407-4; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Hillis AE, 2005, CURR HYPERTENS REP, V7, P72, DOI 10.1007/s11906-005-0058-4; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; *INT STROK CTR, 2007, INT BLOOD PRESS RED; *INT STROK CTR, 2007, SAINT 2 STROK AC ISC; Johnson SC, 2005, NEUROLOGY, V64, P654; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kakuda W, 2008, J CEREBR BLOOD F MET, V28, P887, DOI 10.1038/sj.jcbfm.9600604; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Katz JM, 2005, NEUROSURG CLIN N AM, V16, P463, DOI 10.1016/j.nec.2005.03.002; Kidwell CS, 1999, STROKE, V30, P1174, DOI 10.1161/01.STR.30.6.1174; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Langhorne P, 2005, AGE AGEING, V34, P324, DOI 10.1093/ageing/afi038; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; Lawes CMM, 2004, STROKE, V35, P1024, DOI 10.1161/01.STR.0000126208.14181.DD; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ly JV, 2006, EXPERT OPIN PHARMACO, V7, P1571, DOI 10.1517/14656566.7.12.1571; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; MAYBERG MR, 1994, STROKE, V25, P2315, DOI 10.1161/01.STR.25.11.2315; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mead GE, 2002, AGE AGEING, V31, P429, DOI 10.1093/ageing/31.6.429; Mehdiratta M, 2006, CAN J NEUROL SCI, V33, P214, DOI 10.1017/S031716710000500X; Mendelow AD, 2005, LANCET, V365, P387; Mohr JP, 2001, NEW ENGL J MED, V345, P1444, DOI 10.1056/NEJMoa011258; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Neal B, 2000, LANCET, V356, P1955; Nedeltchev K, 2006, STROKE, V37, P3002, DOI 10.1161/01.STR.0000249417.24085.80; Norrving B, 2003, LANCET NEUROL, V2, P238, DOI 10.1016/S1474-4422(03)00352-1; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Qizilbash N, 1995, LANCET, V346, P1647; Qureshi AI, 2006, CRIT CARE MED, V34, P1975, DOI 10.1097/01.CCM.0000220763.85974.E8; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rodgers A, 1998, LANCET, V352, P1801; Rothrock S, 2005, BIOPHARM INT, V18, P28; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2006, LANCET NEUROL, V5, P323, DOI 10.1016/S1474-4422(06)70408-2; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2001, LANCET, V357, P1612, DOI 10.1016/S0140-6736(00)04730-9; Sandercock P, 1997, LANCET, V349, P1569; Sandercock P, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000029; Sherman DG, 2007, LANCET, V369, P1347, DOI 10.1016/S0140-6736(07)60633-3; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Sprigg N, 2006, J HYPERTENS, V24, P1413, DOI 10.1097/01.hjh.0000234123.55895.12; *STROK TRIALS REG, ECASS III PLAC CONTR; *STROK TRIALS REG, REOPRO RET REP STROK; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Taylor FC, 2001, BMJ-BRIT MED J, V322, P321, DOI 10.1136/bmj.322.7282.321; Thomas D, 2006, INT J STROKE, V1, P245, DOI 10.1111/j.1747-4949.2006.00059.x; Thrift AG, 1995, EPIDEMIOL REV, V17, P361, DOI 10.1093/oxfordjournals.epirev.a036199; Thrift AG, 2006, STROKE, V37, P877, DOI 10.1161/01.STR.0000202588.95876.a7; Thrift AG, 2001, STROKE, V32, P1732, DOI 10.1161/01.STR.32.8.1732; Topol EJ, 2003, CIRCULATION, V108, P399, DOI 10.1161/01.CIR.0000084501.48570.F6; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213; Wardlaw JM, 1996, J NEUROL, V243, P274, DOI 10.1007/BF00868526; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Warlow C. P., 2001, PRACTICAL GUIDE MANA; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; Whisnant JP, 1997, STROKE, V28, P1840, DOI 10.1161/01.STR.28.9.1840; Whiteley W, 2006, INT J STROKE, V1, P172, DOI 10.1111/j.1747-4949.2006.00043.x; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145	157	1908	2029	11	431	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1612	1623		10.1016/S0140-6736(08)60694-7	http://dx.doi.org/10.1016/S0140-6736(08)60694-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468545				2022-12-28	WOS:000255715400029
J	Wolf, D; Wolf, AM				Wolf, Dominik; Wolf, Anna Maria			Mesenchymal stem cells as cellular immunosuppressants	LANCET			English	Editorial Material							VERSUS-HOST-DISEASE; REGULATORY T-CELLS; GRAFT		[Wolf, Dominik] Med Univ Innsbruck, Dept Haematol & Oncol, A-6020 Innsbruck, Austria; [Wolf, Anna Maria] Med Univ Innsbruck, Tyrolean Canc Res Ctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Wolf, D (corresponding author), Med Univ Innsbruck, Dept Haematol & Oncol, A-6020 Innsbruck, Austria.	dominik.wolf@i-med.ac.at						Deeg HJ, 2007, BLOOD, V109, P4119, DOI 10.1182/blood-2006-12-041889; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Wolf D, 2007, TRANSPLANTATION, V83, P1107, DOI 10.1097/01.tp.0000260140.04815.77	9	34	36	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1553	1554		10.1016/S0140-6736(08)60666-2	http://dx.doi.org/10.1016/S0140-6736(08)60666-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468526				2022-12-28	WOS:000255715400004
J	Zmuda, JM; Kammerer, CM				Zmuda, Joseph M.; Kammerer, Candace M.			Snipping away at osteoporosis susceptibility	LANCET			English	Editorial Material							HIGH-BONE-MASS; RISK; MUTATION; FRACTURE; LINKAGE		[Zmuda, Joseph M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Zmuda, Joseph M.; Kammerer, Candace M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zmuda, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15261 USA.	zmudaj@edc.pitt.edu		Kammerer, Candace M/0000-0002-2841-4761				Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Fox KM, 1998, OSTEOPOROSIS INT, V8, P557, DOI 10.1007/s001980050099; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; JI W, 2008, NAT GENET; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; LETTRE G, 2008, NAT GENET; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; MOFFETT SP, 2008, J CLIN ENDOCRINOL ME; Pennisi E, 2007, SCIENCE, V318, P1842, DOI 10.1126/science.318.5858.1842; Richards J.B., 2008, LANCET; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Zmuda Joseph M, 2005, Curr Osteoporos Rep, V3, P111, DOI 10.1007/s11914-005-0019-5	17	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 3	2008	371	9623					1479	1480		10.1016/S0140-6736(08)60600-5	http://dx.doi.org/10.1016/S0140-6736(08)60600-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18455229				2022-12-28	WOS:000255668300004
J	Carracedo, A; Salmena, L; Pandolfi, PP				Carracedo, Arkaitz; Salmena, Leonardo; Pandolfi, Pier Paolo			SnapShot: PTEN signaling pathways	CELL			English	Editorial Material							TUMOR-SUPPRESSOR; GENE		[Carracedo, Arkaitz; Salmena, Leonardo; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Carracedo, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.		Carracedo, Arkaitz/F-7029-2011	Carracedo, Arkaitz/0000-0001-5957-1260; Salmena, Leonardo/0000-0003-4023-658X				Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039	8	11	11	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					550	U15		10.1016/j.cell.2008.04.023	http://dx.doi.org/10.1016/j.cell.2008.04.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455993	Bronze			2022-12-28	WOS:000255503900025
J	O'Neill, LAJ				O'Neill, Luke A. J.			Immunology - How frustration leads to inflammation	SCIENCE			English	Editorial Material							INTERLEUKIN-1 PRODUCTION; ALVEOLAR MACROPHAGES; NALP3 INFLAMMASOME; CRYSTALS; SILICA; CELLS		Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie						Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; HUNTER J, 1794, TREATISE GUN SHOT WO; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; McDermott MF, 2007, TRENDS MOL MED, V13, P381, DOI 10.1016/j.molmed.2007.07.005; OGHISO Y, 1986, MICROBIOL IMMUNOL, V30, P1189, DOI 10.1111/j.1348-0421.1986.tb03047.x; OGHISO Y, 1987, MICROBIOL IMMUNOL, V31, P275, DOI 10.1111/j.1348-0421.1987.tb03090.x; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; PIGUET PF, 1993, CYTOKINE, V5, P57, DOI 10.1016/1043-4666(93)90024-Y; Wang YH, 2004, INT J ONCOL, V25, P173	13	38	39	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					619	620		10.1126/science.1158398	http://dx.doi.org/10.1126/science.1158398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451288				2022-12-28	WOS:000255454300029
J	Naldi, L				Naldi, Luigi			The search for effective and safe disease control in psoriasis	LANCET			English	Editorial Material							RISK; CYCLOSPORINE; COHORT		[Naldi, Luigi] Osped Riuniti Bergamo, Unit Dermatol, I-24100 Bergamo, Italy; [Naldi, Luigi] Osped Riuniti Bergamo, GISED Study Ctr, I-24100 Bergamo, Italy	Ospedali Riuniti di Bergamo; Ospedali Riuniti di Bergamo	Naldi, L (corresponding author), Osped Riuniti Bergamo, Unit Dermatol, I-24100 Bergamo, Italy.	Luigi.naldi@gised.it	Naldi, Luigi/K-6343-2016; Naldi, Luigi/AFM-8982-2022	Naldi, Luigi/0000-0002-3160-2835; Naldi, Luigi/0000-0002-3160-2835				HARPER JI, 1984, LANCET, V2, P981; Huerta C, 2007, ARCH DERMATOL, V143, P1559, DOI 10.1001/archderm.143.12.1559; Katz KA, 2006, BRIT J DERMATOL, V154, P809, DOI 10.1111/j.1365-2133.2006.07225.x; Liptak P, 2006, NAT CLIN PRACT NEPHR, V2, P398, DOI 10.1038/ncpneph0225; Marcil I, 2001, LANCET, V358, P1042, DOI 10.1016/S0140-6736(01)06179-7; Naldi L, 2003, J INVEST DERMATOL, V120, P738, DOI 10.1046/j.1523-1747.2003.12145.x; Papp K, 2008, LANCET, V371, P1337, DOI 10.1016/S0140-6736(08)60593-0; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x; Remuzzi G, 2004, LANCET, V364, P1723, DOI 10.1016/S0140-6736(04)17360-1; Setty AR, 2007, ARCH INTERN MED, V167, P1670, DOI 10.1001/archinte.167.15.1670; UPDIKE J, 1980, PROBLEMS OTHER STORI, P181; van de Kerkhof PCM, 2000, DERMATOLOGY, V200, P292, DOI 10.1159/000018390	12	3	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 19	2008	371	9621					1311	1312		10.1016/S0140-6736(08)60571-1	http://dx.doi.org/10.1016/S0140-6736(08)60571-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424307				2022-12-28	WOS:000255208500004
J	Papp, K; Bissonnette, R; Rosoph, L; Wasel, N; Lynde, CW; Searles, G; Shear, NH; Huizinga, RB; Maksymowych, WP				Papp, K.; Bissonnette, R.; Rosoph, L.; Wasel, N.; Lynde, C. W.; Searles, G.; Shear, N. H.; Huizinga, R. B.; Maksymowych, W. P.			Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study	LANCET			English	Article							INTERMITTENT SHORT COURSES; CALCINEURIN INHIBITOR; CYCLOSPORINE; TRIAL; THERAPY; ISA(TX)247; SAFETY; COHORT	Background The use of systemic calcineurin inhibitors for the treatment of patients with psoriasis is limited by toxicity, particularly nephrotoxicity. ISA247, a novel inhibitor, was effective and well tolerated in a phase 11 study of patients with plaque psoriasis. Therefore its efficacy was assessed in this phase III study. Methods 451 patients aged 18-65 years with plaque psoriasis involving at least 10% of the body surface area were randomly assigned in equal proportions to receive placebo or ISA247 at 0. 2 mg/kg, 0 . 3 mg/kg, or 0 . 4 mg/kg orally twice a day in dermatology clinics. The primary endpoint was a 75% reduction in the psoriasis area and severity index (PASI 75) score at week 12. Treatment allocation was concealed from patient and physicians doing the assessments by use of sealed envelopes. The method of analysis was by modified intention to treat. The trial is registered at ClinicalTrials.gov, number NCT00244842. Findings 107, 113, and 116 patients were assigned to the ISA247 0.2 mg/kg, 0.3 mg/kg, and 0.4 mg/kg groups, respectively, and 115 to the placebo group. At week 12, PASI 75 scores were achieved in the ISA247 0.2 mg/kg, 0. 3 mg/kg, and 0.4 mg/kg groups by 14 (16%; 95% CI 9-24) of 105, 26 (25%; 17-24) of 111, and 44 (47%; 27-57) of 113 patients, respectively, and in the placebo group by 4 (4%; 0-8) of 113 patients. Efficacy was maintained during 24 weeks. Mild to moderate glomerular filtration rate reductions were noted in seven patients in the I SA247 0.4 mg/kg group and in one in the ISA247 0.3 mg/kg group. ISA247 blood concentrations showed a strong correlation with mean percentage reduction in PASI. Interpretation ISA247 was safe and effective in the treatment of patients with moderate to severe psoriasis during 24 weeks, with the highest dose providing the best efficacy. The strong correlation between ISA247 concentrations and efficacy might allow for accurate dosing of patients compared with existing calcineurin inhibitors. Funding Isotechnika.	[Papp, K.] Prob Med Res, Waterloo, ON, Canada; [Bissonnette, R.] Innovaderm Res, Montreal, PQ, Canada; [Rosoph, L.] N Bay Dermatol Clin, N Bay, ON, Canada; [Wasel, N.] Stratica Med, Edmonton, AB, Canada; [Lynde, C. W.] Lynderm Res, Markham, ON, Canada; [Searles, G.] Western Canada Dermatol Inst, Edmonton, AB, Canada; [Shear, N. H.] Sunnybrook Dermatol, Toronto, ON, Canada; [Huizinga, R. B.] Isotechnika, Edmonton, AB, Canada; [Maksymowych, W. P.] Univ Alberta, Edmonton, AB, Canada	Innovaderm Research Inc.; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Alberta	Papp, K (corresponding author), 135 Union St E, Waterloo, ON N2J 1C4, Canada.	kapapp@probitymedical.com		Huizinga, Robert/0000-0001-8703-7655; Maksymowych, Walter/0000-0002-1291-1755; Papp, Kim A./0000-0001-9557-3642				Abel M. D., 2001, Journal of Heart and Lung Transplantation, V20, P161, DOI 10.1016/S1053-2498(00)00290-4; Aspeslet L, 2001, TRANSPLANT P, V33, P1048, DOI 10.1016/S0041-1345(00)02325-3; Bissonnette R, 2006, J AM ACAD DERMATOL, V54, P472, DOI 10.1016/j.jaad.2005.10.061; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Hankin CS, 2005, DRUG BENEFIT TRENDS, V17, P200; Ho VC, 1999, BRIT J DERMATOL, V141, P283; Ho VCY, 2001, J AM ACAD DERMATOL, V44, P643, DOI 10.1067/mjd.2001.112400; Koo J, 1998, BRIT J DERMATOL, V139, P88; KOO J, 1995, DERMATOL CLIN, V13, P897, DOI 10.1016/S0733-8635(18)30052-4; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Maksymowych WP, 2002, J RHEUMATOL, V29, P1646; Markham T, 2002, CLIN EXP DERMATOL, V27, P111, DOI 10.1046/j.1365-2230.2002.00998.x; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Paul CF, 2003, J INVEST DERMATOL, V120, P211, DOI 10.1046/j.1523-1747.2003.12040.x; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; ZACHARIAE H, 1992, J AM ACAD DERMATOL, V26, P415, DOI 10.1016/0190-9622(92)70065-N	17	61	63	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 19	2008	371	9621					1337	1342		10.1016/S0140-6736(08)60593-0	http://dx.doi.org/10.1016/S0140-6736(08)60593-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PE	18424323				2022-12-28	WOS:000255208500024
J	Denny, MW				Denny, Mark W.			Biophysics - The intrigue of the interface	SCIENCE			English	Editorial Material							WATER		[Denny, Mark W.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Stanford University	Denny, MW (corresponding author), Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	mwdenny@stanford.edu		Denny, Mark/0000-0003-0277-9022				Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bush JWM, 2007, ADV INSECT PHYSIOL, V34, P117, DOI 10.1016/S0065-2806(07)34003-4; Bush JWM, 2006, ANNU REV FLUID MECH, V38, P339, DOI 10.1146/annurev.fluid.38.050304.092157; CASSIE ABD, 1945, NATURE, V155, P21, DOI 10.1038/155021a0; Choi CH, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2337669; Denny M., 1993, AIR WATER; Obst BS, 1996, NATURE, V384, P121, DOI 10.1038/384121a0; Ou J, 2004, PHYS FLUIDS, V16, P4635, DOI 10.1063/1.1812011; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; Prakash M, 2008, SCIENCE, V320, P931, DOI 10.1126/science.1156023; Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01; QUERE D, 2008, ANN REV MAT RES, V18; RUBEGA MA, 1993, THESIS U CALIFORNIA; VOGEL S, 1988, LIFES DEVICES; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g	15	20	22	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					886	886		10.1126/science.1158189	http://dx.doi.org/10.1126/science.1158189			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487182				2022-12-28	WOS:000255868300030
J	Pilet, S; Baker, MB; Stolper, EM				Pilet, Sebastien; Baker, Michael B.; Stolper, Edward M.			Metasomatized lithosphere and the origin of alkaline lavas	SCIENCE			English	Article							OCEAN ISLAND BASALTS; PARTIAL MELTING EXPERIMENTS; GARNET PYROXENITE; 3 GPA; QUARTZ THOLEIITES; HIGH-PRESSURES; MANTLE; PERIDOTITE; MORB; GENESIS	Recycled oceanic crust, with or without sediment, is often invoked as a source component of continental and oceanic alkaline magmas to account for their trace-element and isotopic characteristics. Alternatively, these features have been attributed to sources containing veined, metasomatized lithosphere. In melting experiments on natural amphibole-rich veins at 1.5 gigapascals, we found that partial melts of metasomatic veins can reproduce key major- and trace-element features of oceanic and continental alkaline magmas. Moreover, experiments with hornblendite plus lherzolite showed that reaction of melts of amphibole-rich veins with surrounding lherzolite can explain observed compositional trends from nephelinites to alkali olivine basalts. We conclude that melting of metasomatized lithosphere is a viable alternative to models of alkaline basalt formation by melting of recycled oceanic crust with or without sediment.	[Pilet, Sebastien; Baker, Michael B.; Stolper, Edward M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Pilet, S (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	sebastien.pilet@unil.ch						Caroff M, 1997, CONTRIB MINERAL PETR, V127, P369, DOI 10.1007/s004100050286; Dasgupta R, 2006, J PETROL, V47, P647, DOI 10.1093/petrology/egi088; Dasgupta R, 2007, J PETROL, V48, P2093, DOI 10.1093/petrology/egm053; FREY FA, 1978, J PETROL, V19, P463, DOI 10.1093/petrology/19.3.463; GREEN TH, 1967, EARTH PLANET SC LETT, V2, P41, DOI 10.1016/0012-821X(67)90171-9; HALLIDAY AN, 1995, EARTH PLANET SC LETT, V133, P379, DOI 10.1016/0012-821X(95)00097-V; HARTE B, 1993, PHILOS T ROY SOC A, V342, P1, DOI 10.1098/rsta.1993.0001; Hirose K, 1997, GEOPHYS RES LETT, V24, P2837, DOI 10.1029/97GL02956; HIROSE K, 1993, EARTH PLANET SC LETT, V114, P477, DOI 10.1016/0012-821X(93)90077-M; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Hirschmann MM, 2003, GEOLOGY, V31, P481, DOI 10.1130/0091-7613(2003)031<0481:AMGBPM>2.0.CO;2; Hirschmann MM, 1996, CONTRIB MINERAL PETR, V124, P185, DOI 10.1007/s004100050184; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; Kogiso T, 2003, EARTH PLANET SC LETT, V216, P603, DOI 10.1016/S0012-821X(03)00538-7; KUSHIRO I, 1996, EARTH PROCESSES READ, P109; Lloyd F.E., 1975, PHYS CHEM EARTH, V9, P389, DOI DOI 10.1016/0079-1946(75)90030-0; Lundstrom CC, 2000, CHEM GEOL, V162, P105, DOI 10.1016/S0009-2541(99)00122-9; MCKENZIE D, 1995, J PETROL, V36, P133, DOI 10.1093/petrology/36.1.133; MORRIS EM, 1987, 215 GEOL SOC AM; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; Pertermann M, 2003, J PETROL, V44, P2173, DOI 10.1093/petrology/egg074; Pilet S, 2005, EARTH PLANET SC LETT, V236, P148, DOI 10.1016/j.epsl.2005.05.004; Pilet S, 2004, GEOLOGY, V32, P113, DOI 10.1130/G19953.1; Prytulak J, 2007, EARTH PLANET SC LETT, V263, P388, DOI 10.1016/j.epsl.2007.09.015; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Stolper E, 2007, AM J SCI, V307, P1051, DOI 10.2475/08.2007.01; Stracke A, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000223; Sun S.-S., 1989, GEOLOGICAL SOC LONDO, V42, P323, DOI [10.1144/GSL.SP.1989.042.01.19, DOI 10.1144/GSL.SP.1989.042.01.19]; TAKAHASHI E, 1983, AM MINERAL, V68, P859; Tiepolo M, 2000, EARTH PLANET SC LETT, V176, P185, DOI 10.1016/S0012-821X(00)00004-2; Tiepolo M, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000064; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Wasylenki LE, 2003, J PETROL, V44, P1163, DOI 10.1093/petrology/44.7.1163	33	453	481	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 16	2008	320	5878					916	919		10.1126/science.1156563	http://dx.doi.org/10.1126/science.1156563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487189				2022-12-28	WOS:000255868300038
J	Mariani, FV; Ahn, CP; Martin, GR				Mariani, Francesca V.; Ahn, Christina P.; Martin, Gail R.			Genetic evidence that FGFs have an instructive role in limb proximal-distal patterning	NATURE			English	Article							APICAL ECTODERMAL RIDGE; VERTEBRATE LIMB; CHICK LIMB; FEEDBACK LOOP; MOUSE EMBRYOS; BUD; OUTGROWTH; GROWTH; AXIS; DIFFERENTIATION	Half a century ago, the apical ectodermal ridge (AER) at the distal tip of the tetrapod limb bud was shown to produce signals necessary for development along the proximal-distal (P-D) axis, but how these signals influence limb patterning is still much debated(1,2). Fibroblast growth factor (FGF) gene family members are key AER-derived signals(3,4), with Fgf4, Fgf8, Fgf9 and Fgf17 expressed specifically in the mouse AER(5). Here we demonstrate that mouse limbs lacking Fgf4, Fgf9 and Fgf17 have normal skeletal pattern, indicating that Fgf8 is sufficient among AER-FGFs to sustain normal limb formation. Inactivation of Fgf8 alone causes a mild skeletal phenotype(6,7); however, when we also removed different combinations of the other AER-FGF genes, we obtained unexpected skeletal phenotypes of increasing severity, reflecting the contribution that each FGF can make to the total AER-FGF signal. Analysis of the compound mutant limb buds revealed that, in addition to sustaining cell survival, AER-FGFs regulate P-D-patterning gene expression during early limb bud development, providing genetic evidence that AER-FGFs function to specify a distal domain and challenging the long-standing hypothesis that AER-FGF signalling is permissive rather than instructive for limb patterning. We discuss how a two-signal model for P-D patterning can be integrated with the concept of early specification to explain the genetic data presented here.	[Mariani, Francesca V.; Ahn, Christina P.; Martin, Gail R.] Univ Calif San Francisco, Dept Anat, Sch Med, San Francisco, CA 94158 USA; [Mariani, Francesca V.; Ahn, Christina P.; Martin, Gail R.] Univ Calif San Francisco, Program Dev Biol, Sch Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martin, GR (corresponding author), Univ Calif San Francisco, Dept Anat, Sch Med, San Francisco, CA 94158 USA.	gail.r.martin@ucsf.edu		Mariani, Francesca/0000-0003-1619-8763	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008696, R01HD034380] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD034380-07, F32 HD008696, F32 HD008696-02, R01 HD034380-05, F32 HD008696-03, R01 HD34380, R01 HD034380-08, R01 HD034380-09, F32 HD008696-01, R01 HD034380, R01 HD034380-06] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Colvin JS, 2001, DEVELOPMENT, V128, P2095; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hung IH, 2007, DEV BIOL, V307, P300, DOI 10.1016/j.ydbio.2007.04.048; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172; MADEN M, 1980, J EMBRYOL EXP MORPH, V56, P201; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon AM, 2000, DEVELOPMENT, V127, P989; NISWANDER L, 1993, CELL, V75, P579, DOI 10.1016/0092-8674(93)90391-3; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; STOCUM DL, 1984, DIFFERENTIATION, V27, P13, DOI 10.1111/j.1432-0436.1984.tb01403.x; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; WOLPERT L, 1979, J EMBRYOL EXP MORPH, V50, P175; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 2000, DEVELOPMENT, V127, P1833; Zucker RM, 1999, METHODS, V18, P473, DOI 10.1006/meth.1999.0815	31	244	248	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					401	U56		10.1038/nature06876	http://dx.doi.org/10.1038/nature06876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18449196	Green Accepted			2022-12-28	WOS:000255868400054
J	Tsintzos, SI; Pelekanos, NT; Konstantinidis, G; Hatzopoulos, Z; Savvidis, PG				Tsintzos, S. I.; Pelekanos, N. T.; Konstantinidis, G.; Hatzopoulos, Z.; Savvidis, P. G.			A GaAs polariton light-emitting diode operating near room temperature	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; SEMICONDUCTOR MICROCAVITIES; AMPLIFIER; LASERS	The increasing ability to control light-matter interactions at the nanometre scale has improved the performance of semiconductor lasers in the past decade. The ultimate optimization is realized in semiconductor microcavities, in which strong coupling between quantum-well excitons and cavity photons gives rise to hybrid half-light/half-matter polariton quasiparticles(1). The unique properties of polaritons - such as stimulated scattering(2,3), parametric amplification(4-6), lasing(7-10), condensation(11-13) and superfluidity(14,15) - are believed to provide the basis for a new generation of polariton emitters and semiconductor lasers. Until now, polariton lasing and nonlinearities have only been demonstrated in optical experiments, which have shown the potential to reduce lasing thresholds by two orders of magnitude compared to conventional semiconductor lasers(16). Here we report an experimental realization of an electrically pumped semiconductor polariton light-emitting device, which emits directly from polariton states at a temperature of 235 K. Polariton electroluminescence data reveal characteristic anticrossing between exciton and cavity modes, a clear signature of the strong coupling regime. These findings represent a substantial step towards the realization of ultra-efficient polaritonic devices with unprecedented characteristics.	[Tsintzos, S. I.; Pelekanos, N. T.; Savvidis, P. G.] Univ Crete, Dept Mat Sci & Technol, Iraklion 71003, Greece; [Hatzopoulos, Z.] Univ Crete, Dept Phys, Iraklion 71003, Greece; [Pelekanos, N. T.; Konstantinidis, G.; Hatzopoulos, Z.; Savvidis, P. G.] Inst Elect Struct & Laser, Fdn Res & Technol Hellas, Iraklion 71110, Greece	University of Crete; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Savvidis, PG (corresponding author), Univ Crete, Dept Mat Sci & Technol, POB 2208, Iraklion 71003, Greece.	psav@materials.uoc.gr	Tsintzos, Symeon/E-3861-2017; Konstantinidis, George/A-1719-2014; Savvidis, Pavlos G/A-4157-2009; Hatzopoulos, Zaharias/G-8312-2011; PELEKANOS, NIKOS T/E-2207-2015	Tsintzos, Symeon/0000-0003-3491-3513; Konstantinidis, George/0000-0002-1072-9618; Savvidis, Pavlos G/0000-0002-8186-6679; Tsintzos, Symeon/0000-0002-9503-964X				Bajoni D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.113303; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; Butov LV, 2007, NATURE, V447, P540, DOI 10.1038/447540a; Carlin JF, 2000, SEMICOND SCI TECH, V15, P145, DOI 10.1088/0268-1242/15/2/312; Carusotto I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166401; Christopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126405; Ciuti C, 2000, PHYS REV B, V62, pR4825, DOI 10.1103/PhysRevB.62.R4825; Dang LS, 1998, PHYS REV LETT, V81, P3920, DOI 10.1103/PhysRevLett.81.3920; Deng H, 2003, P NATL ACAD SCI USA, V100, P15318, DOI 10.1073/pnas.2634328100; Deng H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146402; Imamoglu A, 1996, PHYS REV A, V53, P4250, DOI 10.1103/PhysRevA.53.4250; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kavokin A, 2003, PHYS LETT A, V306, P187, DOI 10.1016/S0375-9601(02)01579-7; Khalifa AA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2844860; Malpuech G, 2002, APPL PHYS LETT, V81, P412, DOI 10.1063/1.1494126; Porras D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.085304; Saba M, 2001, NATURE, V414, P731, DOI 10.1038/414731a; Sapienza L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136806; Sapienza L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2739308; Savvidis PG, 2000, PHYS REV LETT, V84, P1547, DOI 10.1103/PhysRevLett.84.1547; Senellart P, 2000, PHYS REV B, V62, P16263, DOI 10.1103/PhysRevB.62.R16263; Tartakovskii AI, 2000, PHYS REV B, V62, pR2283, DOI 10.1103/PhysRevB.62.R2283; Tischler JR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.036401; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314	24	198	199	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					372	375		10.1038/nature06979	http://dx.doi.org/10.1038/nature06979			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480820				2022-12-28	WOS:000255868400047
J	Yu, XK; Jin, L; Zhou, ZH				Yu, Xuekui; Jin, Lei; Zhou, Z. Hong			3.88 angstrom structure of cytoplasmic polyhedrosis virus by cryo-electron microscopy	NATURE			English	Article							PROTEIN-RNA INTERACTIONS; ELECTRON CRYOMICROSCOPY; SPHERICAL VIRUSES; FOURIER SYNTHESIS; ATOMIC-STRUCTURE; REOVIRUS CORE; GENOME; VISUALIZATION; CYPOVIRUS; REVEALS	Cytoplasmic polyhedrosis virus (CPV) is unique within the Reoviridae family in having a turreted single-layer capsid contained within polyhedrin inclusion bodies, yet being fully capable of cell entry and endogenous RNA transcription(1-4). Biochemical data have shown that the amino-terminal 79 residues of the CPV turret protein (TP) is sufficient to bring CPV or engineered proteins into the polyhedrin matrix for micro-encapsulation(5,6). Here we report the three-dimensional structure of CPV at 3.88 angstrom resolution using single-particle cryo-electron microscopy. Our map clearly shows the turns and deep grooves of alpha-helices, the strand separation in beta-sheets, and densities for loops and many bulky side chains; thus permitting atomic model-building effort from cryoelectron microscopy maps. We observed a helix-to-beta-hairpin conformational change between the two conformational states of the capsid shell protein in the region directly interacting with genomic RNA. We have also discovered a messenger RNA release hole coupled with the mRNA capping machinery unique to CPV. Furthermore, we have identified the polyhedrin-binding domain, a structure that has potential in nanobiotechnology applications.	[Yu, Xuekui; Jin, Lei; Zhou, Z. Hong] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Yu, Xuekui; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yu, Xuekui; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.	Hong.Zhou@UCLA.edu	Zhou, Z Hong/HDN-0747-2022		NCRR NIH HHS [P41 RR002250-226489, P41 RR002250-217385, P41 RR002250-200043, P41 RR002250, P41 RR002250-190043] Funding Source: Medline; NIAID NIH HHS [R01 AI069015-01A1, R01 AI069015-03, R01 AI069015-02, R01 AI069015] Funding Source: Medline; NIGMS NIH HHS [R01 GM071940, R01 GM071940-03, R01 GM071940-01A2, R01 GM071940-04, R01 GM071940-02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker Matthew L., 2008, P89; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; Coulibaly F, 2007, NATURE, V446, P97, DOI 10.1038/nature05628; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; DeLano WL, 2002, PYMOL USERS MANUAL; DI X, 1991, VIROLOGY, V180, P153; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hagiwara K, 2000, J GEN VIROL, V81, P1143, DOI 10.1099/0022-1317-81-4-1143; Hagiwara K, 2003, J GEN VIROL, V84, P2439, DOI 10.1099/vir.0.19216-0; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Ikeda K, 2006, PROTEOMICS, V6, P54, DOI 10.1002/pmic.200500022; Ikeda K, 2001, J VIROL, V75, P988, DOI 10.1128/JVI.75.2.988-995.2001; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Liu HR, 2008, J STRUCT BIOL, V161, P64, DOI 10.1016/j.jsb.2007.09.016; Ludtke SJ, 2008, STRUCTURE, V16, P441, DOI 10.1016/j.str.2008.02.007; Mertens PPC, 2005, VIRUS TAXONOMY, P447; Nakagawa A, 2003, STRUCTURE, V11, P1227, DOI 10.1016/j.str.2003.08.012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Xia Q, 2003, J BIOL CHEM, V278, P1094, DOI 10.1074/jbc.M205964200; XU PT, 1993, VIROLOGY, V197, P726, DOI 10.1006/viro.1993.1648; Zhang H, 1999, J VIROL, V73, P1624, DOI 10.1128/JVI.73.2.1624-1629.1999; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhou ZH, 2003, ADV PROTEIN CHEM, V64, P93; Zhou ZH, 2003, STRUCTURE, V11, P651, DOI 10.1016/S0969-2126(03)00091-1	37	224	250	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					415	U73		10.1038/nature06893	http://dx.doi.org/10.1038/nature06893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18449192	Green Accepted			2022-12-28	WOS:000255868400057
J	Werner, RM; Goldman, LE; Dudley, RA				Werner, Rachel M.; Goldman, L. Elizabeth; Dudley, R. Adams			Comparison of change in quality of care between safety-net and non-safety-net hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAY-FOR-PERFORMANCE; COMMUNITY-HEALTH CENTERS; US HOSPITALS; DISPARITIES; MORTALITY; MEDICAID; WILL	Context Safety- net hospitals ( ie, those that predominantly treat poor and under-served patients) often have lower quality of care than non - safety- net hospitals. While public reporting and pay for performance have the potential to improve quality of care at poorly performing hospitals, safety- net hospitals may be unable to invest in quality improvement. As such, some have expressed concern that these incentives have the potential to worsen existing disparities among hospitals. Objective To examine trends in disparities of quality of care between hospitals with high and low percentages of Medicaid patients. Design and Setting Longitudinal study of the relationship between hospital performance and percentage Medicaid coverage from 2004 to 2006, using publicly available data on hospital performance. A simulation model was used to estimate payments at hospitals with high and low percentages of Medicaid patients. Main Outcome Measures Changes in hospital performance between 2004 and 2006, estimating whether disparities in hospital quality between hospitals with high and low percentages of Medicaid patients have changed. Results Of the 4464 participating hospitals, 3665 ( 82%) were included in the final analysis. Hospitals with high percentages of Medicaid patients had worse performance in 2004 and had significantly smaller improvement over time than those with low percentages of Medicaid patients. Hospitals with low percentages of Medicaid patients improved composite acute myocardial infarction performance by 3.8 percentage points vs 2.3 percentage points for those with high percentages, an absolute difference of 1.5 ( P=. 03). This resulted in a relative difference in performance gains of 39%. Larger performance gains at hospitals with low percentages of Medicaid patients were also seen for heart failure ( difference of 1.4 percentage points, P= 0.04) and pneumonia ( difference of 1.3 percentage points, P <. 001). Over time, hospitals with high percentages of Medicaid patients had a lower probability of achieving high-performance status. In a simulation model, these hospitals were more likely to incur financial penalties due to low performance and were less likely to receive bonuses. Conclusions Safety- net hospitals tended to have smaller gains in quality performance measures over 3 years and were less likely to be high- performing over time than non - safety- net hospitals. An incentive system based on these measures has the potential to increase disparities among hospitals.	[Werner, Rachel M.] Univ Penn, Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Werner, Rachel M.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Goldman, L. Elizabeth; Dudley, R. Adams] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Dudley, R. Adams] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werner, RM (corresponding author), Univ Penn, Sch Med, Div Gen Internal Med, 1230 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rwerner@mail.med.upenn.edu		Werner, Rachel/0000-0003-3435-4221				*AG HLTH CAR RES Q, 2007, HCUP FACT BOOK 8 SER; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Ayanian JZ, 1998, HEALTH AFFAIR, V17, P194, DOI 10.1377/hlthaff.17.6.194; BUCKLEY L, 2007, CMS OUTLINES VALUE B; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Casalino LP, 2007, HLTH AFF MILLWOOD, V26, P1794, DOI DOI 10.1377/HLTHAFF.26.3.W405; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Chin MH, 2007, MED CARE, V45, P1135, DOI 10.1097/MLR.0b013e31812da80e; Frolich A, 2007, HEALTH POLICY, V80, P179, DOI 10.1016/j.healthpol.2006.03.001; Goldman LE, 2007, INQUIRY-J HEALTH CAR, V44, P137, DOI 10.5034/inquiryjrnl_44.2.137; Goldman LE, 2007, MED CARE, V45, P579, DOI 10.1097/MLR.0b013e318041f723; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, AM HLTH CAR SAF NET; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meyer JA, 2004, HOSP QUALITY INGREDI; REGENSTEIN M, 2005, STRESSES SAFETY NET; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2007, JAMA-J AM MED ASSOC, V297, P740, DOI 10.1001/jama.297.7.740; SILOWCARROL S, 2007, HOSP QUALITY IMPROVE; Weil A, 2003, HEALTH AFFAIR, V22, P13, DOI 10.1377/hlthaff.22.1.13; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	28	225	225	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 14	2008	299	18					2180	2187		10.1001/jama.299.18.2180	http://dx.doi.org/10.1001/jama.299.18.2180			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299XX	18477785	Bronze			2022-12-28	WOS:000255790000025
J	Hume, AJ; Finkel, JS; Kamil, JP; Coen, DM; Culbertson, MR; Kalejta, RF				Hume, Adam J.; Finkel, Jonathan S.; Kamil, Jeremy P.; Coen, Donald M.; Culbertson, Michael R.; Kalejta, Robert F.			Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function	SCIENCE			English	Article							HUMAN CYTOMEGALOVIRUS REPLICATION; CELL-CYCLE; UL97; MECHANISMS; INHIBITORS; COMPLEX; FAMILY; TARGET; POTENT; PP65	As obligate intracellular parasites, viruses expertly modify cellular processes to facilitate their replication and spread, often by encoding genes that mimic the functions of cellular proteins while lacking regulatory features that modify their activity. We show that the human cytomegalovirus UL97 protein has activities similar to cellular cyclin- cyclin- dependent kinase ( CDK) complexes. UL97 phosphorylated and inactivated the retinoblastoma tumor suppressor, stimulated cell cycle progression in mammalian cells, and rescued proliferation of Saccharomyces cerevisiae lacking CDK activity. UL97 is not inhibited by the CDK inhibitor p21 and lacks amino acid residues conserved in the CDKs that permit the attenuation of kinase activity. Thus, UL97 represents a functional ortholog of cellular CDKs that is immune from normal CDK control mechanisms.	[Hume, Adam J.; Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Hume, Adam J.; Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Finkel, Jonathan S.; Culbertson, Michael R.] Univ Wisconsin, Lab Genet Biol, Madison, WI 53706 USA; [Finkel, Jonathan S.; Culbertson, Michael R.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kamil, Jeremy P.; Coen, Donald M.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School	Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.	rfkalejta@wisc.edu	Kamil, Jeremy P./Q-9688-2018; Finkel, Jonathan/ADD-4684-2022; Hume, Adam/ABA-7439-2020	Kamil, Jeremy P./0000-0001-8422-7656; Finkel, Jonathan/0000-0002-4244-5337; Hume, Adam/0000-0001-8454-3472	NCI NIH HHS [T32 CA009135-31, T32 CA009135] Funding Source: Medline; NIAID NIH HHS [AI26077, R56 AI064703, T32 AI07245, R56 AI026077, R56-AI064703] Funding Source: Medline; NIGMS NIH HHS [T32 GM007215, T32 GM077078-01, GM65172] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026077, T32AI007245, R56AI026077, R56AI064703, U01AI026077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215, F31GM077078, R01GM065172] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2001, BBA-REV CANCER, V1471, pM123, DOI 10.1016/S0304-419X(01)00019-1; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; HARPER JW, 1993, CELL, V75, P805; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; JAULT FM, 1995, J VIROL, V69, P6697, DOI 10.1128/JVI.69.11.6697-6704.1995; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kamil JP, 2007, J VIROL, V81, P10659, DOI 10.1128/JVI.00497-07; Lolli G, 2005, CELL CYCLE, V4, P572, DOI 10.4161/cc.4.4.1607; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; SULLIVAN V, 1992, NATURE, V359, P85, DOI 10.1038/359085a0; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Welburn JPI, 2007, J BIOL CHEM, V282, P3173, DOI 10.1074/jbc.M609151200; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H	20	176	181	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 9	2008	320	5877					797	799		10.1126/science.1152095	http://dx.doi.org/10.1126/science.1152095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467589				2022-12-28	WOS:000255644400042
J	Ball, P				Ball, Philip			Science & music: Facing the music	NATURE			English	Editorial Material																		Huron D, 2001, MUSIC PERCEPT, V19, P1, DOI 10.1525/mp.2001.19.1.1; Meyer L., 1956, EMOTION MEANING MUSI; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2	3	31	33	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 8	2008	453	7192					160	162		10.1038/453160a	http://dx.doi.org/10.1038/453160a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464725				2022-12-28	WOS:000255592400022
J	Muneepeerakul, R; Bertuzzo, E; Lynch, HJ; Fagan, WF; Rinaldo, A; Rodriguez-Iturbe, I				Muneepeerakul, Rachata; Bertuzzo, Enrico; Lynch, Heather J.; Fagan, William F.; Rinaldo, Andrea; Rodriguez-Iturbe, Ignacio			Neutral metacommunity models predict fish diversity patterns in Mississippi-Missouri basin	NATURE			English	Article							RELATIVE SPECIES ABUNDANCE; BIODIVERSITY; COMMUNITIES; ECOLOGY	River networks, seen as ecological corridors featuring connected and hierarchical dendritic landscapes for animals and plants, present unique challenges and opportunities for testing biogeographical theories and macroecological laws(1). Although local and basin- scale differences in riverine fish diversity have been analysed as functions of energy availability and habitat heterogeneity(2), scale- dependent environmental conditions(3) and river discharge(4,5), a model that predicts a comprehensive set of system-wide diversity patterns has been hard to find. Here we show that fish diversity patterns throughout the Mississippi - Missouri River System are well described by a neutral metacommunity model coupled with an appropriate habitat capacity distribution and dispersal kernel. River network structure acts as an effective template for characterizing spatial attributes of fish biodiversity. We show that estimates of average dispersal behaviour and habitat capacities, objectively calculated from average runoff production, yield reliable predictions of large- scale spatial biodiversity patterns in riverine systems. The success of the neutral theory in two- dimensional forest ecosystems(6-8) and here in dendritic riverine ecosystems suggests the possible application of neutral metacommunity models in a diverse suite of ecosystems. This framework offers direct linkage from large- scale forcing, such as global climate change, to biodiversity patterns.	[Muneepeerakul, Rachata; Bertuzzo, Enrico; Rodriguez-Iturbe, Ignacio] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Bertuzzo, Enrico; Rinaldo, Andrea] Ecole Polytech Fed Lausanne, Fac ENAC, Lab Ecohydrol, CH-1015 Lausanne, Switzerland; [Lynch, Heather J.; Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Rinaldo, Andrea] Univ Padua, Dipartimento Ingn Idraul Marittima Ambientale & G, I-35131 Padua, Italy; [Rinaldo, Andrea] Univ Padua, Ctr Int Idrol Dino Tonini, I-35131 Padua, Italy	Princeton University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University System of Maryland; University of Maryland College Park; University of Padua; University of Padua	Muneepeerakul, R (corresponding author), Princeton Univ, Dept Civil & Environm Engn, E Quad, Princeton, NJ 08544 USA.	rmuneepe@princeton.edu; irodrigu@princeton.edu	Bertuzzo, Enrico/U-7129-2017; Lynch, Heather J/E-7371-2012	Bertuzzo, Enrico/0000-0001-5872-0666; 				Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Angermeier PL, 1998, ECOLOGY, V79, P911, DOI 10.1890/0012-9658(1998)079[0911:LVRIOL]2.0.CO;2; Bertuzzo E, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005533; Campos D, 2006, THEOR POPUL BIOL, V69, P88, DOI 10.1016/j.tpb.2005.09.001; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Dingman S., 2002, PHYS HYDROLOGY; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Etienne RS, 2005, ECOL LETT, V8, P493, DOI 10.1111/j.1461-0248.2005.00745.x; Fernandes CC, 2004, SCIENCE, V305, P1960, DOI 10.1126/science.1101240; Gebert W. A., 1987, AVERAGE ANN RUNOFF U; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hubbell Stephen P., 2001, V32, pi; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Master L.L., 1998, RIVERS LIFE CRITICAL; Matthews W. J., 1998, PATTERNS FRESHWATER; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Muneepeerakul R, 2007, J THEOR BIOL, V245, P351, DOI 10.1016/j.jtbi.2006.10.005; *NATURESERVE, 2004, DISTR NAT US FISH WA; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; SEABER PR, 1994, 2294 US GEOL SURV; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Walker SC, 2007, OIKOS, V116, P143, DOI 10.1111/j.2006.0030-1299.15300.x; Xenopoulos MA, 2006, ECOLOGY, V87, P1907, DOI 10.1890/0012-9658(2006)87[1907:GWTFUS]2.0.CO;2; [No title captured]	30	266	272	2	160	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					220	U9		10.1038/nature06813	http://dx.doi.org/10.1038/nature06813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464742	Bronze			2022-12-28	WOS:000255592400039
J	Semenza, GL				Semenza, Gregg L.			A new weapon for attacking tumor blood vessels	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANGIOGENESIS		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.							Alani RM, 2004, CANCER BIOL THER, V3, P498, DOI 10.4161/cbt.3.6.930; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187	5	29	34	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 8	2008	358	19					2066	2067		10.1056/NEJMcibr0800272	http://dx.doi.org/10.1056/NEJMcibr0800272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296WY	18463385				2022-12-28	WOS:000255577700014
J	Warren, WC; Hillier, LW; Graves, JAM; Birney, E; Ponting, CP; Grutzner, F; Belov, K; Miller, W; Clarke, L; Chinwalla, AT; Yang, SP; Heger, A; Locke, DP; Miethke, P; Waters, PD; Veyrunes, F; Fulton, L; Fulton, B; Graves, T; Wallis, J; Puente, XS; Lopez-Otin, C; Ordonez, GR; Eichler, EE; Chen, L; Cheng, Z; Deakin, JE; Alsop, A; Thompson, K; Kirby, P; Papenfuss, AT; Wakefield, MJ; Olender, T; Lancet, D; Huttley, GA; Smit, AFA; Pask, A; Temple-Smith, P; Batzer, MA; Walker, JA; Konkel, MK; Harris, RS; Whittington, CM; Wong, ESW; Gemmell, NJ; Buschiazzo, E; Jentzsch, IMV; Merkel, A; Schmitz, J; Zemann, A; Churakov, G; Kriegs, JO; Brosius, J; Murchison, EP; Sachidanandam, R; Smith, C; Hannon, GJ; Tsend-Ayush, E; McMillan, D; Attenborough, R; Rens, W; Ferguson-Smith, M; Lefevre, CM; Sharp, JA; Nicholas, KR; Ray, DA; Kube, M; Reinhardt, R; Pringle, TH; Taylor, J; Jones, RC; Nixon, B; Dacheux, JL; Niwa, H; Sekita, Y; Huang, XQ; Stark, A; Kheradpour, P; Kellis, M; Flicek, P; Chen, Y; Webber, C; Hardison, R; Nelson, J; Hallsworth-Pepin, K; Delehaunty, K; Markovic, C; Minx, P; Feng, YC; Kremitzki, C; Mitreva, M; Glasscock, J; Wylie, T; Wohldmann, P; Thiru, P; Nhan, MN; Pohl, CS; Smith, SM; Hou, SF; Renfree, MB; Mardis, ER; Wilson, RK				Warren, Wesley C.; Hillier, LaDeana W.; Graves, Jennifer A. Marshall; Birney, Ewan; Ponting, Chris P.; Grutzner, Frank; Belov, Katherine; Miller, Webb; Clarke, Laura; Chinwalla, Asif T.; Yang, Shiaw-Pyng; Heger, Andreas; Locke, Devin P.; Miethke, Pat; Waters, Paul D.; Veyrunes, Frederic; Fulton, Lucinda; Fulton, Bob; Graves, Tina; Wallis, John; Puente, Xose S.; Lopez-Otin, Carlos; Ordonez, Gonzalo R.; Eichler, Evan E.; Chen, Lin; Cheng, Ze; Deakin, Janine E.; Alsop, Amber; Thompson, Katherine; Kirby, Patrick; Papenfuss, Anthony T.; Wakefield, Matthew J.; Olender, Tsviya; Lancet, Doron; Huttley, Gavin A.; Smit, Arian F. A.; Pask, Andrew; Temple-Smith, Peter; Batzer, Mark A.; Walker, Jerilyn A.; Konkel, Miriam K.; Harris, Robert S.; Whittington, Camilla M.; Wong, Emily S. W.; Gemmell, Neil J.; Buschiazzo, Emmanuel; Jentzsch, Iris M. Vargas; Merkel, Angelika; Schmitz, Juergen; Zemann, Anja; Churakov, Gennady; Kriegs, Jan Ole; Brosius, Juergen; Murchison, Elizabeth P.; Sachidanandam, Ravi; Smith, Carly; Hannon, Gregory J.; Tsend-Ayush, Enkhjargal; McMillan, Daniel; Attenborough, Rosalind; Rens, Willem; Ferguson-Smith, Malcolm; Lefevre, Christophe M.; Sharp, Julie A.; Nicholas, Kevin R.; Ray, David A.; Kube, Michael; Reinhardt, Richard; Pringle, Thomas H.; Taylor, James; Jones, Russell C.; Nixon, Brett; Dacheux, Jean-Louis; Niwa, Hitoshi; Sekita, Yoko; Huang, Xiaoqiu; Stark, Alexander; Kheradpour, Pouya; Kellis, Manolis; Flicek, Paul; Chen, Yuan; Webber, Caleb; Hardison, Ross; Nelson, Joanne; Hallsworth-Pepin, Kym; Delehaunty, Kim; Markovic, Chris; Minx, Pat; Feng, Yucheng; Kremitzki, Colin; Mitreva, Makedonka; Glasscock, Jarret; Wylie, Todd; Wohldmann, Patricia; Thiru, Prathapan; Nhan, Michael N.; Pohl, Craig S.; Smith, Scott M.; Hou, Shunfeng; Renfree, Marilyn B.; Mardis, Elaine R.; Wilson, Richard K.			Genome analysis of the platypus reveals unique signatures of evolution	NATURE			English	Article							MONODELPHIS-DOMESTICA; PHYLOGENETIC ANALYSIS; MONOTREME; CHROMOSOMES; INSIGHTS; FAMILY; ELECTRORECEPTION; CATHELICIDINS; ARRANGEMENT; EXPRESSION	We present a draft genome sequence of the platypus, Ornithorhynchus anatinus. This monotreme exhibits a fascinating combination of reptilian and mammalian characters. For example, platypuses have a coat of fur adapted to an aquatic lifestyle; platypus females lactate, yet lay eggs; and males are equipped with venom similar to that of reptiles. Analysis of the first monotreme genome aligned these features with genetic innovations. We find that reptile and platypus venom proteins have been co- opted independently from the same gene families; milk protein genes are conserved despite platypuses laying eggs; and immune gene family expansions are directly related to platypus biology. Expansions of protein, non- protein- coding RNA and microRNA families, as well as repeat elements, are identified. Sequencing of this genome now provides a valuable resource for deep mammalian comparative analyses, as well as for monotreme biology and conservation.	[Warren, Wesley C.; Hillier, LaDeana W.; Chinwalla, Asif T.; Yang, Shiaw-Pyng; Locke, Devin P.; Fulton, Lucinda; Fulton, Bob; Graves, Tina; Wallis, John; Nelson, Joanne; Hallsworth-Pepin, Kym; Delehaunty, Kim; Markovic, Chris; Minx, Pat; Feng, Yucheng; Kremitzki, Colin; Mitreva, Makedonka; Glasscock, Jarret; Wylie, Todd; Wohldmann, Patricia; Thiru, Prathapan; Nhan, Michael N.; Pohl, Craig S.; Smith, Scott M.; Hou, Shunfeng; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Graves, Jennifer A. Marshall; Miethke, Pat; Waters, Paul D.; Veyrunes, Frederic; Deakin, Janine E.; Alsop, Amber; Thompson, Katherine; Kirby, Patrick; Huttley, Gavin A.; Attenborough, Rosalind] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; [Birney, Ewan; Flicek, Paul; Chen, Yuan] EBI, EMBL, Cambridge CB10 1SD, England; [Ponting, Chris P.; Heger, Andreas; Webber, Caleb] Univ Oxford, Dept Human Physiol Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England; [Grutzner, Frank; Tsend-Ayush, Enkhjargal] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Genet, Adelaide, SA 5005, Australia; [Belov, Katherine; Whittington, Camilla M.; Wong, Emily S. W.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Miller, Webb; Harris, Robert S.; Hardison, Ross] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Clarke, Laura] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Veyrunes, Frederic; Rens, Willem; Ferguson-Smith, Malcolm] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Puente, Xose S.; Lopez-Otin, Carlos; Ordonez, Gonzalo R.] Univ Oviedo, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain; [Eichler, Evan E.; Chen, Lin; Cheng, Ze] Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; [Papenfuss, Anthony T.; Wakefield, Matthew J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Olender, Tsviya; Lancet, Doron] Weizmann Inst Sci, Dept Mol Genet, Crown Human Genome Ctr, IL-76100 Rehovot, Israel; [Smit, Arian F. A.] Inst Syst Biol, Seattle, WA 98103 USA; [Pask, Andrew; Temple-Smith, Peter; Lefevre, Christophe M.; Sharp, Julie A.; Nicholas, Kevin R.; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, CRC Innovat Dairy Prod, Parkville, Vic 3010, Australia; [Temple-Smith, Peter] Monash Inst Med Res, Clayton, Vic 3168, Australia; [Batzer, Mark A.; Walker, Jerilyn A.; Konkel, Miriam K.] Louisiana State Univ, Dept Biol Sci, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA; [Gemmell, Neil J.; Buschiazzo, Emmanuel; Jentzsch, Iris M. Vargas; Merkel, Angelika] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Schmitz, Juergen; Zemann, Anja; Churakov, Gennady; Kriegs, Jan Ole; Brosius, Juergen] Univ Munster, Inst Expt Pathol, D-48149 Munster, Germany; [Murchison, Elizabeth P.; Sachidanandam, Ravi; Smith, Carly; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Lefevre, Christophe M.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3080, Australia; [Ray, David A.] W Virginia Univ, Dept Biol, Morgantown, WV 26505 USA; [Kube, Michael; Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Pringle, Thomas H.] Sperling Fdn, Eugene, OR 97405 USA; [Taylor, James] NYU, Courant Inst, New York, NY 10012 USA; [Jones, Russell C.; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Newcastle, NSW 2308, Australia; [Dacheux, Jean-Louis] INRA, CNRS, UMR 6073, F-37380 Nouzilly, France; [Niwa, Hitoshi; Sekita, Yoko] RIKEN, CDB, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; [Stark, Alexander; Kheradpour, Pouya; Kellis, Manolis] MIT, Broad Inst, Cambridge, MA 02139 USA; [Stark, Alexander; Kheradpour, Pouya; Kellis, Manolis] Harvard Univ, Broad Inst, Cambridge, MA 02139 USA	Washington University (WUSTL); Australian National University; John Curtin School of Medical Research; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Adelaide; University of Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wellcome Trust Sanger Institute; University of Cambridge; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Weizmann Institute of Science; Institute for Systems Biology (ISB); University of Melbourne; Monash University; Louisiana State University System; Louisiana State University; University of Canterbury; University of Munster; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Monash University; West Virginia University; Max Planck Society; New York University; University of Newcastle; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; RIKEN; Iowa State University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Warren, WC (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,4444 Forest Pk Ave, St Louis, MO 63108 USA.	wwarren@wustl.edu; rwilson@wustl.edu	Wong, Emily/C-2302-2018; Mardis, Elaine/W-2202-2019; Waters, Paul/D-1044-2009; Ponting, Chris/AAV-2621-2021; Stark, Alexander/D-1473-2012; Wong, Emily/B-7514-2011; Papenfuss, Anthony T/C-6297-2008; Wakefield, Matthew J/A-7795-2008; Waters, Paul D/B-7871-2015; Nixon, Brett/B-5121-2012; Whittington, Camilla M/H-7589-2013; Gemmell, Neil J/C-6774-2009; Grutzner, Frank/AAD-5834-2020; Hardison, Ross C/G-1142-2010; Puente, Xosé S./ADB-0672-2022; Wilson, Richard K./AAF-4139-2019; Taylor, James/F-1026-2011; Grutzner, Frank/ABB-2820-2021; sachidanandam, ravi/Q-6916-2019; López-Otín, Carlos/AAB-2106-2020; Buschiazzo, Emmanuel/B-5126-2011; Brosius, Jürgen/F-5029-2016; Kellis, Manolis/ABE-7385-2020; Hannon, Gregory/AAB-3568-2019; Huttley, Gavin A/G-5169-2015; Graves, Jennifer A.M./A-1387-2008; Kriegs, Jan Ole/E-3804-2010; Wakefield, Matthew/X-7593-2019; Deakin, Janine/A-1941-2008	Wong, Emily/0000-0003-0315-2942; Stark, Alexander/0000-0003-2611-0841; Papenfuss, Anthony T/0000-0002-1102-8506; Wakefield, Matthew J/0000-0001-6624-4698; Waters, Paul D/0000-0002-4689-8747; Nixon, Brett/0000-0003-2745-8188; Gemmell, Neil J/0000-0003-0671-3637; Hardison, Ross C/0000-0003-4084-7516; Puente, Xosé S./0000-0001-9525-1483; Wilson, Richard K./0000-0002-1992-1358; Taylor, James/0000-0001-5079-840X; Grutzner, Frank/0000-0002-3088-7314; sachidanandam, ravi/0000-0001-9844-4459; López-Otín, Carlos/0000-0001-6964-1904; Brosius, Jürgen/0000-0003-1650-2059; Kellis, Manolis/0000-0001-7113-9630; Huttley, Gavin A/0000-0001-7224-2074; Wakefield, Matthew/0000-0001-6624-4698; Deakin, Janine/0000-0002-1259-3531; Ray, David/0000-0002-3340-3987; Ponting, Chris/0000-0003-0202-7816; Graves, Jennifer/0000-0001-6480-7856; Veyrunes, Frederic/0000-0002-1706-9915; Belov, Katherine/0000-0002-9762-5554; Renfree, Marilyn/0000-0002-4589-0436; Clarke, Laura/0000-0002-5989-6898; Churakov, Gennady/0000-0001-8033-4905; Webber, Caleb/0000-0001-8063-7674; Locke, Devin/0000-0002-2527-0475; Whittington, Camilla/0000-0001-5765-9699; Reinhardt, Richard/0000-0001-9376-2132; Flicek, Paul/0000-0002-3897-7955; Sharp, Julie/0000-0002-4481-5223; Pask, Andrew/0000-0002-1900-2263; Attenborough, Rosalind/0000-0003-2215-6797; Merkel, Angelika/0000-0001-5164-6803; Heger, Andreas/0000-0001-7720-0447; , Peter/0000-0002-4754-369X; Birney, Ewan/0000-0001-8314-8497; Chinwalla, Asif/0000-0001-7831-3996; Murchison, Elizabeth Proby/0000-0001-7462-8907; Mitreva, Makedonka/0000-0001-9572-3436	Medical Research Council [MC_U137761446] Funding Source: Medline; NCI NIH HHS [P01 CA013106-37, P01 CA013106] Funding Source: Medline; NHGRI NIH HHS [R01 HG004037-02, R01 HG002385, R01HG02385, R01 HG002939, R01 HG004037, HG002238, R01 HG002238] Funding Source: Medline; NIGMS NIH HHS [R01 GM59290, R01 GM059290] Funding Source: Medline; Wellcome Trust [062023] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002238, R01HG002939, R01HG002385, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; MRC [MC_U137761446] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aloni R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r88; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Bals R, 2003, CELL MOL LIFE SCI, V60, P711, DOI 10.1007/s00018-003-2186-9; Belov K, 2007, GENOME RES, V17, P982, DOI 10.1101/gr.6121807; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BICK YAE, 1975, CYTOBIOS, V14, P17; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CALDWELL WH, 1887, PHIL T R SOC LOND B, V178, P463; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; DEPLATER G, 1995, TOXICON, V33, P157, DOI 10.1016/0041-0101(94)00150-7; DIENER E, 1965, NATURE, V208, P950, DOI 10.1038/208950a0; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Edwards CA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-157; El-Mogharbel N, 2007, GENOMICS, V89, P10, DOI 10.1016/j.ygeno.2006.07.017; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; GEMMELL NJ, 1995, AUST J ZOOL, V43, P283, DOI 10.1071/ZO9950283; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goodstadt L, 2007, GENOME RES, V17, P969, DOI 10.1101/gr.6093907; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Greaves IK, 2003, CHROMOSOME RES, V11, P503, DOI 10.1023/A:1024982929452; Griffiths M., 1968, ECHIDNAS; Griffiths M., 1978, BIOL MONOTREMES; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grus WE, 2007, MOL BIOL EVOL, V24, P2153, DOI 10.1093/molbev/msm157; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; Heger A, 2007, GENOME RES, V17, P1837, DOI 10.1101/gr.6249707; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Home E., 1802, PHIL T R SOC, V92, P67; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Huttley GA, 2007, MOL BIOL EVOL, V24, P1722, DOI 10.1093/molbev/msm094; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Jovine Luca, 2007, Soc Reprod Fertil Suppl, V63, P187; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Kirsch JAW, 1998, PHILOS T R SOC B, V353, P1221, DOI 10.1098/rstb.1998.0278; Kriegs JO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-190; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; LESTER KS, 1987, SCANNING MICROSCOPY, V1, P401; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; McMillan D, 2007, CHROMOSOME RES, V15, P961, DOI 10.1007/s10577-007-1186-2; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Morel L, 2000, J MOL ENDOCRINOL, V24, P127, DOI 10.1677/jme.0.0240127; MURCHISON EP, IN PRESS GENOME RES, DOI DOI 10.1101/GR.73056.107; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nixon B, 2007, CELL MOL LIFE SCI, V64, P1805, DOI 10.1007/s00018-007-6552-x; Oftedal OT, 2002, J MAMMARY GLAND BIOL, V7, P253, DOI 10.1023/A:1022848632125; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Pettigrew JD, 1999, J EXP BIOL, V202, P1447; Pritchard JK, 2000, GENETICS, V155, P945; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Renfree MB, 1995, REPROD FERT DEVELOP, V7, P1003, DOI 10.1071/RD9951003; RENFREE MB, 1993, MAMMAL PHYLOGENY; Rens W, 2004, P NATL ACAD SCI USA, V101, P16257, DOI 10.1073/pnas.0405702101; Riggio M, 2000, GENE, V260, P67, DOI 10.1016/S0378-1119(00)00469-8; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; SCHEICH H, 1986, NATURE, V319, P401, DOI 10.1038/319401a0; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Temple-Smith P, 2001, REPROD FERT DEVELOP, V13, P487, DOI 10.1071/RD01110; Temple-Smith P.D., 1973, THESIS AUSTR NATL U, DOI 10.25911/5d6cf7aa56c49; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watson JM, 1996, P NATL ACAD SCI USA, V93, P10200, DOI 10.1073/pnas.93.19.10200; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; WRIGLEY JM, 1984, IN VITRO CELL DEV B, V20, P321; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zemann A, 2006, NUCLEIC ACIDS RES, V34, P2676, DOI 10.1093/nar/gkl359	79	514	530	17	306	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 8	2008	453	7192					175	U1		10.1038/nature06936	http://dx.doi.org/10.1038/nature06936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297BP	18464734	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000255592400030
J	Branderhorst, MPA; Londero, P; Wasylczyk, P; Brif, C; Kosut, RL; Rabitz, H; Walmsley, IA				Branderhorst, Matthijs P. A.; Londero, Pablo; Wasylczyk, Piotr; Brif, Constantin; Kosut, Robert L.; Rabitz, Herschel; Walmsley, Ian A.			Coherent control of decoherence	SCIENCE			English	Article							SPONTANEOUS EMISSION; QUANTUM COMPUTATION; DYNAMICS; PULSES	Manipulation of quantum interference requires that the system under control remains coherent, avoiding ( or at least postponing) the phase randomization that can ensue from coupling to an uncontrolled environment. We show that closed- loop coherent control can be used to mitigate the rate of quantum dephasing in a gas- phase ensemble of potassium dimers ( K-2), which acts as a model system for testing the general concepts of controlling decoherence. Specifically, we adaptively shaped the light pulse used to prepare a vibrational wave packet in electronically excited K-2, with the amplitude of quantum beats in the fluorescence signal used as an easily measured surrogate for the purpose of optimizing coherence. The optimal pulse increased the beat amplitude from below the noise level to well above it, and thereby increased the coherence life time as compared with the beats produced by a transform- limited pulse. Closed- loop methods can thus effectively identify states that are robust against dephasing without any previous information about the system- environment interaction.	[Branderhorst, Matthijs P. A.; Londero, Pablo; Wasylczyk, Piotr; Walmsley, Ian A.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Brif, Constantin; Rabitz, Herschel] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Kosut, Robert L.] SCSolutions, Sunnyvale, CA 94085 USA	University of Oxford; Princeton University	Walmsley, IA (corresponding author), Univ Oxford, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	walmsley@physics.ox.ac.uk	Brif, Constantin/A-6779-2008; Brif, Constantin/O-2655-2019	Brif, Constantin/0000-0003-1134-4952; Brif, Constantin/0000-0003-1134-4952; Walmsley, Ian/0000-0002-4714-0575; Wasylczyk, Piotr/0000-0003-0851-9838				Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Bovino FA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.240407; Brif C, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.063404; Brixner T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.208301; DUNN TJ, 1993, PHYS REV LETT, V70, P3388, DOI 10.1103/PhysRevLett.70.3388; DUNN TJ, 1995, PHYS REV LETT, V74, P884, DOI 10.1103/PhysRevLett.74.884; Ekert A, 1998, PHILOS T R SOC A, V356, P1769, DOI 10.1098/rsta.1998.0248; Ekert A, 1996, REV MOD PHYS, V68, P733, DOI 10.1103/RevModPhys.68.733; Grace M, 2007, J PHYS B-AT MOL OPT, V40, pS103, DOI 10.1088/0953-4075/40/9/S06; Hansson T, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.033404; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Hohenester U, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.196801; Hohenester U, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161307; Iaconis C, 1998, OPT LETT, V23, P792, DOI 10.1364/OL.23.000792; JANSZKY J, 1994, PHYS REV A, V50, P732, DOI 10.1103/PhysRevA.50.732; Jirari H, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.022306; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Katz G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.203006; Laarmann T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.058302; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Lidar DA, 1998, PHYS REV LETT, V81, P2594, DOI 10.1103/PhysRevLett.81.2594; Lindinger A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.033001; Preskill J, 1998, P ROY SOC A-MATH PHY, V454, P385, DOI 10.1098/rspa.1998.0167; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; ROSS AJ, 1987, J PHYS B-AT MOL OPT, V20, P6225, DOI 10.1088/0022-3700/20/23/014; Shapiro EA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050501; Sklarz SE, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.053408; Steane AM, 1996, PHYS REV LETT, V77, P793, DOI 10.1103/PhysRevLett.77.793; Tannor DJ, 1999, J PHYS CHEM A, V103, P10359, DOI 10.1021/jp992544x; Vitali D, 1999, PHYS REV A, V59, P4178, DOI 10.1103/PhysRevA.59.4178; Wallentowitz S, 2002, J PHYS B-AT MOL OPT, V35, P1967, DOI 10.1088/0953-4075/35/8/313; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654	33	97	97	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					638	643		10.1126/science.1154576	http://dx.doi.org/10.1126/science.1154576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451296				2022-12-28	WOS:000255454300038
J	Djupedal, I; Ekwall, K				Djupedal, Ingela; Ekwall, Karl			Molecular biology - The paradox of silent heterochromatin	SCIENCE			English	Editorial Material							TRANSCRIPTION; METHYLATION; GENES		[Djupedal, Ingela; Ekwall, Karl] Karolinska Inst, Novum, Univ Coll Sodertorn, Sweden Sch Life Sci,Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden	Karolinska Institutet; Sodertorn University	Djupedal, I (corresponding author), Karolinska Inst, Novum, Univ Coll Sodertorn, Sweden Sch Life Sci,Dept Biosci & Med Nutr, S-14157 Huddinge, Sweden.	karl.ekwall@ki.se		Ekwall, Karl/0000-0002-3029-4041				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lloyd VK, 2003, GENOME, V46, P1104, DOI 10.1139/G03-070; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008	13	8	8	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					624	625		10.1126/science.1158923	http://dx.doi.org/10.1126/science.1158923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451292				2022-12-28	WOS:000255454300033
J	Erickson, JR; Joiner, MLA; Guan, X; Kutschke, W; Yang, JY; Oddis, CV; Bartlett, RK; Lowe, JS; O'Donnell, SE; Aykin-Burns, N; Zimmerman, MC; Zimmerman, K; Ham, AJL; Weiss, RM; Spitz, DR; Shea, MA; Colbran, RJ; Mohler, PJ; Anderson, ME				Erickson, Jeffrey R.; Joiner, Mei-ling A.; Guan, Xiaoqun; Kutschke, William; Yang, Jinying; Oddis, Carmine V.; Bartlett, Ryan K.; Lowe, John S.; O'Donnell, Susan E.; Aykin-Burns, Nukhet; Zimmerman, Matthew C.; Zimmerman, Kathy; Ham, Amy-Joan L.; Weiss, Robert M.; Spitz, Douglas R.; Shea, Madeline A.; Colbran, Roger J.; Mohler, Peter J.; Anderson, Mark E.			A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation	CELL			English	Article							CALMODULIN KINASE-II; DEPENDENT PROTEIN-KINASE; LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; MYOCARDIAL-INFARCTION; SULFOXIDE REDUCTASE; INHIBITION PROTECTS; AUTONOMOUS ENZYME; BINDING DOMAIN; ANGIOTENSIN-II	Calcium/calmodulin (Ca2+/CaM)-dependent protein kinase II (CaMKII) couples increases in cellular Ca2+ to fundamental responses in excitable cells. CaMKII was identified over 20 years ago by activation dependence on Ca2+/CaM, but recent evidence shows that CaMKII activity is also enhanced by pro-oxidant conditions. Here we show that oxidation of paired regulatory domain methionine residues sustains CaMKII activity in the absence of Ca2+/CaM. CaMKII is activated by angiotensin II (AngII)-induced oxidation, leading to apoptosis in cardiomyocytes both in vitro and in vivo. CaMKII oxidation is reversed by methionine sulfoxide reductase A (MsrA), and MsrA(-/-) mice show exaggerated CaMKII oxidation and myocardial apoptosis, impaired cardiac function, and increased mortality after myocardial infarction. Our data demonstrate a dynamic mechanism for CaMKII activation by oxidation and highlight the critical importance of oxidation-dependent CaMKII activation to AngII and ischemic myocardial apoptosis.	[Erickson, Jeffrey R.; Joiner, Mei-ling A.; Guan, Xiaoqun; Kutschke, William; Yang, Jinying; Lowe, John S.; Weiss, Robert M.; Mohler, Peter J.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [O'Donnell, Susan E.; Shea, Madeline A.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA; [Mohler, Peter J.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Aykin-Burns, Nukhet; Zimmerman, Matthew C.; Spitz, Douglas R.] Univ Iowa, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Oddis, Carmine V.] Vanderbilt Univ, Dept Internal Med, Nashville, TN 37232 USA; [Bartlett, Ryan K.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Ham, Amy-Joan L.; Colbran, Roger J.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Ham, Amy-Joan L.] Vanderbilt Univ, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Anderson, ME (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	mark-e-anderson@uiowa.edu	Shea, Madeline A/F-5798-2010; Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244; Shea, Madeline/0000-0003-0814-7069; Zimmerman, Matthew/0000-0001-5658-9051; Joiner, Mei-ling/0000-0002-7775-7349; Spitz, Douglas/0000-0002-1254-8765	NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR017369] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070250, R01HL079031, R01HL062494, R01HL084583, R01HL083422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER; NCRR NIH HHS [K26 RR017369, RR017369] Funding Source: Medline; NHLBI NIH HHS [R01 HL079031, R01 HL 079031, R01 HL070250, R01 HL062494, R01 HL079031-02, R01 HL084583, R01 HL070250-06A1, R01 HL083422, R01 HL 62494, R01 HL062494-09, R01 HL 70250] Funding Source: Medline; NIGMS NIH HHS [R01 GM57001, R01 GM057001] Funding Source: Medline; NIMH NIH HHS [R01 MH063232-08, R01 MH063232] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Bers DM, 2005, NAT MED, V11, P379, DOI 10.1038/nm0405-379; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Doerries C, 2007, CIRC RES, V100, P894, DOI 10.1161/01.RES.0000261657.76299.ff; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hare JM, 2001, CIRC RES, V89, P198, DOI 10.1161/res.89.3.198; Hjalmarson A, 1999, LANCET, V353, P2001; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kinugawa S, 2000, CIRC RES, V87, P392; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Maack C, 2003, CIRCULATION, V108, P1567, DOI 10.1161/01.CIR.0000091084.46500.BB; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Munzel T, 2001, CIRCULATION, V104, P1571, DOI 10.1161/hc3801.095585; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; SAITOH T, 1985, J CELL BIOL, V100, P835, DOI 10.1083/jcb.100.3.835; Santarelli LC, 2006, J PHYSIOL-LONDON, V571, P329, DOI 10.1113/jphysiol.2005.101089; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; SHARMA RV, 1995, NEUROSCIENCE, V66, P433, DOI 10.1016/0306-4522(94)00560-R; Tojo A, 2002, HYPERTENSION, V40, P834, DOI 10.1161/01.HYP.0000039506.43589.D5; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; ZANGERLE L, 1992, J NEUROCHEM, V59, P181, DOI 10.1111/j.1471-4159.1992.tb08889.x; Zhabotinsky AM, 2000, BIOPHYS J, V79, P2211, DOI 10.1016/S0006-3495(00)76469-1; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zimmerman MC, 2004, CIRC RES, V95, P532, DOI 10.1161/01.RES.0000139957.22530.b9	47	807	841	3	81	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 2	2008	133	3					462	474		10.1016/j.cell.2008.02.048	http://dx.doi.org/10.1016/j.cell.2008.02.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295WD	18455987	Bronze, Green Accepted			2022-12-28	WOS:000255503900017
J	Clatworthy, MR; Williams, P; Watson, CJ; Jamieson, NV				Clatworthy, Menna R.; Williams, Paul; Watson, Christopher J.; Jamieson, Neville V.			The calcified abdominal cocoon	LANCET			English	Editorial Material									[Clatworthy, Menna R.; Williams, Paul] Addenbrookes Hosp, Dept Renal Med, Cambridge CB2 0QQ, England; [Watson, Christopher J.; Jamieson, Neville V.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Clatworthy, MR (corresponding author), Addenbrookes Hosp, Dept Renal Med, Cambridge CB2 0QQ, England.	mrc38@cam.ac.uk						GHANDI VC, 1980, ARCH INTERN MED, V140, P1201	1	9	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR-MAY	2008	371	9622					1452	1452		10.1016/S0140-6736(08)60625-X	http://dx.doi.org/10.1016/S0140-6736(08)60625-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440427				2022-12-28	WOS:000255440600026
J	Dinan, A; de Toffol, B; Pallix, M; Breard, G; Babuty, D				Dinan, Annabel; de Toffol, Bertrand; Pallix, Maud; Breard, Guillaume; Babuty, Dominique			Cardiac arrest: it's all in the head	LANCET			English	Editorial Material							ICTAL BRADYCARDIA; SEIZURES; EPILEPSY		[Dinan, Annabel; Breard, Guillaume; Babuty, Dominique] Univ Tours, Hop Trousseau, Cardiol Dept B, F-37044 Tours, France; [de Toffol, Bertrand; Pallix, Maud] Univ Tours, Bretonneau Hosp, Dept Neurol, F-37044 Tours, France	CHU Tours; Universite de Tours; CHU Tours; Universite de Tours	Babuty, D (corresponding author), Univ Tours, Hop Trousseau, Cardiol Dept B, F-37044 Tours, France.	d.babuty@chu-tours.fr		de Toffol, Bertrand/0000-0002-2006-631X				Nei M, 2000, EPILEPSIA, V41, P542, DOI 10.1111/j.1528-1157.2000.tb00207.x; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Reeves AL, 1996, EPILEPSIA, V37, P983, DOI 10.1111/j.1528-1157.1996.tb00536.x; Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6; Tinuper P, 2001, BRAIN, V124, P2361, DOI 10.1093/brain/124.12.2361	5	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR-MAY	2008	371	9622					1476	1476		10.1016/S0140-6736(08)60628-5	http://dx.doi.org/10.1016/S0140-6736(08)60628-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294XW	18440430				2022-12-28	WOS:000255440600029
J	Spalding, KL; Arner, E; Westermark, PO; Bernard, S; Buchholz, BA; Bergmann, O; Blomqvist, L; Hoffstedt, J; Naslund, E; Britton, T; Concha, H; Hassan, M; Ryden, M; Frisen, J; Arner, P				Spalding, Kirsty L.; Arner, Erik; Westermark, Pal O.; Bernard, Samuel; Buchholz, Bruce A.; Bergmann, Olaf; Blomqvist, Lennart; Hoffstedt, Johan; Naslund, Erik; Britton, Tom; Concha, Hernan; Hassan, Moustapha; Ryden, Mikael; Frisen, Jonas; Arner, Peter			Dynamics of fat cell turnover in humans	NATURE			English	Article							ADIPOSE-TISSUE CELLULARITY; MECHANISMS LINKING OBESITY; NUCLEAR TESTS; ADIPOCYTES; DISEASE; NUMBER; SIZE; C-14; AGE	Obesity is increasing in an epidemic manner in most countries and constitutes a public health problem by enhancing the risk for cardiovascular disease and metabolic disorders such as type 2 diabetes(1,2). Owing to the increase in obesity, life expectancy may start to decrease in developed countries for the first time in recent history(3). The factors determining fat mass in adult humans are not fully understood, but increased lipid storage in already developed fat cells ( adipocytes) is thought to be most important(4,5). Here we show that adipocyte number is a major determinant for the fat mass in adults. However, the number of fat cells stays constant in adulthood in lean and obese individuals, even after marked weight loss, indicating that the number of adipocytes is set during childhood and adolescence. To establish the dynamics within the stable population of adipocytes in adults, we have measured adipocyte turnover by analysing the integration of C-14 derived from nuclear bomb tests in genomic DNA(6). Approximately 10% of fat cells are renewed annually at all adult ages and levels of body mass index. Neither adipocyte death nor generation rate is altered in early onset obesity, suggesting a tight regulation of fat cell number in this condition during adulthood. The high turnover of adipocytes establishes a new therapeutic target for pharmacological intervention in obesity.	[Spalding, Kirsty L.; Arner, Erik; Bergmann, Olaf; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Westermark, Pal O.] Humboldt Univ, ITB, D-10115 Berlin, Germany; [Westermark, Pal O.] Charite, D-10115 Berlin, Germany; [Bernard, Samuel] Fdn Res & Technol, Inst Appl & Computat Math, Iraklion 71110, Greece; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Blomqvist, Lennart; Hoffstedt, Johan; Concha, Hernan; Hassan, Moustapha; Ryden, Mikael; Arner, Peter] Karolinska Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Div Surg, Dept Clin Sci, Danderyd Hosp, SE-18288 Stockholm, Sweden; [Britton, Tom] Stockholm Univ, Dept Math, S-10691 Stockholm, Sweden	Karolinska Institutet; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Karolinska Institutet; Karolinska University Hospital; Danderyds Hospital; Karolinska Institutet; Stockholm University	Spalding, KL (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	kirsty.spalding@ki.se; jonas.frisen@ki.se; peter.arner@ki.se	spalding, kirsty/I-6046-2017; Hassan, Moustapha/H-9260-2015; Spalding, Kirsty/CAF-4248-2022; Buchholz, Bruce A/G-1356-2011; Bergmann, Olaf/A-5706-2009; Arner, Erik/A-1895-2010; Bernard, Samuel/A-5623-2009	Hassan, Moustapha/0000-0003-1927-5859; Spalding, Kirsty/0000-0002-5189-7028; Buchholz, Bruce A/0000-0002-9531-551X; Bergmann, Olaf/0000-0003-1065-4107; Arner, Erik/0000-0003-1225-4908; Bernard, Samuel/0000-0002-8442-9968; Westermark, Pal/0000-0002-6637-2566; Arner, Peter/0000-0002-6208-6220	NCRR NIH HHS [P41 RR013461, RR13461] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTMAN DG, 1991, PRACTICAL STAT MED R, P164; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; HAGER A, 1978, AM J CLIN NUTR, V31, P68; HARKNESS DD, 1972, NATURE, V240, P302, DOI 10.1038/240302a0; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Joulia-Ekaza D, 2006, EXP CELL RES, V312, P3458, DOI 10.1016/j.yexcr.2006.07.010; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; KRAL JG, 1977, EUR J CLIN INVEST, V7, P413, DOI 10.1111/j.1365-2362.1977.tb01628.x; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; LIBBY WF, 1964, SCIENCE, V146, P1171; Lofgren P, 2005, J CLIN ENDOCR METAB, V90, P6207, DOI 10.1210/jc.2005-0596; MILLER WH, 1984, J LIPID RES, V25, P336; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; PETRUSCHKE T, 1993, J CLIN ENDOCR METAB, V76, P742, DOI 10.1210/jc.76.3.742; PRINS JB, 1994, BIOCHEM BIOPH RES CO, V201, P500, DOI 10.1006/bbrc.1994.1730; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Raff MC, 1996, CELL, V86, P173, DOI 10.1016/S0092-8674(00)80087-2; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Sims E A, 1968, Trans Assoc Am Physicians, V81, P153; Spalding KL, 2005, NATURE, V437, P333, DOI 10.1038/437333a; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487	30	1497	1546	8	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 5	2008	453	7196					783	787		10.1038/nature06902	http://dx.doi.org/10.1038/nature06902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18454136				2022-12-28	WOS:000256415300044
J	Boden, WE; Diamond, GA				Boden, William E.; Diamond, George A.			DTCA for PTCA - Crossing the line in consumer health education?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Boden, William E.] SUNY Buffalo, Sch Med, Div Cardiovasc Med, Buffalo, NY USA; [Boden, William E.] SUNY Buffalo, Sch Publ Hlth, Div Cardiovasc Med, Buffalo, NY USA; [Boden, William E.] Buffalo Gen Hosp, Buffalo, NY 14203 USA; [Diamond, George A.] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Buffalo General Medical Center; Cedars Sinai Medical Center	Boden, WE (corresponding author), SUNY Buffalo, Sch Med, Div Cardiovasc Med, Buffalo, NY USA.							Aikin K, 2004, PATIENT PHYS ATTITUD; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; BOROW W, 1993, MED MARKETING ME SEP, P68; GASCOIGNE D, 2004, PLYM M PA IMS HLTH S, P111; VOGT DU, 2005, C RES SERV REP C WAS, P1	5	18	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2008	358	21					2197	2200		10.1056/NEJMp0801433	http://dx.doi.org/10.1056/NEJMp0801433			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303EK	18480195				2022-12-28	WOS:000256023600001
J	Bartlett, BL; Tyring, SK				Bartlett, Brenda L.; Tyring, Stephen K.			Ustekinumab for chronic plaque psoriasis	LANCET			English	Editorial Material							INTERLEUKIN-12; GUIDELINES; MANAGEMENT; BIOLOGICS; ARTHRITIS; CARE		[Bartlett, Brenda L.; Tyring, Stephen K.] Univ Texas Houston, Hlth Sci Ctr, Ctr Clin Studies, Houston, TX 77030 USA; [Bartlett, Brenda L.; Tyring, Stephen K.] Univ Texas Houston, Hlth Sci Ctr, Dept Dermatol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Tyring, SK (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Ctr Clin Studies, Houston, TX 77030 USA.	styring@ccstexas.com						Bose A, 2007, HUM IMMUNOL, V68, P823, DOI 10.1016/j.humimm.2007.08.002; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Gottlieb A, 2008, J AM ACAD DERMATOL, V58, P851, DOI 10.1016/j.jaad.2008.02.040; Gottlieb AB, 2008, J DERMATOL TREAT, V19, P5, DOI 10.1080/09546630701364768; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Moreno SE, 2006, J IMMUNOL, V177, P3218, DOI 10.4049/jimmunol.177.5.3218; Nijsten T, 2005, J AM ACAD DERMATOL, V52, P434, DOI 10.1016/j.jaad.2004.10.862; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Shaker OG, 2006, CLIN BIOCHEM, V39, P119, DOI 10.1016/j.clinbiochem.2005.11.008	12	33	33	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 17	2008	371	9625					1639	1640		10.1016/S0140-6736(08)60702-3	http://dx.doi.org/10.1016/S0140-6736(08)60702-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302XB	18486724				2022-12-28	WOS:000256002200004
J	Ueda, K				Ueda, Kiyoshi			Chemistry - To be or not to be localized	SCIENCE			English	Editorial Material							N-2; PHOTOIONIZATION; INTERFERENCE; MOLECULES; C2H2		[Ueda, Kiyoshi] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Tohoku University	Ueda, K (corresponding author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	ueda@tagen.tohoku.ac.jp						Adachi J, 2007, J PHYS B-AT MOL OPT, V40, pF285, DOI 10.1088/0953-4075/40/20/F01; BAGUS PS, 1972, J CHEM PHYS, V56, P224, DOI 10.1063/1.1676850; CEDERBAUM LS, 1977, J CHEM PHYS, V66, P5084, DOI 10.1063/1.433763; COHEN HD, 1966, PHYS REV, V150, P30, DOI 10.1103/PhysRev.150.30; Ehara M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181144; Hergenhahn U, 2001, J PHYS CHEM A, V105, P5704, DOI 10.1021/jp0038456; Kempgens B, 1997, PHYS REV LETT, V79, P3617, DOI 10.1103/PhysRevLett.79.3617; Liu XJ, 2006, J PHYS B-AT MOL OPT, V39, P4801, DOI 10.1088/0953-4075/39/23/001; PUTTNER R, 2008, VERHANDL DPG 6, V43, P141; Rolles D, 2005, NATURE, V437, P711, DOI 10.1038/nature04040; Schoffler MS, 2008, SCIENCE, V320, P920, DOI 10.1126/science.1154989; Thiel A, 2003, J CHEM PHYS, V119, P2088, DOI 10.1063/1.1584658	12	10	10	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 16	2008	320	5878					884	885		10.1126/science.1157968	http://dx.doi.org/10.1126/science.1157968			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AH	18487181				2022-12-28	WOS:000255868300029
J	Ott, E				Ott, Edward			Edward N. Lorenz (1917-2008) - Obituary	NATURE			English	Biographical-Item									[Ott, Edward] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Ott, Edward] Univ Maryland, Dept Elect & Comp Engn, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ott, E (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	edott@umd.edu	Ott, Edward/F-5609-2017; O, E/F-1630-2015	Ott, Edward/0000-0002-9395-5062; 				LORENZ EEN, PUBLICATION LIST	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 15	2008	453	7193					300	300		10.1038/453300a	http://dx.doi.org/10.1038/453300a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480808				2022-12-28	WOS:000255868400034
J	Eikelboom, J; Guyatt, G; Hirsh, J				Eikelboom, John; Guyatt, Gordon; Hirsh, Jack			Guidelines for anticoagulant use in acute coronary syndromes	LANCET			English	Editorial Material							UNFRACTIONATED HEPARIN; ENOXAPARIN; FONDAPARINUX		[Eikelboom, John] Hamilton Gen Hosp, Thrombosis Serv, Hamilton, ON L8L 2X2, Canada; [Guyatt, Gordon] Dept Clin Epidemiol & Biostat, CLARITY Res Grp, W Hamilton, ON, Canada; [Hirsh, Jack] Henderson Res Ctr, Hamilton, ON, Canada; [Hirsh, Jack] McMaster Univ, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Eikelboom, J (corresponding author), Hamilton Gen Hosp, Thrombosis Serv, Hamilton, ON L8L 2X2, Canada.	eikelbj@mcmaster.ca	Eikelboom, John/AAG-6117-2019	Eikelboom, John/0000-0003-4126-1285				*AM HEARTH ASS, METH MAN ACC AHA GUI; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	8	13	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 10	2008	371	9624					1559	1561		10.1016/S0140-6736(08)60670-4	http://dx.doi.org/10.1016/S0140-6736(08)60670-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298VO	18468530				2022-12-28	WOS:000255715400008
J	Guyatt, GH; Oxman, AD; Kunz, R; Falck-Ytter, Y; Vist, GE; Liberati, A; Schunemann, HJ				Guyatt, Gordon H.; Oxman, Andrew D.; Kunz, Regina; Falck-Ytter, Yngve; Vist, Gunn E.; Liberati, Alessandro; Schunemann, Holger J.		GRADE Working Grp	GRADE: going from evidence to recommendations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [Oxman, Andrew D.; Vist, Gunn E.] Norwegian Knowledge Ctr Hlth Serv, N-0130 Oslo, Norway; [Kunz, Regina] Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; [Falck-Ytter, Yngve] Case Western Reserve Univ, Div Gastroenterol, Case Med Ctr, Cleveland, OH 44106 USA; [Liberati, Alessandro] Univ Modena, Bologna, Italy; [Liberati, Alessandro] Agenzia Sanit Reg, Bologna, Italy; [Schunemann, Holger J.] Italian Natl Canc Inst Regina Elena, Dept Epidemiol, CLARITY Res Grp, Rome, Italy	McMaster University; Norwegian Knowledge Centre for Health Services; University of Basel; Case Western Reserve University; Universita di Modena e Reggio Emilia	Guyatt, GH (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Falck-Ytter, Yngve/GZH-0993-2022; Oxman, Andrew/Y-3004-2019; Yngve Falck-Ytter, AGAF/AAC-5362-2019; Djulbegovic, Benjamin/I-3661-2012; Fervers, Béatrice/AAD-1847-2022; Whittington, Craig/B-1380-2008	Oxman, Andrew/0000-0002-5608-5061; Yngve Falck-Ytter, AGAF/0000-0002-4688-3211; Djulbegovic, Benjamin/0000-0003-0671-1447; Fervers, Béatrice/0000-0003-3498-6499; Whittington, Craig/0000-0002-1950-0334; Flottorp, Signe/0000-0003-2961-7461; Tuut, Mariska/0000-0002-0880-6215; Schunemann, Holger/0000-0003-3211-8479				Devereaux PJ, 2001, BMJ-BRIT MED J, V323, P1218, DOI 10.1136/bmj.323.7323.1218; Fleisher LA, 2005, CHEST, V128, p17S, DOI 10.1378/chest.128.2_suppl.17S; Geerts W, 2005, CHEST, V128, P3775, DOI 10.1378/chest.128.5.3775; OConnor AM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; Schunemann HJ, 2003, CAN MED ASSOC J, V169, P677	5	1156	1230	0	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2008	336	7652					1049	1051		10.1136/bmj.39493.646875.AE	http://dx.doi.org/10.1136/bmj.39493.646875.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304IN	18467413	Green Published			2022-12-28	WOS:000256103300027
J	Kropelin, S; Verschuren, D; Lezine, AM; Eggermont, H; Cocquyt, C; Francus, P; Cazet, JP; Fagot, M; Rumes, B; Russell, JM; Darius, F; Conley, DJ; Schuster, M; von Suchodoletz, H; Engstrom, DR				Kroepelin, S.; Verschuren, D.; Lezine, A. -M.; Eggermont, H.; Cocquyt, C.; Francus, P.; Cazet, J. -P.; Fagot, M.; Rumes, B.; Russell, J. M.; Darius, F.; Conley, D. J.; Schuster, M.; von Suchodoletz, H.; Engstrom, D. R.			Climate-driven ecosystem succession in the Sahara: The past 6000 years	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; AFRICAN DUST; VEGETATION; FEEDBACKS; MONSOON; SHIFTS; SIMULATIONS; MIDHOLOCENE; TERMINATION; SAHEL	Desiccation of the Sahara since the middle Holocene has eradicated all but a few natural archives recording its transition from a "green Sahara" to the present hyperarid desert. Our continuous 6000- year paleoenvironmental reconstruction from northern Chad shows progressive drying of the regional terrestrial ecosystem in response to weakening insolation forcing of the African monsoon and abrupt hydrological change in the local aquatic ecosystem controlled by site- specific thresholds. Strong reductions in tropical trees and then Sahelian grassland cover allowed large- scale dust mobilization from 4300 calendar years before the present ( cal yr B. P.). Today's desert ecosystem and regional wind regime were established around 2700 cal yr B. P. This gradual rather than abrupt termination of the African Humid Period in the eastern Sahara suggests a relatively weak biogeophysical feedback on climate.	[Kroepelin, S.; Darius, F.] Univ Cologne, Africa Res Unit, Inst Prehist Archaeol, D-50823 Cologne, Germany; [Verschuren, D.; Eggermont, H.; Cocquyt, C.; Fagot, M.; Rumes, B.] Univ Ghent, Limnol Unit, Dept Biol, B-9000 Ghent, Belgium; [Lezine, A. -M.; Cazet, J. -P.] CNRS CEA UVSQ, Lab Sci Climat & Environm, UMR 1572, F-91191 Gif Sur Yvette, France; [Cocquyt, C.] Natl Bot Garden Belgium, B-1860 Meise, Belgium; [Francus, P.] Ctr Eau Terre & Environm, Inst Natl Rech Sci, Quebec City, PQ G1K 9A9, Canada; [Francus, P.] Univ Quebec, Geotop, Geochem & Geodynam Res Ctr, Montreal, PQ H3C 3P8, Canada; [Russell, J. M.] Brown Univ, Providence, RI 02912 USA; [Conley, D. J.] Lund Univ, Geobiosphere Ctr, Dept Geol, SE-22362 Lund, Sweden; [Schuster, M.] Univ Poitiers, Inst Int Paleoprimatol Paleontol Humaine Evolut &, CNRS, UMR 6046, F-86022 Poitiers, France; [von Suchodoletz, H.] Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; [von Suchodoletz, H.] Univ Bayreuth, Lehrstuhl Geomorphol, D-95440 Bayreuth, Germany; [Engstrom, D. R.] Sci Museum Minnesota, St Croix Watershed Res Stn, Marine St Croix, MN 55047 USA	University of Cologne; Ghent University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; University of Quebec Montreal; Brown University; Lund University; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Bayreuth	Kropelin, S (corresponding author), Univ Cologne, Africa Res Unit, Inst Prehist Archaeol, Jennerstr 8, D-50823 Cologne, Germany.	s.kroe@uni-koeln.de	Lézine, Anne-Marie/A-5618-2013; Francus, Pierre/H-3713-2019	Francus, Pierre/0000-0001-5465-1966; Schuster, Mathieu/0000-0002-4412-8685; LEZINE, Anne-Marie/0000-0002-3555-5124; Engstrom, Daniel/0000-0002-8066-029X; Conley, Daniel Joseph/0000-0001-9668-9284; Rumes, Bob/0000-0001-8549-6743; Cocquyt, Christine/0000-0002-0047-4180				Adkins J, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001200; Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; CAPOTREY R, 1961, MEM I RECH SAHAR, V5, P65; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Claussen M, 1997, GLOBAL ECOL BIOGEOGR, V6, P369, DOI 10.2307/2997337; Dekker SC, 2007, GLOBAL CHANGE BIOL, V13, P671, DOI 10.1111/j.1365-2486.2007.01327.x; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; Fleitmann D, 2003, SCIENCE, V300, P1737, DOI 10.1126/science.1083130; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Ganopolski A, 1998, SCIENCE, V280, P1916, DOI 10.1126/science.280.5371.1916; Goudie AS, 2001, EARTH-SCI REV, V56, P179, DOI 10.1016/S0012-8252(01)00067-8; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hoelzmann P, 2004, DEV PALEOENVIRON RES, V6, P219; *INT AT EN AG, 2007, RAF8036 IAEA; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Joussaume S, 1999, GEOPHYS RES LETT, V26, P859, DOI 10.1029/1999GL900126; Kaufman YJ, 2002, NATURE, V419, P215, DOI 10.1038/nature01091; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Koren I, 2006, ENVIRON RES LETT, V1, DOI 10.1088/1748-9326/1/1/014005; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; KUTZBACH JE, 1982, J ATMOS SCI, V39, P1177, DOI 10.1175/1520-0469(1982)039<1177:TSOTAA>2.0.CO;2; Kutzbach JE, 1997, SCIENCE, V278, P440, DOI 10.1126/science.278.5337.440; Maley J, 2000, GLOBAL PLANET CHANGE, V26, P121, DOI 10.1016/S0921-8181(00)00039-4; Maslin M, 2004, SCIENCE, V306, P2197, DOI 10.1126/science.1107481; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Renssen H, 2006, QUATERN INT, V150, P95, DOI 10.1016/j.quaint.2005.01.001; Rial JA, 2004, CLIMATIC CHANGE, V65, P11, DOI 10.1023/B:CLIM.0000037493.89489.3f; Salzmann U, 2002, QUATERNARY RES, V58, P73, DOI 10.1006/qres.2002.2356; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Shinn EA, 2000, GEOPHYS RES LETT, V27, P3029, DOI 10.1029/2000GL011599; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Waller MP, 2007, J BIOGEOGR, V34, P1575, DOI 10.1111/j.1365-2699.2007.01721.x; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Washington R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025827; Washington R, 2003, ANN ASSOC AM GEOGR, V93, P297, DOI 10.1111/1467-8306.9302003; White F., 1983, VEGETATION AFRICA DE	42	428	438	5	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					765	768		10.1126/science.1154913	http://dx.doi.org/10.1126/science.1154913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467583				2022-12-28	WOS:000255644400031
J	Moore, JP; Klasse, PJ; Dolan, MJ; Ahuja, SK				Moore, John P.; Klasse, P. J.; Dolan, Matthew J.; Ahuja, Sunil K.			AIDS/HIV - A STEP into darkness or light?	SCIENCE			English	Editorial Material							PREVENTIVE VACCINE; HIV-1; MEASLES; SUSCEPTIBILITY; TRANSMISSION; RESPONSES; ALLELES; IMPACT; MUMPS; CCR5		[Moore, John P.; Klasse, P. J.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Dolan, Matthew J.] San Antonio Mil Med Ctr, Infect Dis Clin Res Program, Ft Sam Houston, TX 78234 USA; [Dolan, Matthew J.] San Antonio Mil Med Ctr, Infect Dis Clin Res Program, Lackland AFB, TX USA; [Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV 1 Infect, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Cornell University; San Antonio Military Medical Center; San Antonio Military Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Moore, JP (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10065 USA.	jpm2003@med.cornell.edu; ahujas@uthscsa.edu	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X				Ahuja SK, 2004, LANCET, V363, P2103, DOI 10.1016/S0140-6736(04)16536-7; Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Blower S., 2003, AIDS Reviews, V5, P113; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cohen J, 2005, SCIENCE, V307, P23, DOI 10.1126/science.307.5706.23; Cohen J, 2007, SCIENCE, V318, P1048, DOI 10.1126/science.318.5853.1048; Desrosiers RC, 2004, NAT MED, V10, P221, DOI 10.1038/nm0304-221; Dhiman N, 2007, J INFECT DIS, V195, P21, DOI 10.1086/510596; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; Gallo RC, 2005, LANCET, V366, P1894, DOI 10.1016/S0140-6736(05)67395-3; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Killian MS, 2004, AIDS, V18, P161, DOI 10.1097/00002030-200401230-00004; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Ovsyannikova IG, 2007, VACCINE, V25, P3090, DOI 10.1016/j.vaccine.2007.01.020; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SHAN M, 2001, PLOS PATHOG, V3, pE169; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; St Sauver JL, 2001, VACCINE, V19, P1363, DOI 10.1016/S0264-410X(00)00376-5; van Asten L, 2004, AIDS, V18, P1885, DOI 10.1097/00002030-200409240-00004	26	42	44	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 9	2008	320	5877					753	755		10.1126/science.1154258	http://dx.doi.org/10.1126/science.1154258			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VB	18467578				2022-12-28	WOS:000255644400026
J	Qaseem, A; Snow, V; Shekelle, P; Hopkins, R; Forciea, MA; Owens, DK				Qaseem, Amir; Snow, Vincenza; Shekelle, Paul; Hopkins, Robert, Jr.; Forciea, Mary Ann; Owens, Douglas K.		Clin Efficacy Assessment Subcomm	Screening for osteoporosis in men: A clinical practice guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ANDROGEN DEPRIVATION THERAPY; BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; PROSTATE-CANCER; QUANTITATIVE ULTRASOUND; RISK-FACTORS; FRACTURE RISK; HORMONE AGONISTS; ELDERLY-MEN; HEEL ULTRASOUND	Description: The American College of Physicians developed this guideline to present the available evidence on risk factors and screening tests for osteoporosis in men. Methods: Published literature on this topic was identified by using MEDLINE (1990 to July 2007). Reference mining was done on the retrieved articles, references of previous reviews, and solicited articles from experts. The inclusion criteria for the studies were measuring risk factors for low bone mineral density or osteoporotic fracture in men or comparing 2 different methods of assessment for the presence of osteoporosis in men. This guideline grades the evidence and recommendations by using the American College of Physicians' clinical practice guidelines grading system. Recommendation 1: The American College of Physicians recommends that clinicians periodically perform individualized assessment of risk factors for osteoporosis in older men (Grade: strong recommendation; moderate-quality evidence). Recommendation 2: The American College of Physicians recommends that clinicians obtain dual-energy x-ray absorptiometry for men who are at increased risk for osteoporosis and are candidates for drug therapy (Grade: strong recommendation; moderate-quality evidence). Recommendation 3: The American College of Physicians recommends further research to evaluate osteoporosis screening tests in men.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Arkansas, Little Rock, AR 72204 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Santa Monica, CA USA; RAND Corp, Santa Monica, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA	American College of Physicians; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org						Adler RA, 2003, CHEST, V123, P2012, DOI 10.1378/chest.123.6.2012; Adler RA, 2003, MAYO CLIN PROC, V78, P723, DOI 10.4065/78.6.723; Adler RR, 2001, J CLIN DENSITOM, V4, P225, DOI 10.1385/JCD:4:3:225; Bakhireva LN, 2004, AM J PREV MED, V26, P436, DOI 10.1016/j.ampere.2004.02.013; Bano G, 1999, INT J OBESITY, V23, P361, DOI 10.1038/sj.ijo.0800827; Bateman C, 2006, SAMJ S AFR MED J, V96, P19; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Brunader R, 2002, AM FAM PHYSICIAN, V65, P1357; Chen Z, 2002, CANCER-AM CANCER SOC, V95, P2136, DOI 10.1002/cncr.10967; Daniell HW, 2000, J UROLOGY, V163, P181, DOI 10.1016/S0022-5347(05)68000-7; Diamond TH, 2004, J UROLOGY, V172, P529, DOI 10.1097/01.ju.0000130508.61020.66; Donaldson MMK, 1999, OSTEOPOROSIS INT, V10, P316, DOI 10.1007/s001980050234; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Gonnelli S, 2005, OSTEOPOROSIS INT, V16, P963, DOI 10.1007/s00198-004-1771-6; Halling A, 2005, OSTEOPOROSIS INT, V16, P999, DOI 10.1007/s00198-004-1796-x; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Hatano T, 2000, BJU INT, V86, P449, DOI 10.1046/j.1464-410X.2000.00774.x; Hoidrup S, 1999, AM J EPIDEMIOL, V149, P993; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; Kanis JA, 2001, CALCIFIED TISSUE INT, V69, P218, DOI 10.1007/s00223-001-1046-6; Kiebzak GM, 2002, ARCH INTERN MED, V162, P2217, DOI 10.1001/archinte.162.19.2217; Krupski TL, 2004, CANCER-AM CANCER SOC, V101, P541, DOI 10.1002/cncr.20388; Kung AWC, 2005, OSTEOPOROSIS INT, V16, P849, DOI 10.1007/s00198-004-1778-z; Li-Yu JT, 2005, OSTEOPOROSIS INT, V16, P1789, DOI 10.1007/s00198-005-1929-x; Liu H, 2008, ANN INTERN MED, V148, P685, DOI 10.7326/0003-4819-148-9-200805060-00009; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Lopez AM, 2005, OSTEOPOROSIS INT, V16, P707, DOI 10.1007/s00198-004-1799-7; Melton LJ, 2003, J UROLOGY, V169, P1747, DOI 10.1097/01.ju.0000059281.67667.97; Mulleman D, 2002, OSTEOPOROSIS INT, V13, P388, DOI 10.1007/s001980200044; Naves M, 2005, OSTEOPOROSIS INT, V16, P603, DOI 10.1007/s00198-004-1727-x; Nayak S, 2006, ANN INTERN MED, V144, P832, DOI 10.7326/0003-4819-144-11-200606060-00009; Oefelein MG, 2001, J UROLOGY, V166, P1724, DOI 10.1016/S0022-5347(05)65661-3; OEFELEIN MG, 1999, UROL CLIN N AM, V23, P361; Pacini Stefania, 1999, Italian Journal of Anatomy and Embryology, V104, P195; Rothenberg RJ, 2004, J CLIN DENSITOM, V7, P101, DOI 10.1385/JCD:7:1:101; Roy DK, 2003, OSTEOPOROSIS INT, V14, P19, DOI 10.1007/s00198-002-1317-8; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Shekelle P, 2007, SCREENING MEN OSTEOP; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908; Stehman-Breen CO, 1999, AM J KIDNEY DIS, V33, P941, DOI 10.1016/S0272-6386(99)70430-0; STEWART A, 1995, BRIT J RADIOL, V68, P614, DOI 10.1259/0007-1285-68-810-614; Stoch SA, 2001, J CLIN ENDOCR METAB, V86, P2787, DOI 10.1210/jc.86.6.2787; TRAVERSGUSTAFSON D, 1995, CALCIFIED TISSUE INT, V57, P267, DOI 10.1007/BF00298881; Varenna M, 2005, OSTEOPOROSIS INT, V16, P1749, DOI 10.1007/s00198-005-1914-4; Welch Ailsa, 2004, Osteoporos Int, V15, P217, DOI 10.1007/s00198-003-1410-7; Yaturu S, 2006, PROSTATE CANCER P D, V9, P35, DOI 10.1038/sj.pcan.4500846	49	121	128	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					680	684		10.7326/0003-4819-148-9-200805060-00008	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458281				2022-12-28	WOS:000255731800006
J	Sullivan, LE; Fiellin, DA				Sullivan, Lynn E.; Fiellin, David A.			Narrative review: Buprenorphine for opioid-dependent patients in office practice	ANNALS OF INTERNAL MEDICINE			English	Review							PRIMARY-CARE; PRECIPITATED WITHDRAWAL; CLINICAL-PHARMACOLOGY; NALOXONE COMBINATIONS; MAINTENANCE TREATMENT; SUBLINGUAL-TABLET; OPIATE DEPENDENCE; METHADONE; ABUSE; DETOXIFICATION	profile of opioid dependence in the United States is changing. Abuse of prescription opioids is more common than that of illicit opioids: Recent data indicate that approximately 1.6 million persons abuse or are dependent on prescription opioids, whereas 323 000 abuse or are dependent on heroin. Despite this prevalence, nearly 80% of opioid-dependent persons remain untreated. One option for expanding treatment is the use of buprenorphine and the buprenorphine-naloxone combination. Buprenorphine is a partial opioid agonist that can be prescribed by trained physicians and dispensed at pharmacies. This article addresses the clinical presentation of a patient with opioid dependence and describes the relatively new practice of office-based treatment with buprenorphine-naloxone. The different components of treatment; the role of the physician who provides this treatment; and the logistics of treating this growing, multifaceted patient, population are also examined.	[Sullivan, Lynn E.; Fiellin, David A.] Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Sullivan, LE (corresponding author), Yale Univ, Sch Med, 367 Cedar St,POB 208093, New Haven, CT 06520 USA.	lynn.sullivan@yale.edu		Fiellin, David/0000-0002-4006-010X	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020576, R01DA019511, K12DA000167] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA020576-01, R01 DA019511, K12 DA00167, K12 DA000167, R01 DA020576] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ACKER CJ, 1993, J PSYCHOACTIVE DRUGS, V25, P193, DOI 10.1080/02791072.1993.10472271; Alford DP, 2007, J GEN INTERN MED, V22, P171, DOI 10.1007/s11606-006-0023-1; Alford DP, 2006, ANN INTERN MED, V144, P127, DOI 10.7326/0003-4819-144-2-200601170-00010; Allen JP, 1997, J STUD ALCOHOL, V58, P7; *AM AC PAIN MED AM, 2007, DEF REL US OP TREATM; Amass L, 2004, AM J ADDICTION, V13, pS42, DOI 10.1080/10550490490440807; AMASS L, 1994, J ADDICT DIS, V13, P33; Amato L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005031, DOI 10.1002/14651858.CD005031]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 1993, Alcohol Clin Exp Res, V17, P1130; [Anonymous], 2006, MMWR RECOMM REP; Barry DT, 2007, J GEN INTERN MED, V22, P242, DOI 10.1007/s11606-006-0050-y; Becker WC, 2008, DRUG ALCOHOL DEPEN, V94, P38, DOI 10.1016/j.drugalcdep.2007.09.018; Book SW, 2007, AM J PSYCHIAT, V164, P979, DOI 10.1176/appi.ajp.164.6.979; Bruce RD, 2006, JAIDS-J ACQ IMM DEF, V41, P563, DOI 10.1097/01.qai.0000219769.89679.ec; Carroll KM, 1997, MED CLIN N AM, V81, P927, DOI 10.1016/S0025-7125(05)70556-3; Chiang CN, 2003, DRUG ALCOHOL DEPEN, V70, pS39, DOI 10.1016/S0376-8716(03)00058-9; Colameco S, 2005, J ADDICT DIS, V24, P25, DOI 10.1300/J069v24n02_03; Collins ED, 2005, JAMA-J AM MED ASSOC, V294, P903, DOI 10.1001/jama.294.8.903; CRITSCHRISTOPH P, 1999, ARCH GEN PSYCHIAT, V56, P505; *CTR SUBST AB TREA, 2003, PAT FAM BROCH INTR O; Dasgupta A, 2007, AM J CLIN PATHOL, V128, P491, DOI 10.1309/FQY06F8XKTQPM149; DEAN JC, 1984, INT J ADDICT, V19, P859, DOI 10.3109/10826088409061991; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fiellin DA, 2008, AM J ADDICTION, V17, P116, DOI 10.1080/10550490701860971; Fiellin DA, 2007, J ADDICT MED, V1, P62, DOI 10.1097/ADM.0b013e3180473c11; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Finch JW, 2007, J ADDICT MED, V1, P104, DOI 10.1097/ADM.0b013e31809b5df2; Fudala PJ, 1998, DRUG ALCOHOL DEPEN, V50, P1, DOI 10.1016/S0376-8716(98)00008-8; Fudala PJ, 2003, NEW ENGL J MED, V349, P949, DOI 10.1056/NEJMoa022164; Glasper A, 2005, ADDICT BIOL, V10, P149, DOI 10.1080/13556210500123126; GOURLAY DL, URINE DRUG TESTING C; Greenwald MK, 2003, AM J ADDICTION, V12, P365, DOI 10.1080/10550490390226941; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Jacobs EA, 1999, ADDICTION, V94, P140; Johnson RE, 2003, DRUG ALCOHOL DEPEN, V70, pS87, DOI 10.1016/S0376-8716(03)00062-0; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Jones Hendree E, 2004, Sci Pract Perspect, V2, P4; Kakko J, 2003, LANCET, V361, P662, DOI 10.1016/S0140-6736(03)12600-1; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; Lofwall MR, 2005, ADDICT DISORD TREAT, V4, P49, DOI 10.1097/01.adt.0000145126.17405.6a; LOPEZ F, 1994, TECHNICAL ASSISTANCE, V13; Luzzi VI, 2004, CLIN CHEM, V50, P717, DOI 10.1373/clinchem.2003.028878; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; McCance-Katz EF, 2007, DRUG ALCOHOL DEPEN, V91, P269, DOI 10.1016/j.drugalcdep.2007.06.007; McCance-Katz EF, 2006, CLIN INFECT DIS, V43, pS224, DOI 10.1086/508187; McCance-Katz EF, 2006, CLIN INFECT DIS, V43, pS235, DOI 10.1086/508188; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; Mendelson J, 1999, PSYCHOPHARMACOLOGY, V141, P37, DOI 10.1007/s002130050804; Mendelson J, 1996, CLIN PHARMACOL THER, V60, P105, DOI 10.1016/S0009-9236(96)90173-3; Mendelson J, 1997, BIOL PSYCHIAT, V41, P1095, DOI 10.1016/S0006-3223(96)00266-1; Mendelson J, 2003, DRUG ALCOHOL DEPEN, V70, pS29, DOI 10.1016/S0376-8716(03)00057-7; Mintzer IL, 2007, ANN FAM MED, V5, P146, DOI 10.1370/afm.665; Montoya ID, 2005, J SUBST ABUSE TREAT, V28, P247, DOI 10.1016/j.jsat.2005.01.004; NESTLER EJ, 1997, NEW TREATMENTS OPIAT, P286; O'Brien C P, 1978, Ann N Y Acad Sci, V311, P232, DOI 10.1111/j.1749-6632.1978.tb16779.x; O'Brien CP, 2006, AM J PSYCHIAT, V163, P764, DOI 10.1176/appi.ajp.163.5.764; O'Connor PG, 1998, JAMA-J AM MED ASSOC, V279, P229, DOI 10.1001/jama.279.3.229; OConnor PG, 1997, ANN INTERN MED, V127, P526, DOI 10.7326/0003-4819-127-7-199710010-00004; Petry NM, 2000, DRUG ALCOHOL DEPEN, V58, P9, DOI 10.1016/S0376-8716(99)00071-X; PICKWORTH WB, 1993, CLIN PHARMACOL THER, V53, P570, DOI 10.1038/clpt.1993.72; PRESTON KL, 1990, DRUG ALCOHOL DEPEN, V25, P27, DOI 10.1016/0376-8716(90)90136-3; PRESTON KL, 1988, PSYCHOPHARMACOLOGY, V94, P484, DOI 10.1007/BF00212842; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; Rosado J, 2007, DRUG ALCOHOL DEPEN, V90, P261, DOI 10.1016/j.drugalcdep.2007.04.006; Schackman BR, 2006, CLIN INFECT DIS, V43, pS247; Stein MD, 2005, J GEN INTERN MED, V20, P1038, DOI 10.1111/j.1525-1497.2005.0228.x; Strain EC, 1997, PSYCHOPHARMACOLOGY, V129, P329, DOI 10.1007/s002130050199; STRAIN EC, 1995, J PHARMACOL EXP THER, V272, P628; Strang J, 2003, BRIT MED J, V327, P321, DOI 10.1136/bmj.327.7410.321; *SUBST AB MENT HLT, 2004, TREATM IMPR PROT TIP, V40; *SUBST AB MENT HLT, 2005, TREATM EP DAT SET; *SUBST AB MENT HLT, 2005, TREATM IMPR PROT TIP, V43; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER H; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS191, DOI 10.1086/508183; *US PREV TASK FORC, 2000, US PREV SERV TASK FO; WALSH SL, 1994, CLIN PHARMACOL THER, V55, P569, DOI 10.1038/clpt.1994.71; WALSH SL, 1995, PSYCHOPHARMACOLOGY, V119, P268, DOI 10.1007/BF02246290; 2006, 277006111 FINAL; 2002, SUBUTEX SUBOXONE PAC; 2005, METHADONE HYDROCHLOR; 1995, NARCAN NALOXONE HYDR	85	41	41	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					662	670		10.7326/0003-4819-148-9-200805060-00006	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458279	Green Accepted			2022-12-28	WOS:000255731800004
J	MacMahon, S; Alderman, MH; Lindholm, LH; Liu, LS; Sanchez, RA; Seedat, YK				MacMahon, Stephen; Alderman, Michael H.; Lindholm, Lars H.; Liu, Lisheng; Sanchez, Ramiro A.; Seedat, Yackoob K.			Blood-pressure-related disease is a global health priority	LANCET			English	Editorial Material							BURDEN; STROKE; TRIAL		[MacMahon, Stephen] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia; [Alderman, Michael H.] Yeshiva Univ Albert Einstein Coll Med, New York, NY USA; [Lindholm, Lars H.] Umea Univ, Umea, Sweden; [Liu, Lisheng] Fu Wai Hosp, Chinese Acad Med Sci, Beijing, Peoples R China; [Sanchez, Ramiro A.] Univ Dr Rene G Favaloro, Inst Cardiol Cirugia Cardiovasc, Buenos Aires, DF, Argentina; [Seedat, Yackoob K.] Univ Kwazulu Natal, Nelson R Mandela Sch Med, Durban, South Africa	University of Sydney; Yeshiva University; Umea University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; University of Kwazulu Natal	MacMahon, S (corresponding author), Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia.	smacmahon@george.org.au		MacMahon, Stephen/0000-0003-2064-7699				Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2005, PREV CHRON DIS VIT I; Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9; Kitahata MM, 2002, BMJ-BRIT MED J, V325, P954, DOI 10.1136/bmj.325.7370.954; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MCFADYEN J, 2007, INT DRUG PRICE INDIC; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Riley S, 2006, CARDIOVASCULAR MARKE; Turnbull F, 2003, LANCET, V362, P1527	11	56	60	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1480	1482		10.1016/S0140-6736(08)60632-7	http://dx.doi.org/10.1016/S0140-6736(08)60632-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298ED	18456084				2022-12-28	WOS:000255668300005
J	Weinstein, SL; Dolan, LA; Cheng, JCY; Danielsson, A; Morcuende, JA				Weinstein, Stuart L.; Dolan, Lori A.; Cheng, Jack C. Y.; Danielsson, Aina; Morcuende, Jose A.			Adolescent idiopathic scoliosis	LANCET			English	Review							TERM FOLLOW-UP; CHARLESTON BENDING BRACE; POSTERIOR SPINAL-FUSION; THORACIC PEDICLE SCREWS; NON-TREATED SCOLIOSIS; QUALITY-OF-LIFE; PULMONARY-FUNCTION; CURVE PROGRESSION; WILMINGTON BRACE; BOSTON BRACE	Adolescent idiopathic scoliosis (AIS) affects 1-3% of children in the at-risk population of those aged 10-16 years. The aetiopathogensis of this disorder remains unknown, with misinformation about its natural history. Non-surgical treatments are aimed to reduce the number of operations by preventing curve progression. Although bracing and physiotherapy are common treatments in much of the world, their effectiveness has never been rigorously assessed. Technological advances have much improved the ability of surgeons to safely correct the deformity while maintaining sagittal and coronal balance. However, we do not have long-term results of these changing surgical treatments. Much has yet to be learned about the general health, quality of life, and self-image of both treated and untreated patients with AIS.	[Weinstein, Stuart L.; Dolan, Lori A.; Morcuende, Jose A.] Univ Iowa, Dept Orthopaed Surg & Rehabil, Iowa City, IA USA; [Cheng, Jack C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Danielsson, Aina] Univ Gothenburg, Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden	University of Iowa; Chinese University of Hong Kong; Sahlgrenska University Hospital; University of Gothenburg	Weinstein, SL (corresponding author), Univ Iowa Hosp & Clin, Dept Orthopaed Surg & Rehabil, 200 Hawkins Dr, Iowa City, IA 52242 USA.	stuart-weinstein@uiowa.edu	Cheng, Jack/J-3878-2018	Cheng, Jack/0000-0001-8153-364X; Weinstein, Stuart/0000-0002-3676-6687; Dolan, Lori/0000-0003-2455-2187				AGADIR M, 1989, J ORTHOPAED RES, V7, P690, DOI 10.1002/jor.1100070509; Al-Sayyad MJ, 2005, CLIN ORTHOP RELAT R, P61, DOI 10.1097/01.blo.0000163244.77486.47; Allington NJ, 1996, J BONE JOINT SURG AM, V78A, P1056, DOI 10.2106/00004623-199607000-00010; ASCANI E, 1986, SPINE, V11, P784, DOI 10.1097/00007632-198610000-00007; Bagnall KM, 2001, SPINE, V26, P1022, DOI 10.1097/00007632-200105010-00007; Bashiardes S, 2004, HUM GENET, V115, P81, DOI 10.1007/s00439-004-1121-y; BASSETT GS, 1987, CLIN ORTHOP RELAT R, P164; BASSETT GS, 1986, J BONE JOINT SURG AM, V68A, P602, DOI 10.2106/00004623-198668040-00019; Belmont PJ, 2001, SPINE, V26, P2340, DOI 10.1097/00007632-200111010-00010; Benli IT, 2006, SPINE, V31, P1828, DOI 10.1097/01.brs.0000227256.15525.9b; Betz RR, 2005, CLIN ORTHOP RELAT R, P55, DOI 10.1097/01.blo.0000163472.46511.a8; Betz RR, 1999, SPINE, V24, P225, DOI 10.1097/00007632-199902010-00007; Beuerlein M, 2001, SPINE, V26, P237, DOI 10.1097/00007632-200102010-00007; BJURE J, 1973, CLIN ORTHOP RELAT R, P44; BLOUNT WP, 1973, ISRAEL J MED SCI, V9, P745; BRANTHWAITE MA, 1986, BRIT J DIS CHEST, V80, P360, DOI 10.1016/0007-0971(86)90089-6; Braun JT, 2006, SPINE, V31, P1314, DOI 10.1097/01.brs.0000218662.78165.b1; Bridwell KH, 2007, J BONE JOINT SURG AM, V89A, P1654, DOI 10.2106/JBJS.G.00425; Bullmann V, 2003, SPINE, V28, P1306, DOI 10.1097/00007632-200306150-00016; BUNNELL WP, 1986, SPINE, V11, P773, DOI 10.1097/00007632-198610000-00003; Burton DC, 2005, SPINE, V30, P1979, DOI 10.1097/01.brs.0000176196.94565.d6; Burwell R G, 2003, Pediatr Rehabil, V6, P137; Chan V, 2002, AM J HUM GENET, V71, P401, DOI 10.1086/341607; Cheung KMC, 2003, SPINE, V28, P1941, DOI 10.1097/01.BRS.0000083140.80750.93; Chu WCW, 2006, SPINE, V31, pE19, DOI 10.1097/01.brs.0000193892.20764.51; CLAYSON D, 1987, SPINE, V12, P983, DOI 10.1097/00007632-198712000-00007; Coe JD, 2006, SPINE, V31, P345, DOI 10.1097/01.brs.0000197188.76369.13; Coillard C, 2003, EUR SPINE J, V12, P141, DOI 10.1007/s00586-002-0467-x; COLLIS DK, 1969, J BONE JOINT SURG AM, VA 51, P425, DOI 10.2106/00004623-196951030-00001; COTREL Y, 1988, CLIN ORTHOP RELAT R, P10; d'Amato CR, 2001, SPINE, V26, P2006; Danielsson AJ, 2003, SPINE, V28, pE373, DOI 10.1097/01.BRS.0000084267.41183.75; Danielsson AJ, 2001, EUR SPINE J, V10, P278, DOI 10.1007/s005860100309; Danielsson AJ, 2003, SPINE, V28, P2078; DEKONING HJ, 2007, EFFECTIVENESS BRACIN; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; DICKSON JH, 1995, J BONE JOINT SURG AM, V77A, P513, DOI 10.2106/00004623-199504000-00003; Dickson Robert A., 1994, P421; DWYER AF, 1974, J BONE JOINT SURG BR, VB 56, P218, DOI 10.1302/0301-620X.56B2.218; Early SD, 2002, SPINE, V27, P2368, DOI 10.1097/00007632-200211010-00011; EDGAR MA, 1988, J BONE JOINT SURG BR, V70, P712, DOI 10.1302/0301-620X.70B5.3192566; EMANS JB, 1986, SPINE, V11, P792, DOI 10.1097/00007632-198610000-00009; Emery E, 1997, Eur Spine J, V6, P158, DOI 10.1007/BF01301429; FALLSTROM K, 1986, SPINE, V11, P756; FERNANDEZFELIBERTI R, 1995, J PEDIATR ORTHOPED, V15, P176; FOWLES JV, 1978, CLIN ORTHOP RELAT R, P212; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; GAVIN TM, 2001, PEDIAT SPINE PRINCIP; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; Goldbloom R.B., 1994, CANADIAN TASK FORCE, P346; Graham EJ, 2000, SPINE, V25, P2319, DOI 10.1097/00007632-200009150-00009; GRIMARD G, 2002, SCOL RES SOC ANN M, P112; Guo X, 2003, J BONE JOINT SURG BR, V85B, P1026, DOI 10.1302/0301-620X.85B7.14046; Hadley Miller N, 2000, Spine (Phila Pa 1976), V25, P2416; HAMMERBERG KW, 1988, ORTHOPEDICS, V11, P1365; Harrington PR, 2002, J BONE JOINT SURG AM, V84A, P316, DOI 10.2106/00004623-200202000-00020; Huynh AM, 2007, EUR SPINE J, V16, P523, DOI 10.1007/s00586-006-0235-4; Inoue M, 2005, SPINE, V30, P108, DOI 10.1097/01.brs.0000149075.96242.0e; Inoue Masatoshi, 2002, Stud Health Technol Inform, V91, P90; Justice CM, 2003, SPINE, V28, P589, DOI 10.1097/00007632-200303150-00014; KAFER ER, 1977, B EUR PHYSIOPATH RES, V13, P299; KAHANOVITZ N, 1989, SPINE, V14, P483, DOI 10.1097/00007632-198905000-00001; Kaneda K, 1996, SPINE, V21, P1250, DOI 10.1097/00007632-199605150-00021; Katz DE, 1997, SPINE, V22, P1302, DOI 10.1097/00007632-199706150-00005; KEARON C, 1993, AM REV RESPIR DIS, V148, P288, DOI 10.1164/ajrccm/148.2.288; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kim YJ, 2006, SPINE, V31, P291, DOI 10.1097/01.brs.0000197865.20803.d4; Kim YJ, 2004, SPINE, V29, P333, DOI 10.1097/01.BRS.0000109983.12113.9B; KOLINDSORENSEN V, 1973, ACTA ORTHOP SCAND, V44, P98; Korovessis P, 2000, SPINE, V25, P2064, DOI 10.1097/00007632-200008150-00010; Kuklo TR, 2005, SPINE, V30, P222, DOI 10.1097/01.brs.0000150482.26918.d8; Lenke LG, 2004, SPINE, V29, P2055, DOI 10.1097/01.brs.0000138274.09504.38; Lenke LG, 2004, J PEDIATR ORTHOPED, V24, P329, DOI 10.1097/01241398-200405000-00017; Lenke LG, 2003, SPINE, V28, pS36, DOI 10.1097/00007632-200308011-00007; Lin MC, 2001, ARCH PHYS MED REHAB, V82, P335, DOI 10.1053/apmr.2001.21528; Little DG, 2000, J BONE JOINT SURG AM, V82A, P685, DOI 10.2106/00004623-200005000-00009; Lonner BS, 2006, J BONE JOINT SURG AM, V88A, P1022, DOI 10.2106/JBJS.E.00001; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe T, 2002, SPINE, V27, P768, DOI 10.1097/00007632-200204010-00016; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Lowe TG, 2003, SPINE, V28, pS208, DOI 10.1097/01.BRS.0000092483.10776.2A; Maiocco B, 1997, SPINE, V22, P2537, DOI 10.1097/00007632-199711010-00014; MAYO NE, 1994, SPINE, V19, P1573, DOI 10.1097/00007632-199407001-00005; MEROLA AA, 2003, SCOL RES SOC M 2003; MILLER JAA, 1984, SPINE, V9, P632, DOI 10.1097/00007632-198409000-00015; MILLER NH, 2003, 38 ANN M SCOL RES SO; MOE JH, 1983, CLIN ORTHOP RELAT R, P133; Morcuende JA, 2003, SPINE, V28, P2025, DOI 10.1097/01.BRS.0000083235.74593.49; Muschik MT, 2006, EUR SPINE J, V15, P1128, DOI 10.1007/s00586-005-0034-3; NACHEMSON A, 1968, ACTA ORTHOP SCAND, V39, P466, DOI 10.3109/17453676808989664; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Nachemson AL., 1982, REPORT PREVALANCE NA; Negrini A, 2001, EUR MED PHYS, V37, P181; Negrini S, 2005, Eura Medicophys, V41, P183; NILSONNE U, 1968, ACTA ORTHOP SCAND, V39, P456, DOI 10.3109/17453676808989663; O'Neill PJ, 2005, J BONE JOINT SURG AM, V87A, P1069, DOI 10.2106/JBJS.C.01707; OLAFSSON Y, 1995, J PEDIATR ORTHOPED, V15, P524, DOI 10.1097/01241398-199507000-00023; Olafsson Y, 1999, EUR SPINE J, V8, P402, DOI 10.1007/s005860050194; Parent S, 2004, SPINE, V29, P239, DOI 10.1097/01.BRS.0000109995.64028.FE; Parent Stefan, 2005, Instr Course Lect, V54, P529; PEHRSSON K, 1991, THORAX, V46, P474, DOI 10.1136/thx.46.7.474; Pehrsson K, 2001, THORAX, V56, P388, DOI 10.1136/thorax.56.5.388; PETERSON LE, 1995, J BONE JOINT SURG AM, V77A, P823, DOI 10.2106/00004623-199506000-00002; PIAZZA MR, 1990, J PEDIATR ORTHOPED, V10, P39; PICAULT C, 1981, SPINE, V11, P77; PONSETI IV, 1950, J BONE JOINT SURG AM, V52, P131; Poon AMS, 2006, SPINE, V31, P2043, DOI 10.1097/01.brs.0000231796.49827.39; PRICE CT, 1990, SPINE, V15, P1294, DOI 10.1097/00007632-199012000-00011; Price CT, 1997, J PEDIATR ORTHOPED, V17, P703, DOI 10.1097/00004694-199711000-00002; Rahman T, 2005, J PEDIATR ORTHOPED, V25, P420, DOI 10.1097/01.bpo.0000161097.61586.bb; Rajwani T, 2004, SPINE, V29, pE145, DOI 10.1097/01.BRS.0000120507.36611.8D; RICHARDS BS, 1994, SPINE, V19, P1598, DOI 10.1097/00007632-199407001-00008; Rigo M, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-11; Rowe DE, 1997, J BONE JOINT SURG AM, V79A, P664, DOI 10.2106/00004623-199705000-00005; Salehi LB, 2002, HUM GENET, V111, P401, DOI 10.1007/s00439-002-0785-4; SCHATZINGER LH, 1979, AM J NURS, V79, P1608, DOI 10.2307/3424697; Sevastik JA, 2006, STUD HEALTH TECHNOL, V123, P552; Spoonamore MJ, 2004, SPINE, V29, P1458, DOI 10.1097/01.BRS.0000128756.89367.9E; Sucato DJ, 2004, SPINE, V29, P554, DOI 10.1097/01.BRS.0000106495.91477.92; Suk SI, 2005, SPINE, V30, P1602, DOI 10.1097/01.brs.0000169452.50705.61; Suk SI, 2001, SPINE, V26, P2049, DOI 10.1097/00007632-200109150-00022; Szappanos L, 1997, Acta Chir Hung, V36, P343; Tang NLS, 2006, SPINE, V31, P2463, DOI 10.1097/01.brs.0000239179.81596.2b; Tones M, 2006, SPINE, V31, P3027, DOI 10.1097/01.brs.0000249555.87601.fc; Trivedi JM, 2001, J PEDIATR ORTHOPED, V21, P277, DOI 10.1097/00004694-200105000-00002; TURI M, 1993, SPINE, V18, P417; US Preventive Services Task Force, 2004, SCREEN ID SCOL AD RE; Veldhuizen AG, 2002, MED ENG PHYS, V24, P209, DOI 10.1016/S1350-4533(02)00008-5; Vijvermans V, 2004, J PEDIATR ORTHOP B, V13, P143, DOI 10.1097/00009957-200405000-00001; Villemure I, 2004, EUR SPINE J, V13, P83, DOI 10.1007/s00586-003-0565-4; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003; Weinstein SL, 2003, JAMA-J AM MED ASSOC, V289, P559, DOI 10.1001/jama.289.5.559; WEINSTEIN SL, 2007, BRAIST BRACING ADOLE; Weiss HR, 2006, SCOLIOSIS SPINAL DIS, V1, DOI [10.1186/1748-7161-1-5, 10.1186/1748-7161-1-1]; Weiss Hans-Rudolf, 2003, Pediatr Rehabil, V6, P183; Weiss Hans-Rudolf, 2002, Stud Health Technol Inform, V91, P342; Wiley JW, 2000, SPINE, V25, P2326, DOI 10.1097/00007632-200009150-00010; Wise CA, 2000, SPINE, V25, P2372, DOI 10.1097/00007632-200009150-00017; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f	144	682	765	17	179	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2008	371	9623					1527	1537		10.1016/S0140-6736(08)60658-3	http://dx.doi.org/10.1016/S0140-6736(08)60658-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298ED	18456103				2022-12-28	WOS:000255668300030
J	Thornton, TM; Pedraza-Alva, G; Deng, B; Wood, CD; Aronshtam, A; Clements, JL; Sabio, G; Davis, RJ; Matthews, DE; Doble, B; Rincon, M				Thornton, Tina M.; Pedraza-Alva, Gustavo; Deng, Bin; Wood, C. David; Aronshtam, Alexander; Clements, James L.; Sabio, Guadalupe; Davis, Roger J.; Matthews, Dwight E.; Doble, Bradley; Rincon, Mercedes			Phosphorylation by p38 MAPK as an alternative pathway for GSK3 beta inactivation	SCIENCE			English	Article							BETA-CATENIN; KINASE PATHWAY; IN-VIVO; C-MYC; ACTIVATION; CHECKPOINT; PROTEIN; CELLS; PROGRESSION; GSK-3-BETA	Glycogen synthase kinase 3 beta (GSK3 beta) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3 beta activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3 beta by phosphorylation at the N terminus, preventing Akt- mediated phosphorylation does not affect the cell- survival pathway activated through the GSK3 beta substrate beta- catenin. Here, we show that p38 mitogen- activated protein kinase ( MAPK) also inactivates GSK3 beta by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of beta- catenin. p38 MAPK- mediated phosphorylation of GSK3 beta occurs primarily in the brain and thymocytes. Activation of beta- catenin- mediated signaling through GSK3 beta inhibition provides a potential mechanism for p38 MAPK- mediated survival in specific tissues.	[Thornton, Tina M.; Pedraza-Alva, Gustavo; Wood, C. David; Aronshtam, Alexander; Matthews, Dwight E.; Rincon, Mercedes] Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA; [Deng, Bin] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Deng, Bin; Matthews, Dwight E.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Clements, James L.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Sabio, Guadalupe; Davis, Roger J.] Univ Massachusetts, Program Mol Med, Worcester, MA 01605 USA; [Doble, Bradley] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada	University of Vermont; University of Vermont; University of Vermont; Roswell Park Cancer Institute; University of Massachusetts System; University of Massachusetts Worcester; McMaster University	Rincon, M (corresponding author), Univ Vermont, Dept Med, Immunobiol Program, Burlington, VT 05405 USA.	mrincon@uvm.edu	Doble, Bradley/V-7848-2019; Sabio, Guadalupe/H-9733-2015	Doble, Bradley/0000-0002-0260-2983; Sabio, Guadalupe/0000-0002-2822-0625; Wood, David/0000-0002-0758-0592; Davis, Roger/0000-0002-0130-1652	NCRR NIH HHS [P20 RR016462, P20 RR021905, P20 RR16462, P20 RR15557, P20 RR015557] Funding Source: Medline; NIAID NIH HHS [R01 AI051454, R01 AI051454-03, R01 AI051454-02, R01 AI051454-04, R01 AI051454-01A1, R01 AI051454-05] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015557, P20RR021905, P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051454] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Diehl NL, 2000, J EXP MED, V191, P321, DOI 10.1084/jem.191.2.321; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Dmitrieva NI, 2002, P NATL ACAD SCI USA, V99, P184, DOI 10.1073/pnas.231623498; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kurosu T, 2005, APOPTOSIS, V10, P1111, DOI 10.1007/s10495-005-3372-z; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; Pedraza-Alva G, 2006, EMBO J, V25, P763, DOI 10.1038/sj.emboj.7600972; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	23	349	370	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					667	670		10.1126/science.1156037	http://dx.doi.org/10.1126/science.1156037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451303	Green Accepted			2022-12-28	WOS:000255454300047
J	Hamilton, DP; Kruger, H				Hamilton, Douglas P.; Krueger, Harald			The sculpting of Jupiter's gossamer rings by its shadow	NATURE			English	Article							DUST GRAINS; GALILEO; EJECTION; DYNAMICS; VOYAGER; SYSTEM	Dust near Jupiter is produced when interplanetary impactors collide energetically with small inner moons, and is organized into a main ring, an inner halo, and two fainter and more distant gossamer rings(1,2). Most of these structures are constrained by the orbits of the moons(3) Adrastea, Metis, Amalthea and Thebe, but a faint outward protrusion called the Thebe extension behaves differently and has eluded understanding. Here we report on dust impacts detected during the Galileo spacecraft's traversal of the outer ring region(4): we find a gap in the rings interior to Thebe's orbit(5), grains on highly inclined paths, and a strong excess of submicrometre- sized dust just inside Amalthea's orbit. We present detailed modelling that shows that the passage of ring particles through Jupiter's shadow creates the Thebe extension and fully accounts for these Galileo results. Dust grains alternately charge and discharge when traversing shadow boundaries, allowing the planet's powerful magnetic field to excite orbital eccentricities(6) and, when conditions are right, inclinations as well.	[Hamilton, Douglas P.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Krueger, Harald] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Krueger, Harald] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany	University System of Maryland; University of Maryland College Park; Max Planck Society; Max Planck Society	Hamilton, DP (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	dphamil@umd.edu						Burns JA, 1999, SCIENCE, V284, P1146, DOI 10.1126/science.284.5417.1146; Burns JA, 2004, CAMB PLANET, P241; de Pater I, 1999, ICARUS, V138, P214, DOI 10.1006/icar.1998.6068; GRUN E, 1992, SPACE SCI REV, V60, P317, DOI 10.1007/BF00216860; GURNETT DA, 1983, ICARUS, V53, P236, DOI 10.1016/0019-1035(83)90145-8; Hamilton DP, 1996, ICARUS, V119, P153, DOI 10.1006/icar.1996.0008; HAMILTON DP, 1993, ICARUS, V101, P244, DOI 10.1006/icar.1993.1022; HAMILTON DP, 1993, NATURE, V364, P695, DOI 10.1038/364695a0; HORANYI M, 1993, NATURE, V363, P144, DOI 10.1038/363144a0; HORANYI M, 1991, J GEOPHYS RES-SPACE, V96, P19283, DOI 10.1029/91JA01982; Horanyi M, 1996, NATURE, V381, P293, DOI 10.1038/381293a0; KRUGER H, 2003, THESIS R KARLS U SHA; MOISSL R, 2005, GALILEOS STAUBMESSUN; Ockert-Bell ME, 1999, ICARUS, V138, P188, DOI 10.1006/icar.1998.6072; SCHAFFER L, 1995, J GEOPHYS RES-SPACE, V100, P213, DOI 10.1029/94JA01144; SHOWALTER MR, 2007, AAS DIV DYN ASTR M; SHOWALTER MR, IN PRESS ICARUS; Srama R, 2006, PLANET SPACE SCI, V54, P967, DOI 10.1016/j.pss.2006.05.021; Throop HB, 2004, ICARUS, V172, P59, DOI 10.1016/j.icarus.2003.12.020	19	26	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					72	75		10.1038/nature06886	http://dx.doi.org/10.1038/nature06886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451856				2022-12-28	WOS:000255398800040
J	Marquis, M; Tans, P				Marquis, Melinda; Tans, Pieter			Climate change - Carbon crucible	SCIENCE			English	Editorial Material									[Marquis, Melinda] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Marquis, Melinda; Tans, Pieter] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA	Marquis, M (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, 216 UCB, Boulder, CO 80309 USA.	melinda.marquis@noaa.gov	Tans, Pieter/AAG-8273-2019; Marquis, Melinda/K-8895-2015	Tans, Pieter/0000-0002-9883-0787; 				Bergamaschi P, 2005, ATMOS CHEM PHYS, V5, P2431, DOI 10.5194/acp-5-2431-2005; Crisp D, 2004, ADV SPACE RES-SERIES, V34, P700, DOI 10.1016/j.asr.2003.08.062; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Hamazaki T., 2004, P 20 ISPRS C 7 IST T, P225; Peters W, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006157; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; 2005, 13 WMO IAEA M EXP CA	7	34	35	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					460	461		10.1126/science.1156451	http://dx.doi.org/10.1126/science.1156451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436764				2022-12-28	WOS:000255249300025
J	Mookherjee, M; Stixrude, L; Karki, B				Mookherjee, Mainak; Stixrude, Lars; Karki, Bijaya			Hydrous silicate melt at high pressure	NATURE			English	Article							UPPER-MANTLE; MOLECULAR-DYNAMICS; UNITED-STATES; WATER; H2O; DENSITY; GLASSES; SYSTEM; EARTH; SPECIATION	The structure and physical properties of hydrous silicate melts and the solubility of water in melts over most of the pressure regime of Earth's mantle ( up to 136 GPa) remain unknown. At low pressure ( up to a few gigapascals) the solubility of water increases rapidly with increasing pressure(1), and water has a large influence on the solidus temperature, density(2), viscosity(3) and electrical conductivity. Here we report the results of first- principles molecular dynamics simulations of hydrous MgSiO(3) melt. These show that pressure has a profound influence on speciation of the water component, which changes from being dominated by hydroxyls and water molecules at low pressure(4) to extended structures at high pressure. We link this change in structure to our finding that the water - silicate system becomes increasingly ideal at high pressure: we find complete miscibility of water and silicate melt throughout almost the entire mantle pressure regime. On the basis of our results, we argue that a buoyantly stable melt at the base of the upper mantle would contain approximately 3 wt% water and have an electrical conductivity of 18 S m(-1), and should therefore be detectable by means of electromagnetic sounding.	[Stixrude, Lars] UCL, Dept Earth Sci, London WC1E 6BT, England; [Mookherjee, Mainak] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Karki, Bijaya] Louisiana State Univ, Dept Comp Sci, Baton Rouge, LA 70803 USA; [Karki, Bijaya] Louisiana State Univ, Dept Geol & Geophys, Baton Rouge, LA 70803 USA	University of London; University College London; Yale University; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Stixrude, L (corresponding author), UCL, Dept Earth Sci, Gower St, London WC1E 6BT, England.	stixrude@umich.edu	Stixrude, Lars/C-5625-2012; Mookherjee, Mainak/F-7949-2010	Stixrude, Lars/0000-0003-3778-2432; Mookherjee, Mainak/0000-0002-0605-5964				Bhattarai D., 2006, VIS GEOSCI, V11, P1, DOI DOI 10.1007/S10069-006-0003-Y; CLOSMANN C, 1995, AM MINERAL, V80, P201; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Goldman N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.217801; GREAVES GN, 1995, PHYS REV B, V52, P6358, DOI 10.1103/PhysRevB.52.6358; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; ITO E, 1987, NATURE, V328, P514, DOI 10.1038/328514a0; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015; LANGE RA, 1994, REV MINERAL, V30, P331; MATSUI T, 1986, NATURE, V319, P303, DOI 10.1038/319303a0; Matsukage KN, 2005, NATURE, V438, P488, DOI 10.1038/nature04241; MERMIN ND, 1965, PHYS REV, V137, P1441, DOI 10.1103/PhysRev.137.A1441; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Ochs FA, 1999, SCIENCE, V283, P1314, DOI 10.1126/science.283.5406.1314; Panero WR, 2004, EARTH PLANET SC LETT, V221, P421, DOI 10.1016/S0012-821X(04)00100-1; PITZER KS, 1994, J CHEM PHYS, V101, P3111, DOI 10.1063/1.467624; Pohlmann M, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184209; Sakamaki T, 2006, NATURE, V439, P192, DOI 10.1038/nature04352; Shen AH, 1997, NATURE, V385, P710, DOI 10.1038/385710a0; Song TRA, 2004, NATURE, V427, P530, DOI 10.1038/nature02231; Stalder R, 2001, CONTRIB MINERAL PETR, V140, P607, DOI 10.1007/s004100000212; Stixrude L, 2005, SCIENCE, V310, P297, DOI 10.1126/science.1116952; STOLPER E, 1982, GEOCHIM COSMOCHIM AC, V46, P2609, DOI 10.1016/0016-7037(82)90381-7; Toffelmier DA, 2007, NATURE, V447, P991, DOI 10.1038/nature05922; WENTZCOVITCH RM, 1992, PHYS REV B, V45, P11372, DOI 10.1103/PhysRevB.45.11372; Zhang YX, 1999, REV GEOPHYS, V37, P493, DOI 10.1029/1999RG900012; ZHANG YX, 1991, NATURE, V351, P306, DOI 10.1038/351306a0	30	101	107	3	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 24	2008	452	7190					983	986		10.1038/nature06918	http://dx.doi.org/10.1038/nature06918			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291PF	18432243				2022-12-28	WOS:000255208600037
J	Rius, J; Guma, M; Schachtrup, C; Akassoglou, K; Zinkernagel, AS; Nizet, V; Johnson, RS; Haddad, GG; Karin, M				Rius, Jordi; Guma, Monica; Schachtrup, Christian; Akassoglou, Katerina; Zinkernagel, Annelies S.; Nizet, Victor; Johnson, Randall S.; Haddad, Gabriel G.; Karin, Michael			NF-kappa B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1 alpha	NATURE			English	Article							IKK-BETA; CUTTING EDGE; CELLS; EXPRESSION; OXYGEN; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; CARCINOGENESIS; INFLAMMATION; INHIBITION; PREVENTION	The hypoxic response is an ancient stress response triggered by low ambient oxygen ( O(2)) ( ref. 1) and controlled by hypoxia-inducible transcription factor- 1 ( HIF- 1), whose a subunit is rapidly degraded under normoxia but stabilized when O(2)- dependent prolyl hydroxylases ( PHDs) that target its O(2)- dependent degradation domain are inhibited(2-4). Thus, the amount of HIF-1 alpha, which controls genes involved in energy metabolism and angiogenesis, is regulated post- translationally. Another ancient stress response is the innate immune response, regulated by several transcription factors, among which NF-kappa B plays a central role(5,6). NF-kappa B activation is controlled by I kappa B kinases ( IKK), mainly IKK-beta, needed for phosphorylation- induced degradation of I kappa B inhibitors in response to infection and inflammation(7). IKK-beta is modestly activated in hypoxic cell cultures when PHDs that attenuate its activation are inhibited(8). However, defining the relationship between NF-kappa B and HIF-1 alpha has proven elusive. Using in vitro systems, it was reported that HIF-1 alpha activates NF- kappa B(9), that NF-kappa B controls HIF-1 alpha transcription(10) and that HIF-1 alpha activation may be concurrent with inhibition of NF-kappa B(11). Here we show, with the use of mice lacking IKK-beta in different cell types, that NF-kappa B is a critical transcriptional activator of HIF-1 alpha and that basal NF-kappa B activity is required for HIF-1 alpha protein accumulation under hypoxia in cultured cells and in the liver and brain of hypoxic animals. IKK-beta deficiency results in defective induction of HIF-1 alpha target genes including vascular endothelial growth factor. IKK-beta is also essential for HIF-1 alpha accumulation in macrophages experiencing a bacterial infection. Hence, IKK-beta is an important physiological contributor to the hypoxic response, linking it to innate immunity and inflammation.	[Rius, Jordi; Guma, Monica; Karin, Michael] Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Rius, Jordi; Guma, Monica; Schachtrup, Christian; Akassoglou, Katerina; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Rius, Jordi; Guma, Monica; Karin, Michael] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA; [Zinkernagel, Annelies S.; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Sch Med, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Johnson, Randall S.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Zinkernagel, Annelies S/F-1780-2017; Johnson, Randall/AAM-1189-2021; Nizet, Victor/AAF-3190-2019	Zinkernagel, Annelies S/0000-0003-4700-1118; Johnson, Randall/0000-0002-4084-6639; Akassoglou, Katerina/0000-0002-2632-1465; guma, monica/0000-0003-1951-9411; Nizet, Victor/0000-0003-3847-0422	NCI NIH HHS [R01 CA118165] Funding Source: Medline; NCRR NIH HHS [P41 RR004050-208577, P41 RR004050] Funding Source: Medline; NIAID NIH HHS [R01 AI043477-12, R01 AI043477] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Elson DA, 2000, CANCER RES, V60, P6189; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; HACKER H, 2006, SCI STKE, V357, pRE13, DOI DOI 10.1126/STKE.3572006RE13; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Leach RM, 1998, BRIT MED J, V317, P1370, DOI 10.1136/bmj.317.7169.1370; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Makino Y, 2003, J IMMUNOL, V171, P6534, DOI 10.4049/jimmunol.171.12.6534; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Paul SAM, 2004, J CELL PHYSIOL, V200, P20, DOI 10.1002/jcp.10479; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Riboldi E, 2005, J IMMUNOL, V175, P2788, DOI 10.4049/jimmunol.175.5.2788; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304	30	1085	1142	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 5	2008	453	7196					807	U9		10.1038/nature06905	http://dx.doi.org/10.1038/nature06905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308UK	18432192	Green Accepted, Bronze			2022-12-28	WOS:000256415300049
J	Maguire, AM; Simonelli, F; Pierce, EA; Pugh, EN; Mingozzi, F; Bennicelli, J; Banfi, S; Marshall, KA; Testa, F; Surace, EM; Rossi, S; Lyubarsky, A; Arruda, VR; Konkle, B; Stone, E; Sun, JW; Jacobs, J; Dell'Osso, L; Hertle, R; Ma, JX; Redmond, TM; Zhu, XS; Hauck, B; Zelenaia, O; Shindler, KS; Maguire, MG; Wright, JF; Volpe, NJ; McDonnell, JW; Auricchio, A; High, KA; Bennett, J				Maguire, Albert M.; Simonelli, Francesca; Pierce, Eric A.; Pugh, Edward N., Jr.; Mingozzi, Federico; Bennicelli, Jeannette; Banfi, Sandro; Marshall, Kathleen A.; Testa, Francesco; Surace, Enrico M.; Rossi, Settimio; Lyubarsky, Arkady; Arruda, Valder R.; Konkle, Barbara; Stone, Edwin; Sun, Junwei; Jacobs, Jonathan; Dell'Osso, Lou; Hertle, Richard; Ma, Jian-xing; Redmond, T. Michael; Zhu, Xiaosong; Hauck, Bernd; Zelenaia, Olga; Shindler, Kenneth S.; Maguire, Maureen G.; Wright, J. Fraser; Volpe, Nicholas J.; McDonnell, Jennifer Wellman; Auricchio, Alberto; High, Katherine A.; Bennett, Jean			Safety and efficacy of gene transfer for Leber's congenital amaurosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RETINITIS-PIGMENTOSA; LIGHT REFLEX; VISUAL CYCLE; CHILDHOOD BLINDNESS; RPE65 MUTATIONS; CANINE MODEL; THERAPY; ISOMEROHYDROLASE; DYSTROPHY; VISION	Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment epithelium-specific 65-kDa protein gene (RPE65). We investigated the safety of subretinal delivery of a recombinant adeno-associated virus (AAV) carrying RPE65 complementary DNA (cDNA) (ClinicalTrials.gov number, NCT00516477). Three patients with LCA2 had an acceptable local and systemic adverse-event profile after delivery of AAV2.hPPE65v2. Each patient had a modest improvement in measures of retinal function on subjective tests of visual acuity. In one patient, an asymptomatic macular hole developed, and although the occurrence was considered to be an adverse event, the patient had some return of retinal function. Although the follow-up was very short and normal vision was not achieved, this study provides the basis for further gene therapy studies in patients with LCA.	[Maguire, Albert M.; Pierce, Eric A.; Pugh, Edward N., Jr.; Bennicelli, Jeannette; Lyubarsky, Arkady; Shindler, Kenneth S.; Maguire, Maureen G.; Volpe, Nicholas J.; Bennett, Jean] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Maguire, Albert M.; Mingozzi, Federico; Marshall, Kathleen A.; Arruda, Valder R.; Sun, Junwei; Zhu, Xiaosong; Hauck, Bernd; Zelenaia, Olga; Wright, J. Fraser; McDonnell, Jennifer Wellman; High, Katherine A.; Bennett, Jean] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Maguire, Albert M.; Pierce, Eric A.; Bennicelli, Jeannette; Lyubarsky, Arkady; Arruda, Valder R.; Konkle, Barbara; Shindler, Kenneth S.; Maguire, Maureen G.; Wright, J. Fraser; Volpe, Nicholas J.; High, Katherine A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Simonelli, Francesca; Testa, Francesco; Rossi, Settimio] Univ Naples 2, Naples, Italy; [Simonelli, Francesca; Banfi, Sandro; Surace, Enrico M.; Auricchio, Alberto] Telethon Inst Genet & Med, Naples, Italy; [Auricchio, Alberto] Univ Naples Federico 2, Naples, Italy; [Stone, Edwin] Univ Iowa, Carver Ctr, Coll Med, Iowa City, IA USA; [Jacobs, Jonathan; Dell'Osso, Lou] Vet Affairs Med Ctr, Cleveland, OH USA; [Hertle, Richard] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Ma, Jian-xing] Univ Oklahoma, Oklahoma City, OK USA; [Redmond, T. Michael] NEI, Bethesda, MD 20892 USA; [Surace, Enrico M.; High, Katherine A.] Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Universita della Campania Vanvitelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Howard Hughes Medical Institute	Bennett, J (corresponding author), FM Kirby Ctr Mol Ophthalmol, Stellar Chance Labs 309C, 422 Curie Blvd, Philadelphia, PA 19104 USA.	jebennet@mail.med.upenn.edu	Testa, Francesco/J-3185-2012; Shindler, Kenneth/D-2095-2009; Banfi, Sandro/K-3963-2018; Rossi, Settimio/AHI-1119-2022; Simonelli, Francesca/AHE-7571-2022; High, Katherine A./AAB-9322-2020; AURICCHIO, Alberto/AHE-7979-2022; Konkle, Barbara A/AAD-7712-2022; Rossi, Settimio/J-4922-2012; Konkle, Barbara/GPX-3325-2022	Banfi, Sandro/0000-0002-6541-8833; Simonelli, Francesca/0000-0001-8520-6769; AURICCHIO, Alberto/0000-0002-0832-2472; Konkle, Barbara A/0000-0002-3959-8797; Pierce, Eric/0000-0002-2354-4102; Surace, Enrico Maria/0000-0002-2975-942X; Testa, Francesco/0000-0002-1482-1577; Redmond, T. Michael/0000-0002-1813-5291; Stone, Edwin M./0000-0003-3343-4414	Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [UL1 RR024134] Funding Source: Medline; NEI NIH HHS [EY-10820, R01 EY010820, R01 EY010820-11, R01 EY010820-13, R01 EY010820-12] Funding Source: Medline; Telethon [TGM06B01, GGP07180] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [Z01EY000260, R01EY010820] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Telethon(Fondazione Telethon); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre G D, 1998, Mol Vis, V4, P23; Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Beck RW, 2007, OPHTHALMOLOGY, V114, P1804, DOI 10.1016/j.ophtha.2007.06.047; Bennicelli J, 2008, MOL THER, V16, P458, DOI 10.1038/sj.mt.6300389; Bergamin O, 2003, INVEST OPHTH VIS SCI, V44, P1546, DOI 10.1167/iovs.02-0468; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; BIRCH EE, 1987, VISION RES, V27, P499, DOI 10.1016/0042-6989(87)90034-4; FOSNAUGH JS, 1992, METHOD FIND EXP CLIN, V14, P545; GASS JDM, 1988, ARCH OPHTHALMOL-CHIC, V106, P629, DOI 10.1001/archopht.1988.01060130683026; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HO AC, 1999, RETINA VITREOUS MACU, P217; Jacobs JB, 2006, INVEST OPHTH VIS SCI, V47, P2865, DOI 10.1167/iovs.05-1233; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; JOSEPH DP, 2001, RETINA, P2562; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; NARFSTROM K, 1989, BRIT J OPHTHALMOL, V73, P750, DOI 10.1136/bjo.73.9.750; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Seiple W, 2004, DOC OPHTHALMOL, V109, P255, DOI 10.1007/s10633-005-0567-0; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068	25	1595	1731	2	154	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 22	2008	358	21					2240	2248		10.1056/NEJMoa0802315	http://dx.doi.org/10.1056/NEJMoa0802315			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303EK	18441370	Green Accepted			2022-12-28	WOS:000256023600006
J	Cnossen, JS; Vollebregt, KC; de Vrieze, N; ter Riet, G; Mol, BWJ; Franx, A; Khan, KS; van der Post, JAM				Cnossen, Jeltsje S.; Vollebregt, Karlijn C.; de Vrieze, Nynke; ter Riet, Gerben; Mol, Ben W. J.; Franx, Arie; Khan, Khalid S.; van der Post, Joris A. M.			Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSIVE DISORDERS; DIAGNOSTIC-ACCURACY; LIKELIHOOD RATIOS; PREGNANCY; RISK; PREVENTION; MANAGEMENT; STATEMENT; MEDLINE; LONDON	Objective To determine the accuracy of using systolic and diastolic blood pressure, mean arterial pressure, and increase of blood pressure to predict pre-eclampsia. Design Systematic review with meta-analysis of data on test accuracy. Data sources Medline, Embase, Cochrane Library, Medion, checking reference lists of included articles and reviews, contact with authors. Review methods Without language restrictions, two reviewers independently selected the articles in which the accuracy of blood pressure measurement during pregnancy was evaluated to predict pre-eclampsia. Data were extracted on study Characteristics, quality, and results to construct 2x2 tables. Summary receiver operating characteristic curves and likelihood ratios were generated for the various levels and their thresholds. Results 34 studies, testing 60 599 women (3341 cases of pre-eclampsia), were included. In women at low risk for pre-eclampsia, the areas under the summary receiver operating characteristic curves for blood pressure measurement in the second trimester were 0.68 (95% confidence interval 0.64 to 0.72) for systolic blood pressure, 0.66 (0.59 to 0.72) for diastolic blood pressure, and 0.76 (0.70 to 0.82) for mean arterial pressure. Findings for the first trimester showed a similar pattern. Second trimester mean arterial pressure of 90 mm Hg or more showed a positive likelihood ratio of 3.5 (95% confidence interval 2.0 to 5.0) and a negative likelihood ratio of 0.46 (0.16 to 0.75). In women deemed to be at high risk, a diastolic blood pressure of 75 mm Hg or more at 13 to 20 weeks' gestation best predicted pre-eclampsia: positive likelihood ratio 2.8 (1.8 to 3.6), negative likelihood ratio 0.39 (0.18 to 0.71). Additional subgroup analyses did not show improved predictive accuracy. Conclusion When blood pressure is measured in the first or second trimester of pregnancy, the mean arterial pressure is a better predictor for pre-eclampsia than systolic blood pressure, diastolic blood pressure, or an increase of blood pressure.	[Cnossen, Jeltsje S.; de Vrieze, Nynke] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1100 DD Amsterdam, Netherlands; [ter Riet, Gerben] Univ Zurich, Horten Ctr, Zurich, Switzerland; [Vollebregt, Karlijn C.; Mol, Ben W. J.; van der Post, Joris A. M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1100 DD Amsterdam, Netherlands; [Franx, Arie] St Elizabeth Hosp, Dept Obstet & Gynaecol, Tilburg, Netherlands; [Khan, Khalid S.] Birmingham Womens Hosp, Dept Obstet & Gynaecol, Birmingham, W Midlands, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Zurich; University of Amsterdam; Academic Medical Center Amsterdam; Elisabeth-TweeSteden Ziekenhuis (ETZ); Birmingham Women's Hospital	Cnossen, JS (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Meibergdreef 15, NL-1100 DD Amsterdam, Netherlands.	j.s.cnossen@amc.uva.nl	Franx, Arie/AAA-1739-2021; Riet, Gerben ter/A-6943-2011; Khan, Khalid S/AAT-8824-2020; Mol, Ben/I-4526-2012; Franx, Arie/D-6335-2011; van der Post, Joris A M/A-8991-2008	Riet, Gerben ter/0000-0002-2231-7637; Khan, Khalid S/0000-0001-5084-7312; van der Post, Joris/0000-0003-3311-2116				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bachmann LM, 2002, J AM MED INFORM ASSN, V9, P653, DOI 10.1197/jamia.M1124; BROWN MA, 1994, AM J OBSTET GYNECOL, V171, P661, DOI 10.1016/0002-9378(94)90079-5; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Brown MA, 1998, AUST NZ J OBSTET GYN, V38, P262, DOI 10.1111/j.1479-828X.1998.tb03062.x; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; CHESLEY LC, 1988, AM J OBSTET GYNECOL, V159, P275, DOI 10.1016/S0002-9378(88)80067-X; Cnossen Jeltsje S, 2006, BMC Pregnancy Childbirth, V6, P29, DOI 10.1186/1471-2393-6-29; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Conde-Agudelo A, 1994, Obstet Gynecol Surv, V49, P210, DOI 10.1097/00006254-199403000-00027; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; DEKKER GA, 1991, AM J OBSTET GYNECOL, V165, P160, DOI 10.1016/0002-9378(91)90245-M; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2004, COCHRANE DB SYST REV; EASTERLING TR, 1990, OBSTET GYNECOL, V76, P1061; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Leeflang M, 2007, CLIN CHEM, V53, P164, DOI 10.1373/clinchem.2006.076398; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Meads CA, 2008, HEALTH TECHNOL ASSES, V12, P1; OBRIEN WF, 1990, OBSTET GYNECOL, V75, P445; OBRIEN WF, 1992, CLIN OBSTET GYNECOL, V35, P351; Pomini F, 2001, J Matern Fetal Med, V10, P398, DOI 10.1080/714052781; Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646; Rang S, 2004, J HYPERTENS, V22, P369, DOI 10.1097/00004872-200402000-00022; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Sebire NJ, 2001, BRIT J OBSTET GYNAEC, V108, P61, DOI 10.1111/j.1471-0528.2001.00021.x; Shennan A, 1996, LANCET, V347, P139, DOI 10.1016/S0140-6736(96)90338-4; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; VATTEN LJ, 2004, OBSTET GYNECOL SURV, V59, P645; Visser W, 1999, BEST PRACT RES CL OB, V13, P131, DOI 10.1053/beog.1999.0011; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; *YAL U SCH MED, 2003, FIND EV PUBMED; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	43	148	157	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2008	336	7653					1117	1120		10.1136/bmj.39540.522049.BE	http://dx.doi.org/10.1136/bmj.39540.522049.BE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18480117	Bronze, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000255975100040
J	Grantcharov, TP; Reznick, RK				Grantcharov, Teodor P.; Reznick, Richard K.			Teaching rounds - Teaching procedural skills	BRITISH MEDICAL JOURNAL			English	Editorial Material							OPERATING-ROOM; PERFORMANCE; SIMULATION; SURGERY		[Grantcharov, Teodor P.; Reznick, Richard K.] Univ Toronto, Toronto, ON M5B 1W8, Canada; [Reznick, Richard K.] St Michaels Hosp, Div Gen Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Grantcharov, TP (corresponding author), Univ Toronto, Toronto, ON M5B 1W8, Canada.	grantcharovt@smh.toronto.on.ca						Aggarwal R, 2007, J AM COLL SURGEONS, V204, P697, DOI 10.1016/j.jamcollsurg.2007.01.016; Aggarwal R, 2006, ANN SURG, V244, P310, DOI 10.1097/01.sla.0000218094.92650.44; Baskett RJF, 2004, ANN THORAC SURG, V78, P1236, DOI 10.1016/j.athoracsur.2004.04.041; George JH, 2001, FAM MED, V33, P577; Grantcharov TP, 2007, SURG ENDOSC, V21, P2240, DOI 10.1007/s00464-007-9356-z; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Kneebone RL, 2007, MED EDUC, V41, P808, DOI 10.1111/j.1365-2923.2007.02799.x; MacKenzie CL, 2001, MINIM INVASIV THER, V10, P121; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Schijven MP, 2004, SURG ENDOSC, V18, P121, DOI 10.1007/s00464-003-9040-x; Walker M., 1998, TEACHING LEARNING ME, P171	11	140	141	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 17	2008	336	7653					1129	1131		10.1136/bmj.39517.686956.47	http://dx.doi.org/10.1136/bmj.39517.686956.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302NM	18483056	Green Published			2022-12-28	WOS:000255975100043
J	Jin, LY; Williamson, A; Banerjee, S; Philipp, I; Rape, M				Jin, Lingyan; Williamson, Adam; Banerjee, Sudeep; Philipp, Isabelle; Rape, Michael			Mechanism of ubiquitin-chain formation by the human anaphase-promoting complex	CELL			English	Article							CONJUGATING ENZYMES; POLYUBIQUITIN CHAIN; FUNCTIONAL-ANALYSIS; DESTRUCTION BOX; PROTEINS; DOMAIN; PROCESSIVITY; DEGRADATION; PROTEOMICS; SUBSTRATE	The anaphase-promoting complex (APC/C) orchestrates progression through mitosis by decorating cell-cycle regulators with ubiquitin chains. To nucleate chains, the APC/C links ubiquitin to a lysine in substrates, but to elongate chains it modifies lysine residues in attached ubiquitin moieties. The mechanism enabling the APC/C, and ubiquitin ligases in general, to switch from lysine residues in substrates to specific ones in ubiquitin remains poorly understood. Here, we determine the topology and the mechanism of assembly for the ubiquitin chains mediating functions of the human APC/C. We find that the APC/C triggers substrate degradation by assembling K11-linked ubiquitin chains, the efficient formation of which depends on a surface of ubiquitin, the TEK-box. Strikingly, homologous TEK-boxes are found in APC/C substrates, where they facilitate chain nucleation. We propose that recognition of similar motifs in substrates and ubiquitin enables the APC/C to assemble ubiquitin chains with the specificity and efficiency required for tight cell-cycle control.	[Jin, Lingyan; Williamson, Adam; Banerjee, Sudeep; Philipp, Isabelle; Rape, Michael] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rape, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 16 Barker Hall, Berkeley, CA 94720 USA.	mrape@berkeley.edu		Rape, Michael/0000-0003-4849-6343	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083064] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003088] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083064-01, R01 GM083064] Funding Source: Medline; NIH HHS [DP2 OD003088, DP2 OD003088-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lin YQ, 2002, J BIOL CHEM, V277, P21913, DOI 10.1074/jbc.M109398200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Tolbert BS, 2005, BIOCHEMISTRY-US, V44, P16385, DOI 10.1021/bi0514459; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wirth KG, 2004, GENE DEV, V18, P88, DOI 10.1101/gad.285404; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	31	378	416	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 16	2008	133	4					653	665		10.1016/j.cell.2008.04.012	http://dx.doi.org/10.1016/j.cell.2008.04.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485873	Green Accepted, Bronze			2022-12-28	WOS:000255903300020
J	Zhang, Z; Lotti, F; Dittmar, K; Younis, I; Wan, L; Kasim, M; Dreyfuss, G				Zhang, Zhenxi; Lotti, Francesco; Dittmar, Kimberly; Younis, Ihab; Wan, Lili; Kasim, Mumtaz; Dreyfuss, Gideon			SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing	CELL			English	Article							SPINAL MUSCULAR-ATROPHY; DISEASE GENE-PRODUCT; MOTOR-NEURON COMPLEX; MESSENGER-RNA; ASSEMBLY MACHINE; IN-VIVO; PROTEIN; SURVIVAL; COMPONENT; MOUSE	The survival of motor neurons (SMN) protein is essential for the biogenesis of small nuclear RNA (snRNA)-ribonucleoproteins (snRNPs), the major components of the pre-mRNA splicing machinery. Though it is ubiquitously expressed, SMN deficiency causes the motor neuron degenerative disease spinal muscular atrophy (SMA). We show here that SMN deficiency, similar to that which occurs in severe SMA, has unexpected cell type-specific effects on the repertoire of snRNAs and mRNAs. It alters the stoichiometry of snRNAs and causes widespread pre-mRNA splicing defects in numerous transcripts of diverse genes, preferentially those containing a large number of introns, in SMN-deficient mouse tissues. These findings reveal a key role for the SMN complex in RNA metabolism and in splicing regulation and indicate that SMA is a general splicing disease that is not restricted to motor neurons.	[Zhang, Zhenxi; Lotti, Francesco; Dittmar, Kimberly; Younis, Ihab; Wan, Lili; Kasim, Mumtaz; Dreyfuss, Gideon] Univ Penn, Sch Med, Dept Biochem & Biophys, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Dreyfuss, Gideon/D-1218-2013; Younis, Ihab/M-1849-2019; Lotti, Francesco/AAC-3186-2019	Dreyfuss, Gideon/0000-0001-8129-8774; Younis, Ihab/0000-0003-3329-5979; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Balabanian S, 2007, NEUROL RES, V29, P413, DOI 10.1179/016164107X159243; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Cifuentes-Diaz Carmen, 2002, Semin Pediatr Neurol, V9, P145, DOI 10.1053/spen.2002.33801; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Iannaccone Susan T, 2004, Curr Neurol Neurosci Rep, V4, P74, DOI 10.1007/s11910-004-0016-6; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Olaso R, 2006, PHYSIOL GENOMICS, V24, P97, DOI 10.1152/physiolgenomics.00134.2005; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Paradis C, 2007, RNA, V13, P1287, DOI 10.1261/rna.403607; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2001, CURR BIOL, V11, P1079, DOI 10.1016/S0960-9822(01)00316-5; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; SAUTERER RA, 1988, EXP CELL RES, V176, P344, DOI 10.1016/0014-4827(88)90336-9; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; WANG J, 1995, RNA, V1, P335; Wang J, 2001, J BIOL CHEM, V276, P9599, DOI 10.1074/jbc.M009162200; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9; ZIEVE GW, 1988, J MOL BIOL, V199, P259, DOI 10.1016/0022-2836(88)90312-9	62	463	473	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 16	2008	133	4					585	600		10.1016/j.cell.2008.03.031	http://dx.doi.org/10.1016/j.cell.2008.03.031			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	301NQ	18485868	Green Accepted, Bronze			2022-12-28	WOS:000255903300015
J	Kindig, DA; Asada, Y; Booske, B				Kindig, David A.; Asada, Yukiko; Booske, Bridget			A population health framework for setting national and state health goals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kindig, David A.; Booske, Bridget] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA; [Asada, Yukiko] Dalhousie Univ, Fac Med, Dept Epidemiol & Community Hlth, Halifax, NS, Canada	University of Wisconsin System; University of Wisconsin Madison; Dalhousie University	Kindig, DA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut Room,760 WARF, Madison, WI 53726 USA.	dakindig@wisc.edu		Asada, Yukiko/0000-0002-3121-0719				Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; EVANS RG, 1990, SOC SCI MED, V31, P1347, DOI 10.1016/0277-9536(90)90074-3; Fox DM, 2006, HEALTH ECON POLICY L, V1, P395, DOI 10.1017/S1744133106006037; Gakidou E, 2000, MEASURING PREFERENCE, P1; Graham H, 2004, MILBANK Q, V82, P101, DOI 10.1111/j.0887-378X.2004.00303.x; Kindig DA, 2007, MILBANK Q, V85, P139, DOI 10.1111/j.1468-0009.2007.00479.x; Kindig DA, 2006, JAMA-J AM MED ASSOC, V296, P2611, DOI 10.1001/jama.296.21.2611; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; STODDART G, 1995, 46 CAN I ADV RES; *U WI POP HLTH I, 2007, HLTH WISC REP CARD; *UN HLTH FDN, 2007, AM HLTH RANK CALL AC; *US DEP HHS, HLTH PEOPL 2020 SYST; *US DEP HHS, HLTH PEOPL 2020 REG; World Health Organization, 2000, WORLD HLTH REP 2000	14	76	78	0	26	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 7	2008	299	17					2081	2083		10.1001/jama.299.17.2081	http://dx.doi.org/10.1001/jama.299.17.2081			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296NI	18460667				2022-12-28	WOS:000255552700025
J	Cadarette, SM; Katz, JN; Brookhart, MA; Sturmer, T; Stedman, MR; Solomon, DH				Cadarette, Suzanne M.; Katz, Jeffrey N.; Brookhart, M. Alan; Sturmer, Til; Stedman, Margaret R.; Solomon, Daniel H.			Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; ALENDRONATE 70 MG; PROPENSITY SCORE; POSTMENOPAUSAL OSTEOPOROSIS; HIP-FRACTURES; RISEDRONATE; WOMEN; RALOXIFENE; PERSISTENCE; BISPHOSPHONATES	Background: Little information is available on the comparative effectiveness of osteoporosis pharmacotherapies. Objective: To compare the relative effectiveness of osteoporosis treatments to reduce nonvertebral fracture risk among older adults. Design: Cohort study. Setting: Enrollees in 2 statewide pharmaceutical benefit programs for persons age 65 years or older. Patients: 43 135 new recipients of oral bisphosphonates, nasal calcitonin, and raloxifene who began treatment from 2000 to 2005. The mean age was 79 years (SD, 6.9), and 96% were women. Measurements: The primary outcome was nonvertebral fracture (hip, humerus, or radius or ulna) within 12 months of treatment initiation. Cox proportional hazard models stratified by state and adjusted for risk factors for fracture were used to compare fracture rates. Alendronate was the reference category in all analyses. Results: A total of 1051 nonvertebral fractures were observed within 12 months (2.62 fractures per 100 person-years). No large differences in fracture risk were found between risedronate (hazard ratio [HR], 1.01 [95% CI, 0.85 to 1.21]) or raloxifene (HR, 1.18 [CI, 0.96 to 1.46]) and alendronate. However, among those with a fracture history, raloxifene recipients experienced more nonvertebral fractures within 12 months (HR, 1.78 [CI, 1.20 to 2.63]) compared with alendronate recipients. Patients who received calcitonin experienced more nonvertebral fractures than those who received alendronate (HR, 1.40, [CI, 1.20 to 1.63]). Results were similar in sensitivity analyses that examined different lengths of follow-up (6 months and 24 months), were restricted to hip fracture as the outcome, and were completed in various subgroups. Limitation: Confounder adjustment was limited to health care utilization data, and the confidence bounds of some comparisons were too wide to rule out potential clinically important differences between agents. Conclusion: Differences in fracture risk between risedronate or raloxifene and alendronate were small. Nasal calcitonin recipients may have a higher risk for nonvertebral fractures compared with alendronate recipients. Future studies that can better adjust for possible confounding may further clarify these relationships.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Boston Univ, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Cadarette, SM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suitte 3030, Boston, MA 02120 USA.		Stürmer, Til/AAB-5459-2022; Cadarette, Suzanne/A-2608-2014	Cadarette, Suzanne/0000-0002-8584-9649	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, K24AR002123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023178, K25AG027400, R21AG027066] Funding Source: NIH RePORTER; NIAMS NIH HHS [K24 AR002123-08, P60 AR47782, K24 AR02123, K24 AR002123, P60 AR047782] Funding Source: Medline; NIA NIH HHS [R21 AG027066, K25 AG027400, R01 AG023178] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen MR, 2006, BONE, V39, P1130, DOI 10.1016/j.bone.2006.05.007; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2006, VALUE HEALTH, V9, P54, DOI 10.1111/j.1524-4733.2006.00081.x; Bonnick S, 2006, J CLIN ENDOCR METAB, V91, P2631, DOI 10.1210/jc.2005-2602; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Cadarette SM, 2007, MED CARE, V45, P896, DOI 10.1097/MLR.0b013e318054689f; Chesnut CH, 2000, AM J MED, V109, P267, DOI 10.1016/S0002-9343(00)00490-3; Clowes JA, 2004, J CLIN ENDOCR METAB, V89, P1117, DOI 10.1210/jc.2003-030501; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Delmas PD, 2007, J CLIN ENDOCR METAB, V92, P1296, DOI 10.1210/jc.2006-1526; Ensrud KE, 2008, J BONE MINER RES, V23, P112, DOI 10.1359/JBMR.070904; Fitt NS, 2001, CAN MED ASSOC J, V164, P777; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P108, DOI 10.1007/s00198-003-1516-y; Lindsay R, 2007, BONE, V40, pS32, DOI 10.1016/j.bone.2007.03.004; Luckey M, 2004, MENOPAUSE, V11, P405, DOI 10.1097/01.GME.0000119981.77837.1F; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; *NAT OST FDN, 2004, PHYS GUID PREV TREAT; PECK WA, 1993, AM J MED, V94, P646; RAY WA, 1992, J CLIN EPIDEMIOL, V45, P703, DOI 10.1016/0895-4356(92)90047-Q; Recker RR, 2007, BONE, V40, P843, DOI 10.1016/j.bone.2006.11.001; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/jbmr.2005.20.1.141; Sambrook PN, 2004, J INTERN MED, V255, P503, DOI 10.1111/j.1365-2796.2004.01317.x; Schneeweiss S, 2004, J GEN INTERN MED, V19, P444, DOI 10.1111/j.1525-1497.2004.30109.x; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Schousboe JT, 2006, J BONE MINER RES, V21, P1557, DOI 10.1359/JBMR.060711; Seeman E, 2007, BONE, V41, P308, DOI 10.1016/j.bone.2007.06.010; Silverman SL, 2007, OSTEOPOROSIS INT, V18, P25, DOI 10.1007/s00198-006-0274-z; Solomon DH, 2005, ARCH INTERN MED, V165, P2414, DOI 10.1001/archinte.165.20.2414; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Sturmer T, 2007, AM J EPIDEMIOL, V165, P1110, DOI 10.1093/aje/kwm074; Thiebaut ACM, 2007, ANN INTERN MED, V146, P65, DOI 10.7326/0003-4819-146-1-200701020-00012; Watts NB, 2005, J BONE MINER RES, V20, P2097, DOI 10.1359/JBMR.050814; Watts Nelson B, 2004, J Manag Care Pharm, V10, P142	42	71	72	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2008	148	9					637	646		10.7326/0003-4819-148-9-200805060-00003	http://dx.doi.org/10.7326/0003-4819-148-9-200805060-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299BW	18458276	Green Accepted			2022-12-28	WOS:000255731800001
J	Aranson, IS; Snezhko, A; Olafsen, JS; Urbach, JS				Aranson, I. S.; Snezhko, A.; Olafsen, J. S.; Urbach, J. S.			Comment on "long-lived giant number fluctuations in a swarming granular nematic"	SCIENCE			English	Editorial Material									[Aranson, I. S.; Snezhko, A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Olafsen, J. S.] Baylor Univ, Dept Phys, Waco, TX 76798 USA; [Urbach, J. S.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA	United States Department of Energy (DOE); Argonne National Laboratory; Baylor University; Georgetown University	Aranson, IS (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	aronson@msd.anl.gov	Aranson, Igor/I-4060-2013; Snezhko, Alexey/S-3758-2017	Snezhko, Alexey/0000-0001-5634-6228; Olafsen, Jeffrey/0000-0003-0184-8014; Urbach, Jeffrey/0000-0002-1593-520X				Aranson IS, 2000, PHYS REV LETT, V84, P3306, DOI 10.1103/PhysRevLett.84.3306; Kohlstedt KL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.068001; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Olafsen JS, 1998, PHYS REV LETT, V81, P4369, DOI 10.1103/PhysRevLett.81.4369; Ramaswamy S, 2003, EUROPHYS LETT, V62, P196, DOI 10.1209/epl/i2003-00346-7; Rouyer F, 2000, PHYS REV LETT, V85, P3676, DOI 10.1103/PhysRevLett.85.3676	6	44	44	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 2	2008	320	5876					612	612		10.1126/science.1153456	http://dx.doi.org/10.1126/science.1153456			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451285				2022-12-28	WOS:000255454300023
J	Keenlyside, NS; Latif, M; Jungclaus, J; Kornblueh, L; Roeckner, E				Keenlyside, N. S.; Latif, M.; Jungclaus, J.; Kornblueh, L.; Roeckner, E.			Advancing decadal-scale climate prediction in the North Atlantic sector	NATURE			English	Article							THERMOHALINE CIRCULATION; INTERDECADAL VARIATIONS; SURFACE-TEMPERATURE; VARIABILITY; PREDICTABILITY; OSCILLATION; RAINFALL	The climate of the North Atlantic region exhibits fluctuations on decadal timescales that have large societal consequences. Prominent examples include hurricane activity in the Atlantic(1), and surface- temperature and rainfall variations over North America(2), Europe(3) and northern Africa(4). Although these multidecadal variations are potentially predictable if the current state of the ocean is known(5-7), the lack of subsurface ocean observations(8) that constrain this state has been a limiting factor for realizing the full skill potential of such predictions(9). Here we apply a simple approach - that uses only sea surface temperature ( SST) observations - to partly overcome this difficulty and perform retrospective decadal predictions with a climate model. Skill is improved significantly relative to predictions made with incomplete knowledge of the ocean state(10), particularly in the North Atlantic and tropical Pacific oceans. Thus these results point towards the possibility of routine decadal climate predictions. Using this method, and by considering both internal natural climate variations and projected future anthropogenic forcing, we make the following forecast: over the next decade, the current Atlantic meridional overturning circulation will weaken to its long- term mean; moreover, North Atlantic SST and European and North American surface temperatures will cool slightly, whereas tropical Pacific SST will remain almost unchanged. Our results suggest that global surface temperature may not increase over the next decade, as natural climate variations in the North Atlantic and tropical Pacific temporarily offset the projected anthropogenic warming.	[Keenlyside, N. S.; Latif, M.] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Jungclaus, J.; Kornblueh, L.; Roeckner, E.] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Max Planck Society	Keenlyside, NS (corresponding author), Leibniz Inst Marine Sci, Dusternbrooker Weg 20, D-24105 Kiel, Germany.	nkeenlyside@ifm-geomar.de	Keenlyside, Noel S/E-8303-2013; Latif, Mojib/C-2428-2016	Keenlyside, Noel S/0000-0002-8708-6868; Latif, Mojib/0000-0003-1079-5604				Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Bjerknes J., 1964, ADV GEOPHYS, V10, P1, DOI [10.1016/S0065-2687(08)60005-9, DOI 10.1016/S0065-2687(08)60005-9]; Boer GJ, 2000, CLIM DYNAM, V16, P469, DOI 10.1007/s003820050340; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Collins M, 2006, J CLIMATE, V19, P1195, DOI 10.1175/JCLI3654.1; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; Curry RG, 1998, NATURE, V391, P575, DOI 10.1038/35356; De Coetlogon G, 2006, J PHYS OCEANOGR, V36, P2119, DOI 10.1175/JPO2963.1; DELWORTH T, 1993, J CLIMATE, V6, P1993, DOI 10.1175/1520-0442(1993)006<1993:IVOTTC>2.0.CO;2; Eden C, 2001, J CLIMATE, V14, P676, DOI 10.1175/1520-0442(2001)014<0676:NAIVOR>2.0.CO;2; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; FOLLAND CK, 1986, NATURE, V320, P602, DOI 10.1038/320602a0; Goldenberg SB, 2001, SCIENCE, V293, P474, DOI 10.1126/science.1060040; Griffies SM, 1997, SCIENCE, V275, P181, DOI 10.1126/science.275.5297.181; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; Jungclaus JH, 2005, J CLIMATE, V18, P4013, DOI 10.1175/JCLI3462.1; Keenlyside N, 2005, TELLUS A, V57, P340, DOI 10.1111/j.1600-0870.2005.00107.x; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; KUSHNIR Y, 1994, J CLIMATE, V7, P141, DOI 10.1175/1520-0442(1994)007<0141:IVINAS>2.0.CO;2; Latif M, 2006, J CLIMATE, V19, P5971, DOI 10.1175/JCLI3945.1; Latif M, 2006, J CLIMATE, V19, P4631, DOI 10.1175/JCLI3876.1; Lee TCK, 2006, J CLIMATE, V19, P5305, DOI 10.1175/JCLI3912.1; Mann ME, 1998, NATURE, V392, P779, DOI 10.1038/33859; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Solomon S., 2007, PHYS SCI BASIS WORKI; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Vellinga M, 2004, J CLIMATE, V17, P4498, DOI 10.1175/3219.1	29	543	559	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2008	453	7191					84	88		10.1038/nature06921	http://dx.doi.org/10.1038/nature06921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451859				2022-12-28	WOS:000255398800043
J	Min, SK; Zhang, XB; Zwiers, F				Min, Seung-Ki; Zhang, Xuebin; Zwiers, Francis			Human-induced arctic moistening	SCIENCE			English	Article							LAND PRECIPITATION; CLIMATE-CHANGE; ATTRIBUTION; CIRCULATION	The Arctic and northern subpolar regions are critical for climate change. Ice- albedo feedback amplifies warming in the Arctic, and fluctuations of regional fresh water inflow to the Arctic Ocean modulate the deep ocean circulation and thus exert a strong global influence. By comparing observations to simulations from 22 coupled climate models, we find influence from anthropogenic greenhouse gases and sulfate aerosols in the space- time pattern of precipitation change over high-latitude land areas north of 55 degrees N during the second half of the 20th century. The human- induced Arctic moistening is consistent with observed increases in Arctic river discharge and freshening of Arctic water masses. This result provides new evidence that human activity has contributed to Arctic hydrological change.	[Min, Seung-Ki; Zhang, Xuebin; Zwiers, Francis] Environm Canada, Div Climate Res, Toronto, ON M3H 5T4, Canada	Environment & Climate Change Canada	Zwiers, F (corresponding author), Environm Canada, Div Climate Res, Toronto, ON M3H 5T4, Canada.	Francis.Zwiers@ec.gc.ca	Zhang, Xuebin/ABD-7511-2021; Min, Seung-Ki/B-1431-2010	Min, Seung-Ki/0000-0002-6749-010X				*ACIA, 2008, ARCT CLIM IMP ASS SC; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Allen MR, 2003, CLIM DYNAM, V21, P477, DOI 10.1007/s00382-003-0313-9; Allen MR, 1999, CLIM DYNAM, V15, P419, DOI 10.1007/s003820050291; Gillett NP, 2005, NATURE, V437, P496, DOI 10.1038/437496a; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Gruza G, 1999, CLIMATIC CHANGE, V42, P219, DOI 10.1023/A:1005480719118; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; IPCC, 2007, CONTRIBUTION WORKING; Lambert FH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023654; Lambert FH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019545; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Miller RL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006323; Moritz RE, 2002, SCIENCE, V297, P1497, DOI 10.1126/science.1076522; Peterson BJ, 2002, SCIENCE, V298, P2171, DOI 10.1126/science.1077445; Peterson BJ, 2006, SCIENCE, V313, P1061, DOI 10.1126/science.1122593; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Santer BD, 2007, P NATL ACAD SCI USA, V104, P15248, DOI 10.1073/pnas.0702872104; SERREZE M, 2007, GEOPHYS RES LETT, V34; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Thompson DWJ, 2000, J CLIMATE, V13, P1018, DOI 10.1175/1520-0442(2000)013<1018:AMITEC>2.0.CO;2; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Willett KM, 2007, NATURE, V449, P710, DOI 10.1038/nature06207; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	28	138	141	6	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 25	2008	320	5875					518	520		10.1126/science.1153468	http://dx.doi.org/10.1126/science.1153468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18440925				2022-12-28	WOS:000255249300047
J	Organ, CL; Schweitzer, MH; Zheng, WX; Freimark, LM; Cantley, LC; Asara, JM				Organ, Chris L.; Schweitzer, Mary H.; Zheng, Wenxia; Freimark, Lisa M.; Cantley, Lewis C.; Asara, John M.			Molecular phylogenetics of mastodon and Tyrannosaurus rex	SCIENCE			English	Article							SEQUENCES		[Freimark, Lisa M.; Cantley, Lewis C.; Asara, John M.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Cantley, Lewis C.; Asara, John M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Organ, Chris L.] Harvard Univ, Cambridge, MA 02138 USA; [Organ, Chris L.] Museum Comparat Zool, Cambridge, MA 02138 USA; [Schweitzer, Mary H.; Zheng, Wenxia] N Carolina State Univ, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] N Carolina Museum Nat Sci, Raleigh, NC 27601 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; University of North Carolina; North Carolina State University	Asara, JM (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	jasara@bidmc.harvard.edu	schweitzer, mary h/A-6756-2010; Cantley, Lewis C/D-1800-2014; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; Cantley, Lewis C/0000-0002-1298-7653; 	NIGMS NIH HHS [F32 GM075490] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075490] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asara JM, 2008, SCIENCE, V319, DOI 10.1126/science.1147364; Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P21; Rohland N, 2007, PLOS BIOL, V5, P1663, DOI 10.1371/journal.pbio.0050207; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330	11	39	41	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					499	499		10.1126/science.1154284	http://dx.doi.org/10.1126/science.1154284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436782				2022-12-28	WOS:000255249300041
J	Rosenthal, PJ				Rosenthal, Philip J.			Artesunate for the treatment of severe falciparum malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLUS SULFADOXINE-PYRIMETHAMINE; CONTROL AUDITORY EVALUATION; ARTEMISININ DERIVATIVES; DIHYDROARTEMISININ-PIPERAQUINE; ARTEMETHER-LUMEFANTRINE; INTRAVENOUS QUINIDINE; UNITED-STATES; CHILDREN; COMBINATION; EFFICACY		Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, Box 0811, San Francisco, CA 94143 USA.	prosenthal@medsfgh.ucsf.edu						[Anonymous], 2007, Wkly Epidemiol Rec, V82, P360; [Anonymous], 2007, ASS SAF ART COMP PRE; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BREWER TG, 1994, AM J TROP MED HYG, V51, P251, DOI 10.4269/ajtmh.1994.51.251; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Chen LH, 2007, JAMA-J AM MED ASSOC, V297, P2251, DOI 10.1001/jama.297.20.2251; Clark RL, 2004, BIRTH DEFECTS RES B, V71, P380, DOI 10.1002/bdrb.20027; Day N, 2007, AM J TROP MED HYG, V77, P29; Deen JL, 2001, T ROY SOC TROP MED H, V95, P424, DOI 10.1016/S0035-9203(01)90204-4; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Faiz MA, 2005, LANCET, V366, P717; Flick K, 2004, MOL BIOCHEM PARASIT, V134, P3, DOI 10.1016/j.molbiopara.2003.09.010; Freedman DO, 2006, NEW ENGL J MED, V355, P967; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Hien TT, 2005, ANTIMICROB AGENTS CH, V49, P871, DOI 10.1128/AAC.49.2.871.2005; HIEN TT, 1996, J ENGL J MED, V335, P76; HOFFMAN SL, 2006, TROPICAL INFECT DIS, V2, P1024; Hutagalung R, 2006, AM J TROP MED HYG, V74, P211, DOI 10.4269/ajtmh.2006.74.211; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; JONES KL, 2007, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD005967.PUB2, 10.1002/14651858.CD005967.pub2]; Karema C, 2006, T ROY SOC TROP MED H, V100, P1105, DOI 10.1016/j.trstmh.2006.01.001; Karunajeewa HA, 2007, JAMA-J AM MED ASSOC, V297, P2381, DOI 10.1001/jama.297.21.2381; Kissinger E, 2000, AM J TROP MED HYG, V63, P48, DOI 10.4269/ajtmh.2000.63.48; Ladhani S, 2007, LANCET INFECT DIS, V7, P349, DOI 10.1016/S1473-3099(07)70110-X; Leonardi E, 2001, T ROY SOC TROP MED H, V95, P182, DOI 10.1016/S0035-9203(01)90157-9; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; McGready R, 2001, CLIN INFECT DIS, V33, P2009, DOI 10.1086/324349; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Miller LG, 1997, NEW ENGL J MED, V336, P1328, DOI 10.1056/NEJM199705013361818; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Nontprasert A, 2000, AM J TROP MED HYG, V62, P409, DOI 10.4269/ajtmh.2000.62.409; PHILLIPS RE, 1985, NEW ENGL J MED, V312, P1273, DOI 10.1056/NEJM198505163122001; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; PUKRITTAYAKAMEE S, 1994, T ROY SOC TROP MED H, V88, P324, DOI 10.1016/0035-9203(94)90102-3; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ribeiro I R, 1998, Med Trop (Mars), V58, P50; Rosenthal PJ, 1996, NEW ENGL J MED, V335, P138, DOI 10.1056/NEJM199607113350218; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Thwing Julie, 2007, Morbidity and Mortality Weekly Report, V56, P23; Toovey S, 2004, T ROY SOC TROP MED H, V98, P261, DOI 10.1016/j.trstmh.2003.11.001; Van Vugt M, 2000, AM J TROP MED HYG, V62, P65, DOI 10.4269/ajtmh.2000.62.65; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; White NJ, 2003, AM J RESP CRIT CARE, V167, P673, DOI 10.1164/rccm.2212001; WHITE NJ, 1983, J CARDIOVASC PHARM, V5, P173, DOI 10.1097/00005344-198303000-00001; WHITE NJ, 1981, LANCET, V2, P1069, DOI 10.1016/S0140-6736(81)91275-7; *WHO, 2006, GUID TREAT MAL; Woodrow CJ, 2005, POSTGRAD MED J, V81, P71, DOI 10.1136/pgmj.2004.028399; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985; 2001, T R SOC TROP MED HYG, V95, P637	55	103	108	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 24	2008	358	17					1829	1836		10.1056/NEJMct0709050	http://dx.doi.org/10.1056/NEJMct0709050			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291PL	18434652				2022-12-28	WOS:000255209200009
J	Imai, Y; Kuba, K; Neely, GG; Yaghubian-Malhami, R; Perkmann, T; van Loo, G; Ermolaeva, M; Veldhuizen, R; Leung, YHC; Wang, HL; Liu, HL; Sun, Y; Pasparakis, M; Kopf, M; Mech, C; Bavari, S; Peiris, JSM; Slutsky, AS; Akira, S; Hultqvist, M; Holmdahl, R; Nicholls, J; Jiang, CY; Binder, CJ; Penninger, JM				Imai, Yumiko; Kuba, Keiji; Neely, G. Greg; Yaghubian-Malhami, Rubina; Perkmann, Thomas; van Loo, Geert; Ermolaeva, Maria; Veldhuizen, Ruud; Leung, Y. H. Connie; Wang, Hongliang; Liu, Haolin; Sun, Yang; Pasparakis, Manolis; Kopf, Manfred; Mech, Christin; Bavari, Sina; Peiris, J. S. Malik; Slutsky, Arthur S.; Akira, Shizuo; Hultqvist, Malin; Holmdahl, Rikard; Nicholls, John; Jiang, Chengyu; Binder, Christoph J.; Penninger, Josef M.			Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury	CELL			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LOW-DENSITY-LIPOPROTEIN; 1918 PANDEMIC VIRUS; FACTOR-KAPPA-B; OXIDIZED PHOSPHOLIPIDS; TRANSCRIPTION FACTORS; PULMONARY SURFACTANT; APOLIPOPROTEIN-E; APOPTOTIC CELLS; SYNCYTIAL VIRUS	Multiple lung pathogens such as chemical agents, H5N1 avian flu, or SARS cause high lethality due to acute respiratory distress syndrome. Here we report that Toll-like receptor 4 (TLR4) mutant mice display natural resistance to acid-induced acute lung injury (ALI). We show that TLR4-TRIF-TRAF6 signaling is a key disease pathway that controls the severity of ALI. The oxidized phospholipid (OxPL) OxPAPC was identified to induce lung injury and cytokine production by lung macrophages via TLR4-TRIF. We observed OxPL production in the lungs of humans and animals infected with SARS, Anthrax, or H5N1. Pulmonary challenge with an inactivated H5N1 avian influenza virus rapidly induces ALI and OxPL formation in mice. Loss of TLR4 or TRIF expression protects mice from H5N1-induced ALI. Moreover, deletion of ncf1, which controls ROS production, improves the severity of H5N1-mediated ALI. Our data identify oxidative stress and innate immunity as key lung injury pathways that control the severity of ALI.	[Kuba, Keiji] Tokyo Med & Dent Univ, Med Res Inst, Chiyoda Ku, Tokyo 1010062, Japan; [Perkmann, Thomas; Binder, Christoph J.] Med Univ Vienna, Inst Med & Chem Lab Diagnost, A-1090 Vienna, Austria; [Perkmann, Thomas; Binder, Christoph J.] Austrian Acad Sci, CeMM, Res Ctr Mol Med, A-1090 Vienna, Austria; [van Loo, Geert; Ermolaeva, Maria; Pasparakis, Manolis] European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Ermolaeva, Maria; Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Veldhuizen, Ruud] Univ Western Ontario, Lawson Hlth Res Inst, Dept Med, London, ON N6A 4V2, Canada; [Veldhuizen, Ruud] Univ Western Ontario, Lawson Hlth Res Inst, Dept Physiol & Pharmacol, London, ON N6A 4V2, Canada; [Nicholls, John] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Leung, Y. H. Connie; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Wang, Hongliang; Liu, Haolin; Sun, Yang; Jiang, Chengyu] Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China; [Wang, Hongliang; Liu, Haolin; Sun, Yang; Jiang, Chengyu] Chinese Acad Med Sci, Beijing 100005, Peoples R China; [Kopf, Manfred] Swiss Fed Inst Technol, CH-8952 Zurich, Switzerland; [Mech, Christin; Bavari, Sina] USA, Med Res Inst Infect Dis, Frederick, MD 21701 USA; [Slutsky, Arthur S.] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Slutsky, Arthur S.] Univ Toronto, Dept Crit Care, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Akira, Shizuo] Osaka Univ, Dept Host Def, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Hultqvist, Malin; Holmdahl, Rikard] BMC, Med Inflammat Res, Lund, Sweden; [Hultqvist, Malin; Holmdahl, Rikard] Karolinska Inst, Med Inflammat Res, MBB, Stockholm, Sweden; [Imai, Yumiko; Kuba, Keiji; Neely, G. Greg; Yaghubian-Malhami, Rubina; Penninger, Josef M.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria	Tokyo Medical & Dental University (TMDU); Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; European Molecular Biology Laboratory (EMBL); University of Cologne; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Hong Kong; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Osaka University; Karolinska Institutet; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Imai, Y (corresponding author), Akita Univ, Sch Med, Global COE Program, Akita 0108543, Japan.	imai@med.akita-u.ac.jp; josef.penninger@imba.oeaw.ac.at	Penninger, Josef M/I-6860-2013; Leung, Connie/C-4600-2009; Holmdahl, Rikard/AAI-7682-2020; neely, graham/A-6511-2011; Bavari, Sina/L-3642-2019; Wang, Hongliang/J-1941-2012; Kopf, Manfred/B-6907-2009; Neely, Greg/AAB-4642-2020; van Loo, Geert/C-1505-2009; Pasparakis, Manolis/H-9292-2017; Imai, Yumiko/GXW-1144-2022; Slutsky, Arthur/M-3325-2019; Akira, Shizuo/C-3134-2009; Pasparakis, Manolis/N-4350-2019; , van Loo Geert/AAD-1220-2019; , 孙阳/B-2495-2016; Perkmann, Thomas/F-3074-2012; Veldhuizen, Ruud/G-3352-2011; Nicholls, John Malcolm/C-4375-2009; Peiris, Joseph Sriyal Malik/C-4380-2009	Penninger, Josef M/0000-0002-8194-3777; Bavari, Sina/0000-0001-8424-5635; Wang, Hongliang/0000-0002-3304-2683; Kopf, Manfred/0000-0002-0628-7140; Neely, Greg/0000-0002-1957-9732; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; , van Loo Geert/0000-0002-8427-4775; , 孙阳/0000-0002-1463-689X; Veldhuizen, Ruud/0000-0002-8802-1580; Leung, Connie YH/0000-0003-1102-4684; Binder, Christoph J./0000-0001-8313-7050; Nicholls, John Malcolm/0000-0001-7217-7444; Perkmann, Thomas/0000-0002-7976-0285; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bailey TC, 2004, J APPL PHYSIOL, V96, P1674, DOI 10.1152/japplphysiol.01143.2003; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Capote KR, 2003, J BIOL CHEM, V278, P20461, DOI 10.1074/jbc.M212697200; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Friedman P, 2002, J BIOL CHEM, V277, P7010, DOI 10.1074/jbc.M108860200; Furnkranz A, 2005, ARTERIOSCL THROM VAS, V25, P633, DOI 10.1161/01.ATV.0000153106.03644.a0; Guarner J, 2003, AM J PATHOL, V163, P701, DOI 10.1016/S0002-9440(10)63697-8; Haeberle HA, 2002, J INFECT DIS, V186, P1199, DOI 10.1086/344644; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; JACOBS DM, 1977, J IMMUNOL, V118, P21; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374; Martin TR, 1999, CHEST, V116, p2S, DOI 10.1378/chest.116.suppl_1.2S; McKinney LC, 2003, VIRUS RES, V97, P117, DOI 10.1016/j.virusres.2003.08.007; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; *WHO, 2008, SARS; World Health Organization, 2005, AV INFL ASS PAND THR; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	51	980	1055	7	195	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 18	2008	133	2					235	249		10.1016/j.cell.2008.02.043	http://dx.doi.org/10.1016/j.cell.2008.02.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	289JY	18423196	Bronze, Green Published			2022-12-28	WOS:000255052000014
J	Sandoval, H; Thiagarajan, P; Dasgupta, SK; Schumacher, A; Prchal, JT; Chen, M; Wang, J				Sandoval, Hector; Thiagarajan, Perumal; Dasgupta, Swapan K.; Schumacher, Armin; Prchal, Josef T.; Chen, Min; Wang, Jin			Essential role for Nix in autophagic maturation of erythroid cells	NATURE			English	Article							IN-VITRO; MICE; APOPTOSIS; SURVIVAL; RETICULOCYTES; ERYTHROBLASTS; MITOCHONDRIA; PHOSPHATIDYLSERINE; ERYTHROPOIESIS; INHIBITOR	Erythroid cells undergo enucleation and the removal of organelles during terminal differentiation(1-3). Although autophagy has been suggested to mediate the elimination of organelles for erythroid maturation(2-6), the molecular mechanisms underlying this process remain undefined. Here we report a role for a Bcl- 2 family member, Nix ( also called Bnip3L)(7-9), in the regulation of erythroid maturation through mitochondrial autophagy. Nix(-/-) mice developed anaemia with reduced mature erythrocytes and compensatory expansion of erythroid precursors. Erythrocytes in the peripheral blood of Nix(-/-) mice exhibited mitochondrial retention and reduced lifespan in vivo. Although the clearance of ribosomes proceeded normally in the absence of Nix, the entry of mitochondria into autophagosomes for clearance was defective. Deficiency in Nix inhibited the loss of mitochondrial membrane potential (Delta Psi(m)), and treatment with uncoupling chemicals or a BH3 mimetic induced the loss of Delta Psi(m) and restored the sequestration of mitochondria into autophagosomes in Nix(-/-) erythroid cells. These results suggest that Nix- dependent loss of Delta Psi(m) is important for targeting the mitochondria into autophagosomes for clearance during erythroid maturation, and interference with this function impairs erythroid maturation and results in anaemia. Our study may also provide insights into molecular mechanisms underlying mitochondrial quality control involving mitochondrial autophagy.	[Sandoval, Hector; Chen, Min; Wang, Jin] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA; [Thiagarajan, Perumal; Dasgupta, Swapan K.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Schumacher, Armin] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Prchal, Josef T.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84132 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah	Chen, M (corresponding author), Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA.	minc@bcm.tmc.edu; jinwang@bcm.tmc.edu		Wang, Jin/0000-0002-3116-0838; Wang, Jin/0000-0002-7882-1699; Sandoval, Hector/0000-0002-9186-7384; Chen, Min/0000-0002-0093-9056; Thiagarajan, Perumal/0000-0003-2186-7036	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074949, F31AI058932, R01AI056210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087710] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI074949-01, R01 AI056210-05, R01 AI056210, R01 AI074949, F31 AI058932] Funding Source: Medline; NIGMS NIH HHS [R01 GM087710] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; HEYNEN MJ, 1982, CELL TISSUE RES, V224, P397, DOI 10.1007/BF00216882; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Imazu T, 1999, ONCOGENE, V18, P4523, DOI 10.1038/sj.onc.1202722; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KENT G, 1966, AM J PATHOL, V48, P831; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mok H, 2004, DEVELOPMENT, V131, P4871, DOI 10.1242/dev.01342; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398; Sivilotti Marco L A, 2004, Toxicol Rev, V23, P169; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takano-Ohmuro H, 2000, EUR J CELL BIOL, V79, P759, DOI 10.1078/0171-9335-00096; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Vannucchi AM, 2001, BLOOD, V97, P3040, DOI 10.1182/blood.V97.10.3040; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	32	829	868	3	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 10	2008	454	7201					232	U66		10.1038/nature07006	http://dx.doi.org/10.1038/nature07006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	323RU	18454133	Green Accepted			2022-12-28	WOS:000257466900047
J	Brodersen, P; Sakvarelidze-Achard, L; Bruun-Rasmussen, M; Dunoyer, P; Yamamoto, YY; Sieburth, L; Voinnet, O				Brodersen, Peter; Sakvarelidze-Achard, Lali; Bruun-Rasmussen, Marianne; Dunoyer, Patrice; Yamamoto, Yoshiharu Y.; Sieburth, Leslie; Voinnet, Olivier			Widespread translational inhibition by plant miRNAs and siRNAs	SCIENCE			English	Article							ARABIDOPSIS-THALIANA; SILENCING PATHWAYS; DECAPPING COMPLEX; SMALL RNAS; MICRORNAS; GENE; ARGONAUTE1; STRESS; SPECIALIZATION; IDENTIFICATION	High complementarity between plant microRNAs ( miRNAs) and their messenger RNA targets is thought to cause silencing, prevalently by endonucleolytic cleavage. We have isolated Arabidopsis mutants defective in miRNA action. Their analysis provides evidence that plant miRNA- guided silencing has a widespread translational inhibitory component that is genetically separable from endonucleolytic cleavage. We further show that the same is true of silencing mediated by small interfering RNA ( siRNA) populations. Translational repression is effected in part by the ARGONAUTE proteins AGO1 and AGO10. It also requires the activity of the microtubule- severing enzyme katanin, implicating cytoskeleton dynamics in miRNA action, as recently suggested from animal studies. Also as in animals, the decapping component VARICOSE ( VCS)/ Ge- 1 is required for translational repression by miRNAs, which suggests that the underlying mechanisms in the two kingdoms are related.	[Brodersen, Peter; Sakvarelidze-Achard, Lali; Bruun-Rasmussen, Marianne; Dunoyer, Patrice; Voinnet, Olivier] CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, F-67084 Strasbourg, France; [Yamamoto, Yoshiharu Y.] Nagoya Univ, Ctr Gene Res, Chikusa Ku, Aichi 4648602, Japan; [Sieburth, Leslie] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Nagoya University; Utah System of Higher Education; University of Utah	Voinnet, O (corresponding author), CNRS, Inst Biol Mol Plantes, Unite Propre Rech 2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr	Yamamoto, Yoshiharu Y./B-6574-2011	Yamamoto, Yoshiharu Y./0000-0002-9667-0572; Voinnet, Olivier/0000-0001-6982-9544				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bouquin T, 2003, J CELL SCI, V116, P791, DOI 10.1242/jcs.00274; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jones J, 2006, PROF ENG, V19, P19; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lo C, 2005, FEBS LETT, V579, P1498, DOI 10.1016/j.febslet.2005.01.062; Lynn K, 1999, DEVELOPMENT, V126, P469; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Parry DH, 2007, CURR BIOL, V17, P2013, DOI 10.1016/j.cub.2007.10.058; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Rodriguez AJ, 2005, RNA, V11, P646, DOI 10.1261/rna.7198205; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Wang HP, 2008, MOL BIOL CELL, V19, P105, DOI 10.1091/mbc.E07-06-0583; Wang JF, 2004, NUCLEIC ACIDS RES, V32, P1688, DOI 10.1093/nar/gkh332; Webb M, 2002, DEVELOPMENT, V129, P123; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383	44	1063	1148	7	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 30	2008	320	5880					1185	1190		10.1126/science.1159151	http://dx.doi.org/10.1126/science.1159151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306FF	18483398				2022-12-28	WOS:000256233000030
J	Chien, KR				Chien, Kenneth R.			Regenerative medicine and human models of human disease	NATURE			English	Editorial Material							SMOOTH-MUSCLE; CARDIOVASCULAR PROGENITORS; HEART; CELL; DIFFERENTIATION; CARDIOMYOCYTE		Massachusetts Gen Hosp, Cardiovasc Res Ctr, Simches Res Ctr, Boston, MA 02114 USA; Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Simches Res Ctr, 185 Cambridge St, Boston, MA 02114 USA.	kchien@partners.org						Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kaye DM, 2008, ANNU REV MED, V59, P13, DOI 10.1146/annurev.med.59.052407.103237; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Mather PJ, 2007, HEART FAIL REV, V12, P167, DOI 10.1007/s10741-007-9018-1; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Slepian MJ, 2008, NAT CLIN PRACT CARD, V5, P64, DOI 10.1038/ncpcardio1085; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	16	66	69	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2008	453	7193					302	305		10.1038/nature07037	http://dx.doi.org/10.1038/nature07037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	301AI	18480810				2022-12-28	WOS:000255868400036
J	Zethelius, B; Berglund, L; Sundstrom, J; Ingelsson, E; Basu, S; Larsson, A; Venge, P; Arnlov, J				Zethelius, Bjorn; Berglund, Lars; Sundstrom, Johan; Ingelsson, Erik; Basu, Samar; Larsson, Anders; Venge, Per; Arnlov, Johan			Use of multiple biomarkers to improve the prediction of death from cardiovascular causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; BRAIN NATRIURETIC PEPTIDE; SERUM CYSTATIN-C; RISK PREDICTION; MEDIATED INFLAMMATION; MYOCARDIAL-INFARCTION; GENERAL-POPULATION; INSULIN-RESISTANCE; SURVIVAL ANALYSIS; 70-YEAR-OLD MEN	Background: The incremental usefulness of adding multiple biomarkers from different disease pathways for predicting the risk of death from cardiovascular causes has not, to our knowledge, been evaluated among the elderly. Methods: We used data from the Uppsala Longitudinal Study of Adult Men (ULSAM), a community-based cohort of elderly men, to investigate whether a combination of biomarkers that reflect myocardial cell damage, left ventricular dysfunction, renal failure, and inflammation (troponin I, N-terminal pro-brain natriuretic peptide, cystatin C, and C-reactive protein, respectively) improved the risk stratification of a person beyond an assessment that was based on the established risk factors for cardiovascular disease (age, systolic blood pressure, use or nonuse of antihypertensive treatment, total cholesterol, high-density lipoprotein cholesterol, use or nonuse of lipid-lowering treatment, presence or absence of diabetes, smoking status, and body-mass index). Results: During follow-up (median, 10.0 years), 315 of the 1135 participants in our study (mean age, 71 years at baseline) died; 136 deaths were the result of cardiovascular disease. In Cox proportional-hazards models adjusted for established risk factors, all of the biomarkers significantly predicted the risk of death from cardiovascular causes. The C statistic increased significantly when the four biomarkers were incorporated into a model with established risk factors, both in the whole cohort (C statistic with biomarkers vs. without biomarkers, 0.766 vs. 0.664; P<0.001) and in the group of 661 participants who did not have cardiovascular disease at baseline (0.748 vs. 0.688, P=0.03). The improvement in risk assessment remained strong when it was estimated by other statistical measures of model discrimination, calibration, and global fit. Conclusions: Our data suggest that in elderly men with or without prevalent cardiovascular disease, the simultaneous addition of several biomarkers of cardiovascular and renal abnormalities substantially improves the risk stratification for death from cardiovascular causes beyond that of a model that is based only on established risk factors.	[Zethelius, Bjorn; Berglund, Lars; Ingelsson, Erik; Basu, Samar; Arnlov, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, SE-75185 Uppsala, Sweden; [Berglund, Lars] Uppsala Univ, Uppsala Clin Res Ctr, SE-75185 Uppsala, Sweden; [Sundstrom, Johan; Larsson, Anders; Venge, Per] Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Arnlov, J (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	johan.arnlov@pubcare.uu.se	Sundstrom, Johan/R-2139-2019; Berglund, Lars/AAD-3856-2019; Berglund, Lars/AAA-3188-2019; Ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Berglund, Lars/0000-0002-7437-9047; Ärnlöv, Johan/0000-0002-6933-4637; Sundström, Johan/0000-0003-2247-8454				Antolini L, 2004, COMMUN STAT-THEOR M, V33, P2117, DOI 10.1081/STA-200026579; Barbier CE, 2006, J AM COLL CARDIOL, V48, P765, DOI 10.1016/j.jacc.2006.05.041; Byberg L, 2000, DIABETOLOGIA, V43, P54, DOI 10.1007/s001250050007; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Emberson JR, 2007, J AM COLL CARDIOL, V49, P311; Groenning BA, 2004, HEART, V90, P297, DOI 10.1136/hrt.2003.026021; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Helmersson J, 2004, CIRCULATION, V109, P1729, DOI 10.1161/01.CIR.0000124718.99562.91; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Kannel William B., 1995, Am J Geriatr Cardiol, V4, P10; Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x; Larsson A, 2005, SCAND J CLIN LAB INV, V65, P301, DOI 10.1080/00365510510013839; Lucia P, 2001, INT J CARDIOL, V77, P215, DOI 10.1016/S0167-5273(00)00429-0; Moller CS, 2006, J INTERN MED, V260, P22, DOI 10.1111/j.1365-2796.2006.01642.x; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P1433; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wasen E, 2004, J INTERN MED, V256, P70, DOI 10.1111/j.1365-2796.2004.01340.x; Wohlin M, 2007, CYTOKINE, V38, P130, DOI 10.1016/j.cyto.2007.05.014; Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433	31	691	895	4	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 15	2008	358	20					2107	2116		10.1056/NEJMoa0707064	http://dx.doi.org/10.1056/NEJMoa0707064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300TY	18480203				2022-12-28	WOS:000255849300004
J	Brunnschweiler, CN; Bulte, EH				Brunnschweiler, C. N.; Bulte, E. H.			Economics - Linking natural resources to slow growth and more conflict	SCIENCE			English	Editorial Material							CIVIL-WAR		[Brunnschweiler, C. N.] Swiss Fed Inst Technol, Ctr Econ Res, Zurich, Switzerland; [Bulte, E. H.] Univ Wageningen & Res Ctr, Dev Econ Grp, NL-6700 HB Wageningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wageningen University & Research	Brunnschweiler, CN (corresponding author), Swiss Fed Inst Technol, Ctr Econ Res, Zurich, Switzerland.	cbrunnschweiler@ethz.ch		Bulte, Erwin/0000-0001-9491-5268; Brunnschweiler Valente, Christa/0000-0002-8610-6433				Collier P, 2004, OXFORD ECON PAP, V56, P563, DOI 10.1093/oep/gpf064; Czelusta Jesse, 2004, CHALLENGE, V47, P6, DOI DOI 10.1080/05775132.2004.11034243; GREENE WH, 2003, ECONOMETRIC ANAL, pCH9; Ross ML, 2004, J PEACE RES, V41, P337, DOI 10.1177/0022343304043773; Ross ML, 2001, WORLD POLIT, V53, P325, DOI 10.1353/wp.2001.0011; Rosser A., 2006, WORKING PAPER SERIES, V268; Sachs JD., 1997, NATURAL RESOURCE ABU; Sala-i-Martin X., 2003, ADDRESSING NATURAL R; *WORLD BANK, 1997, 17046 WORLD BANK; 2005, J CONFL RES      AUG, P49	10	71	74	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					616	617		10.1126/science.1154539	http://dx.doi.org/10.1126/science.1154539			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	295DD	18451286				2022-12-28	WOS:000255454300027
J	Vanhollebeke, B; De Muylder, G; Nielsen, MJ; Pays, A; Tebabi, P; Dieu, M; Raes, M; Moestrup, SK; Pays, E				Vanhollebeke, Benoit; De Muylder, Geraldine; Nielsen, Marianne J.; Pays, Annette; Tebabi, Patricia; Dieu, Marc; Raes, Martine; Moestrup, Soren K.; Pays, Etienne			A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HUMAN SERUM; LYTIC FACTOR; APOLIPOPROTEIN L-1; PROTEIN; IDENTIFICATION; ENDOCYTOSIS; BINDING	The protozoan parasite Trypanosoma brucei is lysed by apolipoprotein L-I, a component of human high- density lipoprotein ( HDL) particles that are also characterized by the presence of haptoglobin- related protein. We report that this process is mediated by a parasite glycoprotein receptor, which binds the haptoglobin- hemoglobin complex with high affinity for the uptake and incorporation of heme into intracellular hemoproteins. In mice, this receptor was required for optimal parasite growth and the resistance of parasites to the oxidative burst by host macrophages. In humans, the trypanosome receptor also recognized the complex between hemoglobin and haptoglobin- related protein, which explains its ability to capture trypanolytic HDLs. Thus, in humans the presence of haptoglobin- related protein has diverted the function of the trypanosome haptoglobin- hemoglobin receptor to elicit innate host immunity against the parasite.	[Vanhollebeke, Benoit; De Muylder, Geraldine; Pays, Annette; Tebabi, Patricia; Pays, Etienne] Univ Libre Bruxelles, Inst Mol Biol & Med, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Nielsen, Marianne J.; Moestrup, Soren K.] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus, Denmark; [Dieu, Marc; Raes, Martine] Univ Namur, Unit Cellular Biochem & Biol, B-5000 Namur, Belgium	Universite Libre de Bruxelles; Aarhus University; University of Namur	Pays, E (corresponding author), Univ Libre Bruxelles, Inst Mol Biol & Med, Mol Parasitol Lab, 12 Rue Profs Jeener & Brachet, B-6041 Gosselies, Belgium.	epays@ulb.ac.be	Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019	Moestrup, Søren Kragh/0000-0003-3862-2107; Vanhollebeke, Benoit/0000-0002-0353-365X; Dieu, Marc/0000-0002-3902-542X	Lundbeck Foundation [R7-2006-752] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden)		BERGER BJ, 1993, BIOCHEM PHARMACOL, V46, P149, DOI 10.1016/0006-2952(93)90359-5; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bridges DJ, 2008, PROTEOMICS, V8, P83, DOI 10.1002/pmic.200700607; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; Koda Y, 1998, AM J HUM GENET, V62, P245, DOI 10.1086/301701; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lepesheva GI, 2007, CHEM BIOL, V14, P1283, DOI 10.1016/j.chembiol.2007.10.011; Lugli EB, 2004, MOL BIOCHEM PARASIT, V138, P9, DOI 10.1016/j.molbiopara.2004.07.004; MAEDA N, 1985, J BIOL CHEM, V260, P6698; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Pays E, 2006, NAT REV MICROBIOL, V4, P477, DOI 10.1038/nrmicro1428; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Raper J, 1999, INFECT IMMUN, V67, P1910; Raper J, 1996, J EXP MED, V183, P1023, DOI 10.1084/jem.183.3.1023; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; Steverding D, 2006, MICROBES INFECT, V8, P2777, DOI 10.1016/j.micinf.2006.08.007; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2007, J EUKARYOT MICROBIOL, V54, P448, DOI 10.1111/j.1550-7408.2007.00285.x; Vanhollebeke B, 2007, P NATL ACAD SCI USA, V104, P4118, DOI 10.1073/pnas.0609902104; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	26	187	189	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 2	2008	320	5876					677	681		10.1126/science.1156296	http://dx.doi.org/10.1126/science.1156296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	295DD	18451305				2022-12-28	WOS:000255454300050
J	Moore, A				Moore, Andrew			Science teaching must evolve	NATURE			English	Editorial Material									European Mol Biol Org, Sci & Soc Programme, D-69117 Heidelberg, Germany		Moore, A (corresponding author), European Mol Biol Org, Sci & Soc Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.							BRYSON V, 1965, EVOLVING GENES PROTE; FALKA H, 2007, INT J SCI ED; Miller JD, 2006, SCIENCE, V313, P765, DOI 10.1126/science.1126746; Williams J, 2008, EVOLUTION ED OUTREAC, V1, P87, DOI DOI 10.1007/S12052-007-0006-7; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	5	7	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 1	2008	453	7191					31	32		10.1038/453031a	http://dx.doi.org/10.1038/453031a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294ID	18451837				2022-12-28	WOS:000255398800023
J	Nordin, P; van der Linden, W				Nordin, Par; van der Linden, Willem			Volume of procedures and risk of recurrence after repair of groin hernia: national register study	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; HOSPITAL VOLUME; FOLLOW-UP; MORTALITY; QUALITY; SURGEON; METAANALYSIS; CANCER; IMPACT	Objective To determine whether the association between volume and outcome found in major surgery also holds true for a minor operation. Design Review of outcomes after hernia surgery in Sweden. Setting Surgical units registered with the Swedish hernia register, which in 2004 covered about 95% of all hernia operations in Sweden. Participants 86 409 patients over 15 years, who underwent 96 601 unilateral or bilateral groin hernia repairs (94 077 inguinal and 2524 femoral) in 1996-2004 at the participating surgical units. Main outcome measure Re-operation for recurrence. Results There was a significantly higher rate of re-operation in surgeons who carried out 1-5 repairs a year than in surgeons who carried out more repairs. There was no association between outcome and further increases in volume. Although about half of surgeons in Sweden who repair hernias are low volume operators, they performed only 8.4% of all repairs. Conclusions Sweden's numerous low volume hernia surgeons perform such a small proportion of all operations that the impact of their inferior results on the nationwide re-operation rate is minimal. Volume indicates an approximate minimum value for the number of hernia repairs a surgeon should do each year but the outcome in surgeons who carry out more than that number disqualifies volume as an indicator of proficiency.	[Nordin, Par; van der Linden, Willem] Ostersund Hosp, Dept Surg, S-83183 Ostersund, Sweden		Nordin, P (corresponding author), Ostersund Hosp, Dept Surg, S-83183 Ostersund, Sweden.	par.nordin@jll.se	Nordin, Pär/Y-6278-2019	Nordin, Par/0000-0001-6117-5777				Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bittner R, 2005, SURG ENDOSC, V19, P605, DOI 10.1007/s00464-004-9049-9; Carter D, 2003, BRIT MED J, V326, P832, DOI 10.1136/bmj.326.7394.832; COX DR, 1972, J R STAT SOC B, V34, P187; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Dimick JB, 2005, WORLD J SURG, V29, P1217, DOI 10.1007/s00268-005-7989-4; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Haapaniemi S, 2002, EUR J SURG, V168, P22, DOI 10.1080/110241502317307535; HAAPANIEMI S, 2001, THESIS LINKOPING U L; Haapaniemi S, 2007, RECURRENT HERNIA PRE, P3; Holt PJE, 2007, EUR J VASC ENDOVASC, V34, P646, DOI 10.1016/j.ejvs.2007.07.021; Kald A, 1998, EUR J SURG, V164, P45; Khuri SF, 2005, WORLD J SURG, V29, P1222, DOI 10.1007/s00268-005-7987-6; Lunde A S, 1980, Vital Health Stat 2, P1; Martling A, 2002, BRIT J SURG, V89, P1008, DOI 10.1046/j.1365-2168.2002.02151.x; Nilsson E., 2000, HERNIA, V4, P286, DOI [10.1007/BF01201085, DOI 10.1007/BF01201085]; Nilsson E, 2002, HERNIA, P567; O'Neill L, 2000, NEUROLOGY, V55, P773, DOI 10.1212/WNL.55.6.773; Schmedt CG, 2005, SURG ENDOSC, V19, P188, DOI 10.1007/s00464-004-9126-0; Sheldon TA, 2004, QUAL SAF HEALTH CARE, V13, P325, DOI 10.1136/qshc.2004.012161; VANDERHOFF JW, 1983, SCI TECHNOLOGY POLYM, V1, P1	22	57	57	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 26	2008	336	7650					934	937		10.1136/bmj.39525.514572.25	http://dx.doi.org/10.1136/bmj.39525.514572.25			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296KC	18426843	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000255540900031
J	Benfey, PN; Mitchell-Olds, T				Benfey, Philip N.; Mitchell-Olds, Thomas			Perspective - From genotype to phenotype: Systems biology meets natural variation	SCIENCE			English	Editorial Material							GENETIC-VARIATION; NETWORK; EVOLUTIONARY; PROTEIN; EPISTASIS; DISEASE; TRAITS	The promise that came with genome sequencing was that we would soon know what genes do, particularly genes involved in human diseases and those of importance to agriculture. We now have the full genomic sequence of human, chimpanzee, mouse, chicken, dog, worm, fly, rice, and cress, as well as those for a wide variety of other species, and yet we still have a lot of trouble figuring out what genes do. Mapping genes to their function is called the "genotype-to-phenotype problem," where phenotype is whatever is changed in the organism when a gene's function is altered.	[Benfey, Philip N.; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Benfey, Philip N.] Duke Univ, Inst Genome Sci & Policy, Ctr Syst Biol, Durham, NC 27708 USA	Duke University; Duke University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Mitchell-Olds, Thomas/K-8121-2012	Mitchell-Olds, Thomas/0000-0003-3439-9921	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081883] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM081883-010003, P50 GM081883-01, P50 GM081883-02, P50 GM081883-020003, P50 GM081883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Jonsson H, 2005, BIOINFORMATICS, V21, pI232, DOI 10.1093/bioinformatics/bti1036; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Kusterer B, 2007, GENETICS, V177, P1839, DOI 10.1534/genetics.107.077628; Makino T, 2006, MOL BIOL EVOL, V23, P784, DOI 10.1093/molbev/msj090; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; SLONIM N, 2006, MOL SYST BIOL, V2; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155	19	136	143	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 25	2008	320	5875					495	497		10.1126/science.1153716	http://dx.doi.org/10.1126/science.1153716			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292EM	18436781	Green Accepted			2022-12-28	WOS:000255249300040
